Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Cell type enhanced"	"Detected in all"	9	"Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.8	10.1	9.3	9.0	8.9	9.9	29.9	13.7	10.9	8.3	7.4	10.2	6.7	0.6	3.4	17.9	11.4	7.9	7.1	7.1	17.0	12.5	3.0	9.1	6.1	6.9	8.1	6.4	21.7	8.5	6.3	15.6	20.3	6.8	17.6	8.6	1.9	9.5	14.4	2.8	5.9	3.4	4.4	3.1	5.6	3.9	10.0	1.4	6.6	35.3	3.1	4.9	7.9	6.1	7.1	6.4	3.6	9.1	17.5	18.7	12.5	13.4	13.5	9.3	2.4	1.0	15.6	10.9	12.7	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9	32.8	38.8	3.0	17.4	14.2	235.7	71.2	99.3	10.7	23.9	136.1	732.4	65.1	36.5	37.7	19.2	43.8	67.4	23.3	57.5	45.9	24.0	51.4	20.7	30.1	51.9	289.2	69.3	93.9	98.0	23.3	35.4	45.1	10.1	50.5	26.9	42.5	48.8	26.4	43.9	53.7	621.3	19.4	29.2	45.9	51.3	8.7	178.4	135.1	14.6	50.6
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81117295-81166077	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;intestine: 28.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	6	"CACO-2: 30.3;SH-SY5Y: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	2.8	4.7	14.3	3.2	16.6	3.7	0.9	19.0	29.0	1.2	3.3	16.5	0.0	28.7	1.0	1.1	1.7	1.2	2.7	2.3	23.6	13.9	1.2	1.2	9.7	1.5	20.1	13.6	1.0	17.9	3.6	6.4	2.6	11.0	2.4	1.1	4.1	5.6	3.6	1.1	1.9	20.3	1.3	35.3	5.9	4.5	1.3	9.8	0.0	1.3	0.0	1.0	1.3	1.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	1.2	1.4	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.1	0.5	0.3	0.1	1.3	2.5	0.2	0.0	0.0	2.9	10.4	0.2	0.0	1.5	0.1	0.3	0.8	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	14.3	16.6	19.0	22.3	23.6	13.9	20.1	13.6	11.0	9.8	29.8	23.6	0.0	0.8	0.2	43.5	2.2	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.1	6.9	0.0	1.6	0.1	0.4	1.0	5.8	0.0	2.0	20.6	1.7	0.6	4.1	0.0	1.4	0.6	5.0	0.0	4.5	8.3	1.3	4.5	2.5	0.8	4.1	0.0	0.8	0.5	0.2	0.3	1.9	0.7	7.2	0.1
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.3	5.0	6.5	25.4	26.5	7.0	15.4	25.6	12.4	13.2	3.4	4.8	0.0	7.1	16.6	12.0	6.0	3.6	8.3	13.3	14.7	3.1	8.7	2.5	4.9	20.1	0.6	10.4	33.2	15.8	25.3	32.3	16.2	13.4	2.4	3.2	2.4	15.5	3.8	0.1	0.2	7.5	3.0	7.8	1.4	6.7	1.8	16.0	8.1	4.4	5.5	5.9	3.4	21.1	8.2	1.8	2.3	19.3	18.8	6.2	9.2	5.8	1.6	1.2	0.1	19.3	0.5	20.2	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9	8.9	7.0	0.8	6.8	8.8	7.5	9.2	12.7	6.7	9.1	7.0	0.0	7.0	5.0	8.4	0.5	13.5	3.1	0.0	15.5	4.4	11.6	8.9	4.7	12.1	6.5	3.2	4.1	17.2	11.6	1.1	18.7	7.7	3.3	3.6	5.2	6.1	14.7	3.5	14.9	15.3	1.5	12.9	15.5	0.5	2.5	6.6	8.8	1.0	3.5	7.6
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	11.1	7.4	12.0	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28.0	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21.0	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10.0	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4.0	0.1	1.6	0.6	6.4	14.1	11.0	6.0	12.6	9.9	6.2	7.3	8.3	7.8	5.9	28.4	10.0	2.8	10.2	7.9	8.6	11.4	10.4	8.8	8.1	4.1	12.3	6.9	3.5	8.8	14.4	11.2	26.0	19.3	11.5	8.8	11.1	8.3	10.9	10.3	7.4	8.8	6.9	13.1	10.6	9.7	10.6	13.6	4.9	5.7	8.5	3.6	21.9	9.8	14.0	11.6	7.8	11.2	5.1	8.1	12.4	7.3	6.9	5.4	8.2	6.0	3.5	5.4	3.7	3.9	5.8	5.4	6.9	4.5	2.2	6.8	0.7	3.3	1.0	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4.0	0.7	1.0	0.6	12.0	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8	3.0	12.0	3.4	9.2	16.6	41.6	5.4	22.9	13.4	14.8	24.4	27.5	0.5	3.3	12.7	2.3	9.8	23.9	0.0	12.5	0.6	5.7	12.2	10.5	19.5	3.7	35.0	23.6	14.7	16.7	6.3	9.2	7.7	6.8	2.8	32.6	10.6	12.7	24.6	8.9	16.5	23.8	6.5	15.9	3.9	16.5	22.1	0.5	2.5	22.6	11.2
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.2;breast: 15.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 11.4;Leydig cells: 29.4;Paneth cells: 10.4;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Group enriched"	"Detected in some"	4	"ASC diff: 15.4;HDLM-2: 6.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6"	"HPA007982, HPA011933"	Approved				"Intracellular and membrane"	NA	NA					"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0.0	5.5	0.7	1.0	0.8	0.8	1.8	1.0	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12.0	0.7	3.5	0.9	4.4	0.0	1.5	1.0	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4.0	0.0	0.9	0.5	1.0	0.6	2.9	0.6	0.0	0.0	0.0	0.0	2.8	0.4	2.0	0.0	0.0	0.2	15.4	0.5	0.3	0.4	0.4	0.1	0.5	2.3	0.2	0.0	0.2	1.2	1.0	0.0	0.1	0.0	0.3	6.8	1.0	0.0	0.0	0.5	0.0	0.0	1.2	0.2	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.3	0.0	0.0	1.4	0.1	0.7	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.2	0.8	2.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	1.0	0.6	1.8	1.2	0.0	0.5	2.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4.0	0.0	0.6	0.0	0.9	0.6	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	1.1	1.0	11.4	0.0	0.2	0.3	1.2	0.8	0.0	4.7	0.1	0.0	7.5	0.0	0.0	0.4	29.4	0.0	3.3	7.2	8.4	1.0	0.4	10.4	8.5	0.7	0.0	0.0	1.0	0.0	2.0	1.3	0.2	0.0	12.1	0.4
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 21.0;RH-30: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	12.0	6.0	13.6	8.2	9.9	3.8	10.7	14.5	14.2	10.2	14.1	4.7	9.7	10.4	9.3	9.9	13.6	7.6	17.7	5.6	10.0	9.0	9.0	10.3	7.5	4.7	5.9	10.6	7.6	9.8	8.6	15.9	10.6	7.3	12.2	9.1	7.6	12.2	12.0	19.6	29.5	17.8	13.8	5.4	6.5	9.3	11.0	6.4	1.5	9.5	6.9	6.8	13.5	11.8	0.7	3.0	0.5	3.6	7.7	4.6	1.4	1.3	1.6	10.0	3.7	5.9	3.8	4.1	3.1	3.7	5.3	9.3	4.3	6.0	0.0	2.8	4.9	1.9	4.7	9.1	4.5	6.8	1.0	5.5	0.6	2.8	7.4	21.0	0.6	0.7	6.3	5.7	3.4	6.8	4.1	4.0	1.2	1.4	2.6	3.6	3.5	0.3	0.5	11.3	4.0	2.6	0.1	17.5	0.9	4.2	8.5	9.9	5.6	2.6	3.1	3.8	4.5	1.9	1.0	3.1	4.9	5.8	4.6	2.1	0.7	0.2	1.8	3.0	0.3	3.9	0.4	3.0	0.5	1.2	3.6	0.5	0.3	4.6	2.1	2.3	0.7	3.0	0.7	0.1	7.7	3.1	3.0	0.4	1.4	13.6	9.9	14.5	14.2	10.0	9.0	5.9	10.6	7.3	6.4	6.0	6.5	0.5	6.7	26.4	15.8	7.8	10.2	8.1	11.4	7.0	13.7	3.9	1.7	5.0	4.1	9.8	13.2	0.0	5.6	2.1	13.5	6.7	0.0	8.6	4.7	11.1	8.6	12.9	9.4	0.8	9.2	7.6	10.1	8.2	13.8	3.7	6.3	8.6	10.6	5.0	8.5	32.3	14.4	13.8	12.8	26.1	4.5	5.1	8.5	7.1
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Cytosol	"Nucleoplasm, Nuclear bodies"	"CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.4	1.4	0.6	0.4	8.8	0.3	0.5	0.3	0.7	2.3	1.1	0.1	1.2	0.3	0.5	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.5	3.5	0.8	2.9	1.6	0.7	0.9	0.5	1.8	1.0	1.1	6.2	6.9	1.4	0.3	1.3	5.1	1.9	20.3	0.8	0.7	1.7	5.5	1.0	1.0	1.9	3.8	6.7	0.4	2.5	2.2	12.2	1.3	3.9	0.9	0.5	2.7	0.4	1.4	3.9	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1	6.0	6.7	0.5	3.6	3.5	20.7	11.6	5.1	6.7	4.5	0.0	21.6	6.7	0.0	3.2	9.1	6.1	2.9	0.0	3.3	5.8	3.1	3.2	1.1	7.5	2.2	20.6	6.9	4.9	2.1	12.6	10.9	3.2	6.8	0.0	3.2	9.6	3.8	2.5	7.4	2.8	25.5	0.0	5.6	8.1	19.0	3.4	5.1	2.5	4.7	3.3
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.0"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 53.3;Enterocytes: 82.1;Ito cells: 40.5;Paneth cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 3.6;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 5.0;monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.5;ASC TERT1: 12.6;EFO-21: 16.4;HUVEC TERT2: 59.9;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	NA	NA					"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	25.5	5.1	3.2	9.3	4.3	0.2	15.6	1.6	3.6	15.1	20.1	3.7	13.1	4.9	12.7	11.0	12.1	13.9	11.0	15.4	3.7	3.2	13.6	3.4	55.0	19.1	4.9	3.6	5.9	6.1	21.6	2.7	44.1	5.3	12.3	14.7	12.3	6.9	10.6	14.2	8.0	11.1	8.2	3.7	14.8	8.1	3.5	3.6	1.7	12.9	6.8	5.4	9.3	11.2	0.1	5.0	0.3	3.6	0.0	0.1	0.7	0.0	0.2	0.1	0.0	18.5	12.6	0.0	0.8	1.6	0.0	0.0	0.1	0.1	0.0	16.4	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	2.7	0.0	0.4	5.2	0.0	0.1	0.0	0.0	59.9	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	46.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.7	3.2	4.3	1.6	3.6	3.7	3.2	4.9	3.6	5.3	3.6	3.0	12.2	0.0	0.2	4.6	0.0	3.9	0.0	4.0	2.3	0.0	0.0	0.5	0.0	2.5	0.0	53.3	82.1	0.0	1.2	36.2	20.2	0.5	0.0	0.0	10.2	0.0	5.2	40.5	25.4	0.7	10.9	5.6	5.0	15.4	26.0	2.3	0.0	50.9	3.2	0.0	0.2	38.8	15.3	0.1	0.7	4.6	2.2	0.0	26.4	0.4
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 32.2;Karpas-707: 45.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.1	4.7	5.4	7.7	6.4	5.7	3.7	15.8	32.2	8.2	10.4	2.5	10.6	10.5	2.9	12.2	4.0	2.6	4.6	5.2	16.7	6.8	3.0	4.4	5.2	6.9	4.2	7.6	3.0	4.0	9.1	6.0	2.7	7.4	7.7	4.7	3.9	45.6	3.3	5.8	6.1	4.8	2.1	4.2	4.9	1.9	2.2	1.6	8.7	5.3	3.0	6.9	4.7	4.1	12.5	4.3	9.3	15.7	2.4	5.7	5.1	2.7	6.1	8.8	6.7	5.6	9.2	8.7	6.4	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0	11.9	9.1	12.3	14.9	21.3	3.3	5.7	17.8	5.3	11.4	14.0	2.0	21.6	5.0	21.9	11.4	11.1	9.1	0.0	27.5	25.3	15.5	15.7	13.9	15.1	21.7	6.4	5.2	6.2	9.1	6.8	10.3	22.8	37.1	25.2	16.6	17.6	20.6	5.8	9.2	16.3	3.7	0.0	12.4	34.8	31.5	23.8	19.0	22.3	13.4	15.2
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Cell line enhanced"	"Detected in all"		"MCF7: 115.3"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.4	30.8	25.5	37.9	19.7	20.5	28.5	28.4	34.6	42.0	33.7	20.2	18.7	18.7	21.9	38.9	21.4	20.1	18.0	26.4	18.3	42.6	7.3	14.1	18.4	21.7	21.9	23.0	36.9	29.3	22.3	21.0	14.0	20.2	31.4	18.4	12.3	20.8	26.9	115.3	28.9	29.4	6.6	30.3	22.1	27.3	23.6	12.7	19.4	38.4	29.3	24.3	23.7	31.0	17.8	11.9	40.6	34.3	25.0	28.2	13.5	40.1	28.5	22.6	10.9	16.1	23.8	19.5	33.9	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8	14.9	24.3	13.4	13.8	11.0	24.3	13.8	40.8	5.3	11.4	21.0	11.8	15.1	11.6	21.0	1.2	19.6	22.2	0.0	30.3	25.7	18.8	34.2	2.3	38.4	20.2	39.7	28.8	24.5	23.7	3.1	26.4	18.1	10.1	17.2	36.1	35.8	43.4	17.3	29.0	13.9	24.0	25.8	11.8	0.9	5.1	12.2	19.6	18.1	26.9	30.8
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.8	56.3	21.5	22.1	26.8	32.8	11.9	15.3	22.6	31.7	28.3	24.8	21.3	23.3	13.6	33.6	13.3	10.0	23.8	31.8	20.4	22.3	27.1	15.3	35.7	15.5	16.8	17.5	18.4	30.2	19.1	21.5	20.4	25.1	6.9	25.7	19.6	24.5	17.6	19.0	27.8	8.5	11.6	25.4	15.1	18.5	11.7	16.8	24.7	37.4	29.6	18.1	15.7	26.8	12.7	23.0	21.2	22.6	6.8	19.4	19.2	17.3	23.9	22.8	19.5	19.1	18.9	20.8	15.8	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7	14.9	12.8	36.4	20.9	21.2	67.1	26.8	28.1	12.0	10.3	57.6	39.3	25.4	18.3	18.1	2.9	17.0	18.8	0.0	26.0	20.6	22.1	24.5	13.9	74.6	19.3	57.2	18.5	12.9	19.7	7.4	39.7	13.5	21.9	19.8	19.0	52.5	20.4	19.2	25.1	18.3	109.8	19.4	23.3	11.6	16.2	24.0	32.4	17.1	20.1	24.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.6	2.4	15.0	0.0	11.1	12.7	8.0	13.3	12.3	8.7	7.7	0.1	9.7	0.0	0.0	17.0	7.5	0.3	8.3	5.3	11.5	6.0	6.5	0.3	0.0	0.0	5.8	0.1	2.6	6.6	0.0	10.8	9.8	18.9	17.7	3.9	0.0	0.1	3.9	0.0	5.1	1.1	6.4	0.0	3.7	2.7	9.1	0.1	2.9	0.9	19.3	25.4	0.1	0.0	24.0	9.1	0.0	8.1	13.9	15.5	11.9	0.1	11.1	1.3	0.4	2.8	11.3	1.3	12.9	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8	3.0	2.1	8.6	11.6	2.2	41.5	5.5	5.1	0.0	4.5	26.2	31.4	9.5	0.0	10.4	71.8	31.5	0.0	0.0	1.5	6.5	7.3	18.3	4.7	0.2	2.7	39.7	0.0	44.8	8.8	51.9	25.3	9.5	6.8	10.0	0.0	20.1	1.0	0.0	33.2	4.4	33.7	19.4	22.9	12.2	11.5	1.5	10.4	13.8	0.0	7.2
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 124.0;Hepatocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.7	24.8	10.8	19.9	33.9	19.1	9.5	19.2	23.8	26.1	20.5	22.0	16.9	46.3	22.2	25.9	15.4	16.6	16.6	14.9	24.9	10.3	17.0	14.0	10.2	23.6	29.7	10.8	16.2	22.1	21.7	20.8	24.9	18.5	15.2	13.6	14.5	6.4	18.9	11.2	16.2	11.6	5.1	9.2	17.0	18.4	21.9	17.4	16.1	18.6	10.9	8.3	45.1	15.8	14.5	11.1	47.6	11.4	19.6	24.6	13.5	12.4	12.9	13.8	12.1	24.6	17.9	7.9	11.2	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5	8.9	7.0	28.6	15.3	22.9	17.3	18.2	30.6	1.4	9.1	94.2	37.3	20.9	21.6	18.1	124.0	20.4	37.5	0.0	37.1	5.8	28.2	27.6	8.1	146.0	15.4	30.2	23.8	39.3	62.3	81.3	38.0	22.3	28.7	15.4	25.9	45.2	27.4	21.0	32.2	42.8	41.0	12.9	26.9	32.0	10.8	18.2	20.4	15.2	19.8	17.2
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	4	"granulocytes: 25.4;Ito cells: 12.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"HEL: 28.3;K-562: 15.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	28.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	25.4	0.0	0.1	0.0	0.0	12.3	2.2	1.3	4.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 12578.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.5	0.9	38.0	1.4	0.0	104.9	0.1	4.0	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.7	2.3	0.0	0.0	3.7	0.0	0.7	1.8	57.1	35.8	0.0	0.0	0.0	128.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	41.0	0.0	0.1	179.4	0.3	13.8	0.2	14.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	848.6	37.7	0.0	1.3	0.0	0.0	12578.5	10.2	1.4	9.1	0.0	0.0	0.1	0.0	19.0	2.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Cell line enhanced"	"Detected in many"		"A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		7400000	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	51.5	9.8	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	52.8	71.5	0.0	43.8	1.8	0.0	20.4	0.0	37.7	2.3	0.2	0.4	4.6	21.1	3.1	6.1	0.6	0.0	0.3	33.4	0.5	72.9	7.6	14.9	1.2	0.1	0.0	0.2	2.0	0.2	0.0	1.6	61.8	7.2	0.0	0.1	0.0	61.4	5.9	0.0	0.0	30.4	7.5	2.1	25.3	1.3	0.6	18.9	0.1	6.8	0.0	11.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0	547.9	38.9	0.0	51.1	22.0	0.0	6.4	58.6	36.1	144.5	36.6	0.0	172.1	14.9	468.5	0.9	32.1	19.7	0.0	274.5	87.0	24.3	117.9	4.7	0.4	16.1	0.0	5.2	20.3	0.0	0.0	2.8	1.7	5.0	36.1	30.9	0.8	473.1	58.5	0.4	1.1	0.3	0.0	9.5	1.2	0.7	5.8	52.5	0.5	28.7	32.0
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	21.3	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8	0.0	14.0	8.8	0.0	0.7	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.2	1.7	0.2	0.4	0.5	5.8	0.0	0.0	0.2	0.5	0.1	4.7	0.6	31.1	0.0	14.9	3.1	110.3	0.4	0.0	54.2	0.0	19.0	0.4	3.2	0.0	1.5	0.4	0.3	0.2	0.0	0.9	0.0	0.0	0.3	0.1	51.7	0.5	0.1
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 28.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1.0	0.6	0.1	1.0	4.0	6.0	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.5	0.9	0.2	0.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.4	28.8	0.7	0.0	0.0	0.3	0.1	0.2	0.7	0.0	0.8	0.1	0.0	0.0	0.6	0.8	3.3	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	0.6	0.0	0.9	2.1	2.7	1.4	0.0	0.0	0.0	0.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AP000812.4		ENSG00000284844			11	72105924-72109329	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;cervix, uterine: 1.1;testis: 2.0"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.4;RH-30: 1.2;SK-MEL-30: 2.9;WM-115: 1.1"															NA	NA																							0.0	0.0		0.0		1.1	0.0		0.9	1.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.6	0.0	0.0	0.0		0.0	0.0	2.0			0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.5	0.5	0.0	0.0	0.0	0.9	0.5	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	20.3	29.3	12.6	20.2	19.2	15.3	17.0	17.2	18.2	25.7	23.7	23.9	25.0	12.1	14.1	23.0	21.6	28.7	22.2	23.7	14.8	22.3	26.1	12.1	31.1	12.3	27.0	24.0	37.2	20.1	24.2	24.5	21.5	17.0	19.7	15.4	22.5	23.9	17.4	34.4	17.4	25.9	18.1	17.2	32.8	16.2	16.4	27.3	14.7	19.5	14.3	11.0	18.5	17.1	10.1	20.8	32.2	18.2	18.7	16.7	18.8	33.3	17.3	31.0	19.8	9.4	22.2	27.2	13.3	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3	14.9	36.4	18.8	19.6	14.0	4.0	23.6	30.6	8.1	10.3	17.4	9.8	27.3	19.9	24.2	1.1	17.9	37.6	0.0	29.9	25.3	15.5	19.0	16.1	35.8	24.8	12.7	30.5	22.7	22.7	3.0	16.1	21.7	32.1	55.1	36.8	13.3	23.6	40.2	16.6	22.1	8.2	19.4	18.6	5.6	10.2	14.2	37.3	27.4	26.6	21.6
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869516-102901899	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 92.8;parathyroid gland: 30.0"	"Cell type enhanced"	"Detected in single"	20	"Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	2.0	92.8	3.7	0.7	8.6	0.5	2.6	4.5	6.4	4.0	2.0	2.2	0.4	1.3	3.8	3.2	2.1	2.1	5.2	10.0	5.7	3.1	7.4	22.4	1.7	0.9	2.8	4.4	3.9	8.7	30.0	2.4	0.5	4.6	4.2	0.8	8.9	2.2	3.4	6.0	1.8	1.3	3.9	2.7	5.6	1.7	3.5	1.6	0.3	3.2	1.0	0.7	1.8	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	3.9	14.3	8.9	0.3	0.3	2.6	4.1	3.5	6.2	7.6	10.6	0.6	0.2	1.2	5.4	0.3	0.2	12.1	0.7	6.4	0.0	3.5	0.0	1.7	10.4	4.1	0.2	0.1	1.9	1.6	0.8	0.0	11.2	0.2	13.2	0.0	0.2	5.5	0.1	2.4	0.3	6.8	0.0	0.6	27.2	0.0	0.1	1.3	0.1	0.4	14.6	0.0	0.2	1.9	4.9	22.7	0.3	0.1	1.3	0.0	2.0	0.0	0.3	0.2	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.7	8.6	4.5	6.4	5.7	3.1	2.8	4.4	4.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740421-121928801	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	15.4	16.9	14.6	16.8	18.8	14.7	16.9	23.1	20.8	17.4	18.8	17.6	12.6	13.5	14.4	14.3	15.7	13.6	14.4	27.5	15.0	18.4	23.1	23.0	14.0	11.7	17.6	14.0	14.4	13.4	23.6	22.5	15.0	15.4	16.5	20.0	19.0	14.1	16.6	33.6	12.0	16.2	25.8	15.6	12.9	12.0	18.1	14.6	21.4	22.0	11.2	14.3	22.8	15.2	14.0	14.4	17.1	11.5	9.9	16.0	8.5	10.0	17.1	13.3	11.2	9.2	11.0	9.1	8.8	15.9	10.6	11.2	22.2	12.5	12.4	7.3	10.1	7.1	10.3	12.3	8.8	10.3	20.4	10.9	4.4	7.5	17.9	9.4	18.9	10.4	8.0	8.2	11.0	23.3	12.5	11.5	8.2	6.8	25.7	8.4	6.3	10.2	7.8	6.8	10.9	8.2	10.0	14.0	7.2	13.4	8.6	3.8	12.4	12.0	8.5	18.2	8.9	6.2	4.8	14.1	6.1	6.0	9.1	15.7	22.4	30.8	15.1	9.5	13.2	5.1	17.1	11.1	14.7	16.0	11.1	15.5	13.0	13.9	13.7	9.4	14.0	15.7	14.3	8.1	9.9	11.5	14.4	13.6	8.5	14.6	18.8	23.1	20.8	15.0	18.4	17.6	14.0	15.4	14.6	8.9	15.8	7.4	11.5	7.4	21.9	62.1	7.6	12.0	14.8	19.2	11.8	6.1	14.9	9.2	5.3	13.6	18.8	0.0	11.6	8.0	10.8	18.1	11.6	23.8	8.5	22.3	21.2	26.4	14.8	5.8	19.0	10.5	13.5	6.4	14.8	18.4	12.5	14.4	24.4	29.3	31.4	0.0	11.7	23.5	33.8	15.3	7.2	10.4	15.0	14.6
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.7	3.9	7.7	4.1	10.0	14.6	2.0	6.1	6.8	3.5	5.9	4.8	6.5	9.6	9.1	4.9	5.6	4.1	5.8	5.1	5.5	7.7	3.4	8.7	4.8	4.8	5.3	10.5	9.4	9.4	3.2	5.4	10.4	7.7	7.4	8.2	8.4	6.6	6.9	2.0	7.1	9.7	6.3	4.1	3.9	5.6	5.3	15.1	4.0	5.5	5.2	6.4	7.1	3.3	10.5	7.1	5.0	5.9	11.5	8.8	4.9	5.0	5.7	4.4	4.6	48.5	5.8	11.5	9.8	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9	35.7	21.0	122.7	17.4	11.2	101.7	35.4	10.2	13.4	19.4	21.0	198.3	14.8	5.0	7.7	12.8	18.8	4.9	0.0	10.6	10.5	26.4	9.5	12.7	21.2	26.0	57.2	19.5	36.8	82.2	2.7	36.5	48.1	25.3	9.0	15.9	35.9	7.6	10.5	26.2	10.3	196.6	25.8	17.3	18.7	33.6	10.8	3.5	111.7	11.7	9.9
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 162.5;Proximal tubular cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.6	4.5	6.3	3.2	7.9	8.5	9.8	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.4	9.7	6.8	9.4	5.2	4.6	41.8	8.0	3.7	4.9	15.0	6.0	5.3	3.9	7.0	6.6	2.6	9.0	7.6	3.9	5.6	5.1	8.2	3.8	4.4	7.3	12.0	7.9	11.3	6.5	4.3	5.1	9.3	14.1	2.5	6.5	4.7	6.2	14.9	7.8	15.1	2.7	3.5	4.0	3.2	4.1	4.7	4.0	9.4	7.9	1.8	5.1	4.3	2.2	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1	0.0	7.7	5.2	22.9	4.6	17.8	32.7	28.1	13.4	4.5	26.2	23.6	37.5	162.5	21.0	2.6	11.2	33.1	23.3	14.0	23.8	11.3	45.7	1.1	16.0	11.6	12.7	22.0	11.1	9.4	1.0	13.3	7.6	11.8	44.1	16.4	8.5	13.9	23.7	10.6	92.2	32.2	12.9	7.5	9.4	11.7	3.6	30.4	13.1	23.0	22.0
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		Yes	Yes			"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	33.0	24.4	16.3	11.5	0.9	2.1	20.7	27.1	12.7	65.7	27.7	68.2	23.2	10.8	18.7	11.1	34.1	26.7	29.0	18.2	70.0	9.8	11.1	19.3	25.0	42.5	0.5	25.8	27.2	1.0	1.9	22.7	20.4	5.2	15.3	17.7	21.9	8.6	27.9	33.7	15.4	20.0	14.9	27.1	25.1	11.7	31.5	12.0	10.5	8.7	14.1	7.6	37.9	43.6	18.2	15.6	25.8	16.1	8.8	28.6	28.3	15.8	38.2	12.1	14.0	18.8	15.4	15.0	23.6	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1	0.0	3.2	4.5	1.1	1.0	1.0	3.4	2.5	1.4	2.3	3.5	2.0	9.8	1.7	3.9	16.9	1.6	5.3	70.0	4.2	59.5	3.8	0.7	55.2	2.4	14.8	1.6	5.8	3.1	2.4	9.5	1.4	5.5	0.0	18.0	5.7	3.5	3.6	3.5	0.4	1.9	2.5	6.5	2.1	16.2	31.6	1.0	6.9	4.9	9.8	1.4
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.6	28.6	42.7	20.5	0.9	1.4	16.4	20.0	10.8	41.5	38.3	37.0	12.6	41.6	10.4	7.9	17.3	30.7	30.9	13.7	34.3	18.2	50.8	24.8	16.4	31.2	0.1	13.0	24.4	0.7	0.6	24.3	15.2	4.1	19.0	27.4	15.4	16.1	18.1	19.8	47.5	18.6	26.5	13.7	12.7	32.2	39.3	17.2	9.0	8.2	9.3	13.2	17.8	8.0	13.6	13.3	14.0	8.8	7.4	16.6	17.1	14.9	52.0	11.8	7.8	31.3	8.0	19.9	33.6	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4	0.0	0.3	2.2	0.3	3.9	0.0	1.1	0.0	0.0	3.4	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.4	46.7	0.0	76.2	4.7	0.4	4.6	0.6	23.9	0.0	0.0	4.9	6.3	0.0	0.6	4.4	1.7	0.0	4.2	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.3	0.7	2.0	2.0	7.6	2.5	6.3	1.4
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 72.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 101.7;Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 30.0"					"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA					"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	0.6	0.5	0.9	0.9	1.2	0.7	1.5	0.7	2.0	0.4	0.6	0.6	0.2	0.0	0.8	1.3	0.5	0.6	2.6	0.9	0.9	1.1	0.8	1.8	1.3	2.2	1.2	0.2	0.4	0.5	0.1	1.3	1.2	1.7	0.5	0.8	1.1	0.5	0.9	2.3	0.6	0.4	1.1	2.1	3.4	0.4	72.0	0.6	0.7	0.8	1.0	1.3	0.5	0.4	2.1	1.0	1.7	1.0	1.0	0.6	0.2	0.2	0.1	0.7	0.3	0.2	0.7	0.3	1.3	0.6	0.9	3.5	0.9	0.1	0.0	0.1	0.5	0.8	0.0	0.0	0.7	0.6	0.0	3.8	0.1	0.3	0.0	1.1	0.0	0.2	0.9	0.7	0.7	0.5	1.1	0.6	0.4	0.1	0.0	1.2	0.0	1.1	0.6	30.0	0.1	0.8	0.1	0.2	0.6	0.7	1.2	1.4	0.4	0.0	0.2	0.1	0.1	0.1	1.3	0.3	0.2	4.2	0.3	0.7	1.4	1.9	0.6	0.8	0.0	0.0	0.0	0.1	1.7	0.6	1.0	0.0	1.9	0.0	0.0	0.9	2.1	0.0	0.0	0.1	1.0	0.3	1.0	0.0	0.2	0.9	1.2	0.7	1.6	0.9	1.1	1.2	0.2	1.7	0.6	0.0	0.3	0.0	0.6	1.0	2.5	1.2	0.0	1.4	3.4	1.8	0.0	0.4	1.7	1.5	101.7	0.6	0.0	0.0	0.9	0.7	0.4	1.1	0.0	0.0	3.2	0.0	1.7	1.8	1.3	11.5	1.4	1.0	5.0	1.8	0.0	1.7	0.9	0.3	0.4	0.3	0.8	6.5	0.5	69.6	19.2	1.0	0.2	0.0	0.4	1.4
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 54.9;Basal keratinocytes: 60.9;Spermatogonia: 54.9;Suprabasal keratinocytes: 65.1;Urothelial cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		No	No			"Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	4.4	1.9	3.2	11.8	4.8	16.1	4.9	1.2	5.8	7.3	5.4	5.4	3.6	3.7	6.8	5.0	10.0	4.1	3.9	3.6	3.4	2.8	2.2	2.1	5.3	8.2	5.1	1.9	5.8	3.7	3.6	6.3	3.8	4.5	5.7	6.1	1.9	4.7	6.5	12.4	16.3	4.5	7.5	5.3	4.7	3.8	9.5	3.9	25.8	4.0	8.0	9.9	8.3	7.8	9.7	6.6	6.0	3.4	6.1	16.0	2.0	7.8	4.3	11.9	6.1	1.6	2.0	8.2	9.6	5.6	9.4	10.9	5.5	7.8	8.5	4.6	3.9	5.8	8.6	8.5	5.6	13.5	6.7	4.4	8.4	8.0	5.8	0.6	9.4	8.5	2.7	0.8	8.3	4.6	3.2	3.2	9.4	4.7	23.9	9.1	6.5	16.8	9.8	9.4	4.9	2.2	14.5	12.0	7.7	2.8	6.6	3.7	6.0	8.8	10.1	3.5	7.1	10.3	9.4	2.7	12.2	8.6	7.1	8.6	7.2	8.0	17.2	4.9	7.2	8.1	2.9	1.7	6.0	4.8	3.4	3.1	8.9	5.3	5.2	3.0	9.7	2.5	3.6	0.5	6.1	2.9	6.6	16.0	2.0	3.2	4.8	1.2	5.8	3.4	2.8	5.1	1.9	4.5	3.9	6.0	2.1	9.5	54.9	60.9	3.3	12.5	15.3	12.0	9.1	8.7	0.0	9.4	3.3	6.8	8.1	7.5	3.4	23.3	6.0	13.6	7.7	21.0	15.0	3.6	10.6	1.6	1.2	12.3	8.8	3.6	5.8	8.8	3.3	17.2	11.3	3.3	5.6	5.8	9.6	0.6	6.8	19.4	15.5	19.7	54.9	65.1	4.2	8.6	11.0	57.3
BCKDK		ENSG00000103507	"Branched chain ketoacid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	15.4	29.7	11.9	13.1	15.0	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16.0	19.9	11.2	9.3	8.0	11.7	25.9	10.6	15.3	12.0	6.9	26.8	26.6	33.0	6.3	6.8	13.6	18.2	20.5	11.6	17.4	14.3	14.4	12.6	15.9	19.6	24.8	24.3	13.4	12.2	17.1	23.1	19.8	12.1	12.7	8.2	27.7	16.0	13.8	25.4	18.5	13.9	24.3	25.2	9.6	17.0	21.1	11.2	21.2	17.7	22.8	26.4	13.1	9.3	16.2	37.1	31.1	8.8	12.7	9.8	8.5	16.6	17.9	16.9	31.5	18.9	12.6	17.9	16.4	12.3	30.5	9.9	10.4	18.4	9.2	16.9	18.9	10.9	19.4	13.2	16.9	6.0	6.1	21.5	13.9	17.7	12.2	33.0	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5.0	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15.0	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3	17.9	17.8	27.4	21.2	16.5	11.0	32.1	25.5	13.4	9.1	19.2	0.0	47.3	68.0	57.7	2.2	20.9	39.3	0.0	68.3	54.7	20.7	26.1	33.4	34.7	83.9	11.1	19.1	27.0	41.9	3.6	19.2	56.7	11.8	95.6	20.5	22.1	49.3	40.3	24.1	65.3	7.2	45.3	28.9	16.7	15.2	24.0	58.0	14.4	26.7	19.3
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR, RhoGEF and GTPase activating protein"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	14.5	8.4	24.0	9.1	41.2	26.7	10.5	14.2	26.5	13.6	9.7	10.3	10.6	8.7	9.2	13.9	19.3	10.8	8.3	7.8	20.9	13.0	16.3	8.3	11.3	10.9	16.0	15.6	8.8	12.9	14.5	14.9	15.7	14.2	7.0	6.8	8.3	15.5	9.7	3.4	12.8	8.7	9.0	9.5	9.1	14.0	9.6	15.4	11.8	16.6	5.5	9.2	9.2	8.8	1.5	0.8	1.2	1.0	2.8	6.6	2.5	19.0	8.2	12.7	13.0	7.6	5.2	19.2	6.9	6.5	6.4	5.2	14.4	7.7	13.3	12.9	5.9	6.2	19.6	1.3	19.2	1.8	25.4	13.2	11.6	11.3	11.4	9.9	10.7	6.1	4.4	13.0	9.5	8.4	11.4	22.3	9.6	44.4	6.3	2.9	12.5	10.0	8.4	10.7	15.1	8.1	13.2	5.1	8.7	9.9	12.1	11.7	11.1	12.6	10.9	5.2	8.5	6.9	8.8	25.1	3.8	0.4	6.2	5.7	1.4	5.8	4.7	9.9	8.1	5.9	0.0	1.0	0.0	6.6	0.4	2.3	1.4	3.3	3.3	0.8	1.5	2.6	3.6	1.2	2.8	1.0	0.8	1.6	2.5	24.0	41.2	14.2	24.9	20.9	13.0	16.0	15.6	14.2	15.4	8.9	11.5	3.0	9.5	13.7	24.0	7.3	20.4	2.7	19.4	17.4	21.6	10.5	8.3	12.4	3.9	22.4	11.1	0.0	14.1	5.9	7.3	10.2	10.4	18.4	6.0	22.3	19.1	62.0	10.8	7.7	8.1	5.4	5.0	6.4	12.0	13.4	21.8	5.8	5.3	14.3	8.0	0.0	8.6	1.6	6.8	13.8	9.0	9.2	11.2	11.5
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.3	12.8	11.9	5.1	9.4	13.4	7.2	6.8	9.6	8.4	8.0	8.8	3.6	16.4	5.4	12.7	9.6	7.1	16.7	10.1	10.4	13.2	7.6	22.3	8.1	7.3	5.2	20.6	7.9	8.9	4.9	13.1	11.7	6.8	12.4	3.7	18.1	7.1	7.7	5.9	10.3	4.8	8.0	5.8	7.6	10.5	19.3	5.6	6.1	15.8	8.9	13.6	13.4	7.0	6.2	9.5	4.6	7.4	19.4	8.8	9.9	5.9	10.4	9.5	13.3	22.0	6.4	10.2	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4	29.8	26.2	37.9	25.6	40.9	59.4	42.2	30.6	10.7	35.2	34.9	180.6	28.6	1.7	22.3	35.8	45.7	44.5	0.0	26.8	18.3	30.5	38.3	29.9	44.3	26.3	65.2	31.2	46.1	58.6	13.7	42.0	32.8	21.9	31.5	36.3	39.9	28.2	25.9	55.5	19.2	89.9	38.8	42.4	52.0	44.5	47.9	31.8	56.8	37.0	38.9
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 124.9;Hofbauer cells: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 38.8;HMC-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	11.4	11.1	15.6	18.6	15.0	15.3	12.0	8.2	12.7	11.1	13.9	20.3	2.1	8.0	11.3	9.6	15.7	10.0	12.3	17.0	18.0	9.5	8.3	10.2	14.1	22.9	20.9	12.0	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6.0	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.5	2.0	3.0	4.0	6.0	5.8	2.4	5.4	8.3	6.0	7.9	3.8	2.9	6.7	2.7	25.8	5.2	1.3	3.6	4.3	11.0	1.9	1.3	38.8	2.4	1.7	6.7	8.1	42.0	8.4	5.6	9.4	8.7	3.2	8.1	4.9	10.4	19.5	7.1	1.2	4.8	3.4	1.4	3.7	1.4	7.0	5.5	1.6	7.3	3.0	4.8	2.6	7.8	4.0	4.7	3.8	1.4	4.2	7.9	5.9	2.3	9.8	5.7	3.6	1.4	2.6	5.2	10.2	4.1	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0.0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0.0	0.5	15.6	15.0	8.2	12.7	18.0	9.5	20.9	12.0	14.5	16.5	26.8	18.1	10.4	3.8	22.1	9.6	5.7	2.5	6.7	6.8	7.0	3.9	4.0	0.0	7.0	11.1	12.4	19.7	46.7	7.6	11.6	12.4	6.3	124.9	16.3	112.6	9.5	6.4	30.7	61.7	7.6	7.5	31.6	27.0	22.6	41.6	46.4	10.6	48.2	6.3	18.1	8.4	6.5	7.4	24.1	9.6	27.5	2.9	3.9	21.8	2.3
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932838	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	8.9	7.0	9.4	7.9	12.4	0.9	10.7	14.1	9.2	19.4	20.6	10.9	7.7	6.2	16.3	12.3	8.4	10.9	10.8	11.0	7.7	6.1	8.2	4.6	7.4	2.9	7.3	7.6	16.1	10.6	10.0	14.0	7.4	8.5	12.8	9.3	10.9	12.6	14.2	8.4	11.3	9.8	16.5	12.2	3.4	12.1	7.8	9.2	0.3	19.4	7.8	5.7	16.0	11.4	1.8	1.1	3.6	0.8	0.9	1.4	0.3	7.3	3.7	14.3	12.1	7.5	4.8	2.5	7.4	7.7	4.3	5.1	6.2	6.4	2.2	3.4	9.4	3.1	7.8	6.3	8.0	6.4	2.4	3.6	2.8	3.5	10.3	4.0	3.8	19.7	4.2	3.4	5.8	4.3	6.4	0.0	4.1	4.4	1.5	5.0	3.1	2.6	3.1	7.7	2.6	1.7	0.0	5.6	0.0	8.9	6.9	1.4	4.6	8.2	4.2	4.9	18.2	7.1	1.9	3.7	3.1	5.0	6.4	6.8	0.4	6.8	2.8	2.7	2.6	2.5	2.0	0.8	0.6	1.4	0.5	0.9	1.8	1.4	1.2	0.3	1.5	1.0	1.1	3.6	0.9	0.6	1.1	0.7	0.3	9.4	12.4	14.1	9.2	7.7	6.1	7.3	7.6	8.5	9.2	32.8	24.8	0.0	6.7	10.8	6.0	19.0	10.2	13.4	9.1	10.4	19.6	10.0	1.7	9.8	0.6	2.1	9.0	0.0	8.1	0.7	13.3	12.9	15.0	7.2	2.7	11.1	17.3	8.0	4.0	1.7	31.1	3.5	8.5	1.0	13.6	12.9	7.7	3.5	29.4	4.7	19.0	6.5	14.1	2.3	3.6	8.5	4.2	0.0	10.0	4.2
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 14.7;Club cells: 22.7;Collecting duct cells: 57.6;Glandular cells: 28.8;Intestinal endocrine cells: 17.6;Melanocytes: 27.0;Muller glia cells: 44.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.7;MCF7: 9.4;SH-SY5Y: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.7	5.0	0.0	2.0	4.6	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	0.0	1.0	2.9	6.9	0.0	0.0	4.6	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.6	2.8	5.7	0.3	0.0	0.0	0.0	0.0	7.2	9.4	0.6	0.1	1.8	0.1	3.2	0.1	2.8	0.1	3.6	0.1	0.2	15.6	0.2	2.5	2.5	0.7	1.9	0.0	0.0	4.0	3.2	0.1	3.4	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2	6.0	0.0	0.0	1.3	2.4	0.2	3.6	5.1	14.7	22.7	57.6	0.0	0.0	1.7	2.9	1.1	0.3	0.0	0.0	0.3	0.2	1.4	28.8	0.0	0.0	0.1	0.0	17.6	4.9	0.0	1.6	2.8	0.3	27.0	0.0	0.0	44.8	0.7	0.0	3.5	0.0	1.2	0.0	1.4	1.6	1.3	1.9	0.0	0.0	0.0	1.0
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.1	15.0	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12.0	7.0	15.5	6.1	21.7	10.8	11.0	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.6	8.8	14.0	13.6	10.8	12.0	12.1	10.5	10.5	4.7	8.7	2.0	14.0	24.2	9.0	10.9	7.3	9.3	16.5	6.0	5.0	6.1	5.8	7.3	9.7	1.7	4.8	9.9	8.8	7.7	10.3	16.2	30.2	2.5	3.9	10.0	12.9	10.8	1.4	1.6	3.1	2.8	5.0	3.9	11.0	3.0	8.9	12.3	5.7	5.7	12.8	7.6	14.1	14.3	5.9	4.0	33.3	21.4	11.4	7.3	7.2	1.4	1.7	0.6	5.1	3.9	6.2	0.5	2.0	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8	98.3	38.9	17.1	16.1	29.8	51.7	46.4	12.7	21.4	39.8	19.2	76.6	14.0	1.7	27.3	2.4	119.4	12.7	0.0	24.7	19.4	40.9	19.9	23.1	15.5	16.2	33.4	24.1	109.2	20.0	2.3	31.4	17.4	40.5	15.4	16.3	38.7	36.3	20.9	40.3	10.7	29.9	64.7	45.7	17.7	11.1	31.5	16.7	13.8	13.4	22.7
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17.0	11.8	11.5	12.0	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11.0	10.7	11.6	16.6	12.9	15.6	10.5	13.0	10.9	12.3	12.0	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7.0	5.6	1.1	5.5	4.7	6.9	8.3	8.4	11.0	11.1	6.2	6.6	5.0	7.2	5.1	6.0	9.5	4.8	6.4	8.0	3.1	6.1	4.9	9.3	8.8	5.0	6.2	4.6	4.7	7.2	10.0	6.2	7.3	5.6	5.3	11.1	7.4	5.8	7.1	9.7	17.1	8.8	2.9	13.3	10.5	6.4	5.4	3.0	8.7	5.9	7.7	4.9	10.7	8.1	6.8	7.2	4.4	6.5	7.1	4.1	6.8	8.6	5.5	4.2	11.7	5.0	19.8	11.2	15.2	8.9	10.1	5.9	3.3	2.0	7.5	3.1	1.7	2.1	2.6	3.0	2.4	1.6	2.6	5.6	2.8	4.1	7.0	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2	20.8	34.2	19.5	20.3	19.2	29.1	12.7	5.1	24.1	25.0	24.4	33.4	12.4	6.6	10.9	55.6	17.1	7.5	0.0	8.6	10.3	13.1	23.9	24.3	8.7	7.9	23.8	18.4	8.6	14.8	30.8	15.3	17.2	15.1	10.0	8.1	11.8	12.5	6.6	9.6	9.6	32.5	6.5	17.3	33.7	23.0	21.0	63.2	17.5	8.1	23.8
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685986	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 224.1;Late spermatids: 273.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.8	9.9	9.8	7.2	11.6	26.5	9.6	10.0	12.8	8.3	9.3	10.0	8.0	8.6	10.1	7.0	9.4	8.4	7.3	8.8	8.6	8.7	8.4	9.3	7.9	9.7	9.2	8.5	9.7	7.8	9.4	10.4	9.8	12.0	8.3	9.0	6.7	8.9	9.7	19.1	12.7	9.3	9.1	11.1	9.6	7.9	55.9	10.1	12.4	9.5	5.6	10.4	10.2	11.8	12.7	11.7	25.7	13.5	16.6	18.5	11.6	9.9	14.6	12.0	13.7	12.8	10.8	20.0	13.9	11.7	16.2	12.5	19.6	6.9	19.1	8.4	13.1	9.2	12.2	16.7	11.4	17.4	12.2	10.8	23.6	9.1	13.1	16.2	20.7	16.0	12.2	16.2	14.0	22.8	14.0	14.0	13.3	24.5	6.3	13.3	12.5	17.2	20.0	16.1	10.5	15.4	16.0	13.0	17.0	10.7	20.9	14.9	11.0	16.3	13.9	13.6	14.4	15.3	13.2	12.9	10.4	9.7	9.4	9.8	16.1	20.3	21.1	9.9	11.5	11.4	16.1	13.0	24.0	14.7	13.5	14.3	12.7	15.4	14.7	11.7	12.5	14.6	14.8	25.7	16.6	10.6	8.4	18.5	11.6	9.8	11.6	10.0	12.8	8.6	8.7	9.2	8.5	12.0	10.1	20.8	9.1	7.5	8.2	10.0	8.1	10.6	17.8	13.4	10.3	10.4	27.5	11.4	5.0	11.0	224.1	9.3	12.8	0.0	6.6	12.6	8.5	9.9	8.1	7.9	9.3	3.2	9.2	8.6	6.4	273.6	12.4	11.3	3.3	20.8	10.6	7.8	11.8	10.5	12.7	11.9	11.5	6.5	10.7	49.2	33.7	11.0	18.8	10.1	9.3	11.2
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748018	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	10.5	7.7	6.2	10.4	8.1	29.2	10.7	16.5	13.1	10.7	9.5	10.4	5.0	6.8	14.4	8.9	10.7	12.9	10.7	7.0	5.4	4.2	8.2	5.3	10.7	12.3	8.3	7.0	12.5	9.2	11.3	9.5	9.9	7.5	9.0	6.3	9.6	12.1	8.5	11.1	14.2	10.5	8.3	5.1	12.2	9.2	23.7	11.4	24.3	12.0	7.8	11.4	11.5	9.4	1.2	3.5	2.3	1.8	9.3	4.2	1.3	5.4	8.5	8.4	4.1	5.3	4.5	43.2	6.7	4.5	7.9	5.9	7.5	4.6	9.4	3.1	6.7	7.8	4.6	8.5	6.8	5.7	9.9	9.1	12.1	16.9	5.0	6.2	17.1	11.3	5.7	5.7	11.7	7.0	4.4	6.1	9.8	12.8	9.5	4.9	13.1	10.7	14.1	10.7	4.0	8.0	14.4	5.9	6.5	4.2	8.6	5.0	7.8	7.3	5.2	6.2	5.5	5.3	16.7	7.7	9.4	8.0	8.0	12.4	7.7	8.6	17.4	7.3	14.1	8.0	2.2	1.8	2.3	2.7	1.6	4.2	1.1	2.1	2.5	1.5	1.2	2.5	2.9	1.3	9.3	1.5	3.5	1.3	1.3	6.2	8.1	16.5	13.1	5.4	4.2	8.3	7.0	7.5	11.4	14.9	10.6	4.5	4.7	12.6	4.4	3.5	0.0	4.0	7.9	7.0	5.9	3.6	0.0	3.6	1.6	7.5	4.4	0.0	4.7	4.6	4.1	4.4	8.1	2.4	5.5	7.9	9.8	8.6	4.8	0.4	6.1	5.2	1.7	1.0	5.0	4.5	4.3	2.9	5.6	1.8	3.8	6.5	4.7	15.8	11.7	16.2	3.1	7.5	5.8	5.5
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	"BR serine/threonine kinase 2"	Q8IWQ3	11	1389899-1462689	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 34.9;pancreas: 78.8"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 79.7;Cone photoreceptor cells: 33.4;Horizontal cells: 65.2;Muller glia cells: 24.5;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 9.9;CACO-2: 7.9;HAP1: 7.4;NTERA-2: 15.3;SCLC-21H: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073690			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA073690: "	"unprognostic (5.47e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.17e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.86e-1)"	1.5	3.5	13.6	1.5	12.8	1.3	1.3	30.8	34.9	1.3	1.5	10.0	0.0	1.7	1.4	1.3	1.3	1.4	1.9	1.5	15.6	10.6	1.4	1.3	1.4	1.3	8.3	17.2	1.4	78.8	1.6	4.6	1.8	9.5	1.6	1.4	2.2	1.6	1.4	1.5	1.5	1.9	1.4	6.5	1.3	1.9	5.5	9.2	0.0	1.9	0.0	1.3	1.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.0	9.1	9.9	0.1	0.3	0.0	0.1	0.1	0.7	0.3	7.9	0.5	0.0	1.4	0.1	0.1	0.0	7.4	0.0	0.6	0.9	3.9	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.9	0.2	0.0	0.3	0.1	0.0	0.1	0.9	0.0	0.0	15.3	2.7	1.2	0.0	0.0	0.0	0.1	0.1	35.8	5.3	1.8	0.1	2.5	0.2	0.2	0.4	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	13.6	12.8	30.8	23.3	15.6	10.6	8.3	17.2	9.5	9.2	0.0	0.0	0.0	0.1	0.2	79.7	2.2	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	0.2	65.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	24.5	0.5	0.0	1.1	0.0	27.0	6.5	8.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 68.1"	"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1.0	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43.0	22.5	10.0	32.8	16.4	22.6	10.8	16.9	21.8	20.0	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22.0	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1	0.0	1.0	7.8	0.2	0.5	0.0	0.8	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.2	8.3	0.0	0.0	0.0	0.0	8.1	0.3	0.2	0.0	0.2	6.6	0.0	0.0	1.3	1.3	4.7	0.3	1.7	0.0	1.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	68.0	14.1	0.4	0.6	2.5	2.0	0.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Group enriched"	"Detected in many"	7	"Spermatocytes: 66.9;Spermatogonia: 28.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008419			Supported	Cytosol		Yes	Yes			Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.8	11.1	35.5	14.1	0.9	2.5	11.5	20.8	11.7	22.3	19.4	16.2	8.4	19.8	11.7	7.5	20.5	24.7	33.5	11.3	24.3	17.0	18.0	28.9	28.7	15.0	0.0	26.1	15.9	0.5	0.6	13.6	12.8	4.4	16.1	22.9	24.9	21.1	22.2	7.4	20.4	15.9	24.0	18.4	12.7	21.9	29.2	15.0	6.8	11.1	23.2	14.3	12.8	12.3	4.5	16.2	14.3	13.5	9.3	17.1	18.1	17.0	18.4	11.1	18.8	32.4	9.1	29.3	22.2	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1	3.0	1.4	0.8	0.3	0.7	0.4	0.4	0.0	0.0	3.4	0.0	0.0	1.3	0.0	0.3	2.5	0.0	0.3	0.0	0.0	5.1	0.4	0.2	0.0	0.2	4.3	0.0	0.0	1.3	0.6	2.4	1.4	1.5	0.0	0.0	1.4	0.0	0.8	0.8	0.4	0.0	0.1	6.5	0.0	66.9	28.8	0.3	0.7	0.8	1.7	0.4
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408261	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 176.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018558, HPA044999"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	47.5	28.1	141.5	26.9	148.2	57.2	21.5	149.6	176.0	27.4	55.9	49.4	20.7	53.9	20.3	41.7	58.8	48.6	29.5	52.3	139.8	86.1	61.5	39.0	38.7	27.8	85.2	100.1	20.9	22.6	41.4	27.6	38.6	106.1	33.7	60.5	22.2	33.2	43.5	100.2	19.3	50.6	42.6	71.1	29.3	35.6	22.3	49.8	12.6	22.7	18.8	37.8	32.7	21.8	45.7	42.8	90.3	53.7	88.8	118.3	109.4	26.9	37.6	44.9	17.2	50.5	44.5	38.4	49.8	42.7	38.5	41.8	40.0	47.9	29.2	26.0	58.7	18.1	45.2	28.1	69.2	64.2	56.8	18.0	30.9	32.4	36.6	27.7	46.8	24.9	27.9	34.6	37.7	13.4	25.6	86.8	20.3	14.2	40.1	52.7	91.7	15.4	45.8	26.1	74.4	52.6	30.9	40.1	19.7	31.8	83.3	94.1	39.5	43.5	76.2	27.8	38.9	50.4	16.4	53.8	32.5	20.8	34.0	41.4	22.4	50.6	32.1	51.4	39.4	45.1	90.3	31.8	71.0	96.0	37.9	118.3	45.7	102.5	101.0	42.8	35.7	74.8	88.1	47.0	88.8	53.7	40.5	105.6	109.4	141.5	148.2	149.6	176.0	139.8	86.1	85.2	100.1	106.1	49.8	360.3	314.0	329.2	485.1	503.7	1352.9	743.7	341.4	1962.0	494.8	378.6	115.8	358.0	389.6	484.7	100.9	794.0	1033.1	23.3	391.9	774.4	358.4	298.0	468.8	297.5	680.0	570.5	576.0	585.0	268.2	58.5	195.1	732.5	595.5	1203.7	393.5	1076.8	427.8	540.1	470.2	1073.9	291.0	310.4	582.3	94.1	162.2	507.4	959.8	581.7	530.3	385.0
CALM2	"CAMII, PHKD"	ENSG00000143933	"Calmodulin 2"	P0DP24	2	47160082-47176601	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB007790, HPA044999"	Approved					NA	Yes					"CAB007790: AB_562257, HPA044999: AB_2679177"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (1.24e-1)"	65.6	87.3	153.0	41.3	162.1	25.3	89.8	132.9	169.5	58.4	88.7	62.8	38.8	68.4	60.1	73.8	50.8	71.6	51.3	55.0	160.4	133.1	57.9	62.0	63.9	48.4	135.8	147.6	57.5	28.1	37.7	51.2	59.3	119.6	60.4	92.3	29.3	60.4	77.7	30.2	31.0	77.7	81.7	139.9	77.3	50.0	79.1	114.9	43.8	60.0	31.0	57.1	56.5	37.1	53.2	82.3	190.9	141.0	38.4	40.3	130.5	165.2	63.6	73.6	32.6	42.0	47.6	47.2	163.8	101.5	97.6	84.2	62.5	62.2	70.4	74.4	119.1	72.0	43.0	62.4	57.7	128.7	53.9	29.5	60.0	38.3	90.9	54.1	72.8	47.5	27.2	56.2	87.0	98.6	85.5	65.4	23.1	56.2	58.0	232.8	43.3	84.9	62.8	57.1	201.5	32.5	21.2	86.9	66.5	109.4	30.3	54.0	137.6	52.9	52.5	71.2	82.5	39.0	38.9	75.4	72.8	80.7	43.6	114.7	46.1	40.3	74.9	49.5	50.4	93.3	140.3	98.3	190.9	29.8	141.0	32.3	53.2	37.2	35.8	82.3	36.9	33.2	36.4	102.4	38.4	122.1	78.5	40.3	130.5	153.0	162.1	132.9	169.5	160.4	133.1	135.8	147.6	119.6	114.9	1289.3	525.2	388.5	961.5	1581.7	610.3	547.0	499.4	2395.7	1222.7	720.6	92.3	798.8	1953.0	1859.0	214.5	598.0	903.4	654.1	600.7	481.0	1210.0	791.7	634.5	511.4	1131.6	322.6	573.5	257.8	884.6	184.8	977.2	1240.6	1680.3	1146.1	906.5	1779.4	1759.7	1027.7	811.8	737.6	257.4	892.6	1822.0	1588.7	733.3	1453.8	213.5	621.1	614.7	973.8
CALM3	PHKD	ENSG00000160014	"Calmodulin 3"	P0DP25	19	46601074-46610793	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 181.1"	"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 1472.6;Late spermatids: 2084.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044999	Approved					NA	NA					"HPA044999: AB_2679177"	"unprognostic (3.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.01e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.10e-4)"	"unprognostic (2.72e-1)"	23.0	29.0	113.3	27.0	142.8	30.5	15.6	76.6	181.1	27.4	31.6	21.5	8.2	37.4	24.5	18.8	22.5	25.9	25.2	47.5	120.2	75.6	23.4	25.3	19.3	29.7	70.1	110.8	37.4	19.3	16.5	16.0	24.5	90.5	25.6	30.0	17.8	12.4	31.6	52.7	15.3	41.7	31.3	34.7	18.5	22.8	44.7	20.5	27.1	22.3	8.6	30.6	28.5	17.4	13.0	17.4	82.2	34.2	18.8	35.3	26.8	52.7	62.2	73.3	25.8	38.8	52.0	15.8	54.0	49.6	53.3	71.3	52.5	51.2	45.1	22.7	86.6	37.7	37.2	72.8	47.0	68.0	54.9	47.1	61.8	30.4	60.0	21.0	49.0	84.7	50.8	16.0	41.3	33.2	41.1	66.0	52.4	45.5	67.8	50.5	36.1	47.3	109.8	34.3	82.8	24.5	83.4	39.0	17.1	50.5	66.5	37.2	39.6	44.0	29.6	17.2	76.0	34.3	53.1	47.2	28.9	50.3	22.1	42.1	42.6	34.3	36.7	29.4	39.9	37.9	28.5	30.2	46.3	13.0	34.2	11.7	13.0	18.7	17.4	17.4	11.5	21.7	14.0	82.2	18.8	33.2	10.4	35.3	26.8	113.3	142.8	76.6	181.1	120.2	75.6	70.1	110.8	90.5	20.5	38.7	58.6	96.7	64.3	50.8	127.6	153.9	81.5	71.0	31.8	66.3	11.8	167.0	220.5	222.6	1472.6	81.0	327.1	327.1	193.5	389.2	117.3	73.9	104.9	82.7	633.9	84.2	117.6	106.8	253.0	2084.0	99.0	107.0	87.7	757.4	160.9	101.7	206.9	178.9	115.2	292.8	57.1	90.5	138.2	657.1	168.6	57.6	154.6	174.0	160.4	94.5
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 76.7;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 94.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		550000	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.7	3.0	0.0	15.4	5.7	7.5	8.8	4.9	10.1	9.6	5.4	0.6	0.2	2.0	5.9	1.5	0.6	0.0	1.1	6.3	0.1	21.6	11.9	7.0	7.5	8.6	1.0	94.0	6.0	0.9	14.2	1.5	8.3	8.4	0.2	1.5	0.2	3.7	2.2	0.0	8.7	2.1	0.1	5.8	0.0	0.1	0.2	6.0	0.6	1.0	3.8	1.5	0.1	0.8	1.3	0.9	15.2	4.4	4.6	5.7	6.5	11.0	0.1	0.0	0.2	9.8	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6	0.0	1.9	6.4	17.8	4.4	8.1	0.0	10.2	1.4	2.3	10.4	2.0	0.4	8.3	13.1	1.5	22.7	2.0	0.0	3.6	1.0	11.6	14.9	31.0	21.2	76.7	0.0	5.8	17.8	40.5	3.9	33.4	50.8	5.0	19.0	1.3	30.9	6.0	3.5	42.5	35.3	8.0	58.2	35.0	1.1	1.1	3.3	0.7	7.5	5.5	10.8
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.7;U-266/70: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.6	3.0	0.2	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.6	2.0	1.4	0.3	0.2	1.5	1.4	3.6	0.5	0.5	47.7	1.8	5.7	8.5	0.2	0.5	0.1	5.2	0.1	2.3	1.2	0.1	6.4	0.3	3.1	0.1	0.2	0.7	3.0	11.1	2.3	2.0	0.0	1.2	8.5	1.6	2.6	0.1	2.8	4.6	2.1	5.7	2.1	0.0	0.4	1.5	1.4	0.1	2.5	3.7	7.9	1.7	22.0	6.9	4.8	3.7	3.7	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8	3.0	28.0	44.7	7.2	20.4	148.3	10.3	15.3	20.1	29.6	1.8	369.1	0.2	0.0	7.8	7.2	8.3	8.8	0.0	19.1	0.7	22.0	3.5	22.0	11.0	15.1	42.9	15.4	11.1	39.3	7.4	21.9	37.1	3.3	24.4	26.1	18.0	9.6	35.1	57.3	0.5	206.3	25.8	9.2	3.9	9.6	36.0	0.2	10.2	29.3	16.3
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Group enriched"	"Detected in some"	6	"Peritubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.6;hTERT-RPE1: 6.9;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.9	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	11.6	0.0	6.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	1.6	0.0	0.0	0.2	2.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.3	0.3	0.0	6.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1"	"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.6	0.0	0.1	0.2	0.3	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3	0.0	0.0	0.0	0.0	3.1	0.1	11.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.2	1.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.5	16.1	5.4	35.2	67.4	5.7	34.1	22.8	13.4	11.6	9.8	4.1	20.9	5.0	23.7	17.0	0.5	10.0	5.3	13.7	8.0	2.5	0.0	5.3	11.2	17.9	0.0	0.0	43.0	7.3	10.4	25.8	21.3	11.9	2.6	0.8	9.3	25.3	3.9	2.1	0.8	2.3	13.9	5.4	4.0	18.9	0.1	13.7	9.9	4.3	4.4	4.6	6.9	4.6	14.0	0.1	5.6	7.1	35.5	8.4	15.1	6.7	7.3	3.6	17.9	18.3	1.3	16.7	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5	38.7	29.9	22.6	16.0	16.4	72.0	243.3	58.6	20.1	28.4	27.9	82.5	0.4	5.0	6.4	2.9	29.8	57.0	0.0	17.5	0.4	34.7	31.3	9.3	49.4	15.8	68.3	99.5	19.6	16.8	4.5	18.7	21.0	5.0	2.8	82.1	41.3	11.4	45.6	18.7	17.7	71.5	6.5	33.3	2.9	4.4	27.9	0.9	17.5	41.1	16.3
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.3;SK-BR-3: 58.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	11.1	8.0	7.3	13.9	5.3	8.7	8.6	7.6	13.2	10.6	8.7	12.5	12.0	8.2	8.1	9.8	4.1	17.4	5.7	6.5	8.4	7.5	6.8	5.6	6.2	5.6	2.6	7.6	9.5	4.6	5.9	10.5	7.3	16.3	9.0	10.6	6.1	12.4	5.8	7.8	12.7	11.4	5.3	6.8	46.3	11.6	7.6	4.3	5.5	16.2	3.8	8.8	4.4	58.3	3.7	5.6	10.9	4.8	11.0	7.9	12.7	4.2	10.3	3.8	4.5	7.7	8.4	21.9	2.8	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4	14.9	9.4	11.5	7.6	8.4	55.8	6.1	15.3	6.7	9.1	7.0	94.2	130.5	11.6	10.6	1.9	18.0	50.5	0.0	17.2	36.6	11.5	7.3	16.1	7.8	22.8	25.4	23.0	12.3	13.6	2.3	11.8	10.5	11.8	5.4	20.0	16.3	16.9	51.8	17.7	27.0	74.1	45.3	50.6	0.5	10.6	11.0	67.9	22.4	26.2	10.7
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell type enhanced"	"Detected in many"	27	"Bipolar cells: 47.8;Early spermatids: 236.0;Late spermatids: 80.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.4;JURKAT: 27.3;MOLT-4: 12.0;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	0.9	0.3	1.1	0.0	0.3	3.0	3.6	3.6	0.0	0.0	0.0	1.9	0.1	2.4	0.1	3.0	0.3	2.6	39.4	2.4	0.5	1.3	0.0	0.1	0.2	0.1	0.1	0.0	7.6	0.8	2.2	0.6	27.3	0.0	1.4	0.2	0.0	12.0	0.0	1.8	0.0	0.1	1.8	2.3	0.1	1.3	0.0	8.6	15.4	0.5	0.0	2.6	0.1	0.0	0.2	0.0	7.5	4.4	0.0	6.6	1.2	0.1	0.0	3.6	0.0	2.8	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6	0.0	0.6	4.2	0.2	1.0	47.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	236.0	0.7	0.0	0.0	0.0	0.1	1.6	0.4	4.6	0.2	0.2	0.0	0.0	0.6	1.0	80.4	3.7	1.1	0.0	0.0	0.1	2.1	0.8	0.0	1.4	0.0	4.1	0.0	4.5	3.2	6.1	0.9	0.0	29.9	0.0	0.3
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 36.4;Rod photoreceptor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.2;U-87 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.9	8.5	0.9	4.3	3.1	5.5	0.3	3.4	3.7	3.3	1.5	3.1	1.5	3.0	3.7	6.6	3.4	14.7	2.3	4.2	2.0	0.1	7.8	3.4	18.2	1.1	3.1	0.5	2.7	4.2	3.6	6.2	2.1	2.9	1.5	4.4	2.6	0.1	1.6	1.3	4.1	1.9	1.0	7.2	8.1	2.1	3.7	3.4	3.5	3.1	5.0	2.8	1.3	10.2	2.2	0.5	3.9	1.1	2.0	5.7	7.7	7.3	2.8	0.4	0.2	0.1	20.8	2.9	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0	6.0	15.1	8.5	1.9	3.3	36.4	5.7	0.0	1.4	5.7	1.8	15.7	0.2	0.0	0.4	0.0	4.4	0.5	0.0	1.4	0.1	4.5	1.4	16.2	0.2	3.8	7.9	4.1	3.1	1.9	0.4	1.1	3.6	8.5	0.0	1.4	3.8	0.8	0.0	1.1	0.0	24.1	0.0	2.0	0.1	1.4	4.6	0.2	0.7	2.3	0.8
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 58.8;Late spermatids: 64.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.5	9.4	7.0	13.5	21.1	19.7	10.7	10.4	11.0	8.5	7.8	9.8	5.4	19.4	8.7	21.0	6.0	10.4	8.6	11.2	6.7	13.3	16.9	9.6	6.3	9.6	14.3	21.9	9.2	12.7	16.6	8.0	18.2	11.5	19.9	14.8	11.1	10.5	8.2	12.1	24.3	18.0	5.1	10.5	10.7	15.8	8.2	17.2	8.2	14.0	26.9	10.8	13.6	7.3	8.6	5.9	18.2	26.8	14.5	7.0	5.7	5.9	5.7	40.3	23.9	14.7	13.1	15.4	6.9	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8	8.9	3.5	4.1	5.1	7.0	21.6	7.0	20.4	8.1	6.8	8.7	2.0	7.4	3.3	8.7	15.7	17.5	18.2	0.0	9.0	6.7	12.5	10.8	5.8	18.3	7.1	58.8	33.0	12.9	13.9	64.8	19.0	13.7	8.5	15.4	15.9	5.1	7.5	11.5	29.7	8.4	6.4	19.4	21.3	0.7	2.4	5.3	2.9	7.1	15.6	5.8
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.6	16.9	24.2	32.8	20.2	27.7	23.2	16.3	28.3	24.2	23.3	26.0	8.3	31.2	19.6	28.4	12.2	21.7	24.7	24.5	15.3	34.9	20.1	9.6	11.0	31.5	17.3	14.4	12.5	18.9	16.0	16.5	20.0	13.8	30.6	24.9	22.9	28.1	14.2	40.9	25.1	12.4	29.9	15.2	28.1	35.1	12.4	36.3	14.6	11.7	17.6	16.9	11.6	14.1	15.7	12.6	14.1	12.4	18.3	29.2	16.5	27.7	19.0	27.4	21.6	27.3	19.2	23.2	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6	8.9	13.5	11.5	4.9	6.9	31.0	0.8	17.8	8.1	6.8	8.7	49.1	16.3	6.6	11.8	25.6	5.7	28.0	46.7	16.9	26.3	10.3	10.9	1.1	23.7	22.3	42.9	26.5	11.1	17.8	13.0	26.2	7.5	5.0	28.9	25.6	10.2	20.3	25.9	18.0	7.3	19.9	6.5	9.2	25.8	16.4	6.0	10.1	4.1	21.2	9.0
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.9	14.0	13.4	8.0	9.1	7.4	4.3	9.6	8.0	5.6	5.2	30.1	17.9	0.1	4.9	11.9	10.2	22.0	14.7	9.8	9.4	9.7	8.2	0.0	12.6	10.6	9.4	1.7	1.5	8.4	26.9	10.7	13.7	11.3	4.6	6.4	0.8	8.5	12.2	12.8	3.1	0.7	12.3	15.8	9.1	5.1	33.0	5.2	12.7	23.8	12.3	6.5	18.0	7.2	5.5	22.6	7.7	0.3	5.3	10.5	10.7	9.0	5.3	3.3	2.1	3.7	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3	11.9	14.8	0.9	33.3	29.0	40.5	6.5	10.2	20.1	14.8	7.0	21.6	1.6	43.1	13.2	0.8	10.8	22.7	0.0	12.7	0.7	17.5	19.6	0.0	13.0	16.2	47.7	13.3	4.9	3.5	0.2	9.2	6.8	10.1	0.0	30.6	11.9	17.9	28.1	8.9	17.0	26.0	19.4	14.4	1.6	1.9	28.4	1.4	12.5	36.5	26.9
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.9	10.6	5.1	6.0	10.0	6.9	7.2	6.7	6.6	10.3	7.9	15.1	6.2	8.7	13.8	9.3	11.6	5.9	14.7	8.6	2.7	15.5	3.7	3.1	6.2	18.0	17.7	5.3	6.5	17.0	18.4	7.1	16.5	14.8	12.5	6.3	12.0	6.9	9.6	10.1	8.8	5.7	5.4	10.4	8.5	2.8	5.9	5.1	2.3	7.1	12.8	5.6	4.6	12.1	5.8	15.2	13.7	10.4	7.4	7.2	9.0	2.1	3.1	12.3	4.2	15.6	7.4	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1	8.9	8.8	18.8	4.9	16.0	12.4	5.9	7.6	1.4	4.5	10.4	43.2	5.2	1.7	5.8	22.7	17.8	6.3	0.0	5.8	8.0	8.0	6.2	3.5	2.6	15.0	12.7	8.1	19.0	52.9	32.8	7.2	29.9	15.1	5.4	4.3	17.5	8.7	8.6	12.0	3.1	33.8	25.8	17.6	38.1	26.2	19.2	5.8	20.0	4.5	9.5
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.3	7.7	3.8	8.9	9.0	5.0	5.8	2.9	1.7	2.7	2.9	2.0	3.6	4.0	3.0	2.7	2.9	1.0	1.0	2.1	2.8	2.9	2.0	12.0	1.9	13.1	1.4	1.5	8.6	3.1	4.5	12.3	6.4	5.6	3.7	2.1	11.7	3.6	2.1	2.0	0.9	2.7	2.0	3.3	4.2	2.3	0.6	4.1	7.4	6.0	6.5	6.8	0.8	8.9	5.6	1.7	2.9	3.1	23.9	2.0	3.2	1.4	6.6	0.6	5.7	6.4	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2	14.9	6.7	21.6	6.8	9.6	44.8	39.9	0.0	10.7	6.8	12.2	25.5	8.9	5.0	6.0	27.4	22.6	8.7	0.0	6.9	53.5	21.6	9.6	8.1	6.7	12.2	3.2	12.1	39.3	11.3	9.0	6.9	10.4	15.1	5.4	16.2	7.4	11.7	7.0	10.3	3.1	27.4	6.5	19.9	9.8	15.8	6.0	38.0	52.3	10.7	3.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA			Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.9	26.3	0.0	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1	0.0	1.6	0.0	28.6	13.4	0.0	0.2	5.1	5.3	11.4	7.0	0.0	4.6	1.7	37.5	0.0	0.1	105.9	0.0	42.7	1.3	0.4	14.4	0.0	8.5	0.3	0.0	16.7	0.0	0.0	0.0	0.0	0.9	0.0	1.0	35.8	0.0	67.6	84.2	0.0	9.9	0.0	0.0	0.4	0.0	1.7	22.5	2.1	0.7	54.6	56.4
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.7	15.7	12.2	15.5	11.2	9.8	8.3	10.4	10.8	11.6	11.6	10.6	14.0	19.9	15.0	11.6	19.7	9.8	16.8	12.5	16.0	14.2	10.6	16.2	11.6	8.9	13.0	23.9	15.9	10.1	11.7	15.7	17.2	8.8	12.0	14.1	25.5	17.0	11.1	23.5	32.6	16.2	17.5	11.6	10.7	15.2	13.2	20.6	8.8	12.7	13.0	20.3	15.5	22.7	11.3	14.9	7.7	12.2	11.7	18.2	13.1	17.2	15.8	27.6	30.0	32.3	11.2	14.9	15.3	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3	17.9	8.3	18.6	13.2	20.9	11.5	14.9	7.6	5.3	10.3	3.5	3.9	9.0	6.6	8.7	7.0	12.0	7.7	0.0	9.4	7.7	8.2	13.2	12.7	9.4	9.1	9.5	16.1	12.9	21.5	3.6	8.6	10.8	18.6	7.2	7.2	6.8	9.1	14.4	11.0	9.2	13.7	19.4	9.9	22.4	13.0	17.3	8.6	19.8	8.4	16.3
CBLL2	"CT138, FLJ25735, HAKAIL, ZNF645"	ENSG00000175809	"Cbl proto-oncogene like 2"	Q8N7E2	X	22272943-22274461	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	52	"testis: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNB1IP1	"C14orf18, HEI10"	ENSG00000100814	"Cyclin B1 interacting protein 1"	Q9NPC3	14	20311368-20333312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 88.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.37e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.79e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.52e-1)"	12.6	9.7	10.9	9.8	13.7	14.2	27.2	14.5	16.4	20.3	13.4	13.2	17.2	9.9	20.4	24.2	17.4	18.8	12.4	33.8	11.1	11.2	31.2	34.4	15.4	11.2	13.4	11.1	49.1	20.6	14.5	12.1	14.4	15.9	18.0	14.5	15.8	14.0	12.3	20.6	14.6	10.0	27.6	15.8	11.3	13.0	9.7	13.9	11.2	35.8	15.3	16.1	33.6	17.7	9.3	13.7	3.5	3.1	4.4	10.7	3.0	6.7	5.5	31.5	30.2	16.1	22.2	25.4	8.2	16.6	12.7	16.9	18.7	7.5	23.4	5.5	6.0	12.9	12.1	21.8	15.6	17.3	6.7	18.5	13.8	5.2	17.6	47.5	25.4	13.0	30.2	26.4	9.1	88.5	15.5	9.6	28.4	16.8	18.6	8.3	10.7	14.7	17.3	18.9	14.7	10.6	18.2	15.6	9.8	13.3	9.9	25.1	26.1	5.7	13.3	37.0	18.2	4.2	18.7	4.0	7.3	9.3	8.7	10.7	8.7	10.9	16.0	2.4	21.5	8.3	3.5	3.1	0.0	6.7	1.1	9.1	9.3	7.4	8.3	13.7	8.4	7.7	10.7	0.5	4.4	1.1	13.7	9.9	3.0	10.9	13.7	14.5	16.4	11.1	11.2	13.4	11.1	15.9	13.9	26.8	25.6	34.4	63.5	51.6	3.2	25.0	56.0	4.0	18.2	22.7	19.6	34.7	87.9	23.7	47.1	18.0	13.1	0.0	33.0	56.8	32.0	34.6	34.6	30.1	15.8	1.6	39.6	16.5	17.5	58.8	47.8	23.1	49.0	8.2	37.0	24.9	27.7	14.0	41.4	71.2	15.5	45.3	24.0	49.1	59.6	35.0	28.5	27.7	41.7	43.6
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.7	18.8	24.1	19.8	10.9	10.5	24.1	16.9	13.0	18.2	19.0	29.0	11.5	10.3	17.7	12.0	11.0	13.0	18.9	14.2	9.3	16.9	50.8	9.5	12.4	31.4	27.3	13.4	11.6	13.5	21.3	15.4	16.1	14.3	21.7	14.6	40.8	20.8	12.0	26.9	18.3	17.9	30.4	13.9	18.2	16.9	12.4	17.4	13.7	11.2	31.4	23.3	14.7	15.2	28.0	20.7	12.2	19.8	17.7	13.3	15.9	30.9	22.5	20.7	15.9	13.8	18.2	19.0	13.7	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0	0.0	4.8	9.7	16.8	41.6	35.9	25.8	38.2	1.4	1.2	14.0	23.6	38.5	11.6	17.9	55.3	20.2	34.4	0.0	17.3	40.4	28.2	30.2	0.0	35.2	23.7	15.9	12.7	14.7	12.6	170.3	16.7	12.9	18.6	10.0	25.9	67.6	35.7	21.2	14.2	15.9	36.1	12.9	30.1	18.4	52.8	47.8	52.7	10.0	21.2	26.8
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Horizontal cells: 211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	17.2	15.2	19.1	8.6	21.1	3.9	14.0	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17.0	11.7	3.5	20.0	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11.0	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2.0	0.1	0.0	0.1	0.0	9.5	9.0	9.7	4.5	9.7	12.0	3.4	11.0	15.6	7.6	8.0	7.3	21.8	0.0	11.8	18.2	5.7	4.4	7.1	6.1	9.3	0.0	5.7	7.4	10.8	2.8	11.0	5.9	3.3	8.4	7.9	12.3	12.4	9.5	25.3	5.9	18.7	0.0	12.3	2.6	0.1	1.0	7.9	12.4	8.7	0.0	16.3	0.0	12.2	18.5	7.0	10.2	18.6	7.8	10.9	6.2	10.1	0.3	25.5	13.9	7.3	15.9	14.5	0.0	0.0	0.0	18.5	0.0	18.6	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	19.1	21.1	29.2	20.4	21.7	17.7	20.0	16.3	19.3	19.9	38.7	29.4	1.4	19.9	10.4	96.7	50.6	25.5	21.4	35.2	41.8	111.9	5.2	11.6	22.3	90.9	47.3	45.2	23.3	35.4	6.1	27.8	25.0	6.9	24.5	3.2	211.4	25.3	42.4	7.1	98.3	40.9	6.8	15.1	9.0	24.1	34.1	46.5	54.5	80.2	32.9	64.0	77.6	45.3	40.8	51.3	6.9	1.1	1.3	26.4	26.8
CDC42BPB	"KIAA1124, MRCKB"	ENSG00000198752	"CDC42 binding protein kinase beta"	Q9Y5S2	14	102932379-103057462	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022821	Approved					NA	NA		12000			"HPA022821: AB_1846376"	"unprognostic (6.73e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.67e-10)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (7.56e-2)"	32.2	22.7	33.1	14.8	33.2	3.1	19.8	30.3	42.1	26.7	21.8	42.3	21.5	26.0	27.0	18.7	28.3	26.0	28.1	30.7	31.4	25.5	23.7	20.1	26.4	7.9	31.2	28.4	29.7	28.8	32.5	25.9	25.6	27.0	25.1	18.2	23.7	23.0	28.8	17.0	23.8	29.6	28.7	24.3	18.3	25.5	21.8	31.0	2.1	26.3	15.9	12.4	25.2	32.6	0.9	0.2	0.0	2.0	0.0	0.4	0.1	13.3	26.7	17.2	12.6	19.2	22.0	17.4	15.3	16.2	16.3	15.0	9.1	15.8	0.0	16.8	29.8	12.4	17.0	17.7	18.3	17.3	16.3	8.0	7.3	21.6	9.1	20.9	0.0	7.9	19.0	18.9	16.7	16.0	17.2	31.5	3.1	5.9	3.8	15.6	28.0	0.1	1.7	8.2	20.9	22.1	0.0	14.5	0.3	20.8	26.3	12.5	13.7	27.2	10.3	11.5	19.1	15.8	4.7	40.1	15.7	10.5	34.5	14.2	4.9	5.3	3.9	17.6	1.6	15.1	0.0	1.4	0.0	0.0	2.0	0.0	0.9	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	33.1	33.2	30.3	42.1	31.4	25.5	31.2	28.4	27.0	31.0	53.6	30.2	6.9	10.7	12.9	45.3	25.4	28.1	33.5	33.0	52.4	31.4	10.5	3.3	26.7	14.0	32.3	28.4	0.0	19.0	8.9	18.2	22.0	12.7	16.3	11.2	54.0	24.2	30.1	12.0	4.9	30.0	12.3	11.8	10.0	14.9	28.0	31.1	17.3	51.9	13.5	42.2	6.5	19.6	13.7	16.0	15.9	14.1	1.0	20.9	28.8
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.6	0.8	0.5	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	7.6	4.8	0.1	2.8	0.0	0.2	14.6	0.9	5.7	0.0	0.2	2.2	0.4	3.1	2.4	0.0	0.1	1.4	0.0	7.2	0.1	0.1	0.0	0.0	2.3	3.8	0.0	0.0	19.7	0.1	1.0	1.8	5.3	0.8	0.8	0.3	2.7	3.4	12.0	10.4	0.5	1.8	12.1	0.3	2.9	11.9	0.2	0.0	0.0	2.1	0.0	0.0	1.4	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7	8.9	6.4	0.0	2.3	5.8	0.0	1.6	2.5	6.7	12.5	1.8	0.0	4.8	0.0	1.7	0.5	0.0	10.6	0.0	5.3	4.1	0.6	2.1	1.1	0.0	0.9	0.0	3.5	0.0	0.0	0.4	0.0	0.2	0.0	1.8	3.3	0.9	2.8	14.0	0.0	0.3	0.0	0.0	0.5	1.7	1.1	7.0	5.6	0.0	3.8	2.0
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.2	4.2	27.6	7.8	0.6	3.7	8.8	5.4	4.3	10.7	11.7	8.9	5.1	9.9	7.6	3.4	9.3	6.2	18.1	6.1	14.8	16.4	15.5	15.0	12.2	4.1	1.0	16.3	5.5	1.9	1.8	9.8	5.6	1.9	4.1	13.9	19.8	14.5	7.3	5.2	14.0	14.6	22.9	7.8	10.1	17.3	22.9	6.3	4.6	10.7	21.9	8.6	17.1	4.7	9.6	7.1	4.4	8.0	3.4	12.1	10.7	9.4	8.1	5.3	6.7	26.5	4.3	15.9	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7	0.0	0.6	2.2	1.1	5.3	7.6	1.3	0.0	1.4	1.2	1.8	0.0	5.3	3.3	1.1	28.3	2.8	0.2	0.0	2.2	5.1	4.6	0.7	4.6	0.0	2.2	3.2	0.0	3.1	1.8	12.9	0.9	1.0	3.3	1.0	1.3	1.3	1.0	1.1	0.7	0.1	4.7	6.5	3.1	28.4	20.6	3.1	1.8	5.1	2.9	0.9
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.9	18.6	49.6	19.6	3.2	5.0	20.4	37.0	27.0	45.2	43.6	43.6	43.3	44.9	14.4	10.1	16.6	30.5	33.7	21.5	47.1	31.9	24.6	23.5	18.4	25.3	0.6	36.0	24.3	0.9	2.1	29.2	28.5	10.3	27.1	29.6	35.9	55.3	50.2	13.0	45.3	25.9	21.8	29.6	39.3	39.4	46.2	22.0	17.2	16.3	23.3	20.4	24.9	37.8	19.2	28.1	40.8	22.1	11.1	19.3	41.2	20.3	50.6	21.7	34.8	40.5	16.6	40.4	23.9	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2	0.0	2.7	2.2	3.6	35.3	1.0	0.5	0.0	14.7	7.9	17.4	0.0	11.0	3.3	0.7	8.8	4.5	1.7	280.4	0.0	116.8	5.1	1.0	0.0	0.8	46.3	0.0	2.9	9.8	15.3	6.3	2.0	8.8	1.7	1.8	4.0	1.0	0.3	0.0	0.7	2.1	0.5	0.0	1.4	104.2	29.6	16.3	18.4	7.0	5.6	6.0
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.7	9.6	7.7	3.1	3.2	6.1	8.1	12.2	6.9	8.7	2.9	7.4	11.2	13.1	6.2	10.5	5.4	10.3	3.3	17.0	5.5	2.9	8.1	5.1	10.8	0.8	13.4	8.3	9.4	7.5	5.7	5.5	8.3	5.8	15.1	8.7	13.4	1.8	9.9	19.2	10.0	23.8	15.8	16.0	7.3	14.6	10.5	18.4	15.6	11.7	7.6	16.5	15.3	7.1	3.6	9.1	16.7	13.2	13.4	5.9	15.3	6.1	8.3	6.6	3.6	4.0	9.0	14.3	8.4	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6	11.9	28.2	16.7	22.2	13.7	17.3	4.8	45.9	18.7	9.1	26.2	23.6	25.3	36.5	23.6	5.0	17.5	42.9	0.0	11.0	16.4	18.6	26.1	9.2	37.6	16.3	17.5	65.1	19.6	16.7	5.4	22.2	13.0	18.6	14.4	38.5	10.3	14.2	35.1	11.7	45.1	33.8	6.5	11.3	23.1	29.8	13.6	23.3	17.5	50.1	18.6
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.3	9.9	7.1	6.5	9.4	7.5	7.0	16.1	7.2	8.0	9.4	12.3	15.0	17.4	9.9	4.7	10.4	12.2	6.5	8.4	6.4	13.3	10.6	15.5	18.5	11.0	6.2	17.3	22.4	8.7	5.7	7.0	4.6	9.7	13.8	9.4	18.1	14.6	6.7	9.2	8.0	13.6	9.9	10.0	8.4	14.7	10.8	8.4	6.5	7.4	7.9	11.4	14.1	16.6	19.3	3.6	11.1	7.2	14.0	12.6	12.3	5.6	8.9	20.4	14.8	21.9	4.3	14.0	4.0	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1	47.6	54.9	22.4	11.6	12.5	31.1	1.2	12.7	53.5	58.0	14.0	25.5	13.8	8.3	17.1	29.6	20.3	32.5	23.3	13.2	19.0	13.9	10.7	79.0	12.3	10.9	38.1	8.7	11.6	8.2	11.1	32.8	22.6	10.1	23.4	23.2	20.4	21.0	46.0	20.1	9.6	39.2	12.9	9.1	104.7	84.3	12.8	25.5	25.5	18.6	12.9
CDK11B	"CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58"	ENSG00000248333	"Cyclin dependent kinase 11B"		1	1635227-1659012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 147.7;Spermatogonia: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025061, HPA073626"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (7.52e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.75e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (6.52e-3)"	10.5	9.8	10.4	11.7	15.1	24.3	8.6	15.0	14.1	9.0	13.3	11.6	6.7	17.4	11.0	6.1	8.6	7.3	7.5	11.2	12.2	9.3	7.9	8.3	12.8	13.1	11.4	9.7	10.3	11.8	9.1	9.6	8.3	11.0	8.9	7.1	7.0	14.0	9.5	33.7	14.0	18.0	14.0	14.8	12.9	9.6	15.8	13.1	12.2	9.5	8.3	10.3	11.6	11.8	5.2	6.2	16.4	4.2	5.1	8.0	2.1	20.5	16.7	12.8	10.1	12.2	8.1	14.3	20.1	11.1	15.8	13.7	18.7	23.3	19.2	20.0	10.0	10.9	18.8	11.7	11.9	9.3	17.4	20.5	20.2	31.1	16.7	14.2	23.0	24.4	10.0	8.1	14.8	11.7	8.9	12.9	21.1	24.5	13.8	8.2	14.4	22.6	22.3	19.2	8.0	20.6	23.3	21.0	15.3	8.4	8.1	14.5	17.7	19.3	19.9	21.3	7.9	14.9	17.1	17.8	15.5	16.4	10.5	19.3	28.4	25.1	38.8	17.9	27.9	10.7	8.2	4.2	6.3	8.0	3.6	4.1	4.2	5.1	5.4	3.1	5.2	5.9	4.4	16.4	5.1	3.8	6.2	4.1	2.1	10.4	15.1	15.0	14.1	12.2	9.3	11.4	9.7	11.0	13.1	17.9	42.1	36.6	15.2	12.8	30.5	36.0	25.5	42.8	48.9	26.2	19.6	25.0	8.3	26.8	28.9	28.9	89.0	23.3	30.7	26.3	20.4	16.2	52.2	33.4	18.4	14.3	27.6	18.4	25.4	16.7	26.7	23.2	5.0	35.1	53.9	22.7	29.9	56.1	25.1	12.6	42.3	51.8	25.5	147.7	172.1	15.2	37.3	27.7	50.7	12.2
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.9	11.1	6.7	6.2	4.9	5.5	6.2	8.1	6.9	11.1	8.3	13.6	5.5	12.7	7.1	8.5	11.3	14.6	13.3	10.2	10.8	8.3	11.4	13.7	7.5	10.5	4.8	18.7	9.6	5.9	7.1	13.5	10.7	4.6	6.7	7.7	23.2	8.4	6.3	4.2	15.3	4.8	7.0	4.4	5.0	10.1	14.4	7.2	4.2	10.7	7.2	4.6	10.3	87.5	7.0	10.1	11.2	8.1	7.2	10.1	8.1	7.0	10.4	6.9	4.9	17.9	7.2	7.9	6.6	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3	23.8	26.1	37.7	45.0	57.5	45.4	12.1	35.7	29.4	40.9	36.6	60.9	27.7	11.6	24.4	15.9	29.6	32.0	23.3	23.8	24.7	35.7	62.9	27.8	38.9	23.9	33.4	29.9	27.6	37.0	14.0	34.5	34.5	25.3	27.9	26.9	31.5	36.1	31.6	31.8	12.9	67.7	32.3	33.0	113.1	90.5	60.3	48.7	42.9	28.8	77.9
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.7	9.4	16.4	15.6	14.8	14.5	11.3	12.6	13.7	11.6	14.6	9.8	10.9	28.6	7.4	13.2	20.4	19.2	13.4	11.1	17.1	14.0	9.9	12.7	11.5	8.8	14.2	19.3	13.9	8.5	14.9	13.2	17.7	13.3	13.6	13.3	21.4	19.8	12.0	8.1	15.3	13.7	23.7	11.1	11.0	17.0	10.9	11.5	10.9	16.0	11.7	17.0	16.0	34.7	11.4	22.2	14.2	24.1	16.1	16.0	15.3	10.3	17.1	16.4	13.8	23.6	11.7	17.5	20.4	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7	41.7	63.7	28.9	17.1	19.1	42.3	25.6	30.6	34.8	47.8	29.6	66.8	11.5	6.6	19.1	10.7	22.5	15.9	0.0	13.4	7.5	19.4	16.3	16.2	20.7	11.6	35.0	18.0	20.3	23.2	7.0	24.2	18.3	13.5	15.4	17.7	26.6	24.2	10.5	16.6	11.1	68.4	6.5	15.6	31.4	31.5	22.8	10.2	22.5	18.8	21.7
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 44.0;Horizontal cells: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.1	0.0	14.3	1.8	13.4	13.7	3.3	6.0	5.7	3.7	4.0	0.1	3.5	25.4	0.7	5.9	5.4	2.1	0.7	8.4	7.1	0.0	3.4	0.0	4.7	0.1	6.2	7.2	0.1	9.7	2.1	10.9	3.9	6.1	4.7	0.1	0.1	31.3	7.4	0.0	0.0	2.8	9.0	0.0	3.9	19.5	19.7	19.3	1.9	1.9	3.2	9.2	15.2	0.0	0.3	6.7	1.9	3.6	11.5	15.9	20.4	13.3	9.2	17.7	13.5	18.1	6.0	9.5	15.5	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5	17.9	3.2	27.7	7.4	0.7	5.1	11.1	10.2	4.0	13.6	10.4	0.0	0.2	6.6	9.4	44.0	2.1	0.0	0.0	5.8	0.1	12.5	8.3	0.0	9.6	4.0	163.7	1.7	1.3	5.1	27.0	14.4	4.6	5.0	1.0	0.1	8.8	9.4	0.2	14.9	18.1	9.5	0.0	6.6	3.8	6.5	1.1	0.0	0.5	0.0	2.3
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.2	14.9	5.6	12.2	0.0	1.5	0.0	0.0	1.3	0.2	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	35.2	2.1	0.0	1.5	0.8	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.2	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	40.6	31.2	30.0	44.3	22.0	18.9	30.0	19.4	23.9	29.5	22.0	35.1	19.8	9.8	12.4	34.7	54.7	23.1	31.9	41.3	19.9	11.7	50.6	10.6	43.9	27.3	28.6	11.1	24.9	23.6	26.4	41.8	50.5	24.7	26.4	10.3	15.7	16.7	25.8	35.4	9.7	25.6	23.5	15.4	33.8	10.3	23.7	17.1	22.2	32.3	25.4	19.2	52.6	40.7	20.0	36.5	36.3	13.7	26.5	19.8	32.4	30.1	23.1	13.2	12.8	9.5	17.4	52.0	22.1	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1	0.0	6.7	15.3	27.9	28.8	24.3	37.2	15.3	4.0	4.5	29.6	3.9	23.1	46.4	30.2	25.1	15.7	50.5	0.0	32.2	31.3	23.1	37.6	5.7	14.8	21.7	28.6	26.9	20.3	19.6	46.6	15.8	10.3	32.1	12.6	30.7	16.0	41.5	33.6	12.4	28.2	12.9	0.0	19.8	18.1	16.8	30.4	21.7	10.2	41.6	53.3
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 44.5;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	16.3	9.1	20.6	13.9	47.0	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21.0	12.9	8.0	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28.0	29.6	9.4	6.1	16.6	11.0	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.9	4.2	11.0	2.9	5.4	14.3	7.8	11.1	15.7	9.8	9.3	2.5	2.9	7.4	7.7	8.0	5.3	4.5	6.5	6.9	13.4	7.8	5.0	10.6	2.8	3.5	11.7	5.6	6.1	10.3	7.1	14.5	26.2	17.4	44.5	6.3	7.7	6.0	22.1	3.0	5.3	8.8	4.8	2.4	7.3	9.3	5.9	6.3	11.6	4.2	5.7	3.9	6.5	6.1	8.1	8.7	4.6	5.1	53.3	8.7	3.3	4.6	6.0	8.5	6.5	7.9	3.3	2.4	6.4	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47.0	17.8	24.6	25.3	17.3	23.8	21.0	14.8	28.0	14.9	6.2	24.4	8.9	23.8	10.8	8.9	5.1	9.4	10.3	8.7	15.7	10.0	0.0	4.6	2.7	42.9	6.0	0.0	3.2	25.8	15.5	10.4	17.4	8.9	10.5	4.8	14.5	35.6	15.3	3.2	9.2	9.4	16.9	7.2	7.4	20.2	5.7	3.5	8.9	6.9	9.2	6.5	27.8	6.5	7.6	22.6	11.4	27.7	5.5	11.8
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 69.8;Paneth cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	11.7	0.8	0.1	0.6	0.0	0.0	12.7	0.2	2.4	0.5	3.1	5.3	8.8	7.0	1.8	0.1	1.0	10.6	2.6	20.1	0.5	1.9	2.3	1.6	17.7	5.4	2.3	0.0	0.0	1.3	1.0	0.0	0.4	17.2	0.0	10.0	0.1	8.5	0.1	9.5	0.6	0.3	10.0	3.4	0.4	0.9	0.0	8.8	1.9	7.5	4.1	1.6	3.6	1.7	7.8	14.7	7.9	3.4	0.0	0.0	4.8	0.0	0.0	2.4	1.1	1.4	0.1	5.0	2.0	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4	0.0	0.3	0.0	6.7	3.1	4.7	25.0	7.6	0.0	1.2	69.8	0.0	4.9	6.6	15.9	1.6	1.9	20.6	0.0	5.8	1.9	4.8	1.9	0.0	3.9	5.1	0.0	5.8	1.3	1.6	2.8	0.9	3.6	3.3	7.2	12.9	19.1	6.3	98.2	1.4	15.4	1.2	6.5	12.5	1.4	10.0	1.1	1.6	0.5	11.5	5.9
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 84.5;Late spermatids: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007053: AB_1233803"	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	5.3	3.3	18.1	6.1	29.4	9.7	6.0	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8.0	22.1	12.9	9.7	3.1	8.0	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7.0	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.9	13.7	16.5	7.4	10.7	7.1	11.9	12.7	4.5	5.9	4.9	4.1	9.3	4.3	8.3	9.0	2.1	5.2	2.5	10.3	11.5	3.0	15.8	5.8	5.7	4.5	6.4	11.9	7.3	5.6	6.1	9.5	11.3	4.4	7.9	4.8	13.0	9.6	5.9	8.6	9.6	1.3	5.2	2.7	9.2	7.0	3.5	5.2	6.7	7.0	13.0	9.0	7.4	10.6	4.8	2.5	23.6	4.9	9.4	5.0	18.9	7.2	1.4	1.9	8.0	9.9	8.7	9.7	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3	3.0	16.2	8.1	13.2	8.8	17.3	6.2	12.7	4.0	7.9	15.7	15.7	5.4	1.7	7.5	84.5	11.7	13.8	0.0	4.1	17.1	10.8	49.2	6.9	10.5	14.4	22.3	12.1	14.7	33.3	95.4	10.0	18.4	25.3	3.6	14.2	34.3	6.0	17.5	15.2	5.6	14.1	6.5	8.5	38.1	14.1	14.2	6.6	12.8	12.9	7.4
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.8	9.1	20.1	11.1	4.1	5.3	37.0	21.0	11.0	26.2	24.5	19.2	16.3	16.1	15.8	7.8	10.5	10.8	15.3	9.2	26.6	18.9	15.0	18.5	15.1	7.3	1.3	14.6	13.4	2.8	2.3	17.7	6.1	7.6	13.2	16.7	17.5	14.7	18.1	13.0	30.3	12.4	8.0	11.5	13.6	29.6	19.3	12.1	7.6	16.6	8.3	10.7	24.0	8.8	107.8	12.0	19.0	10.7	7.3	18.1	17.5	13.9	15.3	8.3	9.6	20.0	10.3	10.7	15.6	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1	14.9	3.7	5.2	20.1	24.8	0.0	2.6	12.7	5.3	9.1	1.8	0.0	78.7	1.7	10.5	0.4	15.0	2.1	0.0	5.0	67.5	17.6	10.9	10.4	8.9	11.6	1.6	5.2	8.6	4.8	0.2	13.8	6.3	82.7	47.7	6.3	3.8	9.0	0.0	4.2	3.8	3.4	0.0	14.4	2.9	7.7	27.5	142.8	5.7	6.8	18.0
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 25.4;Spermatocytes: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.2"	"Group enriched"	"Detected in many"	7	"NK-cells: 7.2;T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.4;THP-1: 21.7"	"Low region specificity"	"Detected in all"							"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.6	16.2	10.8	2.4	13.0	1.6	4.1	8.7	17.1	8.7	5.0	6.1	5.1	5.3	7.2	6.0	2.8	19.5	5.6	3.0	8.6	10.7	8.2	3.2	4.0	2.0	5.8	14.3	9.5	4.8	7.6	10.8	3.1	9.3	6.1	3.4	7.7	3.6	8.6	2.1	3.6	7.6	5.5	3.1	1.6	3.7	17.7	5.2	0.8	6.8	1.2	1.1	6.3	3.0	0.1	0.8	0.4	0.8	7.2	5.0	1.3	2.4	3.0	2.4	7.6	1.7	2.4	1.0	2.2	4.2	5.9	5.5	0.7	3.6	0.0	3.3	3.6	10.3	3.1	0.0	2.1	2.4	5.9	2.5	0.0	1.9	0.0	7.4	2.8	3.4	1.9	4.4	9.3	3.8	4.6	0.0	5.3	0.3	0.0	1.7	7.1	1.9	0.8	1.9	5.3	1.1	0.0	0.0	0.1	7.4	2.0	14.4	4.1	2.5	3.0	3.6	0.8	3.3	21.7	0.0	2.6	1.0	0.5	2.4	3.8	3.6	0.0	9.3	1.9	2.8	0.0	0.7	0.4	1.3	0.8	0.5	0.0	3.0	1.9	0.7	0.1	5.0	3.2	0.1	7.2	0.7	0.8	2.7	1.3	10.8	13.0	8.7	17.1	8.6	10.7	5.8	14.3	9.3	5.2	3.0	4.1	0.0	1.5	1.9	5.2	2.0	2.5	25.4	5.7	1.8	2.0	3.6	1.7	4.2	4.7	0.5	5.4	0.0	1.3	1.9	3.3	2.5	1.1	0.9	0.9	7.9	0.0	0.6	0.0	1.7	4.0	1.1	0.0	0.0	2.0	4.8	1.5	0.0	6.3	5.3	13.5	6.5	2.3	25.0	2.9	1.9	3.3	0.5	2.9	0.7
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 2.4;Distal tubular cells: 1.7;Ductal cells: 1.4;Exocrine glandular cells: 2.0;Melanocytes: 3.3;Pancreatic endocrine cells: 2.0;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	4.1	3.7	2.7	4.7	2.4	5.5	4.7	4.2	2.4	4.9	4.8			6.5	5.6	5.7	4.0	5.0	4.8	2.6	2.8	3.0	5.9	13.0	5.3	5.5	3.0		6.7	5.9	4.2	8.3	5.0		10.3	5.3		5.2	4.5	0.9	14.7	9.1	4.1	3.9	8.8	5.2	5.6			8.2		5.4	3.8	5.1	1.2	1.8	1.5	1.5	1.7	2.7	1.6	4.2	7.8	11.6	6.1	6.8	8.1	24.2	5.3	3.4	5.9	5.5	6.1	8.9	6.4	4.7	4.6	4.8	9.9	9.3	3.9	3.9	3.3	14.9	13.3	15.5	6.0	5.7	4.6	13.6	7.3	8.6	5.2	4.3	10.6	6.5	4.0	5.9	4.6	3.8	10.9	5.4	20.7	5.8	3.7	8.5	10.0	5.1	5.9	5.5	14.1	8.4	22.6	3.5	11.4	2.6	12.2	15.7	9.5	5.5	16.1	9.5	6.8	5.6	9.6	7.2	6.0	4.9	4.7	3.9	0.0	1.5	0.0	2.1	1.0	0.2	1.2	1.6	1.2	1.8	0.3	2.7	0.5	1.5	1.7	0.6	1.6	2.7	1.6											0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.5	11.1	14.6	13.0	13.4	11.8	9.8	5.5	18.0	24.4	20.2	15.8	9.1	13.9	10.0	8.6	14.4	7.4	20.2	128.1	18.5	6.8	9.3	13.0	7.5	11.1	15.7	14.7	9.0	11.6	9.4	14.9	17.2	16.6	15.6	13.3	13.8	12.0	141.4	13.9	14.1	12.0	17.2	10.0	11.2	12.6	445.0	12.9	7.6	15.1	13.3	12.4	9.8	7.4	14.7	10.5	9.8	17.9	7.1	11.4	10.8	12.9	11.1	6.0	9.7	21.4	10.5	13.7	13.7	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5	20.8	25.0	32.0	62.9	79.7	15.3	0.5	48.4	4.0	23.9	45.4	9.8	64.6	59.7	71.7	10.1	44.2	11.3	23.3	53.6	108.9	77.4	41.8	68.1	32.1	111.7	17.5	43.8	34.4	23.2	6.8	59.2	34.0	50.6	54.1	33.5	51.3	55.4	7.0	59.4	66.3	15.3	32.3	54.2	25.9	40.3	75.3	39.1	34.1	78.3	32.5
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 219.8;Late spermatids: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 93.5;REH: 45.7"					"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.2	2.9	8.0	5.1	2.3	2.6	1.7	6.4	4.0	3.2	3.0	7.8	4.8	4.8	3.7	4.3	2.0	3.8	4.4	9.2	7.6	10.5	3.1	12.0	5.5	7.5	1.4	7.4	0.6	2.6	5.0	4.3	20.4	3.0	1.2	19.6	11.5	13.3	5.7	1.2	93.5	0.8	2.5	7.9	2.6	45.7	28.1	8.1	4.4	0.1	4.2	27.3	0.7	2.2	3.7	6.1	0.1	12.3	4.7	10.5	16.5	4.1	12.9	7.1	0.1	6.4	1.5	25.5	13.9	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0	23.8	3.0	11.9	19.5	53.5	0.2	14.8	25.5	4.0	27.3	21.0	0.0	42.7	8.3	31.7	219.8	24.1	11.0	0.0	20.1	3.4	21.6	18.1	24.3	18.4	15.0	0.0	16.1	7.4	23.4	186.0	4.6	21.9	18.6	20.8	46.7	0.5	63.1	14.0	3.2	5.1	0.0	6.5	22.1	2.6	46.4	44.2	14.8	20.3	68.3	23.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	7.9	12.9	10.9	6.2	15.2	44.1	14.0	10.8	14.7	9.4	12.7	6.0	6.3	15.8	9.4	8.6	23.4	18.5	16.5	8.1	11.5	9.3	13.8	10.6	10.1	8.8	7.6	9.7	7.7	9.1	3.3	16.2	22.9	11.2	11.2	14.8	6.6	13.2	6.5	15.9	15.4	9.8	12.1	9.2	7.9	13.9	29.0	7.8	12.1	20.0	15.6	15.5	10.7	11.7	15.6	15.0	22.4	11.3	12.4	15.3	7.8	3.6	7.7	1.8	0.5	2.4	11.6	14.7	6.4	7.7	10.7	17.4	16.6	1.9	2.8	10.1	1.7	12.4	2.5	1.4	2.8	5.8	1.3	7.0	0.4	8.1	7.9	0.4	6.7	3.2	14.3	13.8	9.0	2.8	9.4	13.5	15.6	10.3	4.5	4.9	0.7	4.0	14.7	1.7	3.7	7.4	6.6	0.4	1.1	1.6	1.0	0.6	6.5	1.5	5.8	3.4	6.4	11.6	0.6	2.6	0.0	3.2	0.9	5.1	4.8	8.4	3.7	0.8	4.0	0.8	7.3	10.9	22.4	8.6	11.3	14.8	12.4	12.9	15.3	15.0	15.6	11.1	13.2	10.0	12.4	8.0	11.2	12.8	7.8	10.9	15.2	10.8	12.7	11.5	9.3	7.6	9.7	11.2	7.8	14.9	10.4	2.4	16.5	51.3	6.3	8.9	5.1	48.2	10.3	5.2	11.8	97.9	13.3	21.5	6.2	11.3	9.2	0.0	19.0	285.4	10.2	19.9	15.1	6.6	21.2	1.6	2.9	6.7	8.2	3.6	6.9	10.2	6.8	9.0	11.4	9.0	22.5	14.0	6.7	20.7	8.2	25.8	12.2	25.4	15.8	36.6	54.0	9.6	11.8	28.6
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 55.8;Late spermatids: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	7.6	8.8	10.1	10.4	8.5	5.2	5.6	26.9	11.3	5.9	24.0	6.0	13.8	13.8	11.2	6.5	10.0	7.0	11.2	7.6	8.3	7.3	9.4	10.4	6.7	5.2	7.8	7.9	6.1	12.7	8.4	10.2	10.6	8.2	7.8	11.2	4.6	9.0	19.2	9.7	6.1	15.0	12.7	6.0	6.4	11.7	16.3	9.9	12.8	6.4	6.9	7.2	15.5	11.0	1.9	1.7	3.4	1.6	1.0	2.1	1.3	6.9	5.7	11.6	11.8	6.2	7.6	7.2	13.4	9.2	10.0	7.2	16.6	9.7	7.4	5.9	6.9	8.0	8.6	13.3	9.0	12.6	17.1	7.4	14.1	4.6	5.7	4.3	22.0	8.1	5.5	8.7	7.5	12.7	5.5	7.3	12.1	21.8	0.0	9.0	7.4	16.8	10.3	9.2	10.5	7.1	10.6	11.5	5.1	5.8	6.5	9.9	5.8	5.7	10.9	9.8	9.6	3.9	10.1	7.4	6.4	8.2	11.7	7.3	5.7	10.1	13.6	4.0	9.3	7.6	0.4	0.9	3.4	1.1	1.6	1.9	1.0	1.5	2.1	1.7	1.9	2.1	1.7	0.0	1.0	1.2	1.0	0.6	1.3	10.1	8.5	26.9	11.3	8.3	7.3	7.8	7.9	8.2	9.9	8.9	4.1	4.5	6.7	17.5	19.1	5.0	7.6	0.0	5.7	1.8	23.6	7.2	8.3	8.5	55.8	6.8	9.7	0.0	7.2	8.3	9.3	11.0	0.0	5.4	7.1	17.5	8.1	6.2	7.5	83.1	7.2	6.6	8.5	8.2	7.8	7.1	10.6	11.5	7.8	11.5	16.6	6.5	11.3	27.8	17.5	20.8	8.1	6.9	10.5	9.1
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	9.0	16.4	10.3	11.3	11.7	9.2	13.5	9.3	13.7	9.7	8.8	12.2	10.2	15.9	10.9	10.5	13.4	18.3	6.8	15.2	3.7	14.2	8.1	14.8	17.8	10.0	17.1	14.3	23.8	16.1	18.6	10.3	11.6	12.6	20.0	14.2	12.8	21.3	8.7	23.8	15.6	21.6	22.8	13.7	17.6	45.2	8.8	22.7	14.1	10.1	10.2	12.2	14.0	14.8	8.3	8.4	18.6	13.6	22.9	11.7	13.2	10.0	9.0	38.9	29.9	14.2	10.9	9.8	10.6	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1	11.9	14.3	20.4	20.9	21.4	13.1	12.9	15.3	18.7	7.9	10.4	2.0	18.7	13.3	26.6	3.2	26.7	12.9	0.0	32.7	18.8	16.4	18.5	24.3	23.6	20.6	23.8	18.5	31.9	17.0	4.3	18.1	18.9	15.1	64.9	11.8	16.2	30.5	11.8	29.4	12.7	7.5	0.0	22.7	7.5	24.0	19.3	42.9	23.5	13.1	23.1
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 17.9;Ciliated cells: 34.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	7.1	2.1	7.5	1.8	5.1	0.9	3.0	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3.0	2.0	12.3	10.5	2.0	1.4	1.4	4.9	2.9	4.0	5.7	1.6	2.5	8.4	1.7	3.0	3.0	7.7	3.1	3.7	2.0	1.9	1.4	1.3	5.0	6.1	2.1	7.0	5.6	5.7	1.3	6.0	2.5	3.8	6.7	2.6	6.1	4.9	0.6	2.4	6.5	7.9	0.3	2.1	3.9	2.2	2.6	2.0	5.8	0.4	2.6	4.6	2.2	4.2	0.9	0.6	2.5	6.7	2.4	6.5	2.1	1.7	7.4	5.9	3.5	1.7	3.6	4.6	10.1	1.8	8.5	6.2	2.7	2.6	1.0	0.3	1.9	3.1	0.7	1.6	2.3	0.7	2.8	1.9	6.9	2.3	1.1	1.3	2.5	16.7	0.6	0.1	0.2	5.0	2.7	5.7	2.9	5.7	4.7	0.9	0.4	0.4	1.0	6.2	7.0	6.0	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2.0	12.3	2.9	1.4	17.9	6.9	1.3	3.2	2.7	0.4	0.4	0.0	34.8	4.5	10.4	0.0	0.1	5.0	0.9	0.3	2.1	4.7	0.0	1.6	0.1	4.7	1.2	1.1	0.2	0.3	0.0	1.7	6.7	1.9	0.9	8.3	1.1	0.0	0.0	2.3	0.8	1.2	3.7	3.2	5.5	0.7	0.0	1.3	0.0	0.2	2.4	0.2	2.5	3.4	1.4
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 261.7;Late spermatids: 219.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA027751			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	2.5	2.7	7.0	2.2	7.1	1.6	2.5	7.0	8.5	2.6	2.4	5.9	5.5	2.3	3.9	5.3	2.6	3.7	2.6	6.6	6.1	6.5	4.5	2.8	2.2	2.5	8.0	4.3	3.0	2.4	3.2	6.5	2.2	8.6	2.8	2.6	3.9	2.0	3.2	7.5	2.7	2.5	4.6	8.4	2.7	2.2	33.4	9.3	1.3	3.9	2.1	3.0	2.8	2.2	1.5	2.7	1.0	1.1	1.4	4.0	1.3	1.0	2.1	3.1	2.2	5.4	4.6	1.3	2.9	2.6	1.3	3.2	1.9	1.5	2.7	1.8	1.8	6.0	0.9	2.6	1.8	2.6	2.9	2.0	1.4	2.3	3.3	3.3	0.6	0.9	2.2	4.7	3.9	1.2	2.2	1.3	6.5	1.5	1.2	3.5	1.1	2.1	8.0	2.1	0.6	1.0	3.4	1.3	0.8	1.7	0.9	4.8	1.4	2.1	0.5	3.5	3.7	1.8	1.6	0.9	2.6	0.6	3.5	1.0	3.3	4.4	5.2	4.0	2.1	2.0	0.0	0.9	1.0	0.9	1.1	4.0	1.5	1.4	2.5	2.7	1.0	3.8	3.8	0.2	1.4	0.4	1.6	2.3	1.3	7.0	7.1	7.0	8.5	6.1	6.5	8.0	4.3	8.6	9.3	0.0	3.0	0.0	5.7	9.6	12.7	1.6	0.0	5.3	3.4	5.2	3.9	2.4	8.3	2.6	261.7	3.6	0.5	0.0	4.4	1.6	6.9	4.0	3.5	1.8	3.1	6.4	2.9	3.1	0.6	219.5	4.6	4.0	10.1	2.8	0.7	10.0	1.5	0.9	8.5	6.1	9.6	0.0	5.6	30.5	13.2	9.7	3.8	3.2	1.1	3.3
CDKL4		ENSG00000205111	"Cyclin dependent kinase like 4"	Q5MAI5	2	39175646-39229588	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.2;testis: 7.9"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 3.0;Ciliated cells: 8.1;Club cells: 3.4;Early spermatids: 8.3;Late spermatids: 4.5;Spermatocytes: 6.5;Spermatogonia: 3.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	11	"memory B-cell: 1.6;T-reg: 3.2"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;HL-60: 5.0;RT4: 3.4;SH-SY5Y: 6.8"	"Low region specificity"	"Detected in many"							HPA067895	Uncertain					NA	NA					"HPA067895: AB_2685920"	"unprognostic (3.57e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.46e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.77e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.45e-4)"	"unprognostic (8.59e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.26e-2)"	0.3	1.1	0.3	0.0	0.6	0.0	0.3	0.1	0.7	0.2	0.0			0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.5	0.9	0.2	0.0	0.4	0.1	0.2		0.3	0.3	0.0	1.6	1.2		0.4	0.0		0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.3	7.9			0.3		0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.3	0.7	0.3	5.0	1.1	0.3	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	0.0	0.2	3.4	0.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0											3.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	8.1	3.4	0.0	0.0	0.2	0.0	0.2	8.3	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.3	0.0	0.0	6.5	3.8	0.0	0.0	0.0	0.0	0.0
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	5.5	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.2	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.7	1.3	2.2	0.1	2.0	4.2	1.7	0.8	0.8	7.2	1.6	3.0	0.7	3.8	0.1	2.5	9.0	0.7	4.5	4.5	1.1	2.2	7.4	1.7	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7	23.8	19.0	0.0	8.3	0.8	16.1	12.0	5.1	6.7	9.1	7.0	31.4	20.0	6.6	5.7	27.2	4.5	0.0	0.0	8.1	2.5	3.1	18.1	1.1	3.0	3.7	76.3	2.4	4.9	5.3	41.5	5.5	1.8	0.0	2.8	1.9	27.7	6.6	0.0	4.9	7.5	19.5	32.3	4.2	2.3	9.8	1.1	39.6	0.8	1.5	24.3
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
CDY1	CDY1A	ENSG00000172288	"Chromodomain Y-linked 1"	Q9Y6F8	Y	25622162-25624902	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	47	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY1B		ENSG00000172352	"Chromodomain Y-linked 1B"	Q9Y6F8	Y	24045229-24048019	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	72	"testis: 7.2"	"Cell type enhanced"	"Detected in single"	40	"Early spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2A	CDY2	ENSG00000182415	"Chromodomain Y-linked 2A"	Q9Y6F7	Y	18025787-18028597	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	50	"epididymis: 3.8;testis: 6.0"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"U-266/84: 1.2"									HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2B	CDY	ENSG00000129873	"Chromodomain Y-linked 2B"	Q9Y6F7	Y	17877410-17880220	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	28	"testis: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 565.6;Hepatocytes: 2145.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 96.2;THP-1: 103.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.4	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.8	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3	14.9	74.9	21.0	2.5	14.8	0.0	0.6	565.6	202.1	28.4	15.7	0.0	0.4	0.0	16.2	77.2	1.5	0.0	70.0	17.2	0.8	45.8	1.1	5.8	2145.0	18.9	0.0	36.2	43.0	88.2	134.3	17.3	20.4	37.1	0.0	0.0	8.3	0.9	0.2	93.0	0.5	0.5	0.0	7.2	0.9	1.0	10.2	0.7	20.3	0.0	1.7
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		7500000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.9	9.1	9.6	12.8	9.5	8.9	7.3	7.9	12.8	9.3	11.9	9.8	11.5	8.1	7.9	10.3	7.0	18.0	7.0	19.9	7.3	7.2	9.7	7.9	5.2	18.4	13.4	10.4	14.0	12.9	37.7	13.2	22.1	11.5	6.9	5.7	11.1	6.0	15.7	4.4	9.3	8.7	5.2	7.5	9.2	11.0	9.7	9.5	26.4	12.1	6.2	8.2	25.8	6.5	6.7	3.9	11.2	12.9	8.5	12.3	6.5	7.6	5.9	12.0	14.3	9.6	18.9	8.2	9.2	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2	29.8	24.0	25.9	13.7	17.3	28.5	25.4	137.6	42.8	12.5	50.6	19.6	13.0	31.5	21.9	1.5	9.8	912.6	0.0	29.5	5.6	12.7	14.5	27.6	449.6	16.6	27.0	23.2	25.2	27.6	1.3	17.3	13.9	10.1	5.4	141.3	17.6	37.9	448.9	17.0	124.1	22.7	32.3	11.3	42.6	10.2	17.9	11.3	18.7	459.3	15.2
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6"					"Not detected"	"Not detected"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.4	3.2	0.4	8.1	0.3	0.2	1.3	0.3	0.2	0.4	0.5	0.5	4.0	8.9	2.7	0.0	0.2	0.7	1.2	0.6	0.1	1.5	6.0	4.4	1.3	2.6	0.1	1.0	0.7	0.3	1.0	0.9	0.2	0.3	0.0	14.6	2.8	1.9	0.3	1.2	1.5	1.6	1.4	2.7	0.5	1.4	0.7	1.4	0.1	0.5	0.4	0.9	0.2	6.1	0.2	0.7	5.4	6.8	0.4	0.4	2.6	0.7	0.2	1.0	3.6	1.3	0.3	7.6	0.2	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6	3.0	7.0	0.8	0.0	0.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.2	0.0	0.8	0.0	0.0	0.2	1.1	40.9	0.2	0.0	18.9	0.0	3.2	2.6	0.0	1.4	0.0	0.0	31.1	0.2	1.0	60.4	1.1	8.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	31.9	0.1
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 43.4"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"U-266/70: 13.3"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.1	0.1	0.7	0.1	0.6	0.0	0.1	0.1	0.8	0.1	0.1	0.1	3.6	0.0	0.1	43.4	0.1	0.0	1.4	0.1	0.8	0.5	0.1	6.6	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.3	0.1	1.2	0.1	0.1	1.8	0.1	0.0	1.7	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.8	0.5	1.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 473.2;Rod photoreceptor cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.8	6.8	15.2	12.3	11.3	16.6	2.6	10.7	7.9	5.7	2.5	3.7	5.2	7.8	7.0	8.8	3.9	7.1	7.9	5.6	8.0	2.7	5.9	11.0	6.5	2.4	7.9	15.2	9.2	11.5	5.6	8.3	10.5	7.6	8.4	4.4	12.9	2.6	7.1	2.3	7.6	3.5	5.5	1.7	5.2	26.8	18.2	3.3	3.4	5.5	6.4	7.2	9.5	3.1	7.9	5.7	3.4	7.0	16.2	10.7	5.4	3.9	7.1	8.1	5.6	13.6	7.6	6.6	10.5	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7	65.5	56.6	64.3	103.8	50.8	251.0	33.9	43.3	68.3	67.1	85.5	473.2	14.5	39.7	49.7	11.6	77.2	66.9	46.7	32.4	24.2	77.4	86.0	91.5	61.4	61.8	208.2	84.2	88.4	58.8	14.5	100.4	67.6	64.1	74.9	67.1	159.3	29.5	60.4	116.0	47.5	752.2	58.2	73.1	79.9	36.0	65.6	20.8	48.9	69.8	73.2
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	13.0	10.6	23.9	14.5	4.9	10.5	10.4	18.3	8.8	11.7	12.6	25.9	28.8	34.0	18.8	7.2	15.6	15.7	14.6	9.6	14.5	21.3	6.7	63.1	8.9	13.2	1.5	32.2	12.0	5.4	2.0	14.8	10.5	7.0	13.9	23.2	32.0	30.0	15.4	6.7	47.8	15.8	24.2	21.3	9.6	29.1	22.3	17.9	10.8	17.4	15.1	16.0	15.0	10.4	4.4	16.9	28.0	10.5	9.3	16.9	14.4	8.1	16.8	6.7	12.0	48.5	6.2	24.3	19.8	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5	3.0	0.3	6.0	4.4	5.6	1.4	3.7	33.1	2.7	5.7	7.0	0.0	9.6	3.3	3.7	3.3	1.9	3.3	23.3	1.0	31.3	5.6	2.0	0.0	0.8	9.4	0.0	1.7	4.9	0.0	2.2	1.4	2.4	0.0	4.6	5.6	2.7	2.4	3.7	1.1	6.8	1.5	0.0	4.1	23.3	60.3	4.3	6.5	4.4	12.0	1.4
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.9	4.8	13.7	17.0	3.9	19.5	8.8	7.4	8.7	9.8	14.4	12.1	10.2	17.7	6.3	5.2	10.6	14.4	20.8	13.6	11.5	12.6	16.0	23.3	9.2	20.2	3.8	14.7	17.1	8.2	6.3	12.6	11.2	6.0	10.8	14.2	14.0	15.5	9.2	21.0	11.8	23.7	19.3	18.5	12.2	25.6	9.4	20.6	6.1	6.2	8.1	4.6	8.3	14.7	8.2	10.6	10.1	13.6	3.7	7.9	9.5	6.9	3.9	9.4	16.5	34.6	7.5	15.5	10.0	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6	8.9	4.5	7.5	4.5	5.7	1.0	1.0	0.0	2.7	4.5	1.8	0.0	10.5	0.0	1.7	4.7	2.2	2.0	23.3	1.2	11.7	8.9	2.3	3.5	0.9	8.4	0.0	1.2	3.1	2.1	0.5	5.8	6.6	1.7	2.8	4.7	0.6	1.3	3.5	4.2	3.2	1.2	0.0	2.8	2.5	20.2	1.9	2.9	4.3	7.9	3.4
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: AB_2732242"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	13.7	11.4	14.1	19.0	15.0	25.8	12.5	20.0	16.9	12.1	15.2	16.5	13.4	19.0	15.6	16.7	21.6	12.6	14.3	13.7	12.5	9.8	12.8	13.4	17.0	21.7	15.1	12.6	9.6	16.8	9.6	20.6	22.9	13.0	14.3	12.8	15.5	13.9	14.7	21.0	16.7	18.7	17.8	15.1	24.9	16.8	19.2	14.2	22.3	13.5	12.7	18.4	18.6	14.2	6.6	12.1	19.7	17.0	12.3	12.5	10.1	4.4	11.0	9.3	0.8	8.2	10.8	17.3	9.2	7.7	9.8	10.3	8.6	3.8	0.1	8.9	10.7	7.3	7.3	1.1	9.4	5.7	0.6	9.8	14.7	7.5	8.7	17.8	0.6	25.5	14.6	8.5	9.0	6.7	7.1	12.0	1.5	6.2	0.0	6.8	15.0	10.6	11.4	11.1	7.9	8.7	1.4	1.3	4.4	6.5	21.2	9.1	11.6	7.6	7.9	7.1	11.3	14.0	15.1	13.5	0.6	2.2	5.1	3.4	16.1	0.0	2.2	0.0	3.0	8.9	17.6	14.2	19.7	10.8	16.9	10.0	6.6	8.7	11.6	12.1	4.5	8.3	9.1	18.9	12.3	17.0	6.6	12.5	10.1	14.1	15.0	20.0	16.9	12.5	9.8	15.1	12.6	13.0	14.2	11.9	21.6	16.1	4.3	5.5	20.3	8.9	0.0	10.7	19.4	7.0	88.4	10.0	8.3	9.1	51.1	11.3	10.7	0.0	11.9	12.8	7.7	8.7	62.6	7.3	17.2	20.6	20.3	13.5	18.0	58.8	6.9	15.9	10.1	25.2	8.8	8.1	13.4	10.5	8.1	3.4	107.7	19.4	7.3	13.4	19.2	8.4	19.8	21.8	7.3	13.3
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 335.7"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	14	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	230000000	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.7	90.8	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	80.6	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.4	0.0	38.1	0.2	0.0	0.0	0.2	4.8	0.0	37.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6.0	39.7	0.0	19.4	3.8	0.0	0.8	2.5	4.0	15.9	26.2	0.0	1.2	0.0	49.4	0.0	0.4	0.0	0.0	0.0	0.9	2.2	2.2	0.0	28.7	335.7	0.0	0.0	0.0	0.3	0.0	0.9	3.9	13.5	1.8	0.0	40.4	3.1	0.0	0.0	0.1	1.8	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	1.6
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase, acidic"	Q9BZP6	1	111290862-111320566	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"stomach 1: 66.6"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 22.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC diff: 6.0;HAP1: 3.1"					"Low region specificity"	"Detected in single"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0.0	0.5	1.0	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0.0	0.1	0.6	0.6	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.7	0.2	0.2	0.0	1.6	0.6	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell type enriched"	"Detected in single"	44	"Hofbauer cells: 42.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	42.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.8	13.5	13.8	20.6	13.3	12.0	10.6	20.3	20.0	19.0	23.2	15.1	9.4	21.6	12.0	13.8	13.2	15.8	23.0	10.7	21.3	22.9	19.9	14.3	10.7	16.6	11.4	26.4	21.1	9.6	11.5	21.8	21.4	13.2	13.5	17.9	16.2	17.9	20.6	9.6	20.9	16.3	9.0	12.7	9.9	13.7	15.4	9.8	12.0	10.3	8.3	12.3	11.0	8.5	17.6	11.4	17.0	16.2	14.1	11.9	13.4	12.9	23.0	21.1	19.0	21.0	13.0	21.5	9.4	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6	11.9	7.8	9.0	4.9	17.5	5.0	6.9	5.1	4.0	4.5	5.2	2.0	5.5	10.0	6.6	6.7	8.3	8.3	0.0	10.3	6.5	5.6	8.2	8.1	13.0	9.4	12.7	5.8	6.2	17.2	6.1	5.8	10.7	6.8	11.8	6.3	4.8	7.9	6.6	5.6	15.3	4.8	19.4	8.1	8.0	13.6	16.7	11.6	7.5	6.0	10.9
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.1	13.7	12.0	11.3	1.1	3.3	7.1	11.7	9.7	12.2	9.2	8.7	6.3	11.0	6.3	9.0	6.0	9.5	8.2	6.8	16.9	7.8	6.0	13.9	8.8	5.4	0.1	7.3	12.8	0.7	0.8	14.6	9.0	4.4	9.3	12.2	8.8	9.3	11.5	7.6	13.2	11.1	6.5	5.7	9.3	12.1	21.9	3.6	2.4	6.7	8.6	4.7	19.4	3.8	9.2	6.3	13.7	5.3	7.1	15.3	14.1	10.4	12.7	6.3	7.1	7.5	10.1	8.1	23.6	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5	6.0	8.8	0.8	0.6	3.0	7.4	1.6	0.0	1.4	9.1	8.7	82.5	0.9	0.0	0.2	63.4	1.1	0.4	0.0	0.7	4.0	1.1	0.3	1.1	0.8	2.9	0.0	1.7	1.3	1.9	28.5	1.1	1.0	3.3	0.0	1.1	15.4	0.1	0.0	1.1	5.7	15.0	0.0	0.4	11.5	3.5	1.1	0.8	2.5	1.6	1.0
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23.0	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31.0	21.9	21.8	35.3	28.2	30.1	56.0	23.1	48.1	20.9	36.6	41.5	40.0	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25.0	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.2	6.2	10.4	3.2	11.9	13.1	8.2	9.0	12.8	9.1	12.2	11.6	5.4	2.8	6.1	5.6	5.3	8.9	13.1	4.1	18.7	12.5	11.6	8.5	15.7	14.3	7.1	8.8	14.4	6.0	18.9	11.4	20.2	10.9	5.3	4.5	10.2	37.3	12.9	5.6	10.4	26.8	6.6	5.2	14.2	10.6	12.4	14.8	6.3	5.4	10.5	8.3	7.8	2.9	13.0	6.5	2.4	6.1	8.1	10.2	7.0	9.8	9.8	22.0	9.1	6.5	6.5	7.2	6.9	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13.0	7.4	27.8	43.4	40.1	40.7	31.0	21.9	56.0	23.1	34.4	52.6	41.7	97.6	120.6	205.3	149.9	55.8	85.6	28.1	76.3	79.6	26.2	94.2	37.9	16.6	25.9	1.9	110.1	100.8	23.3	23.3	39.1	151.1	171.5	133.9	37.6	51.4	49.3	128.8	78.0	91.9	5.1	86.0	167.5	146.8	47.7	56.3	46.1	27.4	66.6	71.1	11.1	91.9	109.9	142.2	31.2	22.0	132.6	75.5	146.6	44.8	153.2
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
CLK3	clk3	ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16.0	19.6	21.9	29.3	14.5	23.7	21.8	19.0	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21.0	12.0	23.7	23.2	19.8	38.9	36.0	60.7	46.0	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.6	14.9	15.3	24.2	21.9	26.9	19.3	14.8	20.4	11.4	13.6	30.6	15.8	35.0	14.7	14.3	29.0	19.2	25.0	21.1	13.3	38.5	6.7	19.4	23.2	29.4	28.8	24.0	26.8	24.0	20.8	12.2	14.9	12.7	15.8	19.9	22.7	12.0	22.2	10.1	16.1	9.0	13.4	17.1	16.3	10.6	12.5	12.2	13.6	13.5	15.1	12.9	13.5	11.0	13.0	10.0	8.1	20.0	24.5	19.6	16.8	11.4	33.1	16.4	32.9	34.4	45.0	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46.0	36.0	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3	6.0	35.5	20.9	38.8	40.0	34.9	14.9	20.4	17.4	18.2	12.2	53.0	22.9	26.6	29.6	59.6	28.3	37.1	23.3	21.0	31.4	22.7	32.5	20.8	10.9	24.3	27.0	28.2	17.2	24.0	14.8	25.6	28.5	27.0	32.5	24.6	17.7	28.8	28.1	19.1	14.2	42.2	12.9	24.4	37.1	17.5	36.6	49.0	39.2	22.6	53.1
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 288.4;Late spermatids: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	12.2	16.4	17.0	17.4	18.4	11.4	17.3	53.8	24.1	17.9	12.2	11.9	18.3	12.4	17.0	16.4	10.5	11.0	13.1	11.4	15.9	9.5	11.8	16.0	10.9	20.3	21.2	12.7	17.4	16.2	15.4	20.2	13.9	16.3	16.7	8.9	10.8	14.4	17.0	20.6	19.5	11.3	11.3	25.8	17.0	11.0	15.7	22.0	15.0	15.8	9.7	12.7	11.4	18.0	13.2	7.8	16.1	6.1	7.7	13.8	5.2	6.7	6.3	5.8	8.4	17.5	14.7	9.7	6.7	7.5	4.0	7.4	6.7	5.5	3.9	5.4	2.8	4.5	9.0	7.5	5.4	6.6	14.1	5.9	1.5	11.8	8.1	6.5	3.1	4.9	6.7	7.8	6.4	8.6	13.2	2.7	2.7	3.5	11.6	5.1	2.8	4.0	11.4	3.0	4.6	3.9	4.0	5.2	5.7	3.9	2.1	6.5	4.4	7.5	4.0	6.9	3.4	4.3	6.6	5.6	8.2	2.9	4.2	7.1	7.6	2.8	3.0	5.9	7.6	4.1	6.5	6.1	12.0	10.0	4.1	13.2	13.2	10.3	8.9	5.9	10.4	13.8	10.6	16.1	7.7	4.4	7.8	9.5	5.2	17.0	18.4	53.8	24.1	15.9	9.5	21.2	12.7	16.3	22.0	14.9	26.7	50.0	37.2	28.3	66.4	19.3	7.6	32.1	23.9	14.0	37.3	16.5	5.0	7.3	288.4	24.8	13.5	23.3	4.1	13.0	20.8	26.1	27.6	11.9	8.8	27.0	5.8	17.2	13.1	350.8	28.4	23.8	15.1	12.6	10.7	34.6	6.5	11.8	27.6	7.7	76.4	19.4	36.0	23.2	17.7	21.5	13.3	34.8	9.1	22.2
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.6	5.9	5.4	8.4	8.1	8.2	2.7	14.1	11.6	9.9	9.1	3.7	10.9	3.7	7.3	16.4	7.4	11.4	6.9	10.9	16.7	4.5	2.5	2.9	6.3	4.6	7.2	4.7	3.4	4.8	10.9	13.6	13.4	7.4	9.2	3.1	6.7	7.5	14.8	7.5	2.6	2.7	3.9	11.2	6.9	1.7	6.2	2.4	7.6	7.4	5.3	4.7	10.2	12.6	6.4	4.7	4.2	2.6	12.7	13.4	14.4	4.4	18.9	6.8	4.9	2.3	11.9	4.2	10.6	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0	38.7	23.0	9.8	18.1	27.6	61.3	50.4	12.7	12.0	13.6	14.0	41.2	9.5	1.7	11.5	25.0	28.9	20.3	0.0	14.4	5.7	30.8	25.1	3.5	25.9	10.1	31.8	38.2	28.8	12.7	12.1	22.2	14.3	10.1	8.2	19.3	29.6	19.8	15.3	33.9	17.0	39.4	12.9	30.8	56.9	73.3	32.9	4.3	10.2	14.9	46.9
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1551	"pancreas: 4260.9"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 19853.4"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1100000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	3.0	0.0	1.0	0.0	2.4	1.0	0.0	0.9	0.0	0.5	0.4	1.3	0.1	0.2	0.0	0.3	1.1	0.1	0.4	0.5	0.3	0.0	2.7	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	19853.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	228.2	0.0	0.0	2154.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"granulocytes: 52.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SuSa: 2.5;U-937: 3.1"	"Low region specificity"	"Detected in single"							"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	12.3	0.2	0.2	2.9	0.2	0.0	15.9	0.2	0.2	7.3	6.2	0.2	1.2	0.1	2.9	6.0	8.3	1.0	10.0	10.3	0.2	0.2	2.0	0.8	1.1	1.6	0.2	0.2	0.6	0.9	0.5	0.5	0.7	0.3	6.0	6.9	3.0	5.9	1.3	1.2	13.0	5.3	6.2	0.2	0.5	2.4	2.7	0.2	1.0	0.4	7.9	3.9	4.1	2.0	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.9	1.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.8	1.4	0.0	0.2	0.3	0.3	0.8	0.9	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	7.0	6.7	9.7	15.8	11.0	10.1	11.8	8.4	11.7	21.5	24.1	10.1	4.7	14.7	9.6	12.4	20.2	7.9	12.3	8.7	16.5	10.1	10.9	8.1	7.8	11.2	8.5	11.6	5.5	8.7	6.5	11.8	8.5	11.3	10.0	13.7	17.9	10.8	11.2	11.5	14.7	10.4	4.8	4.7	6.4	11.7	11.5	8.4	6.9	8.6	10.7	8.1	9.5	7.3	12.1	7.3	12.4	9.0	9.2	12.9	9.7	5.1	9.4	12.4	6.4	77.6	5.1	12.2	14.1	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8	8.9	8.6	7.3	3.4	3.2	13.3	7.9	7.6	13.4	15.9	7.0	31.4	14.0	0.0	4.0	20.1	9.0	4.2	23.3	7.4	6.2	6.4	3.4	3.5	7.4	6.6	11.1	8.1	9.2	5.9	8.3	7.2	7.5	3.3	13.6	7.5	10.1	6.4	3.5	6.3	3.5	10.9	6.5	4.9	14.4	9.9	4.1	17.4	8.7	5.4	2.8
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA					"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	19.4	14.3	19.8	12.0	23.3	11.1	13.8	31.6	24.6	18.7	15.0	21.9	7.0	11.3	21.1	15.2	15.8	16.7	13.8	18.7	19.2	18.0	16.0	16.0	13.6	14.4	18.5	15.1	24.7	14.1	22.6	28.6	16.1	21.1	15.3	13.4	16.4	16.8	15.6	35.0	15.6	12.3	17.1	22.6	13.7	12.3	25.8	18.5	18.5	21.1	12.3	18.1	16.2	15.7	12.0	10.0	21.5	12.7	16.7	15.5	9.1	13.6	12.9	13.3	17.7	22.1	17.6	9.6	15.4	16.8	13.1	16.4	11.1	14.1	13.7	13.4	13.9	18.6	13.0	16.7	11.6	18.8	15.4	12.9	11.3	11.2	9.9	12.3	12.6	13.5	13.5	14.9	16.8	10.5	15.1	13.4	9.8	19.6	10.9	19.2	17.1	17.3	20.5	17.4	12.6	11.0	11.3	13.1	14.8	15.5	12.6	14.1	16.5	17.9	20.2	11.2	12.9	12.4	14.3	18.1	16.0	9.5	14.8	16.6	16.8	15.8	19.5	16.1	14.9	21.2	21.5	11.5	14.9	14.1	11.5	15.5	11.0	12.0	11.7	10.0	12.0	13.1	12.1	10.7	16.7	12.7	8.0	10.1	9.1	19.8	23.3	31.6	24.6	19.2	18.0	18.5	15.1	21.1	18.5	20.8	41.3	39.1	72.1	60.1	49.7	39.2	25.5	29.4	34.2	34.9	100.1	25.2	59.7	27.4	14.2	43.4	27.3	0.0	18.1	19.0	52.1	62.8	60.2	23.3	22.5	52.4	39.0	36.2	21.4	15.3	60.4	32.6	40.5	50.5	23.7	70.1	25.3	25.9	65.0	41.4	66.1	19.4	57.9	120.0	69.4	66.1	37.3	43.1	24.7	86.4
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		730000	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.9	23.9	22.7	27.9	19.4	18.3	9.7	17.5	26.9	45.5	51.4	18.7	12.8	14.9	14.1	22.8	23.4	24.1	15.3	11.6	15.8	14.7	19.3	14.4	16.4	32.4	20.9	14.0	13.1	30.1	8.3	24.9	6.1	16.5	20.7	14.9	10.2	12.1	15.8	8.9	35.9	12.7	5.3	7.6	17.0	22.4	33.3	14.5	12.1	14.3	13.3	18.0	22.2	33.4	38.9	11.6	14.9	21.0	20.8	17.7	19.5	24.1	20.6	13.7	15.6	11.8	17.6	10.9	69.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5	14.9	10.1	20.1	16.4	14.8	20.3	11.3	20.4	13.4	22.7	33.2	5.9	26.2	106.1	40.0	1.0	17.9	18.3	0.0	37.1	41.6	27.2	18.5	9.2	25.9	34.6	47.7	18.9	18.4	13.2	2.8	35.9	14.9	52.3	31.5	12.9	73.9	30.9	17.3	33.9	48.5	23.1	32.3	36.5	3.9	13.0	16.6	10.9	18.7	18.8	16.6
COL4A3BP	"CERT, GPBP, STARD11"	ENSG00000113163	"Collagen type IV alpha 3 binding protein"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.0;WM-115: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	30.0	25.5	16.5	17.1	21.9	17.9	21.4	34.4	21.2	26.9	19.9	14.9	21.5	13.5	20.5	11.6	21.9	17.1	17.4	14.9	15.2	16.3	21.1	22.7	19.6	13.4	22.5	12.4	17.9	12.4	24.6	25.9	17.8	18.2	19.0	14.6	14.8	17.5	16.1	33.4	14.2	19.3	18.9	16.6	17.2	17.0	21.3	20.7	17.8	37.4	14.3	15.9	21.8	19.1	6.4	9.8	20.9	16.6	5.1	8.8	5.7	16.6	8.6	8.3	7.2	52.0	14.5	11.1	9.4	11.6	7.2	9.6	12.9	9.6	8.1	20.3	9.9	10.0	10.1	12.6	12.9	11.1	9.9	5.8	6.7	9.5	6.8	13.2	6.6	7.8	10.9	9.2	8.5	9.7	11.8	8.3	10.7	12.1	12.2	9.5	8.8	7.9	5.0	10.7	3.8	6.4	6.7	11.0	7.4	11.8	20.2	6.4	6.4	11.8	8.3	11.6	18.3	8.1	11.4	11.3	4.9	5.9	8.8	7.7	11.3	14.9	9.4	8.5	11.4	45.0	5.0	13.9	10.6	6.0	15.6	5.6	6.0	6.2	5.6	9.8	6.4	5.9	5.8	20.9	5.1	16.6	5.7	8.8	5.7	16.5	21.9	34.4	21.2	15.2	16.3	22.5	12.4	18.2	20.7	56.6	58.5	6.4	28.0	16.7	30.7	32.7	22.9	71.0	75.1	17.4	21.6	13.6	18.3	19.6	83.3	28.1	19.2	0.0	19.2	13.9	20.9	36.3	47.5	17.9	31.6	41.3	26.4	55.9	33.0	73.0	32.2	37.4	49.0	19.8	15.6	31.1	21.5	13.1	39.3	22.3	33.1	19.4	19.6	41.5	31.5	23.3	23.2	21.3	14.3	38.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.1	19.7	2.3	19.5	22.2	19.8	0.8	21.8	27.4	18.7	21.4	16.7	22.4	7.7	9.7	31.1	7.4	26.3	3.7	23.3	5.0	16.7	24.9	13.8	10.5	39.0	41.5	23.0	5.5	25.2	28.9	16.2	16.1	18.0	17.5	12.5	55.7	16.5	15.0	118.8	9.0	41.3	4.8	52.7	6.7	13.6	19.5	10.6	19.7	60.8	9.5	8.4	7.2	61.7	18.0	1.3	13.3	64.7	20.9	33.4	12.8	10.9	16.3	6.1	2.6	6.3	36.0	31.0	23.0	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7	116.1	64.8	45.5	189.7	90.7	68.3	29.9	109.5	88.3	85.3	144.8	9.8	779.9	271.9	173.4	3.6	68.7	98.5	0.0	167.1	75.3	99.4	123.4	70.4	231.9	281.1	23.8	81.1	74.9	149.0	7.4	124.3	142.1	227.7	154.1	89.3	151.7	163.3	110.1	169.0	60.7	34.5	135.8	91.5	4.4	5.3	107.9	542.4	36.6	110.1	180.5
COP1	"FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1, E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 24.8;Extravillous trophoblasts: 29.0;Syncytiotrophoblasts: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	22.4	15.8	14.8	20.1	16.7	19.1	19.3	24.6	19.7	21.4	23.9	15.3	17.7	16.1	23.5	16.5	22.3	14.9	15.5	14.5	12.8	11.6	17.2	22.9	17.8	24.1	13.1	11.3	14.4	20.8	15.6	24.5	17.2	15.7	15.4	26.1	18.1	20.2	21.4	19.2	25.4	22.1	19.7	10.9	27.1	17.5	23.4	15.0	39.3	18.3	15.8	25.0	22.6	17.6	1.5	2.0	13.7	3.4	0.5	2.7	1.0	14.2	7.7	12.5	6.7	12.5	12.9	23.5	11.0	13.5	11.8	11.2	12.9	15.0	29.1	10.9	12.5	8.7	13.4	11.5	16.8	10.6	9.0	7.0	12.3	9.4	12.8	13.2	22.2	14.3	11.3	14.0	11.6	14.8	11.3	16.7	12.4	18.0	11.5	14.0	17.7	13.1	11.7	21.3	25.9	0.8	11.3	10.8	16.9	16.3	43.9	10.0	17.6	12.9	20.6	14.0	21.8	14.6	29.7	16.1	10.0	7.0	13.4	9.4	14.7	25.2	26.4	8.4	13.2	11.5	6.1	2.7	10.1	1.8	3.4	1.4	1.4	2.1	1.4	2.0	1.5	2.7	2.0	13.7	0.5	3.1	1.1	1.5	1.0	14.8	16.7	24.6	19.7	12.8	11.6	13.1	11.3	15.7	15.0	20.8	16.4	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.7	8.7	0.0	24.8	18.3	12.3	0.0	0.0	0.0	0.0	19.7	29.0	0.0	0.0	7.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	18.0	0.0	0.0	17.6	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 8426.3"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	5.0	13.2	1.2	0.0	0.0	0.0	8426.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.0	77.5	0.0	2.3	847.8	0.0	0.7	0.0	0.0	0.0	0.0	0.5	2.4	0.0	1.4	0.0	0.0	0.0
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2"	"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.1	1.6	2.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.7	22.3	12.5	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	26.0
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.6	14.5	18.8	8.3	11.5	11.4	9.8	8.1	13.7	14.0	13.7	13.1	10.6	15.6	9.7	15.5	9.0	10.9	21.6	6.7	16.0	26.3	8.7	12.2	13.4	8.3	12.8	12.2	17.6	10.1	6.8	15.6	18.9	8.7	10.5	8.0	13.9	21.4	7.6	19.3	8.1	5.9	15.4	5.4	6.0	38.3	14.9	11.9	5.4	7.6	15.7	10.3	13.9	13.7	8.2	12.7	12.2	12.0	16.3	17.2	17.2	8.8	7.4	10.0	10.8	30.3	3.5	7.3	12.1	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2	41.7	45.9	13.8	25.5	49.9	31.9	37.0	43.3	32.1	33.0	10.4	23.6	14.6	5.0	17.4	38.0	35.3	24.0	0.0	17.7	9.4	24.3	32.2	30.0	25.1	17.8	27.0	14.5	32.5	38.7	57.1	52.3	33.5	16.9	27.9	22.4	31.4	22.7	17.3	48.1	10.7	15.8	45.3	36.0	33.1	46.0	51.4	25.7	35.9	23.8	31.6
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 741.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.9	24.7	41.6	39.4	43.0	52.7	44.5	52.8	50.2	41.2	43.4	48.1	50.1	19.7	58.5	56.1	44.2	37.8	29.3	71.1	63.0	28.5	17.7	26.7	28.6	22.1	38.7	41.8	43.0	43.1	73.8	46.2	74.5	45.6	47.4	35.6	22.5	29.7	46.4	23.2	38.3	16.9	21.8	40.9	60.2	28.7	33.0	22.4	28.7	64.4	32.1	28.9	39.2	52.6	64.3	38.5	49.3	36.4	47.0	48.5	25.5	32.1	50.3	27.6	35.4	30.4	45.3	30.4	58.6	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1	137.0	158.5	75.9	513.8	608.0	132.0	46.4	73.9	278.4	290.0	109.9	60.9	146.8	77.9	135.8	55.7	139.6	98.3	23.3	160.7	185.9	198.0	381.5	112.3	94.7	120.9	143.0	124.9	225.9	143.6	66.9	96.4	139.7	145.1	118.2	136.8	145.0	155.3	98.2	105.0	78.9	100.0	155.2	201.9	125.6	93.5	741.0	293.5	102.2	111.1	404.2
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"	"Not detected"	"Not detected"											HPA051334			Uncertain	Cytosol		NA	NA			Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2											0.0	0.0	0.0	1.5	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.4	1.1	2.4	0.2	0.0	0.0	1.0
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 287.2;Late spermatids: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.6	25.8	14.7	20.3	19.4	20.8	29.6	31.9	20.1	22.9	21.5	21.2	18.7	19.8	25.3	22.7	24.3	21.0	13.8	32.3	18.5	16.8	33.4	24.6	20.5	22.6	56.4	20.2	18.9	31.4	23.0	15.5	23.2	28.6	33.3	14.7	27.7	10.5	21.6	25.3	26.0	21.2	15.8	25.7	40.7	22.4	18.2	17.6	24.1	34.0	18.2	32.9	38.1	31.8	35.7	21.4	22.8	26.6	35.1	32.9	29.6	28.6	24.2	23.1	11.1	21.2	26.4	17.3	23.8	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6	44.7	51.2	45.8	92.5	50.4	45.6	14.1	25.5	64.3	62.6	40.1	25.5	56.2	28.2	62.7	287.2	39.4	93.0	0.0	60.1	78.4	37.7	85.7	57.8	25.6	57.5	90.6	44.4	40.5	51.6	600.1	27.9	56.2	27.0	73.1	56.1	34.9	72.9	48.0	37.8	40.4	47.4	38.8	58.6	35.2	26.6	42.2	105.8	64.7	38.3	96.3
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19.0	37.3	27.3	23.4	28.0	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24.0	23.2	20.9	21.8	13.0	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4.0	1.2	23.6	11.5	31.3	30.0	15.7	24.1	23.6	30.9	39.5	28.1	27.3	14.8	18.5	17.8	13.5	29.1	18.9	20.2	23.7	42.7	20.4	28.4	51.7	5.7	38.1	11.3	32.3	12.4	15.2	23.0	36.2	42.8	58.0	36.9	29.8	15.6	12.6	36.8	27.1	15.8	17.3	15.3	22.9	17.2	16.7	32.4	22.4	27.9	25.8	19.9	46.4	18.2	26.3	27.3	30.8	19.4	13.9	18.1	33.9	25.5	27.8	14.7	24.6	16.5	23.6	25.1	37.8	14.0	42.6	3.8	1.8	3.4	3.4	0.8	4.0	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9	35.7	17.1	22.2	117.4	69.8	122.3	44.0	38.2	16.0	23.9	22.7	56.9	29.6	6.6	26.6	42.8	62.1	10.7	0.0	35.7	33.5	53.2	138.6	3.5	18.6	19.2	68.3	60.3	44.8	14.9	42.7	79.1	18.5	57.3	11.8	40.8	105.4	42.3	29.6	62.2	4.1	58.4	71.1	106.1	6.0	9.6	91.6	104.9	13.4	31.9	208.0
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165517-64356259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 121.0;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol		NA	NA			Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	7.2	7.8	10.2	11.9	15.1	11.6	8.7	12.2	10.6	8.7	7.4	7.6	11.6	7.0	11.1	9.9	15.7	10.8	7.8	5.6	8.9	7.6	8.6	6.0	8.4	9.6	6.6	4.7	8.5	8.8	10.4	16.1	7.2	7.2	6.8	7.9	10.1	8.2	14.5	6.5	10.4	6.8	11.1	5.3	8.2	6.8	41.3	7.3	11.8	11.5	5.6	11.2	8.3	10.6	4.1	4.1	8.8	5.1	5.3	8.0	2.4	5.1	10.9	7.9	10.2	6.8	9.3	7.2	6.4	6.6	10.9	9.8	8.7	10.1	8.1	3.5	10.1	11.4	11.9	20.6	12.9	12.8	15.4	5.3	7.6	8.7	5.8	7.8	14.0	9.0	8.2	17.2	11.1	15.9	9.5	11.9	8.4	9.2	8.5	9.8	7.1	7.1	4.4	7.4	6.8	5.7	12.0	9.9	6.5	8.8	20.8	12.8	7.8	8.4	5.1	7.4	13.6	8.9	5.5	12.8	9.9	11.9	7.9	7.9	9.8	18.9	6.9	9.2	10.3	6.1	0.9	3.6	5.6	5.7	5.1	8.0	3.6	5.1	4.1	2.7	4.1	5.1	4.7	8.8	5.3	4.3	4.1	3.9	2.4	10.2	15.1	12.2	10.6	8.9	7.6	6.6	4.7	7.2	7.3	26.8	9.9	7.1	8.7	10.3	44.6	6.5	5.1	16.0	13.6	5.2	64.8	5.8	1.7	8.2	121.0	8.4	8.4	0.0	6.1	7.4	8.9	7.9	3.5	4.0	9.4	9.5	21.9	9.2	9.7	209.9	5.8	10.3	6.8	10.0	10.0	6.9	9.1	7.0	9.6	8.7	29.5	6.5	8.5	27.2	18.4	13.7	3.4	7.7	10.3	10.1
CSNK1G2	CK1g2	ENSG00000133275	"Casein kinase 1 gamma 2"	P78368	19	1941149-1981338	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 218.1;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034868: AB_10671235, HPA056572: AB_2683178"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.51e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.83e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-2)"	18.7	22.2	24.8	34.9	19.5	38.1	16.7	30.8	28.9	14.1	19.0	18.2	18.9	27.0	16.5	19.0	22.1	16.9	20.4	16.0	23.3	18.3	19.3	17.9	21.8	35.1	17.3	21.2	18.6	27.0	11.4	24.4	16.7	18.7	18.7	8.7	19.7	26.6	16.0	29.0	23.3	22.1	15.1	12.7	39.1	24.1	58.5	17.4	20.6	16.5	18.1	32.2	17.1	17.1	4.0	5.9	11.2	14.1	3.5	4.9	2.3	23.3	12.6	17.5	27.5	6.2	11.6	14.7	14.5	9.6	11.1	13.6	10.3	12.8	14.7	12.2	9.2	6.1	16.9	9.4	17.7	4.9	13.3	20.4	10.4	20.5	17.4	9.9	16.5	26.4	11.5	11.7	11.5	7.4	8.5	13.1	18.4	21.7	50.6	7.3	13.6	32.8	21.8	31.8	6.5	14.2	28.6	11.1	23.8	8.3	24.6	28.3	23.2	11.0	18.1	16.0	6.9	11.5	27.3	15.6	14.0	11.0	29.3	16.8	32.7	17.3	18.0	14.2	15.7	14.6	2.8	4.0	5.0	4.9	6.2	3.5	3.9	3.6	4.2	3.9	4.0	2.9	4.1	11.2	3.5	14.1	5.9	2.5	2.3	24.8	19.5	30.8	28.9	23.3	18.3	17.3	21.2	18.7	17.4	14.9	17.0	12.0	15.7	19.5	44.1	10.1	7.6	13.4	14.8	10.4	39.3	9.9	8.3	15.1	218.1	19.9	22.5	0.0	25.3	17.2	15.8	22.1	29.9	14.0	12.9	23.8	29.2	14.1	17.0	503.0	19.0	20.5	13.5	5.4	20.2	21.3	24.4	16.5	17.7	12.6	37.2	12.9	14.4	15.6	13.1	22.1	15.2	27.3	18.0	28.5
CSNK1G3		ENSG00000151292	"Casein kinase 1 gamma 3"	Q9Y6M4	5	123512099-123617045	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027010	Approved					NA	NA					"HPA027010: AB_10602803"	"unprognostic (1.28e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.92e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.38e-1)"	20.7	15.0	15.5	21.7	22.7	11.1	37.7	23.7	31.7	18.8	24.0	8.6	11.2	23.5	19.4	18.4	18.8	14.6	17.7	14.0	22.2	18.0	16.2	27.7	29.0	21.8	13.3	17.7	18.7	15.8	18.6	18.1	16.2	16.6	13.2	27.4	9.1	15.3	14.1	15.6	13.4	24.9	18.6	16.1	16.5	18.2	16.4	11.4	17.2	16.2	16.5	17.4	21.9	18.2	13.6	5.3	11.3	5.9	12.7	9.5	5.1	13.1	12.6	19.0	18.0	19.4	21.8	9.4	14.3	17.1	15.8	23.7	11.3	21.1	0.0	18.6	17.1	18.4	9.6	15.2	28.2	27.4	19.8	10.4	9.3	14.7	12.0	17.3	4.8	9.6	18.4	18.4	17.8	33.8	18.9	17.2	6.5	5.2	10.7	13.3	9.1	6.5	6.0	10.7	10.4	8.7	7.3	20.1	12.5	11.8	14.5	16.5	12.0	15.8	10.5	23.1	16.5	13.8	13.7	15.7	23.4	17.6	14.1	15.7	12.0	13.2	11.8	14.0	14.0	15.0	11.3	5.8	2.5	7.1	5.6	9.5	13.6	5.9	6.2	5.3	12.9	6.1	6.4	4.6	12.7	5.9	4.7	7.3	5.1	15.5	22.7	23.7	31.7	22.2	18.0	13.3	17.7	16.6	11.4	20.8	13.1	23.3	20.5	18.3	27.5	18.7	5.1	18.7	12.5	10.4	7.9	7.5	18.3	20.1	6.7	24.5	25.7	0.0	21.9	13.3	21.6	23.4	5.7	20.9	8.5	85.8	31.4	31.9	15.4	9.7	18.4	16.5	15.1	24.4	23.7	25.7	24.4	40.3	18.4	17.0	2.8	0.0	15.5	22.0	52.1	16.4	5.6	27.4	22.3	37.6
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	21.5	26.7	23.2	20.6	31.3	16.7	24.1	26.3	32.8	22.2	26.1	28.2	19.5	21.9	24.3	15.7	31.9	23.3	17.7	29.2	21.8	21.9	24.5	23.1	18.6	21.9	21.3	22.6	24.9	27.5	27.7	24.6	23.1	29.4	20.7	24.2	19.6	23.8	22.4	58.8	27.0	22.5	23.3	21.3	21.8	26.5	51.6	23.2	30.3	22.4	22.4	25.7	26.2	22.8	19.8	25.4	23.3	27.3	18.7	19.4	15.7	44.4	39.7	36.7	22.6	14.0	24.5	23.8	26.1	26.4	30.3	33.8	40.0	29.2	39.7	16.8	21.5	42.6	34.5	40.3	39.1	43.2	13.9	14.6	53.8	10.6	38.7	24.1	46.7	11.9	22.4	41.4	27.9	77.7	29.7	32.7	34.5	52.8	26.2	27.7	14.7	56.1	16.6	52.5	39.9	27.4	33.4	32.1	32.4	26.1	28.2	38.4	30.6	22.3	43.0	39.7	29.7	28.7	18.3	30.7	32.2	27.6	20.8	38.6	27.2	64.0	39.2	16.1	28.1	32.5	23.3	19.7	22.2	16.1	27.3	19.4	19.8	15.7	15.5	25.4	18.9	16.0	15.0	12.1	18.7	25.2	21.1	16.4	15.7	23.2	31.3	26.3	32.8	21.8	21.9	21.3	22.6	29.4	23.2	59.6	72.9	45.0	31.0	36.5	45.7	53.7	33.1	80.3	85.3	41.8	29.5	35.3	34.9	61.1	104.2	34.8	33.8	0.0	43.6	47.2	34.8	36.9	60.3	26.4	28.9	57.2	33.8	22.1	30.2	104.8	38.0	35.3	13.5	67.7	41.3	34.4	54.4	24.6	34.6	56.2	26.8	51.8	32.5	61.3	54.1	43.8	51.4	32.4	39.1	45.0
CSNK2A2	"CK2alpha', CSNK2A1"	ENSG00000070770	"Casein kinase 2 alpha 2"	P19784	16	58157907-58197920	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 194.0;Late spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.49e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.40e-5)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (6.84e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	22.8	14.5	15.2	15.2	14.2	14.8	33.5	11.1	17.0	20.4	22.2	12.6	15.1	11.7	19.0	21.4	20.2	15.8	18.7	19.7	12.8	11.5	16.2	21.1	20.0	28.7	10.8	13.9	23.9	28.1	34.3	14.4	29.1	11.6	22.0	15.0	12.9	15.6	15.2	25.4	50.5	18.0	18.8	11.2	26.6	21.1	69.1	10.2	44.3	25.9	12.0	18.5	28.9	33.8	8.9	8.0	8.7	14.1	12.8	14.5	11.7	18.5	20.9	16.2	19.3	22.9	32.4	28.6	14.4	22.2	28.7	18.2	39.1	15.9	33.9	20.3	20.2	14.3	21.9	29.1	26.0	36.5	11.2	15.9	18.6	14.0	34.9	35.2	30.0	19.1	31.7	39.0	21.7	38.8	29.2	30.0	30.8	37.4	9.9	17.4	12.9	29.6	24.9	26.0	9.5	24.3	40.4	33.1	17.9	21.3	20.7	13.7	15.6	34.5	16.2	27.5	25.5	10.1	25.2	24.6	19.7	23.4	15.4	19.2	22.7	18.6	48.2	17.5	20.8	18.3	8.7	14.1	7.4	11.9	12.4	13.5	8.9	14.2	11.6	8.0	7.8	14.3	14.5	0.7	12.8	10.8	7.6	10.7	11.7	15.2	14.2	11.1	17.0	12.8	11.5	10.8	13.9	11.6	10.2	11.9	16.1	14.2	9.3	26.3	21.2	19.7	10.2	13.4	3.4	8.7	3.9	13.4	6.6	13.1	194.0	21.7	13.4	23.3	14.7	21.3	13.6	13.7	8.1	16.3	14.8	17.5	16.1	16.0	26.2	237.3	13.3	17.6	11.8	6.4	12.3	21.7	19.9	13.1	18.4	11.5	21.4	12.9	15.5	43.2	38.8	25.3	20.5	15.2	15.1	20.1
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665236-31670343	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved					NA	NA					"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	28.1	30.5	26.6	28.8	28.0	30.3	27.6	26.9	42.9	29.9	32.7	30.8	24.0	13.9	26.2	101.7	51.5	30.1	32.0	43.8	24.4	23.1	41.1	49.8	34.4	33.8	25.4	24.6	32.9	42.1	3.5	26.4	39.6	23.6	34.3	26.0	30.4	30.3	32.5	40.8	58.3	31.6	32.2	26.6	33.3	26.9	66.0	20.8	60.2	38.5	41.8	33.4	28.3	25.9	20.6	24.9	21.3	22.8	16.3	20.2	16.0	0.0	6.6	0.0	10.9	6.6	11.1	8.1	15.3	26.4	31.2	29.5	0.0	9.6	23.5	8.2	11.2	7.6	0.0	0.0	26.9	30.6	11.4	27.4	0.0	0.0	0.0	16.9	25.7	0.0	21.4	0.0	0.0	0.0	0.0	0.1	13.0	0.0	0.0	0.0	0.0	14.6	0.0	7.8	17.6	0.0	11.9	0.0	15.0	14.9	8.8	0.0	18.6	0.1	0.0	11.6	7.1	0.1	0.0	7.5	13.1	15.8	14.8	0.0	9.7	15.1	14.9	9.3	0.0	11.8	16.5	22.8	21.3	16.2	22.3	16.0	20.6	16.7	16.7	21.1	16.4	14.4	12.7	18.4	16.3	14.1	24.9	20.2	16.0	26.6	28.0	26.9	42.9	24.4	23.1	25.4	24.6	23.6	20.8	47.6	61.3	116.2	104.5	165.3	59.1	72.4	79.0	78.9	69.4	96.0	11.8	179.7	228.8	159.2	342.7	124.4	178.9	23.3	152.4	207.2	146.1	108.2	129.0	116.0	254.7	46.1	120.6	101.3	177.4	185.4	142.4	189.2	145.1	172.3	148.8	98.5	153.7	196.4	117.8	289.9	31.0	135.8	118.5	386.2	176.3	162.9	235.8	124.6	164.7	113.8
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679801-79756623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 89.2;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	10.6	8.2	6.2	12.8	9.5	21.8	9.5	7.5	12.2	7.9	12.0	14.4	5.3	13.4	11.9	9.3	11.4	9.8	10.0	6.6	6.8	5.7	8.9	13.4	10.2	14.4	12.3	5.1	7.7	13.4	4.6	7.9	10.6	9.1	9.1	6.2	8.4	10.6	8.3	12.1	20.9	13.8	8.2	6.8	15.3	12.2	27.2	10.6	26.2	9.4	8.8	14.8	11.4	8.9	0.7	1.5	6.4	1.0	2.4	2.0	0.5	8.1	9.1	5.1	7.2	4.1	3.4	16.9	5.5	4.0	5.0	5.0	6.0	5.2	10.4	2.6	3.6	6.1	10.0	4.3	5.7	2.1	9.6	7.8	5.4	4.5	8.1	5.9	23.7	13.3	5.7	5.5	5.4	2.5	3.1	6.0	7.9	6.5	5.3	1.9	7.3	15.8	18.7	7.9	2.7	12.2	12.3	6.7	12.5	3.7	8.5	7.9	8.1	6.5	6.5	8.7	4.0	5.2	13.9	8.2	8.7	12.6	3.4	5.9	4.5	16.6	10.3	7.4	12.0	6.1	0.0	1.0	6.4	1.3	0.9	1.1	0.7	1.0	2.0	1.5	0.4	1.3	0.7	2.7	2.4	0.9	0.2	0.3	0.5	6.2	9.5	7.5	12.2	6.8	5.7	12.3	5.1	9.1	10.6	0.0	2.6	3.7	4.2	7.6	9.8	3.1	5.1	6.7	3.4	3.5	13.7	7.8	1.7	4.4	89.2	5.2	11.7	23.3	6.2	6.5	4.2	8.1	6.9	5.5	7.7	22.3	5.8	7.4	7.3	97.9	7.2	9.5	6.8	0.0	15.1	7.8	8.0	14.4	9.9	5.7	14.3	0.0	5.1	5.9	6.8	8.8	15.9	13.3	10.6	11.5
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	32.9	22.5	15.9	21.9	13.9	19.9	41.1	12.2	16.4	34.8	30.7	27.6	31.8	24.2	34.5	30.7	31.3	30.9	43.4	25.9	15.5	8.6	34.1	47.5	30.2	33.2	15.0	13.1	44.9	50.8	28.8	12.6	71.3	15.9	41.5	19.8	35.4	34.3	31.5	23.2	30.5	41.3	33.7	12.4	39.1	34.2	15.1	16.1	33.2	41.0	27.2	29.9	32.5	28.4	3.4	6.6	29.3	12.4	6.7	11.0	7.5	10.3	13.3	7.8	25.8	21.4	20.0	29.6	13.9	20.0	13.4	11.7	17.3	25.8	6.2	12.1	24.5	9.2	21.1	11.6	16.7	6.9	22.2	9.1	23.8	16.3	23.1	25.7	14.6	33.4	22.7	20.4	10.2	11.5	21.3	19.7	9.8	19.3	22.4	14.2	28.9	12.8	42.7	5.5	16.5	13.7	17.7	11.1	13.5	17.1	12.7	5.2	13.1	12.1	26.4	13.1	10.4	14.5	35.2	17.2	21.4	13.1	16.3	6.0	14.4	9.3	14.7	19.1	13.9	11.8	20.3	12.4	29.3	11.0	10.2	7.1	3.4	6.7	7.0	6.6	3.2	4.3	5.7	24.5	6.7	10.4	2.3	5.6	7.5	15.9	13.9	12.2	16.4	15.5	8.6	15.0	13.1	15.9	16.1	41.7	40.2	27.7	26.3	24.3	14.0	27.9	45.9	9.4	20.5	29.6	2.0	35.7	28.2	31.7	1.5	43.6	72.4	46.7	37.2	35.9	36.1	31.8	17.4	49.9	35.0	6.4	20.8	58.3	79.9	2.0	55.0	36.2	32.1	26.2	44.5	46.7	32.1	35.1	41.4	42.5	24.7	25.8	34.0	1.6	4.7	17.8	45.4	46.7	37.6	26.7
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846739	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 169.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	44.5	43.6	28.2	31.6	34.8	17.6	39.6	57.1	33.4	49.0	48.4	36.7	47.7	24.4	50.4	32.9	38.0	41.9	37.7	34.6	31.2	16.5	32.8	32.6	51.3	31.3	37.1	19.9	52.5	53.9	33.7	25.4	42.9	31.0	40.5	38.6	29.3	45.8	60.9	48.8	39.9	36.1	44.1	25.7	38.1	43.1	21.0	40.9	62.9	40.1	32.8	33.9	46.1	63.0	7.3	9.3	18.7	9.7	8.2	11.5	7.1	11.0	4.8	23.1	14.7	20.8	35.9	7.7	12.0	22.8	11.9	10.7	6.1	18.1	13.6	13.8	25.5	4.6	8.9	9.6	11.7	12.5	4.5	4.1	18.8	7.4	4.9	19.4	8.5	11.0	34.3	12.4	10.8	9.2	25.6	18.6	8.3	9.8	24.1	5.9	5.1	9.1	5.1	11.7	7.0	6.1	12.2	169.3	17.8	9.3	16.1	4.3	9.6	16.7	9.6	14.4	14.7	17.4	14.9	14.9	10.6	11.6	11.9	4.2	7.2	7.7	16.4	11.9	7.9	8.2	11.5	9.7	14.7	6.9	9.0	8.2	7.3	9.9	8.0	9.3	6.5	11.5	8.7	18.7	8.2	7.7	7.7	6.4	7.1	28.2	34.8	57.1	33.4	31.2	16.5	37.1	19.9	31.0	40.9	68.5	36.0	33.5	41.6	60.0	18.7	31.1	79.0	13.4	23.9	45.4	15.7	36.7	13.3	64.0	44.2	58.1	55.7	0.0	117.0	34.7	57.1	49.1	24.3	49.7	36.0	19.1	46.8	80.4	63.9	111.0	48.1	36.8	40.5	66.7	42.3	41.1	88.4	51.8	45.6	23.9	10.8	71.1	55.2	5.8	25.8	66.6	47.0	40.6	35.4	58.0
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		10000	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.8	6.9	2.9	9.0	11.3	16.2	21.4	10.9	13.8	7.6	8.9	10.0	13.0	0.0	6.7	13.5	3.1	13.3	7.0	20.7	6.1	0.0	5.5	9.7	7.4	22.6	10.3	0.0	2.4	8.3	50.9	8.0	9.6	8.6	10.6	4.4	3.1	0.0	12.5	5.0	3.9	0.0	11.8	6.5	1.0	4.4	5.5	0.1	24.3	10.6	2.4	7.5	6.0	10.8	12.2	12.1	10.4	2.6	8.4	5.5	7.7	10.2	6.8	0.2	0.0	0.0	6.1	5.4	10.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3	62.5	19.3	0.0	13.3	26.8	9.6	33.8	71.4	14.7	31.8	22.7	0.0	27.6	19.9	10.8	21.9	17.5	10.3	0.0	4.2	7.7	21.7	12.0	1.1	13.9	6.3	9.5	43.5	19.0	9.5	32.3	66.4	5.5	8.5	0.0	17.7	7.1	10.0	5.8	92.3	14.9	1.6	25.8	22.7	2.8	15.8	25.1	7.9	2.2	29.9	14.2
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.4	34.0	15.8	19.3	20.5	16.1	13.4	18.0	19.0	17.0	19.4	22.7	28.2	16.7	20.3	9.7	19.2	29.1	32.9	18.9	15.7	17.0	17.2	14.1	24.2	17.8	11.6	12.8	22.4	22.7	28.9	16.0	19.0	26.0	16.5	15.0	17.8	15.2	24.7	16.1	14.9	8.0	12.4	23.0	24.7	23.6	17.1	13.3	21.9	9.7	19.6	8.0	18.1	18.3	17.4	26.2	15.8	10.6	18.7	16.9	25.6	11.7	15.2	22.3	19.9	31.3	18.8	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6	8.9	25.8	20.1	22.0	14.5	30.0	55.8	20.4	33.5	14.8	14.0	13.7	36.6	18.3	35.9	197.3	26.9	10.5	23.3	28.8	45.9	24.6	20.8	18.5	10.5	28.6	19.1	28.7	14.1	17.2	37.1	35.6	23.8	13.5	29.7	16.0	31.3	33.5	10.5	33.9	21.9	53.9	32.3	28.4	43.0	28.9	17.6	25.7	23.6	26.6	17.4
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.3	2.9	3.4	3.8	5.4	7.8	3.1	13.8	20.2	14.4	8.5	2.4	4.4	10.7	5.0	13.5	15.7	3.6	4.0	8.4	21.5	47.2	6.1	5.3	5.2	2.0	10.7	5.3	25.3	8.5	6.8	17.4	18.2	13.7	5.8	7.6	2.2	9.4	20.1	1.4	5.2	7.7	3.6	2.9	4.9	4.7	6.9	10.3	4.7	3.2	4.4	3.3	11.7	4.0	3.4	5.4	4.0	6.7	6.5	24.7	5.6	8.6	5.6	24.8	23.5	12.0	18.1	6.0	5.2	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7	41.7	25.6	39.6	48.8	106.7	75.4	32.7	25.5	12.0	19.4	17.4	88.4	5.4	5.0	18.3	32.8	37.9	13.4	46.7	16.5	3.8	37.2	52.3	78.5	22.1	19.0	63.5	29.9	21.5	32.3	24.7	23.6	47.1	70.9	34.3	10.3	22.6	15.2	18.7	19.8	10.3	49.3	6.5	34.4	52.6	13.8	135.9	3.4	73.4	12.0	56.3
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8;HUVEC TERT2: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.3	8.8	6.2	0.2	0.1	14.0	1.2	1.7	7.2	8.2	2.6	0.1	0.1	1.8	0.3	0.1	17.1	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.9	0.0	38.8	0.5	2.9	1.3	0.5	11.3	22.0	2.5	6.6	3.7	6.0	0.5	2.6	0.0	10.0	16.9	0.0	0.7	7.8	0.0	20.1	18.3	4.0	4.5	0.0	1.8	7.7	13.5	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3	47.6	65.3	5.9	0.6	3.2	19.8	1.9	40.8	16.0	40.9	21.0	2.0	5.6	1.7	27.2	1.2	13.0	2.1	0.0	20.1	14.4	11.4	3.9	23.1	16.3	21.3	17.5	0.0	79.2	64.1	2.2	13.8	42.1	11.8	30.7	7.7	14.5	31.5	1.7	12.7	5.9	2.9	0.0	2.3	3.9	4.1	2.8	11.9	0.7	2.8	9.3
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 80.4;Enterocytes: 44.6;Late spermatids: 59.2"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.1;HaCaT: 8.4;HMC-1: 17.2;MCF7: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.7	1.4	10.1	0.4	0.1	1.9	6.1	1.0	1.1	0.9	1.4	0.2	0.6	6.1	3.4	8.4	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.2	1.1	7.3	0.4	0.2	6.6	0.6	0.1	0.4	0.1	0.7	8.7	0.0	0.3	0.6	2.8	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	1.4	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5	80.4	21.1	2.7	6.6	10.3	0.0	34.6	2.5	2.7	19.4	0.0	0.0	0.1	1.7	7.8	19.1	2.8	44.6	0.0	30.2	0.1	3.1	14.5	15.0	0.8	0.4	4.8	8.1	8.6	1.2	59.2	2.8	1.4	0.0	0.0	13.0	1.6	13.0	28.8	5.3	0.3	0.1	12.9	2.1	0.9	3.4	3.6	0.1	14.9	16.9	10.7
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028569, HPA064809"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028569: AB_10794319, HPA064809: AB_2685357"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	18.8	10.2	12.6	16.6	16.4	10.0	17.2	14.5	29.5	22.5	30.1	13.6	11.5	18.5	33.1	11.5	20.2	18.5	21.9	49.2	12.4	11.0	10.9	11.0	24.5	11.6	11.9	16.8	18.8	21.7	11.1	14.6	26.0	19.7	21.3	6.9	18.2	15.3	25.8	45.2	17.8	17.0	38.8	10.6	14.7	23.3	15.7	12.7	11.8	11.4	11.6	12.9	26.7	17.8	15.0	14.7	23.9	15.6	17.3	19.5	11.0	25.7	20.5	12.8	16.1	9.6	10.9	19.8	35.6	28.7	29.1	19.2	37.7	7.8	14.3	17.5	31.2	20.5	20.6	12.5	20.2	10.6	20.9	20.8	5.7	25.1	21.6	30.6	13.8	21.7	24.7	25.3	26.4	15.2	17.5	24.1	9.8	18.1	24.9	17.7	16.8	13.7	10.4	19.9	10.5	16.5	17.2	18.9	13.3	17.5	20.3	20.3	14.1	24.0	28.9	20.4	15.7	20.8	10.9	45.1	37.5	17.0	33.5	44.4	27.8	22.8	16.5	29.8	14.5	19.9	22.1	14.2	23.9	19.5	15.6	14.0	13.5	14.8	17.9	12.6	15.0	11.3	10.8	23.9	17.3	10.6	14.7	17.6	11.0	12.6	16.4	14.5	29.5	12.4	11.0	11.9	16.8	19.7	12.7	23.8	10.9	16.6	82.6	89.4	12.3	27.3	17.8	5.3	7.9	10.4	2.0	40.8	14.9	91.0	24.5	19.4	61.2	0.0	75.9	65.4	32.8	38.1	20.7	6.0	20.1	11.1	26.2	20.3	16.7	17.7	21.0	12.0	35.4	33.3	33.0	11.1	89.1	42.1	21.2	11.5	10.2	32.3	50.1	15.2	15.6	62.7	77.9	17.5	20.3	41.6
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 84.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	16.7	15.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	12.9	19.8	0.0	10.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	14.6	7.3	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	1.1	0.0	0.5	0.0	4.1	2.5	0.0	0.0	1.2	6.1	0.0	0.0	0.0	0.0	3.4	4.3	0.7	0.1	0.0	0.0	1.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0.0	1.0	13.5	2.2	5.1	0.0	4.0	4.5	3.5	3.9	0.0	0.0	0.0	1.3	2.9	0.0	0.0	0.0	0.0	9.3	0.5	0.0	0.0	0.1	9.5	0.0	0.6	0.3	0.9	19.2	0.0	13.5	0.0	0.0	84.2	0.3	0.0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0.0	0.0	0.0	1.3
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA					"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.6	2.9	0.0	0.9	0.3	8.4	19.4	2.8	0.6	0.1	0.0	0.0	0.3	8.5	2.8	0.0	2.7	0.0	3.5	3.8	1.6	0.0	4.9	0.0	4.0	0.5	0.5	0.5	0.0	1.7	0.2	1.7	0.9	0.5	0.0	0.0	1.9	0.1	0.3	0.0	0.4	0.2	1.0	0.0	2.1	0.7	0.0	0.8	7.1	6.8	3.5	2.6	0.8	1.6	0.0	0.0	1.6	2.6	1.0	1.7	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9	0.0	0.0	0.0	0.1	0.5	18.2	9.1	2.5	0.0	1.2	3.5	15.7	0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.6	0.0	2.2	0.9	4.6	0.0	1.3	33.4	2.9	8.6	0.0	0.0	1.7	1.0	5.0	0.0	0.2	39.2	0.2	0.0	3.5	0.3	8.9	12.9	4.1	0.1	0.2	0.5	0.2	0.0	1.3	0.1
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 36.9;SH-SY5Y: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.3	2.3	6.5	1.2	10.9	9.2	0.8	21.7	13.2	7.7	8.2	26.1	4.9	0.0	9.1	24.6	7.6	5.3	23.5	4.5	9.9	0.0	9.0	0.0	6.2	9.1	3.9	16.7	1.0	7.7	0.4	6.5	4.1	9.8	12.3	0.0	0.0	1.8	19.8	1.5	0.8	0.0	7.8	36.9	6.8	0.0	15.2	0.2	33.0	13.7	18.3	35.6	2.8	16.5	2.6	9.7	8.9	1.2	24.0	6.8	5.5	1.6	15.1	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0	32.8	31.3	4.2	4.0	12.2	2.7	11.4	68.8	30.8	13.6	66.3	3.9	1.7	106.1	15.6	17.1	4.5	78.7	0.0	26.7	0.8	23.5	37.8	0.0	94.3	0.9	0.0	32.8	9.2	2.2	18.4	14.7	1.5	11.8	1.0	77.8	59.7	34.2	73.6	70.4	219.6	8.0	12.9	18.9	5.0	5.6	12.5	0.7	3.3	85.4	6.5
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.7	13.4	0.7	0.6	0.3	0.4	0.1	4.4	0.7	0.2	17.1	10.6	0.0	0.8	0.0	6.2	0.0	0.1	9.0	0.5	0.5	0.1	0.3	0.9	0.0	8.6	0.1	0.8	0.1	0.7	0.1	9.7	0.2	2.3	0.0	3.6	0.5	2.5	0.1	1.4	0.2	0.3	0.5	0.0	7.6	0.7	0.4	1.0	0.3	0.0	10.7	0.7	0.7	0.9	1.2	0.8	12.7	0.2	0.1	2.7	9.3	2.5	7.4	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9	26.8	17.1	39.8	83.5	59.4	4.0	32.5	38.2	33.5	17.0	78.5	27.5	13.7	150.9	113.3	87.7	94.4	114.4	0.0	28.5	24.3	96.9	77.4	109.8	27.2	186.9	0.0	143.9	57.7	101.8	14.7	167.1	97.2	97.8	79.4	47.6	79.4	71.2	98.2	143.9	116.9	22.9	103.5	127.7	2.6	12.4	51.8	15.1	33.1	63.1	53.8
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.2	12.1	7.5	8.2	11.5	7.3	16.4	12.1	6.6	6.4	1.2	3.9	2.3	2.5	18.7	5.3	10.7	3.5	1.6	2.5	11.4	10.7	0.9	12.7	1.7	8.0	0.1	4.1	16.6	5.7	5.7	2.8	16.3	3.0	1.2	7.2	5.9	9.5	8.1	1.1	2.8	7.2	3.2	2.2	3.7	44.7	3.8	3.5	8.4	6.5	10.5	8.9	18.8	5.3	6.9	15.4	3.6	9.2	7.7	7.6	7.2	12.0	11.4	9.7	2.3	7.0	1.0	10.7	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0	0.0	2.1	0.9	7.0	7.1	4.9	3.1	2.5	0.0	2.3	3.5	7.9	2.3	1.7	2.4	1.4	6.0	3.6	0.0	15.0	1.5	12.7	3.3	0.0	0.9	0.7	4.8	9.7	10.4	1.2	1.4	6.6	0.5	6.8	0.0	5.5	2.2	5.0	3.5	21.9	22.0	7.6	58.2	23.7	6.3	6.0	5.9	1.4	5.0	3.6	3.7
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.6	21.5	11.2	9.1	19.0	7.9	21.4	10.4	11.9	17.3	12.8	11.5	13.2	6.8	20.6	19.0	16.1	19.3	10.0	19.2	11.2	11.9	14.1	18.1	8.5	15.2	11.9	11.4	39.0	28.4	15.5	31.7	9.3	12.3	15.3	13.7	10.8	16.1	12.7	16.8	11.5	9.2	15.4	16.7	13.6	11.5	9.2	11.3	22.2	18.4	15.5	17.7	14.4	14.7	12.1	8.4	3.3	6.2	14.9	16.2	6.7	9.6	8.8	13.1	12.8	16.2	46.2	11.3	8.5	14.0	12.5	10.6	10.5	2.4	17.0	11.4	7.2	7.8	6.3	14.6	13.0	18.4	7.1	10.7	8.9	8.5	19.9	25.3	10.8	4.7	31.0	18.9	11.7	38.0	24.1	18.6	11.8	19.9	5.4	18.8	8.3	13.2	10.6	10.6	5.2	13.8	12.2	19.1	9.8	14.1	7.4	15.2	7.4	4.7	13.1	37.7	10.4	8.5	6.4	9.4	7.4	10.4	10.7	11.2	6.4	7.4	10.4	10.1	10.2	2.7	3.3	5.1	2.6	11.1	5.5	15.1	12.1	12.3	12.1	8.4	9.6	16.2	14.8	1.9	14.9	6.2	6.2	8.2	6.7	11.2	19.0	10.4	11.9	11.2	11.9	11.9	11.4	12.3	11.3	6.0	10.5	39.8	17.8	14.1	5.0	21.8	17.8	20.1	7.9	7.0	0.0	22.0	19.9	12.0	1.2	11.3	3.4	0.0	15.9	23.6	15.8	9.8	25.3	25.4	17.0	1.6	9.8	13.5	29.4	1.5	25.0	11.3	11.8	26.2	11.4	15.8	10.5	17.5	13.1	22.8	6.2	6.5	10.3	16.4	16.4	15.7	10.9	20.0	23.2	6.3
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 84.2;Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved		Uncertain	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9.0	9.3	2.5	7.3	5.4	8.1	11.8	14.0	5.9	22.0	11.0	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14.0	4.8	8.8	11.0	7.0	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.9	4.5	4.9	5.9	7.1	12.0	3.4	8.7	8.7	9.1	6.2	2.0	3.8	5.1	2.6	14.6	5.0	4.9	5.3	5.6	9.3	2.4	5.7	9.3	6.0	2.2	6.4	2.6	5.0	7.0	8.5	9.3	8.9	10.9	6.6	3.7	12.0	3.5	7.2	4.7	2.0	2.3	5.2	1.3	5.4	1.8	8.8	4.5	6.1	4.4	2.7	5.3	7.4	7.7	24.3	5.9	5.6	3.4	6.6	5.7	5.7	8.6	5.7	3.6	2.5	3.0	6.6	3.6	20.3	9.8	3.5	6.0	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2.0	1.6	13.8	13.3	20.4	16.4	10.7	9.0	8.1	11.8	12.2	9.2	26.8	13.3	11.1	5.8	13.3	46.4	9.5	12.7	29.4	17.0	15.7	31.4	5.9	5.0	10.9	8.6	14.9	3.2	23.3	7.8	4.9	18.1	8.2	23.1	7.4	7.8	84.2	12.2	24.5	20.2	17.3	15.3	13.1	86.0	10.0	5.8	50.7	8.5	3.5	17.0	6.2	34.9	25.8	12.0	20.0	12.7	12.2	2.2	14.9	7.6	5.6
DUPD1	DUSP27	ENSG00000188716	"Dual specificity phosphatase and pro isomerase domain containing 1"	Q68J44	10	75037836-75058514	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"skeletal muscle: 38.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042964	Uncertain					NA	NA					"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.5	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.7;hTCEpi: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.5	1.7	2.4	38.1	22.3	2.9	35.4	10.3	23.8	9.6	6.0	2.6	0.7	10.3	24.8	27.4	0.9	1.7	8.7	11.2	19.4	4.7	0.4	12.0	2.5	43.7	0.2	0.8	21.3	76.4	10.8	17.6	12.4	7.4	1.5	1.8	13.9	15.3	2.5	1.1	1.0	1.5	1.6	1.6	41.1	3.2	6.4	16.9	1.1	7.5	3.1	9.6	16.3	1.2	7.6	1.4	0.4	19.5	16.9	8.4	16.4	2.7	2.9	1.6	0.6	15.1	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7	381.2	398.8	474.0	769.9	1136.9	64.0	181.6	236.9	45.5	126.3	200.7	25.5	239.6	48.0	361.0	67.1	510.4	567.7	46.7	76.6	355.3	824.5	763.6	295.5	297.9	967.3	46.1	687.8	403.9	1172.3	21.1	356.4	1745.4	514.5	55.9	830.1	603.1	188.6	648.8	292.4	25.4	177.1	756.7	886.8	11.8	23.0	1710.3	486.7	546.6	309.1	534.2
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;HaCaT: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.1	2.6	0.2	0.2	19.2	9.9	0.2	4.1	10.8	6.9	5.3	0.1	1.7	4.8	1.4	10.7	5.0	42.3	0.9	4.0	6.0	12.3	0.5	8.2	1.2	0.7	4.5	3.6	5.6	13.8	2.9	7.4	7.5	3.2	0.2	1.2	0.8	1.7	6.5	0.1	0.7	2.8	0.6	1.3	0.3	0.4	11.7	0.3	2.3	3.7	15.8	1.2	0.5	0.5	17.5	2.5	0.9	2.1	1.5	3.5	0.9	5.3	5.1	2.9	2.0	2.6	5.4	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1	0.0	1.7	1.9	12.6	45.2	4.5	3.3	10.2	8.1	6.8	3.5	19.6	2.2	0.0	27.3	29.1	6.3	1.0	0.0	7.8	2.7	8.3	10.9	135.7	50.4	22.0	1.6	42.1	1.8	11.0	2.7	23.0	23.9	21.9	13.6	9.9	13.5	21.9	0.0	12.0	0.7	32.3	0.0	5.1	3.8	2.0	36.1	2.9	29.9	2.2	14.4
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	19.6	16.1	15.1	15.1	17.9	29.5	21.4	31.8	21.5	23.1	16.8	16.4	16.2	16.3	29.9	19.8	38.7	37.4	15.2	15.2	17.2	13.9	19.3	16.5	17.2	21.5	12.7	15.8	26.4	14.9	11.6	28.2	19.1	14.0	18.2	16.8	16.5	22.3	20.3	16.2	27.9	19.7	18.9	13.4	21.5	15.4	19.7	13.8	28.7	16.8	16.2	29.3	20.4	27.3	29.9	20.9	42.6	19.1	28.0	37.6	29.2	19.4	8.4	9.1	9.6	16.5	20.7	16.3	14.3	18.7	18.6	19.1	12.1	14.8	25.3	9.2	15.4	16.7	13.6	11.2	28.8	18.0	17.4	11.7	15.5	6.4	18.5	17.3	17.4	14.6	16.7	35.0	16.6	23.1	16.2	20.6	12.4	16.4	14.9	20.6	10.8	16.7	18.6	14.6	18.3	11.7	6.7	24.5	22.7	15.0	16.2	13.5	7.3	13.2	15.8	16.8	11.4	8.4	9.3	11.7	13.3	16.4	15.2	16.8	15.9	12.6	33.4	12.3	17.7	12.9	24.7	19.1	42.6	26.8	16.9	34.6	29.9	31.7	31.6	20.9	28.1	33.9	31.8	29.1	28.0	16.9	15.9	37.6	29.2	15.1	17.9	31.8	21.5	17.2	13.9	12.7	15.8	14.0	13.8	8.9	11.8	34.3	47.9	73.8	9.4	6.9	33.1	26.8	22.7	12.2	3.9	27.8	43.1	24.2	5.9	29.2	13.5	23.3	24.2	35.1	26.6	23.0	41.4	12.9	27.5	4.8	11.5	29.4	22.3	5.6	26.7	20.5	21.9	42.3	19.0	9.3	22.5	17.8	24.1	38.5	13.9	6.5	22.8	23.6	31.8	72.5	32.3	32.4	17.2	54.2
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	15.6	12.1	15.0	16.0	17.2	37.8	21.2	27.2	20.3	14.0	14.2	13.9	16.6	11.7	19.5	14.0	12.7	15.6	12.1	11.9	12.6	12.7	14.0	11.4	14.1	18.5	18.6	13.1	18.4	16.7	10.7	18.7	16.4	14.7	13.6	16.0	15.2	13.8	15.1	8.6	12.6	14.4	16.5	12.0	17.4	13.8	8.2	19.4	11.1	15.9	9.4	18.4	14.4	14.1	16.0	17.8	18.7	15.4	23.1	19.4	10.6	18.2	17.3	18.9	12.7	10.1	11.0	17.9	14.6	19.1	22.6	17.5	24.5	16.1	11.1	15.3	17.7	14.2	13.2	14.7	17.9	22.0	14.5	13.0	9.9	15.7	15.9	21.4	21.1	9.9	14.8	19.7	19.6	35.3	12.8	15.7	15.6	17.6	12.2	16.2	17.0	12.3	24.0	30.2	19.4	25.1	18.1	18.5	18.2	12.7	22.5	12.1	25.7	12.4	20.8	24.2	21.7	18.1	24.4	10.9	19.5	18.2	15.2	31.1	20.6	17.0	26.5	12.1	21.4	19.2	18.7	13.9	10.2	16.1	15.4	19.4	15.5	18.1	15.3	17.8	16.0	17.5	19.1	5.5	23.1	9.2	8.2	15.3	10.6	15.0	17.2	27.2	20.3	12.6	12.7	18.6	13.1	14.7	19.4	17.9	10.9	26.6	12.4	12.0	14.1	4.4	7.6	4.0	12.5	7.0	7.9	18.4	18.3	17.8	3.2	19.6	5.3	0.0	21.0	18.7	16.5	15.2	17.4	6.6	17.6	9.5	10.9	16.5	25.1	0.5	8.1	14.3	10.1	19.0	9.7	11.1	16.9	5.8	16.6	14.6	15.6	0.0	20.0	10.6	12.0	11.4	14.8	20.1	11.8	10.7
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 75.2;testis: 18.6;tongue: 26.0"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 345.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	75.2	0.1	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	1.0	26.0	1.9	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	12.2	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	10.9	0.6	0.0	0.0	0.7	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	345.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	54.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.6	2.7	1.8	2.5	0.0	0.0	0.1
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.2	6.2	10.9	12.7	0.9	1.9	0.1	0.7	5.9	0.1	1.4	0.1	4.8	18.3	0.1	0.6	0.0	1.1	2.0	0.8	0.4	1.3	4.8	2.9	3.8	2.0	0.6	0.2	0.2	0.4	0.0	8.0	0.3	0.8	0.2	0.2	0.0	0.0	0.7	0.5	0.2	2.7	0.7	1.3	0.1	0.4	0.7	1.2	3.2	0.6	1.0	0.8	8.7	2.0	0.1	4.1	0.0	0.2	0.1	0.0	0.0	10.5	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5											6.0	4.8	5.9	152.9	159.6	6.2	14.2	5.1	52.2	26.1	7.0	7.9	141.3	24.9	33.6	35.0	22.7	0.0	0.0	13.2	71.8	47.7	52.8	87.4	10.2	17.0	14.3	2.4	14.7	2.8	40.7	12.7	10.4	59.1	43.3	1.0	9.0	46.1	1.1	5.6	11.8	18.7	0.0	52.6	28.9	29.2	80.9	56.8	6.4	0.8	72.6
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.4	0.1	1.1	2.2	0.3	3.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	17.7	2.1	0.1	0.0	0.0	2.5	5.1	2.9	0.0	4.4	0.2	1.3	1.1	0.0	0.0	4.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4	0.0	0.0	0.0	1.0	0.6	0.5	2.0	2.5	0.0	0.0	17.4	3.9	0.0	232.1	1.7	237.5	0.7	0.0	0.0	0.9	0.1	2.4	0.7	0.0	0.0	0.5	6.4	1.7	3.1	0.0	743.6	8.1	0.8	6.8	1.0	0.0	2.7	0.9	0.0	10.3	33.5	0.2	0.0	1.0	85.0	5.2	0.1	0.1	0.0	0.0	0.1
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12474210-12562383	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 56.3;Intestinal endocrine cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 6.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 23.7;RT4: 21.6;SuSa: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	6.4	32.8	6.3	14.8	7.5	3.4	12.5	16.4	7.1	8.8	13.1	6.7	9.5	13.6	11.0	9.1	9.5	6.8	12.3	5.8	6.7	5.4	6.6	34.2	17.0	13.2	8.0	3.6	8.5	13.9	11.6	31.4	21.3	7.7	13.9	11.7	9.2	17.4	9.5	8.3	7.9	20.1	5.7	9.1	12.2	9.9	8.6	9.2	40.7	10.8	6.8	16.7	10.9	13.4	0.1	0.2	1.4	0.1	0.1	6.9	0.5	2.7	4.0	5.1	2.7	1.8	2.3	8.5	1.6	3.7	4.1	5.9	11.9	5.2	0.2	0.9	1.8	7.2	1.8	9.0	1.5	5.8	8.7	4.5	0.4	4.3	13.3	3.8	0.8	1.8	1.8	4.5	3.3	10.7	4.6	3.1	4.6	2.3	7.3	0.3	5.9	1.0	0.6	23.7	7.1	1.3	1.2	1.7	4.9	2.5	21.6	7.8	7.4	6.5	8.7	4.3	19.7	3.3	1.5	2.8	1.8	5.4	1.1	1.9	5.2	6.0	0.9	2.5	1.8	2.5	0.0	0.0	0.0	1.1	0.1	4.6	0.1	3.2	1.5	0.2	0.1	1.1	0.7	1.4	0.1	0.0	0.0	6.9	0.5	6.3	7.5	16.4	7.1	6.7	5.4	8.0	3.6	7.7	9.2	26.8	56.3	2.9	13.7	2.5	4.2	11.2	17.8	16.0	14.8	3.5	2.0	8.1	0.0	11.0	1.1	6.3	28.9	0.0	21.0	2.7	4.1	30.4	23.1	28.4	4.4	6.4	47.6	6.7	8.3	2.0	5.5	2.6	5.0	4.6	7.1	37.1	19.9	17.6	6.3	4.1	4.8	0.0	3.1	1.6	5.8	1.6	25.2	13.4	16.1	12.8
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667890	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.5;Late spermatids: 252.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	5.2	3.9	10.1	7.1	9.7	4.9	5.3	4.1	8.3	5.6	10.1	11.4	4.6	7.8	6.1	8.4	7.5	18.5	8.0	3.8	8.7	7.8	5.5	2.3	9.9	7.2	8.4	3.9	4.4	6.6	5.2	19.5	3.6	9.5	4.6	11.5	4.7	6.1	4.3	2.0	7.9	11.0	6.4	9.0	6.9	8.3	30.8	10.2	8.0	5.8	3.4	7.6	6.0	6.1	6.4	11.2	21.7	13.9	4.3	8.1	4.7	5.3	5.8	2.6	6.5	6.6	13.1	2.5	5.1	5.9	5.2	5.6	3.1	5.7	3.5	3.6	6.4	6.6	4.0	1.6	4.1	5.8	10.0	6.4	1.8	2.0	2.0	2.8	7.5	5.9	3.7	5.8	8.6	3.1	5.8	15.9	4.3	1.8	3.2	5.6	4.6	4.1	1.8	1.0	6.6	3.5	3.0	1.7	1.3	6.3	3.7	6.7	3.8	5.3	2.1	3.7	3.6	4.7	2.1	11.4	10.7	5.8	2.7	2.9	2.3	2.7	1.8	12.1	1.3	5.4	18.3	10.4	19.4	5.9	12.5	4.6	6.4	6.8	5.4	11.2	6.2	4.6	5.5	21.7	4.3	13.9	6.4	8.1	4.7	10.1	9.7	4.1	8.3	8.7	7.8	8.4	3.9	9.5	10.2	17.9	4.8	6.0	10.2	19.1	2.6	1.9	7.6	64.3	11.4	5.2	43.2	1.0	3.3	7.4	103.5	9.0	14.8	0.0	8.2	3.0	9.3	7.5	6.9	0.9	7.3	1.6	34.1	9.8	12.7	252.1	7.8	16.2	8.5	6.4	18.0	9.2	7.0	14.0	6.3	3.0	16.3	6.5	7.2	68.7	18.8	18.6	0.8	8.6	18.5	6.4
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100005	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 20.1;Early spermatids: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	2.8	4.6	9.2	2.0	16.3	1.0	3.0	2.9	9.6	3.4	4.7	2.2	3.8	3.5	6.8	9.2	4.2	8.4	3.5	7.4	17.4	3.4	4.7	3.0	3.4	2.3	3.3	6.8	4.4	4.3	7.7	10.6	2.7	3.7	4.2	3.0	3.0	2.8	5.4	3.8	3.4	3.0	8.6	2.9	4.0	9.1	10.4	4.7	6.2	4.6	1.1	1.9	4.0	2.7	4.1	1.5	2.0	0.8	2.2	3.2	1.3	0.1	2.4	2.9	1.4	3.9	2.2	0.0	1.1	1.8	4.6	1.6	2.3	3.0	1.0	6.0	1.2	3.3	0.3	5.7	0.8	3.5	5.8	3.2	10.6	1.8	1.6	1.7	2.6	6.5	1.7	0.5	2.3	1.1	2.9	2.6	0.0	3.1	1.6	2.7	1.0	5.0	2.5	2.4	1.0	2.0	4.9	4.5	0.3	1.0	1.1	3.6	1.5	4.0	1.7	2.9	0.2	0.8	1.0	2.0	2.5	2.1	1.7	0.9	2.0	2.4	0.1	3.1	0.4	3.7	2.0	0.5	1.9	2.3	0.8	2.3	4.1	2.1	3.1	0.6	2.2	2.7	2.7	1.3	2.2	0.4	1.5	3.2	1.3	9.2	16.3	2.9	9.6	17.4	3.4	3.3	6.8	3.7	4.7	0.0	2.7	1.7	1.2	0.9	1.7	6.5	2.5	20.1	2.3	1.8	2.0	2.0	5.0	0.6	10.4	1.0	1.6	0.0	0.6	1.2	1.3	0.9	1.1	1.0	0.6	1.6	2.4	1.8	0.6	4.6	1.7	0.1	0.0	1.8	2.0	4.5	0.5	2.5	2.5	2.3	1.0	0.0	1.4	4.7	3.1	1.4	0.6	0.0	2.1	1.3
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 136.7;T-cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.3	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.6	2.1	0.0	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	14.2	0.0	17.5	0.1	2.6	12.5	14.5	3.4	0.4	5.4	0.0	0.2	12.1	0.1	17.4	15.5	0.8	0.7	0.2	2.8	0.0	1.0	7.2	0.0	0.0	4.1	0.0	0.9	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7	0.0	10.6	47.7	90.1	86.0	22.1	33.5	2.5	0.0	1.2	8.7	21.6	0.8	1.7	0.9	0.7	8.2	3.3	0.0	1.2	1.1	24.2	63.5	105.8	2.8	75.6	0.0	84.2	8.6	27.5	0.7	1.7	90.7	136.7	0.0	12.3	1.3	0.9	2.9	1.8	1.0	2.5	0.0	35.3	0.5	4.3	95.9	1.4	346.4	21.8	28.5
DUSP21		ENSG00000189037	"Dual specificity phosphatase 21"	Q9H596	X	44844004-44844888	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 15.9"	"Group enriched"	"Detected in some"	54	"Early spermatids: 58.8;Late spermatids: 167.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 1.7;K-562: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (5.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.1	0.1	5.0	4.1	5.9	4.6	5.4	14.1	0.0	30.0	5.5	1.3	0.5	3.4	4.5	3.2	3.0	1.5	16.9	4.8	0.0	19.3	10.2	13.0	46.8	12.3	3.8	13.9	4.3	22.6	0.0	7.7	6.2	8.3	22.2	1.0	0.4	22.9	22.1	18.9	0.0	0.0	5.8	7.2	2.1	5.8	12.8	9.1	20.0	23.4	2.4	12.9	16.0	16.5	4.9	0.2	0.6	0.0	4.4	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3	38.7	65.7	25.0	97.5	66.2	8.4	26.4	94.3	38.8	83.0	48.8	5.9	13.5	222.2	148.8	39.6	154.1	106.2	0.0	394.0	20.1	31.9	94.9	53.1	219.9	155.2	1.6	34.0	66.3	86.6	5.5	24.5	94.8	40.5	32.5	101.6	59.7	258.6	101.7	14.9	620.9	7.1	12.9	32.0	3.2	13.0	65.1	4.8	43.7	91.6	102.1
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.2	11.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8	0.0	0.0	0.0	0.2	0.0	76.1	54.3	0.0	0.0	0.0	0.0	39.3	0.0	18.3	0.3	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	23.8	24.6	0.0	0.0	4.4	0.0	0.0	1.7	0.0	0.0	13.3	1.6	0.0	5.6	0.8	58.5	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 131.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 18.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	131.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.5	19.2	7.4	7.9	21.6	11.6	6.3	8.0	19.2	18.8	22.8	18.4	7.1	1.6	12.7	15.0	39.0	9.2	11.4	9.8	19.9	3.6	8.7	5.3	8.8	15.0	26.4	0.6	5.6	10.7	17.8	14.5	12.6	20.6	13.1	5.4	4.8	1.8	21.9	7.6	2.7	2.7	3.4	15.1	14.0	3.4	22.3	4.0	26.1	11.2	4.1	7.5	9.4	6.3	23.6	21.3	28.1	14.9	13.6	21.3	14.5	30.2	13.2	9.8	13.0	0.4	25.3	7.5	7.1	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8	23.8	16.8	7.2	42.9	19.9	16.3	242.3	48.4	14.7	9.1	40.1	23.6	14.4	34.9	42.9	73.8	32.1	42.0	0.0	50.5	17.5	18.4	41.2	38.1	99.4	73.0	19.1	34.9	27.6	34.5	128.1	13.6	40.3	10.1	32.5	17.6	14.8	50.2	28.1	24.8	69.4	16.6	32.3	35.5	2.4	2.9	25.2	37.6	6.4	14.6	32.8
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	29.9	17.8	0.8	2.2	0.0	1.5	2.3	12.7	7.0	3.1	0.3	5.7	0.0	6.3	1.0	4.9	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.1	13.1	15.4	5.7	0.1	0.1	1.3	14.0	12.6	0.0	2.0	3.1	27.1	18.4	0.3	0.5	2.3	16.1	5.9	0.1	9.8	3.2	15.2	46.1	0.3	3.2	0.3	16.0	5.1	0.0	0.0	1.6	3.5	0.4	0.0	15.6	2.6	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2	0.0	3.2	1.4	94.6	10.8	34.2	1.9	28.1	29.4	15.9	0.0	11.8	2.7	0.0	64.0	3.5	10.8	0.4	0.0	66.9	37.5	8.4	20.9	5.8	0.0	19.5	41.3	93.8	19.6	5.0	19.7	0.3	25.0	62.4	131.7	7.6	0.9	166.3	0.0	0.0	0.0	2.8	12.9	12.2	0.6	0.4	10.5	14.9	8.5	2.2	92.0
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497838-110511544	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal glandular cells: 372.8;Urothelial cells: 958.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.4;non-classical monocyte: 8.8;plasmacytoid DC: 13.3"	"Group enriched"	"Detected in many"	19	"dendritic cells: 13.3;monocytes: 8.8;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 87.7;Karpas-707: 34.0;U-266/70: 48.5"	"Region enhanced"	"Detected in many"		"cerebellum: 68.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.9"							NA	NA						"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	13.7	11.0	2.8	12.4	5.1	14.5	11.2	19.8	5.2	15.1	12.5	3.3	7.7	5.4	9.1	8.8	55.5	5.6	24.2	11.3	5.2	3.3	9.1	13.1	12.1	9.3	2.9	2.8	6.5	3.9	5.5	8.0	45.1	5.6	15.6	12.4	21.0	9.4	10.0	1.8	6.5	17.6	10.3	7.1	11.4	10.2	13.1	2.1	4.8	7.8	21.9	47.8	31.6	14.3	0.2	13.3	0.4	8.8	0.0	3.4	0.5	4.4	3.0	0.6	1.5	2.4	10.2	2.2	10.6	24.0	5.7	6.9	1.9	6.0	0.5	2.0	2.5	12.2	1.4	0.6	5.5	9.3	12.7	0.3	2.4	0.5	1.1	9.1	0.6	3.2	3.9	7.6	18.2	87.7	2.5	3.5	0.2	0.4	34.0	17.0	1.2	0.1	1.8	2.0	0.4	4.6	0.0	1.3	7.8	19.5	8.7	0.3	0.8	0.7	1.7	3.5	5.7	0.9	0.7	5.5	1.9	1.3	4.6	5.0	48.5	8.6	1.2	7.5	3.3	1.3	0.4	0.2	0.0	3.4	2.0	1.2	0.2	1.8	1.0	0.9	0.0	0.0	1.1	0.1	0.0	8.8	13.3	0.0	0.5	2.8	5.1	19.8	5.2	5.2	3.3	2.9	2.8	5.6	2.1	3.0	8.5	17.2	372.8	58.6	8.2	28.2	7.6	0.0	18.2	33.2	5.9	30.4	5.0	26.2	1.0	35.0	36.5	0.0	4.2	9.9	26.3	104.8	3.5	4.0	9.3	0.0	46.8	165.1	18.3	1.9	1.4	20.8	150.1	76.7	7.8	2.5	31.7	14.0	0.7	0.3	10.6	0.0	31.1	1.0	9.1	89.1	114.9	25.9	7.6	958.4
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056550	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 104.2;Suprabasal keratinocytes: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 41.4;hTERT-HME1: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073007	Approved					NA	NA					"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	5.5	5.9	7.8	4.3	8.5	1.6	3.7	6.5	19.2	8.6	2.9	15.3	3.4	2.4	5.6	2.4	22.0	4.4	5.3	8.3	7.3	4.8	3.6	2.5	7.0	5.6	9.9	10.0	4.7	4.3	3.9	3.8	8.9	4.9	4.0	2.3	4.6	5.2	5.3	11.4	24.1	3.5	4.2	4.8	10.7	3.7	5.4	9.2	3.2	3.4	15.0	8.6	5.8	14.7	1.0	7.5	1.7	10.7	2.3	8.2	1.7	7.6	1.6	1.9	4.4	6.3	5.5	2.3	7.7	14.8	7.7	5.6	2.1	3.9	2.1	2.1	11.4	3.9	9.0	7.4	28.0	5.3	1.8	3.0	10.0	3.9	3.7	5.1	8.9	6.1	5.7	41.4	9.9	35.3	5.3	7.3	6.2	5.7	6.1	6.1	2.1	6.6	12.7	4.8	2.1	14.0	5.6	1.7	5.6	3.2	3.3	2.4	7.2	3.4	3.2	5.4	1.6	1.1	21.6	9.5	14.9	9.6	15.6	23.5	2.9	2.7	3.4	8.2	15.1	4.7	0.9	3.9	1.7	6.0	10.7	8.2	1.0	7.2	4.3	5.0	0.6	5.3	4.8	1.4	2.3	10.0	7.5	4.6	1.7	7.8	8.5	6.5	19.2	7.3	4.8	9.9	10.0	4.9	9.2	8.9	0.6	1.5	23.5	104.2	4.7	15.3	0.0	1.4	5.7	0.0	0.0	0.4	1.7	3.3	1.1	11.3	0.7	0.0	2.3	3.4	9.0	3.2	0.0	0.4	6.7	0.0	2.4	28.3	10.7	0.0	8.1	8.3	20.3	0.0	2.9	0.9	7.4	0.0	4.6	0.9	1.0	25.8	15.1	3.2	4.3	118.3	1.0	4.5	2.9	24.4
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554044-1571920	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.3	2.2	18.8	3.2	18.8	7.5	3.5	20.0	30.2	1.9	4.3	4.2	1.4	1.7	5.9	4.8	3.5	4.0	5.4	5.7	16.6	9.3	2.6	3.7	3.6	3.5	5.5	11.2	2.2	12.7	1.7	10.8	2.8	5.1	3.0	4.1	2.7	5.1	2.7	6.1	3.2	6.3	9.3	3.6	6.3	4.3	2.4	5.1	0.0	2.6	2.2	2.3	2.7	1.6	0.1	0.1	0.0	0.0	0.0	0.7	0.0	1.8	0.8	1.0	0.1	0.0	0.1	2.2	0.1	1.2	0.4	1.2	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.4	0.0	0.1	0.1	0.0	1.8	0.0	6.2	0.0	0.4	0.0	0.0	1.9	0.1	0.1	0.7	0.0	0.2	0.0	5.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.0	2.3	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	18.8	18.8	20.0	30.2	16.6	9.3	5.5	11.2	5.1	5.1	3.0	0.6	0.0	5.6	8.8	101.5	5.2	5.1	0.0	0.0	12.2	45.2	0.1	1.7	6.9	0.2	2.2	22.7	0.0	9.6	0.4	4.5	12.8	0.0	0.4	0.4	85.8	40.5	1.3	0.0	0.0	0.6	0.3	5.0	1.8	20.2	16.0	9.8	17.5	0.4	1.1	36.7	6.5	5.1	0.2	0.4	4.3	4.9	1.3	16.8	9.8
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.4	8.1	16.6	11.6	7.9	8.6	14.7	9.3	11.8	9.4	9.9	11.5	9.2	14.0	6.3	16.2	12.4	7.1	12.1	9.0	11.1	21.4	5.2	41.4	13.5	7.0	11.8	16.3	15.2	8.7	10.8	12.2	18.7	10.8	9.7	19.8	15.6	32.5	9.8	10.4	21.4	11.2	17.5	10.3	4.8	27.8	9.1	12.9	9.8	13.6	17.1	9.6	21.1	14.5	14.5	5.8	13.5	15.2	12.4	12.9	3.9	8.0	7.7	22.1	17.1	20.0	10.2	18.4	14.0	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3	17.9	21.0	14.9	21.8	33.3	28.8	68.6	17.8	18.7	21.6	10.4	25.5	8.2	0.0	11.5	21.3	24.8	20.2	23.3	12.6	9.6	20.6	24.7	24.3	15.3	13.8	44.5	20.5	28.3	24.3	15.3	15.0	20.8	23.6	6.4	16.5	15.6	16.7	20.4	18.4	8.1	19.4	12.9	24.5	15.8	14.0	27.7	12.8	30.6	13.6	28.3
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 145.5;Late spermatids: 469.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.4	5.9	4.8	4.5	0.7	2.7	1.7	2.5	2.3	0.8	3.3	1.3	10.6	3.2	0.1	2.9	1.2	1.9	2.2	4.9	7.3	0.6	5.4	0.8	4.0	0.3	1.8	6.1	1.2	0.8	2.8	8.2	0.6	3.3	1.4	1.9	0.4	4.3	1.9	0.8	2.0	2.5	2.0	0.9	0.1	0.6	5.4	2.1	12.2	13.8	4.2	4.2	0.2	4.7	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6	0.0	1.1	13.7	3.6	3.1	14.9	5.3	5.1	1.4	0.0	15.7	19.6	1.8	8.3	11.7	145.5	5.7	9.1	0.0	3.7	1.5	4.0	5.4	1.1	3.0	4.9	9.5	19.5	6.2	9.2	469.8	6.6	2.7	5.0	3.6	9.4	8.1	8.6	8.6	4.9	11.2	13.0	0.0	2.3	22.4	14.0	2.5	1.1	6.9	8.5	3.2
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 72.1;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.8	7.8	11.7	8.4	5.9	8.1	9.4	14.1	9.2	6.9	3.9	10.3	7.7	25.8	17.4	20.3	4.2	16.1	9.3	5.5	7.4	11.1	12.2	4.1	5.2	3.9	2.3	9.4	9.1	6.6	7.9	18.6	14.9	11.7	3.8	11.0	5.1	13.5	8.8	7.9	8.0	4.6	10.1	9.0	12.6	21.5	11.6	11.4	8.0	17.4	15.5	18.3	5.9	7.9	8.1	8.3	5.4	7.9	5.7	11.0	10.4	7.5	11.1	6.5	1.0	14.3	10.5	6.4	11.3	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9	8.9	12.2	6.4	9.1	10.1	17.2	33.5	22.9	12.0	10.3	1.8	21.6	2.7	0.0	17.2	0.4	10.5	72.1	0.0	15.8	6.4	18.2	11.3	5.7	4.7	14.1	76.3	23.6	6.2	11.6	1.6	10.6	9.8	8.5	6.4	50.5	15.3	15.6	48.2	12.4	7.5	21.9	12.9	21.1	2.5	8.7	14.2	3.8	21.0	26.7	28.1
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	9	"testis: 85.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 369.7;Late spermatids: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2.0	1.7	1.7	1.8	1.8	1.9	2.0	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2.0	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3.0	3.8	4.1	5.8	7.2	4.6	2.3	4.6	5.3	5.8	0.6	3.1	5.7	0.3	6.5	3.6	4.0	2.9	4.3	4.2	4.3	6.6	4.0	0.8	3.3	16.4	3.4	3.2	4.9	9.2	3.7	12.2	9.9	7.4	6.3	1.6	6.5	4.7	4.0	3.2	8.5	5.2	1.0	1.7	0.7	2.7	2.4	6.4	1.8	0.0	1.5	0.4	2.3	3.3	8.7	1.8	3.1	0.5	6.2	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1.0	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1	11.9	14.4	11.1	13.1	7.9	20.7	19.4	5.1	12.0	13.6	15.7	9.8	12.9	26.6	22.0	369.7	9.3	4.0	0.0	23.8	10.1	17.5	12.6	17.3	9.2	41.7	12.7	5.2	9.2	15.7	289.4	14.1	15.9	15.1	18.0	47.3	16.6	22.1	15.8	29.7	28.1	17.0	6.5	15.6	20.0	31.5	6.6	8.2	17.3	15.6	9.8
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.5	6.0	17.0	10.2	7.6	7.9	5.8	4.1	8.2	6.9	9.4	8.3	4.5	11.8	8.9	4.4	14.9	2.4	9.7	3.5	14.7	4.3	4.1	5.4	2.2	5.7	4.5	2.1	3.1	8.2	1.9	6.4	8.0	7.1	4.3	7.6	5.1	5.8	13.1	5.9	5.3	2.3	10.4	3.4	4.3	6.8	14.0	1.1	5.8	3.2	11.5	11.0	6.9	0.7	7.4	16.0	10.2	1.8	4.9	6.2	9.5	1.2	3.6	6.7	3.8	23.0	4.7	1.7	7.5	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0	11.9	13.8	8.3	8.5	6.6	67.2	33.6	2.5	183.4	29.6	31.4	308.3	19.8	11.6	8.1	23.6	8.2	3.9	0.0	8.1	7.3	13.9	8.8	8.1	3.6	7.8	73.1	50.7	6.7	7.3	46.6	16.1	6.2	6.8	14.4	6.1	33.9	8.4	3.5	16.6	15.3	32.1	19.4	9.2	314.4	93.7	6.5	12.4	18.5	6.3	4.3
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38832005	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		5700000	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	33.0	52.0	17.6	21.7	20.9	14.7	29.6	11.4	19.8	14.8	34.1	19.5	19.8	25.8	16.8	15.4	30.2	18.9	30.6	130.6	18.6	15.5	40.0	105.8	16.9	19.6	22.2	17.2	16.0	36.5	11.5	11.3	32.8	17.5	20.9	27.1	20.8	27.4	15.2	130.9	18.7	24.4	27.0	13.3	28.1	24.8	26.2	20.6	15.9	24.5	43.5	21.5	21.3	19.3	68.7	60.7	49.9	61.1	61.4	72.6	83.3	12.6	55.6	8.6	14.3	33.7	17.5	12.7	6.2	10.9	5.5	5.6	35.7	25.1	19.8	24.5	14.7	5.0	6.0	14.4	14.9	4.3	68.5	8.0	24.0	16.9	28.8	34.3	25.4	24.3	23.2	38.6	7.2	12.5	10.9	13.0	26.2	11.3	33.1	12.1	23.7	17.7	14.6	5.7	55.9	13.4	20.1	26.0	39.4	34.8	28.8	10.8	13.9	32.7	16.2	17.2	5.8	21.8	57.1	10.9	9.7	8.3	9.6	5.8	25.1	29.1	18.9	14.8	32.8	18.6	49.1	61.1	49.9	51.9	46.8	48.9	68.7	50.9	51.2	60.7	62.2	45.7	51.4	8.1	61.4	38.3	41.4	72.6	83.3	17.6	20.9	11.4	19.8	18.6	15.5	22.2	17.2	17.5	20.6	80.4	82.4	123.2	165.8	73.0	19.3	280.9	234.4	97.7	73.9	137.9	15.7	632.1	432.7	146.8	45.4	83.1	264.9	46.7	80.0	307.0	84.6	125.8	115.7	460.6	245.2	35.0	181.6	92.7	111.3	42.2	121.1	102.2	138.3	289.5	227.3	54.7	110.4	235.9	134.4	659.8	17.5	77.6	99.9	79.1	47.7	79.4	485.8	139.5	278.3	180.2
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.8	26.4	21.2	32.2	20.3	18.4	27.9	21.6	19.7	19.3	24.5	24.2	28.3	32.8	23.7	23.7	34.7	29.6	27.5	19.7	24.9	20.3	42.2	33.8	28.7	36.4	16.7	28.7	30.9	14.7	24.9	18.2	19.7	20.4	20.5	25.9	54.0	31.7	18.1	41.9	15.7	36.7	26.6	24.4	29.8	34.7	22.3	38.5	24.6	20.5	26.4	47.5	41.5	55.5	18.4	30.9	41.8	35.2	19.6	11.1	41.5	19.5	22.9	32.3	32.2	33.5	22.4	37.9	32.1	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6	35.7	43.2	44.9	27.9	21.2	28.0	44.8	43.3	34.8	29.6	41.8	15.7	180.9	56.3	48.3	6.9	22.4	43.3	116.8	39.3	64.2	22.2	37.8	19.7	55.5	47.3	30.2	37.0	20.3	29.0	11.9	31.9	31.4	23.6	59.5	60.3	40.2	46.9	35.1	35.3	51.5	23.0	12.9	17.0	32.5	42.3	19.6	310.3	35.0	47.0	25.5
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	23.3	12.0	7.4	9.3	8.1	11.2	14.6	12.3	17.7	39.0	37.6	13.7	13.9	12.5	16.1	13.5	46.4	13.9	12.7	12.5	17.5	27.4	6.7	13.7	9.1	8.9	8.0	13.0	0.1	9.1	4.9	15.6	11.3	6.8	9.7	5.5	9.5	12.6	8.8	10.4	16.7	6.7	7.7	3.9	8.6	16.9	18.1	6.2	7.3	9.0	8.3	8.8	15.1	11.0	23.7	6.5	5.6	3.7	12.5	15.8	16.8	6.8	19.8	9.3	15.3	0.2	7.6	8.9	13.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8	62.5	27.7	15.7	36.6	17.3	37.2	25.3	33.1	53.5	58.0	21.0	13.7	40.9	18.3	31.1	1.7	56.2	26.2	0.0	42.4	72.4	35.3	31.0	39.4	15.8	34.3	44.5	14.5	29.4	21.6	2.1	52.9	24.7	20.3	23.4	22.2	48.9	41.0	24.6	79.2	28.5	24.1	38.8	34.2	2.6	3.4	8.8	34.1	30.2	26.2	36.3
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627576	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA					"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	12.7	10.3	7.2	12.3	7.6	18.6	10.7	8.8	6.6	15.8	10.7	6.1	20.9	7.3	9.6	12.4	9.5	8.9	8.5	11.1	5.7	5.5	11.5	15.9	10.4	9.3	7.9	5.0	8.8	36.7	18.5	18.4	14.4	8.3	11.4	12.6	7.3	28.0	20.9	12.7	8.9	10.8	7.0	7.5	11.1	19.0	4.6	7.3	8.7	15.7	6.3	17.3	21.5	19.2	6.6	2.6	1.5	0.7	1.6	2.4	0.6	4.9	3.3	7.2	4.7	13.3	9.3	11.5	7.1	9.2	5.1	7.5	7.4	3.6	38.2	4.3	4.9	7.9	4.5	5.2	4.0	7.5	13.4	3.4	4.1	3.3	7.5	8.3	5.0	9.7	3.5	6.4	4.7	10.2	7.6	5.5	4.5	2.4	13.7	3.9	5.6	4.7	4.0	5.3	9.3	3.8	18.5	10.0	6.8	6.3	9.4	5.6	7.7	4.2	10.9	7.2	9.1	4.0	3.0	4.3	4.4	4.7	9.9	4.4	25.7	12.9	27.0	6.2	4.6	5.9	1.1	0.7	1.5	1.7	0.6	1.9	4.7	1.7	2.4	0.9	6.6	1.5	1.1	0.2	1.6	0.2	2.6	1.4	0.6	7.2	7.6	8.8	6.6	5.7	5.5	7.9	5.0	8.3	7.3	8.9	6.9	11.2	8.5	18.0	6.0	4.8	17.8	4.0	1.2	12.2	7.9	3.7	0.0	3.3	0.1	7.7	8.6	0.0	5.5	5.9	13.0	14.2	1.1	11.3	4.1	1.6	13.1	9.8	5.7	0.4	6.9	6.4	30.4	1.0	26.4	2.9	8.4	8.5	5.3	2.6	1.8	0.0	10.3	2.6	3.4	15.9	5.6	7.5	5.1	12.1
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.7	16.5	20.2	19.4	27.3	20.2	36.0	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22.0	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27.0	14.4	5.0	32.9	4.2	9.3	3.8	4.5	2.4	14.0	6.8	12.1	18.2	19.9	33.6	11.5	19.8	22.8	16.3	16.1	9.6	6.1	7.5	10.4	26.9	21.8	15.0	16.1	24.0	22.7	35.3	8.1	15.9	12.5	11.6	17.1	9.6	11.0	26.5	16.5	15.5	27.9	23.0	22.6	15.8	11.7	7.1	32.0	4.7	8.0	13.2	7.4	12.5	15.1	9.7	16.8	12.3	20.2	9.6	6.3	9.7	14.2	8.6	12.3	12.3	12.1	16.6	24.0	21.7	16.5	10.8	12.8	9.8	17.7	2.3	15.2	13.2	30.3	4.2	5.8	4.0	3.6	6.7	3.1	3.5	4.0	4.1	8.4	5.0	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1	14.9	23.6	17.2	22.6	10.6	28.5	28.8	22.9	13.4	26.1	15.7	11.8	29.7	11.6	22.9	1.0	27.0	7.3	0.0	22.0	29.4	26.2	25.6	23.1	20.8	27.4	27.0	13.8	23.4	28.6	2.4	39.1	46.9	30.4	32.5	20.8	31.3	33.9	10.5	37.4	15.1	22.8	45.3	18.6	9.8	29.6	12.7	12.7	15.8	27.6	17.2
EIF4EBP3	4E-BP3	ENSG00000243056	"Eukaryotic translation initiation factor 4E binding protein 3"	O60516	5	140547666-140549578	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 25.4;Paneth cells: 17.5;Undifferentiated cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.3;HSkMC: 14.3;JURKAT: 24.6;Karpas-707: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045537	Uncertain					NA	NA					"HPA045537: AB_10965796"	"unprognostic (7.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.82e-2)"	"unprognostic (3.75e-1)"	19.3	23.9	6.8	8.0	11.1	7.4	25.5	3.1	7.9	11.0	34.9	9.7	16.9	8.8	11.2	14.0	17.2	26.5	13.6	27.9	6.9	6.0	18.5	32.2	16.0	18.4	13.7	10.4	15.6	34.7	1.2	6.2	4.9	17.5	14.5	12.4	18.0	34.0	27.5	78.6	17.5	16.3	16.7	16.7	11.1	19.4	21.8	8.0	7.2	18.3	24.6	10.7	16.9	9.9	14.6	42.2	8.0	17.7	7.9	16.3	8.4	0.2	1.0	0.9	1.3	11.2	11.8	2.0	0.9	0.2	0.5	1.0	2.0	0.8	0.5	5.2	2.1	0.7	0.7	0.4	1.0	0.6	1.7	3.3	0.1	1.9	3.6	15.3	5.7	2.9	14.3	1.4	0.9	0.7	2.7	1.6	24.6	0.3	16.9	0.6	0.0	4.4	10.5	1.3	3.0	3.6	4.6	0.7	0.1	1.7	2.1	5.4	0.7	1.6	13.6	4.4	1.3	1.8	6.8	1.3	4.7	0.9	3.0	0.6	1.5	1.2	0.5	3.2	11.4	1.2	2.4	16.1	0.5	4.3	17.7	5.3	14.2	7.9	3.9	13.5	14.6	16.3	12.9	8.0	7.9	12.7	42.2	6.1	8.4	6.8	11.1	3.1	7.9	6.9	6.0	13.7	10.4	17.5	8.0	0.0	10.7	2.2	0.5	0.2	0.0	0.3	5.1	13.4	7.9	0.0	0.0	0.7	3.3	6.8	1.0	0.4	15.4	0.0	25.4	0.7	0.6	0.5	11.5	7.6	2.2	0.0	8.2	1.8	4.7	1.0	1.7	2.1	0.0	10.0	16.6	0.0	17.2	17.5	0.0	4.2	0.0	0.0	0.1	0.9	0.5	0.5	0.8	0.0	18.1	0.3
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Enzymes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	14.8	15.3	18.7	11.5	23.4	6.7	19.4	20.0	27.4	33.4	14.8	21.8	35.2	10.8	27.3	14.4	12.8	18.6	17.5	16.0	17.7	19.0	19.1	22.8	13.6	15.4	17.6	13.6	18.9	12.6	14.3	17.4	12.7	23.3	15.9	18.0	13.9	11.1	36.1	28.8	13.4	12.3	16.0	15.8	16.1	12.1	15.0	15.5	16.0	19.9	13.8	20.3	14.7	12.0	16.2	12.2	11.6	18.2	15.8	20.8	11.0	14.5	15.2	11.6	11.1	17.2	15.1	8.3	7.5	13.6	17.7	15.8	12.6	6.2	27.4	11.8	14.4	15.7	9.9	12.8	17.8	20.9	4.9	5.3	18.4	10.1	20.9	15.4	9.9	13.7	15.9	27.6	12.1	18.7	12.8	16.5	21.3	20.7	17.0	18.0	9.0	21.1	16.9	13.1	14.0	5.3	16.0	11.3	10.5	17.6	12.0	7.0	12.2	8.5	7.3	14.3	11.1	13.9	11.5	11.6	12.1	15.9	12.6	10.8	7.2	11.5	21.0	12.0	11.2	12.3	11.6	10.1	8.2	19.4	14.4	20.8	12.5	16.6	18.3	11.8	16.2	15.0	17.0	2.8	15.8	18.2	12.2	15.6	11.0	18.7	23.4	20.0	27.4	17.7	19.0	17.6	13.6	23.3	15.5	3.0	10.1	10.4	6.7	2.4	6.7	14.6	7.6	13.4	12.5	7.0	21.6	12.5	6.6	10.5	5.9	8.7	7.7	0.0	8.6	12.1	6.4	6.2	8.1	14.7	13.2	14.3	1.2	9.8	11.5	2.7	7.8	7.2	1.7	7.2	8.1	8.7	8.4	8.6	9.6	11.1	11.1	0.0	6.6	11.4	16.1	2.0	8.7	11.5	9.9	5.1
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.7	11.3	19.2	11.9	12.2	13.2	17.2	7.6	11.0	11.4	11.0	14.4	5.8	16.4	6.7	15.0	10.5	12.7	27.7	10.4	12.7	15.9	18.4	12.3	13.0	11.2	13.9	29.2	13.9	12.9	10.9	16.5	13.8	10.0	12.6	9.5	13.0	22.6	9.0	5.8	8.4	9.1	13.8	19.8	7.9	17.3	9.0	10.2	10.8	20.9	6.1	6.5	26.9	13.7	13.1	16.7	9.7	17.0	16.3	11.4	13.8	8.1	10.8	15.5	7.3	25.6	8.4	9.0	10.8	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6	62.5	45.1	44.7	19.0	21.9	43.6	25.4	53.5	29.4	18.2	24.4	33.4	15.3	3.3	13.2	12.6	27.2	22.2	46.7	16.0	15.4	23.4	24.1	24.3	24.1	15.9	23.8	23.7	34.4	59.8	3.4	26.7	31.6	8.5	20.8	23.1	31.8	20.2	26.6	28.7	9.2	31.1	25.8	15.6	20.6	29.9	22.6	25.3	26.6	20.3	30.6
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.3"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.3	6.3	8.2	2.5	1.4	3.0	3.5	2.8	3.4	1.5	1.7	20.3	2.5	3.5	3.4	1.8	1.2	1.3	2.5	7.9	1.7	3.3	2.4	2.5	5.0	11.3	2.0	2.1	6.8	1.7	0.6	3.7	2.0	4.8	1.4	5.2	3.5	2.6	7.5	2.4	3.4	3.0	1.7	4.3	3.0	5.9	2.5	1.7	6.1	6.1	5.3	3.2	7.0	3.1	1.8	6.5	4.3	2.8	1.4	2.6	2.3	3.8	3.8	8.2	2.4	2.7	4.4	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1	6.0	1.0	3.2	0.8	0.8	7.9	23.5	5.1	2.7	3.4	1.8	5.9	0.7	10.0	0.9	28.2	1.5	0.3	0.0	2.0	0.6	1.2	1.3	2.3	5.8	2.0	28.6	1.2	1.3	1.5	14.1	2.8	3.1	6.8	0.0	1.5	7.5	1.1	1.1	2.1	6.3	6.7	0.0	2.0	1.6	1.3	0.4	0.3	0.0	1.0	0.3
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039142-64130819	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 76.4;Melanocytes: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9;MAIT T-cell: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 41.3;RPMI-8226: 18.5;U-266/70: 39.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB009495, HPA027730"	Supported					NA	Yes					"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	5.5	24.9	2.2	10.6	1.6	8.0	7.7	2.3	1.8	15.8	10.0	3.5	36.1	5.1	11.9	15.0	7.4	7.9	10.6	4.1	1.9	1.7	6.4	21.5	12.3	12.6	2.1	1.6	14.7	44.1	2.9	32.8	10.1	1.8	6.6	3.9	5.0	23.2	34.9	4.2	6.6	11.5	4.1	2.2	9.9	8.8	2.8	1.6	11.6	7.5	5.9	16.7	10.0	7.7	0.1	5.7	12.9	0.7	3.0	12.2	1.0	2.2	1.8	0.9	2.4	2.2	1.8	4.5	1.9	4.3	1.3	1.2	1.2	1.2	2.9	1.3	1.4	2.1	1.5	1.2	1.9	3.3	0.8	1.1	2.6	0.9	1.8	13.9	1.2	0.9	2.1	5.3	3.7	11.8	1.9	2.5	2.8	1.8	41.3	1.2	1.5	1.8	0.5	0.4	2.1	1.6	2.0	2.0	18.5	1.1	3.0	3.2	2.0	1.8	3.1	4.5	1.8	1.7	2.7	2.4	1.1	2.7	2.6	1.2	39.0	10.2	2.2	2.1	1.4	1.9	12.9	0.7	0.2	4.6	0.4	12.2	0.1	3.0	3.2	0.3	0.1	0.7	1.3	3.3	3.0	0.2	5.7	0.7	1.0	2.2	1.6	2.3	1.8	1.9	1.7	2.1	1.6	1.8	1.6	0.0	42.2	9.0	42.2	19.6	3.2	5.6	15.3	6.7	7.9	12.2	5.9	6.5	1.7	9.4	1.8	10.8	7.1	0.0	24.0	6.6	16.0	38.4	8.1	21.3	7.7	3.2	76.4	14.1	12.1	1.1	4.4	18.6	70.9	8.2	7.8	4.0	16.0	7.6	5.6	3.7	26.0	0.0	15.1	3.9	4.1	39.4	45.9	42.7	7.6	52.1
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690326-23713500	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 64.5;stomach 1: 30.0"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 28.1;Enterocytes: 26.1;Mucus-secreting cells: 126.1;Paneth cells: 28.8;Undifferentiated cells: 53.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"OE19: 30.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.7"	"Not detected"	"Not detected"			HPA076875	Approved				"Intracellular and membrane"	NA	NA					"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.3	0.1	8.1	0.2	0.0	0.1	0.1	0.2	11.4	17.3	0.2	0.1	7.0	1.1	0.1	0.9	0.1	64.5	0.1	0.1	0.0	0.2	0.1	1.0	0.5	0.1	0.1	0.1	0.5	0.0	0.8	0.1	0.1	2.6	12.6	0.2	14.0	0.1	0.1	0.1	11.8	0.9	0.1	0.1	30.0	0.1	0.1	0.2	0.1	2.2	7.6	6.3	3.9	0.9	0.6	3.6	0.4	1.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.4	0.5	0.3	0.3	0.2	0.3	0.3	0.3	0.1	0.9	0.3	0.4	2.1	1.5	0.2	0.6	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	1.0	0.0	0.0	0.4	28.1	4.0	6.8	0.0	0.0	0.2	0.0	0.6	0.1	0.0	26.1	0.0	1.8	0.0	0.0	1.0	4.6	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.1	0.0	19.2	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	53.3	10.4
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell type enriched"	"Detected in many"	6	"Hofbauer cells: 646.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.5	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5	0.0	3.4	0.8	0.0	16.7	0.0	7.5	10.2	4.0	0.0	0.0	0.0	4.0	0.0	0.0	3.8	4.7	0.0	0.0	0.0	3.4	16.5	0.0	1.1	0.8	646.4	0.0	0.0	4.3	113.2	4.2	4.0	57.6	18.6	1.0	0.0	0.7	0.1	0.0	0.7	3.1	4.1	58.2	9.2	1.4	1.0	13.2	8.5	0.0	0.0	0.0
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 49.0"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		3400000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3"															NA	NA						"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.5	0.2	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.0	0.0	1.8	10.7	0.1	3.1	0.0	0.0	0.4	0.8	1.9	0.0	9.6	5.2	0.3	2.5	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.1	0.0	1.0	1.2	4.8	0.0	1.0	0.5	0.0	1.8	2.2	0.0	0.0	1.8	19.4	6.3	3.4	1.8	0.1	0.1	3.0	0.0	4.6	3.0	0.0	0.0	0.0	0.2	0.0	0.1	16.3	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3	3.0	5.6	0.0	11.2	2.4	3.1	0.3	2.5	24.1	6.8	5.2	17.7	4.4	8.3	8.3	0.0	0.0	3.9	0.0	12.2	2.1	0.5	10.4	0.0	9.0	0.6	1.6	12.7	0.6	0.0	0.0	0.6	0.0	3.3	1.0	5.6	1.2	11.6	3.4	0.4	4.5	12.2	0.0	0.1	0.0	0.0	5.8	4.7	2.5	4.7	9.0
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 26.2;Hep G2: 83.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	26.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	83.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	1.4	7.7	0.0	0.1	0.8	5.7	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.7	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4	0.0	0.0	173.3	0.0	0.0	0.0	0.4	119.8	0.0	0.0	57.6	0.0	0.1	132.6	0.0	0.0	0.0	8164.5	140.2	0.0	0.1	0.0	0.3	133.2	5503.1	1.4	0.0	251.5	124.0	159.5	0.0	0.0	0.0	0.0	0.0	830.4	0.0	0.1	3221.0	0.0	668.9	0.0	0.0	0.0	0.0	0.1	0.0	1.1	51.0	1046.9	0.0
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.9	16.5	12.8	13.5	22.9	24.2	14.2	15.0	17.2	10.6	9.5	8.2	18.0	9.3	19.8	26.4	8.7	13.2	13.0	11.0	15.6	11.8	8.8	29.7	15.6	10.4	11.4	19.6	18.8	14.0	12.1	14.4	11.2	16.2	13.0	13.1	33.0	13.7	16.9	10.0	8.5	7.1	16.8	20.3	3.5	10.5	13.5	12.4	8.9	20.4	17.1	42.1	15.8	18.0	15.3	19.0	15.5	14.4	13.7	16.9	14.9	23.2	20.2	11.2	20.4	8.2	16.8	9.6	16.7	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4	6.0	10.7	11.2	8.9	13.9	12.3	31.9	17.8	8.1	7.9	17.4	23.6	8.0	3.3	8.2	4.2	11.2	4.1	0.0	11.0	5.7	12.4	14.8	16.2	12.2	6.9	36.5	13.8	10.4	8.9	2.5	16.4	6.9	15.1	10.0	7.6	7.8	11.0	0.0	20.1	5.4	20.2	12.9	20.3	12.9	15.8	11.3	6.3	6.9	6.6	23.8
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.5	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	18.6	10.8	15.3	10.3	22.6	30.1	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.9	3.9	12.0	10.6	9.2	19.5	11.7	9.2	9.4	7.1	25.1	29.8	29.7	2.8	13.5	21.0	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	15.5	7.4	13.6	6.2	12.1	18.2	8.8	15.0	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2	17.9	18.3	5.8	13.7	9.2	12.4	13.2	5.1	20.1	10.3	8.7	3.9	25.0	10.0	6.9	1.7	10.5	7.3	0.0	3.6	12.2	8.9	6.8	10.4	10.4	9.4	7.9	8.6	10.4	8.5	1.7	10.0	6.9	25.3	9.0	16.3	20.3	4.6	13.1	13.4	4.1	18.8	12.9	8.1	47.7	30.4	5.9	6.2	5.0	13.6	5.9
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 138.8;Proximal tubular cells: 112.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.1;U-266/70: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.1	0.1	0.0	0.0	1.8	3.1	2.6	0.5	0.1	1.9	0.0	10.1	2.1	0.0	1.4	3.5	2.2	1.3	4.2	2.7	5.7	0.1	6.9	4.2	0.1	5.1	0.2	0.0	2.8	1.7	8.4	0.1	2.5	10.2	4.6	0.8	8.7	0.6	7.6	0.0	12.1	11.3	1.4	2.1	2.9	1.0	7.0	6.6	4.1	0.4	0.1	0.0	1.2	0.4	0.1	1.6	24.7	7.5	0.0	2.7	0.0	1.5	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2	6.0	8.8	14.1	16.1	6.8	12.4	9.2	33.1	2.7	3.4	26.2	55.0	33.8	66.3	17.3	41.1	6.2	12.3	0.0	4.1	6.5	4.3	10.2	5.7	20.8	17.6	28.6	7.5	11.6	6.7	138.8	17.8	9.6	11.8	6.4	11.4	17.8	11.6	14.0	9.2	112.3	19.5	0.0	3.1	18.1	6.4	9.8	27.3	7.5	17.2	19.0
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in many"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes			"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	34.0	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.2	28.8	55.2	56.0	2.6	4.1	1.3	79.9	0.8	3.6	0.1	6.5	15.8	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	3.2	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7	8.9	6.1	0.0	732.1	416.1	8.9	221.1	15.3	12.0	54.6	27.9	2.0	150.7	3.3	97.9	3.5	21.5	61.9	0.0	105.2	503.8	71.2	120.1	10.3	9.2	22.4	0.0	55.8	20.9	1.2	4.9	525.0	6.6	21.9	4.6	119.3	1.5	144.0	32.8	986.1	15.3	12.4	213.4	132.8	6.6	21.1	259.6	149.4	5.0	30.8	351.4
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 83.0;Leydig cells: 43.4;Peritubular cells: 42.1;Sertoli cells: 58.2;Smooth muscle cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		5500	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.2	15.0	49.1	52.8	61.7	13.2	66.9	67.0	25.2	21.8	8.4	0.6	0.0	0.9	72.6	6.4	0.1	8.9	17.8	10.7	4.4	13.5	6.4	18.3	24.0	57.7	0.0	0.0	66.2	0.0	20.6	15.8	48.4	21.4	0.0	0.2	2.3	21.0	21.1	0.0	0.0	11.7	34.3	5.5	1.3	17.7	2.1	4.3	0.0	3.7	13.1	0.1	48.1	22.4	19.8	7.5	0.4	24.2	30.4	15.8	20.2	10.2	0.1	0.0	0.0	41.7	0.0	29.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7	0.0	7.4	0.0	10.9	7.6	0.8	1.6	2.5	0.0	2.3	0.0	0.0	6.3	0.0	8.8	0.5	23.9	0.0	0.0	4.2	23.1	83.0	4.1	0.0	0.0	4.2	14.3	0.0	34.4	0.0	1.9	43.4	2.2	15.1	0.0	1.4	29.2	3.0	0.0	42.1	0.0	1.0	58.2	43.4	0.5	8.3	4.4	10.0	0.0	0.6	1.7
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell type enhanced"	"Detected in all"	7	"Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.0	2.7	0.5	0.7	12.0	18.2	1.0	15.9	22.8	17.6	20.8	10.2	11.4	30.9	0.5	25.9	0.2	8.5	5.5	7.0	9.1	6.5	1.1	1.1	2.9	0.1	44.0	0.6	0.8	20.3	13.5	13.5	25.1	7.5	9.9	10.5	0.4	40.1	6.4	5.8	4.6	1.1	1.4	56.1	5.1	12.7	0.7	40.1	2.2	0.4	6.5	1.9	5.3	7.9	3.5	0.6	0.4	0.9	7.9	3.4	0.6	0.3	0.3	23.5	19.4	15.7	2.1	0.7	5.6	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9	14.9	18.4	30.6	44.0	25.1	4.9	1.7	35.7	28.1	19.4	8.7	37.3	19.0	6.6	17.0	15.1	19.7	11.7	46.7	145.3	59.9	74.1	89.1	12.7	90.3	9.7	1.6	24.1	49.1	14.2	13.2	25.6	9.7	258.1	5.4	84.9	1.5	80.1	7.0	13.1	12.2	15.0	6.5	22.1	8.0	6.8	18.6	35.4	152.0	40.1	37.6
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.4	17.2	19.3	24.8	3.4	17.7	16.6	6.2	12.1	2.2	2.2	1.2	8.4	15.5	7.6	7.6	4.1	6.4	12.4	0.6	5.9	2.8	5.0	6.5	9.8	2.0	4.9	15.5	6.7	10.8	12.8	14.6	13.7	1.8	4.5	2.6	11.1	1.4	1.0	2.4	3.9	3.8	4.8	0.0	5.0	4.0	6.1	3.1	1.9	6.5	6.2	14.2	4.3	9.2	3.2	2.6	11.0	6.6	7.7	11.3	7.0	3.9	4.0	2.1	9.4	1.9	20.6	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1	17.9	16.5	3.7	19.2	24.4	15.5	13.5	7.6	2.7	10.3	17.4	25.5	9.5	1.7	6.7	0.3	7.4	3.3	0.0	3.2	24.1	26.4	15.0	2.3	6.6	5.3	14.3	1.2	8.6	2.8	0.0	12.0	5.8	10.1	2.8	7.9	31.5	5.3	14.4	19.4	2.9	19.8	6.5	10.5	0.7	3.3	15.9	13.2	4.3	4.8	24.8
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FK506 binding protein 1A"	P62942	20	1368978-1393172	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 152.2;TIME: 176.4"									"CAB004639, HPA051798"	Uncertain					NA	NA		16000000			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	106.0	42.4	67.3	55.0	114.8	44.4	63.5	15.8	55.8	33.2	39.7	22.1	33.8	32.7	45.5	45.9	42.7	33.8	32.0	36.4	51.7	30.6	41.9	41.7	59.2	84.1	26.0	36.5	41.7	57.7	20.6	21.7	65.0	22.5	34.4	49.4	21.4	30.8	40.6	38.9	31.5	37.1	56.0	23.3	68.0	33.0	21.1	28.4	47.4	62.2	39.7	48.3	48.1	37.0	13.3	63.6	88.4	94.3	14.5	18.6	84.3	71.4	19.8	15.8	22.8	53.5	67.2	20.8	45.4	30.8	36.4	33.8	19.8	27.8	29.3	14.6	42.3	52.9	32.9	20.4	83.1	47.9	8.4	22.1	30.0	9.3	37.6	32.9	34.8	16.7	39.0	26.5	33.7	34.8	42.5	152.2	33.0	27.4	15.1	42.8	8.9	34.0	48.0	33.9	25.3	38.8	29.2	27.6	35.4	47.0	18.1	26.3	19.9	22.4	45.3	75.2	22.1	17.7	29.7	176.4	135.4	22.7	28.8	33.5	7.5	16.3	30.6	23.3	35.4	29.9	23.9	79.4	88.4	11.5	94.3	10.2	12.8	13.9	13.2	63.6	13.3	14.8	14.2	77.9	14.5	90.3	31.6	18.6	84.3	67.3	114.8	15.8	55.8	51.7	30.6	26.0	36.5	22.5	28.4	80.4	70.6	192.2	178.9	233.8	16.6	52.9	173.3	66.9	58.0	164.0	0.0	249.8	202.2	393.2	31.1	486.6	196.8	23.3	297.3	496.2	197.8	189.6	142.9	99.4	651.5	33.4	317.5	445.0	487.0	41.0	185.2	363.6	229.5	390.5	244.5	40.1	382.3	768.7	153.1	245.7	11.0	135.8	189.1	153.9	133.6	261.7	193.6	124.6	263.1	202.2
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FK506 binding protein 1B"	P68106	2	24049701-24063681	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1;intestine: 24.9"	"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.9;NTERA-2: 21.3;SH-SY5Y: 15.5;SuSa: 23.9;TIME: 18.6"	"Low region specificity"	"Detected in all"							"HPA045572, HPA051798"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	2.9	5.9	25.0	2.8	30.7	1.9	5.9	15.7	23.1	5.1	7.2	1.6	7.4	24.9	3.6	4.2	4.5	4.5	7.1	3.4	31.1	14.0	4.4	4.6	9.0	2.2	13.0	19.7	4.6	4.9	6.4	2.8	5.6	7.9	5.1	4.6	2.4	3.3	9.2	1.1	3.6	6.7	4.0	5.2	1.8	13.3	1.6	4.4	0.6	5.0	1.1	3.2	7.1	3.5	1.5	2.2	4.4	0.8	0.3	5.4	1.1	0.1	0.9	8.5	0.0	5.4	2.1	3.0	2.8	2.9	1.2	1.8	0.5	1.0	0.0	2.1	5.0	7.7	3.3	12.5	9.8	0.8	1.4	8.0	2.9	0.1	21.9	2.0	0.0	7.0	2.0	2.3	2.9	0.6	7.3	7.9	3.3	0.7	0.0	2.8	0.0	0.9	0.0	21.3	0.7	1.5	1.5	0.7	0.0	0.9	0.5	2.1	15.5	0.1	0.0	2.7	23.9	0.5	1.0	18.6	0.0	2.6	0.1	0.6	0.5	0.2	0.0	3.1	0.0	0.6	1.3	0.8	4.4	0.3	0.7	0.0	0.3	0.6	0.5	2.2	1.5	0.0	0.2	0.1	0.3	0.0	0.4	5.4	1.1	25.0	30.7	15.7	23.1	31.1	14.0	13.0	19.7	7.9	4.4	0.0	5.0	0.0	11.5	8.1	1.2	0.4	28.1	1.4	0.0	7.0	0.0	4.5	11.6	24.5	0.4	9.3	9.3	0.0	33.8	22.1	7.8	15.8	1.1	9.8	6.2	1.6	9.1	11.1	3.4	1.8	2.6	9.4	27.0	19.8	7.9	12.1	37.4	28.1	3.9	4.1	2.5	25.8	11.2	1.4	3.0	6.5	4.3	0.0	3.4	14.5
FKBP2	"FKBP-13, PPIase"	ENSG00000173486	"FK506 binding protein 2"	P26885	11	64241003-64244132	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 119.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		400000	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	18.2	35.8	28.9	20.2	35.5	12.1	20.2	18.8	27.1	31.3	28.0	20.3	87.8	39.0	24.4	102.7	20.8	25.5	30.3	28.0	29.7	35.7	40.3	89.6	18.8	17.0	39.3	24.8	22.1	107.2	34.0	57.2	59.2	29.0	26.1	21.9	19.4	59.3	116.6	11.8	18.5	30.2	19.7	28.5	20.9	31.1	19.8	20.6	12.4	63.2	18.6	18.8	21.3	23.9	21.3	119.6	29.0	25.4	20.0	30.7	15.5	24.2	32.0	17.3	35.0	37.5	21.4	24.6	29.4	29.9	22.3	20.7	31.5	54.7	18.0	46.9	36.1	30.5	31.8	13.7	24.4	10.6	22.3	11.9	19.9	42.6	32.1	49.3	16.5	28.0	24.9	36.4	29.5	32.6	32.2	17.7	16.3	14.9	53.9	26.4	40.1	18.0	26.1	20.2	41.7	28.9	16.1	17.1	65.5	40.3	24.4	24.2	21.1	20.2	57.2	32.4	12.7	22.0	14.3	16.7	26.8	23.9	42.6	15.7	32.8	10.2	14.6	35.9	17.4	30.3	29.0	24.5	3.4	24.1	25.4	30.7	21.3	19.2	23.3	23.2	20.5	13.0	18.1	9.1	20.0	20.8	119.6	7.1	15.5	28.9	35.5	18.8	27.1	29.7	35.7	39.3	24.8	29.0	20.6	137.0	150.2	102.0	207.7	146.1	76.1	98.2	310.8	108.4	116.0	369.9	21.6	256.2	349.8	239.2	83.7	136.1	585.6	23.3	222.4	308.7	201.1	281.8	142.9	635.0	211.8	30.2	328.9	152.9	95.0	70.2	213.2	169.2	285.1	186.7	264.4	122.7	276.9	273.5	239.7	629.6	65.3	181.1	142.1	273.8	237.0	146.9	518.9	105.4	226.6	265.6
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	37.3	41.6	60.6	31.9	27.0	29.4	23.9	23.0	26.4	36.3	40.1	36.3	32.1	19.9	24.3	25.9	20.6	31.1	45.0	29.6	51.9	28.7	26.8	16.4	32.3	46.9	26.6	28.2	17.7	27.7	30.9	21.1	19.7	33.6	47.3	31.7	23.6	15.1	43.1	45.6	45.3	37.9	30.7	41.9	39.5	43.6	44.7	24.2	58.1	43.2	37.0	14.5	36.8	22.9	35.2	47.7	53.6	21.2	30.4	27.8	48.1	14.5	17.6	25.4	45.1	31.0	16.8	19.5	25.9	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4	38.7	36.9	49.1	82.5	42.5	68.8	177.9	45.9	77.6	69.4	89.0	9.8	264.9	213.9	116.4	165.9	49.2	61.3	0.0	64.1	95.4	67.9	74.9	51.0	84.7	113.7	38.1	53.9	39.3	36.8	297.6	74.8	68.0	65.8	155.9	63.2	57.4	80.6	52.6	91.9	168.1	44.8	103.5	53.3	145.7	112.4	41.9	138.0	47.9	83.1	70.8
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.3	34.2	9.9	16.6	12.3	7.3	47.5	15.1	5.4	25.0	16.9	34.0	18.8	20.5	4.3	9.7	17.4	21.1	61.5	20.5	30.1	37.5	39.4	22.6	25.1	12.0	9.5	17.6	6.2	6.6	18.8	29.5	29.6	14.9	14.5	20.8	20.7	29.3	10.0	44.1	30.9	16.0	84.3	45.3	24.7	18.6	17.4	12.3	21.0	19.6	14.3	20.5	17.5	47.8	7.6	64.7	64.4	12.0	7.7	12.3	38.7	13.8	38.0	7.3	11.2	30.3	10.9	26.4	12.5	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1	6.0	8.6	47.9	182.5	127.9	60.2	11.7	40.8	16.0	12.5	50.6	70.7	148.6	131.0	77.3	90.2	33.8	86.8	0.0	22.4	85.7	62.6	189.3	39.1	41.9	54.7	92.2	101.7	12.3	15.0	26.1	32.2	42.7	87.7	52.3	61.6	41.8	62.2	84.2	36.4	112.7	51.3	84.1	88.6	179.1	92.0	116.1	186.7	20.2	77.5	121.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 325.8;Peritubular cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	5.0	2.2	9.7	14.4	103.4	64.4	0.1	2.7	0.1	1.8	4.1	3.8	0.9	25.0	2.6	0.5	1.5	0.0	5.7	12.1	4.3	9.8	5.5	10.7	1.9	5.3	81.0	6.7	1.1	97.8	49.2	3.1	29.7	1.9	10.5	5.0	11.4	10.2	19.0	3.2	27.9	12.6	2.5	1.1	1.6	12.4	2.5	12.2	8.0	3.0	3.7	2.2	2.2	2.6	0.5	2.2	14.3	7.9	23.2	2.6	2.3	0.3	3.8	4.6	5.3	31.7	0.8	13.2	1.0	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4	11.9	9.9	41.7	52.1	15.7	1.7	110.1	79.0	21.4	13.6	5.2	0.0	0.6	19.9	0.5	8.8	66.1	19.7	163.5	6.9	0.9	22.2	38.7	36.0	165.7	28.8	0.0	20.1	130.8	325.8	11.8	149.0	56.5	6.8	91.0	17.5	3.7	3.3	9.3	205.4	16.3	18.2	142.3	28.8	11.6	19.2	18.6	0.3	117.1	19.5	19.5
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FK506 binding protein 6"	O75344	7	73328164-73358637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 62.1;Late spermatids: 61.4;Spermatocytes: 105.5;Spermatogonia: 35.0"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;Karpas-707: 1.5;SiHa: 2.1;U-266/84: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA061109	Enhanced					NA	NA					"HPA061109: AB_2684430"	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.5	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.3	2.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.7	1.3	0.0	0.4	0.3	0.3	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.4	0.0	20.1	2.3	0.0	0.0	0.0	0.0	0.3	62.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	61.4	2.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.1	0.0	0.3	0.0	0.0	105.5	35.0	0.0	0.1	0.0	0.0	0.1
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.1	9.0	52.8	32.8	0.5	10.9	18.1	2.0	6.4	0.1	0.6	1.7	2.4	19.9	1.8	0.1	2.3	0.9	3.5	1.4	1.3	1.7	2.5	1.7	8.1	1.1	1.3	22.0	0.5	8.0	1.1	14.7	6.5	2.1	0.8	1.1	8.4	0.1	1.9	1.9	1.2	1.1	0.9	2.5	10.7	2.3	2.7	0.2	3.2	10.6	2.3	0.0	1.8	4.5	0.1	2.1	6.0	3.7	2.3	4.3	1.0	2.1	2.2	0.8	6.8	2.7	8.0	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2	6.0	2.6	2.2	6.7	6.3	4.6	12.6	2.5	2.7	3.4	7.0	0.0	6.2	1.7	9.1	116.0	18.6	0.1	0.0	7.4	18.5	67.2	3.6	13.9	9.8	5.3	4.8	1.2	13.5	4.3	22.0	59.2	4.8	16.9	1.8	4.8	3.7	4.0	0.0	45.6	3.5	3.3	6.5	39.2	3.7	5.5	5.1	4.2	5.0	2.6	3.4
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 972.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA			Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.9	26.5	20.8	39.5	21.5	33.8	52.2	29.9	31.9	22.9	31.8	25.1	50.5	21.2	48.7	36.7	15.4	20.1	12.8	41.7	6.5	25.8	60.9	19.8	34.6	30.2	37.0	19.6	43.6	44.1	40.2	20.6	13.1	44.1	23.5	41.3	41.4	50.5	19.9	61.6	35.6	58.7	42.5	33.2	38.5	37.4	17.3	72.4	30.8	24.2	23.1	42.1	21.0	17.3	37.3	16.5	20.4	57.2	27.4	28.7	26.2	55.9	22.7	38.6	22.2	24.6	64.8	31.5	25.4	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9	8.9	1.4	107.1	128.1	84.6	57.2	2.0	71.4	2.7	5.7	96.0	13.7	219.4	210.5	151.9	314.6	76.6	289.8	233.6	111.8	173.9	174.8	132.3	54.0	55.9	208.7	93.8	197.7	79.8	159.9	972.7	188.7	127.3	192.3	254.3	108.6	104.6	130.6	224.5	155.6	222.1	41.3	97.0	149.9	203.6	97.7	103.1	261.7	163.0	127.0	126.6
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.4;fHDF/TERT166: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.1	13.6	5.3	21.9	50.4	58.4	7.1	38.7	40.3	12.8	20.4	5.9	17.0	0.0	15.8	71.8	20.5	14.0	7.8	18.9	14.7	0.0	2.3	1.2	14.6	5.8	21.0	0.0	2.1	37.9	11.5	11.4	11.1	30.5	16.1	0.0	2.7	1.4	26.0	6.9	0.0	3.6	1.1	14.3	7.2	0.0	14.3	0.0	14.3	2.4	5.0	12.1	22.1	11.3	13.7	14.1	7.9	3.5	21.5	21.0	20.2	13.0	8.8	4.6	8.9	0.0	20.5	0.0	41.7	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4	11.9	20.0	0.0	12.5	30.5	7.7	38.3	15.3	6.7	7.9	17.4	9.8	17.1	5.0	16.3	0.5	65.3	16.9	0.0	36.7	25.2	46.6	8.5	5.7	10.5	6.7	11.1	11.7	58.9	6.2	0.7	33.9	4.5	57.3	3.6	27.2	34.3	30.2	17.5	51.9	7.4	4.5	45.3	51.9	0.9	0.9	25.0	11.0	1.3	21.4	8.6
FMO1		ENSG00000010932	"Flavin containing monooxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 70.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 142.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	36	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	36	"B-cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA078132	Approved					NA	NA					"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	3.4	3.6	0.1	0.1	0.3	0.0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0.0	2.5	3.0	5.0	3.3	1.8	0.9	0.1	0.0	70.4	1.0	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0.0	4.0	4.2	1.5	0.1	4.0	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.4	2.9	0.0	8.7	5.1	0.0	0.0	3.5	0.0	0.2	11.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	10.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	2.5	142.2	0.0	6.5	1.4	0.0	0.0	1.9	0.7	0.0	0.0	0.0
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 428.8;Club cells: 348.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028261	Approved					NA	NA					"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	29.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3	428.8	20.8	0.0	5.3	0.3	0.2	6.9	0.0	62.9	348.1	1.8	0.0	0.0	0.0	0.0	2.7	5.3	0.0	0.0	0.0	0.0	0.6	3.0	3.5	0.0	0.0	0.0	0.0	4.3	0.0	2.3	0.9	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.4	0.2	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	1.1
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 378.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 25.4;ASC TERT1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	5.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0.0	0.3	5.1	32.1	27.3	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	378.8	0.0	0.0	0.0	4.9	6.9	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	6.5	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.9;HSkMC: 9.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.5	5.0	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	2.6	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.2	0.6	1.3	0.6	0.3	2.2	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.3	1.6	0.4	0.5	2.5	3.5	0.0	0.2	0.0	1.5	1.5	3.0	5.7	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.5	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2	0.0	1.6	0.5	3.8	2.5	0.0	3.5	2.5	6.7	0.0	8.7	0.0	2.1	24.9	1.6	4.0	0.9	8.6	0.0	1.2	1.2	3.1	1.1	1.1	19.8	3.2	0.0	1.2	1.8	5.7	0.4	1.4	2.3	5.0	1.8	1.9	1.5	0.9	0.0	0.4	33.2	0.0	0.0	1.2	0.2	0.2	1.4	1.6	0.5	1.4	1.7
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716683-82730328	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		14000	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	17.6	18.3	27.9	10.8	26.3	12.3	15.7	19.5	27.3	15.3	17.4	27.4	10.0	11.8	18.4	16.7	16.4	16.6	13.0	12.7	26.1	20.8	18.8	23.1	12.8	12.9	25.7	23.0	21.9	15.3	10.8	11.4	17.1	22.2	17.1	14.4	13.2	17.2	20.0	7.3	16.1	13.6	20.3	30.7	13.7	12.6	8.8	21.6	8.2	15.1	9.8	17.5	12.1	12.9	16.5	23.2	18.5	15.5	18.5	23.0	17.1	10.9	44.3	12.1	16.0	5.9	11.3	10.0	20.6	11.5	19.9	16.3	23.4	7.7	9.0	13.8	16.6	18.4	12.6	11.0	15.6	18.0	6.0	19.5	15.1	24.8	26.9	10.5	10.5	8.5	10.4	18.5	18.9	10.4	12.2	14.3	12.8	14.5	5.7	25.4	20.8	20.5	15.6	5.5	24.1	19.3	15.4	30.8	14.0	14.1	21.1	10.1	21.5	34.0	15.4	16.6	21.9	25.7	15.3	12.6	38.7	13.3	27.3	30.3	11.7	12.8	22.4	18.0	13.4	17.8	17.0	14.2	18.5	20.4	15.5	20.0	15.7	19.9	19.5	11.7	16.5	23.0	16.7	2.1	18.5	8.4	23.2	18.6	17.1	27.9	26.3	19.5	27.3	26.1	20.8	25.7	23.0	22.2	21.6	11.9	12.0	13.7	25.9	13.4	17.8	5.2	20.4	10.7	12.5	10.4	7.9	80.4	19.9	17.2	1.3	11.7	9.5	23.3	9.9	35.3	15.1	14.6	12.7	9.0	28.7	3.2	7.5	11.6	9.4	2.3	26.2	11.8	21.9	28.9	13.3	29.2	14.9	17.3	29.7	15.8	14.3	12.9	17.6	9.7	22.6	13.4	52.3	14.9	16.9	21.3
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18.0	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25.0	22.1	22.2	22.4	17.6	19.4	21.1	33.0	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4.0	8.5	6.9	15.9	12.8	7.8	13.3	7.9	6.8	20.2	15.1	9.1	10.4	8.7	16.2	22.8	13.6	10.3	9.1	18.8	13.9	8.1	12.5	4.9	13.8	14.2	15.7	12.9	12.1	14.8	16.0	24.8	9.8	10.8	10.5	5.1	6.6	11.4	16.2	16.9	17.3	7.0	15.4	27.0	41.3	14.0	17.0	23.5	22.4	9.1	12.1	8.4	13.0	13.5	14.7	8.8	11.2	10.5	6.9	18.0	13.8	18.6	14.5	8.5	14.7	20.1	28.0	18.7	15.1	16.4	19.6	13.3	2.6	9.0	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6.0	4.0	3.2	4.7	6.7	4.0	19.3	7.1	5.0	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5	23.8	28.6	15.3	12.6	15.0	27.8	9.5	15.3	16.0	22.7	24.4	60.9	16.1	8.3	16.1	102.1	20.4	83.6	0.0	24.3	13.5	15.3	23.7	17.4	25.9	31.3	11.1	28.3	21.5	37.8	102.9	23.3	25.0	15.1	16.2	53.5	15.6	29.1	45.8	17.7	26.4	25.2	19.4	15.3	30.2	26.3	19.4	26.0	27.3	45.3	36.3
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501689-19522145	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 226.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	Vesicles		NA	NA			Vesicles		"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	20.3	18.5	30.6	11.7	34.3	17.5	23.9	13.5	32.2	18.1	31.0	24.5	23.0	22.7	15.0	22.6	19.0	13.4	17.5	40.7	31.1	17.5	21.1	21.3	22.1	13.1	29.2	20.6	9.9	28.3	35.3	13.9	15.5	20.8	21.4	32.5	12.5	20.4	24.9	42.4	18.5	20.8	27.2	25.3	10.1	22.8	14.8	23.8	9.6	17.9	21.7	12.7	22.8	12.4	4.6	7.4	23.9	12.4	3.7	7.4	4.6	14.8	17.9	9.8	11.7	47.6	17.6	14.2	15.4	26.4	12.0	14.9	10.2	26.6	11.1	19.8	22.3	13.2	12.9	13.7	18.1	14.6	12.1	21.2	9.3	17.6	21.9	28.9	12.2	8.7	18.5	29.4	12.8	15.0	22.3	16.1	14.5	5.1	11.6	13.0	26.8	10.7	11.3	11.5	23.3	13.9	15.4	18.1	16.1	29.7	22.8	11.5	10.5	14.9	17.9	14.2	15.9	18.3	14.7	16.9	10.2	9.1	13.4	9.4	10.9	10.2	7.8	15.6	18.2	9.0	23.9	11.8	6.4	5.7	10.5	7.3	4.6	6.8	6.6	7.4	3.7	3.6	5.7	19.8	3.7	12.4	4.6	7.4	4.6	30.6	34.3	13.5	32.2	31.1	17.5	29.2	20.6	20.8	23.8	35.7	72.1	27.9	29.4	20.8	14.8	63.5	35.7	26.8	26.1	8.7	25.5	63.8	19.9	79.5	27.6	16.8	94.2	23.3	143.1	66.0	28.2	77.4	3.5	20.0	53.4	30.2	32.1	17.8	30.7	51.5	26.4	32.5	23.6	22.6	50.6	19.8	66.9	87.7	35.7	39.2	21.5	12.9	25.5	71.0	39.2	25.7	226.1	21.8	61.0	49.4
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 50.5;Enterocytes: 47.9;Muller glia cells: 24.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"AF22: 9.4;NTERA-2: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	20.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9	0.0	0.0	0.0	0.0	50.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.7	0.1	2.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	2.7	0.0	1.5	0.1
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.1	0.5	0.6	13.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3											3.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Group enriched"	"Detected in some"	8	"RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.5	0.1	0.1	0.0	10.4	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3	32.8	5.8	2.2	16.1	3.7	0.0	0.2	17.8	33.5	29.6	22.7	2.0	0.0	18.3	16.4	0.0	0.0	136.8	0.0	33.4	0.0	0.3	3.4	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.6	1.3	0.0	3.6	63.3	0.2	14.4	98.2	0.0	32.1	0.2	0.0	1.0	0.0	0.1	18.2	0.0	0.5	77.9	19.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	11.1			0.2		0.0	0.0	0.0	0.3	0.9	1.4	1.3	0.8	0.7	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	4.6	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.3	2.8	0.0	0.0	2.4	0.0	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	1.3	0.0	0.0	0.5	0.2	0.3	0.7	0.4	0.9	0.0	0.0	0.3	1.4	0.8	0.7	0.0	0.7	0.6											20.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.0	0.0	0.0
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 4.2;salivary gland: 3.0"	"Group enriched"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Early spermatids: 4.1;Late spermatids: 10.4;Spermatocytes: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.9;SuSa: 5.3;U-2197: 3.6"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.9	0.0	4.2	0.0			0.0	0.9	0.0		0.0		0.0	0.0		3.0	0.0	0.0	0.0	1.2	0.0		0.0	0.7	1.5			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.5	1.2	0.0	0.0	1.2	0.3	0.0	0.7	0.6	1.1	0.3	0.0	0.0	5.3	0.0	0.0	0.0	0.3	1.4	3.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase alpha and beta subunits"	Q3T906	12	101745497-101830938	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		47000	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	15.2	6.5	21.9	11.9	23.0	15.2	12.2	13.9	25.6	14.0	21.3	10.3	5.9	10.3	9.0	6.5	11.7	7.1	11.0	15.9	17.9	13.7	11.0	7.3	19.6	20.3	14.4	13.0	6.6	11.4	29.9	9.0	10.8	10.9	15.6	22.5	11.3	37.6	10.2	10.8	18.1	14.5	11.7	13.1	15.4	15.2	7.4	10.8	24.5	10.5	8.6	12.6	14.7	14.8	3.9	5.8	5.9	3.4	14.2	16.4	2.7	8.2	8.0	3.0	5.1	25.3	12.0	9.3	11.8	24.3	11.7	15.4	6.1	5.8	17.3	8.5	16.1	9.6	10.8	13.8	15.1	18.3	8.1	7.3	7.4	7.4	8.7	4.7	6.7	15.0	9.3	8.4	11.1	6.6	29.2	20.4	13.9	11.5	5.2	10.9	12.5	20.2	9.5	10.3	10.2	5.8	4.8	15.4	23.2	18.8	21.5	6.5	5.3	19.5	14.0	27.7	11.7	14.3	4.4	20.1	11.1	6.0	9.2	6.5	14.2	14.5	9.9	12.6	10.0	6.8	5.9	3.1	3.4	16.4	2.9	5.4	2.4	3.6	8.9	5.8	3.9	4.6	7.1	1.2	14.2	3.4	5.8	2.6	2.7	21.9	23.0	13.9	25.6	17.9	13.7	14.4	13.0	10.9	10.8	56.6	54.2	24.1	31.6	14.9	24.2	36.8	20.4	9.4	29.6	21.0	23.6	20.7	6.6	9.5	0.4	12.7	22.0	0.0	13.2	12.5	11.8	33.9	118.0	8.3	40.7	7.9	17.3	8.0	31.8	2.2	15.8	35.6	40.5	40.5	27.1	29.3	13.7	74.8	12.0	13.3	35.5	0.0	10.3	8.9	30.9	12.5	7.3	61.8	37.4	40.8
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.3;skin 1: 34.4"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 4.8;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.8"	"Group enriched"	"Detected in some"	4	"BEWO: 66.4;SK-BR-3: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	1.7	0.6	1.5	0.2	2.4	2.8	15.9	2.0	1.6	10.2	0.9	0.2	10.8	0.3	0.9	3.8	40.3	0.7	1.0	1.6	1.9	1.2	2.5	4.9	2.3	0.2	0.7	1.4	0.5	1.5	12.9	2.6	31.0	0.8	6.1	0.2	1.8	17.5	9.7	0.9	34.4	0.7	5.1	0.6	0.6	1.3	1.6	0.4	0.4	2.8	22.3	25.3	6.7	16.9	0.1	0.2	4.8	0.2	0.5	0.6	4.5	3.2	0.0	0.4	0.9	0.1	0.1	66.4	0.3	0.4	0.2	0.3	0.2	2.3	0.4	0.1	0.0	0.4	2.0	4.0	0.4	0.9	0.9	1.8	0.1	0.6	1.2	0.0	0.2	0.3	0.1	1.7	1.9	0.0	0.0	0.3	0.7	0.6	1.2	0.0	4.2	0.6	0.5	0.2	1.0	0.7	0.2	0.3	0.5	0.4	12.6	0.7	0.5	0.6	34.9	0.8	5.7	4.2	0.1	0.3	0.2	0.8	1.0	0.4	0.8	0.5	0.4	0.2	0.5	0.5	0.0	0.2	4.8	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.6	4.5	1.5	2.4	2.0	1.6	1.9	1.2	0.7	1.4	0.8	0.4	3.0	7.2	0.0	18.6	35.5	20.9	1.2	0.0	6.7	29.6	19.2	58.9	48.9	0.0	2.8	6.0	3.1	0.5	0.0	8.0	69.0	6.1	30.1	10.3	5.7	6.7	11.1	3.4	3.1	1.3	2.1	0.0	2.7	20.3	1.0	0.6	1.7	4.8	0.0	0.4	1.7	11.8	0.0	6.1	5.1	5.3	115.9	154.4	1.3	0.4	97.4
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"retina: 51.5"	"Group enriched"	"Detected in some"	26	"Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 86.9"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA					"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	86.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 26.5;granulocytes: 19.8;Hofbauer cells: 31.0;monocytes: 15.4;Pancreatic endocrine cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 56.3;REH: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA048330"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	13.1	10.7	24.5	35.8	17.0	78.2	17.0	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13.0	14.1	19.1	42.8	13.4	19.0	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6.0	21.0	18.3	3.8	5.3	7.4	7.6	5.4	5.3	8.9	4.3	3.9	5.3	4.6	4.4	6.3	5.2	12.0	12.8	39.5	7.4	4.2	8.4	10.4	7.7	6.2	3.3	48.1	4.8	22.4	6.2	5.4	5.3	47.0	45.0	3.5	7.3	5.0	6.7	4.7	8.0	16.2	8.1	20.3	5.4	14.3	26.1	56.3	6.6	23.1	8.2	74.7	10.5	11.7	6.4	10.1	10.7	5.8	6.8	10.0	16.3	3.4	9.2	51.1	4.4	5.0	6.6	6.3	5.1	12.9	11.9	35.4	6.5	27.9	4.5	6.9	10.3	10.5	5.3	15.9	4.0	3.8	4.0	4.3	6.0	4.1	3.2	3.1	21.0	3.8	18.3	5.3	2.6	7.4	24.5	17.0	32.9	35.3	21.9	17.4	13.4	19.0	15.7	11.1	3.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.9	5.2	0.0	7.8	1.7	9.4	0.0	0.0	0.0	0.0	10.9	5.1	0.0	0.0	19.8	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	15.4	0.0	0.0	22.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	1.9	5.8	1.9	4.1	0.5	8.5	0.6	1.8	1.8	3.2	3.0	3.3	10.6	0.1	0.1	5.2	0.1	5.8	4.3	5.5	20.4	3.8	4.9	0.6	6.7	0.1	15.8	8.3	1.0	3.0	1.3	2.3	0.3	0.3	33.6	0.5	0.0	2.1	2.6	11.3	1.1	4.1	5.7	0.0	5.1	9.3	1.8	0.0	3.1	13.7	18.5	1.0	0.0	4.4	5.6	1.6	6.3	0.1	0.0	12.0	0.1	2.3	1.2	4.2	8.3	7.8	5.6	1.8	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7	14.9	44.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	30.7	0.0	0.0	1.5	1.7	7.0	0.0	0.0	0.0	0.0	1.6	22.7	0.0	0.0	17.4	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	47.7	0.0	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.4"	"Cell type enriched"	"Detected in some"	168	"Cone photoreceptor cells: 310.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HeLa: 1.5;U-937: 1.8"					"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0.0		0.4	0.2	1.6	1.5	0.4	0.0	0.2	0.4	0.1	1.0			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0.0	0.1	0.1	0.6	0.4	0.0	4.1	0.1	0.0	0.0	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.2	1.5	0.2	0.0	0.4	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.4	0.2	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	310.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 199.3;Late spermatids: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.3	28.3	20.6	32.7	13.9	22.6	16.3	27.0	25.3	33.7	32.2	29.6	15.2	23.4	38.0	17.7	24.2	35.0	19.3	17.1	16.6	35.7	24.6	32.5	21.1	26.3	24.2	37.6	26.4	23.7	22.9	24.0	18.4	28.6	19.8	23.2	39.6	31.8	18.6	26.7	37.3	21.4	37.3	17.8	36.1	34.6	22.8	29.9	18.8	22.0	25.3	34.8	27.9	21.4	29.8	13.0	27.2	30.0	28.0	26.5	22.3	45.7	38.0	56.5	63.4	25.3	33.0	39.5	29.6	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1	44.7	44.6	45.7	42.2	21.6	25.9	26.2	20.4	115.1	78.5	24.4	7.9	38.5	18.3	42.3	199.3	33.5	64.5	23.3	44.2	36.6	30.1	27.3	60.3	23.7	51.8	23.8	29.2	52.8	50.9	301.8	41.1	31.9	32.1	62.3	38.4	32.6	42.6	35.9	46.7	29.3	28.8	32.3	43.2	51.5	36.8	18.3	45.2	56.5	40.9	36.7
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.5	12.2	15.5	13.3	7.7	9.1	11.2	8.2	10.9	11.7	8.6	14.9	6.4	13.3	5.6	10.7	10.9	19.8	23.7	13.5	13.0	8.0	9.8	11.2	17.6	6.3	7.6	16.5	7.1	7.0	10.3	12.0	15.7	7.1	10.0	8.9	18.2	6.8	8.4	14.0	10.1	7.7	19.7	13.0	11.9	10.0	18.9	11.7	8.6	7.2	21.6	14.6	14.8	15.0	9.1	10.1	20.9	6.8	10.4	19.4	10.9	8.8	12.3	2.8	6.4	14.8	8.2	10.4	11.9	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4	17.9	8.6	7.8	6.7	27.2	15.0	11.2	2.5	18.7	6.8	3.5	13.7	6.2	6.6	7.2	4.8	9.0	3.5	0.0	5.4	6.0	11.5	9.1	1.1	7.8	5.4	19.1	12.6	7.4	7.3	2.1	17.5	4.6	3.3	2.8	7.4	11.3	5.8	7.0	18.0	5.6	16.9	0.0	7.6	15.1	12.6	35.0	5.4	6.1	8.0	4.6
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.6	2.5	10.9	13.6	6.5	8.7	12.9	7.3	11.3	4.6	7.0	2.3	2.1	2.1	3.3	5.5	7.9	2.5	2.7	5.0	9.8	8.4	6.9	7.2	2.3	3.1	6.5	6.2	2.4	5.8	4.6	6.0	5.1	6.1	7.6	8.7	6.9	2.3	9.1	2.6	4.6	3.7	4.7	2.7	2.5	7.3	12.4	0.8	3.7	6.2	5.8	8.8	3.9	4.1	2.1	7.3	2.6	8.5	8.0	3.7	3.1	10.0	6.9	3.3	3.7	7.0	3.9	5.9	6.8	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9	3.0	0.6	0.0	1.6	4.1	11.4	6.3	2.5	0.0	4.5	5.2	43.2	7.5	1.7	1.7	3.1	6.7	1.3	0.0	1.3	4.6	4.8	2.2	1.1	2.5	4.6	15.9	1.7	4.3	2.2	3.3	5.8	2.4	1.7	4.6	1.4	5.8	1.1	2.9	3.5	4.1	30.6	6.5	6.6	12.5	2.7	4.1	5.3	2.2	2.1	1.8
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983682	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	24.3	23.7	14.3	20.8	21.4	30.9	25.7	18.4	16.7	17.6	18.2	14.0	17.7	11.8	20.7	15.6	21.3	17.7	14.8	26.2	16.7	13.0	27.5	22.1	18.8	26.9	21.2	12.9	21.8	23.0	22.3	32.2	21.1	21.4	20.8	19.3	13.1	25.5	15.6	53.9	18.6	15.8	22.9	20.5	22.5	20.2	15.9	21.5	35.4	26.1	31.8	27.8	22.1	16.9	21.0	16.0	29.9	32.1	25.9	28.1	19.2	34.2	16.4	29.0	26.5	15.4	16.0	20.5	35.8	23.9	39.6	41.4	38.0	23.8	38.5	23.2	21.6	33.6	27.3	31.4	29.3	61.2	21.7	31.1	33.9	27.1	34.3	7.5	42.8	21.3	9.5	17.0	52.2	17.5	12.5	24.9	26.9	35.1	25.3	44.9	23.9	33.5	39.2	24.1	41.8	17.2	26.9	36.6	26.1	23.5	34.6	18.6	15.3	30.0	16.8	30.4	23.4	23.4	43.5	12.6	35.6	27.5	29.9	36.0	11.1	25.6	45.3	24.0	30.7	30.8	23.8	21.1	29.9	20.8	24.5	25.8	21.0	22.1	21.3	16.0	18.4	22.2	24.2	24.0	25.9	32.1	8.2	28.1	19.2	14.3	21.4	18.4	16.7	16.7	13.0	21.2	12.9	21.4	21.5	32.8	31.1	44.9	101.4	65.9	23.1	47.4	17.8	45.5	30.7	26.2	31.4	65.0	69.6	36.4	42.5	37.9	16.0	23.3	40.9	71.6	41.6	50.0	40.3	18.4	45.8	27.0	13.7	28.3	32.7	8.9	28.4	37.8	30.4	19.0	18.1	49.8	25.8	18.2	34.6	35.3	35.7	38.8	59.0	45.9	63.7	46.0	48.7	40.6	27.7	61.2
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.3	14.5	27.0	40.9	26.1	20.8	17.5	15.6	34.3	35.4	50.8	31.0	18.3	31.1	20.2	20.2	25.2	18.6	27.1	36.5	43.9	26.5	29.1	24.3	13.3	17.6	18.4	29.2	22.3	17.7	23.5	20.5	26.8	18.4	22.8	28.1	23.7	16.6	22.3	20.2	32.4	25.3	23.8	13.3	11.5	23.5	28.2	22.4	18.9	21.5	22.6	18.3	20.6	21.4	25.7	17.9	22.8	18.5	11.5	22.0	13.8	16.8	25.5	13.5	16.6	29.3	18.5	27.8	18.8	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6	8.9	10.4	32.3	23.0	39.3	30.6	12.3	15.3	5.3	11.4	12.2	56.9	47.2	18.3	28.5	7.6	20.2	15.4	0.0	31.4	44.3	29.3	18.8	18.4	14.8	34.9	47.7	17.2	20.9	15.4	3.4	20.8	33.0	30.4	66.7	17.7	27.7	27.2	14.0	20.8	15.7	30.4	25.8	24.0	22.3	24.5	44.9	51.1	31.9	22.7	26.5
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 6.7"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037767	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	8.7	8.8	16.5	6.9	17.9	2.4	10.8	20.3	19.5	14.3	10.1	5.1	9.1	4.6	17.2	16.6	8.3	12.1	11.4	8.1	11.9	8.7	7.3	4.7	8.7	4.7	5.8	11.3	16.8	7.4	14.4	18.6	10.2	6.5	24.8	7.6	7.5	7.7	24.3	7.7	6.8	6.0	18.4	6.8	5.3	7.5	9.7	6.4	2.9	9.8	5.1	3.6	13.7	10.5	0.6	0.4	0.1	0.8	6.7	1.0	0.5	4.1	2.1	21.4	8.8	4.7	5.2	3.8	3.4	4.5	6.9	6.3	0.2	3.9	0.0	2.9	3.4	4.0	0.3	5.8	2.4	8.5	4.4	7.2	2.4	15.0	1.3	2.4	0.4	1.6	5.3	2.2	5.0	4.3	9.7	5.1	5.1	3.1	10.7	10.6	1.9	2.5	1.3	8.9	0.4	2.1	6.4	14.1	2.4	4.8	1.2	5.0	5.4	6.6	1.5	6.7	6.9	9.7	1.4	5.4	6.9	4.8	0.5	6.3	0.7	1.4	5.9	6.1	0.0	4.0	0.0	0.1	0.0	1.0	0.8	0.6	0.2	0.5	0.7	0.4	0.6	0.5	0.6	0.1	6.7	0.2	0.0	0.1	0.5	16.5	17.9	20.3	19.5	11.9	8.7	5.8	11.3	6.5	6.4	0.0	3.2	0.0	7.0	5.5	21.3	6.5	5.1	5.3	5.7	5.2	25.5	0.3	18.3	2.4	1.5	8.3	0.7	0.0	3.0	0.3	11.3	4.2	3.5	0.8	5.3	27.0	8.6	9.2	7.0	1.5	11.2	3.8	6.8	3.6	3.0	12.0	2.5	0.6	13.4	1.3	8.2	12.9	7.6	6.7	8.1	3.9	0.3	1.5	1.3	3.0
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved					NA	NA		34000			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (3.19e-1)"	18.4	16.9	9.6	16.7	11.1	9.2	25.9	12.4	14.8	11.2	38.0	14.8	11.7	34.1	12.4	12.4	16.7	9.1	14.6	8.7	9.9	8.4	16.4	22.9	10.5	11.3	10.9	7.9	14.1	24.1	22.9	8.0	11.8	10.8	10.4	19.5	9.7	27.0	15.4	24.2	20.1	59.3	12.0	9.9	14.0	13.9	11.7	9.7	11.9	13.3	14.8	12.5	13.8	12.0	8.7	9.9	10.4	15.1	5.0	10.9	7.5	11.1	10.1	6.5	10.5	22.9	14.4	12.9	10.7	16.2	11.8	13.4	14.4	3.5	5.2	9.1	17.5	26.5	10.5	15.4	11.1	10.6	9.8	11.9	8.4	14.7	12.6	20.1	6.5	14.2	15.5	19.1	20.1	7.9	12.3	26.3	9.2	18.8	5.9	15.0	9.5	8.2	5.3	8.9	12.6	15.5	9.9	11.8	7.5	17.3	13.2	15.7	6.5	14.4	25.0	12.7	17.2	8.1	6.1	19.6	13.7	11.0	16.9	12.1	7.6	8.9	2.9	21.9	7.1	6.7	9.4	10.4	10.4	10.9	15.1	9.1	8.7	8.9	9.3	9.9	5.1	7.5	8.9	4.0	5.0	8.2	7.5	9.0	7.5	9.6	11.1	12.4	14.8	9.9	8.4	10.9	7.9	10.8	9.7	3.0	8.0	3.0	2.3	3.4	5.3	5.5	7.6	0.0	6.8	5.2	5.9	6.1	1.7	8.5	1.0	4.6	34.5	23.3	13.5	12.8	6.0	2.1	5.8	10.5	12.1	6.4	2.4	5.5	16.5	1.3	13.6	5.4	3.3	8.2	13.7	3.9	11.3	23.0	9.2	5.5	5.9	6.5	4.1	4.5	7.7	5.4	5.0	5.0	11.5	2.0
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;GAMG: 4.9;U-266/70: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.7	0.0	0.0	0.2	3.1	2.7	4.9	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.3	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.7	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6	0.0	0.0	0.0	0.3	0.3	13.6	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	118.3	0.3	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	42.9	0.0	0.6	0.0	44.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.4	15.9	1.8	0.0	0.8	2.1	2.5	0.3	0.0	0.5	0.4	0.3
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593692	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Ito cells: 134.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.7;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 7.7;monocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2;HUVEC TERT2: 15.3;SCLC-21H: 17.8;TIME: 20.1;U-138 MG: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034609	Enhanced					NA	NA					"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0.0	1.1	3.0	1.0	5.5	6.3	4.8	14.0	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0.0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.7	2.4	0.9	1.5	4.0	1.2	1.5	0.1	0.0	0.7	0.3	7.3	1.9	1.7	0.5	0.1	2.5	27.2	0.9	0.0	1.1	0.1	0.1	0.2	0.2	0.6	0.7	9.1	3.2	2.3	15.3	0.0	0.1	0.0	3.7	1.0	0.0	0.3	1.4	0.1	0.6	0.0	0.3	0.0	0.0	0.0	17.8	1.4	1.1	0.2	0.0	0.2	0.0	0.1	20.1	12.3	0.8	2.6	0.3	0.1	0.0	0.7	3.1	0.0	0.1	0.2	0.5	1.3	0.0	1.9	0.0	0.5	0.1	0.0	0.7	0.6	0.1	0.0	7.7	0.0	5.2	0.0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8	0.0	8.9	2.7	0.2	1.9	7.8	14.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	9.7	18.0	0.0	0.0	0.0	0.2	1.0	0.1	1.1	1.5	0.1	0.0	2.4	134.4	11.6	3.6	0.0	1.1	3.3	1.0	0.0	12.5	0.1	0.0	2.5	0.0	0.9	0.0	2.1	0.5	6.4	1.4	0.1	1.9	0.0	0.4
HELZ2	"KIAA1769, PDIP1, PRIC285"	ENSG00000130589	"Helicase with zinc finger 2"	Q9BYK8	20	63558086-63574239	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Urothelial cells: 49.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.2;GAMG: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051267	Uncertain					NA	NA					"HPA051267: "	"unprognostic (1.86e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.16e-1)"	3.2	2.1	0.7	4.6	0.9	13.3	3.1	0.0	0.7	2.4	2.4			3.1	2.3	0.3	4.2	2.9	2.5	2.7	0.3	0.7	3.5	4.6	5.8	3.6	0.7		2.2	3.7	0.7	3.1	1.8		2.4	0.4		10.4	0.7	1.1	2.4	3.4	0.6	0.6	9.5	5.6	0.5			3.5		1.3	2.2	1.9	0.9	0.4	2.7	0.8	0.3	0.8	0.8	5.2	2.0	0.6	2.0	1.2	1.6	3.9	1.9	2.8	33.2	12.9	5.4	6.8	0.1	4.1	0.7	19.2	8.3	0.4	2.0	1.3	2.0	0.9	0.1	2.2	1.8	2.7	0.1	13.0	2.0	1.4	2.4	0.4	0.7	1.5	0.1	0.9	2.2	0.4	5.2	0.6	5.4	1.0	1.4	6.2	1.2	1.1	2.0	0.9	6.1	0.5	1.8	5.9	0.4	13.4	0.4	1.8	1.6	2.4	3.2	4.8	2.6	1.9	2.9	0.3	0.1	3.4	0.9	2.8	0.4	0.8	1.9	0.8	0.6	0.3	0.4	0.5	0.6	0.4	0.9	0.3	0.5	2.7	0.3	0.4	0.0	0.5	0.8											8.9	8.9	1.4	18.9	7.7	1.0	3.7	10.2	1.4	10.3	8.7	0.0	1.6	0.0	7.8	0.0	13.7	16.3	0.0	6.7	11.3	7.8	25.2	0.0	4.0	3.1	0.0	29.6	6.7	2.7	0.0	6.6	11.6	3.3	1.8	13.3	2.8	14.0	10.7	2.1	0.6	2.7	6.5	7.6	0.6	0.2	7.3	1.6	13.8	10.4	49.9
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA					"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	14.4	11.7	20.3	12.9	23.5	28.9	15.5	30.4	29.7	17.4	15.3	14.7	13.8	7.0	15.8	8.9	10.3	10.7	12.1	17.6	19.4	14.3	11.9	11.4	14.9	15.2	12.8	23.7	23.8	11.5	44.8	20.1	12.7	19.1	11.4	11.8	11.0	11.4	14.0	31.7	14.6	13.9	15.7	11.7	17.4	13.5	13.5	15.8	16.6	17.2	11.3	15.3	12.9	11.6	9.8	7.0	17.6	5.7	2.8	6.6	1.4	7.5	9.9	11.1	3.8	19.7	12.7	3.7	6.0	7.7	6.2	7.2	6.1	3.0	11.3	5.5	11.2	5.7	8.3	17.9	5.1	8.5	8.7	6.1	24.5	14.1	4.4	3.2	18.1	14.7	9.0	5.0	8.7	8.6	5.4	13.0	7.7	24.6	5.0	5.3	12.3	6.3	3.6	5.5	5.8	5.1	6.9	12.3	6.6	2.5	18.7	10.0	5.0	10.6	7.2	6.3	14.0	3.6	7.2	14.5	8.1	7.5	6.9	7.8	5.6	9.5	7.9	4.6	13.5	2.8	17.6	3.7	7.4	5.0	3.3	3.8	5.3	5.5	4.4	3.2	9.8	5.6	5.6	12.9	2.8	5.7	7.0	6.6	1.4	20.3	23.5	30.4	29.7	19.4	14.3	12.8	23.7	19.1	15.8	6.0	36.1	26.8	9.3	13.3	57.2	57.0	7.6	18.7	20.5	21.0	62.8	7.2	1.7	8.7	18.5	26.3	11.5	0.0	12.2	9.1	17.5	12.6	48.6	17.9	15.0	81.0	9.8	51.5	39.1	12.5	25.6	22.8	18.6	23.4	12.8	25.1	10.8	13.6	37.4	13.2	54.8	6.5	17.8	45.5	28.9	13.4	7.4	34.8	12.0	9.3
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.2	10.3	7.2	3.0	6.0	4.5	2.0	3.8	4.5	4.9	4.7	5.3	0.7	5.2	4.6	6.4	7.4	5.3	7.6	3.7	3.6	3.2	4.9	33.3	12.0	1.7	2.3	7.8	2.7	3.7	2.9	5.8	7.3	3.1	6.4	4.4	12.8	2.2	4.6	2.4	1.7	2.6	2.1	4.0	4.5	6.2	10.3	0.4	1.7	11.3	7.9	4.6	9.1	2.6	3.0	3.9	3.0	9.2	9.6	9.1	5.9	3.5	5.6	1.4	2.0	4.9	4.2	3.7	4.8	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4											20.8	19.7	23.1	13.0	14.5	100.9	54.0	28.1	17.4	25.0	61.1	139.4	22.6	1.7	24.7	11.1	39.4	24.9	0.0	26.5	13.6	21.3	18.7	3.5	30.6	16.6	116.0	27.0	36.8	21.8	10.6	52.0	17.3	65.8	26.2	29.8	46.8	29.3	31.6	49.1	16.6	140.1	64.7	24.7	57.9	59.4	18.3	14.9	30.2	30.9	10.1
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.6;hTERT-HME1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.3	1.1	1.4	2.4	7.9	16.7	4.7	8.3	15.4	8.7	5.8	1.9	8.6	7.8	4.0	27.6	4.0	2.6	2.0	7.6	8.3	3.4	2.3	5.4	3.3	1.2	4.5	13.4	9.8	7.9	9.4	8.3	37.6	4.9	9.6	4.1	3.9	3.4	17.7	2.2	9.2	3.2	0.4	4.8	2.0	10.4	9.7	3.2	5.6	1.4	1.9	1.9	9.6	6.1	3.2	2.4	1.0	6.0	15.0	9.9	5.4	9.3	6.2	6.5	1.6	4.5	6.2	6.1	4.1	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5	6.0	5.8	8.8	7.9	31.9	24.1	18.5	7.6	4.0	2.3	8.7	104.1	5.8	1.7	3.6	2.6	9.3	9.2	23.3	7.9	13.2	7.3	12.5	15.1	11.0	8.3	30.2	26.5	8.6	27.9	2.7	7.8	17.3	13.5	2.8	10.1	9.2	7.4	8.6	12.4	5.0	59.1	6.5	11.3	3.0	7.0	44.4	6.2	13.1	5.2	10.4
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.9;fHDF/TERT166: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.8	8.2	5.1	8.6	13.4	18.4	4.6	55.9	34.6	21.0	13.6	4.6	10.8	8.0	4.4	62.8	13.1	12.1	5.7	8.3	28.4	5.2	2.8	3.7	13.5	3.5	7.1	4.5	6.6	9.0	9.7	11.2	10.0	26.4	13.0	4.5	3.9	4.1	32.3	9.8	3.2	5.3	3.0	5.3	14.3	4.3	2.1	2.8	9.5	6.5	2.5	2.8	18.2	7.8	7.9	11.1	4.8	5.7	17.7	11.1	6.2	27.2	9.6	2.8	3.3	5.1	20.3	8.7	3.8	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6	44.7	27.7	32.0	24.8	44.8	51.3	21.2	12.7	17.4	15.9	17.4	41.2	23.4	6.6	17.2	55.0	28.7	37.8	0.0	10.6	35.6	22.1	32.9	30.0	21.3	20.3	50.9	21.2	31.3	32.9	34.9	24.7	27.8	16.9	16.2	25.6	23.2	28.7	31.6	18.0	18.2	45.2	6.5	25.8	22.4	10.2	53.2	13.0	27.3	17.7	45.1
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 alpha subunit inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	8.8	12.7	11.6	11.9	10.8	7.6	12.9	9.5	14.1	9.2	10.7	11.5	8.8	9.7	11.6	10.4	11.1	9.6	12.5	16.0	10.2	9.4	10.3	8.8	9.3	12.3	13.0	9.5	14.5	14.3	17.1	10.6	10.2	10.8	10.7	9.3	9.2	10.6	12.1	46.8	13.3	10.6	14.9	9.7	11.1	10.0	17.9	10.3	13.5	8.1	14.8	12.3	10.8	10.8	9.7	8.5	16.9	14.0	10.1	11.3	9.3	9.1	9.7	13.1	13.2	20.4	8.5	11.4	9.8	23.7	14.6	17.2	15.0	7.9	9.9	8.9	14.6	10.8	10.7	11.5	8.8	15.9	10.9	7.0	9.4	8.6	11.4	10.6	11.3	12.6	8.3	8.9	14.1	15.5	20.6	8.2	13.3	4.1	5.6	16.3	9.6	12.1	7.4	4.3	7.8	4.7	8.8	16.3	4.8	10.1	12.3	5.0	8.3	8.4	5.2	9.2	11.5	17.8	6.1	6.8	7.5	9.7	7.3	9.8	7.6	7.7	7.6	12.4	9.3	5.5	13.1	8.8	16.9	9.8	12.4	9.6	9.7	10.1	9.0	8.5	7.5	9.8	9.9	9.3	10.1	14.0	3.1	11.3	9.3	11.6	10.8	9.5	14.1	10.2	9.4	13.0	9.5	10.8	10.3	0.0	6.2	14.3	9.8	9.7	16.8	34.6	12.7	4.0	5.7	10.4	15.7	23.3	8.3	15.7	15.4	9.0	14.8	0.0	12.1	15.1	7.1	8.2	5.8	8.7	13.0	23.8	12.7	7.4	17.7	39.0	10.3	10.4	3.3	16.2	11.3	14.3	15.3	14.0	11.3	14.7	21.9	6.5	12.2	39.9	22.2	10.2	27.3	11.7	11.4	8.4
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.2	6.7	9.3	7.1	10.9	5.7	6.3	5.7	6.9	8.1	7.8	7.7	3.2	11.1	7.8	9.0	3.0	5.6	12.0	6.6	11.8	8.0	6.0	16.1	8.4	8.1	9.1	12.8	20.0	6.2	9.7	10.4	10.6	7.7	12.0	19.7	11.0	12.0	11.6	62.4	16.8	7.3	9.5	6.2	6.0	10.2	27.3	3.9	7.3	7.1	4.1	5.5	10.4	11.2	7.3	10.8	6.5	18.5	11.6	8.0	10.8	13.0	8.6	7.5	5.8	9.6	9.0	10.4	18.2	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3	50.6	37.0	12.9	14.8	54.6	47.6	27.1	22.9	64.3	20.5	26.2	66.8	9.7	5.0	12.5	82.7	29.3	18.8	70.0	18.3	7.9	25.0	26.7	45.1	33.6	19.9	69.9	35.7	23.9	54.6	73.8	20.4	35.5	20.3	15.4	24.2	28.9	17.0	17.3	35.0	13.4	60.3	25.8	37.0	35.4	26.0	70.4	11.9	47.3	22.4	23.0
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60.0	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.5	8.6	5.2	21.0	15.1	1.0	2.3	2.3	2.6	2.7	1.3	2.3	0.0	5.3	4.3	16.0	0.2	3.9	6.0	6.5	42.6	1.6	19.0	3.0	6.5	11.8	5.2	5.2	22.9	3.9	11.8	17.8	6.1	6.4	3.6	11.0	5.2	19.8	3.1	6.5	3.7	2.2	2.3	12.7	7.8	4.7	0.5	11.7	0.7	5.2	4.8	5.2	0.1	2.6	1.6	2.9	2.1	21.5	9.1	4.3	10.5	11.3	25.8	15.3	3.7	18.6	2.8	4.9	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0.0	0.5	58.8	53.6	8.5	25.2	60.0	39.9	66.1	16.4	26.4	38.6	14.9	31.1	34.2	22.5	8.2	100.5	179.2	58.6	29.4	29.6	61.1	143.3	6.0	29.9	26.8	2.4	43.9	23.1	0.0	58.5	1.5	18.6	91.5	42.8	127.8	14.7	209.7	64.5	159.0	115.1	3.1	12.0	28.9	42.2	32.5	35.2	61.0	53.9	17.5	17.7	62.8	59.6	45.3	63.6	0.9	1.7	8.3	8.0	30.2	23.3	40.0
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	46.3	13.4	12.7	15.9	15.9	12.7	49.2	11.7	13.7	23.6	24.8	11.9	15.9	9.9	28.3	22.8	22.9	24.1	18.8	69.0	13.4	11.8	23.4	21.1	20.2	20.9	15.5	8.2	23.6	15.4	49.7	21.2	20.5	15.2	23.2	12.8	15.6	18.8	18.1	45.9	18.7	25.0	32.9	15.9	20.1	20.5	14.7	14.2	15.2	37.9	26.0	14.4	33.6	34.6	3.1	11.3	17.6	10.1	3.3	4.4	3.7	9.5	9.1	6.9	7.8	32.1	20.3	6.9	10.1	11.8	8.3	7.0	10.0	7.0	10.4	8.6	12.4	4.2	12.3	5.2	11.3	11.7	15.0	8.1	10.4	10.3	7.6	13.3	11.2	6.6	19.0	22.3	3.2	9.3	8.6	10.0	7.6	3.3	20.8	13.3	5.0	9.2	7.8	1.7	8.6	5.5	12.4	24.5	10.3	13.6	15.0	1.0	5.8	13.7	15.8	9.4	7.8	17.8	20.6	12.9	13.0	8.9	14.9	7.2	11.4	17.9	10.9	6.3	11.8	12.1	6.6	10.1	4.8	3.5	7.6	4.4	2.4	3.2	3.7	11.3	3.1	2.9	3.5	17.6	3.3	8.6	1.4	3.2	3.7	12.7	15.9	11.7	13.7	13.4	11.8	15.5	8.2	15.2	14.2	11.9	40.1	19.6	37.7	59.1	15.0	138.1	28.1	60.2	40.9	31.4	17.7	14.6	5.0	10.7	17.4	81.2	34.9	0.0	21.3	10.5	36.9	34.5	13.9	44.7	26.7	30.2	35.6	49.7	100.8	22.3	39.7	52.2	55.6	6.4	26.9	10.8	18.6	21.6	35.3	28.4	23.7	51.8	63.4	10.0	7.6	65.6	12.9	17.3	20.1	42.6
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	10.2	22.1	12.6	8.4	17.6	9.0	12.4	29.3	23.8	11.1	11.0	12.4	6.2	4.8	12.4	9.6	7.1	10.8	8.6	16.5	15.8	16.6	15.6	16.3	7.1	9.8	15.7	19.0	17.6	12.0	16.5	25.1	7.3	29.9	14.7	7.0	11.3	9.3	11.1	9.7	5.1	6.6	12.7	19.0	7.5	8.7	37.7	14.0	17.1	19.0	4.8	9.6	10.0	7.8	8.4	9.2	8.8	2.3	5.4	10.4	3.5	24.6	12.0	17.2	13.4	11.5	14.9	1.7	16.7	10.0	12.4	14.5	9.7	17.2	15.9	20.5	7.7	24.3	0.7	23.0	6.6	20.8	8.8	11.2	38.2	9.4	3.9	7.2	10.0	15.9	9.4	3.6	9.2	5.4	19.0	7.1	26.0	13.3	10.4	16.9	12.4	20.5	15.4	12.9	12.5	15.1	23.8	19.3	2.5	10.2	8.0	17.0	10.0	25.4	11.8	23.0	9.5	35.2	9.8	5.0	14.6	8.8	20.5	18.2	15.4	8.6	20.8	14.3	13.7	5.6	8.8	1.3	4.0	5.6	2.1	10.4	8.4	4.9	7.2	3.9	5.4	7.2	7.4	0.2	5.4	2.3	9.2	4.4	3.5	12.6	17.6	29.3	23.8	15.8	16.6	15.7	19.0	29.9	14.0	23.8	14.8	13.8	7.6	4.9	88.3	34.8	17.8	30.8	21.6	29.6	39.3	6.6	29.9	7.9	9.5	10.8	1.3	0.0	7.3	8.2	10.6	11.9	53.2	14.9	7.6	44.5	4.7	15.4	4.0	5.8	31.4	7.5	5.0	3.6	6.2	35.2	6.8	2.8	30.4	15.6	75.2	12.9	14.1	110.2	89.0	3.8	1.4	13.8	6.6	4.3
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9.0	3.4	1.1	3.3	1.0	1.7	3.7	3.2	6.0	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4.0	6.5	9.1	1.5	11.1	0.6	5.0	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1.0	3.8	7.7	1.0	0.7	1.7	0.5	0.5	0.5	0.1	0.0	3.0	10.6	0.1	0.0	0.0	13.0	1.0	0.0	0.2	0.0	4.2	0.1	0.0	0.4	4.9	0.2	0.1	6.2	0.0	0.0	0.0	3.2	0.0	2.8	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.2	0.9	8.0	0.0	0.1	0.1	14.4	0.0	1.1	0.0	11.7	7.8	10.3	0.8	0.4	7.7	4.3	1.1	0.0	0.0	7.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.0	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1.0	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2	6.0	7.8	0.0	1.8	4.5	4.3	3.2	17.8	1.4	4.5	7.0	2.0	8.1	0.0	3.8	0.0	0.9	2.7	0.0	2.9	11.6	10.6	1.6	0.0	0.9	2.3	3.2	4.7	0.0	0.0	0.0	0.3	0.0	3.3	0.0	3.9	11.4	2.6	2.9	0.0	1.5	1.2	0.0	1.4	0.9	0.7	5.1	5.1	0.0	9.0	0.8
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.2	31.0	20.2	14.2	35.4	21.2	24.9	15.1	19.5	16.0	16.7	23.6	16.2	26.4	10.3	27.5	28.8	24.2	45.6	25.3	21.9	38.0	20.2	21.0	27.8	18.3	32.5	31.4	12.9	20.2	19.0	38.3	44.1	15.8	27.6	20.7	20.9	17.1	20.7	31.0	17.0	17.6	27.6	13.8	22.3	15.7	27.8	16.0	26.5	34.9	16.9	12.2	42.7	19.1	13.6	39.5	27.3	15.3	35.1	14.7	21.1	21.0	19.2	15.0	14.8	23.0	15.7	30.8	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7	47.6	43.2	23.8	25.3	26.8	53.1	98.6	45.9	37.5	36.4	38.4	47.1	26.9	1.7	35.4	22.3	29.2	24.7	0.0	30.4	29.3	24.4	33.4	20.9	43.1	21.9	77.9	45.8	31.3	25.6	21.6	26.2	26.1	25.3	40.5	28.4	20.9	40.0	17.3	36.7	12.2	31.9	12.9	33.0	17.1	43.7	36.4	31.7	37.1	29.2	40.4
HYKK	"AGPHD1, LOC123688"	ENSG00000188266	"Hydroxylysine kinase"	A2RU49	15	78507564-78537372	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 24.9;Late spermatids: 27.7;Proximal tubular cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 7.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5;U-266/84: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040706	Approved		Approved	Vesicles,Aggresome		NA	NA			Vesicles	Aggresome	"HPA040706: AB_10795528"	"unprognostic (9.26e-2)"	"unprognostic (1.98e-4)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.90e-2)"	6.3	7.5	6.4	4.8	8.0	1.7	7.7	2.3	6.1	8.2	14.3	2.5	6.8	11.1	6.4	11.0	7.0	6.5	7.5	8.5	4.3	3.5	19.4	10.5	3.6	4.3	3.5	3.6	9.7	15.5	4.0	8.8	1.5	4.3	8.0	6.2	10.1	7.9	10.1	8.9	3.9	21.2	9.4	3.4	1.6	6.8	7.8	2.2	5.7	7.3	3.7	4.1	7.1	5.1	0.4	0.6	0.8	0.2	0.5	7.1	1.2	3.1	5.1	0.5	9.0	2.0	4.4	1.9	1.0	2.1	3.0	3.5	1.7	3.7	2.5	1.1	2.0	5.2	3.6	8.2	2.7	2.8	1.1	17.5	1.1	2.2	4.2	5.1	0.3	1.4	4.0	5.1	1.1	2.3	1.0	2.1	10.7	3.0	6.5	1.7	3.8	2.9	0.5	0.5	7.6	6.5	1.7	9.9	2.0	5.6	3.5	0.9	1.2	2.2	6.7	7.9	1.4	7.6	0.2	0.9	1.9	1.4	3.6	3.3	10.2	17.8	0.1	2.2	0.1	2.7	0.8	0.2	0.5	0.3	0.1	0.4	0.4	2.4	0.4	0.1	0.4	7.1	1.3	0.8	0.5	0.1	0.6	1.0	1.2	6.4	8.0	2.3	6.1	4.3	3.5	3.5	3.6	4.3	2.2	11.9	2.6	0.9	6.2	3.2	2.7	4.4	0.0	4.0	1.2	7.0	2.0	6.0	24.9	1.9	11.0	4.5	2.8	0.0	6.8	3.6	3.6	3.7	0.0	5.0	0.7	0.0	4.1	5.5	0.6	27.7	4.9	0.6	6.8	0.0	3.4	4.8	2.4	3.1	3.5	33.6	1.8	0.0	3.7	3.2	7.5	1.4	2.9	0.0	6.0	3.5
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Intestinal cell kinase"	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9.0	5.3	44.3	12.3	12.2	13.0	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15.0	5.6	12.6	14.8	7.6	7.0	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5.0	2.1	5.1	1.9	10.1	6.9	6.3	10.0	11.7	4.6	8.5	7.5	8.6	2.7	1.6	3.7	2.8	14.1	2.4	3.4	12.0	4.8	9.9	13.0	4.7	2.8	2.3	14.8	3.2	3.4	3.7	8.8	5.3	3.2	3.7	5.4	6.9	8.2	5.3	15.5	17.0	4.4	3.6	4.2	3.8	18.0	4.2	5.8	4.5	5.0	3.1	3.7	16.3	7.3	4.5	11.2	6.4	10.3	6.5	7.3	5.7	12.0	5.6	4.4	11.4	4.3	3.1	1.5	2.4	3.3	5.8	6.2	3.1	5.6	5.0	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6	17.9	16.8	7.1	4.3	6.9	30.5	8.7	7.6	17.4	26.1	3.5	35.3	17.7	11.6	8.9	1.8	8.7	9.5	0.0	21.0	27.3	8.2	14.5	19.7	12.3	5.2	25.4	8.6	8.0	10.4	1.1	13.3	6.0	3.3	5.4	25.7	20.1	16.6	2.9	26.9	3.8	41.7	6.5	14.4	6.4	2.7	7.3	48.6	7.5	12.3	8.0
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332653	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.1	10.8	10.9	17.0	16.7	9.3	10.0	26.1	16.9	10.3	10.3	12.4	11.4	4.7	15.3	13.2	17.9	16.4	14.9	7.9	13.1	6.9	12.4	9.9	14.9	12.2	20.3	7.9	9.6	13.3	18.0	13.6	11.2	11.9	14.0	10.9	10.5	11.4	9.7	17.6	22.2	9.8	16.4	10.5	18.7	10.8	8.3	18.6	12.9	14.3	8.4	17.1	18.1	12.8	12.6	14.8	14.1	9.6	11.9	11.2	5.8	3.6	12.9	3.7	6.3	14.3	12.4	4.7	3.2	11.3	9.5	8.4	2.9	6.7	7.1	5.5	8.8	9.0	4.1	5.0	12.7	12.3	6.9	5.7	9.9	6.0	2.3	10.9	1.9	10.4	8.2	9.7	9.1	14.2	18.7	14.0	4.7	8.4	3.5	20.8	4.1	6.9	3.1	3.6	11.8	4.1	7.1	6.3	4.1	10.7	3.3	1.1	2.1	2.0	3.6	5.2	6.9	4.8	8.3	7.2	6.7	3.5	5.2	2.3	2.1	2.1	5.0	7.9	4.7	7.6	14.1	9.6	10.4	10.1	7.6	10.3	9.4	10.5	11.2	8.9	12.6	10.2	10.4	11.4	11.9	9.0	14.8	9.9	5.8	10.9	16.7	26.1	16.9	13.1	6.9	20.3	7.9	11.9	18.6	11.9	24.0	17.7	29.3	21.6	11.3	4.5	15.3	14.7	13.6	15.7	127.6	8.6	1.7	11.4	2.0	27.7	11.8	0.0	11.8	4.6	9.8	23.2	36.9	10.2	15.8	17.5	10.9	15.4	26.9	3.0	15.3	17.7	18.6	13.6	15.1	11.6	13.3	14.4	12.0	4.8	52.3	6.5	6.4	2.6	6.4	25.5	12.7	20.3	13.6	25.7
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 20.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	9.0	7.1	2.0	0.2	3.6	5.2	2.1	3.6	11.5	5.0	5.6	5.6	14.7	17.9	9.9	7.3	6.0	12.2	0.0	9.3	1.0	2.9	1.7	2.5	4.2	3.9	4.7	15.2	8.1	6.6	1.6	4.1	0.8	5.8	7.2	4.9	1.2	5.5	5.2	1.8	9.7	25.6	2.9	2.1	5.5	5.2	2.1	14.2	5.9	15.4	0.0	0.0	1.6	12.3	2.2	2.6	7.3	10.8	14.0	5.0	3.1	3.6	4.1	1.9	0.9	11.6	9.4	12.8	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3											0.0	5.0	8.9	3.6	1.6	0.0	0.8	0.0	2.7	0.0	0.0	0.0	3.5	0.0	10.6	2.7	0.6	10.5	0.0	10.9	3.6	2.4	2.6	4.7	0.8	12.5	0.0	3.5	1.3	11.9	5.2	0.9	5.3	6.8	1.8	6.8	0.0	12.0	20.1	0.7	2.0	0.0	0.0	0.5	0.2	0.5	4.3	1.3	14.4	8.0	9.6
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		130000000	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	20.9	17.6	11.0	22.3	11.9	7.5	37.0	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14.0	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11.0	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.9	18.5	29.2	10.1	45.2	32.1	13.3	35.3	69.8	41.8	51.0	19.3	28.3	9.0	9.4	57.7	41.0	19.3	16.3	29.9	42.0	15.7	14.8	13.0	17.7	15.0	30.3	10.4	14.9	30.8	14.1	28.2	21.6	42.9	39.8	7.8	11.9	10.7	54.5	18.0	9.2	17.8	18.4	20.4	21.8	9.6	15.3	9.6	30.6	19.2	5.1	11.5	16.7	23.1	19.4	29.8	16.1	11.9	46.0	52.5	23.7	21.7	17.1	7.8	4.8	12.7	38.9	15.7	24.4	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11.0	11.9	9.4	14.6	11.1	9.2	11.5	14.0	11.5	11.0	41.7	17.0	28.3	58.4	44.9	13.9	0.3	66.2	18.7	15.9	54.1	7.9	94.6	49.7	120.2	46.5	56.1	64.4	46.7	108.6	153.9	93.0	39.7	29.0	24.9	111.6	7.9	36.5	84.1	50.9	110.9	66.2	80.3	81.0	196.6	43.0	50.2	101.4	57.5	138.6	74.7	29.6	155.2	137.9	31.1	15.7	37.8	92.0	54.3	41.7	41.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170401-238203729	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	17.0	17.1	19.4	31.3	22.2	34.6	24.2	34.1	23.4	18.7	23.4	29.5	22.0	20.5	23.0	22.7	19.4	19.0	21.8	20.9	20.6	19.8	17.8	20.8	27.1	25.7	23.9	21.4	22.1	24.1	17.5	24.7	18.1	22.7	21.5	18.9	20.2	19.0	24.9	32.8	19.4	19.0	26.5	19.8	22.2	18.1	21.2	25.5	23.9	22.6	19.0	24.8	18.1	26.1	18.9	20.7	24.1	18.1	17.4	23.8	16.2	17.9	11.7	17.3	16.9	13.5	9.0	17.7	19.0	12.9	19.3	16.8	10.8	9.6	11.5	4.9	13.7	23.1	15.4	22.3	15.8	19.6	20.5	22.2	29.8	11.6	23.7	20.8	19.0	23.6	9.4	10.9	20.5	20.7	9.5	14.4	15.7	22.9	7.5	16.4	21.6	19.1	25.9	16.1	17.0	11.3	23.4	35.4	10.6	14.2	8.6	25.5	12.6	12.8	13.8	30.4	13.8	10.8	19.8	12.9	18.8	17.2	25.2	20.2	13.4	13.4	20.7	15.4	21.4	15.9	24.1	15.1	19.6	22.5	18.1	20.1	18.9	20.0	21.0	20.7	18.5	23.8	18.6	5.3	17.4	15.1	15.8	22.4	16.2	19.4	22.2	34.1	23.4	20.6	19.8	23.9	21.4	22.7	25.5	11.9	22.4	26.5	25.9	24.0	27.2	20.9	5.1	17.4	13.6	24.4	27.5	31.9	36.5	21.9	7.1	20.3	20.0	23.3	24.8	34.9	21.1	24.0	33.4	14.1	30.1	36.5	18.3	17.2	12.7	9.1	26.2	19.1	28.7	35.1	21.4	23.4	21.2	17.5	27.6	24.2	27.2	32.3	28.0	48.7	60.2	25.1	33.8	27.1	22.5	19.3
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	77.0	30.0	4.3	34.6	8.5	6.8	18.5	11.5	10.9	17.8	16.5	23.7	34.2	32.9	64.8	12.3	27.3	21.1	9.8	18.8	6.9	25.8	29.3	12.0	27.0	14.1	19.5	28.3	20.6	9.4	16.5	16.9	18.7	9.2	10.6	6.7	21.1	38.1	12.4	28.4	11.6	25.3	10.5	24.6	59.8	30.2	21.5	55.2	11.8	14.6	23.8	17.2	13.7	15.3	22.7	1.7	5.9	30.2	14.5	21.6	34.2	49.3	71.3	48.0	30.6	60.3	31.5	34.1	22.3	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8	0.0	14.1	25.2	11.0	11.8	8.1	8.2	20.4	6.7	19.4	10.4	5.9	9.6	6.6	45.8	0.6	13.7	36.0	0.0	97.4	17.8	12.1	24.0	12.7	32.6	52.7	15.9	19.7	10.4	45.4	1.8	16.7	26.5	13.5	11.8	24.2	14.0	61.0	24.6	20.1	13.3	5.0	0.0	14.5	1.7	6.3	11.4	10.3	14.0	28.8	23.4
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.2	3.7	0.1	0.5	4.0	3.4	16.2	1.3	16.9	2.3	2.2	1.7	17.1	0.0	0.4	2.0	30.8	0.4	0.4	4.3	3.1	1.0	1.2	0.3	0.8	4.7	2.0	0.0	0.5	2.1	0.7	8.5	11.0	6.1	4.7	0.1	0.8	5.2	2.7	0.0	0.0	0.8	0.1	2.0	3.6	0.8	0.0	0.2	5.1	23.4	0.2	0.1	1.6	0.0	0.1	0.4	0.4	0.8	4.8	5.3	0.4	3.2	3.3	1.7	5.1	1.0	11.3	2.2	0.9	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6	0.0	5.5	0.9	18.1	7.1	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	8.5	3.3	2.1	1.1	0.0	3.5	0.4	1.0	20.2	0.0	4.7	2.9	0.0	0.0	1.3	2.5	1.1	0.9	4.3	5.0	2.8	0.1	1.7	10.4	0.0	0.0	1.0	0.0	0.0	3.1	0.4	0.4	6.5	0.8	1.5	0.4	22.1
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell type enhanced"	"Detected in many"	14	"Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	15.0	12.4	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	12.8	0.7	0.0	7.8	17.0	2.4	7.8	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.7	0.0	0.0	0.0	3.7	0.0	0.1	1.9	0.1	0.0	6.7	0.0	0.7	0.0	0.0	20.6	4.7	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.9	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8	8.9	20.8	0.8	4.1	1.3	0.3	2.2	0.0	6.7	20.5	3.5	0.0	0.2	0.0	0.6	3.6	29.3	0.0	0.0	1.0	0.1	17.3	1.4	26.5	0.0	8.9	0.0	0.0	36.2	118.3	3.0	6.6	66.9	5.0	2.8	1.0	0.2	2.8	0.0	10.6	0.2	0.0	0.0	7.2	0.7	0.9	1.1	0.2	2.5	0.2	2.2
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	4.0	2.8	3.7	10.2	17.2	4.0	7.6	5.4	6.0	5.5	3.4	5.2	9.2	7.5	6.3	4.0	4.4	3.1	4.9	8.7	13.2	2.9	8.8	3.1	2.1	5.8	12.1	10.8	9.1	7.8	7.6	4.5	10.6	8.9	9.0	8.1	6.9	16.6	2.9	10.5	6.8	1.0	0.0	4.7	7.0	3.4	4.8	4.7	5.1	2.0	2.0	3.7	4.7	3.6	4.0	5.9	10.8	7.9	7.4	1.4	9.1	5.2	8.4	10.9	8.0	7.7	32.7	4.1	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7	17.9	17.0	15.7	9.4	9.6	5.7	4.1	22.9	6.7	10.3	31.4	19.6	12.5	18.3	10.9	12.6	12.4	13.8	0.0	15.4	7.3	9.3	8.1	20.9	7.3	15.2	7.9	3.5	12.9	29.8	16.3	11.5	22.9	10.1	18.0	9.3	9.1	12.5	5.8	10.6	11.3	25.0	6.5	8.6	27.0	12.6	10.3	23.3	41.5	7.8	11.2
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.2	13.4	13.7	9.8	15.1	21.6	16.4	16.5	18.9	20.7	20.2	37.6	31.3	9.9	16.0	21.0	28.2	25.7	20.8	33.3	25.2	7.4	6.7	28.8	11.4	22.5	15.8	11.8	13.0	11.0	17.0	17.4	27.4	18.7	15.5	14.4	16.3	17.2	16.1	10.1	17.2	6.2	6.6	12.5	15.9	14.5	28.9	22.9	12.3	35.3	8.4	6.1	30.8	12.1	18.5	14.1	14.5	10.7	15.0	24.7	14.8	16.1	12.2	13.7	14.3	14.5	15.3	7.6	14.4	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3	11.9	17.9	13.3	15.9	13.4	19.6	20.1	7.6	28.1	33.0	29.6	23.6	15.1	5.0	11.7	46.0	17.5	21.6	0.0	14.1	17.6	16.0	23.0	18.5	43.1	14.0	14.3	11.5	16.5	22.8	102.3	20.8	21.2	25.3	23.4	15.8	34.3	16.6	21.0	14.5	18.0	26.8	12.9	17.8	25.7	21.5	14.2	39.2	20.6	9.9	38.9
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.7	1.4	0.9	1.4	0.6	32.4	2.5	0.1	0.4	3.6	2.2	0.2	0.8	0.0	1.1	0.0	0.3	19.8	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.5	1.6	0.0	4.5	0.1	0.4	2.4	0.0	0.0	2.0	11.2	3.2	1.0	1.6	0.0	0.1	0.3	1.2	9.3	0.4	0.3	0.3	3.6	0.7	0.1	8.2	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4	3.0	3.8	0.0	1.4	1.4	71.2	33.4	17.8	8.1	0.0	15.7	5.9	7.3	1.7	4.7	45.5	26.9	30.6	0.0	7.2	0.7	4.8	2.8	3.5	17.4	0.8	0.0	9.2	50.3	2.6	34.6	3.4	0.7	3.3	0.0	12.2	5.4	3.9	20.4	31.1	2.4	2.7	19.4	14.6	1.9	1.7	1.0	11.9	0.7	10.0	1.4
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	15.3	15.2	8.2	15.4	10.8	15.9	16.9	10.6	13.3	16.6	14.0	13.6	17.8	9.9	21.5	15.3	12.7	17.2	12.1	9.2	7.5	4.8	13.2	9.8	13.7	9.9	10.9	7.3	20.1	17.5	17.0	13.7	12.4	9.6	16.5	9.3	20.2	16.6	19.8	15.7	14.2	15.7	18.0	6.1	15.0	13.4	36.0	8.4	14.8	18.1	10.5	11.0	20.1	14.8	3.6	1.4	4.2	2.6	5.7	5.9	2.8	9.3	5.7	19.1	14.5	8.0	4.3	8.6	7.5	11.9	15.0	16.3	10.6	6.2	13.8	10.9	11.7	11.5	6.1	13.4	7.1	13.0	9.1	10.7	18.9	5.8	11.9	10.7	12.9	7.5	11.0	5.0	10.0	8.5	9.1	8.3	14.8	13.1	9.8	9.3	5.3	23.2	10.3	9.3	4.8	9.7	18.5	13.0	7.5	8.8	9.5	20.4	12.5	8.9	9.8	8.7	11.6	8.5	4.8	12.3	10.4	9.1	7.7	6.7	8.2	5.0	11.6	5.5	14.6	9.6	4.2	2.6	0.8	5.8	2.6	4.3	3.1	3.5	5.9	1.2	3.6	2.6	4.5	0.2	5.7	2.2	1.4	2.5	2.8	8.2	10.8	10.6	13.3	7.5	4.8	10.9	7.3	9.6	8.4	41.7	25.0	4.7	9.1	4.0	14.0	23.7	15.3	12.0	25.0	10.4	41.2	6.6	3.3	8.3	10.9	11.4	10.7	0.0	8.3	3.6	6.6	9.7	17.4	10.6	7.2	14.3	12.6	17.2	8.8	22.8	9.2	8.4	6.8	11.8	16.7	11.4	10.5	5.8	12.0	3.8	29.4	12.9	9.2	23.2	10.5	5.6	9.3	12.5	13.8	9.2
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113108-42121358	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA					"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	16.9	15.9	30.2	13.6	28.6	8.6	14.0	24.0	42.0	11.2	11.9	10.9	13.1	14.9	13.9	8.9	11.4	14.2	11.8	7.6	27.8	11.5	10.0	11.8	7.2	11.2	27.6	18.0	23.5	16.5	14.8	11.9	10.7	26.0	12.9	9.6	6.0	17.3	14.5	20.1	19.9	13.4	9.7	13.9	15.6	13.0	7.8	29.7	5.3	11.7	6.4	10.4	11.2	21.7	2.0	1.6	0.1	0.4	0.6	2.7	0.8	10.8	21.0	3.1	11.6	4.4	3.6	13.7	7.1	3.8	15.8	7.8	14.2	8.9	21.4	17.9	5.4	11.9	16.3	12.7	11.3	5.6	11.9	26.4	5.3	12.9	12.8	4.6	14.2	14.3	4.3	9.6	8.8	5.6	4.3	6.2	5.4	13.3	4.1	4.2	11.7	33.8	10.4	6.6	27.2	0.0	8.1	6.1	14.1	4.2	11.0	15.0	6.6	7.6	16.7	5.7	2.4	12.3	6.8	4.8	8.0	8.1	11.6	12.6	11.0	10.5	11.9	5.8	12.2	4.4	0.0	0.4	0.0	0.8	0.0	1.7	2.0	1.9	2.4	1.6	1.6	2.7	0.7	0.1	0.6	0.1	0.4	0.3	0.8	30.2	28.6	24.0	42.0	27.8	11.5	27.6	18.0	26.0	29.7	11.9	11.5	13.1	11.2	10.9	14.2	4.7	20.4	4.0	5.7	17.4	9.8	20.4	3.3	7.9	1.0	17.1	3.8	0.0	6.8	15.3	10.1	8.2	11.5	13.7	10.6	9.5	15.1	19.0	8.5	1.3	30.2	7.2	6.8	6.4	8.6	5.8	6.5	5.8	27.3	2.5	7.4	12.9	10.0	4.7	19.6	12.2	9.4	6.4	16.9	7.3
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016953	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016953: AB_1851277"	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	18.5	19.5	21.2	16.0	27.4	34.3	21.6	29.4	37.1	22.1	24.1	28.2	22.3	16.5	30.1	24.8	21.2	32.9	24.5	21.1	18.3	19.2	22.6	16.1	20.8	18.3	19.0	25.7	29.5	23.2	38.8	22.0	32.7	24.6	21.2	19.4	29.3	23.6	27.5	24.6	27.6	19.2	25.2	20.1	22.0	21.9	30.7	22.8	26.9	26.5	19.1	22.1	24.4	22.0	25.0	24.0	40.4	23.6	24.8	28.6	23.3	19.1	23.4	21.3	16.2	16.9	17.9	22.4	13.9	22.7	23.3	20.3	17.0	22.9	17.6	19.9	24.3	25.7	16.2	26.5	23.3	14.1	22.9	17.0	25.8	19.3	20.1	24.3	28.1	31.0	19.0	26.1	15.3	31.5	18.0	14.6	20.7	26.6	27.6	22.0	34.9	23.8	32.9	18.6	13.7	15.1	19.6	14.1	32.2	21.3	29.1	19.9	21.0	13.2	25.0	26.5	11.6	24.5	18.2	18.7	18.9	16.7	14.9	14.9	21.2	21.8	25.9	16.3	13.8	15.4	23.4	23.6	40.4	25.7	22.3	22.1	21.1	22.5	25.5	24.0	25.0	28.6	23.3	26.1	24.8	23.3	14.5	21.5	23.3	21.2	27.4	29.4	37.1	18.3	19.2	19.0	25.7	24.6	22.8	11.9	13.7	18.8	38.6	18.8	41.0	0.6	17.8	24.1	14.8	27.9	29.5	43.8	29.9	35.7	7.2	16.8	22.2	0.0	44.9	35.8	24.2	20.6	33.4	9.3	32.0	36.5	29.1	16.5	14.9	9.4	25.9	18.3	40.5	53.3	18.0	36.1	31.7	25.9	36.4	25.6	34.3	45.3	33.0	35.4	22.7	18.6	85.7	25.5	24.7	24.6
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	13.1	10.8	17.8	11.3	10.0	11.4	6.0	8.8	11.5	10.9	8.5	6.8	6.3	19.5	8.9	8.7	10.6	8.5	13.8	8.4	13.0	10.0	8.1	28.1	6.7	5.1	7.5	14.8	12.9	9.5	9.6	10.1	12.6	8.0	10.5	17.3	23.5	12.4	10.0	5.8	30.0	4.7	6.8	9.9	4.3	24.0	19.9	6.2	5.4	15.1	11.1	9.5	10.3	6.9	7.1	8.4	15.9	6.5	12.2	13.5	9.6	12.0	9.4	10.1	16.4	21.2	7.3	6.7	11.6	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7	32.8	30.4	27.2	23.8	44.8	44.6	22.6	25.5	21.4	30.7	12.2	51.1	12.1	3.3	11.8	1.8	50.4	18.7	46.7	10.4	13.1	28.5	21.6	33.6	22.2	14.6	55.6	23.7	43.0	37.4	3.5	26.2	31.3	21.9	8.2	25.7	32.4	13.2	17.5	21.5	9.3	45.4	19.4	33.9	41.9	36.2	53.4	17.6	45.8	18.9	26.1
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74825582-75032622	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	11.6	9.5	11.1	13.2	11.9	15.1	12.4	19.0	11.6	16.7	12.2	13.3	15.3	7.2	25.1	13.0	12.0	13.2	12.0	10.0	10.6	9.5	9.0	7.3	9.2	9.0	9.0	9.9	24.6	13.3	24.8	31.1	9.4	8.9	13.5	9.6	10.1	17.9	12.0	15.3	10.6	11.3	16.2	9.3	10.4	13.0	12.8	12.1	26.6	13.0	8.9	12.5	14.3	12.7	3.2	1.9	1.6	1.1	5.3	3.7	1.5	3.9	4.1	7.4	6.3	5.9	8.7	3.6	3.5	7.0	3.0	3.4	2.7	4.6	8.5	1.9	6.4	3.2	3.1	3.9	3.1	5.0	3.6	5.7	3.1	3.3	3.9	4.4	7.4	2.1	5.6	5.0	4.2	6.7	9.9	3.5	6.7	3.3	7.3	3.8	4.3	7.1	3.4	4.1	4.3	22.9	11.1	3.8	1.8	2.2	2.0	3.7	6.2	3.6	6.6	3.2	2.8	3.7	2.9	4.2	4.3	5.1	2.8	3.3	5.4	6.3	5.7	4.6	7.8	0.9	0.7	1.1	1.6	3.2	0.9	3.4	2.4	2.4	2.7	1.2	3.2	3.7	3.4	0.9	5.3	0.8	1.9	2.4	1.5	11.1	11.9	19.0	11.6	10.6	9.5	9.0	9.9	8.9	12.1	41.7	50.1	23.2	20.4	17.6	50.8	43.1	10.2	38.8	35.2	8.7	64.8	8.7	8.3	8.6	4.4	18.6	17.3	23.3	15.8	8.8	28.2	22.8	39.4	14.4	9.7	41.3	22.8	13.5	11.0	6.7	39.1	13.9	13.5	4.6	18.3	49.8	10.2	14.4	37.8	8.0	53.6	25.8	24.0	25.6	21.2	15.3	19.0	34.6	15.5	17.1
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.3	17.8	12.4	8.4	11.1	21.5	11.3	13.2	20.4	14.6	28.3	9.3	14.9	18.4	12.0	17.8	11.4	16.9	11.8	24.1	16.2	16.7	17.7	13.3	11.7	12.5	18.1	14.8	10.6	11.9	18.3	22.9	11.8	15.0	16.6	19.6	14.9	19.1	19.8	25.7	13.0	44.1	27.9	16.0	16.2	28.4	12.9	9.5	14.7	19.3	16.4	11.6	6.9	10.6	28.1	25.5	16.0	9.0	25.9	14.0	11.3	14.7	21.8	23.8	17.5	11.7	10.9	16.1	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1	23.8	17.6	14.7	9.0	14.9	30.8	23.6	20.4	24.1	20.5	26.2	29.5	18.8	8.3	9.4	17.4	18.6	10.4	0.0	6.5	13.0	11.4	13.2	23.1	9.0	11.5	42.9	24.1	12.3	16.1	11.0	15.5	11.1	13.5	12.6	12.1	15.3	8.2	8.6	17.3	8.7	25.3	38.8	13.9	69.0	33.2	17.6	28.3	20.2	11.4	7.2
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31115754-31131393	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 17.8;neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	18.4	21.7	22.7	29.4	23.6	26.6	29.7	48.9	30.8	28.0	24.8	18.3	27.5	15.7	29.8	48.3	16.7	35.0	28.2	32.7	23.0	21.2	20.8	18.9	26.3	29.0	20.2	21.0	52.8	31.4	38.0	22.2	31.5	16.8	21.2	17.7	22.1	35.1	26.2	39.8	22.1	19.7	25.9	20.5	27.4	18.6	27.3	18.4	30.2	31.7	22.6	22.2	20.2	26.6	2.1	4.1	17.8	4.6	1.7	2.9	1.9	7.7	12.0	15.0	4.5	17.8	13.4	15.4	6.9	13.3	11.2	12.3	6.0	17.0	18.3	11.0	8.6	10.2	9.3	23.9	11.6	11.1	15.3	16.2	7.9	8.8	19.0	16.0	13.1	14.4	12.6	23.4	8.3	24.2	14.7	10.6	19.4	21.1	15.1	5.7	22.6	20.2	24.8	16.9	18.8	7.3	32.6	12.3	21.5	9.0	4.6	15.8	16.1	4.2	11.7	5.8	9.6	12.7	21.8	6.3	4.7	10.1	5.3	5.0	14.4	14.5	10.4	7.2	17.5	7.1	3.9	4.4	17.8	1.9	2.4	2.4	2.1	2.2	2.6	4.1	1.8	2.9	2.1	17.4	1.7	4.6	1.4	1.3	1.9	22.7	23.6	48.9	30.8	23.0	21.2	20.2	21.0	16.8	18.4	17.9	15.6	17.9	35.9	18.4	17.8	15.2	12.7	4.0	14.8	8.7	13.7	25.5	18.3	19.6	99.8	18.5	18.6	23.3	23.2	17.7	24.7	25.4	27.6	11.1	26.6	30.2	23.6	16.5	29.2	102.1	49.8	22.4	23.6	22.6	19.7	36.9	14.8	17.5	50.9	12.4	23.7	25.8	17.5	30.4	18.8	13.7	38.0	20.0	20.7	22.1
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell type enhanced"	"Detected in many"	19	"Exocrine glandular cells: 663.7;Mucus-secreting cells: 890.7;Pancreatic endocrine cells: 205.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 29.2"														"Secreted to digestive system"	NA	NA		4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	17.9	1.4	17.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	38.1	2.8	0.4	0.1	46.5	0.0	663.7	0.0	1.6	15.7	9.2	0.0	0.6	0.0	112.7	0.0	0.8	0.0	5.8	2.9	5.0	9.0	890.7	0.0	205.3	113.2	0.0	0.2	0.0	0.0	0.1	0.3	0.7	47.2	0.0	0.0	128.7	3.4
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"prostate: 163.5"	"Cell type enriched"	"Detected in some"	36	"Glandular cells: 729.8"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.0;NB-4: 10.2"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.0	0.1	0.0	0.1	0.0	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.5	0.0	0.1	2.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.2	0.0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0.0	0.9	5.0	0.5	0.3	0.2	0.2	0.6	0.8	1.8	0.2	0.0	0.8	2.0	0.2	0.0	0.3	1.7	1.1	0.0	1.3	0.4	0.0	0.3	3.1	0.5	0.3	0.3	0.4	0.5	0.0	1.1	1.5	2.0	0.3	1.8	1.2	10.2	1.1	1.7	0.0	0.9	0.0	2.9	0.0	1.7	0.9	1.6	0.3	1.4	1.3	0.2	1.3	0.4	0.8	1.3	1.9	4.9	1.7	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1.0	1.0	1.0	0.8	1.0	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	13.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	729.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	5.0	0.6	0.0	0.0	0.0	9.2
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718256	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA					"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	15.4	12.9	17.6	12.5	17.6	19.4	14.7	38.4	16.9	15.9	13.6	17.4	9.5	10.1	17.7	11.8	12.2	14.6	11.1	11.7	15.1	8.8	11.5	11.1	12.7	12.6	18.2	8.8	23.6	12.2	22.3	21.8	17.2	15.5	16.3	12.5	14.1	13.8	11.9	12.4	12.8	14.7	15.8	13.0	13.5	11.6	10.6	19.6	20.5	12.9	6.5	12.8	14.7	14.7	7.4	4.6	9.5	11.4	4.2	8.9	2.9	6.1	4.9	10.3	14.6	9.8	12.8	7.9	8.2	8.3	8.9	8.9	7.9	5.4	10.0	8.4	11.5	7.0	8.7	13.5	8.8	14.1	9.3	10.8	20.3	6.2	7.1	9.1	19.0	14.8	8.5	14.2	10.1	17.3	9.0	11.0	8.8	24.9	10.3	8.7	7.4	9.8	7.8	6.1	5.7	4.8	9.6	12.4	4.7	8.2	8.8	6.9	11.0	11.6	8.5	6.1	7.2	8.7	16.4	13.6	7.1	11.2	8.4	13.2	8.6	9.5	11.6	6.5	10.7	10.4	9.5	4.2	6.6	8.9	7.7	8.0	5.8	7.0	7.4	4.6	7.4	6.0	7.8	2.9	4.2	11.4	4.1	6.7	2.9	17.6	17.6	38.4	16.9	15.1	8.8	18.2	8.8	15.5	19.6	11.9	17.6	9.0	9.7	14.4	19.3	8.9	17.8	13.4	13.6	7.0	17.7	8.2	1.7	7.3	18.1	13.1	11.6	0.0	5.7	9.8	11.4	13.8	13.9	12.2	9.5	12.7	16.1	20.9	12.6	5.2	12.7	11.0	13.5	5.4	12.3	10.4	8.1	11.5	24.4	5.0	21.0	19.4	10.5	7.1	8.7	15.7	11.0	13.6	11.1	11.2
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	22.9	13.0	3.0	8.6	5.7	12.8	33.0	7.9	3.7	16.6	14.0	6.8	9.3	2.9	21.2	12.7	15.1	11.0	20.6	14.1	5.4	2.6	12.4	11.0	19.8	10.9	5.2	2.4	17.4	10.2	5.0	3.5	18.3	6.3	13.7	4.5	16.7	8.0	11.1	23.0	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7.0	20.3	28.0	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.4	3.8	8.5	5.1	10.0	13.2	7.8	11.4	11.9	12.0	10.3	10.8	5.2	0.0	5.6	17.4	4.7	5.0	5.0	5.2	17.8	1.9	1.3	6.3	4.8	8.1	15.5	1.7	2.2	19.5	9.6	7.9	5.3	6.0	16.7	1.4	1.1	0.2	15.1	5.9	0.2	5.9	2.0	3.5	1.8	1.5	15.1	0.0	8.5	1.6	0.1	0.0	9.0	6.0	11.9	7.7	5.1	3.2	21.0	12.8	8.5	9.3	7.2	1.5	0.8	0.0	3.0	1.9	9.7	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0.0	0.1	0.3	3.3	1.3	0.6	0.1	0.0	0.5	3.0	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2	38.7	6.9	2.4	13.7	29.2	0.0	20.6	15.3	12.0	11.4	5.2	0.0	18.7	3.3	8.7	94.1	30.9	3.2	0.0	6.4	7.9	22.8	18.0	4.7	14.5	9.0	0.0	0.0	43.0	13.7	6.2	23.6	16.6	16.9	0.0	1.6	4.5	14.9	1.7	32.5	6.4	0.7	6.5	25.9	6.7	13.7	22.1	40.2	4.4	1.0	9.4
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.0	13.3	10.2	16.9	13.5	18.3	7.4	10.6	10.2	8.6	9.6	7.7	16.9	10.6	4.8	13.0	28.9	10.3	3.8	6.5	3.3	18.3	6.7	7.8	4.5	8.8	15.5	5.9	28.7	18.1	5.9	6.9	3.6	26.0	12.8	7.7	5.2	3.4	10.7	14.9	5.1	10.7	19.3	6.0	8.4	7.4	15.8	6.6	9.6	3.7	4.0	9.3	6.8	16.4	8.5	11.7	5.2	5.4	15.2	13.7	12.8	35.4	17.0	3.8	4.3	19.4	50.9	4.3	9.3	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5	3.0	2.4	22.9	4.6	2.6	5.6	2.7	7.6	2.7	3.4	1.8	2.0	2.2	0.0	6.6	0.6	3.0	0.9	0.0	5.6	5.4	7.5	5.1	5.7	1.1	25.0	33.4	2.4	2.5	10.7	1.5	6.6	14.1	3.3	10.0	2.1	3.1	10.2	2.9	5.6	1.5	3.1	0.0	2.1	1.9	12.4	2.8	3.1	10.1	2.5	6.2
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 14.7;neutrophil: 37.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in all"		"BEWO: 37.6;hTCEpi: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	9.4	6.6	23.5	23.6	26.2	29.4	17.0	9.9	16.8	11.0	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6.0	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20.0	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20.0	1.0	1.6	37.2	1.9	2.4	5.6	1.6	7.0	1.1	4.9	2.7	2.1	2.5	37.6	4.6	2.2	4.7	4.0	6.0	3.3	6.9	8.3	7.0	2.2	14.3	5.7	24.5	2.9	5.0	6.2	5.0	5.5	6.5	3.2	9.2	9.2	4.0	69.7	3.8	11.5	32.0	11.9	5.6	2.7	5.0	6.4	5.5	5.6	3.1	4.6	18.2	1.8	7.4	8.3	3.8	5.4	16.7	6.3	5.6	3.5	22.6	9.3	15.9	18.8	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6.0	2.6	4.3	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1.0	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9	29.8	17.0	3.0	42.2	31.9	7.0	19.8	12.7	33.5	28.4	5.2	19.6	59.9	3.3	10.9	1.0	19.3	16.9	0.0	38.9	46.0	10.8	19.1	23.1	6.8	15.7	3.2	12.7	12.9	7.9	1.3	4.0	11.8	3.3	2.8	41.8	15.6	22.5	10.5	4.2	8.1	23.2	19.4	4.1	9.8	10.4	34.3	96.6	8.7	49.0	20.7
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 30.0;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.8	0.0	0.0	7.4	7.6	0.0	2.9	2.1	2.7	1.9	0.8	2.1	23.5	1.1	7.8	0.0	4.8	0.7	0.5	1.4	0.4	1.1	7.1	1.1	0.0	0.5	3.8	5.5	6.0	1.0	1.7	1.5	0.7	4.7	0.0	1.2	17.3	0.5	0.0	0.0	2.4	0.2	4.3	2.0	1.7	0.4	6.4	0.0	0.0	0.0	1.7	1.8	2.7	5.4	0.0	0.3	4.6	5.4	0.0	0.8	1.0	0.0	8.8	15.6	15.2	0.3	0.5	4.4	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4	14.9	12.8	11.9	6.5	2.9	0.6	2.8	2.5	8.1	7.9	0.0	5.9	8.4	0.0	3.6	3.0	5.7	12.0	0.0	2.7	3.1	3.5	6.3	1.1	0.0	9.5	0.0	13.2	12.3	14.3	2.4	30.0	14.0	3.3	32.5	12.8	0.8	6.7	10.5	20.1	0.3	0.4	6.5	2.1	5.2	1.1	3.0	3.0	0.5	10.8	9.3
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 40.4;lung: 50.4"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 391.0"	"Group enriched"	"Detected in many"	7	"lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 40.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 40.4"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	3.7	3.4	2.3	7.0	3.9	8.6	3.0	1.7	5.0	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4.0	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1.0	1.9	3.6	1.6	3.3	4.2	2.0	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0.0	0.0	0.8	0.0	9.9	0.1	0.0	3.9	10.2	0.1	2.1	5.7	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.3	0.0	0.4	0.0	0.8	0.3	0.2	0.0	0.7	0.5	0.1	2.5	0.7	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.0	0.1	0.0	0.0	0.0	10.9	0.0	0.1	0.6	0.0	0.2	2.8	0.3	2.8	2.2	1.4	1.2	1.1	1.2	0.7	0.0	0.0	0.0	2.4	0.0	0.5	0.0	5.8	1.2	0.0	3.1	0.0	0.9	0.0	0.0	1.5	0.9	0.0	0.0	40.4	0.0	3.0	0.2	0.0	0.8	2.3	3.9	1.7	5.0	1.8	1.4	2.2	3.6	1.9	2.4	29.8	391.0	17.5	1.5	2.2	7.5	6.9	5.1	5.3	30.7	26.2	0.0	0.0	1.7	0.8	0.4	4.5	0.0	0.0	2.3	0.1	9.4	0.6	12.8	7.8	4.6	44.5	0.0	9.2	74.8	0.0	17.5	19.9	11.8	10.8	0.0	11.0	1.1	0.0	11.3	15.2	0.9	0.0	3.9	0.2	0.4	2.8	0.3	0.8	0.0	0.5
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.8	5.3	10.2	9.0	8.9	8.4	5.4	6.8	8.4	6.2	10.1	5.6	9.9	5.6	7.5	4.3	19.1	6.5	11.4	3.3	10.4	4.9	5.4	11.4	8.8	7.2	5.9	11.4	5.1	9.4	5.7	11.0	10.8	9.0	8.2	4.7	10.3	3.7	14.6	4.1	5.1	5.0	13.4	8.9	6.7	4.8	15.4	9.1	5.0	9.8	8.1	3.5	12.1	7.1	5.3	24.9	3.2	10.5	5.6	5.7	7.0	3.7	11.4	8.5	1.6	9.3	5.5	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9	8.9	4.6	2.7	2.8	1.0	5.6	18.3	5.1	6.7	10.3	0.0	5.9	4.1	5.0	5.4	0.6	3.6	5.6	0.0	1.2	1.7	2.4	3.6	9.2	5.9	5.4	11.1	1.2	4.3	6.6	0.2	2.6	4.5	3.3	10.8	5.2	5.7	4.2	4.3	4.9	5.0	4.8	0.0	4.1	4.6	3.0	2.4	5.8	5.0	4.9	3.0
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	"Q8WZ04, Q96E66"	11	72080331-72110782	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 49.8;testis: 47.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 522.5;Late spermatids: 1781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 27.7"									HPA039949	Approved		Uncertain	Microtubules		NA	NA			Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	3.5	3.7	10.6	2.0	11.1	2.1	7.1	3.7	8.9	7.1	4.2	14.0	6.1	3.2	6.0	13.6	3.5	49.8	5.3	2.6	8.8	7.6	9.0	6.2	6.2	2.6	7.7	8.5	8.5	7.0	7.1	8.9	4.4	10.6	7.5	6.2	7.3	4.3	4.7	5.2	4.5	2.5	4.8	7.7	3.2	3.6	47.8	8.9	3.1	9.3	2.4	3.5	3.5	2.6	4.3	4.2	9.2	2.9	10.1	6.2	2.0	2.6	9.8	6.2	5.0	5.4	4.8	1.5	3.1	2.5	2.8	2.5	4.7	14.3	3.4	4.7	5.3	6.9	5.3	4.4	7.4	3.2	6.4	4.3	2.5	4.5	3.3	0.9	2.0	2.7	2.1	3.8	4.3	3.3	4.6	1.0	7.2	2.7	5.3	4.1	9.3	6.0	4.0	3.1	15.4	2.6	7.3	6.3	5.2	11.0	3.2	5.8	4.5	6.1	14.0	7.5	4.5	27.7	2.4	4.6	3.0	4.2	8.0	2.1	5.7	6.2	3.9	2.9	1.7	3.3	2.3	2.9	5.0	3.1	2.8	3.2	4.2	3.3	2.6	1.7	4.3	3.0	3.0	9.2	10.1	1.8	4.2	6.2	2.0	10.6	11.1	3.7	8.9	8.8	7.6	7.7	8.5	10.6	8.9	0.0	1.0	6.1	6.6	2.1	3.7	1.7	5.1	115.1	9.1	3.5	11.8	11.0	10.0	6.1	522.5	4.5	3.1	0.0	2.1	6.7	4.1	11.4	0.0	5.6	2.7	6.4	1.2	3.1	1.0	1781.2	13.8	2.2	1.7	1.8	8.8	12.6	1.8	2.9	9.6	14.6	12.6	6.5	7.1	69.5	22.8	2.0	11.0	2.6	4.3	4.7
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 347.5;Early spermatids: 112.5;Rod photoreceptor cells: 298.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	2.9	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.6	0.0	0.6	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.1	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.4	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7	0.0	5.4	0.0	2.4	0.3	11.3	0.6	0.0	57.6	7.9	3.5	347.5	0.4	0.0	0.3	112.5	1.1	0.0	0.0	0.2	0.7	0.4	1.2	2.3	0.0	0.2	4.8	0.0	1.3	0.0	27.7	0.6	0.9	1.7	0.0	0.0	15.7	0.1	0.0	0.4	0.0	298.8	0.0	1.0	7.0	6.0	0.4	0.7	0.0	0.0	0.8
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350541	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	24	"neutrophil: 37.5"	"Lineage enriched"	"Detected in many"	36	"granulocytes: 37.5"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 27.2;OE19: 28.5;RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		28000000	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	13.1	8.8	9.7	5.1	13.7	4.2	14.7	10.1	18.4	13.5	17.8	7.5	12.9	13.4	15.1	14.1	27.3	11.2	19.3	7.9	9.2	7.6	9.5	7.6	8.4	6.6	6.9	9.0	11.3	26.4	18.5	19.5	11.0	9.0	15.0	18.5	12.8	42.6	15.2	3.6	13.3	13.3	14.4	5.8	8.4	21.3	9.1	6.2	0.0	9.5	16.7	18.2	12.6	12.9	0.2	0.2	37.5	0.5	0.2	1.0	0.1	0.1	3.0	0.9	0.0	3.1	3.0	3.3	2.1	2.5	1.1	1.4	2.5	9.7	0.0	2.3	2.0	1.1	0.4	3.8	1.7	0.8	0.0	3.4	4.3	3.8	2.0	0.5	0.6	1.2	1.9	2.9	0.7	0.5	7.6	27.2	0.1	2.7	0.0	0.3	5.7	0.0	0.3	3.4	28.5	1.6	0.1	0.0	0.0	14.1	9.9	1.3	5.4	1.1	9.1	3.1	1.6	8.2	2.7	10.6	1.5	1.3	0.4	2.8	0.2	0.1	1.4	1.1	0.0	1.1	1.5	0.5	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	1.0	0.1	37.5	0.2	0.1	0.0	0.0	0.1	9.7	13.7	10.1	18.4	9.2	7.6	6.9	9.0	9.0	6.2	8.9	20.5	6.9	7.0	3.5	6.8	2.1	28.1	18.7	6.8	22.7	7.9	28.7	1.7	15.0	0.8	20.4	18.1	0.0	33.2	5.4	6.9	10.2	2.3	7.5	6.5	9.5	20.8	30.1	5.9	1.8	12.7	1.4	0.0	1.0	32.2	11.7	15.8	28.1	15.6	1.6	12.6	0.0	4.7	1.7	1.5	4.1	14.2	4.4	25.5	7.2
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.6	15.9	31.9	13.3	19.3	14.5	18.5	24.4	20.9	26.5	23.7	23.8	27.7	30.9	30.3	20.1	20.2	30.0	29.8	35.7	31.3	24.9	17.8	9.9	16.6	12.9	15.6	13.0	14.8	11.2	22.1	19.2	28.5	28.3	20.7	15.8	17.5	39.6	38.7	13.0	10.5	17.1	16.3	31.2	13.9	11.9	19.7	27.5	25.7	14.5	19.7	11.0	19.8	15.5	20.5	26.9	14.0	11.2	28.5	34.6	21.2	24.4	36.2	24.5	43.6	19.7	36.5	23.1	16.1	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6	26.8	21.9	30.2	40.5	73.6	8.5	16.9	38.2	6.7	13.6	24.4	13.7	40.9	39.7	65.3	10.2	19.0	20.0	46.7	20.4	39.4	31.3	59.4	9.2	116.5	44.9	9.5	20.8	17.2	91.3	18.3	20.8	67.7	50.6	88.4	17.0	33.9	70.1	21.0	20.5	28.5	5.6	6.5	53.6	16.3	44.5	58.8	43.3	40.5	16.8	65.5
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 596.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	23.9	33.0	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27.0	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31.0	22.7	42.0	24.1	44.5	34.4	29.2	30.8	46.0	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24.0	134.9	27.4	56.7	19.0	25.2	25.9	28.3	42.0	20.9	44.1	26.2	42.2	29.1	20.0	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.8	40.7	22.3	31.3	30.9	37.3	22.3	24.3	32.6	33.3	30.2	35.2	20.0	31.6	23.0	27.7	26.8	26.6	17.4	26.0	25.8	26.8	21.2	11.5	22.2	38.9	47.3	21.1	24.3	41.1	25.3	23.4	31.2	44.6	29.4	28.8	22.0	62.4	28.0	46.3	41.8	29.7	25.5	27.2	29.6	32.0	14.7	36.1	29.1	23.7	30.3	30.2	22.3	30.9	75.8	26.9	23.8	36.4	25.9	27.3	23.8	69.8	37.4	62.8	38.0	22.1	42.4	38.2	46.8	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6.0	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31.0	34.4	29.2	26.1	20.9	8.9	38.8	57.0	73.8	31.5	79.0	54.9	17.8	10.7	19.4	38.4	39.3	23.7	124.3	17.7	223.1	33.7	242.0	0.0	38.5	28.5	33.0	88.2	19.6	43.1	46.2	114.4	60.6	34.4	35.6	596.7	33.1	29.7	40.5	12.6	77.6	82.3	41.7	90.9	21.5	75.0	82.4	25.8	32.5	25.9	14.5	55.8	29.7	45.4	69.4	97.8
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.4	21.7	2.9	13.2	17.6	11.3	11.0	33.2	36.1	26.5	24.4	24.1	13.8	19.4	13.6	52.0	22.4	21.3	9.2	29.5	18.9	20.1	16.8	11.2	12.5	21.8	5.5	14.7	23.1	8.7	8.4	36.1	10.9	8.3	11.8	11.4	2.1	9.7	22.1	21.3	7.4	14.0	8.3	38.6	12.5	15.3	18.7	14.3	15.0	22.6	7.9	2.8	12.3	13.3	23.1	30.1	6.6	5.0	10.8	25.2	20.6	26.9	21.4	12.1	6.1	25.0	24.3	12.7	13.0	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1	35.7	59.6	38.8	149.8	229.1	5.9	17.0	45.9	29.4	45.5	21.0	3.9	51.1	63.0	81.6	1.1	21.1	72.0	210.2	69.2	75.4	38.0	143.0	94.4	63.8	45.6	17.5	115.4	21.5	64.9	0.7	11.2	56.1	82.7	15.4	50.2	16.4	93.5	56.1	15.6	27.9	6.9	0.0	70.0	0.9	4.4	190.7	56.1	56.1	31.9	222.1
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 115.1;Late spermatids: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.3	14.2	8.5	10.0	12.6	22.2	6.7	5.4	10.9	10.1	11.1	5.7	9.6	8.8	11.4	8.9	11.0	8.1	14.5	8.6	8.4	12.8	14.5	12.0	10.6	6.1	15.9	7.2	7.5	15.2	11.3	7.3	16.6	22.3	13.3	20.5	10.5	14.8	8.3	6.9	11.8	8.6	12.0	6.2	6.9	11.7	9.9	14.7	6.1	9.8	5.4	8.4	6.0	8.9	21.4	15.4	11.2	14.2	11.0	10.5	6.9	7.2	7.2	21.0	24.6	10.3	14.0	16.6	7.5	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2	6.0	4.3	4.2	7.5	6.2	10.0	8.0	2.5	1.4	1.2	5.2	9.8	10.3	6.6	7.7	115.1	7.0	8.8	0.0	7.4	9.1	7.1	4.5	2.3	6.8	8.8	4.8	9.1	9.8	9.2	149.4	11.5	5.3	10.1	2.8	8.4	16.0	6.9	10.5	11.0	6.8	7.2	0.0	5.1	10.4	8.2	7.2	8.2	8.7	9.4	2.7
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 43.8;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	24.4	11.0	13.3	4.7	2.6	1.6	0.1	3.6	1.0	1.5	0.7	1.1	0.6	9.0	0.5	0.8	1.2	3.8	0.5	0.3	0.8	2.0	0.1	6.9	6.8	4.7	1.0	1.0	12.1	0.3	0.3	0.0	1.0	17.5	3.3	0.0	1.7	0.0	0.1	12.7	0.5	7.8	0.5	4.5	4.6	1.1	0.3	4.9	3.4	4.9	7.4	1.0	0.9	2.2	6.1	3.4	1.3	3.1	1.3	1.6	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4	3.0	7.9	4.7	3.2	2.4	4.9	1.4	2.5	6.7	5.7	0.0	2.0	7.5	19.9	1.2	8.5	2.4	17.0	0.0	3.6	5.4	2.8	1.9	1.1	2.0	5.1	3.2	43.8	4.9	8.9	1.9	4.0	7.0	3.3	0.0	22.4	32.9	1.2	8.6	3.5	1.1	3.8	0.0	3.1	0.0	0.2	3.8	0.7	11.5	23.7	2.3
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.9	7.4	6.4	10.6	5.2	5.0	12.1	8.5	4.2	5.8	6.0	10.7	7.9	15.4	13.8	4.5	5.7	11.9	5.6	6.5	2.3	12.2	27.8	10.8	9.8	7.9	6.7	10.1	13.8	5.8	8.5	4.6	5.2	7.7	5.2	11.3	15.8	20.3	3.3	6.8	14.3	24.5	11.4	6.9	16.7	14.3	7.0	15.6	5.2	10.8	11.9	11.9	5.8	10.2	11.8	4.0	11.0	11.5	7.8	17.7	10.1	12.4	11.5	29.4	13.6	14.5	8.9	14.9	7.1	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5	23.8	21.5	21.9	31.0	34.3	50.6	12.6	22.9	9.4	5.7	19.2	72.6	23.2	11.6	19.1	3.8	18.7	26.2	0.0	16.4	25.3	18.1	32.9	10.4	17.4	16.3	54.0	35.1	19.0	12.4	8.6	26.7	15.7	30.4	16.2	23.6	25.8	19.2	21.0	11.7	14.7	70.3	32.3	26.9	14.2	26.4	37.3	41.2	28.0	24.2	25.2
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.5;THP-1: 25.7"	"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.6	4.0	6.3	4.2	1.0	0.8	10.6	1.3	1.7	4.0	5.6	18.7	5.0	5.9	0.4	1.5	3.4	3.4	5.2	2.3	5.6	2.0	2.3	3.3	1.8	8.8	2.5	5.2	9.2	1.0	2.5	1.2	2.0	1.1	1.7	2.0	2.8	10.7	1.0	2.9	3.6	7.1	2.9	3.4	0.5	5.7	4.4	20.3	7.0	6.9	2.6	27.5	3.9	4.9	11.2	5.8	13.4	25.7	5.0	0.4	3.4	1.5	2.4	7.8	4.0	11.3	0.6	3.1	6.8	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1	6.0	9.8	47.7	14.5	46.5	15.2	2.7	50.9	4.0	12.5	34.9	45.2	12.9	6.6	14.2	1.6	13.5	6.6	0.0	12.8	7.7	11.3	11.9	7.0	12.1	26.3	27.0	9.8	17.2	81.7	1.9	4.9	40.3	35.4	45.9	10.1	10.6	13.0	7.0	1.8	20.1	34.7	6.5	5.2	10.0	15.0	47.8	5.6	16.6	8.9	10.0
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191744-40215575	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 13.9;Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	7.7	7.0	29.6	4.7	22.8	3.7	2.2	14.3	32.0	3.3	3.4	5.3	1.8	4.4	4.5	1.8	3.7	3.1	4.0	8.2	28.2	11.2	4.7	2.1	4.2	4.6	11.5	9.4	4.3	8.1	4.7	5.2	3.7	9.0	4.6	2.0	2.4	6.9	4.8	22.9	5.6	5.0	4.0	5.3	6.7	6.2	6.6	7.1	2.3	3.3	2.6	2.4	3.8	5.4	0.8	0.0	0.0	0.2	0.0	0.9	0.0	6.3	7.6	2.4	5.6	2.2	1.3	6.5	4.4	2.2	2.0	2.1	1.7	1.8	5.8	4.6	1.5	5.1	2.1	0.9	2.3	0.3	11.0	7.2	1.5	3.2	1.7	4.2	1.3	3.7	1.2	5.5	2.2	1.5	2.3	1.9	8.2	5.5	9.9	0.6	3.8	4.8	2.3	2.8	2.1	5.0	5.9	2.5	3.4	1.8	4.0	7.9	11.4	5.1	1.9	10.4	1.5	2.5	2.3	3.1	5.4	5.2	7.8	8.5	13.1	7.5	2.6	6.2	2.4	7.8	0.0	0.1	0.0	0.4	0.2	0.0	0.8	0.2	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	29.6	22.8	14.3	28.7	28.2	11.2	11.5	9.4	9.0	7.1	0.0	0.0	2.2	1.5	1.3	13.9	2.4	0.0	0.0	0.0	7.0	7.9	0.6	0.0	2.3	2.6	2.3	2.6	0.0	3.6	0.7	1.9	2.0	0.0	2.6	2.2	22.3	4.1	3.7	2.2	6.5	2.8	1.1	1.7	1.0	1.9	5.2	3.4	1.9	4.6	3.7	7.3	6.5	2.6	2.6	1.7	2.4	1.1	1.9	2.1	1.7
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 75.8"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 120.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11.0	8.1	14.7	11.6	12.0	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19.0	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12.0	1.8	3.5	5.6	16.7	14.8	8.0	8.5	2.6	3.2	8.2	6.5	4.6	7.8	5.3	14.8	16.3	6.3	24.1	5.1	11.4	14.7	4.8	7.0	2.9	13.9	6.1	17.8	10.1	17.7	7.1	10.2	26.9	5.1	6.8	5.8	5.3	8.3	21.8	7.3	7.7	12.7	4.1	20.8	11.9	19.2	8.8	11.2	19.0	19.8	5.2	12.8	7.4	14.6	7.3	8.2	7.7	22.2	38.1	4.2	17.7	16.6	24.4	12.0	13.0	17.5	11.5	8.1	9.2	5.6	14.0	11.8	27.8	4.3	7.7	9.2	2.4	12.0	2.4	2.0	2.6	3.5	7.6	2.3	2.0	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19.0	20.8	19.7	19.7	21.8	18.7	22.9	9.6	17.8	5.3	6.8	10.4	23.6	21.6	16.6	18.8	9.8	69.5	120.7	23.3	23.8	13.7	11.6	23.2	25.4	45.6	44.4	17.5	40.3	49.7	42.7	44.8	8.9	39.8	20.3	37.9	41.8	14.5	24.8	77.2	6.0	21.1	53.6	32.3	11.2	11.4	13.6	26.2	28.7	21.2	36.5	30.8
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 49.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.5	22.4	2.3	4.0	1.6	3.8	5.7	2.6	1.8	8.5	5.2	3.4	11.9	4.2	13.6	2.8	8.5	6.8	1.0	3.6	4.4	23.0	1.7	0.9	6.1	1.5	4.1	0.7	4.5	5.9	2.3	4.2	2.2	9.0	1.6	2.0	1.8	18.3	4.3	3.5	4.0	1.5	1.2	5.9	3.1	5.2	6.9	9.6	6.2	1.9	2.4	1.9	4.1	2.7	2.9	3.4	1.7	0.4	3.6	3.9	6.0	3.3	22.5	17.5	6.5	2.2	2.2	2.5	5.2	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3											3.0	13.8	9.7	13.7	0.0	3.6	2.0	15.3	9.4	4.5	0.0	3.9	0.7	0.0	4.2	3.7	1.6	11.2	0.0	2.3	1.2	1.8	6.5	1.1	8.1	4.4	1.6	12.6	4.9	7.8	4.5	4.4	6.2	0.0	49.5	6.4	2.2	3.3	7.8	1.1	2.5	2.7	0.0	0.6	4.5	2.4	0.0	0.0	5.1	6.7	5.0
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.3;brain: 13.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"pons and medulla: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA			Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.5	3.6	0.1	0.5	0.0	0.1	0.0	1.3	4.1	0.4	5.7	0.0	13.2	0.1	0.0	4.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.6	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	7.9	0.0	0.0	1.3	6.7	2.7	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.2	0.0	2.1	2.0	0.0	0.8	4.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0.0	13.2	0.0	0.0	1.9	0.0	0.6	0.1	0.6	2.5	0.0	0.0	0.0	5.2	3.9	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	18.5	14.5	13.7	20.1	14.5	41.0	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18.0	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20.0	28.5	17.9	13.0	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17.0	18.0	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.4	7.0	5.6	5.7	7.9	10.5	9.4	10.3	11.2	10.2	8.3	8.4	7.3	10.9	17.8	14.7	9.4	14.0	9.0	6.9	11.5	27.3	7.0	10.1	12.8	7.3	9.2	10.1	21.9	9.4	7.6	12.3	15.2	9.0	4.7	8.2	4.7	21.8	10.0	6.0	11.9	7.2	5.8	4.6	9.2	7.8	10.6	8.1	4.1	15.5	11.2	6.0	15.0	9.2	9.3	4.8	6.0	7.8	10.7	20.0	18.8	9.2	13.9	22.7	16.3	11.2	9.6	6.7	8.6	4.0	2.9	2.0	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2.0	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13.0	12.3	14.3	77.4	39.5	24.5	32.1	64.0	51.3	27.5	38.2	57.6	46.6	27.9	100.1	16.2	11.6	17.3	3.2	38.8	49.0	23.3	29.5	16.3	51.8	41.5	60.0	61.1	46.1	68.3	43.6	22.1	61.3	3.8	39.1	76.0	54.0	23.4	36.2	25.5	35.7	24.6	48.8	27.2	56.9	19.4	48.6	31.4	55.2	68.6	22.0	30.5	24.4	35.7
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 35.7;Alveolar cells type 2: 51.9;Cytotrophoblasts: 48.5;Ductal cells: 34.2;Pancreatic endocrine cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 44.9;U-138 MG: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.9	7.5	5.9	7.8	17.3	25.8	3.7	32.3	25.3	15.1	16.3	5.1	5.9	6.9	8.5	32.3	13.3	6.1	8.8	17.1	34.1	13.4	5.9	11.2	8.5	1.0	6.9	10.0	11.9	20.7	7.4	28.4	44.9	12.6	10.0	7.6	5.0	1.3	9.9	3.8	6.3	5.0	3.3	7.5	4.3	9.3	12.1	0.0	3.7	5.1	3.5	3.4	12.4	3.0	5.3	10.1	3.4	5.4	10.0	48.3	19.8	14.3	7.3	0.0	0.0	1.4	34.7	2.7	5.0	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5	35.7	51.9	0.0	0.0	0.0	0.0	0.0	0.0	24.1	13.6	10.4	0.0	48.5	1.7	34.2	0.0	0.0	0.0	0.0	23.2	22.4	0.0	0.0	4.7	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	27.1	0.0	0.0	31.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.4	12.7	0.2	0.0	0.0	0.0	6.4	0.2	0.0	0.3	0.5	7.0	6.5	0.7	5.2	0.1	2.4	4.0	9.5	3.9	0.8	13.8	18.3	0.1	7.1	0.0	0.5	12.1	2.9	0.1	5.2	0.2	7.4	1.4	0.4	5.8	0.1	2.4	0.0	1.6	3.8	4.3	9.1	8.7	5.6	0.0	0.0	13.3	8.8	3.1	9.4	2.5	4.3	0.2	0.0	1.0	3.7	3.9	0.0	0.0	1.2	0.0	7.4	2.3	2.9	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6	32.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.0	0.0	0.0	3.3	9.7	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	7.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696303	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	23.9	11.8	10.5	20.5	15.0	24.8	19.1	26.8	14.9	22.2	21.8	15.0	14.0	8.0	24.5	13.2	16.6	18.3	20.6	37.4	11.3	8.4	17.1	12.4	23.1	21.4	14.4	9.6	21.6	11.4	16.9	12.3	21.0	11.9	18.4	8.3	21.7	12.8	18.5	19.6	15.4	14.7	20.4	13.2	30.4	16.4	26.5	12.3	12.9	15.5	12.8	15.4	19.0	26.8	1.9	3.5	18.3	8.5	1.1	2.6	2.3	10.2	7.7	9.8	9.6	18.9	15.2	4.5	10.2	11.2	12.7	10.3	3.5	2.1	11.1	7.2	19.9	9.3	3.8	6.4	7.2	8.1	9.7	14.1	9.0	10.5	5.0	9.9	6.9	9.7	10.9	5.0	15.8	8.3	8.1	30.8	8.2	5.5	14.7	10.1	7.3	12.4	7.3	6.1	2.1	8.3	6.6	25.2	7.2	4.6	4.7	5.0	12.1	6.9	8.3	8.5	12.9	8.3	6.9	27.7	32.5	8.6	17.6	12.3	14.7	14.8	4.1	7.0	5.6	8.4	8.8	8.5	10.4	2.2	8.3	2.3	1.5	2.6	2.1	3.5	1.9	2.5	2.5	18.3	1.1	8.2	1.3	1.9	2.3	10.5	15.0	26.8	14.9	11.3	8.4	14.4	9.6	11.9	12.3	17.9	12.6	8.8	5.9	6.9	13.9	9.9	2.5	4.0	5.7	15.7	13.7	2.7	8.3	3.7	7.1	33.7	2.1	0.0	6.9	2.9	7.4	8.9	3.5	8.3	13.8	17.5	4.1	39.3	38.3	4.4	13.8	15.3	21.9	8.2	3.3	7.5	4.9	0.0	12.4	2.1	15.0	19.4	11.4	18.0	6.1	9.8	1.1	8.7	4.4	3.7
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	12.0	8.0	13.1	17.7	12.6	9.1	14.6	23.1	14.0	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15.0	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13.0	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.7	5.4	10.3	8.8	6.4	7.5	6.7	5.4	4.8	6.2	6.6	7.7	3.5	9.8	3.9	13.7	8.9	11.9	10.5	10.8	7.6	7.1	8.6	12.8	5.0	7.5	4.9	13.2	6.2	4.7	12.6	6.5	5.9	9.7	8.1	7.4	32.2	11.3	6.6	4.9	8.9	6.7	6.3	3.4	8.3	9.8	9.5	7.8	5.7	3.5	5.9	5.3	10.1	10.8	0.9	9.4	4.4	16.2	7.5	7.6	9.8	7.1	25.5	6.6	5.3	9.0	9.0	13.7	8.0	17.5	3.8	2.3	5.0	3.0	8.9	6.2	7.1	4.5	4.3	8.8	5.0	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14.0	11.9	7.8	12.8	8.9	9.2	12.4	17.9	12.6	14.2	8.2	8.8	15.7	17.9	10.2	8.1	19.4	14.0	21.6	16.7	3.3	8.0	2.6	11.3	5.9	0.0	6.5	9.4	7.8	10.8	3.5	7.3	6.4	22.3	14.8	4.3	7.0	2.5	10.6	9.0	0.0	18.0	9.4	18.9	9.7	7.0	11.7	5.9	28.6	6.5	8.0	13.5	29.6	10.3	27.7	12.1	10.9	12.9
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.9	1.8	0.0	0.0	4.2	11.3	1.0	4.2	22.7	2.2	2.1	0.1	3.0	1.7	6.2	5.8	1.6	4.0	7.2	2.1	5.7	2.3	5.7	15.0	4.0	0.0	20.1	6.9	0.0	14.8	2.8	3.4	9.8	8.4	7.3	2.1	3.7	16.8	15.3	5.6	0.1	5.9	0.7	5.7	2.4	3.9	4.8	6.8	8.8	18.6	5.3	3.5	3.5	3.4	0.9	0.8	0.7	6.2	6.3	3.6	1.1	0.2	3.9	13.7	9.1	0.0	2.8	9.8	3.2	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6	6.0	22.4	10.4	17.9	4.4	17.5	21.8	2.5	16.0	34.2	10.4	5.9	0.7	3.3	2.1	4.9	3.8	7.7	0.0	19.7	0.9	5.1	22.3	5.7	9.6	7.1	0.0	33.5	9.8	22.1	2.3	21.9	18.4	0.0	1.0	12.1	42.4	18.9	5.8	13.4	6.8	2.5	12.9	8.0	1.4	15.0	8.8	2.3	6.9	10.0	19.3
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.5	7.0	6.3	7.0	8.8	15.4	1.6	9.4	5.4	7.1	5.4	2.1	10.2	0.1	8.4	14.2	2.8	11.9	2.1	6.5	3.6	6.2	5.2	0.5	16.2	3.1	2.7	0.5	0.6	12.4	16.1	7.4	2.6	7.9	4.8	0.5	2.3	4.1	11.3	18.7	0.3	8.6	2.0	7.5	5.8	2.7	4.2	1.7	10.6	7.9	2.3	3.5	9.9	8.7	7.4	2.7	4.6	6.4	9.9	17.9	7.5	19.9	4.9	3.4	4.2	0.1	15.8	6.1	5.2	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0	17.9	16.2	4.7	10.4	11.1	0.5	8.9	10.2	1.4	11.4	3.5	0.0	0.9	3.3	2.3	0.4	15.8	1.7	0.0	3.8	1.7	7.7	7.3	2.3	0.8	2.5	4.8	0.0	28.8	12.5	1.1	15.0	5.1	5.0	13.6	4.9	5.2	8.9	0.0	14.2	1.5	0.4	6.5	10.5	8.7	2.1	12.9	0.1	10.2	4.3	14.4
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.9	7.0	20.5	17.6	15.0	20.1	14.5	16.0	18.5	14.4	18.2	9.0	7.6	17.7	10.2	17.2	12.8	8.5	12.9	12.4	24.6	9.0	13.7	15.8	9.7	11.9	15.8	17.5	12.2	16.6	15.3	14.0	17.2	16.6	13.5	15.6	31.5	14.5	20.6	9.7	8.1	14.8	16.8	12.4	8.9	14.0	36.9	8.6	12.1	8.9	10.4	14.8	11.1	7.7	12.0	16.8	7.7	31.1	12.9	11.7	7.4	10.7	14.8	12.9	11.5	7.7	18.0	19.2	17.2	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7	14.9	24.0	20.7	17.4	32.3	22.8	28.8	12.7	16.0	10.3	15.7	25.5	27.6	6.6	16.6	2.6	20.3	9.3	0.0	18.3	26.6	23.5	24.4	12.8	17.9	21.1	27.0	11.6	30.7	26.3	2.2	24.7	25.3	20.3	27.9	15.6	18.9	15.5	7.0	38.5	13.1	21.1	19.4	19.1	24.6	24.0	32.5	40.5	25.5	15.1	23.0
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 133.3;Urothelial cells: 168.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	8.0	7.2	2.0	4.2	10.5	8.8	9.3	2.0	12.1	4.5	5.4	5.0	18.8	5.3	5.2	4.3	4.4	15.2	4.5	1.9	1.6	12.3	2.3	9.9	12.3	16.0	8.9	3.1	24.4	11.0	1.1	4.5	0.9	4.5	2.0	0.1	4.4	8.0	0.7	4.6	0.1	11.8	0.7	4.3	2.6	0.6	1.6	3.0	4.4	16.4	0.2	0.8	7.2	6.2	0.9	5.7	2.1	6.6	0.1	2.8	2.4	9.9	0.3	12.1	11.3	1.6	4.0	13.4	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6	35.7	41.7	14.7	46.9	103.8	13.9	7.1	5.1	25.4	13.6	3.5	0.0	23.9	1.7	25.2	0.4	36.9	5.2	0.0	9.8	71.1	77.1	32.5	71.4	3.0	109.0	0.0	11.5	14.1	86.6	0.0	7.8	94.5	40.5	78.5	5.3	5.0	17.6	17.5	3.9	2.4	1.1	6.5	75.4	0.0	0.7	74.2	133.3	52.3	5.8	168.4
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Urothelial cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	18.1	8.4	1.6	2.0	0.0	0.0	5.6	0.4	0.2	1.7	1.6	6.0	7.0	3.7	2.5	0.1	3.7	8.6	5.3	10.2	1.9	2.4	1.5	0.2	2.9	4.0	0.3	0.4	0.8	0.1	5.6	1.2	10.6	3.1	0.0	3.3	1.3	0.8	0.4	7.3	2.8	0.4	3.5	7.2	3.9	1.0	3.2	0.7	3.9	8.3	11.6	2.5	5.2	6.2	1.0	3.2	5.6	0.6	0.0	0.0	7.4	0.0	2.8	1.9	4.4	1.9	2.8	0.3	1.1	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8	6.0	14.9	0.9	10.9	7.7	15.8	1.8	15.3	0.0	10.3	7.0	11.8	2.5	1.7	5.5	13.2	0.7	3.1	0.0	4.0	1.3	0.8	9.0	1.1	4.9	1.0	28.6	8.1	0.6	0.8	15.9	0.6	1.4	3.3	0.0	3.4	3.4	7.4	3.5	0.0	1.9	12.3	0.0	1.0	5.4	8.5	8.0	3.3	2.9	5.0	25.4
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1.0	1.2	1.0	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23.0	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2.0	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	4.4	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.1	21.4	0.0	0.1	4.9	5.2	0.6	0.1	0.0	11.4	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	4.7	0.0	0.0	0.1	0.0	0.0	16.9	16.6	26.2	0.0	5.9	0.0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14.0	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14.0	14.6	7.3	1.2	2.3	1.0	1.2	1.1	1.4	2.3	0.7	2.1	1.3	3.0	8.2	29.0	0.1	2.1	6.1	0.6	0.0	0.0	1.2	0.0	11.8	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.2	1.0	0.3	15.1	0.0	2.5	1.6	0.0	1.3	7.1	0.0	0.0	11.7	3.3	2.8	0.0	6.7	0.0	0.0	0.0	0.2	58.2	0.0	0.4	0.6	4.3	0.9	0.1	33.2	0.2	0.1
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784914-64803241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	6.9	6.2	9.4	15.2	10.0	19.1	5.8	12.1	15.6	5.2	5.8	10.1	6.9	4.9	6.2	4.0	4.3	4.4	6.3	5.5	9.4	9.2	6.2	3.1	12.0	22.3	8.3	7.3	4.2	7.2	5.2	8.0	12.3	12.5	6.1	4.7	6.7	9.0	8.9	3.4	5.0	9.9	5.6	6.7	22.6	7.1	5.5	6.6	11.5	8.7	3.9	18.8	6.1	5.1	10.8	5.0	8.2	14.8	2.3	9.6	7.1	6.0	5.5	3.6	6.4	3.2	2.0	8.5	4.5	4.3	5.5	3.9	2.4	2.8	10.5	8.4	5.2	9.7	1.8	4.3	4.4	3.3	13.7	2.1	18.5	7.6	5.0	3.9	9.7	7.0	1.9	2.2	4.3	2.7	3.8	13.4	18.4	1.5	1.0	1.6	7.5	5.7	9.7	2.4	3.6	7.4	12.0	0.4	12.1	3.1	3.0	4.3	6.2	3.9	5.1	4.0	4.3	10.3	15.0	10.3	4.6	10.3	4.2	1.9	1.2	2.3	11.4	4.1	14.7	3.4	2.2	4.2	5.6	5.2	12.2	5.3	10.8	7.0	4.7	4.4	7.6	8.6	6.3	8.2	2.3	14.8	5.0	9.6	7.1	9.4	10.0	12.1	15.6	9.4	9.2	8.3	7.3	12.5	6.6	3.0	4.5	18.1	3.3	1.1	19.5	3.6	2.5	1.4	2.3	1.8	23.6	6.4	3.3	1.3	29.3	15.5	1.8	0.0	1.5	10.2	2.8	2.6	1.1	1.8	9.1	11.1	5.8	20.3	8.5	25.2	3.7	8.3	1.7	8.2	2.0	7.0	0.9	11.5	6.7	2.8	13.8	6.5	2.5	1.8	11.1	1.3	4.2	10.0	1.9	1.6
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 41.6;RT4: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14.0	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33.0	17.8	17.2	18.6	15.3	11.5	26.1	21.0	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1.0	1.3	0.4	9.9	6.2	41.6	6.6	6.8	13.6	11.4	8.8	11.3	8.8	7.5	5.2	5.0	2.1	10.0	6.0	9.1	5.4	15.6	7.8	13.4	2.4	6.4	3.6	4.4	12.1	17.7	1.6	5.9	12.2	7.8	11.4	12.4	9.3	7.5	2.0	4.6	4.1	11.7	5.4	3.4	2.3	12.5	9.4	9.4	3.8	13.5	1.6	11.6	38.5	7.4	8.5	5.2	8.3	23.0	13.7	5.6	2.2	6.1	6.8	8.1	6.1	4.7	6.2	3.5	0.7	8.4	2.6	7.9	2.5	0.7	0.0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0.0	1.0	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5	3.0	6.7	5.1	15.6	15.7	23.8	32.7	17.8	13.4	15.9	21.0	23.6	9.2	16.6	9.0	38.6	10.3	11.9	0.0	10.7	5.5	15.6	20.0	2.3	16.2	9.1	6.4	9.2	15.4	9.5	80.0	19.2	12.2	5.0	1.8	12.5	15.2	12.8	7.0	16.6	10.9	41.2	19.4	12.7	19.5	20.8	16.8	8.7	4.4	9.3	29.0
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain					NA	NA					"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	27.0	5.0	68.3	21.1	56.3	32.1	35.2	14.5	50.4	13.2	7.8	47.5	2.1	5.4	14.6	6.7	18.5	8.6	18.0	22.2	70.5	40.5	6.3	16.8	13.2	25.8	65.3	21.5	12.6	8.3	9.5	4.3	25.1	40.2	7.6	9.6	6.1	7.7	5.7	16.1	8.7	6.5	14.8	81.2	11.7	11.0	20.3	49.1	13.2	8.3	6.6	29.6	13.5	16.3	4.6	6.3	14.4	3.4	1.1	3.7	1.5	19.1	14.6	31.2	14.9	29.6	53.1	39.2	24.4	20.1	21.8	18.0	24.0	25.5	27.9	21.2	36.4	6.4	7.9	9.8	21.5	21.9	37.4	6.7	20.9	11.0	62.8	25.0	9.9	0.9	47.6	9.8	53.8	24.1	21.9	56.7	15.8	13.5	0.0	57.3	10.4	23.1	6.2	15.8	7.3	23.2	28.0	21.3	0.1	14.5	6.7	12.2	20.4	16.8	0.0	18.2	30.1	3.9	18.1	71.2	43.4	18.6	12.5	29.0	0.0	0.0	17.0	28.0	12.7	31.7	6.9	3.3	0.0	2.4	3.4	1.8	3.5	3.3	1.7	1.1	4.6	2.5	2.7	14.4	1.1	3.0	6.3	3.7	1.5	68.3	56.3	14.5	38.9	70.5	40.5	65.3	21.5	40.2	49.1	17.9	22.9	29.6	34.7	26.7	120.4	66.8	25.5	14.7	36.4	17.4	47.1	11.0	0.0	53.8	23.8	54.9	6.3	0.0	45.6	16.9	45.6	49.1	22.1	38.2	32.1	33.4	16.7	59.5	23.4	28.3	50.9	37.5	18.6	87.4	12.9	60.6	85.8	13.1	16.3	4.4	7.3	51.8	51.5	20.6	82.8	21.5	6.5	25.3	12.4	35.8
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"		14	50418501-50561126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 26.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036696, HPA078030"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA036696: AB_10672362, HPA078030: "	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	17.4	11.8	23.4	12.1	44.4	16.5	19.7	24.6	32.3	25.8	17.1	43.5	13.4	11.3	29.9	12.1	18.7	17.4	19.3	10.3	24.4	14.0	10.9	8.7	15.2	9.9	48.8	17.1	29.9	13.3	16.7	17.5	17.3	26.0	16.6	15.1	9.1	16.9	19.9	10.7	24.8	12.7	22.3	30.7	13.0	14.4	6.8	51.1	8.4	15.3	8.7	11.2	19.3	21.2	5.0	2.7	26.1	1.8	5.4	3.9	1.0	22.9	6.9	17.0	14.6	15.7	16.6	16.6	27.1	24.5	18.5	16.5	8.7	16.1	15.9	16.2	24.8	9.8	16.5	15.8	14.6	28.2	13.1	11.5	9.7	12.2	7.8	13.3	8.7	15.4	12.0	12.0	16.2	17.0	29.6	24.2	14.5	9.2	10.4	27.0	8.7	11.7	8.3	8.3	7.4	13.6	14.2	25.8	6.0	18.3	17.9	5.5	12.5	15.3	10.7	10.5	14.3	11.9	6.6	24.6	24.1	16.8	16.4	12.7	7.6	7.7	10.6	9.0	6.1	17.1	26.1	1.5	13.5	3.9	1.8	2.2	3.2	2.4	3.3	1.6	5.0	2.6	2.7	0.6	5.4	1.1	2.7	0.5	1.0	23.4	44.4	24.6	32.3	24.4	14.0	48.8	17.1	26.0	51.1	38.7	17.3	14.6	29.9	62.2	51.9	7.3	20.4	26.8	27.3	26.2	45.2	9.4	16.6	24.0	2.8	33.1	15.9	23.3	18.3	16.7	46.1	53.8	28.9	7.8	7.5	31.8	22.5	35.6	13.9	2.2	39.4	20.9	21.9	17.2	14.2	18.2	23.1	15.0	48.1	9.9	33.6	12.9	40.4	11.2	13.6	75.3	5.5	21.8	16.2	55.0
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21754500-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069"	Approved					NA	NA		250000			"CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	16.1	21.1	32.9	18.3	80.3	20.2	13.6	31.0	54.5	18.6	18.5	23.2	9.6	13.7	17.4	10.6	25.7	16.9	14.9	22.8	32.4	23.4	21.7	16.4	19.9	16.6	18.4	23.6	16.0	19.8	27.4	10.9	17.2	27.6	16.4	19.9	14.2	15.8	17.8	28.2	17.5	15.1	22.8	20.4	19.8	17.2	24.2	21.5	19.5	23.0	11.1	21.4	17.7	15.3	2.5	3.2	13.5	4.9	7.0	13.7	2.5	19.7	12.5	16.1	9.2	19.1	19.2	6.1	21.8	20.4	19.6	19.0	9.9	10.5	10.9	10.9	29.2	18.0	18.8	18.9	17.4	25.6	44.0	17.7	19.8	11.7	11.6	15.7	27.8	20.6	14.3	14.0	23.7	21.9	15.4	26.7	11.9	81.1	12.5	23.9	8.1	18.0	6.1	6.1	26.8	12.3	19.8	39.7	2.9	11.2	16.2	13.1	7.3	23.6	14.2	12.7	16.7	10.7	9.4	23.3	16.4	21.4	18.8	13.8	12.0	14.6	17.0	15.5	13.6	17.7	1.0	4.0	5.8	13.7	4.6	3.9	2.0	2.9	4.9	3.2	2.5	2.8	5.1	13.5	7.0	4.9	3.2	2.7	2.5	32.9	80.3	31.0	54.5	32.4	23.4	18.4	23.6	27.6	21.5	44.7	30.2	28.0	22.1	53.3	23.8	34.6	63.7	21.4	33.0	48.8	51.1	18.0	16.6	24.0	33.2	31.2	46.6	23.3	33.6	18.2	31.5	37.5	93.2	59.4	47.7	27.0	57.3	57.7	88.6	9.9	30.2	59.7	38.8	15.4	44.2	32.3	39.5	28.8	41.8	37.6	21.0	32.3	32.2	70.0	47.7	54.1	16.0	95.8	30.7	34.8
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.3"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 92.3;Early spermatids: 179.3;Late spermatids: 303.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"AF22: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA					"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	17.2	11.9	31.6	3.7	34.5	9.7	6.2	26.1	58.3	11.4	4.0	12.6	8.1	3.2	11.0	14.2	7.4	11.9	10.4	5.1	36.0	28.6	15.0	2.7	6.5	3.9	31.5	36.4	11.3	5.6	10.9	31.5	3.4	37.9	16.6	4.3	5.4	3.4	18.9	2.0	3.5	3.9	11.4	23.1	5.3	4.3	18.2	15.8	0.0	15.3	0.4	3.6	11.1	10.2	3.7	3.0	6.9	1.8	3.3	3.6	2.3	1.1	2.0	60.3	1.9	1.7	1.4	2.3	1.2	1.1	1.0	0.5	1.1	1.8	2.6	2.0	0.7	1.5	3.7	0.6	1.6	1.7	3.8	1.6	2.2	2.4	1.9	1.4	1.0	1.2	1.6	0.8	1.4	1.9	2.1	1.3	1.8	1.9	9.9	0.7	1.6	1.7	1.1	3.5	0.3	1.2	1.9	1.5	0.9	4.3	6.4	3.6	3.3	1.2	4.9	0.8	2.0	3.5	1.3	2.8	2.6	2.7	1.1	1.0	3.2	1.9	1.7	3.8	1.3	1.4	6.9	1.8	3.3	2.3	1.6	2.4	3.7	1.9	2.5	1.6	3.3	2.7	3.6	6.2	3.3	1.5	3.0	2.7	2.3	31.6	34.5	26.1	58.3	36.0	28.6	31.5	36.4	37.9	15.8	20.8	26.0	0.0	12.6	0.7	19.8	0.8	12.7	92.3	15.9	21.0	5.9	0.3	10.0	2.1	179.3	1.1	0.0	0.0	0.0	0.5	1.5	10.1	2.3	0.0	0.2	36.5	2.4	1.8	0.3	303.7	24.5	2.5	1.7	0.0	0.0	16.4	1.7	0.0	51.6	16.2	10.2	6.5	2.0	8.8	2.2	0.9	0.1	0.0	0.0	17.9
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 13.2;Ito cells: 14.7;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	20.4	5.7	14.2	7.5	17.3	0.8	8.2	22.0	23.7	6.6	2.7	2.8	1.0	1.9	8.2	6.2	5.3	7.0	8.8	8.8	11.7	9.1	5.0	1.5	8.5	8.5	7.2	19.9	5.3	3.1	6.4	10.9	8.4	6.6	7.2	2.7	4.1	5.7	8.0	5.0	6.4	2.6	9.8	5.5	7.3	4.6	3.1	4.1	0.9	4.5	5.3	6.1	6.0	4.4	1.1	0.0	0.0	0.3	0.0	0.9	0.0	1.7	4.2	4.7	17.6	6.2	9.4	0.1	6.6	4.7	4.4	1.7	1.7	3.2	0.0	5.9	6.1	7.3	4.3	3.1	2.6	0.3	9.1	2.1	6.2	5.6	0.4	7.1	1.5	9.7	13.0	7.8	1.2	0.5	4.9	9.6	6.7	5.0	17.0	4.3	7.5	0.3	5.7	0.4	5.2	4.9	17.0	0.1	6.0	6.6	0.0	4.4	11.8	5.6	2.3	4.6	0.6	7.7	4.9	15.0	13.2	11.0	0.9	2.4	0.7	2.0	7.2	6.7	1.8	11.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.4	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	14.2	17.3	22.0	23.7	11.7	9.1	7.2	19.9	6.6	4.1	0.0	1.4	1.3	1.1	1.6	2.6	2.8	0.0	0.0	0.0	0.0	5.9	0.0	1.7	0.8	3.7	13.2	0.0	0.0	0.2	0.3	1.7	3.3	0.0	1.0	0.2	0.0	0.0	14.7	2.6	5.7	2.8	0.0	5.0	0.0	0.0	5.6	0.7	0.0	2.1	1.4	10.9	0.0	1.0	1.2	2.1	1.1	0.0	1.0	0.0	0.9
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.4	6.4	2.5	7.5	5.7	6.3	3.5	8.0	6.9	13.4	8.5	9.3	3.3	19.6	10.9	8.8	8.0	7.0	11.1	1.6	2.6	5.6	15.6	12.8	19.5	11.5	18.1	12.0	25.4	13.5	2.9	3.0	0.0	7.3	15.2	1.8	11.3	18.2	6.2	5.7	0.0	16.0	7.5	3.5	10.5	18.3	6.7	19.9	7.9	1.4	8.6	2.9	6.2	0.2	9.9	1.9	3.4	14.0	7.9	13.9	12.5	3.0	5.0	4.2	3.2	10.5	3.5	11.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4	0.0	5.6	1.3	0.4	0.7	5.1	7.8	2.5	1.4	0.0	0.0	0.0	0.3	1.7	0.4	0.3	9.5	0.0	0.0	0.0	1.8	2.8	3.0	10.4	1.0	4.9	1.6	1.7	22.1	2.8	1.3	6.1	0.8	0.0	1.0	0.0	5.1	0.6	0.0	3.5	6.5	1.7	6.5	2.4	0.2	9.7	0.5	0.3	1.0	0.2	0.0
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 143.1;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.6	0.1	0.3	0.2	1.2	5.7	2.7	1.6	0.2	0.2	0.5	16.3	19.4	4.7	1.2	1.5	2.8	15.2	0.0	46.2	0.4	12.0	5.2	0.1	0.5	16.2	2.0	0.1	1.2	4.9	16.4	3.0	0.6	2.3	3.0	0.5	0.3	5.3	0.5	10.3	0.1	1.2	0.1	19.4	0.3	11.6	0.2	27.9	9.0	28.9	19.6	0.3	1.7	0.3	0.1	0.6	22.0	2.5	4.1	1.4	0.2	0.5	0.3	0.3	7.0	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1	26.8	24.1	11.5	34.8	24.3	0.8	1.6	22.9	1.4	22.7	27.9	5.9	41.4	13.3	48.4	89.5	2.3	143.1	0.0	102.6	8.3	3.2	28.0	2.3	1.6	35.8	0.0	63.0	0.6	6.1	214.3	6.6	6.4	16.9	22.6	80.8	1.5	76.0	89.2	9.2	7.9	2.2	0.0	1.0	6.1	1.5	46.5	27.0	20.2	93.7	47.8
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.5	10.2	11.0	17.7	25.1	25.0	24.2	19.4	25.3	23.0	24.0	24.9	9.6	15.0	19.3	21.3	11.0	13.3	18.1	16.8	24.1	16.9	14.5	34.7	14.5	20.8	13.8	21.9	21.0	17.6	16.4	16.6	16.5	19.2	26.1	26.0	19.2	18.9	15.7	8.8	22.4	26.3	6.7	11.4	10.2	26.7	17.9	13.9	16.2	25.6	8.3	7.0	17.5	13.1	20.3	14.1	15.4	40.9	18.3	20.7	12.0	13.0	17.7	9.3	21.2	15.1	9.4	43.2	16.9	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3	29.8	11.5	18.2	10.6	14.2	19.3	23.5	7.6	16.0	19.4	17.4	29.5	38.2	1.7	12.1	2.6	20.2	25.7	0.0	9.9	14.8	20.9	9.0	20.7	39.4	22.3	11.1	16.1	21.5	58.1	3.7	22.7	30.0	10.1	19.8	22.5	12.2	17.6	20.3	25.1	14.0	24.3	12.9	11.5	6.3	7.7	16.7	20.0	23.5	15.6	8.8
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 85.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.2	0.0	1.3	0.0	0.0	5.4	0.1	0.2	0.0	1.1	1.6	0.0	14.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.3	2.7	0.0	0.0	13.9	0.0	0.0	2.0	1.2	1.1	0.0	3.0	0.4	0.9	1.3	4.0	4.0	0.0	2.8	0.0	0.2	12.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0.0	8.3	0.0	0.2	0.3	0.0	0.8	0.0	85.6	13.6	0.0	0.0	0.0	0.0	0.6	12.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.3	0.1	0.0	0.1	0.0
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 255.2;Enterocytes: 275.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 25.1;neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (5.03e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.70e-3)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-2)"	24.9	18.5	63.3	15.3	43.2	15.6	21.1	24.8	52.0	21.3	45.1	30.4	6.3	39.7	24.2	11.4	44.1	28.7	25.6	21.2	37.1	34.0	13.4	8.8	23.3	13.1	33.8	27.4	32.7	13.0	26.1	15.2	27.6	27.6	20.1	36.7	26.2	17.1	18.3	13.9	18.7	49.2	24.0	27.8	15.9	33.7	11.6	19.5	8.4	20.5	18.7	26.0	18.2	22.2	1.4	1.5	25.1	2.7	0.8	3.1	1.4	14.0	7.7	16.4	9.2	41.2	54.6	9.2	10.5	26.0	16.6	19.9	9.1	28.2	14.1	10.4	29.3	19.2	5.2	13.7	12.3	16.3	26.7	15.9	4.3	8.5	15.3	41.4	3.2	12.1	33.7	7.2	19.0	8.6	25.3	42.2	15.5	5.9	18.2	22.0	36.8	14.5	5.0	4.3	28.6	6.7	17.2	9.7	31.7	15.2	8.9	14.5	10.3	6.0	21.1	6.1	13.8	13.8	7.7	29.9	11.0	9.5	12.5	3.6	20.7	9.4	7.2	22.0	6.8	7.7	2.4	2.7	25.1	0.9	1.9	1.4	1.3	2.1	1.6	1.4	1.4	1.5	1.6	11.3	0.8	1.0	1.5	3.1	1.4	63.3	43.2	24.8	52.0	37.1	34.0	33.8	27.4	27.6	19.5	20.8	20.3	9.0	19.0	8.8	28.0	12.7	15.3	20.1	7.9	8.7	21.6	66.6	19.9	31.0	255.2	49.5	275.3	0.0	54.5	107.4	25.7	11.8	2.3	6.4	38.5	7.9	52.6	52.8	25.3	107.0	30.0	18.9	21.9	27.9	135.6	38.1	77.0	98.1	25.8	18.2	32.7	19.4	18.6	10.5	17.5	11.5	28.3	13.1	63.5	18.0
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		NA	NA			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.7	3.8	0.1	1.1	2.6	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4	8.9	0.0	0.0	0.1	0.0	11.0	20.1	2.5	0.0	0.0	0.0	0.0	3.6	5.0	1.0	20.2	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.8	0.3	4.8	0.0	0.0	0.0	42.4	0.9	0.0	0.0	0.0	0.0	55.0	0.5	0.0	1.4	0.0	0.6	0.0	1.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067372	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005184, HPA030262, HPA047825"	Approved	Supported	Supported	Cytosol		NA	NA			Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: "	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	11.8	7.4	14.4	10.9	23.2	25.6	13.7	33.0	24.5	16.3	18.7	12.5	9.3	16.3	15.9	13.3	32.3	8.2	17.0	9.1	13.3	15.9	14.4	32.6	12.6	9.4	13.1	16.8	11.5	8.5	12.2	15.3	13.9	23.8	10.5	18.1	9.5	17.9	11.4	27.1	24.0	26.2	17.8	14.2	9.2	15.7	25.7	13.0	11.7	13.4	22.7	12.4	18.9	22.4	4.9	4.2	3.0	4.5	6.5	7.9	3.6	8.7	11.8	23.3	8.9	7.2	11.9	17.1	12.6	12.7	11.6	13.7	14.1	5.3	12.6	8.8	16.1	17.0	12.4	17.9	23.9	15.9	7.7	5.6	18.8	7.0	22.4	17.5	14.0	40.2	12.7	44.0	14.0	36.5	12.4	10.9	8.7	24.3	21.6	14.8	19.8	9.8	11.1	8.3	10.9	5.7	8.6	15.0	20.3	11.1	36.9	11.5	10.8	10.1	8.3	18.3	33.7	7.5	20.9	10.8	13.9	15.0	9.0	16.7	11.2	32.9	15.7	17.2	20.6	17.0	3.0	4.5	1.2	3.8	4.3	4.7	4.9	5.6	4.3	4.2	2.6	5.4	3.8	0.6	6.5	2.8	1.9	7.9	3.6	14.4	23.2	33.0	24.3	13.3	15.9	13.1	16.8	23.8	13.0	26.8	29.8	23.8	84.4	99.5	34.6	20.2	22.9	24.1	29.6	15.7	15.7	14.3	14.9	31.8	133.3	22.8	95.4	0.0	43.1	33.7	40.4	80.6	139.2	47.8	25.7	31.8	29.7	16.5	30.7	167.7	21.0	26.7	28.7	11.8	32.2	25.1	52.1	31.6	22.3	30.5	21.1	19.4	21.7	56.4	75.8	96.7	27.7	17.0	19.8	153.6
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;SuSa: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	3.6	5.8	4.8	3.7	24.1	10.1	5.6	5.0	4.6	6.9	6.4	6.7	0.6	2.2	4.0	8.6	5.1	4.1	5.6	4.6	4.3	3.8	4.3	1.0	4.1	2.9	10.4	0.9	3.7	10.6	3.2	10.5	3.7	6.0	5.1	4.3	1.9	0.8	6.9	2.4	7.4	3.9	5.5	3.7	3.8	4.0	7.0	1.5	2.3	2.0	2.2	6.4	5.1	0.5	2.5	29.6	3.1	1.2	2.8	7.4	5.5	8.2	3.4	1.4	2.1	0.6	8.6	0.9	4.5	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5	6.0	3.5	6.2	5.5	4.8	2.0	1.7	0.0	1.4	2.3	5.2	2.0	4.8	5.0	7.1	6.3	7.1	9.0	0.0	5.3	6.9	8.3	5.5	2.3	1.3	6.7	0.0	10.3	6.7	6.7	5.9	10.6	6.3	3.3	2.8	5.7	14.5	6.2	13.5	11.0	3.0	2.0	25.8	8.6	31.4	10.6	3.8	4.2	4.4	6.1	5.2
MAPK8	"JNK, JNK1, PRKM8, SAPK1"	ENSG00000107643	"Mitogen-activated protein kinase 8"	P45983	10	48306639-48439360	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004463, CAB069396"	Approved					NA	NA					"CAB004463: AB_675868, CAB069396: AB_1619977"	"unprognostic (7.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (4.23e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (6.06e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.01e-3)"	13.4	11.7	15.3	11.5	18.5	13.3	22.1	33.6	35.2	15.2	13.9	12.9	19.5	16.7	17.1	10.8	16.1	12.4	15.1	11.2	20.0	18.0	20.1	23.6	11.7	12.0	15.9	16.7	18.9	15.3	12.7	23.7	12.2	23.6	13.0	14.3	12.4	17.2	15.9	18.9	10.8	17.7	14.6	13.7	9.6	12.2	23.4	12.2	20.5	22.3	9.0	13.8	11.8	13.0	4.5	4.3	5.2	4.3	4.7	5.7	3.5	16.0	4.3	14.5	8.3	5.6	6.6	11.3	24.2	16.6	14.5	11.9	5.0	16.6	5.8	6.6	13.5	7.6	9.8	5.0	9.3	19.0	34.7	8.3	8.3	5.0	6.8	9.2	14.2	9.8	5.5	10.7	10.8	21.4	8.6	13.3	16.1	13.3	10.7	9.4	4.7	17.3	7.6	9.1	5.8	3.2	11.4	15.0	5.8	8.9	6.2	24.4	19.4	9.4	7.9	10.9	9.8	8.6	6.8	11.4	10.8	26.0	8.2	18.2	3.4	8.3	11.8	7.5	15.1	6.2	0.0	3.3	3.0	4.1	2.8	4.7	4.5	5.7	5.0	3.3	2.9	5.6	3.9	5.2	4.7	4.3	4.3	2.9	3.5	15.3	18.5	33.6	35.2	20.0	18.0	15.9	16.7	23.6	12.2	3.0	11.3	7.8	38.8	39.8	58.6	8.3	22.9	14.7	14.8	7.0	29.5	11.7	10.0	24.2	142.4	17.8	21.0	0.0	22.3	5.8	15.8	35.2	11.5	16.3	8.8	66.7	29.7	8.6	9.9	66.1	13.6	16.2	20.3	31.5	12.5	21.2	25.4	15.0	9.6	19.2	34.4	6.5	25.8	22.7	25.1	32.0	13.2	11.5	11.5	38.7
MAPK9	"JNK2, p54a, PRKM9, SAPK"	ENSG00000050748	"Mitogen-activated protein kinase 9"	P45984	5	180233143-180292099	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 13.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008910	Enhanced					NA	NA					"CAB008910: "	"unprognostic (5.04e-3)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (8.53e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.06e-3)"	"unprognostic (6.83e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.40e-1)"	10.3	12.4	22.9	9.6	31.8	10.3	11.4	48.7	41.4	10.8	12.4	10.6	4.7	10.1	8.7	9.5	8.7	8.8	7.8	14.0	24.3	25.0	12.2	9.7	10.8	10.0	22.0	21.0	8.5	25.9	16.3	8.8	10.9	29.4	11.7	15.3	7.0	9.9	13.1	20.5	6.3	10.4	11.4	16.8	8.6	12.3	9.4	10.3	7.1	15.4	5.1	11.3	9.9	7.3	1.4	1.4	13.2	2.4	1.3	3.1	0.3	17.2	14.3	12.6	15.8	12.5	14.1	27.2	16.6	14.8	14.0	14.1	18.7	12.3	18.5	28.7	17.6	30.8	13.3	13.0	27.9	16.5	69.4	12.5	7.7	15.9	13.3	9.5	15.9	13.5	10.3	12.5	13.6	13.2	14.6	16.6	14.5	8.4	13.4	19.0	22.6	15.8	6.6	8.8	21.4	8.5	15.3	21.5	8.8	10.6	16.5	14.6	10.3	19.5	19.0	13.2	16.4	19.3	13.8	11.9	16.8	16.9	23.6	24.8	9.7	11.4	12.6	17.8	14.9	11.1	13.2	0.6	2.5	2.0	1.3	2.0	1.0	1.5	1.8	1.0	1.4	1.0	1.2	0.9	1.3	2.4	1.4	3.1	0.3	22.9	31.8	48.7	41.4	24.3	25.0	22.0	21.0	29.4	10.3	29.8	11.8	11.5	6.1	9.0	18.3	20.7	10.2	5.3	10.3	8.7	15.7	12.1	5.0	7.1	0.9	15.7	13.5	0.0	13.9	18.8	9.9	10.0	11.5	15.3	10.3	12.7	16.0	13.5	17.2	2.3	9.8	12.8	5.0	10.0	17.1	10.4	10.9	11.5	12.7	9.2	14.2	12.9	7.2	15.9	17.0	9.9	14.9	8.6	14.5	7.3
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	21.2	8.4	11.7	13.2	34.6	20.3	14.6	14.8	33.7	22.7	21.4	16.1	10.4	10.2	10.4	29.9	14.2	16.1	8.7	15.8	16.3	11.9	6.6	17.2	10.5	10.3	26.7	25.4	57.6	28.0	20.2	21.8	24.1	18.9	18.5	13.9	19.8	46.7	18.3	26.4	10.2	18.4	13.5	7.5	11.8	26.2	24.6	3.3	17.1	13.1	9.4	12.1	17.5	29.6	20.5	22.8	14.4	24.7	17.6	20.5	17.3	23.7	20.2	60.9	54.0	8.3	23.2	15.5	6.7	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6	50.6	53.7	28.9	47.2	75.9	11.3	97.2	40.8	6.7	29.6	29.6	19.6	5.0	13.3	28.0	71.3	26.3	27.4	23.3	50.4	7.0	28.6	55.9	34.6	34.4	22.4	0.0	59.3	21.5	27.7	20.1	21.0	27.9	32.1	12.6	32.0	17.7	50.5	21.2	16.3	21.0	14.8	25.8	48.7	11.8	4.1	63.0	13.8	37.4	24.1	68.1
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 193.9;Hofbauer cells: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.4	7.3	3.0	8.6	4.6	11.7	6.9	5.7	8.2	8.8	7.5	11.3	21.9	9.4	5.8	19.1	21.9	8.4	20.9	22.5	7.9	20.8	5.0	49.5	10.3	10.2	9.3	35.6	26.4	9.3	14.0	20.5	28.0	8.8	7.8	16.8	13.9	6.2	18.5	9.5	15.1	35.9	11.4	8.2	30.0	6.7	7.3	14.2	41.0	13.5	5.7	4.0	5.1	14.5	6.5	5.3	9.1	22.1	5.6	7.0	16.0	36.0	14.1	4.2	7.7	7.8	37.0	56.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2	8.9	9.4	7.5	19.5	10.1	0.9	193.9	10.2	6.7	6.8	10.4	0.0	5.0	54.7	35.3	28.4	6.7	23.1	0.0	26.4	5.7	11.0	21.5	35.7	10.9	91.5	0.0	5.8	4.9	48.9	60.2	6.6	40.9	6.8	46.9	13.9	10.8	54.8	8.6	3.2	28.5	2.3	25.8	11.7	3.4	4.3	17.7	4.2	18.7	27.9	30.1
MAPKAPK5	PRAK	ENSG00000089022	"Mitogen-activated protein kinase-activated protein kinase 5"	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21.0	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23.0	28.4	21.1	18.0	18.4	19.8	16.7	22.0	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	14.9	19.8	19.2	16.1	13.9	14.1	29.3	15.0	18.1	23.0	16.0	25.6	12.3	22.6	11.1	17.6	13.7	14.9	25.2	15.7	21.6	15.0	13.8	20.1	13.8	20.5	16.8	25.2	14.2	14.8	22.6	22.0	26.2	17.5	16.9	20.6	27.7	8.9	16.8	16.8	25.0	39.9	27.3	36.8	14.0	24.8	14.0	21.7	18.3	21.7	23.7	20.1	17.0	29.0	20.8	18.3	23.5	28.9	14.7	13.1	13.2	13.4	18.7	18.3	22.4	26.7	15.9	18.4	18.5	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4.0	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22.0	3.0	17.2	13.8	19.4	18.2	45.9	15.7	22.9	9.4	15.9	3.5	39.3	26.2	11.6	25.6	11.1	15.5	36.7	0.0	25.7	28.0	17.4	20.5	2.3	11.1	17.5	22.3	35.2	16.5	15.8	5.6	14.4	16.6	8.5	24.4	39.9	19.2	27.7	28.8	16.6	16.8	34.7	19.4	17.9	18.0	36.8	18.6	25.2	22.3	30.8	24.3
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;U-266/70: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain					NA	NA					"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.9	1.2	0.1	0.0	0.0	1.6	3.3	9.6	3.6	0.0	0.4	1.4	0.0	0.0	0.0	1.0	1.0	6.8	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	4.0	0.0	1.9	2.5	5.0	3.3	1.0	2.3	2.6	3.6	0.3	1.3	2.7	0.5	0.7	0.1	1.6	1.5	1.3	0.9	1.5	0.5	2.2	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.8	3.3	2.7	1.4	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9	0.0	2.7	128.6	0.0	1.5	24.7	2.4	0.0	1.4	4.5	3.5	184.6	0.3	0.0	0.0	4.6	1.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.9	43.0	11.1	0.0	3.1	192.5	1.7	0.0	105.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	172.3	12.9	0.0	0.6	1.5	0.9	0.7	0.8	0.0	0.0
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 371.3;Late spermatids: 1043.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.9	1.7	0.2	1.2	0.3	0.0	0.1	0.0	7.3	0.5	0.1	0.0	0.0	0.4	1.4	0.0	0.0	1.3	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.2	1.1	0.0	12.7	0.0	0.0	0.7	0.1	0.5	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3	3.0	1.0	0.0	0.0	0.1	0.0	0.3	0.0	105.7	15.9	3.5	0.0	0.1	44.7	0.0	371.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1043.9	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.5	0.0	42.4	10.6	0.0	0.1	0.5	0.0	0.0
MARCH11	"MARCH-XI, RNF226"	ENSG00000183654	"Membrane associated ring-CH-type finger 11"	A6NNE9	5	16067139-16180762	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 42.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 83.9;Spermatocytes: 30.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 44.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.91e-3)"				"unprognostic (1.08e-1)"					"unprognostic (2.98e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"			"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"		0.4	1.1	1.8	0.3	3.4	0.3	0.4	3.7	3.7	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.3	2.2	2.0	3.2	0.5	0.5	0.4	0.3	1.5	2.0	0.5	1.0	0.3	6.8	0.4	2.1	0.6	0.4	0.6	1.4	0.3	0.3	0.3	0.4	0.3	0.5	0.3	0.4	42.1	0.0	0.0	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	44.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	3.7	3.7	2.0	3.2	1.5	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	5.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	2.4	6.5	0.0	30.3	1.4	0.0	0.0	0.0	0.0	0.0
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.6	7.2	3.2	15.1	19.9	6.5	5.5	6.1	7.5	4.9	5.1	3.5	2.6	2.2	18.0	13.1	6.5	4.0	4.2	8.6	3.8	11.1	9.9	17.0	3.3	7.8	10.8	2.5	25.7	7.8	9.9	4.7	4.2	7.1	19.2	9.0	2.4	12.5	3.8	10.7	3.4	8.1	6.8	6.8	17.4	5.4	1.0	5.6	11.3	6.7	1.6	9.1	0.4	6.6	11.5	11.6	5.0	5.4	19.3	6.9	4.2	22.8	5.1	11.2	13.3	2.5	11.2	5.1	5.2	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3	3.0	10.9	4.5	0.0	6.6	10.7	38.1	7.6	2.7	3.4	19.2	2.0	6.6	33.2	0.0	8.1	27.0	13.6	23.3	0.0	9.3	10.5	0.0	12.7	24.6	57.4	22.3	11.6	47.9	48.6	36.4	8.6	19.4	23.6	0.0	5.5	17.5	0.0	7.4	11.0	43.4	7.7	12.9	20.6	5.4	8.5	11.3	4.8	18.1	4.6	0.0
MARCH3	"MARCH-III, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030808	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 52.5;Spermatocytes: 61.1;Syncytiotrophoblasts: 82.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.8;naive B-cell: 13.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.1;HUVEC TERT2: 16.7;TIME: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	11.3	6.0	5.6	11.0	9.4	6.6	6.2	5.3	4.8	2.0	10.8	8.2	0.5	2.4	3.7	3.6	3.4	3.2	10.4	15.2	7.8	6.8	2.0	1.9	5.2	5.2	9.5	2.3	4.0	5.0	1.7	10.8	4.0	12.3	2.9	11.8	9.7	11.2	1.1	11.9	11.5	5.2	6.5	16.0	3.7	5.5	14.2	7.6	2.1	3.6	3.4	5.8	6.5	6.7	13.1	0.7	2.5	0.4	1.9	2.6	0.7	0.3	1.2	2.4	1.3	2.1	2.1	0.8	8.5	3.6	6.9	10.2	1.1	0.5	2.3	0.8	1.3	1.5	0.7	3.0	1.5	9.8	0.5	2.7	7.2	2.0	1.1	3.5	2.9	1.8	1.5	0.5	25.1	3.0	1.6	16.7	0.3	3.0	0.4	5.7	0.8	0.3	1.3	2.0	1.8	2.8	0.9	9.6	0.6	0.5	1.2	0.7	0.5	2.0	0.3	1.0	1.2	1.7	3.0	20.3	1.3	1.1	7.9	0.9	1.1	1.3	1.3	5.1	2.3	1.2	0.0	0.2	2.5	0.5	0.4	0.1	8.8	0.6	0.3	0.1	13.1	2.4	0.5	0.8	1.9	0.3	0.7	2.6	0.7	5.6	9.4	5.3	4.8	7.8	6.8	9.5	2.3	12.3	7.6	3.0	3.4	18.2	0.0	5.4	18.3	12.9	17.8	1.4	3.4	0.0	2.0	33.6	0.0	0.0	33.1	6.0	15.5	23.3	0.0	3.1	6.7	0.0	24.3	0.8	7.7	35.0	14.3	11.6	3.5	9.8	0.3	2.0	3.3	0.0	23.4	52.5	0.0	44.4	1.8	0.2	25.6	0.0	0.9	61.1	12.7	7.8	82.5	5.1	21.9	0.0
MARCH4	"KIAA1399, MARCH-IV, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372027	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.6;pituitary gland: 13.1"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014348	Approved					NA	NA					"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.7	2.9	7.0	0.7	11.9	0.7	0.6	1.0	16.6	0.6	1.1	0.3	0.0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2.0	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.6	1.2	0.0	0.0	0.1	0.8	0.0	33.8	11.6	7.3	2.6	0.0	0.5	0.0	5.2	21.5	12.2	0.0	0.0	13.3	7.2	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.6	10.0	4.7	9.5	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	1.1	0.0	0.0	15.9	11.3	11.8	0.0	9.0	0.0	0.0	0.0	2.6	0.0	8.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.0	11.9	1.0	16.6	5.8	5.6	2.0	4.8	3.4	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MARCH5	"FLJ20445, MARCH-V, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291163-92353964	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria		NA	NA			Mitochondria		"HPA056596: AB_2683181"	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	18.2	21.7	17.5	17.7	18.3	20.7	27.1	16.8	25.7	15.5	15.4	12.7	20.7	15.8	19.3	18.8	28.0	14.8	15.4	18.4	15.8	15.1	21.7	27.6	16.5	16.6	16.3	17.9	20.9	16.7	16.3	12.3	16.3	14.8	22.2	14.8	14.5	19.4	19.3	42.6	13.7	16.0	18.1	14.0	12.1	14.4	20.1	13.5	25.0	24.5	21.5	17.3	14.7	21.0	7.3	9.4	16.8	10.2	6.5	8.7	6.6	16.2	8.8	17.5	20.0	11.9	12.4	9.0	14.6	16.1	18.2	18.7	5.9	11.7	9.5	10.1	14.2	8.0	13.4	12.1	12.2	26.2	7.1	14.3	7.6	8.3	13.8	14.5	12.1	7.6	12.7	16.5	12.0	25.2	24.3	16.0	10.2	8.3	11.9	14.5	10.3	10.7	14.0	4.1	10.6	13.3	11.6	17.9	5.6	18.6	10.5	8.1	15.0	12.6	9.4	15.4	8.7	16.4	9.5	15.5	8.6	9.4	9.3	19.9	12.1	9.2	8.4	7.8	16.9	5.7	5.2	8.3	9.0	7.6	10.2	7.6	7.3	8.4	8.0	9.4	6.7	8.7	8.3	16.8	6.5	8.5	6.2	7.8	6.6	17.5	18.3	16.8	25.7	15.8	15.1	16.3	17.9	14.8	13.5	20.8	22.1	26.1	0.0	78.5	12.2	22.9	20.4	9.4	9.1	19.2	7.9	35.2	72.9	0.0	116.8	22.5	30.7	0.0	0.0	36.8	29.4	0.0	28.8	32.6	30.8	9.5	28.6	20.3	24.8	37.2	27.3	19.9	37.1	0.0	22.9	18.6	0.0	23.0	17.3	56.2	10.9	19.4	24.5	37.4	28.3	68.3	54.6	25.5	24.7	0.0
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.6	19.0	31.9	24.7	18.3	14.7	26.1	20.1	18.7	17.3	22.2	18.1	33.9	13.3	30.6	18.7	24.0	17.6	16.9	13.0	23.5	28.2	15.4	17.3	63.2	12.3	12.9	20.5	19.5	17.1	14.4	17.3	19.0	17.9	16.0	14.4	20.7	30.1	15.7	14.4	11.1	15.9	11.6	10.2	13.4	17.3	13.3	19.2	13.5	24.6	13.7	19.9	37.3	20.4	13.1	15.4	17.0	11.1	15.4	21.0	20.5	10.3	14.9	21.1	30.3	19.0	15.5	14.3	14.9	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9	50.6	44.3	66.5	0.0	124.9	104.6	89.0	53.5	62.9	56.9	68.0	62.8	47.1	18.3	0.0	9.4	58.6	66.9	93.5	0.0	24.4	54.5	0.0	48.5	71.6	32.5	128.7	95.5	58.9	54.8	10.0	64.5	39.1	89.4	0.0	73.5	52.7	0.0	56.1	72.2	52.5	79.3	77.6	80.4	84.4	67.3	119.4	68.0	58.0	58.3	0.0
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.4	12.7	34.2	15.3	24.9	32.9	33.1	31.0	31.3	31.9	29.3	26.2	22.2	26.2	14.1	32.2	18.1	23.3	21.0	28.6	40.9	26.8	15.5	35.6	18.4	19.8	24.2	29.1	27.8	29.2	32.7	38.9	33.8	36.4	38.2	19.2	27.0	25.4	32.2	15.1	18.6	27.9	32.3	20.3	18.2	27.7	25.3	21.7	29.3	38.5	20.4	19.1	25.3	18.6	24.8	38.8	21.6	35.4	34.4	34.2	20.6	20.9	17.5	20.2	21.3	35.8	21.2	17.6	31.8	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8	68.5	35.6	53.7	0.0	76.4	37.4	78.7	10.2	57.6	44.3	34.9	25.5	31.0	16.6	0.0	208.1	38.3	17.5	23.3	0.0	29.9	37.4	0.0	53.3	28.0	29.4	46.1	27.6	52.2	38.4	46.0	45.8	42.0	21.9	0.0	24.9	38.9	0.0	17.5	38.5	32.1	34.2	58.2	45.3	77.0	31.7	79.3	37.0	41.5	21.9	0.0
MARCH8	"c-MIR, CMIR, MARCH-VIII, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 106.0;Early spermatids: 508.4;Late spermatids: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014597	Approved					NA	NA					"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	10.0	17.6	13.5	11.4	16.0	28.8	12.1	37.5	12.2	10.3	14.6	24.5	8.5	9.7	14.3	8.2	7.5	11.1	9.9	14.1	12.7	11.8	11.0	16.7	10.3	13.5	19.0	9.3	14.2	18.2	15.1	18.1	13.2	14.5	8.8	12.9	12.9	11.5	11.4	9.0	8.9	18.8	12.4	18.2	14.3	9.7	43.2	14.9	10.5	11.5	8.5	13.6	11.0	8.0	5.3	1.7	13.6	1.8	7.3	4.7	2.4	9.3	9.4	8.0	7.1	11.7	14.6	6.0	4.3	20.1	7.9	8.7	2.4	9.7	13.4	7.4	12.4	7.2	1.7	8.7	7.3	7.4	20.3	9.6	5.2	4.3	5.6	8.1	6.2	23.0	11.9	9.5	4.0	10.7	7.9	12.9	12.9	14.5	13.2	6.1	3.3	6.3	4.0	2.6	1.3	3.0	7.1	8.0	3.9	6.0	5.4	7.1	9.9	8.4	2.0	8.0	8.2	12.4	2.9	8.8	6.3	8.1	9.1	6.7	23.3	18.6	5.9	12.3	8.7	1.6	9.7	1.1	10.0	3.1	1.8	4.7	3.5	3.4	3.3	1.6	5.3	2.7	3.3	13.6	7.3	0.9	1.7	3.1	2.4	13.5	16.0	37.5	12.2	12.7	11.8	19.0	9.3	14.5	14.9	8.9	7.5	13.4	0.0	3.1	6.6	21.0	10.2	6.7	12.5	10.4	106.0	1.7	5.0	0.0	508.4	8.7	20.2	70.0	0.0	1.1	5.6	0.0	17.3	22.5	5.4	11.1	39.0	12.9	15.9	175.4	7.8	7.0	5.0	0.0	11.9	6.3	0.0	10.4	8.5	9.9	23.0	6.5	2.8	21.5	13.4	3.3	1.4	8.3	11.2	0.0
MARCH9	"FLJ36578, RNF179"	ENSG00000139266	"Membrane associated ring-CH-type finger 9"	Q86YJ5	12	57755098-57760407	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.9;Cone photoreceptor cells: 119.8;Horizontal cells: 54.0;Muller glia cells: 63.3;Rod photoreceptor cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	12	"RH-30: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (3.07e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.15e-3)"	"prognostic favorable (1.54e-5)"	"unprognostic (7.76e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	5.9	11.8	11.0	10.7	14.1	6.1	8.8	25.0	16.6	9.5	9.3	7.8	17.5	10.1	6.8	11.9	8.3	9.6	14.3	12.2	10.8	9.9	16.9	5.6	16.5	16.6	7.7	11.0	6.4	14.4	26.3	24.6	10.3	7.4	11.0	9.0	16.8	12.3	17.6	10.5	13.4	12.7	7.0	6.1	19.4	11.6	5.2	6.8	37.6	20.2	6.2	17.8	9.2	7.7	6.8	11.0	2.2	0.7	3.0	6.1	1.3	3.1	1.5	2.4	2.6	0.2	0.0	3.2	0.4	3.3	1.9	1.8	2.0	2.5	7.6	2.6	0.0	3.2	2.8	4.0	3.4	1.2	4.5	4.4	1.0	1.1	1.0	2.3	0.9	1.6	0.4	3.5	0.5	1.9	5.6	0.8	7.7	1.4	7.9	0.5	2.9	4.8	1.1	1.6	2.2	3.4	4.0	110.2	8.2	3.7	2.7	5.6	3.6	0.2	0.2	2.0	1.2	5.6	1.8	0.0	2.4	2.0	1.3	1.5	8.9	4.0	4.7	2.7	0.2	2.4	2.2	0.5	0.1	4.0	0.7	5.9	5.3	6.0	5.2	1.5	6.8	6.1	4.6	0.2	3.0	0.2	11.0	3.6	1.3	11.0	14.1	25.0	16.6	10.8	9.9	7.7	11.0	7.4	6.8	20.8	12.3	17.1	0.0	9.2	72.9	9.4	12.7	1.4	5.7	8.7	119.8	1.6	5.0	0.0	0.3	7.3	5.3	0.0	0.0	0.7	3.1	0.0	2.3	3.9	6.6	54.0	14.6	12.3	1.2	0.8	9.2	3.3	6.8	0.0	8.0	63.3	0.0	2.9	10.6	7.0	188.1	6.5	4.7	2.3	3.4	8.3	0.9	10.1	11.0	0.0
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.6;Cardiomyocytes: 19.9;Cone photoreceptor cells: 29.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 35.7;SuSa: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA					"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	14.3	5.6	11.4	4.6	13.5	0.9	9.0	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5.0	19.1	10.0	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3.0	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5.0	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16.0	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	4.5	1.2	0.0	0.0	1.9	1.5	2.2	1.6	2.4	0.0	0.0	0.0	0.0	0.0	3.3	2.3	9.5	6.2	1.1	0.0	7.0	0.0	2.4	0.0	0.0	0.7	0.9	0.7	5.3	0.0	2.9	0.8	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.5	2.2	0.0	7.1	0.0	0.0	35.7	6.6	5.8	0.3	0.3	0.4	11.1	0.7	0.0	0.0	0.0	3.5	4.8	6.2	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	13.5	15.2	17.5	10.0	12.5	10.3	12.4	13.2	4.6	0.0	0.3	0.5	2.4	3.1	23.6	19.9	0.0	1.4	2.3	3.5	29.5	1.7	0.0	1.6	5.5	3.0	1.1	0.0	0.0	1.8	3.1	1.7	0.0	0.0	0.2	9.5	8.6	4.3	0.3	3.0	2.0	0.0	0.0	0.0	0.2	15.1	0.1	0.0	6.0	0.0	10.6	0.0	15.1	17.9	5.2	2.9	0.8	0.0	0.4	3.9
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.7	15.2	12.5	13.1	6.9	9.0	17.3	9.3	8.9	13.4	10.4	16.3	24.1	16.8	16.4	9.7	14.5	29.5	12.0	14.5	11.6	11.6	9.4	18.5	12.0	10.6	7.7	20.1	24.5	4.9	19.8	12.3	10.7	6.3	11.0	15.9	15.7	19.4	8.8	28.0	21.0	14.3	14.2	18.4	11.1	17.4	9.3	18.6	10.0	18.8	17.2	11.6	16.0	41.1	10.7	14.0	29.9	12.0	10.4	14.2	8.9	18.3	10.3	11.8	12.2	16.5	9.7	10.6	11.3	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7	6.0	5.0	13.9	16.2	22.3	26.0	10.9	35.7	6.7	6.8	19.2	7.9	19.2	1.7	18.5	0.4	11.9	59.3	0.0	18.5	16.8	10.6	28.8	17.3	12.1	15.7	19.1	28.7	13.5	19.5	0.7	11.8	11.3	3.3	8.2	35.1	19.1	20.0	35.9	10.3	6.9	17.8	19.4	9.2	8.4	21.8	30.1	54.3	23.6	28.2	30.9
MARK3	"CTAK1, KP78, PAR-1A"	ENSG00000075413	"Microtubule affinity regulating kinase 3"	P27448	14	103385392-103503831	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	14	"eosinophil: 42.2"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 42.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024652	Approved					NA	NA					"HPA024652: AB_1853582"	"unprognostic (6.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.60e-1)"	20.8	31.9	24.6	20.9	29.5	62.7	19.7	59.1	30.2	25.3	20.8	33.2	19.9	17.4	28.5	28.4	24.4	23.1	22.2	33.6	24.9	22.4	20.3	20.1	25.9	20.8	29.6	23.3	24.6	30.7	28.1	30.9	20.5	27.4	19.3	20.0	23.6	18.3	23.1	40.9	19.9	19.2	26.8	20.9	26.8	26.9	24.1	30.3	29.1	25.8	23.1	23.0	20.8	29.0	1.2	1.2	42.2	1.1	0.8	1.8	0.4	13.4	16.3	23.7	17.9	28.5	22.3	20.5	23.8	25.2	28.9	27.8	12.8	21.1	16.0	15.1	22.4	12.5	25.3	25.9	25.7	36.9	18.6	11.5	20.7	17.3	16.0	53.8	23.5	13.8	25.9	23.8	23.4	47.9	26.4	26.7	16.0	21.2	37.4	21.6	36.0	16.1	20.9	17.4	22.7	24.6	21.1	24.3	12.8	25.5	28.6	20.9	20.9	25.3	17.4	23.2	28.1	23.6	20.2	23.0	15.5	11.1	28.9	21.2	24.2	30.7	19.2	18.9	19.0	20.9	0.4	1.1	42.2	1.1	0.8	0.9	1.2	1.6	1.8	1.1	0.9	1.8	1.4	3.1	0.8	0.7	1.2	1.6	0.4	24.6	29.5	59.1	30.2	24.9	22.4	29.6	23.3	27.4	30.3	53.6	64.4	40.2	43.5	39.3	70.1	69.8	35.7	25.4	52.4	36.6	153.2	26.8	10.0	40.4	26.7	50.1	30.4	186.9	36.6	26.3	42.6	53.5	47.3	26.8	26.4	55.6	30.0	47.3	26.0	38.0	56.4	44.1	35.4	50.5	28.7	36.1	46.0	29.2	55.5	15.8	90.5	32.3	43.7	40.2	55.6	45.7	41.1	42.6	28.4	99.3
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305283	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	11.8	13.0	19.4	10.3	26.0	8.4	15.2	21.9	28.6	11.4	10.2	9.0	12.9	6.6	14.0	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21.0	16.8	13.7	12.9	12.1	15.0	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1.0	2.8	3.5	2.9	1.8	4.3	1.2	8.9	3.8	15.1	11.0	10.8	17.2	4.2	6.6	10.4	9.9	9.3	2.3	5.1	4.3	5.7	12.1	8.2	6.1	10.7	9.7	5.6	7.9	8.8	8.6	4.7	8.2	19.9	2.1	7.5	21.4	13.8	8.3	9.6	17.5	13.2	9.6	10.9	10.8	10.7	7.5	7.6	6.7	6.5	7.4	3.3	29.6	4.9	2.8	9.3	7.2	28.4	12.5	9.8	8.7	5.1	15.3	4.1	12.5	10.7	8.9	6.8	6.0	4.3	12.1	9.6	4.9	9.5	4.0	7.1	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1.0	2.3	2.6	2.9	1.8	2.0	2.8	2.4	1.2	19.4	26.0	21.9	22.7	22.2	15.7	14.3	21.6	15.0	12.3	11.9	1.9	3.0	9.5	22.1	20.9	7.3	10.2	0.0	2.3	8.7	23.6	3.3	10.0	7.8	2.1	10.5	3.3	0.0	5.3	1.1	7.5	8.5	2.3	10.9	5.8	112.8	5.8	18.4	8.4	4.1	15.0	6.1	3.3	2.8	6.0	13.2	7.3	3.2	13.1	5.6	14.6	0.0	7.3	0.5	6.1	21.1	9.6	6.9	3.4	14.0
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 3.6;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51.0	40.1	1.1	1.5	1.4	0.0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0.0	1.2	0.0	1.3	1.2	0.2	0.4	0.0	0.0	0.2	0.0	3.6	0.1	2.2	1.0	1.0	15.0	0.0	0.0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.7	0.0	2.5	0.0	4.4	0.0	0.0	2.5	2.9	0.3	3.6	1.6	0.0	0.8	0.8	0.3	0.0	0.5	0.5	0.8	0.0	9.8	3.1	1.9	0.0	0.5	1.5	0.4	4.5	0.4	4.6	9.9	3.0	5.1	0.2	0.1	26.5	13.2	0.5	0.9	2.7	0.8	2.4	1.3	0.0	1.8	2.8	2.0	0.5	10.8	8.6	2.1	3.3	2.0	0.1	0.0	0.2	0.0	0.0	0.2	3.6	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	2.0	0.1	20.4	13.6	51.0	34.3	16.1	16.3	8.8	19.5	19.9	2.7	0.0	3.7	0.0	1.9	0.8	22.6	0.8	0.0	1.4	0.0	0.0	41.2	0.4	0.0	0.1	13.0	1.0	0.7	0.0	0.4	0.4	0.7	0.9	1.1	0.8	0.2	14.3	0.0	0.6	1.2	6.5	0.6	1.0	5.0	0.0	0.0	3.6	0.3	2.9	1.1	0.1	18.7	0.0	0.8	2.8	4.1	1.3	0.2	1.0	0.4	0.6
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	14.9	12.1	12.3	9.4	16.1	23.1	13.6	16.0	11.6	14.8	16.5	13.9	4.9	23.4	7.5	19.5	30.0	7.4	14.8	9.1	15.7	11.2	8.0	10.6	13.7	12.7	14.0	5.6	13.6	17.7	11.8	24.8	19.8	18.6	13.8	6.1	8.1	7.2	17.6	10.2	8.2	5.8	10.1	10.1	13.9	12.2	20.6	4.4	7.7	8.1	17.1	10.1	18.8	24.6	8.0	14.1	11.2	5.6	13.4	28.7	18.5	14.9	15.8	9.7	8.7	8.5	19.1	7.7	11.8	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8	0.0	1.3	0.0	4.2	3.8	14.9	43.3	2.5	1.4	7.9	3.5	51.1	4.4	1.7	4.2	27.6	5.3	45.1	0.0	5.4	4.0	6.6	7.8	0.0	5.6	5.5	4.8	11.6	3.1	1.6	44.9	8.3	6.4	6.8	1.0	18.3	3.0	6.7	26.6	9.6	4.2	12.7	6.5	6.1	28.4	11.7	2.4	4.6	1.9	18.1	6.0
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.5"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 21.5;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.6	3.5	20.7	8.3	36.1	12.3	1.8	1.1	72.5	3.8	5.3	19.0	0.2	9.1	3.6	4.9	2.2	4.9	3.1	2.1	19.7	9.3	3.6	6.4	4.6	9.9	13.0	33.6	4.6	14.3	7.1	7.7	2.6	13.0	2.7	4.4	0.7	4.6	4.2	2.6	6.9	8.8	3.0	7.9	11.4	3.9	2.1	12.5	1.8	2.4	0.3	9.4	3.3	2.4	4.4	10.3	23.2	9.7	5.8	8.4	3.1	3.3	5.0	2.3	10.1	6.8	5.5	5.5	3.4	2.2	2.4	3.5	5.0	4.7	8.7	5.2	3.4	2.6	1.8	3.3	1.9	1.7	7.4	4.1	4.0	5.2	7.9	5.8	2.1	13.3	6.3	5.7	3.6	1.4	3.3	1.1	6.0	4.0	5.7	2.7	6.0	4.4	7.0	2.4	7.4	6.2	12.1	2.0	6.4	1.8	1.5	3.8	6.2	4.8	2.8	2.0	1.7	3.2	4.9	4.0	3.1	3.3	13.0	1.4	6.2	8.4	8.0	6.8	11.2	2.8	0.1	4.5	9.4	8.4	5.6	6.2	4.1	4.7	3.3	2.1	4.4	3.7	6.4	23.2	5.8	9.7	10.3	5.0	3.1	20.7	36.1	1.1	72.5	19.7	9.3	13.0	33.6	13.0	12.5	6.0	10.3	7.8	0.7	0.5	3.2	1.1	7.6	0.0	3.4	8.7	2.0	0.5	3.3	2.8	9.1	1.6	20.0	0.0	9.2	1.2	2.2	0.8	2.3	12.5	6.9	0.0	2.4	7.4	21.5	24.6	3.7	7.9	5.0	6.4	6.9	0.8	6.1	8.6	6.3	8.7	0.6	0.0	1.8	0.6	2.8	1.9	0.3	9.6	8.6	0.6
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5.0	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6.0	8.2	10.7	5.0	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.6	4.2	2.1	0.1	6.9	6.2	5.0	1.7	2.6	0.6	0.5	3.8	2.1	0.5	3.6	1.4	1.6	6.9	6.4	17.8	0.7	22.6	2.1	18.7	2.4	1.6	0.5	0.0	6.6	10.3	9.8	3.9	7.9	7.3	14.1	1.7	1.8	2.1	4.8	6.6	2.7	0.1	1.4	0.6	3.4	0.6	1.8	0.4	1.7	22.9	3.0	2.4	2.3	0.9	0.1	1.5	1.5	0.1	13.5	1.6	2.3	2.5	2.9	5.5	2.4	0.1	4.3	0.0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5.0	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5.0	29.8	44.7	9.0	428.6	327.4	18.2	114.6	17.8	29.4	59.1	17.4	2.0	33.2	31.5	46.4	104.5	72.0	17.3	0.0	103.5	42.2	34.0	324.3	92.3	37.2	4.6	7.9	30.9	60.2	6.0	92.7	38.3	9.8	45.5	2.8	14.9	56.5	55.6	15.6	30.8	73.9	3.5	38.8	35.8	11.4	8.5	348.9	114.8	15.2	15.0	641.7
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.9	9.6	18.4	6.8	2.8	4.2	10.9	17.9	7.5	29.7	36.6	11.6	12.0	9.6	6.8	7.5	14.4	11.6	11.7	7.1	21.1	8.1	11.3	11.3	6.7	6.7	1.6	4.3	8.5	2.5	3.2	17.9	3.5	3.9	6.4	7.8	8.6	21.6	18.0	7.9	14.0	4.7	13.7	6.7	3.9	9.0	30.7	7.9	7.3	4.5	8.2	11.8	11.3	7.6	7.9	12.7	7.6	9.1	5.5	7.4	15.6	18.9	15.7	2.6	4.2	14.1	8.1	13.1	6.1	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3	6.0	8.5	7.2	4.0	9.7	1.9	1.6	0.0	4.0	9.1	1.8	0.0	3.3	0.0	3.2	1.7	3.6	3.0	0.0	2.2	20.7	5.8	3.3	12.7	1.7	5.1	3.2	4.1	2.5	12.0	1.5	2.8	5.6	0.0	1.8	3.4	1.5	3.6	1.9	2.5	1.4	0.9	0.0	5.9	11.2	16.4	8.7	5.1	8.7	3.5	5.9
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808176-68850686	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 95.6;U-698: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000086: AB_563872, CAB016303: AB_627920"	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	16.6	15.3	11.1	12.5	10.8	23.1	12.5	12.0	11.3	13.1	16.6	13.6	11.9	5.2	8.8	9.4	14.2	12.6	12.3	9.0	8.8	8.6	11.2	25.7	15.9	13.3	14.2	7.1	11.0	21.4	11.4	10.4	24.5	11.9	12.6	21.5	7.8	10.5	11.1	19.5	9.8	7.2	10.8	10.8	15.3	9.8	6.5	11.5	29.5	13.6	10.8	14.1	13.5	12.6	4.9	4.0	19.3	6.4	3.6	4.4	3.0	3.1	7.5	7.9	3.9	10.2	9.5	40.2	8.9	8.9	4.7	7.6	4.5	1.4	33.3	2.5	5.8	1.3	1.9	5.4	95.6	7.6	8.8	3.7	6.1	6.3	20.2	10.0	5.4	5.6	14.6	8.2	18.7	12.8	4.7	13.2	5.8	6.2	8.1	9.0	5.1	7.1	1.8	6.6	1.6	1.4	25.3	5.4	2.7	2.9	26.6	6.0	3.5	5.6	4.4	1.9	16.7	10.4	3.6	14.1	3.6	6.8	2.9	3.1	12.3	7.8	91.9	5.5	2.1	14.7	5.3	5.4	4.8	4.4	4.0	3.9	4.7	3.7	4.1	2.8	4.9	4.0	3.7	19.3	3.6	6.4	4.0	3.8	3.0	11.1	10.8	12.0	11.3	8.8	8.6	14.2	7.1	11.9	11.5	29.8	48.8	22.9	24.5	13.9	27.9	17.8	25.5	97.7	62.6	24.4	31.4	43.9	11.6	18.1	1.1	20.2	16.6	0.0	20.8	23.6	22.4	34.7	31.3	38.4	16.5	28.6	24.1	22.1	44.9	1.8	17.8	21.8	11.8	31.5	23.5	26.4	19.8	20.1	14.2	15.3	34.5	19.4	21.7	13.9	20.6	19.3	78.8	25.4	19.7	74.5
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451286	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm		NA	NA		170000	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: AB_2681962"	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	16.4	13.8	11.8	14.8	13.7	15.5	15.1	19.8	16.5	16.9	14.6	18.8	9.3	10.3	17.9	9.7	15.0	14.3	10.9	12.8	11.6	10.5	13.0	13.3	12.3	17.7	12.0	10.3	22.2	16.2	34.5	21.1	16.5	14.5	12.5	14.2	16.5	13.4	11.6	19.5	16.1	14.1	17.1	14.0	20.4	13.0	15.1	12.1	34.1	13.2	12.1	22.5	16.6	13.4	6.6	4.9	4.4	4.0	5.0	6.1	2.7	8.1	11.0	13.8	9.4	10.1	10.3	11.1	10.0	10.9	13.8	13.5	10.5	8.1	22.0	11.4	12.4	15.8	16.2	16.5	9.9	21.9	21.2	13.8	13.8	10.4	10.5	10.9	24.6	14.6	9.7	10.1	16.9	24.7	8.5	11.7	12.6	17.7	11.9	11.2	4.6	22.9	9.3	8.9	7.9	6.5	17.2	18.6	9.4	8.1	9.5	8.8	10.0	13.2	87.5	11.5	12.3	16.2	14.1	10.4	10.7	13.4	11.9	17.6	10.9	14.6	22.7	10.6	12.1	13.1	3.2	4.0	4.4	5.2	3.9	5.8	6.6	5.5	5.8	4.0	6.4	5.4	6.1	3.3	5.0	2.6	4.9	3.3	2.7	11.8	13.7	19.8	16.5	11.6	10.5	12.0	10.3	14.5	12.1	23.8	11.5	11.9	11.5	24.2	13.6	16.9	10.2	17.4	26.1	8.7	13.7	14.5	3.3	10.8	5.0	19.6	9.5	0.0	10.3	10.6	16.0	13.2	9.2	17.0	12.9	11.1	13.2	17.8	21.9	6.6	13.6	14.7	20.3	10.0	14.1	12.3	11.8	10.5	17.0	7.2	10.5	19.4	13.7	18.4	18.1	28.5	18.5	20.0	16.0	14.0
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain					NA	Yes					"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.6	18.4	24.8	14.6	3.4	5.9	14.4	26.5	18.7	37.2	45.9	14.0	14.1	11.9	8.5	13.0	32.5	12.3	21.6	16.6	41.1	32.5	8.6	9.4	21.8	14.0	1.3	14.5	11.9	2.1	3.0	28.6	16.3	4.8	18.7	18.6	11.9	19.1	30.4	11.9	18.0	6.8	19.8	16.1	14.4	16.7	16.7	7.6	11.4	12.0	16.8	12.5	14.1	13.6	8.6	14.4	11.4	6.9	9.2	20.1	25.4	16.9	24.1	3.8	13.6	17.9	12.7	10.8	27.2	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4	0.0	0.0	0.0	0.4	4.0	0.0	0.3	0.0	1.4	2.3	0.0	0.0	4.2	0.0	0.8	1.8	0.0	1.2	0.0	1.0	36.8	2.1	0.2	0.0	0.2	8.4	0.0	0.0	1.3	0.6	1.8	1.1	2.3	0.0	5.4	1.3	0.0	1.1	2.9	0.0	0.0	0.0	0.0	0.9	10.2	19.0	1.5	7.4	0.0	3.7	1.4
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	6	"RH-30: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	12.2	16.6	6.7	13.8	8.8	8.4	12.3	2.2	6.9	7.6	7.6	4.5	10.8	3.3	9.4	21.2	10.3	9.0	10.7	8.1	5.8	5.0	20.9	15.3	7.7	8.8	7.4	4.6	17.6	34.9	10.9	10.6	8.3	6.5	11.0	10.3	5.3	17.9	17.2	20.4	8.5	5.7	10.5	5.0	8.2	7.3	11.4	5.4	4.5	15.1	15.6	9.8	8.8	7.8	6.1	12.6	0.7	6.7	7.3	18.6	5.1	6.1	11.2	4.7	4.3	6.4	4.4	6.4	6.6	6.0	11.1	6.0	7.8	8.6	7.4	12.3	8.0	6.3	7.3	7.2	10.2	10.8	4.4	8.4	8.6	4.3	9.5	4.5	9.3	4.5	3.9	9.3	12.4	8.7	5.4	5.9	4.8	7.9	7.4	5.6	11.9	6.5	11.1	11.1	8.2	11.3	5.8	78.7	10.9	9.7	7.7	5.0	4.5	6.9	7.6	6.1	4.9	10.0	8.8	4.4	4.5	5.0	7.9	8.7	3.4	2.5	9.0	6.4	6.7	9.3	0.0	4.7	0.0	5.3	6.7	18.6	4.7	6.9	6.5	10.3	6.1	9.5	9.2	0.7	7.3	1.1	12.6	3.3	5.1	6.7	8.8	2.2	6.9	5.8	5.0	7.4	4.6	6.5	5.4	8.9	3.5	8.9	11.4	9.3	2.9	3.6	2.5	1.4	17.0	5.2	0.0	15.0	21.6	15.2	11.3	7.1	1.3	0.0	20.6	19.6	12.0	7.7	12.7	9.0	22.2	3.2	6.3	4.3	1.0	8.6	10.3	9.0	6.8	27.1	5.6	1.6	12.8	0.0	4.6	53.6	5.5	0.0	14.7	4.8	14.7	9.2	8.1	4.3	9.1	10.5
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29.0	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24.0	9.0	13.2	10.0	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22.0	15.6	19.7	17.4	9.6	15.6	6.5	11.0	12.0	10.4	10.6	13.2	12.1	8.0	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16.0	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9.0	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
MGEA5	"MEA5, NCOAT, OGA"	ENSG00000198408	"Meningioma expressed antigen 5 (hyaluronidase)"	O60502	10	101784443-101818465	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA036141: AB_10672079, HPA076501: AB_2686802"	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	29.5	17.5	51.9	27.4	54.4	49.3	35.5	58.9	51.4	24.5	27.0	29.0	20.9	17.6	29.9	36.8	26.0	23.3	19.1	27.4	46.0	29.8	27.7	28.6	24.0	40.1	30.7	43.6	33.8	20.9	53.3	22.1	25.5	42.6	31.6	26.5	30.7	24.4	26.3	25.4	36.6	28.5	37.4	29.5	35.2	23.9	21.9	35.4	32.9	25.9	11.8	39.5	34.3	26.7	8.1	3.3	14.7	5.6	6.8	7.1	1.4	30.8	15.7	23.0	44.6	14.8	36.0	16.0	21.7	22.0	10.1	17.5	11.5	19.8	20.7	15.9	25.9	17.5	22.3	21.5	27.4	21.6	30.2	14.7	20.6	21.9	9.0	16.0	15.2	11.7	34.7	30.8	17.4	41.5	29.1	18.8	18.9	14.5	38.4	17.2	15.7	16.0	15.9	12.7	6.7	16.0	22.3	25.4	15.1	17.0	28.0	10.0	17.7	19.5	10.5	27.1	22.0	27.8	16.6	28.4	15.7	15.2	22.7	24.8	19.2	30.5	16.5	19.7	26.2	8.5	10.5	2.1	6.8	7.1	2.0	5.6	6.4	4.9	6.1	1.3	8.1	6.8	5.7	14.7	6.8	5.6	3.3	4.5	1.4	51.9	54.4	58.9	51.4	46.0	29.8	30.7	43.6	42.6	35.4	107.2	86.7	52.8	42.9	64.5	144.1	0.0	63.7	61.6	70.5	0.0	265.1	31.5	0.0	0.0	86.9	51.4	61.9	23.3	0.0	23.6	49.2	69.4	73.0	70.0	33.8	74.7	86.1	95.8	62.6	94.2	73.4	62.1	62.4	0.0	53.3	63.6	0.0	48.9	59.4	0.0	132.6	25.8	55.6	20.2	36.6	81.8	42.6	117.6	48.7	51.0
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467184-129768007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	11.7	11.3	7.4	15.5	7.6	7.1	11.3	3.5	9.1	8.3	12.2	10.0	19.6	10.8	15.3	17.1	9.9	15.2	14.1	10.5	7.1	7.1	12.6	45.6	7.5	11.6	8.6	6.6	12.3	16.5	5.7	5.8	4.5	9.2	11.2	3.4	11.8	14.9	24.5	14.4	9.2	9.6	10.9	8.1	8.6	9.9	11.7	3.9	16.0	10.2	14.9	14.7	12.6	13.0	20.3	17.7	6.5	15.3	18.2	21.2	16.6	0.0	2.5	2.7	13.0	5.7	11.8	10.2	5.7	6.4	4.2	4.1	15.8	16.9	11.8	9.2	7.4	0.0	7.7	1.7	6.1	1.9	0.0	1.0	2.3	5.8	10.1	8.8	0.2	6.8	7.5	0.0	2.4	0.0	0.0	0.0	20.0	0.0	8.3	5.1	21.3	9.3	12.1	0.6	10.9	10.2	10.8	0.0	4.6	7.8	5.8	2.7	6.8	6.9	2.8	0.0	2.2	11.2	9.2	0.0	5.5	2.8	0.0	0.0	0.0	0.0	6.0	0.0	3.8	0.0	2.6	15.3	6.5	19.1	14.8	18.6	20.3	17.5	17.8	15.8	19.9	17.6	18.9	1.8	18.2	13.7	17.7	21.2	16.6	7.4	7.6	3.5	9.1	7.1	7.1	8.6	6.6	9.2	3.9	11.9	14.7	57.0	56.4	45.4	15.7	37.8	86.6	57.6	15.9	97.7	7.9	41.1	107.8	40.8	70.9	48.0	68.8	23.3	51.1	53.2	48.9	49.8	64.5	419.1	76.3	14.3	52.4	98.2	75.3	90.6	62.5	39.9	62.4	45.9	56.4	33.9	74.4	47.0	51.9	227.8	39.0	45.3	55.7	43.1	97.3	37.3	22.4	67.1	59.6	48.8
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.3	25.4	13.2	13.4	7.9	7.7	17.9	11.4	8.1	9.6	8.2	16.7	12.8	15.7	14.8	13.8	7.2	8.5	10.4	9.4	2.9	21.8	11.6	8.6	17.7	23.0	14.5	12.4	21.4	14.3	6.1	13.4	5.7	6.9	9.2	10.4	12.5	11.5	6.6	23.3	12.9	16.6	19.4	7.5	11.1	23.7	6.9	21.1	8.5	15.6	21.1	17.5	19.0	20.5	11.4	6.6	12.4	12.3	16.2	18.0	10.0	50.5	9.8	18.3	14.2	10.6	7.6	12.5	12.9	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5	23.8	30.6	16.0	25.4	8.1	26.6	8.9	20.4	5.3	6.8	17.4	41.2	19.1	5.0	16.7	16.3	14.6	24.5	0.0	19.7	14.0	16.1	20.3	13.9	27.7	25.8	23.8	35.5	14.1	21.9	20.6	24.7	20.4	20.3	31.5	18.9	21.5	25.2	18.6	23.3	11.0	28.4	0.0	13.7	9.6	11.8	14.3	28.6	21.3	18.7	22.0
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.5	3.4	16.8	11.7	9.0	10.8	4.0	6.9	7.8	5.0	7.3	5.0	3.2	7.3	6.4	9.6	5.4	5.8	9.7	9.4	11.3	9.6	4.5	8.2	4.4	6.9	7.3	16.6	3.5	6.9	10.4	5.8	14.9	7.3	12.4	2.9	11.2	21.7	7.7	4.2	8.0	6.3	4.2	5.3	4.5	52.4	13.9	18.1	8.5	7.6	5.5	13.6	11.9	5.6	6.1	8.9	3.9	10.9	10.6	12.8	6.4	5.3	9.2	11.4	4.0	11.3	5.4	10.6	7.6	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1	44.7	17.7	5.9	14.0	19.5	29.4	15.1	20.4	21.4	34.2	15.7	23.6	10.7	3.3	11.3	3.3	22.5	10.5	0.0	11.2	6.2	22.6	33.3	13.9	26.3	10.8	14.3	23.1	21.5	18.7	3.7	19.0	11.5	25.3	5.4	15.4	16.5	16.7	5.8	23.3	14.4	14.7	0.0	23.4	16.7	11.5	21.5	21.2	10.1	9.4	14.4
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 116.3;Late spermatids: 190.0;Suprabasal keratinocytes: 110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.4;SCLC-21H: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced					NA	NA					"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.6	0.9	0.4	1.5	1.8	0.6	9.3	3.1	1.4	1.0	2.3	1.3	1.7	0.7	4.5	0.9	0.4	13.4	0.5	2.1	0.0	3.5	5.7	0.5	1.9	1.3	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.6	0.5	3.1	2.7	1.2	0.3	1.0	3.6	8.4	1.2	1.7	10.6	6.2	1.9	9.1	0.1	0.8	14.3	5.2	5.3	0.8	5.1	0.3	1.0	3.3	0.6	1.0	2.2	5.2	0.9	6.9	2.0	1.8	2.4	2.7	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8	0.0	9.6	13.2	14.2	116.3	32.0	9.8	12.7	4.0	7.9	22.7	11.8	8.6	8.3	6.8	52.0	10.0	36.6	0.0	1.1	7.0	10.3	10.7	20.7	9.2	5.8	25.4	14.5	13.5	6.2	190.0	19.5	6.4	16.9	3.6	25.0	25.0	5.9	42.1	14.9	18.1	35.7	0.0	16.8	22.9	43.2	110.2	12.6	52.2	28.9	15.9
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 65.2;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 57.2;AF22: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.3	57.2	43.3	6.6	2.5	3.6	5.3	7.7	6.5	8.0	8.2	10.5	3.7	4.2	2.5	7.0	22.4	8.5	3.5	5.4	6.0	0.2	5.2	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.5	7.6	1.9	0.6	0.7	3.1	2.0	1.6	0.1	13.8	1.6	4.2	1.2	11.0	0.0	5.9	11.4	3.0	1.1	3.3	9.8	3.6	14.6	6.8	0.0	4.8	2.6	0.3	13.4	6.8	0.6	0.3	0.1	5.7	0.0	12.9	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1	32.8	16.5	0.0	25.6	19.1	7.7	4.1	7.6	14.7	21.6	22.7	17.7	7.1	1.7	12.3	1.5	24.5	14.4	0.0	7.5	22.8	11.8	5.9	1.1	5.4	1.4	65.2	11.6	85.3	4.4	4.5	27.9	1.1	3.3	0.0	8.1	44.8	5.7	14.4	38.9	1.4	2.5	6.5	2.3	0.2	1.9	8.8	16.7	0.0	18.0	51.2
MINK1	"B55, MAP4K6, MINK, YSK2, ZC3"	ENSG00000141503	"Misshapen like kinase 1"	Q8N4C8	17	4833388-4898061	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056296	Approved					NA	NA					"HPA056296: AB_2683090"	"unprognostic (2.80e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.77e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (8.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.62e-1)"	12.7	14.8	31.4	18.2	46.8	14.9	14.2	30.8	43.5	15.2	26.0	32.6	8.8	33.1	12.4	7.7	40.0	14.3	15.6	9.0	28.4	12.8	13.8	10.0	23.3	17.1	28.6	27.3	27.5	21.5	16.5	15.4	17.4	29.0	14.3	20.7	14.5	21.1	11.3	8.3	47.3	31.1	11.4	24.8	20.0	22.3	14.5	30.9	9.0	12.7	14.6	16.8	14.9	24.1	2.6	1.2	6.4	1.6	0.3	3.0	2.3	18.8	34.5	8.0	13.1	12.8	9.3	23.2	15.0	13.8	12.0	10.1	13.1	13.1	13.4	17.4	15.8	11.9	38.2	6.0	27.1	5.9	19.3	16.8	9.6	21.9	10.2	8.4	3.5	18.8	9.9	20.3	11.3	10.5	10.2	13.0	4.5	10.3	11.7	8.8	11.2	5.7	8.1	6.3	12.3	11.2	7.2	6.7	8.1	18.4	19.3	8.4	6.7	15.6	13.0	9.8	9.2	11.7	4.9	18.7	12.8	5.8	21.7	14.3	6.7	5.4	2.7	11.5	7.7	8.6	0.0	1.6	6.4	2.7	1.6	3.0	2.6	2.8	2.1	1.2	1.5	2.0	0.8	1.3	0.3	0.8	0.8	2.8	2.3	31.4	46.8	30.8	43.5	28.4	12.8	28.6	27.3	29.0	30.9	0.0	1.3	1.9	12.1	36.5	6.4	1.4	12.7	1.4	3.4	5.2	37.3	15.1	5.0	7.8	2.6	8.8	31.0	0.0	9.0	10.5	7.3	11.7	8.1	8.1	17.6	12.7	18.0	13.5	12.1	5.4	15.0	8.8	15.1	45.1	29.6	6.5	11.9	42.1	13.8	7.5	15.5	12.9	4.4	5.0	9.4	52.9	16.4	6.9	27.3	18.7
MKNK1	MNK1	ENSG00000079277	"MAP kinase interacting serine/threonine kinase 1"	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.3"	"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	17.6	12.0	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11.0	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7.0	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11.0	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6.0	33.3	12.1	5.0	22.0	6.1	19.5	13.2	8.8	9.7	7.9	11.7	11.7	9.9	9.9	12.0	16.4	15.3	8.0	12.9	12.2	9.9	13.5	23.7	14.7	16.2	12.9	22.2	13.0	27.3	15.2	13.0	12.3	14.6	22.2	15.4	11.2	15.6	8.6	6.5	14.0	15.9	14.2	9.5	6.5	12.8	10.4	13.0	6.0	11.3	15.7	9.6	18.4	12.9	12.9	20.5	6.2	5.5	19.1	17.3	16.0	18.3	11.7	16.3	11.4	4.4	0.9	13.6	11.0	8.1	13.5	11.0	8.5	18.8	8.0	3.9	12.1	14.3	7.5	11.5	22.0	4.6	6.6	6.8	6.0	4.9	4.8	7.0	33.3	5.0	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7.0	9.9	9.8	11.0	8.7	11.9	22.1	17.5	15.7	12.4	17.9	15.5	15.3	10.7	18.2	21.0	2.0	19.4	6.6	16.1	13.0	14.3	23.5	23.3	32.1	29.7	19.5	15.8	11.5	20.2	113.5	17.5	16.1	18.4	71.2	17.5	19.8	58.2	10.1	16.2	11.9	6.5	28.0	14.0	34.3	10.2	4.6	6.5	14.4	16.8	15.5	9.7	15.4	24.9	14.7	19.5
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAP kinase interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11.0	21.7	33.3	7.5	5.7	10.3	22.0	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13.0	7.0	27.8	16.7	9.1	9.1	16.0	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8.0	6.1	7.5	2.2	13.4	15.1	6.4	14.1	47.8	17.4	14.4	7.9	5.7	5.7	5.8	9.7	23.5	19.0	11.0	16.0	5.9	16.6	8.1	23.2	2.6	25.8	7.5	7.7	12.7	10.3	80.4	15.0	13.8	18.4	56.5	10.8	23.0	13.3	13.5	12.8	13.1	34.0	3.9	7.8	8.9	12.5	16.8	10.2	16.5	17.2	1.8	23.9	10.1	8.7	8.9	10.6	18.7	27.6	34.0	7.5	11.4	18.6	20.2	2.1	8.2	8.4	9.5	55.3	21.4	18.5	16.8	11.3	3.8	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8.0	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1	35.7	53.3	43.1	91.9	73.3	45.8	46.4	30.6	16.0	11.4	34.9	23.6	21.3	8.3	25.3	6.2	35.4	94.0	23.3	48.2	31.0	32.0	121.4	28.8	50.0	30.9	39.7	144.2	58.3	34.6	10.0	18.7	27.4	54.0	19.8	92.4	38.7	46.8	69.1	19.1	18.2	43.0	19.4	34.0	15.5	21.8	102.4	47.3	39.5	64.3	110.6
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	28.4	22.0	17.2	25.5	27.3	23.9	24.3	19.6	25.5	15.5	17.9	9.0	30.0	20.7	30.8	19.1	31.0	13.9	19.3	21.6	19.7	40.9	16.7	21.5	13.2	16.6	22.0	18.4	33.2	23.8	32.6	17.4	16.5	25.6	15.4	14.3	16.9	26.1	14.8	24.5	21.5	32.9	44.2	24.0	16.3	15.6	14.7	31.6	24.8	33.0	23.8	24.6	24.6	33.4	35.1	26.5	16.4	16.0	21.8	10.9	8.7	26.5	17.9	62.3	45.6	18.1	31.2	28.9	22.4	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2	47.6	30.4	57.3	58.0	72.9	58.8	51.3	63.7	33.5	43.3	40.1	33.4	63.4	87.9	55.8	227.6	33.8	112.4	256.9	59.7	76.6	47.0	74.5	36.9	38.9	53.2	112.8	93.6	40.5	91.7	263.0	61.5	68.3	65.8	87.4	100.7	52.1	52.9	123.8	58.7	39.1	43.2	45.3	49.5	153.2	47.1	83.4	115.4	66.0	96.2	100.8
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 562.3;Late spermatids: 587.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.5	14.9	11.2	23.3	22.7	28.8	16.7	17.9	21.3	17.9	12.0	10.7	15.3	9.6	18.4	9.8	6.6	19.3	16.4	19.0	17.3	16.3	21.8	14.3	16.1	26.9	21.4	9.9	25.2	15.3	24.8	15.6	19.1	17.4	21.3	20.3	21.7	18.3	15.2	26.2	11.1	9.9	10.5	22.0	25.3	14.4	17.2	14.9	14.3	8.7	14.8	14.5	7.4	14.8	11.0	16.8	19.0	17.6	14.6	14.3	17.3	22.6	16.5	33.7	32.8	15.8	25.7	21.9	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7	17.9	8.1	9.3	8.8	8.5	14.5	12.1	2.5	17.4	11.4	5.2	3.9	16.1	16.6	13.6	562.3	11.6	7.3	0.0	14.7	16.7	10.4	6.8	18.5	5.4	13.3	11.1	2.4	6.7	9.8	587.8	19.0	7.9	15.1	24.4	11.9	18.1	12.7	12.9	19.4	8.1	12.4	12.9	14.7	60.0	42.8	8.2	13.5	9.6	11.4	7.9
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 16.0;K-562: 17.1"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.6	3.3	3.0	3.1	0.0	0.0	7.0	0.3	0.0	2.8	1.9	8.3	0.0	0.2	0.1	0.0	6.2	8.0	1.3	0.0	0.7	0.0	0.3	6.7	8.9	0.3	0.1	7.8	6.0	0.1	0.0	5.8	0.0	1.2	0.0	16.0	17.1	7.3	0.8	0.0	8.2	3.4	0.0	4.4	10.1	5.9	1.1	4.1	0.0	0.1	0.7	2.4	0.0	3.4	0.0	0.2	2.6	2.3	0.0	7.8	6.6	0.4	5.5	9.2	11.3	5.5	4.5	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3	0.0	0.0	0.0	1.1	0.5	12.6	0.4	0.0	0.0	0.0	0.0	23.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.4	0.0	0.0	0.4	0.0	6.4	0.0	1.2	2.4	1.0	0.0	0.5	0.0	0.0	0.4
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027292			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.4	3.0	0.4	1.7	0.7	2.5	0.7	7.0	2.0	10.1	12.2	0.2	8.4	2.6	0.5	1.3	2.2	0.7	0.6	3.6	28.6	2.9	2.6	0.6	0.4	2.3	3.1	0.3	3.4	2.1	0.9	72.8	6.7	7.9	0.3	0.5	0.6	0.1	6.6	2.3	0.2	90.6	0.1	1.5	7.4	0.4	0.2	0.0	4.1	0.1	1.1	0.7	1.2	0.4	19.6	0.1	2.1	0.2	0.2	38.5	1.9	1.4	2.2	0.2	0.4	0.2	7.7	0.2	17.4	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2	17.9	17.4	0.5	6.5	9.5	36.2	12.2	10.2	214.2	43.3	12.2	174.7	1.0	5.0	7.0	171.0	6.7	3.8	0.0	14.2	2.1	7.6	3.6	3.5	1.7	2.0	15.9	4.6	7.4	1.8	130.3	28.1	4.2	75.9	0.0	2.0	58.0	5.6	0.0	15.2	8.1	441.5	25.8	12.1	81.9	27.2	5.1	1.0	6.7	3.8	3.0
MOS		ENSG00000172680	"MOS proto-oncogene, serine/threonine kinase"	P00540	8	56112942-56113982	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.5"	"Cell type enriched"	"Detected in single"	8	"Early spermatids: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (3.28e-1)"			0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003634	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003634: AB_1851388"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	12.4	23.4	13.9	18.4	14.8	13.7	17.6	18.1	15.7	10.6	15.2	9.8	17.5	13.1	12.5	15.1	19.4	12.5	16.3	31.2	12.2	12.0	25.7	41.7	10.2	15.2	14.3	14.0	10.5	24.2	13.5	9.1	13.9	14.0	13.6	16.3	10.1	17.7	22.5	57.3	16.5	13.4	14.8	12.9	14.6	15.1	7.6	14.0	13.2	14.8	31.2	15.7	14.3	11.6	18.3	28.9	11.2	22.0	20.0	33.5	20.9	26.1	36.9	12.3	14.1	13.3	13.2	17.2	15.5	16.9	32.4	27.6	28.3	16.5	18.2	12.8	15.4	20.0	18.7	25.2	26.7	34.3	9.3	29.9	14.3	17.5	23.5	25.1	29.8	9.8	14.2	12.8	21.5	34.5	11.0	24.6	18.9	23.0	13.3	18.3	32.7	25.7	20.5	9.3	40.8	50.0	13.3	21.9	26.5	23.8	19.4	11.5	22.0	13.4	24.5	30.1	16.5	32.8	24.6	10.4	17.5	19.2	18.4	29.2	13.9	11.0	20.1	20.0	33.4	14.4	11.2	22.0	10.5	17.3	20.7	14.9	18.3	21.1	17.2	28.9	14.8	15.7	17.6	2.0	20.0	17.4	19.4	33.5	20.9	13.9	14.8	18.1	15.7	12.2	12.0	14.3	14.0	14.0	14.0	29.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	38.8	14.8	24.4	0.0	56.1	48.0	41.8	0.0	0.0	0.0	0.0	52.2	30.7	0.0	0.0	1.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	26.2	0.0	0.0	44.8	0.0	0.0	104.5	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054268-10428891	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 597.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 78.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		25000	"Nucleoplasm, Plasma membrane, Cytosol"	"Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	7.0	8.1	8.0	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4.0	3.9	6.0	5.0	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9.0	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0.0	0.8	3.0	7.2	2.9	0.5	0.2	1.7	0.4	0.0	0.5	1.7	2.5	5.3	1.0	15.2	0.5	3.9	0.4	0.0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0.0	0.3	0.8	3.9	1.0	1.8	1.7	2.3	1.3	1.3	3.1	2.0	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1.0	4.1	0.8	3.2	9.0	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8.0	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0.0	9.0	10.0	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27.0	64.1	26.4	29.0	0.0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31.0	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7.0	15.3	17.4	28.6
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.3	6.8	15.4	14.2	9.8	8.8	7.8	9.7	10.1	6.4	7.7	22.3	8.1	9.8	5.2	6.9	10.7	7.8	11.6	10.3	9.2	13.1	9.0	11.7	10.3	20.7	8.2	20.2	4.9	12.8	12.3	7.6	12.8	12.1	18.8	10.5	8.1	6.9	10.8	6.7	11.1	8.2	3.6	11.8	14.7	14.3	7.0	11.6	6.8	18.9	9.9	7.2	8.8	6.1	10.3	8.5	16.6	16.0	6.1	12.2	11.3	22.7	7.0	13.0	10.4	13.1	15.8	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1	53.6	31.2	20.1	6.8	7.2	0.0	84.0	20.4	20.1	13.6	38.4	0.0	19.3	1.7	11.9	5.3	12.8	6.3	0.0	12.8	7.8	17.5	8.3	29.0	9.6	12.6	0.0	8.1	15.4	16.5	4.2	22.2	10.4	10.1	10.8	7.3	0.0	11.7	10.5	31.1	5.7	0.0	6.5	15.5	14.9	19.7	4.4	18.9	11.7	12.1	4.8
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 57.4;Late spermatids: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	12.2	12.3	11.2	10.5	13.8	5.4	9.7	15.6	14.3	10.8	10.4	24.1	11.5	10.3	17.3	15.9	10.5	11.3	13.3	15.8	14.2	12.9	22.0	23.9	14.9	11.4	18.1	9.6	13.6	13.6	9.4	13.1	11.6	16.6	10.8	11.9	13.6	11.3	7.4	34.6	10.5	11.5	14.2	22.1	9.3	9.2	8.4	12.5	8.1	14.7	9.9	13.5	13.6	8.8	4.6	4.8	4.6	6.8	3.4	11.4	4.2	9.4	8.9	4.7	10.5	18.2	5.9	13.5	14.7	8.7	7.3	8.4	13.4	7.6	15.9	14.1	11.8	14.0	6.1	7.3	7.2	13.9	10.1	8.2	7.6	31.0	7.1	11.1	11.6	3.3	9.5	6.6	12.4	9.1	10.4	4.7	4.1	9.9	12.1	4.3	1.8	7.4	5.9	3.6	14.0	9.9	6.1	5.1	6.7	7.9	7.4	7.4	1.0	25.8	18.8	16.2	9.7	5.8	9.0	7.3	17.1	10.8	13.1	11.5	18.0	5.9	13.1	12.4	25.6	9.1	4.6	5.1	4.1	5.5	6.8	9.5	4.6	9.2	7.9	4.8	4.1	5.4	5.1	0.1	3.4	5.4	2.7	11.4	4.2	11.2	13.8	15.6	14.3	14.2	12.9	18.1	9.6	16.6	12.5	14.9	57.4	8.2	7.5	14.4	0.0	10.1	2.5	9.4	11.4	8.7	0.0	8.3	18.3	8.0	40.0	7.0	8.5	0.0	4.9	7.5	10.2	9.9	10.3	16.6	6.7	0.0	9.2	10.4	12.5	61.7	9.8	8.7	1.7	5.4	9.6	0.0	5.8	7.0	11.0	23.3	0.0	6.5	13.3	16.9	11.9	18.1	9.4	12.9	8.9	7.0
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	17.1	16.6	9.6	19.8	20.8	11.7	10.4	17.0	20.4	21.2	20.5	10.2	28.5	12.9	19.1	24.0	16.1	26.1	17.2	24.6	15.5	12.8	13.6	9.9	11.2	14.8	24.5	13.5	17.0	19.1	32.5	21.7	22.6	12.5	13.8	11.7	12.9	15.8	23.0	8.7	8.1	9.1	9.8	14.3	15.9	8.0	12.1	16.7	25.0	9.6	9.8	14.5	15.3	16.4	20.9	8.1	11.5	13.0	15.6	20.7	11.9	18.0	15.2	18.5	16.1	13.9	16.2	18.4	19.1	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6	20.8	9.3	11.7	7.8	4.6	12.5	14.6	12.7	9.4	6.8	17.4	5.9	33.7	10.0	21.4	1.6	9.7	12.0	0.0	20.3	20.8	12.1	8.1	3.5	11.9	19.7	12.7	8.2	10.4	11.4	2.8	12.0	7.7	18.6	21.6	11.8	15.6	19.7	11.5	14.5	8.7	10.5	19.4	8.5	10.6	13.4	6.1	31.5	10.8	10.1	9.0
MYCBP2	"FLJ10106, KIAA0916, PAM"	ENSG00000005810	"MYC binding protein 2, E3 ubiquitin protein ligase"	O75592	13	77044655-77327050	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	28.0	13.4	31.0	26.1	28.8	24.1	22.4	31.3	32.7	15.5	10.9	8.1	11.5	8.0	16.2	26.7	18.9	11.7	11.1	13.5	24.1	18.6	12.3	13.2	12.4	29.8	15.3	31.1	22.8	12.6	14.5	17.2	9.6	20.0	17.9	11.5	9.6	12.9	12.4	13.7	57.6	13.6	13.2	14.0	24.1	10.3	14.1	16.2	18.6	11.6	12.6	30.7	13.3	34.0	8.3	4.6	3.3	3.7	4.2	7.3	2.5	7.8	4.0	4.9	5.3	24.5	10.9	2.8	5.0	7.4	4.4	5.7	3.5	4.1	22.5	3.2	9.8	4.3	7.3	8.4	9.2	6.0	8.9	8.3	19.1	8.2	7.3	8.3	40.0	6.8	12.2	7.7	4.0	8.0	4.3	9.9	8.3	4.0	7.1	7.8	4.7	10.9	27.0	2.6	10.5	5.1	12.5	5.0	5.4	7.4	7.8	7.7	3.6	6.0	8.7	4.5	5.2	3.2	30.7	13.0	4.2	3.5	2.7	4.8	7.7	5.3	16.1	8.5	33.0	4.2	2.0	3.5	3.2	5.8	3.7	5.1	7.9	6.5	5.0	3.2	8.3	7.3	5.8	3.3	4.2	2.5	4.6	7.3	2.5	31.0	28.8	31.3	32.7	24.1	18.6	15.3	31.1	20.0	16.2	35.7	43.3	79.8	35.8	73.2	212.4	65.7	30.6	17.4	26.1	33.2	98.2	33.8	1.7	22.3	46.1	82.8	12.8	23.3	28.6	26.5	62.0	42.9	47.3	46.5	37.4	206.6	31.4	39.3	93.9	20.0	60.9	48.5	30.4	37.9	18.1	141.3	26.4	17.5	90.5	11.2	95.1	103.5	74.0	61.5	64.3	131.7	36.7	68.3	24.7	36.1
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 294.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	2.0	4.1	1.7	2.0	17.3	4.6	4.5	1.4	3.4	3.5	7.6	11.5	2.1	9.2	7.4	2.2	2.4	5.1	8.1	2.5	3.0	3.3	8.4	6.2	4.3	2.1	2.5	4.2	6.1	7.4	3.3	1.8	1.4	1.7	8.0	2.0	17.8	10.9	1.3	7.7	0.1	20.8	4.9	4.9	3.7	2.1	7.9	33.8	3.7	24.6	8.6	3.7	1.8	18.8	9.5	14.8	3.5	10.4	2.3	1.6	4.0	1.2	3.6	10.1	4.4	4.9	1.0	12.3	5.5	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2	20.8	36.3	30.2	28.3	87.0	7.3	74.2	35.7	21.4	18.2	21.0	0.0	113.9	8.3	14.9	36.7	33.1	32.6	0.0	16.2	65.2	75.2	27.4	35.7	1.0	27.7	11.1	80.9	34.4	42.6	12.5	35.6	21.9	75.9	26.2	35.2	15.3	8.1	32.3	58.0	18.8	6.6	135.8	92.6	59.7	17.5	73.4	294.6	88.3	34.8	26.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell type enhanced"	"Detected in single"	29	"Hofbauer cells: 1.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;RH-30: 13.5;RPMI-8226: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.7	1.0	0.7	0.2	5.3	0.1	0.8	0.7	0.4	0.7	0.0	0.4	0.8	13.5	10.9	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	0.1	2.7	0.3	1.0	0.6	3.0	0.1	1.0	0.2	0.2	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 162.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	1.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0.0	3.5	0.0	0.7	0.0	0.5	162.4	0.0	16.0	6.8	0.0	2.0	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.2	0.4	1.4	0.6	1.1	0.0	0.4	0.0	0.0	0.6	0.0	3.2	0.6	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.2
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"HEL: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.2	0.6	1.2	1.0	1.2	0.6	0.7	1.6	0.5	0.4	0.5	1.1	1.1	1.6	0.8	0.2	1.9	0.2	0.5	0.7	0.2	0.6	12.7	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.6	0.5	0.2	0.1	0.1	0.3	0.5	0.1	1.4	0.2	0.4	0.0	0.9	0.0	0.0	0.9	0.3	1.0	0.6	0.3	0.2	0.5	1.1	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.3	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3	3.0	0.6	0.0	0.1	0.1	0.8	1.2	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.3	0.0	0.3	1.0	0.0	1.8	0.0	0.2	0.0	0.0	1.4	2.9	0.2	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.1
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.5	0.0	0.0	1.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8	0.0	0.3	0.0	0.3	1.5	0.9	0.6	0.0	0.0	4.5	0.0	0.0	0.0	1.7	0.5	127.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	34.5	1.1	0.0	0.0	0.0	0.2	68.5	0.3	0.0	1.1	1.4	3.4	0.0	0.0	20.0	5.8	0.9	0.0	0.0	0.0	0.1
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 80.5;Early spermatids: 23.6;Late spermatids: 18.5;Rod photoreceptor cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.3;HEL: 10.4;RT4: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA					"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0	0.0	0.3	0.0	0.3	0.6	2.9	0.4	0.0	0.0	0.0	3.5	80.5	0.0	11.6	0.3	23.6	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.3	18.5	0.3	0.2	0.0	0.0	0.2	1.6	0.1	0.0	0.4	0.1	57.8	0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.0	0.1
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		3600000			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	8.3	6.3	9.9	9.0	20.1	8.7	4.7	4.7	25.0	6.8	8.5	4.6	5.8	11.4	6.2	4.7	6.1	4.8	5.6	5.0	15.3	5.3	7.2	7.6	7.6	9.1	5.0	9.5	4.2	7.3	7.6	4.9	6.8	6.6	4.9	5.1	4.0	6.0	6.2	6.7	8.5	9.2	5.5	4.4	10.9	12.4	2.7	5.5	4.3	5.1	2.6	5.6	6.0	4.4	9.5	26.5	5.1	20.9	5.1	9.9	9.7	1.5	6.0	1.0	6.5	2.6	3.4	6.8	4.5	8.0	5.9	7.4	5.0	12.5	0.6	5.7	6.1	10.2	4.6	2.7	5.0	1.8	7.3	8.4	2.2	3.9	32.2	8.3	5.3	9.5	5.1	5.2	3.9	1.7	7.4	9.1	5.6	6.9	8.9	3.6	6.8	2.4	14.4	3.2	3.8	6.4	6.5	2.4	11.8	3.8	2.4	2.6	3.5	3.6	8.9	9.1	1.0	6.1	6.6	6.7	6.5	4.7	15.1	3.3	4.9	3.8	1.4	3.0	8.2	5.4	1.2	20.9	5.1	9.9	18.2	7.9	9.5	9.8	8.8	26.5	8.3	8.1	7.4	0.6	5.1	11.7	6.8	8.7	9.7	9.9	20.1	4.7	25.0	15.3	5.3	5.0	9.5	6.6	5.5	0.0	2.4	13.7	4.8	2.6	13.3	1.5	7.6	4.0	3.4	5.2	29.5	11.3	1.7	10.2	0.2	6.7	17.1	0.0	7.5	12.5	3.2	3.7	1.1	7.3	25.0	15.9	1.2	8.6	17.2	0.9	7.5	19.1	3.3	25.2	9.9	5.4	8.5	14.4	6.0	7.4	12.5	0.0	3.1	4.4	8.1	2.0	7.9	13.8	10.6	2.1
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.4"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Paneth cells: 25.9"	"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB017782, HPA043704"	Approved					NA	NA					"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.7	3.2	1.5	8.5	1.5	1.9	7.9	1.3	1.5	5.4	15.6	1.0	5.1	9.3	4.4	13.0	4.8	3.5	5.9	2.9	1.7	1.0	8.6	14.3	6.2	6.6	2.5	1.0	3.3	4.2	1.1	4.6	6.0	3.1	7.4	10.3	4.5	3.6	5.4	2.0	1.6	23.4	2.6	2.3	9.8	4.8	4.1	0.5	10.8	2.6	4.3	6.2	3.1	3.0	6.3	8.1	12.3	7.1	8.6	8.5	3.9	18.5	2.3	2.1	2.8	5.6	5.6	4.5	6.8	7.1	7.6	8.7	3.1	4.0	9.0	5.4	4.3	7.0	2.9	3.8	4.4	7.7	8.4	2.0	6.1	2.6	2.3	5.4	2.7	8.4	4.6	5.7	5.1	0.4	1.9	6.6	8.0	5.3	2.5	8.3	3.3	8.0	8.6	2.0	14.6	2.9	4.0	2.0	3.8	8.0	10.7	1.1	1.4	0.3	8.0	4.6	4.7	6.5	8.1	6.6	4.5	2.7	6.9	1.1	1.7	3.2	7.8	4.0	6.2	2.0	5.3	6.4	12.3	4.8	7.1	3.5	6.3	5.0	4.8	8.1	5.4	4.8	5.8	11.2	8.6	6.8	4.7	8.5	3.9	1.5	1.5	1.3	1.5	1.7	1.0	2.5	1.0	3.1	0.5	0.0	2.2	3.0	0.6	0.3	0.0	1.1	0.0	34.8	5.7	5.2	0.0	5.2	1.7	5.3	3.9	1.5	12.6	0.0	6.1	6.9	2.1	1.8	2.3	11.9	6.4	0.0	3.5	2.5	8.4	1.6	3.7	4.6	3.3	2.8	8.8	2.4	4.3	25.9	5.3	10.6	0.0	0.0	4.1	1.4	0.5	0.5	9.2	4.9	7.8	1.2
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391245-18401218	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"intestine: 28.4;liver: 75.5"	"Cell type enhanced"	"Detected in some"	25	"Enterocytes: 16.0;Hepatocytes: 52.3;Paneth cells: 10.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;RT4: 4.2;SCLC-21H: 5.8;SK-BR-3: 3.6"									HPA043704	Uncertain					NA	NA					"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.2	0.1	0.2	2.3	0.3	0.0	0.3	0.1	0.2	0.3	14.0	0.1	0.1	13.0	0.4	0.4	0.1	0.2	0.3	0.4	0.1	0.1	0.6	75.5	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.3	5.1	0.1	0.1	0.1	0.1	0.1	28.4	0.4	0.2	0.6	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.8	0.0	0.2	0.0	1.4	0.0	0.0	0.3	0.3	0.1	0.5	0.1	0.5	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.0	0.9	0.0	0.0	0.9	0.0	2.8	4.2	5.8	0.1	0.1	3.6	0.0	0.5	1.0	0.6	1.5	1.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.0	0.0	0.1	0.0	16.0	0.0	0.0	0.8	0.0	0.1	0.0	52.3	0.2	0.0	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	7.5	0.0	0.1	10.1	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	4.2	0.0
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.7	5.0	8.9	4.6	9.8	9.0	13.6	3.6	7.3	4.6	4.1	4.7	2.9	4.9	1.5	6.6	8.8	1.6	5.3	3.1	5.0	23.3	7.7	17.6	2.0	1.9	6.2	8.0	14.7	14.3	4.7	4.4	3.6	5.7	4.6	6.4	10.7	8.2	6.9	4.5	7.1	2.9	4.2	4.0	3.4	5.7	41.0	2.5	5.0	9.2	8.1	6.4	8.4	5.1	3.7	4.9	6.1	4.1	5.0	7.7	6.1	5.2	3.6	9.5	8.2	8.6	4.4	5.1	3.8	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7	35.7	29.8	13.6	10.7	27.1	97.2	33.1	15.3	20.1	31.8	14.0	49.1	11.2	6.6	12.0	13.1	29.2	24.6	23.3	23.0	14.9	31.2	14.1	18.6	20.3	15.3	58.8	24.2	33.2	25.2	3.8	43.7	26.2	18.6	10.0	22.7	63.8	17.7	35.1	40.7	11.4	67.4	38.8	35.4	32.1	36.8	27.0	4.5	25.4	23.0	14.6
NCOA2	"bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2"	ENSG00000140396	"Nuclear receptor coactivator 2"	Q15596	8	70109762-70403805	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060243			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060243: AB_2684229"	"unprognostic (9.79e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	13.6	13.2	16.9	13.1	14.0	22.5	14.9	19.2	14.0	13.9	17.3	10.1	49.7	12.4	16.6	33.6	20.0	12.5	12.6	15.8	13.9	13.0	16.4	25.5	15.5	16.9	10.8	11.4	18.5	9.7	23.4	17.1	16.2	10.0	14.8	11.8	15.3	14.8	21.7	13.2	14.9	28.8	19.2	9.6	14.5	11.7	15.5	12.9	15.3	13.4	10.3	13.8	18.9	17.2	3.8	2.5	9.4	7.8	2.1	3.8	1.6	8.8	11.0	12.2	6.9	11.1	11.4	12.5	5.1	5.1	3.9	3.8	5.6	10.3	10.5	2.1	9.3	6.5	5.2	14.9	7.0	4.4	24.8	11.8	18.3	5.6	8.9	5.8	3.7	4.9	9.9	7.9	5.3	7.6	6.2	2.7	7.7	5.8	16.0	4.5	8.8	9.1	3.7	6.4	10.1	5.2	9.0	5.1	6.5	6.3	14.7	9.3	6.8	8.8	4.7	7.2	8.9	11.1	6.8	3.5	5.7	7.3	7.2	2.7	21.1	10.8	10.2	5.8	4.9	8.3	4.5	2.5	3.5	3.8	3.9	2.8	2.2	2.3	3.3	2.5	3.8	2.8	2.7	9.4	2.1	7.8	1.1	3.2	1.6	16.9	14.0	19.2	13.5	13.9	13.0	10.8	11.4	10.0	12.9	11.9	24.3	16.7	7.9	14.3	23.6	31.3	33.1	9.4	34.2	24.4	49.1	16.2	10.0	6.0	4.0	14.5	20.6	23.3	10.7	10.2	16.2	17.2	21.9	57.7	14.7	69.9	24.2	22.7	43.2	5.7	18.4	19.9	20.3	4.6	17.5	14.7	10.9	11.5	20.8	15.7	29.6	25.8	15.6	11.2	15.4	18.7	26.5	25.4	16.0	12.2
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 38.1;MCF7: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.9	19.2	5.4	7.3	12.8	15.0	38.1	5.7	8.6	9.8	5.2	9.2	6.5	20.5	3.8	9.8	13.8	14.4	4.2	7.0	7.5	10.8	2.2	2.8	5.4	12.7	7.6	2.2	15.3	6.8	20.2	9.3	10.8	7.9	6.9	3.4	6.3	4.8	5.4	63.9	3.2	3.8	1.9	4.5	7.4	6.1	3.8	8.8	5.4	13.8	1.0	1.9	14.4	17.9	6.1	6.5	8.3	5.6	12.0	5.8	5.1	7.0	2.5	13.2	12.0	21.1	6.8	2.2	3.9	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2	11.9	21.3	77.0	14.2	30.7	16.1	22.0	20.4	22.7	17.0	14.0	7.9	56.2	5.0	11.0	9.0	39.0	7.8	0.0	16.8	23.2	22.6	21.3	8.1	18.4	20.1	12.7	14.3	66.9	49.4	3.6	23.0	45.5	32.1	22.6	11.4	9.7	15.9	14.0	25.8	5.1	22.4	19.4	26.8	22.7	17.8	45.2	74.6	22.4	11.7	56.9
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825649	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004198: AB_1078228, HPA050211: AB_2681052"	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	13.7	13.4	14.7	12.8	23.0	15.8	17.7	31.9	17.3	14.9	16.9	28.5	17.5	16.4	16.7	16.3	17.1	14.9	14.2	11.8	16.2	11.7	13.6	10.8	13.2	10.8	18.7	12.6	15.5	15.8	35.1	17.7	18.1	14.4	13.1	18.8	14.4	16.4	18.4	17.6	18.4	21.2	19.8	21.8	11.2	14.6	22.6	22.6	16.9	17.7	9.7	13.2	16.6	14.6	2.7	3.1	6.5	2.1	2.1	2.7	1.3	14.3	8.6	19.5	11.7	10.7	12.0	12.7	7.0	9.0	12.7	10.2	21.9	10.1	10.2	7.8	12.5	15.5	17.6	17.3	11.8	14.5	5.1	7.8	23.9	9.5	12.9	11.8	13.3	17.7	9.0	21.9	11.9	14.8	8.8	11.9	11.8	12.1	14.1	10.4	9.3	21.2	8.4	4.0	12.1	12.5	14.2	23.5	9.1	9.3	9.6	16.3	11.1	12.8	31.2	12.0	9.4	13.1	10.8	11.6	20.6	12.6	15.2	11.6	16.2	13.5	11.8	13.6	7.9	9.1	3.0	1.7	6.5	2.7	1.6	2.6	2.7	2.5	2.3	3.1	2.1	2.3	1.5	4.4	2.1	2.1	2.8	1.4	1.3	14.7	23.0	31.9	17.3	16.2	11.7	18.7	12.6	14.4	22.6	23.8	13.6	9.7	8.2	15.0	26.7	16.7	22.9	16.0	9.1	15.7	27.5	9.8	5.0	11.3	21.4	11.1	16.8	23.3	10.7	10.0	11.1	13.7	5.8	11.4	9.4	31.8	10.4	13.5	12.9	13.4	16.7	10.1	10.1	9.0	18.4	10.0	12.8	8.6	12.7	8.1	27.6	25.8	13.2	22.1	23.7	18.2	13.3	11.7	16.2	13.9
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	20.4	34.2	24.4	20.3	20.1	15.3	12.2	15.1	17.1	16.6	15.1	18.3	9.4	21.5	10.7	26.3	12.4	15.6	30.0	18.3	24.7	28.6	22.2	21.4	29.6	21.4	19.7	13.4	25.6	15.7	19.2	25.7	30.1	14.2	23.0	30.4	18.6	8.9	16.3	13.3	23.6	8.6	12.1	36.0	9.3	23.6	24.8	10.0	17.2	23.2	8.3	13.9	24.9	10.9	11.8	65.5	10.5	15.3	20.0	17.1	10.1	12.5	20.8	6.1	7.1	12.5	16.3	16.0	14.6	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4	74.5	98.7	86.4	91.4	60.2	144.1	78.9	66.2	61.6	72.8	50.6	149.2	79.2	29.9	80.2	53.7	68.9	164.0	93.5	85.1	85.7	74.0	70.9	83.3	105.0	67.5	122.3	84.4	59.5	70.8	35.4	94.0	84.8	35.4	184.0	101.0	81.4	89.5	133.5	114.2	37.3	152.7	90.5	89.5	82.3	75.1	59.6	73.2	110.7	125.6	110.0
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	24.0	22.0	21.3	21.3	19.0	16.8	18.3	33.8	33.5	24.5	17.2	24.3	17.7	16.4	21.3	19.0	15.7	16.3	21.5	18.2	22.0	14.8	16.0	11.2	23.4	11.9	19.0	15.6	28.6	30.0	13.8	39.5	13.2	28.3	21.3	7.6	32.7	29.2	24.5	62.4	22.8	22.2	17.4	12.2	17.4	24.0	10.8	22.0	9.3	16.7	25.0	7.6	16.3	14.7	0.6	1.7	8.1	4.0	0.2	1.9	0.4	19.7	37.2	10.6	10.1	6.2	8.4	31.8	20.5	10.2	12.0	5.3	19.7	14.6	20.0	15.2	16.7	10.7	18.8	4.2	21.8	4.9	21.1	8.2	16.1	35.1	12.0	12.4	12.1	20.5	13.5	8.2	14.9	8.9	18.4	11.4	9.2	20.6	6.0	10.7	17.0	43.4	14.0	14.8	7.5	36.2	14.1	17.7	10.1	5.7	23.1	28.1	20.5	25.2	21.3	12.9	8.3	17.3	15.3	54.6	27.9	48.3	27.5	43.4	11.5	11.5	12.2	15.9	9.0	26.1	8.1	0.7	1.6	1.9	0.4	0.5	0.6	0.5	1.5	0.3	0.4	0.6	0.5	1.6	0.2	4.0	1.7	0.0	0.4	21.3	19.0	33.8	28.4	22.0	14.8	19.0	15.6	28.3	22.0	107.2	54.1	4.5	21.5	29.7	63.3	27.7	20.4	18.7	56.9	17.4	37.3	6.7	3.3	19.2	1.6	21.0	23.6	0.0	24.0	33.5	32.5	20.3	39.5	16.3	25.4	114.4	18.0	14.7	40.3	4.8	57.5	32.4	15.1	18.0	18.7	30.6	26.9	17.3	61.2	7.0	57.9	6.5	30.6	1.7	10.3	21.3	10.5	13.1	20.4	17.9
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.5	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.5	10.5	5.1	2.2	1.8	3.7	5.4	25.5	12.2	3.4	9.3	17.2	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.6	23.1	12.5	21.1	5.1	8.6	5.4	3.9	0.0	30.6	3.8	5.3	0.0	0.8	3.9	1.7	3.9	24.8	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.9	5.6	3.0	29.6	23.3	7.7	4.9	22.9	1.2	2.7	4.8	15.7	8.6	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1	86.4	87.7	2.0	3.3	10.8	0.3	4.8	7.6	135.1	79.6	0.0	21.6	16.5	1.7	3.2	1.3	16.8	6.9	0.0	4.8	6.4	6.3	3.4	67.4	17.9	4.0	0.0	0.0	15.4	1.8	1.0	5.2	3.8	1.7	0.0	4.2	8.4	3.3	0.0	6.7	10.8	6.0	0.0	8.2	1.2	5.9	9.2	11.6	2.2	2.9	1.6
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase"	Q96PU5	18	58044367-58401540	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 51.3;SK-MEL-30: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved					NA	NA					"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	5.9	6.8	9.1	5.4	38.8	13.2	15.8	21.4	24.7	5.0	22.6	3.2	18.2	11.1	3.6	6.1	7.0	6.0	7.6	12.7	9.8	7.1	29.9	10.1	26.9	2.5	7.2	14.9	3.0	33.2	9.2	16.5	13.0	4.1	30.6	25.2	12.2	16.5	23.2	38.3	5.9	26.8	8.2	3.2	3.1	26.0	4.6	8.8	0.8	9.1	5.5	5.1	14.9	9.3	1.4	0.4	4.7	0.7	0.9	8.1	0.5	18.8	6.8	4.0	6.0	1.4	0.5	13.9	5.4	24.2	13.7	21.0	7.9	10.2	4.0	16.4	2.1	14.4	13.7	5.3	23.6	28.4	9.4	4.7	2.8	4.2	51.3	0.7	0.1	1.7	3.6	15.4	18.5	22.4	10.8	1.0	3.6	4.9	1.8	5.6	4.6	0.2	0.2	3.4	7.0	10.4	3.9	5.4	4.6	13.6	24.7	5.0	1.4	4.4	1.4	40.0	8.1	8.0	1.6	8.1	37.0	11.2	2.1	22.8	2.3	4.0	2.5	7.5	2.9	3.0	4.7	0.6	1.7	0.4	0.7	1.0	1.4	1.3	0.3	0.3	0.6	0.8	0.6	0.3	0.9	0.1	0.4	8.1	0.5	9.1	38.8	21.4	24.7	9.8	7.1	7.2	14.9	4.1	8.8	235.2	122.6	2.7	142.5	100.2	4.9	50.9	56.0	92.3	166.1	59.3	163.0	7.6	41.4	32.0	18.9	9.0	128.1	116.8	42.3	4.2	11.0	173.0	3.5	32.7	6.3	58.8	43.5	9.8	5.4	5.6	3.1	11.5	13.5	8.2	189.6	31.3	41.1	77.0	16.6	59.9	7.5	0.0	5.3	0.2	3.0	46.3	66.9	4.6	64.4	150.4
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 85.6;Early spermatids: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.8	7.8	8.4	12.1	13.5	2.5	8.9	8.0	7.2	6.8	2.4	5.0	11.3	1.7	7.8	6.9	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.7	2.9	7.1	7.6	6.1	10.8	4.3	7.3	12.8	14.7	7.0	10.9	13.4	21.5	9.2	2.7	9.8	3.4	2.5	2.7	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	6.2	4.0	3.4	8.4	4.6	4.2	4.7	6.0	8.7	13.3	8.6	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8	11.9	13.1	13.3	12.5	8.5	20.5	31.9	0.0	85.6	22.7	17.4	27.5	17.5	14.9	8.5	83.6	9.0	5.4	23.3	5.5	6.7	16.2	7.0	17.4	6.6	9.1	17.5	6.9	8.6	6.9	39.7	21.9	8.9	5.0	2.8	5.0	23.4	6.9	4.2	29.7	8.1	24.4	12.9	18.6	59.1	27.4	5.5	24.7	8.6	6.8	9.5
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.9"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2.0	6.5	16.0	3.2	26.9	6.0	2.9	9.1	10.0	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5.0	9.3	4.6	17.3	4.0	3.3	3.0	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3.0	0.9	1.0	1.1	1.3	0.3	2.9	0.3	5.9	2.4	1.8	5.2	7.0	10.5	1.0	2.9	5.5	4.5	3.4	2.2	8.3	0.3	2.1	5.2	4.3	3.3	0.5	5.1	6.3	0.6	0.7	0.8	0.4	1.0	2.3	0.6	1.5	4.4	8.5	4.8	2.2	4.8	0.9	2.6	0.2	0.9	7.5	4.2	0.1	0.5	0.5	0.9	2.3	0.0	0.2	0.1	10.3	2.3	2.2	2.5	1.4	0.1	2.0	0.8	4.9	0.1	0.9	4.7	2.3	3.6	1.4	1.4	2.3	0.1	3.2	0.2	0.8	0.0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1.0	0.8	0.9	0.3	0.9	1.0	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10.0	7.8	5.4	17.3	5.5	14.9	2.7	0.0	3.4	3.8	2.7	1.1	2.5	148.5	29.6	1.8	5.9	0.5	5.0	4.7	122.2	2.4	1.7	0.0	2.2	1.0	5.4	1.4	0.0	0.0	1.8	0.0	2.4	2.5	0.0	80.8	6.4	1.4	0.0	1.0	2.7	5.7	2.9	3.7	5.6	8.4	6.9	6.5	2.2	30.5	4.9	1.8	1.4	0.0	1.7	1.8
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
NEK3	"HSPK36, MGC29949"	ENSG00000136098	"NIMA related kinase 3"	P51956	13	52132639-52159861	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA019062: AB_2670037, HPA043230: AB_2678374"	"unprognostic (8.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.34e-2)"	7.7	2.8	7.1	5.4	12.9	7.1	7.3	3.2	7.1	7.0	13.8	20.4	3.1	7.8	9.1	5.8	3.9	6.0	6.4	5.0	8.7	5.2	6.1	5.7	7.2	4.2	14.0	9.5	7.9	6.4	2.2	3.7	14.8	11.3	5.4	15.0	6.8	5.2	5.0	4.1	5.4	11.7	7.3	9.6	3.9	4.6	14.7	13.3	2.4	5.0	2.7	4.3	6.5	6.0	4.4	7.8	5.9	7.7	2.0	3.5	1.6	0.2	1.4	13.2	7.5	4.2	6.6	0.2	4.2	4.3	5.1	5.7	5.1	7.3	0.0	0.2	5.3	4.2	0.9	0.2	3.2	3.1	8.7	6.9	1.0	1.4	13.7	5.4	12.7	6.8	4.8	5.9	2.6	12.2	3.7	7.8	0.6	1.8	4.4	5.2	3.6	0.6	15.3	12.9	2.7	0.3	0.3	1.1	4.8	7.3	1.3	1.3	9.1	1.9	4.0	8.9	13.0	1.7	16.3	6.7	0.7	4.3	4.0	4.5	4.7	1.6	8.8	1.1	5.0	7.2	5.9	7.7	5.3	2.1	6.6	1.3	4.4	2.5	1.3	7.8	2.5	1.7	0.6	0.5	2.0	1.5	6.9	3.5	1.6	7.1	12.9	3.2	7.1	8.7	5.2	14.0	9.5	11.3	13.3	6.0	6.2	1.9	3.8	2.5	2.2	6.1	7.6	8.1	7.9	7.0	0.0	10.1	11.6	5.4	6.3	21.2	18.6	0.0	15.1	12.1	7.0	4.2	9.3	6.2	15.3	3.2	5.8	20.9	9.9	2.7	6.6	7.9	11.8	34.3	14.6	3.7	11.3	14.0	6.3	5.0	5.8	0.0	7.6	40.9	27.9	3.0	4.0	1.3	17.2	4.8
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.9	10.1	13.9	10.9	12.7	9.2	15.1	9.2	12.5	17.3	17.5	8.8	9.7	13.3	4.3	9.0	19.1	6.1	16.9	10.9	23.2	13.3	7.1	10.4	12.3	11.2	7.9	25.4	10.5	5.6	10.1	22.1	14.8	9.2	6.4	11.7	12.9	10.9	10.9	11.1	13.7	9.3	12.0	13.7	10.0	12.0	12.1	9.8	9.8	18.7	10.3	6.1	19.4	11.9	9.1	11.2	11.1	15.3	5.9	11.6	11.8	18.5	17.0	12.2	17.7	13.1	13.3	12.0	12.5	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4	11.9	5.1	9.5	4.6	3.7	12.7	3.5	0.0	21.4	15.9	5.2	11.8	6.1	8.3	6.4	16.2	5.3	5.1	0.0	8.4	6.8	4.6	6.5	7.0	13.4	7.2	6.4	4.6	4.9	14.9	16.1	13.6	7.0	1.7	5.4	9.6	16.2	7.8	0.0	11.7	14.6	17.4	6.5	5.9	58.3	31.9	3.6	5.6	5.3	8.2	4.1
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129078	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.8;fallopian tube: 12.7;testis: 15.7"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 172.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.5;OE19: 6.4;T-47d: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035565, HPA041399"	Enhanced					NA	NA					"HPA035565: AB_10672095, HPA041399: AB_2677453"	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3.0	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0.0	0.7	0.0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0.0	0.4	0.5	0.3	1.7	0.2	1.1	2.2	0.0	0.0	0.0	0.2	0.1	1.1	0.5	0.2	0.0	0.1	0.4	0.2	0.4	0.0	0.1	0.3	0.6	0.6	0.4	0.3	1.1	1.3	0.3	0.8	0.1	0.6	0.4	0.2	3.5	1.2	0.8	0.0	1.3	0.6	0.8	0.5	6.4	0.6	0.2	0.1	0.0	1.9	0.5	0.6	0.8	0.4	0.0	1.0	1.0	3.3	1.3	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0.0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1	0.0	1.3	2.2	1.7	0.0	8.0	1.6	2.5	172.6	21.6	7.0	13.7	2.2	1.7	1.1	43.0	1.7	0.8	0.0	2.6	1.5	1.1	3.2	2.3	0.9	1.0	12.7	1.7	0.6	0.0	24.4	2.0	0.8	0.0	1.0	0.3	2.4	0.7	0.0	2.1	1.0	11.4	6.5	0.3	21.1	12.0	0.1	1.6	0.0	1.0	0.8
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.4	12.3	11.9	4.6	22.5	29.4	14.8	9.4	15.1	14.6	12.2	11.6	14.0	9.1	15.1	18.1	33.4	1.4	6.1	27.3	9.9	10.0	5.4	24.9	10.4	20.4	26.9	4.5	62.6	39.1	4.4	13.8	14.3	38.4	15.9	4.3	4.4	0.4	26.0	7.8	0.2	4.9	3.0	39.4	11.2	9.6	8.9	4.6	15.6	2.7	5.3	1.8	3.0	5.8	13.3	12.6	12.7	18.4	31.0	10.7	10.8	7.3	6.4	2.0	2.5	5.2	13.4	10.2	14.1	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9	8.9	6.6	9.8	11.0	2.2	0.7	2.5	17.8	1.4	4.5	3.5	0.0	33.9	1.7	35.3	14.7	5.5	12.9	23.3	20.0	103.8	9.9	17.8	21.9	33.3	99.7	0.0	5.8	4.3	10.7	12.3	4.6	30.4	6.8	90.2	15.5	28.1	24.3	15.2	3.5	29.9	1.8	0.0	5.3	1.2	10.6	1.0	30.2	0.0	18.6	8.9
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 85.5;fHDF/TERT166: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	31.7	31.4	24.9	15.2	23.0	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16.0	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18.0	20.0	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18.0	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7.1	1.9	2.3	0.9	6.0	6.9	2.7	85.5	35.8	34.8	16.5	3.5	7.1	2.6	6.2	115.4	2.0	4.4	3.5	4.6	35.2	8.1	5.0	3.5	8.2	1.4	7.2	5.9	7.3	4.3	4.0	22.9	6.9	13.0	6.6	21.6	2.7	6.4	15.9	2.2	5.1	3.5	1.2	5.7	1.4	2.7	5.7	4.5	5.9	3.7	1.4	2.7	14.2	8.2	9.5	3.4	6.0	5.4	14.5	9.8	8.3	28.0	8.9	4.5	4.1	1.7	4.2	5.4	7.5	1.9	2.2	3.0	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6.0	1.4	24.9	23.0	7.8	15.6	23.9	20.4	26.8	13.4	18.0	22.6	26.8	24.2	12.3	15.3	45.6	9.4	150.0	10.2	25.4	21.6	17.4	13.7	11.6	10.0	8.8	2.1	26.3	19.8	46.7	16.9	13.3	24.9	20.4	8.1	19.2	15.2	3.2	19.0	35.0	42.5	1.7	27.0	23.7	28.7	16.2	19.6	10.0	34.6	17.3	36.0	11.6	25.0	19.4	44.2	7.5	5.7	43.0	53.8	20.1	14.9	22.4
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040661, HPA040679"	Approved					NA	NA					"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	3.5	4.6	2.9	11.9	4.5	2.0	4.3	1.7	4.9	5.3	4.0	4.7	1.4	4.2	2.1	5.0	4.8	5.9	4.4	1.6	2.9	1.9	10.4	6.9	5.7	7.8	2.3	2.1	4.4	6.4	8.5	9.7	8.7	5.6	5.6	3.2	5.2	5.3	4.1	0.9	4.4	6.5	1.7	3.0	8.4	4.9	4.9	1.4	4.8	10.7	3.5	15.6	4.5	3.0	4.7	14.7	3.2	1.0	1.3	1.1	0.8	2.2	3.5	3.8	3.0	2.1	2.3	11.6	1.0	2.2	1.4	1.8	5.6	5.2	13.5	3.8	2.9	2.6	3.9	5.5	5.0	1.4	3.5	6.8	3.0	5.7	10.2	3.6	1.9	4.0	5.2	1.9	2.6	6.2	2.0	1.0	2.0	4.4	1.4	1.5	4.8	1.8	3.5	3.5	3.8	1.1	4.9	2.4	6.0	7.5	5.9	6.8	1.6	3.2	6.6	1.6	5.2	9.9	2.5	0.9	1.3	2.5	1.7	1.0	1.6	1.8	9.1	2.2	1.7	3.2	3.2	0.9	1.2	0.8	0.4	0.9	3.0	0.7	0.7	0.1	4.7	0.8	1.1	0.5	1.3	1.0	14.7	0.5	0.8	2.9	4.5	1.7	4.9	2.9	1.9	2.3	2.1	5.6	1.4	8.9	17.1	11.5	7.4	2.5	2.6	1.6	5.1	10.7	13.6	24.4	7.9	14.3	6.6	4.7	7.6	2.1	10.7	0.0	5.3	8.0	4.1	6.9	25.5	4.9	3.3	1.6	9.9	4.3	3.3	1.5	3.1	4.0	3.3	3.6	10.2	1.7	3.7	13.3	2.5	3.0	1.6	0.0	1.2	4.8	5.1	1.4	9.3	4.6	12.4	3.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;skeletal muscle: 83.5"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 105.4;Late spermatids: 383.1;Paneth cells: 157.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"intermediate monocyte: 16.0;non-classical monocyte: 37.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 37.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.0;HeLa: 7.7;HMC-1: 6.6;JURKAT: 6.9;SCLC-21H: 16.4;SiHa: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA					"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	1.1	3.9	18.5	3.0	17.5	2.0	1.0	28.2	27.2	6.1	8.6	0.6	1.2	7.7	13.2	11.0	3.6	2.1	2.0	1.1	12.0	7.6	1.3	1.1	1.3	1.3	4.5	18.9	2.1	12.8	2.9	6.5	13.3	6.1	2.8	7.3	7.8	1.5	1.7	83.5	1.9	11.7	11.7	1.2	2.0	4.4	7.5	2.1	0.0	1.2	8.5	1.1	9.2	1.7	0.4	2.1	1.0	37.1	0.2	0.4	1.2	0.8	0.2	1.3	0.0	0.4	0.1	13.0	0.5	0.8	0.2	0.1	0.3	0.3	0.4	0.7	0.1	0.9	0.7	0.4	0.2	0.1	0.3	0.7	0.2	7.7	0.6	0.0	0.3	6.6	0.2	0.5	0.1	0.6	0.2	0.0	6.9	2.1	0.4	0.2	1.1	1.3	0.8	0.0	0.5	3.9	0.2	0.6	1.4	0.0	0.5	16.4	5.6	8.2	0.0	0.4	2.5	0.7	1.5	0.0	0.1	0.9	0.2	0.2	0.9	0.2	0.3	0.5	0.0	0.3	0.2	1.0	0.2	0.3	16.0	0.4	0.4	0.4	0.4	2.1	0.3	0.4	0.3	1.0	0.2	37.1	1.7	0.1	1.2	18.5	17.5	28.2	27.2	12.0	7.6	4.5	18.9	6.1	2.1	0.0	1.1	1.4	1.3	0.5	42.1	1.2	0.0	0.0	0.0	0.0	88.4	3.4	0.0	9.1	105.4	1.0	6.9	0.0	0.6	10.0	1.9	0.5	0.0	0.0	4.2	3.2	75.1	0.0	4.1	383.1	5.2	2.0	0.0	0.0	92.0	6.4	0.9	157.0	4.9	0.0	83.3	6.5	0.6	47.6	28.8	1.6	94.9	3.9	7.8	0.5
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641266-172691540	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 32.6;Enterocytes: 45.0;Ito cells: 36.2;Leydig cells: 50.6;Paneth cells: 33.1;Smooth muscle cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 27.6;T-47d: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	26.6	11.8	7.5	10.3	3.2	1.5	23.9	0.6	7.0	21.4	17.5	5.6	31.2	5.7	26.7	24.7	14.0	15.8	23.0	19.2	10.7	4.2	7.6	4.4	10.5	7.8	3.1	3.2	20.9	4.8	4.1	6.0	5.1	2.7	20.7	11.6	6.1	4.9	28.4	12.3	14.7	12.1	29.1	1.5	0.6	5.9	6.6	2.8	3.6	7.2	13.9	5.4	16.0	30.8	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.5	2.4	1.3	5.8	0.4	0.2	0.1	5.1	2.3	2.7	4.0	8.7	2.1	0.0	1.4	3.3	3.3	1.3	0.5	2.3	1.8	8.3	0.3	6.2	8.3	0.0	0.4	0.0	1.9	0.0	9.9	0.6	2.7	0.8	0.4	0.9	0.0	2.0	5.8	5.0	1.4	0.1	0.8	2.0	0.2	27.6	6.1	0.9	0.1	1.0	1.0	5.9	4.9	7.8	0.2	2.4	13.0	0.9	0.8	2.0	12.2	1.4	3.2	0.8	0.2	0.0	5.9	0.1	1.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	3.2	0.6	7.0	10.7	4.2	3.1	3.2	2.7	2.8	0.0	3.4	0.0	0.6	4.2	0.1	7.8	0.0	8.1	4.5	0.0	0.0	0.2	0.0	0.3	1.9	32.6	45.0	0.0	0.6	0.2	3.5	1.8	0.0	0.5	0.2	0.0	13.4	36.2	2.4	4.1	50.6	1.8	6.8	1.0	12.5	0.7	3.5	33.1	11.7	0.8	0.3	25.8	30.8	2.1	1.5	4.6	0.1	0.0	15.7	0.9
NGLY1	"FLJ11005, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 518.0;Late spermatids: 684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA					"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.7	14.4	11.4	19.6	11.4	12.9	15.0	17.1	15.0	9.5	12.4	6.9	11.7	10.5	10.2	13.8	13.2	8.4	10.5	14.3	12.0	9.0	12.8	18.1	13.9	17.4	9.5	12.5	10.6	20.7	9.0	11.3	8.7	11.0	10.9	15.2	7.8	12.4	18.0	46.6	9.0	11.2	8.7	10.1	14.6	11.9	42.0	9.0	18.0	10.3	10.9	18.1	11.5	10.6	26.1	39.7	19.9	10.8	22.6	14.7	10.3	12.5	10.7	6.0	12.7	11.6	10.7	8.6	10.8	9.1	13.6	12.3	6.6	9.6	31.9	12.3	9.1	14.1	5.7	20.2	5.7	18.5	15.0	8.6	23.7	8.2	10.7	13.0	21.8	13.0	9.5	7.6	14.9	14.0	14.8	14.5	15.7	22.4	23.0	13.8	5.5	25.9	12.9	8.1	14.7	19.5	26.5	7.9	22.7	12.5	15.4	3.7	4.5	15.6	15.1	10.0	12.0	14.3	18.3	9.8	10.7	11.1	12.9	13.9	28.3	24.4	22.2	12.9	23.7	8.4	19.9	10.8	18.9	13.7	10.1	14.7	26.1	13.8	12.6	16.3	21.7	14.0	13.6	12.8	22.6	8.4	39.7	10.4	10.3	11.4	11.4	17.1	15.0	12.0	9.0	9.5	12.5	11.0	9.0	17.9	12.9	39.7	20.7	11.2	21.6	22.4	22.9	28.1	15.9	5.2	11.8	36.2	29.9	26.6	518.0	20.1	20.2	0.0	38.1	28.0	19.8	22.0	19.7	22.7	21.1	11.1	6.9	15.4	16.4	684.0	13.8	24.8	23.6	20.8	27.3	19.8	25.0	24.6	14.9	29.8	20.4	0.0	14.6	73.4	43.7	12.0	47.4	33.3	28.9	19.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Intestinal endocrine cells: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.2;K-562: 7.8;SCLC-21H: 8.2"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.5	1.1	1.3	0.7	0.1	2.8	0.1	9.2	2.5	0.2	4.0	0.0	2.2	1.0	0.1	1.2	0.5	1.1	0.2	2.8	0.0	2.2	2.9	3.4	1.3	1.2	0.8	2.8	0.0	7.8	0.1	2.8	3.6	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.1	1.9	3.6	8.2	0.1	6.9	5.8	2.0	0.8	4.2	2.2	0.5	0.2	1.8	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8	0.0	2.1	0.0	1.0	1.6	0.1	0.4	0.0	0.0	2.3	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.3	0.0	3.2	0.0	0.2	0.1	1.1	1.0	1.1	0.0	3.4	0.0	0.6	0.0	0.6	0.9	1.7	0.0	0.0	0.5	1.7	0.0	0.0	1.1	1.1	0.0	0.4	0.2	0.0	1.6	0.3	0.0	0.4	0.3
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.2	17.2	7.0	10.3	12.6	9.7	14.6	3.7	6.1	8.3	9.0	7.2	14.2	7.0	4.4	6.0	7.9	10.1	3.7	12.5	7.1	8.5	18.2	16.3	14.6	4.4	14.0	12.0	5.1	7.2	12.0	4.6	11.1	10.7	3.4	18.3	11.0	11.5	3.7	9.5	13.7	14.8	4.8	7.6	10.1	7.7	5.8	8.5	6.9	6.1	3.6	15.7	6.5	2.4	8.0	9.6	10.2	17.1	10.9	8.0	11.9	14.0	9.5	13.3	9.9	5.8	17.2	6.7	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8	101.3	122.0	67.1	53.1	52.4	190.3	63.1	50.9	45.5	75.1	83.7	231.7	56.8	14.9	39.7	13.6	120.9	75.7	23.3	34.0	42.2	62.5	58.7	92.6	44.7	39.4	125.5	69.0	103.2	49.9	13.7	155.3	72.2	49.0	62.3	51.5	160.2	38.7	44.6	126.2	9.7	283.7	90.5	58.5	210.1	183.7	50.1	26.2	126.8	54.0	42.1
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.8	4.7	4.8	7.8	6.0	27.1	4.2	6.3	7.1	3.8	9.9	4.4	9.2	8.5	9.0	14.6	5.8	24.8	5.0	4.6	4.7	5.2	25.6	4.7	5.3	5.1	6.2	7.6	9.1	18.0	9.5	7.7	7.1	5.5	13.4	6.0	5.0	9.1	2.7	11.2	8.4	4.6	14.2	5.7	9.5	3.6	7.1	6.8	29.1	16.4	10.6	8.3	9.3	5.6	7.6	4.6	9.4	9.0	8.6	6.1	5.5	5.7	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5	20.8	5.9	4.7	3.5	4.7	93.3	23.0	10.2	6.7	4.5	31.4	145.3	2.5	1.7	3.3	243.8	10.6	5.9	0.0	5.5	3.0	3.7	5.4	24.2	8.9	7.2	35.0	27.1	10.4	14.2	250.1	5.2	5.0	15.1	4.6	9.4	9.4	5.7	7.0	2.5	6.3	92.4	12.9	3.9	25.8	9.5	4.3	5.4	5.1	8.3	5.8
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	17.0	22.6	19.5	17.2	35.3	22.8	20.5	19.0	25.2	37.1	30.6	25.2	14.7	20.5	27.6	26.1	26.6	16.1	33.5	26.6	34.4	52.1	23.4	20.4	15.1	24.8	23.2	26.3	24.6	28.7	24.2	27.5	21.9	19.9	24.8	21.0	32.3	10.4	20.6	14.6	31.9	17.9	18.2	31.4	23.6	21.9	29.1	15.6	29.3	15.8	16.3	14.7	12.0	11.0	17.2	34.8	23.7	20.9	19.9	22.7	17.4	18.2	25.3	16.2	23.0	20.5	24.3	14.8	23.9	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0	35.7	35.1	55.6	14.2	12.4	85.1	38.9	94.3	16.0	27.3	66.3	110.0	63.6	66.3	62.0	17.1	41.3	50.2	116.8	61.6	49.6	39.9	11.1	22.0	304.8	40.7	122.3	48.9	77.3	77.9	6.8	50.9	41.1	10.1	108.2	32.8	38.5	58.3	45.6	48.1	45.3	119.2	58.2	14.4	60.6	32.8	12.3	68.4	41.5	52.5	15.0
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 89.2;Hepatocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.8;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	29.3	5.4	18.9	6.5	17.3	3.8	19.2	35.6	25.3	12.0	9.9	6.0	4.7	7.4	14.5	5.0	8.2	8.9	8.1	9.6	12.8	9.2	10.8	18.5	7.2	9.0	8.8	15.0	18.2	7.1	28.5	7.9	5.1	10.3	10.7	10.7	8.3	5.8	9.4	18.8	11.5	11.9	12.5	10.3	10.1	8.8	14.5	9.9	23.7	6.9	4.5	8.9	10.1	20.1	1.9	0.3	8.7	0.5	12.9	17.5	3.9	2.8	3.6	4.2	3.1	11.5	12.4	0.8	6.2	5.0	5.7	7.8	3.5	12.7	0.1	4.3	33.8	15.7	3.5	3.7	3.5	9.6	3.7	4.8	7.6	1.8	4.8	7.7	0.5	28.3	11.0	3.6	8.1	2.4	20.9	22.0	5.3	3.6	0.5	21.2	3.5	5.8	1.4	3.1	3.2	3.5	4.3	6.2	0.5	4.2	0.6	1.2	4.8	7.5	1.2	2.0	3.7	3.8	2.3	49.0	5.7	8.4	25.0	4.4	4.3	4.5	0.3	7.0	2.0	4.1	8.7	0.3	7.9	7.2	0.4	12.9	1.4	11.5	8.3	0.3	1.9	14.7	9.3	1.2	12.9	0.5	0.2	17.5	3.9	18.9	17.3	35.6	25.3	12.8	9.2	8.8	15.0	10.3	9.9	8.9	9.1	18.2	17.3	14.7	21.8	11.1	76.5	5.3	14.8	26.2	3.9	0.8	8.3	23.8	6.4	20.4	30.1	46.7	16.8	2.1	11.6	13.9	89.2	122.4	2.4	19.1	17.2	24.5	6.9	9.6	20.1	6.5	11.8	13.6	9.9	12.0	21.3	12.2	19.4	44.1	14.9	0.0	15.3	7.4	50.5	12.9	2.2	38.3	16.9	13.4
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726951	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 142.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 149.4;OE19: 264.4;SiHa: 169.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		310000	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	31.3	24.2	12.8	6.4	20.7	0.6	77.1	2.7	9.1	7.6	23.2	7.8	5.7	29.5	3.9	8.6	36.3	8.2	77.2	9.3	9.9	7.5	44.7	1.2	17.2	6.9	11.3	6.0	3.7	2.5	7.0	3.7	3.5	25.5	9.8	20.8	20.2	10.5	7.6	7.6	2.3	17.7	22.7	10.4	6.0	142.1	3.8	4.9	0.1	25.7	69.7	16.2	21.2	18.9	5.2	3.2	0.9	3.2	15.1	12.3	4.4	13.1	149.4	12.5	55.9	31.2	45.3	4.7	22.3	40.0	23.0	35.6	18.1	85.3	0.4	26.5	115.2	40.2	13.8	4.8	25.1	11.8	5.3	0.2	0.6	37.0	131.8	41.5	3.1	10.7	10.6	15.9	39.9	4.6	34.6	57.0	1.0	5.4	0.9	122.9	42.6	0.6	5.7	6.6	264.4	14.5	1.0	2.6	6.1	45.9	47.9	4.5	1.0	169.7	24.1	99.3	14.9	39.0	10.5	38.6	23.2	9.6	8.7	17.5	0.7	2.9	0.6	29.7	1.7	114.7	0.6	3.2	0.2	5.7	0.3	2.9	5.2	6.6	7.2	3.2	2.1	2.1	4.7	0.9	15.1	0.3	1.2	12.3	4.4	12.8	20.7	2.7	9.1	9.9	7.5	11.3	6.0	25.5	4.9	23.8	13.4	1.4	19.5	4.6	4.0	4.5	203.8	259.6	28.4	40.1	3.9	2.1	124.3	22.1	0.3	55.5	72.0	0.0	134.0	3.1	13.1	25.1	19.6	3.2	12.5	3.2	19.5	31.9	3.3	0.9	23.3	8.2	16.9	222.8	60.8	7.6	63.7	49.1	11.3	24.5	10.7	6.5	17.6	0.2	1.5	4.0	1.6	4.4	33.4	25.4
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"monocytes: 212.8;Proximal tubular cells: 716.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.7	21.6	13.2	29.0	23.3	13.8	14.2	12.4	15.9	11.5	12.9	22.7	4.9	11.2	45.3	21.3	26.9	9.8	13.5	8.6	9.0	26.1	11.5	6.9	26.5	22.7	19.0	6.9	22.1	8.5	10.3	13.9	13.0	16.5	11.1	14.6	39.2	6.7	9.5	28.4	7.9	12.8	17.9	26.9	18.0	14.7	15.7	32.7	17.3	6.8	2.8	5.1	18.8	8.0	39.4	24.7	11.0	4.8	19.1	10.8	4.2	14.4	5.4	14.6	33.1	3.4	12.7	21.0	21.3	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5	8.9	17.3	8.1	35.0	31.3	32.4	60.5	50.9	22.7	10.3	24.4	9.8	36.3	137.6	19.8	39.2	32.9	25.6	23.3	55.3	41.3	45.4	32.3	12.8	167.7	66.5	39.7	4.6	20.3	34.6	38.3	33.1	71.3	64.1	212.8	19.0	47.3	40.8	17.3	38.5	716.7	18.8	25.8	46.2	7.0	10.1	36.0	26.1	17.3	20.9	42.3
NR1D1	"ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092787-40100725	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 57.4;Bipolar cells: 62.8;Suprabasal keratinocytes: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 16.3"	"Group enriched"	"Detected in many"	6	"monocytes: 4.2;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	19.4	15.1	12.2	7.6	14.7	6.0	30.5	30.7	32.5	45.9	13.9	6.4	17.3	15.2	16.5	6.1	16.8	10.7	8.2	43.7	8.8	5.2	9.8	14.8	12.7	8.8	4.7	11.7	33.3	8.3	4.8	10.9	7.3	6.1	15.5	5.5	28.0	53.0	18.6	51.2	79.3	8.8	27.3	6.0	7.8	7.9	7.3	6.8	1.8	13.9	11.7	10.6	28.0	25.4	1.8	1.1	0.1	4.2	0.8	16.3	1.5	2.8	4.2	0.9	3.4	5.0	3.4	1.2	6.4	10.5	2.1	2.7	2.7	10.5	3.5	3.9	7.3	7.1	8.3	2.2	9.6	1.6	3.0	2.3	2.5	4.2	7.1	8.1	3.8	3.8	7.5	7.0	7.2	15.5	7.0	2.6	4.2	3.7	32.9	2.0	2.0	5.6	3.3	1.6	5.8	6.7	4.0	1.3	10.8	2.9	2.6	2.8	1.6	4.0	5.3	6.5	1.6	2.5	3.2	2.6	9.5	9.4	7.7	5.0	11.9	18.1	1.4	12.9	2.2	7.3	0.0	0.4	0.0	3.9	1.6	16.3	1.5	4.9	5.7	0.9	1.8	4.5	3.2	0.1	0.8	4.2	1.1	6.5	1.5	12.2	14.7	30.7	32.5	8.8	5.2	4.7	11.7	6.1	6.8	3.0	1.3	2.4	32.1	57.4	62.8	5.2	5.1	0.0	6.8	1.8	3.9	2.2	6.6	11.9	1.6	10.5	24.4	0.0	10.1	1.0	6.6	19.6	2.3	25.4	2.2	39.7	7.9	4.3	1.8	0.4	20.1	4.6	18.6	0.0	4.3	27.8	19.9	6.6	36.4	6.9	29.2	6.5	18.6	0.5	7.5	70.9	1.9	6.1	3.6	21.3
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.8	9.7	14.1	12.4	8.5	6.8	11.2	8.3	8.6	12.7	9.9	11.7	7.9	13.6	6.1	9.3	8.0	9.1	15.1	8.4	13.0	13.0	10.8	11.3	8.2	7.9	6.2	13.8	11.3	5.8	7.9	12.5	12.1	7.3	9.3	13.3	13.6	10.5	7.7	10.8	27.0	13.0	13.1	10.9	8.7	17.2	11.4	12.1	7.2	8.7	12.2	13.3	12.5	13.0	8.4	12.0	8.1	13.2	7.2	7.2	10.0	8.4	15.2	11.5	11.4	24.2	7.6	12.8	13.9	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2	3.0	6.2	3.7	2.8	6.0	10.2	5.1	5.1	13.4	5.7	3.5	9.8	2.1	0.0	2.1	0.3	6.7	3.2	0.0	3.1	3.5	3.7	4.4	4.7	4.7	2.6	9.5	6.4	8.0	5.6	1.4	4.9	5.8	5.0	2.8	5.0	5.6	2.4	5.8	4.2	2.2	10.4	6.5	3.6	6.7	6.0	6.8	2.9	9.2	3.9	2.6
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;parathyroid gland: 18.6"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 23.1;EFO-21: 23.1;RH-30: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No			"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	8.2	1.8	4.2	2.0	13.0	0.0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1.0	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.0	3.4	23.1	0.2	9.3	1.0	10.7	5.7	3.9	4.4	3.3	1.7	0.8	0.0	23.1	10.4	1.9	4.8	4.8	4.6	2.1	0.0	1.3	0.0	3.7	1.8	1.9	0.0	0.0	4.8	3.1	2.5	0.8	7.6	8.4	0.0	0.0	16.8	3.1	0.5	0.1	0.2	4.5	0.0	1.4	0.0	33.2	4.0	2.5	5.9	2.7	0.1	2.6	0.8	0.2	15.9	1.2	0.1	6.2	3.8	12.9	1.4	6.8	0.0	0.0	0.3	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.0	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3	0.0	3.7	0.0	32.0	11.9	30.8	46.0	2.5	0.0	5.7	7.0	0.0	0.4	3.3	5.0	0.3	46.6	0.0	23.3	8.3	4.1	9.2	4.4	0.0	10.5	6.1	38.1	0.0	119.1	9.7	1.7	3.7	1.3	10.1	1.0	2.0	1.7	11.7	0.0	2.8	1.4	2.6	0.0	14.4	0.7	5.5	13.9	0.2	0.9	0.9	3.7
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Group enriched"	"Detected in some"	5	"Ito cells: 54.6;Peritubular cells: 27.3"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	11.6	0.5	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2	0.0	2.2	0.0	4.6	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.4	0.4	2.1	0.0	0.0	0.2	0.0	0.0	54.6	3.4	4.0	5.5	0.0	1.7	0.0	0.0	1.8	0.0	0.0	27.3	0.0	0.4	0.0	1.9	2.4	7.9	0.1	0.3	0.0	0.0	0.0
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.6;NTERA-2: 21.0"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.1	0.0	8.8	11.2	0.0	4.7	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.7	5.6	0.7	33.6	11.5	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.8	4.6	3.0	11.1	1.9	7.9	10.4	0.0	0.0	9.5	0.2	12.7	0.0	21.0	0.0	8.5	0.0	7.1	0.0	2.1	0.0	0.0	6.6	2.0	0.0	1.8	5.2	0.0	0.0	4.6	2.4	11.1	0.7	0.0	4.4	2.0	7.2	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1	0.0	0.0	0.0	4.8	13.6	1.5	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	9.4	0.0	0.0	0.0	1.3	0.9	4.1	9.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	10.2	8.1	0.6	5.0	0.0	0.0	0.9	2.2	0.0	19.4	0.0	0.1	0.0	12.7	13.4	11.9	8.0	0.2	0.0	0.0	1.1
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343713	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	12.0	18.0	21.6	9.6	21.9	10.2	20.6	14.0	25.5	14.9	14.9	26.0	15.4	12.8	15.7	30.2	14.5	20.5	12.3	16.0	17.3	18.6	10.7	17.5	11.2	12.2	19.5	19.0	28.3	20.9	12.0	19.0	14.1	20.5	16.5	15.3	15.7	16.1	13.0	30.8	13.9	10.1	14.7	20.7	11.3	13.0	8.6	19.1	18.6	3.8	13.2	13.8	14.4	12.1	16.6	15.8	14.3	12.2	14.3	22.2	11.2	23.8	9.8	12.8	4.5	8.8	16.3	9.2	11.5	26.1	13.3	14.0	6.7	11.3	6.6	9.6	14.3	5.1	10.5	11.5	28.4	13.6	24.8	10.3	14.3	18.5	12.6	25.6	11.0	5.9	16.5	18.4	17.2	32.4	18.2	27.5	23.2	4.0	27.1	19.5	14.8	11.4	10.3	7.9	10.6	28.3	14.8	8.0	16.7	13.1	7.8	2.6	10.4	18.7	7.1	10.8	12.0	5.7	11.9	17.7	11.5	10.4	7.5	11.9	6.1	9.9	11.7	14.4	10.6	14.3	14.3	12.2	9.7	11.7	10.3	16.7	16.6	19.2	15.2	15.8	15.0	22.2	19.6	4.5	14.3	10.7	14.7	19.7	11.2	21.6	21.9	14.0	25.5	17.3	18.6	19.5	19.0	20.5	19.1	3.0	5.5	15.9	17.8	25.0	13.1	18.6	43.3	17.4	11.4	15.7	5.9	33.9	74.6	22.6	9.7	21.5	18.6	0.0	34.7	35.6	23.1	17.1	12.7	31.0	32.5	7.9	21.4	30.1	38.4	21.8	25.3	23.9	21.9	32.5	29.1	16.2	26.1	26.9	18.0	39.6	12.8	25.8	23.6	35.8	17.5	27.6	15.8	25.3	31.4	15.7
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		110000	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.8	21.1	7.2	12.2	4.7	4.0	6.7	4.1	3.0	4.8	3.8	19.6	5.4	7.1	2.7	4.6	6.1	10.8	7.7	7.3	7.8	21.6	5.6	10.4	7.2	20.3	11.3	11.0	10.0	5.0	9.4	5.3	11.8	10.2	21.4	7.1	6.6	5.7	14.0	23.8	6.9	16.1	4.0	12.3	8.9	20.4	9.4	11.4	15.2	17.0	8.8	12.5	15.9	3.4	12.5	14.6	12.9	8.3	3.0	7.2	8.6	6.1	14.1	14.4	5.0	20.8	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3	14.9	22.4	43.5	59.4	53.1	115.6	43.3	63.7	46.8	14.8	40.1	111.9	28.0	11.6	15.4	3.0	55.9	18.4	0.0	24.5	26.3	42.3	39.4	12.8	52.1	67.2	160.5	47.2	84.7	91.0	4.0	34.8	58.5	50.6	22.6	24.7	115.6	20.8	19.8	59.4	19.2	125.0	58.2	46.4	44.7	78.0	52.7	16.4	20.1	25.2	59.3
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 411.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.0	9.1	10.2	34.0	14.1	11.5	16.3	13.0	9.4	6.9	46.9	14.6	8.2	3.6	13.0	6.1	7.4	25.5	8.2	14.4	12.5	5.4	30.7	4.4	23.9	32.7	15.9	7.4	30.5	27.5	9.6	21.6	47.1	53.1	14.8	31.1	11.5	10.7	6.0	14.8	15.2	14.4	14.4	12.0	12.4	8.2	8.8	11.2	42.3	7.4	9.5	13.2	25.9	36.5	15.3	18.8	20.8	20.1	8.0	4.7	12.0	10.3	6.5	8.1	12.1	4.2	12.6	24.4	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3	17.9	42.6	40.8	110.6	103.7	39.3	226.3	94.3	91.0	31.8	59.3	58.9	156.3	306.7	20.9	78.9	50.0	102.5	327.1	14.7	23.0	86.0	142.6	25.3	48.9	37.7	39.7	146.0	28.8	34.5	17.0	36.2	31.8	101.3	12.6	83.5	411.5	37.2	85.6	43.9	43.1	40.3	71.1	166.9	28.7	7.7	84.6	137.0	29.9	64.3	133.5
OBSL1	KIAA0657	ENSG00000124006	"Obscurin like 1"	O75147	2	219550729-219571859	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 82.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 829.2;Late spermatids: 1255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.8;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.7;granulocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.0;SK-BR-3: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036404, HPA036405"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA036404: AB_10670437, HPA036405: AB_2675104"	"unprognostic (2.36e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.27e-3)"	"unprognostic (2.89e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.16e-1)"	10.7	26.9	13.4	7.0	11.5	1.2	11.7	18.0	16.2	17.6	8.7	10.3	10.5	3.8	18.2	23.3	7.3	19.9	14.5	30.7	12.8	8.2	19.6	14.5	9.3	3.4	5.5	10.9	82.2	35.6	23.5	16.6	19.3	11.5	15.1	2.3	19.1	25.5	19.1	21.0	14.8	4.8	10.5	8.8	8.2	10.3	15.5	11.5	0.8	34.1	12.4	2.6	10.1	12.1	0.1	2.7	6.8	0.4	0.1	0.2	0.0	9.5	6.4	11.9	24.7	8.2	6.1	45.0	7.2	10.6	9.2	8.5	5.6	14.9	0.0	15.3	9.8	8.9	9.8	9.2	5.4	1.9	0.0	16.1	20.7	6.2	28.3	6.2	0.5	0.1	16.5	4.5	2.1	3.5	16.4	1.0	0.0	8.5	0.2	6.5	23.6	0.0	5.9	28.2	2.7	6.6	10.6	10.4	0.0	16.6	9.0	5.2	17.8	8.2	43.7	16.4	31.4	4.0	17.9	2.4	9.8	10.6	3.0	2.8	0.0	0.0	0.0	5.7	0.0	9.7	6.8	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.8	0.1	0.4	2.7	0.0	0.0	13.4	11.5	18.0	16.2	12.8	8.2	5.5	10.9	11.5	11.5	8.9	14.8	0.0	19.2	7.4	33.3	45.9	25.5	8.1	10.3	50.6	2.0	55.5	44.7	13.5	829.2	12.0	2.0	0.0	10.7	57.4	14.5	10.9	4.6	13.9	6.6	39.7	19.7	10.4	1.0	1255.6	71.4	3.2	13.5	1.0	3.1	79.6	9.7	2.5	69.6	15.4	9.5	12.9	17.5	239.3	51.1	5.8	72.3	0.0	2.3	7.8
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 187.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.2	9.5	4.4	11.0	7.5	6.8	5.2	5.5	6.5	7.0	7.6	4.7	7.0	7.0	3.6	6.9	6.1	7.7	6.7	5.6	6.5	8.2	8.1	5.3	9.6	5.4	6.4	5.0	5.9	7.5	5.2	7.2	4.9	7.7	5.5	5.8	6.7	11.1	4.9	6.3	7.9	10.9	8.0	2.3	7.5	6.3	6.5	9.1	4.9	5.6	4.3	7.6	7.3	4.7	7.3	10.8	6.3	4.6	7.8	4.6	5.8	12.0	4.5	187.1	46.7	6.7	7.0	7.1	3.1	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0	8.9	21.1	23.0	19.4	19.7	31.7	8.5	10.2	17.4	17.0	26.2	25.5	11.3	8.3	13.0	1.5	18.5	26.4	0.0	15.9	12.0	16.5	23.0	6.9	22.9	14.5	27.0	46.2	18.4	24.7	1.5	19.2	19.5	25.3	21.6	26.6	16.0	17.8	15.8	22.3	20.3	25.0	12.9	13.3	5.9	10.9	22.3	25.7	30.9	17.4	22.8
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.7	8.1	16.3	11.3	11.4	13.2	18.5	15.7	21.6	22.8	24.8	10.5	11.6	19.7	8.0	18.8	9.8	11.1	21.8	16.2	30.1	20.8	8.9	21.5	17.3	11.4	13.6	13.3	13.2	10.4	19.1	21.0	34.1	21.5	14.2	25.5	16.3	11.4	39.0	5.0	25.6	9.6	17.1	11.5	9.7	8.9	13.6	15.2	14.0	13.5	8.5	13.1	17.2	43.6	10.7	18.7	14.3	8.7	12.9	14.3	14.2	21.7	23.2	8.7	10.3	14.5	19.7	16.6	28.5	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2	11.9	26.3	13.3	24.0	39.2	11.8	26.6	2.5	12.0	27.3	26.2	19.6	9.4	16.6	25.2	3.1	17.1	28.7	0.0	12.5	15.6	14.9	44.7	15.1	17.8	13.4	20.6	23.2	12.3	32.9	1.4	8.9	28.2	6.8	33.3	18.0	7.6	33.8	24.6	12.0	19.4	5.5	12.9	26.7	12.7	15.0	45.4	27.6	17.5	15.3	110.3
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell type enhanced"	"Detected in many"	4	"granulocytes: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.4	7.7	16.8	7.6	6.8	11.5	13.4	13.1	9.4	12.4	14.7	11.0	15.3	10.2	4.8	11.3	16.2	5.9	11.7	13.8	19.7	11.8	9.4	10.8	5.2	0.7	4.5	18.2	16.0	8.5	8.4	14.6	21.7	11.0	2.9	12.0	7.1	18.0	22.6	0.8	11.6	8.4	24.7	47.4	6.6	17.8	21.7	0.4	3.1	9.5	7.2	7.1	7.0	3.0	5.5	17.3	13.4	8.3	0.2	8.3	14.4	44.3	10.9	49.6	25.5	6.8	6.9	12.2	8.9	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6	3.0	21.5	16.1	27.9	10.5	48.2	3.1	33.1	41.5	33.0	24.4	7.9	23.0	38.1	26.3	31.5	3.0	46.3	0.0	49.4	46.4	13.1	25.6	126.2	10.9	45.2	1.6	36.2	3.1	43.9	20.0	13.3	71.3	28.7	94.6	47.0	14.0	41.8	55.2	12.4	28.6	6.7	12.9	18.2	25.6	42.1	9.2	79.4	12.2	47.1	27.2
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 81.5;Leydig cells: 31.7;Peritubular cells: 76.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.8;HAP1: 8.8;HDLM-2: 11.0;NTERA-2: 8.6;SCLC-21H: 11.2;SH-SY5Y: 7.0;U-2197: 6.8;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.8	1.0	1.4	0.0	8.8	0.5	1.2	11.0	0.3	0.0	1.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	2.0	5.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	8.6	0.0	1.9	0.1	4.0	0.0	0.8	0.0	11.2	7.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.6	4.3	6.8	11.7	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9	3.0	1.4	0.0	14.1	0.2	81.5	0.8	12.7	0.0	1.2	0.0	0.0	0.3	0.0	3.0	3.4	2.4	0.0	0.0	11.6	0.3	5.8	1.3	1.1	0.0	0.2	6.4	3.5	0.6	0.3	4.7	31.7	2.0	0.0	1.0	0.0	19.0	7.3	0.0	76.4	0.5	5.5	0.0	0.4	1.1	0.6	1.0	5.6	2.2	0.0	0.9
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 45.4;MCF7: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.9	45.4	6.8	10.3	2.1	2.3	20.5	8.6	3.5	5.8	5.9	29.7	15.3	4.1	13.1	5.4	7.6	6.6	3.7	6.8	2.2	10.9	10.4	4.8	8.3	14.4	3.4	4.9	7.1	2.7	3.0	5.4	3.9	3.8	7.5	6.3	9.7	3.2	3.4	50.0	5.2	5.4	12.3	15.9	10.9	5.3	5.3	3.1	5.6	19.8	21.7	15.0	8.7	39.0	9.7	3.7	17.3	8.2	12.5	9.9	17.0	11.3	15.3	3.7	3.5	3.4	12.1	2.9	11.8	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5	0.0	1.0	0.5	15.0	12.8	14.8	1.2	20.4	6.7	0.0	17.4	23.6	35.6	26.6	18.7	2.7	15.8	35.5	0.0	17.2	46.7	10.8	17.8	5.7	10.5	8.3	20.6	43.0	12.3	5.6	4.9	10.9	2.5	6.8	14.4	30.6	14.1	16.5	40.3	9.9	10.6	13.1	0.0	7.2	5.7	17.7	16.4	54.7	8.7	29.9	20.6
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 10.2;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0.0	0.7	1.0	2.2	1.0	0.7	3.4	0.6	4.0	3.3	1.0	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2.0	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1.0	1.7	0.0	0.6	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	5.7	11.7	30.3	13.6	4.0	3.3	1.6	8.8	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8"									HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.7	0.0	0.2	0.1	0.0	0.0	4.4	0.0	0.1	0.6	0.4	14.8	2.0	0.1	2.4	0.0	0.9	23.0	3.3	4.9	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	14.1	0.2	3.3	0.2	0.0	3.9	1.1	0.2	0.0	3.2	0.0	0.3	0.4	2.7	2.0	0.2	0.1	1.8	1.1	6.0	5.4	1.3	1.9	7.8	0.2	1.3	0.9	7.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.4	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2	0.0	3.4	0.0	6.8	8.8	3.9	0.0	7.6	4.0	4.5	5.2	0.0	38.8	11.6	4.0	5.9	0.0	0.0	0.0	3.7	1.2	0.6	4.0	0.0	0.0	3.5	0.0	4.7	0.0	0.3	4.5	1.7	0.3	1.7	0.0	0.8	1.4	2.7	0.0	1.8	0.0	0.0	0.0	0.1	1.6	1.5	16.7	7.6	1.3	1.9	6.8
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PAN2	"hPAN2, KIAA0710, USP52"	ENSG00000135473	"PAN2 poly(A) specific ribonuclease subunit"	Q504Q3	12	56316223-56334053	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.74e-3)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (4.19e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	8.1	13.4	12.8	7.1	17.7	7.4	9.9	21.7	17.6	9.6	9.5	16.1	16.4	11.0	11.2	17.6	7.4	11.3	7.8	9.8	13.9	5.1	9.7	17.6	8.7	9.0	19.7	7.0	17.8	12.9	24.3	30.7	9.2	14.6	9.1	9.6	12.6	10.0	14.1	9.1	9.4	10.7	8.8	16.4	10.6	10.5	18.2	19.4	15.3	20.2	4.8	11.0	11.0	9.2	3.1	7.6	3.9	8.1	3.8	5.2	3.4	2.8	4.4	10.8	3.5	9.5	10.8	7.1	2.2	3.0	5.0	2.3	2.6	5.7	7.9	8.6	4.3	2.7	6.0	12.7	8.4	2.8	3.5	6.2	10.1	4.2	2.5	8.4	2.2	5.4	10.1	11.4	5.3	15.5	13.2	3.7	16.8	6.8	19.9	2.9	6.2	7.5	5.6	3.6	4.8	2.9	6.5	7.7	14.2	4.9	2.3	8.6	7.7	4.2	5.5	5.4	12.6	7.1	4.4	1.6	5.2	5.1	2.3	2.0	16.8	6.6	5.2	6.1	4.7	4.2	3.9	5.8	2.3	2.4	8.1	3.7	3.1	1.9	3.5	7.6	2.7	4.1	5.2	0.4	3.8	3.8	2.9	3.0	3.4	12.8	17.7	21.7	17.6	13.9	5.1	19.7	7.0	14.6	19.4	8.9	17.1	4.7	4.8	4.5	25.5	9.0	5.1	16.0	10.3	5.2	25.5	6.5	1.7	2.4	1.2	6.0	5.5	0.0	1.8	4.1	5.6	3.7	5.8	15.3	4.7	14.3	13.8	12.9	5.4	2.1	10.3	6.3	1.7	2.8	9.6	7.2	3.3	8.2	6.0	2.8	16.3	6.5	3.1	19.1	6.1	3.3	4.2	5.7	8.5	2.7
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.1	4.5	10.9	3.2	0.2	5.0	0.4	23.6	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.0	1.4	15.1	0.2	8.4	1.8	10.3	15.7	7.9	0.5	0.1	6.8	14.7	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	0.2	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.3	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8	3.0	6.9	15.7	7.9	6.8	5.9	2.0	7.6	1.4	1.2	8.7	13.7	1.9	1.7	7.6	4.3	7.1	15.1	0.0	4.9	3.0	6.7	4.0	19.5	19.5	10.9	0.0	18.4	11.1	13.9	5.9	14.7	9.2	6.8	30.7	13.6	11.1	6.5	11.2	10.6	20.3	20.2	6.5	8.9	10.0	1.3	4.1	1.1	20.8	12.7	3.3
PARP11	C12orf6	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	7.1	14.5	11.2	8.6	9.2	3.7	8.3	11.0	9.1	6.4	5.4	5.6	4.8	4.9	10.2	7.5	5.0	6.3	5.6	5.1	6.1	5.7	5.7	5.7	6.3	12.8	5.0	5.7	13.1	6.6	10.0	10.4	4.1	7.6	12.0	5.7	7.2	6.6	6.0	4.1	3.9	6.5	7.2	6.1	9.2	4.2	12.8	5.6	16.9	12.3	2.7	12.1	8.3	5.8	10.7	10.2	18.3	10.2	8.2	12.5	7.1	2.3	1.9	12.8	2.0	4.1	6.5	3.6	2.8	4.8	5.0	5.0	7.3	1.8	7.0	1.8	6.2	6.3	2.0	4.2	4.2	8.1	14.1	4.2	10.0	0.0	5.4	4.6	6.7	3.8	5.2	3.3	3.9	11.1	0.0	3.7	13.7	2.6	5.7	7.0	3.3	3.5	2.6	4.7	2.4	0.3	7.1	8.7	1.6	2.3	5.3	0.8	2.9	2.8	2.4	3.6	14.6	0.4	6.1	7.2	4.3	4.3	6.6	3.8	2.7	5.9	9.8	4.1	3.7	1.1	18.3	10.2	10.2	9.2	8.5	12.5	10.7	10.2	6.7	10.2	10.1	11.7	9.4	10.2	8.2	6.4	8.9	4.3	7.1	11.2	9.2	11.0	9.1	6.1	5.7	5.0	5.7	7.6	5.6	8.9	7.4	11.8	4.3	1.6	11.1	3.2	2.5	6.7	2.3	1.8	2.0	3.0	0.0	3.1	60.8	4.5	2.1	0.0	2.6	1.5	4.6	8.0	14.9	3.4	6.2	3.2	3.5	8.0	9.1	25.5	9.8	6.9	1.7	3.6	3.7	6.2	2.9	4.2	8.1	3.3	6.9	6.5	5.1	7.5	8.7	1.6	2.2	10.2	4.3	3.4
PARP12	"FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023744-140063721	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	3.1	1.8	1.0	3.7	0.9	6.1	2.5	0.1	0.7	2.1	2.2			4.2	2.8	4.2	2.1	2.5	3.1	1.7	1.0	1.0	3.1	3.0	5.2	3.8	1.0		3.2	2.7	2.5	3.3	3.4		2.8	3.9		4.3	1.4	0.9	8.6	4.4	1.5	1.3	6.0	2.3	5.7			3.2		2.7	1.9	3.1	1.0	1.3	3.4	2.0	2.3	3.3	2.4	3.7	2.3	0.0	0.4	1.1	0.5	3.9	0.6	0.5	4.7	8.0	2.7	3.5	1.7	2.8	1.1	4.8	3.8	1.5	4.4	1.3	4.7	4.7	1.4	1.4	1.8	2.1	0.4	1.4	1.6	2.6	2.0	4.3	3.3	5.0	2.7	4.1	2.3	0.0	2.9	4.5	12.1	0.2	1.8	7.0	2.0	0.0	0.0	2.1	2.3	1.4	0.0	2.4	1.1	3.5	0.6	0.6	0.9	9.6	1.5	2.2	0.5	3.5	0.1	0.1	0.4	0.9	6.0	0.8	0.7	2.0	2.2	2.9	1.7	1.1	0.3	1.9	2.9	1.3	1.0	0.6	1.9	3.4	2.3	1.9	0.7	3.3	2.4											6.0	11.7	6.0	6.5	5.8	3.0	4.2	10.2	5.3	5.7	10.4	2.0	4.5	1.7	10.9	0.6	11.7	32.5	0.0	22.8	16.4	5.3	10.8	19.6	9.6	21.5	0.0	23.1	6.2	10.2	0.4	6.6	13.9	6.8	12.6	13.2	2.6	27.2	25.9	6.7	5.6	2.2	0.0	5.9	28.7	11.9	8.7	1.7	8.7	8.0	9.2
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 229.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	5.0	3.2	3.4	4.5	10.7	0.0	2.3	15.6	29.6	45.6	2.6	11.9	0.0	9.8	5.2	16.6	4.6	4.6	4.8	6.0	9.1	0.5	5.5	2.3	4.0	10.9	2.4	2.7	6.4	2.4	5.1	2.0	7.2	12.8	4.9	2.6	8.9	1.0	3.1	9.1	1.6	0.4	0.9	4.3	12.8	3.2	1.6	7.2	6.2	0.2	0.0	6.0	1.3	6.7	0.4	2.2	4.3	8.6	1.6	3.9	0.9	2.1	3.5	0.6	1.0	4.8	5.7	2.8	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9	229.3	87.3	41.0	15.2	14.9	1.1	10.1	30.6	52.2	84.2	24.4	3.9	12.0	3.3	28.1	0.3	61.9	21.0	0.0	35.6	24.3	19.7	23.9	30.2	29.6	32.4	0.0	10.3	67.5	50.6	0.2	25.9	50.6	15.1	94.6	14.3	18.7	33.8	17.5	16.3	7.0	0.8	12.9	18.4	1.6	1.1	9.3	4.0	27.4	11.0	21.3
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6"					"Not detected"	"Not detected"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.3	0.6	0.1	0.0	0.0	1.9	0.2	10.6	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	0.4	2.4	6.6	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.2	0.3	4.9	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.6	0.8	5.1	12.6	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4	17.9	12.8	22.9	0.0	0.5	0.0	0.4	0.0	18.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.5	0.5	6.6	0.0	0.0	2.5	3.5	0.0	0.0	3.2	1.7	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	12.9	0.0	0.0
PARP16	"C15orf30, FLJ20509, FLJ25281, pART15"	ENSG00000138617	"Poly(ADP-ribose) polymerase family member 16"	Q8N5Y8	15	65234460-65300618	"Enzymes, Predicted membrane proteins"	"Unfolded protein response"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 31.3;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017081	Approved					NA	NA					"HPA017081: AB_10963218"	"unprognostic (1.17e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.61e-2)"	8.9	14.2	12.0	13.1	11.6	8.0	20.4	32.2	17.7	18.6	12.8	5.6	11.9	9.3	13.1	8.5	10.5	12.0	8.7	7.2	9.7	5.3	9.0	18.1	11.5	14.0	11.5	6.2	17.6	11.3	12.7	8.5	9.2	9.1	11.5	10.4	7.5	10.3	21.4	5.4	10.8	9.7	17.7	8.0	9.3	11.0	7.6	12.0	15.1	9.5	6.3	12.4	14.0	25.6	10.1	4.4	14.1	5.3	10.3	14.2	6.0	3.7	3.8	4.2	6.6	3.5	3.6	1.9	1.7	4.6	4.8	5.0	3.1	3.4	12.1	4.8	2.1	10.3	6.1	19.6	2.4	3.6	4.4	7.8	2.0	4.1	4.3	6.5	5.5	3.8	4.2	4.0	1.2	4.9	7.1	4.4	11.6	5.0	4.6	4.1	4.5	11.4	5.9	2.0	19.3	5.2	21.1	7.7	9.1	3.4	3.4	7.3	4.9	5.3	5.1	4.3	3.5	6.0	5.0	1.8	5.7	4.3	3.2	2.6	8.6	10.1	15.8	4.7	8.2	2.6	14.1	3.3	10.0	11.6	5.3	12.9	7.8	11.2	11.8	4.4	10.1	14.2	10.5	13.0	10.3	5.2	3.9	9.2	6.0	12.0	11.6	32.2	17.7	9.7	5.3	11.5	6.2	9.1	12.0	3.0	1.9	6.6	4.9	4.6	10.8	3.9	7.6	4.0	3.4	3.5	0.0	10.7	0.0	5.2	0.7	3.5	4.0	0.0	7.9	4.2	5.6	2.6	0.0	5.1	3.4	3.2	1.7	1.3	1.8	1.8	9.2	1.8	3.3	4.6	5.2	6.2	3.7	3.4	7.4	3.3	31.3	6.5	4.7	1.6	26.2	3.8	4.6	5.7	6.0	2.4
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.3	14.9	23.0	17.2	7.6	7.3	16.7	22.7	12.4	28.9	35.8	14.1	19.5	15.1	10.3	7.1	25.8	19.2	30.6	10.4	34.2	12.1	14.9	13.8	18.1	23.5	6.8	28.6	7.9	5.0	8.9	18.0	19.9	8.0	14.8	18.5	14.6	20.7	19.8	12.6	14.6	12.3	12.6	23.2	23.3	18.3	31.3	9.8	11.5	10.6	16.0	11.0	25.3	14.1	6.6	15.3	13.0	9.7	10.1	17.6	26.7	12.1	18.4	19.4	24.7	20.1	7.3	12.7	19.5	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4	23.8	6.2	10.4	9.3	5.8	26.8	12.3	5.1	36.1	21.6	7.0	11.8	19.1	6.6	10.5	7.3	10.0	3.4	23.3	7.7	17.9	8.4	3.7	8.1	9.6	10.2	28.6	4.6	6.2	4.9	7.3	10.6	6.4	8.5	4.6	4.2	21.9	8.0	5.5	15.9	5.6	21.7	6.5	9.5	17.7	33.3	4.3	12.5	4.4	5.2	4.6
PARP3	"ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	15.2	29.2	11.2	14.6	17.1	2.8	13.6	5.7	18.8	7.5	17.3	10.6	14.3	26.9	10.3	14.1	10.8	12.1	16.2	12.4	11.6	12.3	17.3	22.3	13.3	9.7	12.0	14.2	8.2	3.9	34.2	9.8	6.2	12.2	12.1	10.7	13.2	14.0	18.1	14.6	6.1	26.3	18.9	8.7	12.8	15.8	4.5	10.2	2.9	17.0	9.6	10.3	15.1	8.9	9.0	2.9	1.7	4.1	6.6	4.9	2.3	5.9	3.3	0.9	9.0	8.7	16.5	2.5	9.8	15.8	12.1	13.6	1.9	15.8	8.1	2.6	16.1	7.0	0.9	2.5	8.8	5.9	19.9	0.6	4.1	6.7	6.3	9.4	2.5	5.7	13.0	5.5	7.7	5.2	18.6	6.0	5.1	1.7	7.7	9.3	1.5	2.2	6.3	1.2	2.0	9.5	3.5	1.5	7.0	7.4	6.5	1.0	3.4	9.9	2.8	5.2	0.7	3.4	2.8	13.6	24.4	5.1	3.6	5.9	11.8	14.3	3.5	15.7	7.4	7.6	0.0	2.6	1.7	3.6	4.1	3.4	9.0	4.2	2.8	2.9	4.3	4.9	4.9	0.1	6.6	2.0	1.2	4.3	2.3	11.2	17.1	5.7	18.8	11.6	12.3	12.0	14.2	12.2	10.2	6.0	10.6	10.1	10.0	2.4	1.7	5.9	12.7	9.4	7.9	0.0	0.0	0.4	6.6	8.8	5.9	3.0	15.8	0.0	5.7	0.3	4.5	3.4	4.6	8.5	3.4	0.0	2.9	1.8	2.2	8.4	4.4	2.9	6.8	6.4	11.0	4.0	7.9	3.5	1.4	16.1	2.1	6.5	6.2	3.2	1.8	1.3	0.5	5.3	11.2	6.4
PARP4	"ADPRTL1, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420926-24512810	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 83.0;granulocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Cytosol		Yes	No			Cytosol		"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	25.3	24.7	6.6	16.7	12.9	11.6	14.6	2.3	7.0	17.8	39.4	16.7	21.6	22.9	19.1	11.2	22.2	14.9	23.8	11.3	7.9	5.6	28.8	17.3	17.8	16.5	14.6	4.4	15.9	15.5	11.2	12.6	14.8	12.5	16.1	24.1	14.0	17.7	30.9	6.5	10.2	49.9	15.5	20.5	28.4	20.4	7.0	12.1	28.8	18.2	11.3	26.2	23.3	13.2	9.0	16.4	26.1	18.6	11.8	12.9	10.6	14.6	13.1	6.4	11.6	17.8	25.4	5.4	17.1	22.4	15.0	13.4	5.3	38.2	11.0	17.1	15.5	16.6	17.1	9.6	17.3	12.3	25.1	6.7	15.7	12.2	12.3	10.2	20.1	15.6	14.6	5.8	12.4	6.6	29.4	24.6	8.6	4.4	4.9	17.7	6.8	12.6	9.7	7.3	34.7	16.2	12.0	12.1	15.4	27.9	30.2	5.9	7.5	12.5	5.0	11.8	8.8	2.5	16.6	34.8	6.8	7.1	8.7	17.4	5.6	6.4	14.5	12.4	10.6	14.8	25.2	12.4	26.1	12.9	15.3	12.9	9.0	10.8	12.8	16.4	5.1	8.1	9.6	14.3	11.8	18.6	6.2	12.7	10.6	6.6	12.9	2.3	7.0	7.9	5.6	14.6	4.4	12.5	12.1	47.6	43.8	12.3	5.6	2.5	6.0	15.5	20.4	83.0	64.8	24.4	2.0	4.6	5.0	20.5	3.5	18.8	54.7	0.0	19.4	7.7	6.9	8.6	92.8	12.9	15.7	1.6	4.7	36.2	23.1	3.1	10.9	25.1	8.5	31.5	26.9	7.0	25.8	48.9	7.8	15.6	6.9	6.5	6.2	2.8	7.2	3.3	1.6	15.2	26.0	14.8
PARP6	pART17	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	13.7	16.6	28.0	12.8	32.4	25.1	26.5	46.6	41.2	15.5	16.2	16.9	18.2	14.1	23.3	23.8	14.0	17.0	20.2	18.4	26.1	22.4	14.3	9.0	15.7	16.8	19.9	21.8	26.3	20.9	20.6	30.8	17.0	19.4	19.3	14.3	14.5	21.3	18.8	23.9	20.3	14.4	19.6	14.2	18.2	18.2	25.1	15.8	9.6	21.7	12.5	15.8	16.3	15.8	4.1	4.0	12.1	5.3	4.3	4.3	2.9	7.3	13.2	13.9	18.1	15.0	12.5	11.3	6.3	9.5	10.4	15.4	8.7	13.3	10.0	3.9	9.5	15.3	9.6	15.3	8.5	6.0	11.9	13.8	14.6	23.1	0.1	12.5	7.5	14.0	16.0	21.0	9.7	26.8	16.4	6.9	16.8	7.4	11.6	8.3	13.3	6.4	13.2	6.4	6.1	0.0	11.9	9.9	7.9	9.6	14.5	39.4	20.9	10.5	8.6	17.1	19.3	10.9	8.7	6.5	13.1	12.0	17.0	9.5	13.1	12.0	10.9	9.4	14.7	9.0	1.7	5.3	12.1	3.8	4.4	2.7	3.3	2.7	4.0	4.0	4.1	4.3	3.2	5.7	4.3	4.9	3.1	4.2	2.9	28.0	32.4	46.6	41.2	26.1	22.4	19.9	21.8	19.4	15.8	20.8	20.5	4.7	8.4	12.8	14.0	14.6	0.0	2.7	15.9	8.7	19.6	5.9	6.6	7.3	49.1	9.8	9.2	0.0	11.2	4.3	9.3	7.6	15.1	4.2	8.1	17.5	16.7	7.4	12.4	137.7	11.5	8.2	15.1	6.4	5.3	7.4	8.1	5.8	9.2	10.3	15.1	6.5	9.5	39.0	8.3	13.8	5.4	7.5	5.6	8.3
PARP8	"FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846522	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"T-cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	6.2	7.8	8.8	17.1	9.5	33.5	5.3	2.4	18.7	5.6	5.5	3.3	0.6	6.8	5.2	5.4	5.2	7.4	12.3	3.6	12.8	8.0	5.8	4.2	10.9	18.2	4.9	11.0	5.9	7.1	9.8	14.4	5.6	5.4	6.1	4.3	4.1	7.6	4.2	1.7	4.2	14.2	5.4	7.0	20.1	10.2	6.4	2.8	9.9	21.9	1.1	12.3	8.8	7.0	7.1	3.9	13.1	5.9	15.5	32.0	9.5	11.6	0.0	5.4	8.6	1.5	2.6	8.6	1.9	7.0	1.9	5.5	0.3	15.4	6.9	8.2	0.2	19.8	5.8	0.9	5.8	4.5	9.7	7.4	5.1	4.7	0.4	2.8	11.9	0.1	3.3	4.9	3.8	2.7	11.6	0.1	10.9	0.7	4.2	2.6	3.8	14.2	15.0	5.8	0.2	2.8	7.2	11.4	7.9	3.5	5.8	6.0	9.3	6.2	10.2	1.6	8.3	0.4	42.0	0.0	0.4	7.3	0.5	5.7	3.1	0.1	13.4	6.5	3.3	7.9	10.3	5.9	13.1	20.6	1.6	32.0	6.0	16.1	23.0	3.9	7.1	10.0	16.7	12.3	15.5	1.1	1.8	9.5	9.5	8.8	9.5	2.4	18.7	12.8	8.0	4.9	11.0	5.4	2.8	29.8	22.6	12.3	4.8	7.1	13.4	4.5	12.7	21.4	21.6	21.0	0.0	17.5	6.6	11.2	19.7	4.5	6.9	0.0	8.8	5.9	9.1	8.6	13.9	3.6	12.9	6.4	14.5	8.6	28.5	11.4	1.1	17.1	8.5	13.6	3.6	0.5	14.3	7.6	2.8	3.7	2.1	6.5	6.9	5.1	5.5	3.4	20.7	90.6	6.5	13.5
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.1;testis: 22.0"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 24.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3.0	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2.0	4.9	3.9	1.4	1.6	4.4	3.4	22.0	7.2	9.0	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1.0	2.7	6.0	3.0	5.0	6.8	9.2	11.6	0.8	1.4	12.3	4.8	1.5	4.5	6.3	5.5	5.1	2.6	1.0	1.1	10.0	12.6	10.4	4.2	3.3	10.6	9.9	7.2	12.6	9.7	0.5	9.8	11.3	0.7	3.3	4.6	1.3	1.9	3.2	11.2	9.3	3.6	3.1	5.7	11.6	10.3	10.2	5.9	4.1	18.5	9.3	3.2	1.7	11.4	16.3	4.9	2.9	5.6	2.1	5.1	4.7	7.1	4.2	6.1	5.6	7.8	6.4	4.8	4.9	12.4	3.8	7.4	5.6	4.8	1.0	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1.0	0.7	6.0	3.0	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2	3.0	9.3	10.6	1.0	2.4	2.3	2.8	2.5	6.7	1.2	3.5	3.9	0.8	0.0	1.2	7.7	2.4	1.8	0.0	1.8	1.5	0.9	2.5	3.5	1.0	1.6	1.6	0.0	27.0	5.3	2.2	5.5	1.9	11.8	1.0	2.9	1.6	0.6	0.0	23.0	1.0	17.7	0.0	0.3	14.7	12.7	1.3	0.2	13.1	2.7	0.7
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 218.2;Spermatocytes: 187.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 61.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	61.3	20.0	19.7	12.5	1.9	3.5	8.3	28.2	13.4	29.0	24.5	6.9	11.4	32.7	10.0	10.8	32.3	16.3	18.9	9.5	31.9	8.0	10.2	7.8	14.2	10.1	0.1	5.1	11.7	0.9	7.8	13.4	7.2	5.2	14.6	16.2	11.5	22.0	34.2	6.9	19.3	6.0	3.5	16.6	17.4	12.1	27.4	8.8	10.9	9.5	7.8	12.2	10.5	12.4	15.8	5.7	13.0	7.8	8.5	19.1	46.0	24.2	29.9	3.1	8.7	15.1	11.6	9.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.9	7.9	0.0	0.3	5.1	0.0	2.3	0.0	0.0	3.1	0.0	0.5	218.2	0.0	1.3	46.7	0.0	40.6	2.9	0.7	0.0	1.0	4.2	0.0	0.0	7.4	1.9	37.5	7.8	0.6	0.0	0.0	4.3	0.0	0.2	0.0	2.8	0.0	0.0	6.5	0.5	187.0	31.0	2.0	5.6	0.0	5.3	0.7
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 968.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.8	17.3	17.7	22.1	38.1	31.5	19.7	35.9	20.5	28.5	36.1	50.2	16.7	27.6	30.5	30.3	33.9	27.2	30.4	35.8	41.2	19.2	44.0	42.2	32.5	49.0	25.5	50.2	51.9	15.7	26.5	32.5	35.2	20.6	26.9	23.4	60.3	27.1	34.0	65.0	24.3	38.3	14.4	21.5	19.4	20.2	23.0	19.9	27.7	16.1	33.8	13.0	27.2	43.5	23.3	22.7	26.3	35.8	20.0	16.8	21.4	31.9	38.9	17.1	26.6	28.2	26.5	33.6	33.4	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2	50.6	33.8	61.0	64.4	155.6	73.9	150.1	58.6	62.9	33.0	75.0	35.3	145.0	66.3	107.5	968.1	68.2	50.9	46.7	96.6	180.3	97.5	60.4	104.1	112.2	107.3	62.0	53.0	50.3	78.3	318.9	66.4	94.5	131.6	139.7	62.0	111.0	87.2	56.9	69.3	69.4	50.7	109.9	107.2	205.7	85.4	137.8	124.0	71.9	52.4	51.7
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.7	11.6	8.1	11.9	16.7	18.6	12.3	22.0	15.7	18.9	16.7	28.3	10.5	7.4	73.8	25.2	19.9	22.5	12.9	16.9	16.2	13.4	9.0	21.2	12.2	12.0	15.0	10.2	18.2	15.7	13.0	18.3	13.1	12.2	20.2	6.9	11.8	16.5	18.8	24.3	6.4	5.4	7.0	18.1	17.3	10.6	10.4	11.9	11.6	16.2	8.0	5.9	14.9	25.7	14.3	11.8	37.7	12.8	30.2	15.1	8.4	20.5	29.7	15.3	29.1	13.6	23.1	14.3	18.9	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6	14.9	18.8	17.9	8.2	12.9	14.3	58.5	17.8	33.5	15.9	14.0	23.6	10.4	11.6	21.4	63.4	19.5	43.0	0.0	19.9	14.2	13.7	9.7	19.7	31.7	32.6	7.9	21.2	25.2	28.9	52.1	18.4	30.0	18.6	33.3	20.4	11.8	20.8	14.8	26.5	19.4	12.4	25.8	13.7	30.0	10.6	18.7	15.6	22.7	20.5	11.0
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;testis: 15.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 21.7;Late spermatids: 58.8;Muller glia cells: 30.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;CACO-2: 17.8;HEL: 21.9;Hep G2: 9.1;NTERA-2: 9.4;SCLC-21H: 6.5;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain					NA	NA					"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.8	1.1	12.0	1.1	11.4	2.0	1.0	3.1	23.9	1.6	1.1	13.7	2.3	1.3	3.2	1.7	2.8	5.7	1.7	4.2	10.0	6.0	1.0	0.6	2.1	0.6	7.8	10.5	4.0	3.1	0.7	1.4	3.6	10.7	2.3	1.3	2.1	1.0	6.4	0.7	0.7	1.1	6.1	10.3	1.0	0.9	15.6	8.7	0.0	0.6	0.0	0.7	0.9	0.4	0.4	0.5	2.7	0.5	0.6	0.2	1.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	17.8	0.0	0.0	4.7	0.0	0.0	0.9	3.9	0.0	0.0	0.0	0.1	21.9	0.0	9.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.2	0.5	9.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6.5	5.2	0.0	0.0	0.4	7.1	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.3	0.6	0.2	2.7	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.2	0.2	2.2	0.6	0.5	0.5	0.2	1.4	12.0	11.4	3.1	11.3	10.0	6.0	7.8	10.5	10.7	8.7	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	6.7	1.2	0.0	0.0	0.1	0.0	0.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	1.7	0.0	0.0	58.8	0.3	0.0	0.0	0.0	0.0	30.2	0.3	0.0	2.5	0.0	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 615.4;Late spermatids: 2143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7000	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	11.8	6.8	5.5	15.5	27.6	14.5	8.1	8.5	18.4	12.0	14.3	26.7	12.4	4.1	4.7	8.9	22.3	9.8	8.3	15.9	7.0	1.2	6.8	9.0	9.4	61.2	29.5	9.0	7.6	11.9	9.2	10.8	8.4	4.3	11.1	12.7	16.7	8.6	8.9	10.0	10.7	11.1	4.4	41.7	7.3	7.1	5.9	14.7	14.4	22.5	7.0	6.4	6.4	35.5	8.3	11.3	9.8	21.4	7.4	8.9	5.8	6.6	7.0	5.6	2.3	4.0	9.2	12.1	8.7	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0	0.0	15.9	13.0	6.8	4.7	11.8	14.9	56.0	10.7	4.5	24.4	0.0	67.4	101.2	15.9	615.4	7.1	65.6	23.3	16.0	30.7	6.8	9.0	9.2	125.6	20.2	15.9	13.4	20.3	10.0	2143.8	25.6	9.3	32.1	21.6	22.6	19.8	17.5	17.3	24.4	119.0	7.1	25.8	11.4	131.3	17.2	5.0	42.4	12.5	30.7	4.5
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in single"	21	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	9.0	6.1	1.2	2.9	1.8	1.4	10.7	7.6	2.0	5.4	4.7	15.0	6.4	16.7	10.1	2.6	2.5	13.0	3.7	4.0	2.2	4.0	31.0	8.5	5.8	21.4	3.7	11.8	6.8	2.8	7.1	4.8	2.3	0.9	3.1	8.6	20.3	1.9	2.9	11.6	9.2	12.4	7.8	3.3	11.2	21.7	1.9	15.5	4.3	5.7	10.4	8.3	13.1	2.3	6.4	0.5	12.9	3.8	4.7	4.7	8.8	5.4	8.7	15.8	10.5	19.7	3.1	8.8	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 253.2"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.1	5.2	0.2	0.7	0.1	11.6	0.0	0.3	8.6	1.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.4	4.0	0.2	6.1	0.2	0.6	0.4	2.1	0.0	0.1	0.0	1.1	0.0	0.0	2.2	5.0	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8	0.0	0.3	0.0	0.0	0.5	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	253.2	0.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.0	0.2	39.2	0.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.9	0.0
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 877.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.3	4.6	9.8	21.9	19.9	21.4	30.1	24.7	24.5	18.4	22.9	12.9	12.7	14.1	16.1	28.2	12.3	19.7	12.4	24.0	16.1	10.2	18.4	19.1	7.4	11.9	32.8	10.7	13.9	13.7	19.9	13.9	23.5	21.7	32.0	4.5	11.0	6.9	17.9	4.2	3.6	12.2	9.9	19.0	18.7	7.1	15.4	10.6	15.7	10.1	9.9	11.0	20.6	19.8	7.8	10.4	13.8	11.0	21.6	15.3	8.1	12.3	12.0	3.2	3.6	14.8	19.6	17.0	11.5	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3	178.6	134.5	154.1	249.6	170.7	50.3	49.5	142.7	231.6	287.8	158.7	39.3	559.5	59.7	337.0	18.9	151.7	227.1	23.3	345.2	636.6	296.9	292.3	254.2	280.2	396.2	66.7	178.5	269.5	152.1	20.5	234.7	267.6	231.2	285.9	259.4	139.7	260.6	167.0	260.3	106.7	46.2	122.9	160.2	185.1	135.1	129.7	877.1	174.3	233.4	256.5
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 542.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.4	30.9	33.6	93.9	30.7	21.9	48.7	45.7	30.6	26.2	42.8	25.6	87.8	23.4	102.6	37.5	72.2	21.3	22.6	43.3	23.1	16.6	13.3	11.2	8.9	56.1	41.2	25.5	31.7	21.5	19.4	28.7	23.1	34.2	53.2	12.0	18.3	63.8	23.0	35.5	24.3	29.1	50.1	66.4	18.0	16.0	26.1	56.6	30.6	25.5	10.7	28.2	41.5	29.9	15.9	41.9	17.0	19.7	29.0	20.7	11.7	50.1	32.1	48.6	21.8	16.4	48.3	30.2	70.3	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3	26.8	33.4	29.0	71.4	30.8	3.3	20.4	96.8	65.6	44.3	40.1	3.9	152.3	13.3	102.2	2.7	35.1	89.5	46.7	79.9	277.0	90.5	103.6	57.6	542.5	131.4	0.0	59.1	95.8	80.7	3.2	54.7	53.4	82.7	48.7	104.5	19.3	96.2	87.1	40.3	54.4	6.1	32.3	34.2	53.4	71.9	25.0	192.7	54.6	97.0	59.2
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.2	5.1	6.4	7.7	29.4	26.7	34.1	15.8	26.5	8.8	24.4	16.3	7.6	0.0	20.6	24.4	5.7	4.4	2.8	9.6	9.4	0.2	3.1	3.6	1.5	19.4	12.2	9.1	0.6	22.8	14.5	6.0	12.6	9.5	29.8	3.5	4.6	21.6	6.0	10.1	2.4	10.6	4.7	18.9	5.3	2.3	4.6	22.8	7.4	4.8	6.9	4.2	7.7	8.6	13.5	10.9	7.5	11.1	16.6	2.3	7.3	10.6	4.2	6.4	1.7	3.7	7.3	7.2	7.7	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5	17.9	27.8	1.5	3.6	4.4	9.3	2.0	25.5	8.1	13.6	5.2	37.3	39.8	0.0	28.0	1.1	21.8	3.3	0.0	25.3	119.9	23.6	13.9	3.5	42.3	10.8	0.0	8.1	37.4	8.4	1.5	22.5	4.5	8.5	1.8	26.1	2.0	13.8	3.5	20.8	4.9	29.6	12.9	7.3	1.2	1.5	3.6	42.0	2.2	16.3	4.3
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 955.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.2	36.1	51.7	81.1	66.6	57.6	92.0	80.9	75.1	42.5	57.3	51.2	65.7	54.0	57.0	79.1	82.6	27.3	38.8	67.7	45.7	42.3	30.6	43.8	28.3	83.1	72.1	44.8	32.9	41.5	52.1	41.1	74.2	78.8	95.7	20.5	37.6	116.5	41.9	39.4	17.2	46.5	43.2	108.3	28.6	41.4	52.7	97.8	60.5	40.2	33.2	66.5	31.9	46.8	45.4	70.0	16.5	76.1	47.0	39.9	51.0	35.9	46.7	110.0	67.8	35.0	53.9	56.4	55.8	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5	53.6	94.6	111.7	205.7	91.5	66.3	27.4	152.8	108.4	161.5	186.7	27.5	420.2	36.5	263.9	6.1	114.4	100.2	23.3	210.7	955.4	173.7	256.1	129.2	285.4	369.6	39.7	151.3	244.9	137.9	12.1	112.2	137.1	189.0	126.2	149.4	95.2	191.3	100.8	126.9	98.3	45.7	84.1	115.4	95.8	139.7	89.6	463.4	112.4	196.3	240.5
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 32.0;U-87 MG: 32.7"	"Low region specificity"	"Detected in all"							"CAB017554, HPA027376"	Approved					NA	NA		22000			"CAB017554: AB_2161138, HPA027376: AB_1855139"	"unprognostic (2.14e-1)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	9.9	16.2	6.8	11.0	10.5	13.4	16.7	7.1	15.6	7.3	15.3	3.3	2.9	15.5	5.4	8.0	11.2	4.4	5.8	27.6	6.9	5.2	6.8	14.2	6.1	21.4	7.2	5.2	19.5	7.2	3.4	7.5	7.9	7.2	6.5	13.1	7.6	14.1	7.6	9.6	24.7	8.4	5.2	10.7	14.2	12.5	11.0	6.7	10.3	5.1	5.0	20.8	18.0	9.8	5.9	2.3	16.0	2.2	1.4	15.8	6.2	14.4	0.6	3.7	9.3	1.5	2.3	5.3	12.7	10.3	6.4	13.7	3.7	3.1	13.7	7.0	3.9	5.3	6.3	2.5	7.9	20.5	2.7	5.1	16.7	3.4	4.3	2.7	8.3	6.2	3.0	2.9	4.4	7.5	8.9	3.4	7.3	3.5	9.5	8.4	1.5	5.2	10.4	9.1	2.9	4.0	5.5	6.1	22.1	3.3	4.6	7.0	8.0	3.3	3.9	4.8	3.3	2.5	3.4	3.9	10.2	3.3	5.3	3.4	32.0	18.5	11.3	32.7	6.0	2.0	12.2	2.2	16.0	2.5	1.5	3.0	4.7	4.2	2.8	2.3	5.9	15.8	9.6	8.5	1.4	1.9	0.4	8.0	6.2	6.8	10.5	7.1	15.6	6.9	5.2	7.2	5.2	7.2	6.7	3.0	5.3	32.2	5.4	44.5	26.8	32.3	5.1	1.4	2.3	3.5	45.2	9.1	5.0	7.7	96.0	8.9	6.0	0.0	3.3	9.6	8.4	5.5	5.7	11.9	8.7	52.4	7.5	23.9	12.9	34.3	3.1	8.8	28.7	5.4	5.2	7.6	9.0	14.0	3.5	1.5	18.9	6.5	12.3	6.3	7.7	37.9	3.4	12.5	6.0	2.1
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.2	11.1	10.0	11.8	8.9	1.2	7.0	10.4	10.5	10.2	0.8	7.0	8.1	11.7	19.5	7.1	3.1	7.4	2.8	10.3	16.3	10.3	7.2	9.1	6.8	6.3	0.0	7.8	18.7	10.8	6.8	0.5	18.5	9.1	10.4	2.9	8.1	5.9	8.2	6.0	0.0	2.4	19.5	9.0	9.1	24.9	10.9	5.7	5.5	7.4	11.2	9.9	3.1	4.7	14.2	18.3	7.2	4.7	12.3	10.1	8.4	5.1	16.0	15.1	4.4	18.0	2.6	7.9	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4	8.9	9.3	13.6	13.9	13.5	20.8	5.0	10.2	1.4	11.4	19.2	5.9	15.1	49.7	8.0	7.3	8.3	46.6	0.0	7.9	3.4	19.5	7.6	1.1	39.8	16.7	41.3	13.3	13.5	13.7	15.0	22.5	7.9	23.6	15.4	45.3	33.6	7.9	43.6	49.5	118.5	9.2	19.4	12.1	3.3	4.4	16.4	6.6	15.8	37.1	8.4
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.6	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.1	9.2	1.9	0.7	10.5	2.1	11.3	6.9	10.0	7.8	5.4	4.9	5.3	2.6	1.3	4.2	4.8	0.7	3.1	0.9	0.9	0.4	5.5	9.6	0.9	14.0	0.5	17.0	7.8	5.4	7.0	9.7	5.4	4.0	7.0	13.5	3.2	17.7	2.5	3.2	14.7	6.0	4.6	6.2	8.3	1.6	0.2	2.6	3.8	4.8	3.2	9.0	6.9	11.0	7.1	6.4	5.4	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8	3.0	1.3	2.9	8.6	4.0	3.4	6.3	0.0	1.4	2.3	1.8	0.0	4.0	3.3	3.6	53.4	2.8	4.5	0.0	4.5	26.4	3.2	5.2	5.7	4.2	13.2	7.9	4.1	4.3	18.9	22.4	3.4	9.6	15.1	8.2	2.4	3.2	2.8	0.0	5.3	11.3	3.9	0.0	9.2	6.4	6.3	3.9	14.9	14.9	3.3	7.1
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA					"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	8.0	0.3	2.0	107.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.5	0.1	0.6	0.0	0.6	1.6	0.5	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4	29.8	13.6	12.6	245.0	9.3	0.0	766.1	28.1	96.4	52.4	359.4	0.0	2.7	11.6	4.3	10.2	89.9	112.9	0.0	4.7	0.7	44.7	113.9	4.7	93.7	42.3	0.0	53.1	160.8	351.0	2.5	124.3	29.1	86.0	1.8	47.0	11.6	8.2	42.1	42.1	35.5	0.3	161.7	181.3	0.2	0.5	8.2	9.2	5.7	27.3	131.1
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.9	5.5	10.8	14.9	7.7	6.9	3.8	14.8	8.9	13.4	18.1	5.2	10.2	5.5	5.3	8.5	9.3	16.0	8.6	8.6	2.4	8.1	5.1	4.5	11.8	8.1	6.5	9.0	5.8	6.5	12.6	13.1	9.7	3.8	11.5	9.8	7.3	7.9	4.8	12.6	4.7	6.5	4.9	11.3	12.5	7.7	16.0	4.7	7.8	11.1	6.3	12.3	5.0	4.6	4.5	6.7	3.2	3.5	5.4	7.4	3.3	5.6	13.0	12.0	10.1	7.5	5.2	5.4	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9	8.9	18.5	5.9	4.3	4.6	7.9	4.5	7.6	1.4	4.5	8.7	13.7	9.1	6.6	2.7	0.1	1.8	5.1	0.0	2.5	1.6	4.2	6.7	5.8	11.5	2.1	4.8	3.5	6.7	0.6	1.9	2.8	0.8	3.3	0.0	4.0	8.4	2.8	5.8	4.2	8.1	6.3	0.0	3.1	4.4	1.3	2.0	3.0	1.9	5.8	7.0
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537964-2603188	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.1	14.9	21.0	11.6	31.9	14.2	14.2	29.6	26.4	10.5	15.6	14.5	10.4	17.2	13.0	14.0	13.8	15.3	10.8	14.8	17.2	13.5	17.6	12.6	13.4	13.5	11.3	20.6	14.8	28.2	34.5	13.9	17.1	16.7	13.6	15.3	12.8	16.5	13.2	18.2	14.1	19.1	12.9	10.9	13.7	13.4	14.2	10.1	14.1	16.1	10.6	13.9	12.3	13.3	5.1	9.1	14.7	9.4	5.4	6.0	4.5	8.5	11.0	13.8	9.1	14.2	11.9	14.6	14.3	9.2	12.8	10.8	11.0	10.3	14.1	9.8	13.8	10.9	13.6	16.4	10.3	12.2	25.1	11.1	7.5	14.5	18.2	12.4	12.3	19.7	10.8	19.0	13.8	9.2	12.4	11.7	12.9	13.9	11.5	15.0	18.1	12.4	8.7	8.7	16.0	9.8	25.4	13.7	12.8	12.4	7.7	21.7	11.2	18.5	21.3	7.7	9.2	19.7	15.5	14.3	14.0	13.9	13.6	12.3	15.3	14.6	22.1	6.7	8.6	12.1	3.9	7.9	9.0	5.1	9.3	4.8	5.1	4.7	6.0	6.7	4.5	5.3	4.9	14.7	5.4	9.4	9.1	2.3	4.5	21.0	31.9	29.6	26.4	17.2	13.5	11.3	20.6	16.7	10.1	14.9	18.4	17.1	18.3	23.7	56.0	28.1	43.3	21.4	14.8	10.4	51.1	38.1	11.6	20.5	12.0	15.5	32.9	0.0	20.5	24.1	22.4	24.3	7.0	38.5	22.9	69.9	20.7	23.9	46.7	21.8	29.4	21.5	20.3	30.7	31.7	39.4	25.3	17.5	41.8	34.2	41.5	45.3	18.6	36.7	40.5	29.7	87.5	17.5	27.9	19.6
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	12.2	16.5	11.7	14.3	14.0	12.5	18.6	14.6	22.1	8.4	13.9	8.3	9.9	13.6	10.4	9.9	22.0	11.5	13.4	22.6	14.2	12.1	13.9	26.3	8.5	17.6	9.9	11.8	11.9	30.2	8.1	9.6	10.3	10.4	10.1	10.4	8.5	16.0	11.4	27.4	15.2	12.0	10.2	7.5	13.0	11.7	13.6	5.1	17.6	16.3	17.4	14.5	11.6	12.9	4.0	6.7	7.7	3.1	3.3	3.7	1.4	19.2	37.1	7.9	22.3	5.6	4.5	18.6	9.9	6.2	16.7	9.4	46.2	11.2	24.9	18.4	8.6	8.6	16.9	37.2	18.7	6.9	12.2	29.3	29.9	17.4	24.1	12.7	28.3	17.5	5.6	13.8	19.5	21.1	5.5	12.2	20.4	37.4	10.3	6.5	34.9	38.3	28.3	30.1	16.9	26.3	29.4	8.8	19.9	10.8	26.8	29.1	16.4	17.2	24.2	10.7	6.6	30.6	15.7	10.5	8.5	18.6	17.1	24.1	21.6	31.7	35.8	11.1	23.2	14.2	7.7	2.4	0.7	2.5	2.5	3.7	3.6	2.9	2.8	2.0	4.0	2.9	3.6	2.0	3.3	3.1	6.7	2.0	1.4	11.7	14.0	14.6	22.1	14.2	12.1	9.9	11.8	10.4	5.1	3.0	6.7	6.7	10.3	10.2	9.2	12.6	20.4	4.0	0.0	5.2	13.7	5.6	5.0	4.0	12.9	5.3	6.3	0.0	6.7	12.5	3.3	9.0	0.0	21.9	6.4	6.4	12.6	4.3	6.9	15.9	5.5	4.8	3.3	2.8	8.9	3.9	6.9	5.8	6.3	9.0	12.2	6.5	5.5	9.8	9.4	15.2	5.1	4.4	14.0	11.6
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell type enhanced"	"Detected in single"	35	"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HEK 293: 4.1;HeLa: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		47000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.3	1.2	0.8	0.0	0.0	2.0	0.6	0.0	0.0	0.0	1.2	0.6	2.0	0.2	0.0	0.6	2.7	0.0	0.0	0.0	1.9	4.1	0.8	3.5	0.3	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.7	0.6	0.0	0.5	0.4	2.2	0.4	0.0	2.7	1.6	0.2	0.2	0.0	2.6	0.8	0.2	0.5	0.1	0.0	0.6	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.6	1.3	0.8	1.1	1.7	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.8;HDLM-2: 3.5;hTCEpi: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025879			Approved	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	5.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.1
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.4"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	2.7	10.3	3.8	1.9	7.2	0.7	3.4	3.2	3.5	2.2	2.1	2.0	7.8	1.0	2.7	4.7	4.8	2.8	2.6	5.5	3.0	3.0	2.1	1.8	1.6	1.0	4.2	1.6	5.8	4.2	16.9	14.2	1.8	4.7	4.3	2.5	6.5	6.8	5.1	57.4	2.5	1.3	3.4	3.1	2.3	3.7	3.5	2.7	0.8	6.5	12.6	2.8	3.1	3.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	8.6	12.2	0.7	7.3	4.3	4.1	7.6	1.6	1.5	0.3	0.1	3.5	7.7	0.0	4.9	0.2	8.9	3.4	14.4	5.9	0.4	22.1	14.7	4.0	9.9	3.2	4.5	0.0	0.0	5.5	6.0	1.4	9.9	7.4	8.4	7.3	6.1	0.0	7.9	6.2	6.2	0.4	9.6	14.3	16.3	0.0	0.0	0.0	2.2	4.1	7.6	9.0	7.7	10.1	0.1	9.5	3.6	0.3	4.3	0.0	3.7	1.5	4.2	10.1	9.4	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.2	3.2	2.9	3.0	3.0	4.2	1.6	4.7	2.7	0.0	3.0	0.0	4.0	2.2	1.8	5.6	2.5	6.7	2.3	10.4	7.9	0.8	0.0	1.5	0.3	3.5	0.5	0.0	2.2	0.9	0.5	8.7	5.8	1.5	1.3	3.2	2.4	6.2	6.0	0.0	2.8	0.2	1.7	0.0	2.0	1.3	4.4	0.0	8.1	1.1	2.9	0.0	1.3	0.0	0.7	3.0	0.5	0.0	2.4	7.0
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892300-18984598	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	9.5	8.6	4.0	9.8	8.3	10.8	7.9	10.9	5.9	8.7	7.7	7.8	4.5	10.1	8.5	5.4	5.8	8.3	10.9	8.6	4.2	3.7	6.2	29.4	5.4	14.1	7.1	3.6	14.5	13.1	8.8	16.9	11.6	6.9	8.3	5.2	9.5	7.4	12.4	6.0	6.9	10.1	4.9	6.6	8.5	6.9	12.4	5.4	29.6	9.2	3.4	9.1	7.2	10.4	3.0	3.2	9.9	5.6	4.2	3.4	2.6	8.4	7.9	4.6	7.7	6.3	5.9	13.0	3.7	3.1	5.4	6.0	8.3	5.5	9.8	2.8	4.7	8.6	7.8	8.3	9.5	5.9	4.9	8.7	11.8	12.3	10.0	4.5	11.0	15.2	9.8	6.4	6.6	9.6	9.0	5.6	10.4	3.9	6.1	3.7	8.6	11.5	18.4	5.7	3.8	8.7	9.2	9.6	10.9	3.5	3.7	4.0	6.2	11.3	11.5	5.0	16.2	14.4	6.4	9.9	7.4	4.3	7.9	5.7	6.0	5.0	7.5	4.2	6.0	4.0	5.1	4.6	9.9	3.2	5.6	3.4	2.5	2.6	2.3	3.2	3.0	3.2	3.0	8.2	4.2	3.6	1.7	3.2	2.6	4.0	8.3	10.9	5.9	4.2	3.7	7.1	3.6	6.9	5.4	8.9	14.6	6.2	5.3	5.8	9.7	19.0	15.3	1.4	4.5	8.7	9.8	14.3	0.0	5.1	4.3	5.8	7.7	23.3	4.4	14.6	5.1	5.9	1.1	44.0	6.8	4.8	4.1	19.0	17.6	4.7	6.9	6.4	5.0	1.0	6.5	23.5	6.5	9.5	7.4	3.9	12.4	0.0	3.4	5.4	7.2	4.1	8.8	4.6	11.9	3.3
PHKB		ENSG00000102893	"Phosphorylase kinase regulatory subunit beta"	Q93100	16	47461123-47701523	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA073380			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA073380: AB_2686598"	"unprognostic (2.87e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.98e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (3.89e-9)"	"unprognostic (3.56e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.53e-2)"	16.9	31.7	11.1	18.1	16.0	11.6	20.6	13.3	16.6	17.2	19.5	16.8	19.5	17.3	22.8	17.6	20.5	12.3	17.0	22.6	11.5	12.4	22.8	16.6	17.0	11.5	14.3	13.0	14.6	21.8	30.0	25.7	17.1	19.9	18.1	19.9	16.1	25.3	21.1	65.6	9.8	24.2	27.0	14.0	17.6	18.5	16.1	10.2	25.2	25.6	23.4	16.3	15.6	15.3	23.1	14.6	12.6	15.6	12.4	11.8	8.7	13.9	20.6	23.7	15.6	16.6	15.8	29.7	16.6	16.1	12.0	6.0	11.2	24.2	16.9	25.1	24.0	9.4	19.8	22.2	25.8	16.9	5.2	11.7	16.0	18.5	37.5	14.8	17.3	19.1	14.1	13.2	8.0	15.1	25.8	23.2	20.8	22.0	10.8	17.2	9.9	16.7	17.1	10.0	23.3	15.8	28.8	29.0	28.5	23.9	12.0	12.5	14.3	27.3	36.6	4.5	27.2	14.0	14.4	25.6	21.8	10.3	11.0	8.7	12.3	9.0	21.9	13.8	11.8	9.0	7.1	15.0	12.6	9.0	13.4	11.8	23.1	9.5	7.3	14.6	23.1	9.5	9.1	7.8	12.4	15.6	10.0	11.0	8.7	11.1	16.0	13.3	16.6	11.5	12.4	14.3	13.0	19.9	10.2	17.9	33.1	36.9	14.7	7.9	32.4	53.8	35.7	20.1	43.3	40.1	94.2	38.8	19.9	17.4	51.2	33.8	39.9	0.0	13.7	21.6	20.6	31.2	17.4	28.1	24.9	22.3	29.3	38.6	50.7	63.4	23.6	27.8	8.5	62.3	34.8	34.7	23.3	20.1	33.6	32.3	71.2	25.8	13.7	50.7	13.0	6.4	28.3	20.3	33.7	23.8
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 50.9"	"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced					NA	NA					"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.8	3.2	5.4	1.4	0.4	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.2	1.6	1.2	0.2	0.8	0.8	2.1	0.8	3.0	0.7	0.8	1.5	3.3	3.4	2.3	1.6	0.7	0.8	0.3	2.1	2.2	4.0	0.1	1.3	2.2	5.6	1.0	0.9	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.2	0.1	0.5	1.2	1.9	0.8	0.5	1.7	4.5	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8	11.9	3.4	25.1	6.4	1.1	4.0	1.4	50.9	4.0	6.8	26.2	0.0	6.6	1.7	13.2	2.2	1.4	11.4	23.3	10.9	11.6	6.1	9.6	8.1	41.4	11.0	11.1	16.0	20.9	30.5	5.6	16.7	6.0	1.7	8.2	10.9	4.8	12.7	10.5	15.2	9.0	4.3	12.9	1.0	7.6	9.4	0.9	6.1	8.7	14.4	7.0
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 304.4;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol		NA	NA			Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favorable (7.90e-4)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.7	9.0	7.6	9.3	7.1	5.8	17.1	9.6	14.4	13.2	15.1	7.8	6.9	11.9	11.4	9.9	6.7	13.2	7.9	12.2	10.6	6.4	21.9	6.5	15.0	21.8	11.0	10.0	9.3	7.8	6.6	12.6	5.9	6.3	13.4	8.5	8.8	6.9	9.5	31.5	11.8	14.8	10.5	9.9	10.5	16.0	11.9	15.8	15.1	15.5	10.2	7.0	7.8	21.8	9.2	7.2	17.1	8.7	7.9	8.1	9.0	10.1	8.8	13.9	7.5	8.1	16.1	19.6	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3	11.9	23.7	12.6	12.5	18.7	8.9	10.6	2.5	25.4	29.6	17.4	9.8	26.7	23.2	11.4	304.4	9.9	23.2	0.0	21.4	32.3	12.9	24.0	12.7	19.5	25.4	19.1	15.6	9.2	22.4	1171.9	16.1	24.0	11.8	42.3	15.6	9.8	16.8	15.0	21.9	32.7	8.4	0.0	12.5	127.4	23.3	20.1	63.2	26.2	19.6	12.4
PHLPP1	"KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP"	ENSG00000081913	"PH domain and leucine rich repeat protein phosphatase 1"	O60346	18	62715450-62980433	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0"	"Cell type enhanced"	"Detected in many"	8	"Muller glia cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 7.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.7;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020200	Uncertain				"Intracellular and membrane"	NA	NA					"HPA020200: AB_2670383"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (5.35e-8)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.25e-2)"	5.8	10.6	22.1	2.3	34.1	7.4	7.4	8.3	29.6	4.3	6.0	48.0	0.9	6.2	4.4	2.5	6.1	4.0	4.9	3.0	22.4	12.3	4.0	18.5	3.4	3.0	44.4	13.8	5.5	8.0	9.6	5.6	6.3	20.6	5.0	6.7	4.4	11.2	4.5	3.9	9.1	5.5	4.0	18.6	2.0	5.6	11.5	44.8	2.3	5.6	1.6	4.1	5.6	3.2	0.6	0.7	7.7	0.2	0.6	2.4	0.1	9.0	3.4	14.0	4.6	2.4	2.0	10.9	2.7	2.5	5.4	5.6	7.4	5.5	6.1	1.7	4.1	2.1	11.1	7.2	4.3	7.0	18.8	6.0	2.0	3.7	13.7	3.4	3.1	1.0	2.1	2.9	5.8	5.3	4.4	3.8	3.3	5.2	12.3	5.2	2.0	2.3	2.7	5.6	1.8	3.3	21.7	7.9	7.3	3.1	11.8	6.5	2.6	3.0	6.8	5.6	8.5	3.0	8.9	4.8	4.5	2.1	2.6	6.3	1.4	0.7	7.2	2.6	3.6	3.4	0.0	0.2	0.1	0.7	0.0	0.0	0.6	0.1	0.0	0.7	0.2	0.4	0.1	7.7	0.6	0.2	0.3	2.4	0.1	22.1	34.1	8.3	21.1	22.4	12.3	44.4	13.8	20.6	44.8	3.0	1.0	0.0	3.7	14.9	14.8	3.3	15.3	8.1	5.7	0.0	27.5	10.8	1.7	2.5	26.9	5.8	5.6	0.0	3.6	4.7	6.0	6.4	2.3	16.3	2.1	25.4	11.6	6.2	2.8	24.6	5.5	4.6	23.6	3.6	7.9	82.5	3.7	5.8	3.5	1.8	16.7	0.0	4.4	5.0	16.9	16.3	21.9	0.0	11.5	7.4
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 29.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	No			Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	6.4	4.7	12.5	7.0	10.9	8.1	8.4	17.4	14.9	4.4	16.6	4.6	4.3	15.8	5.8	4.9	2.7	4.7	4.1	4.6	11.7	9.0	5.4	4.9	4.8	5.0	6.2	14.9	7.2	4.9	10.2	7.3	4.3	12.6	4.7	17.8	13.2	2.9	5.7	5.3	3.0	29.9	7.0	7.6	3.9	4.2	10.8	4.7	1.0	9.9	1.1	4.9	4.7	9.8	2.4	2.2	1.2	0.7	3.5	1.5	0.4	4.9	6.5	7.1	7.9	5.7	6.9	4.1	7.4	6.7	10.7	8.8	5.9	1.6	9.8	2.9	12.2	7.7	10.5	10.2	3.8	13.9	3.4	5.5	2.7	5.6	3.9	4.5	2.3	4.3	5.1	2.2	15.2	5.0	4.5	4.0	3.4	2.4	2.7	7.4	10.4	3.2	1.8	5.5	1.5	1.7	5.1	6.2	3.2	5.1	3.8	6.2	3.3	15.9	4.4	2.6	5.7	5.4	1.4	5.5	10.8	7.8	4.5	6.1	6.1	4.3	10.1	6.7	1.9	2.4	0.8	0.5	0.2	1.0	0.7	0.9	2.4	0.8	1.5	0.6	1.6	1.1	0.9	1.2	3.5	0.7	2.2	1.3	0.4	12.5	10.9	17.4	14.9	11.7	9.0	6.2	14.9	12.6	4.7	8.9	2.1	5.2	4.7	8.2	18.7	2.3	0.0	2.7	4.5	3.5	98.2	3.8	0.0	2.4	9.7	3.7	51.9	0.0	2.0	0.3	7.2	5.0	10.3	3.9	1.3	22.3	5.8	3.1	5.4	3.6	4.9	2.2	13.5	2.8	6.7	6.3	2.8	31.6	4.9	4.3	60.3	6.5	5.6	29.1	18.3	8.0	1.1	3.5	7.2	2.1
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208497-178232791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		190000	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	18.7	13.1	10.5	25.0	10.8	9.8	15.5	8.3	10.9	13.9	24.3	13.4	14.4	15.1	13.5	14.9	10.7	13.6	17.5	15.5	8.9	4.9	18.1	44.4	14.7	16.8	13.7	9.3	13.2	18.0	11.9	11.9	11.8	10.2	12.4	23.9	12.1	12.3	13.7	20.2	7.6	29.8	14.1	10.7	20.2	15.3	16.4	11.7	16.3	16.6	10.5	17.4	14.0	11.8	13.9	32.8	16.7	21.7	10.7	14.0	14.3	5.8	2.4	5.8	2.3	14.7	11.7	8.8	3.7	4.1	4.9	7.9	6.2	7.5	7.6	11.2	11.2	6.2	3.8	5.0	9.4	5.7	15.6	5.0	9.7	9.8	4.4	23.9	5.5	6.3	13.3	9.9	6.2	15.1	10.1	16.3	11.4	7.1	17.7	7.4	8.5	7.7	2.9	1.2	7.3	8.0	5.1	2.8	15.3	8.9	5.3	3.6	3.3	5.8	3.4	6.1	7.1	3.7	4.5	6.6	5.1	4.6	3.3	3.9	11.3	3.1	4.6	1.5	5.9	3.4	6.3	19.5	16.7	10.0	21.7	10.1	13.9	11.3	11.4	25.2	12.6	14.0	11.3	4.4	10.7	21.3	32.8	12.9	14.3	10.5	10.8	8.3	10.9	8.9	4.9	13.7	9.3	10.2	11.7	17.9	14.7	36.2	35.3	9.5	20.4	15.7	33.1	12.0	9.1	22.7	23.6	14.0	16.6	17.9	16.8	22.4	97.5	0.0	16.2	15.1	23.7	24.7	12.7	27.6	27.2	14.3	18.5	22.7	23.8	45.2	39.4	30.7	23.6	63.1	33.9	26.4	14.7	54.6	23.7	31.0	26.5	12.9	16.5	28.6	23.7	9.2	18.4	34.6	33.9	31.3
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678935-130746829	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	15.5	16.2	11.6	11.6	15.9	10.6	14.9	14.7	17.2	16.5	13.1	14.9	9.5	10.3	18.8	12.0	12.9	15.6	12.0	12.2	9.7	10.0	14.9	28.2	13.7	12.4	12.0	11.4	17.8	12.0	40.7	20.6	14.4	17.3	14.1	11.6	14.1	14.0	15.4	14.8	16.0	13.4	14.6	12.1	18.5	13.3	14.9	11.8	29.7	18.1	10.2	13.6	16.5	13.9	8.4	9.6	12.0	8.5	11.5	13.7	7.0	14.3	9.1	13.4	9.7	19.9	15.9	9.3	10.7	12.9	14.8	17.2	11.8	12.2	16.9	13.5	10.8	11.8	20.6	22.0	16.6	23.3	10.2	8.2	13.8	10.5	8.2	9.1	20.9	6.9	10.9	12.0	15.8	10.0	9.3	13.7	9.9	16.0	8.6	13.0	12.6	17.1	6.4	16.9	13.0	9.0	12.0	15.6	15.2	9.7	11.8	12.4	9.1	15.4	9.7	10.8	16.5	13.4	9.2	10.8	11.4	9.9	12.8	8.5	10.1	9.1	22.3	12.5	8.0	10.5	12.0	7.2	9.2	9.4	8.4	13.7	8.4	8.6	6.9	9.6	5.7	10.1	9.0	6.0	11.5	8.5	3.4	9.3	7.0	11.6	15.9	14.7	17.2	9.7	10.0	12.0	11.4	17.3	11.8	6.0	5.4	0.0	3.4	3.4	8.2	7.5	15.3	14.7	11.4	10.4	13.7	4.6	1.7	4.1	3.4	6.7	5.3	0.0	5.1	3.1	3.5	3.7	9.2	15.6	5.1	4.8	2.9	8.0	6.7	2.7	8.9	3.8	5.0	5.4	6.2	8.0	5.3	5.8	11.0	4.9	12.0	6.5	3.2	10.8	12.7	3.9	3.5	4.6	5.8	2.5
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.3	2.0	1.1	4.7	2.5	24.0	1.1	3.4	2.3	3.6	4.6	4.3	6.2	1.7	1.3	5.1	3.6	2.1	3.3	2.1	28.1	1.4	35.7	1.3	5.9	4.8	0.6	66.4	8.5	4.1	2.1	1.4	2.5	0.6	1.5	30.6	10.0	0.3	0.8	1.9	3.2	3.8	5.7	2.0	4.8	3.7	7.3	0.6	18.8	10.0	2.0	2.4	0.3	0.6	4.9	0.5	1.0	1.2	1.3	4.0	6.0	1.3	4.7	2.5	119.4	0.5	9.0	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6	20.8	23.1	27.2	134.9	113.6	4.2	17.3	12.7	4.0	22.7	8.7	0.0	27.3	5.0	30.7	3.8	14.3	33.2	46.7	15.5	92.9	73.9	69.5	46.4	27.1	44.8	14.3	35.6	9.2	40.0	10.4	7.5	45.8	42.2	101.0	11.9	4.3	37.7	17.5	2.8	13.0	0.9	0.0	57.5	3.3	34.5	199.7	67.5	126.4	6.6	399.5
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.6	0.8	1.7	0.3	0.2	1.3	1.1	1.4	1.6	1.4	1.4	1.4	8.0	0.5	0.5	0.6	1.1	2.7	1.0	1.5	60.3	2.1	9.7	1.6	1.4	0.7	2.3	6.5	0.6	0.9	1.7	1.0	1.3	0.6	1.0	10.2	74.7	0.9	1.3	0.8	4.8	18.2	0.6	2.5	1.0	0.6	73.6	1.6	0.2	0.6	0.8	1.2	0.8	0.8	4.3	2.1	3.1	0.3	0.4	0.2	0.3	1.1	136.0	120.2	15.3	1.5	2.0	0.4	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3	11.9	48.0	109.2	9.5	18.0	2.3	2.0	0.0	14.7	12.5	3.5	2.0	5.3	3.3	2.8	1.4	4.3	4.0	0.0	3.1	5.0	7.5	4.0	22.0	5.4	6.3	11.1	12.6	3.1	9.1	1.4	1.7	18.6	89.4	163.3	6.6	2.3	1.6	3.5	3.9	5.4	2.2	0.0	8.1	2.1	1.5	12.0	2.1	70.8	8.1	3.9
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.5;SK-BR-3: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.3	4.9	3.3	6.2	2.6	1.9	18.9	4.6	7.5	5.6	4.0	8.1	6.3	13.2	5.9	1.2	11.3	6.3	6.3	3.5	2.0	9.9	26.2	5.4	11.7	9.8	12.2	11.7	10.5	3.7	11.7	3.4	5.8	3.0	18.0	9.0	7.4	46.5	1.6	16.5	5.9	20.9	6.9	7.7	7.9	27.7	5.5	15.6	2.9	5.6	11.8	8.2	9.0	41.3	28.9	3.2	5.4	15.6	4.7	3.5	15.0	5.7	7.5	23.9	15.2	11.2	8.7	6.6	9.4	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5	59.6	91.3	64.7	240.2	201.8	30.4	27.9	68.8	20.1	45.5	76.8	2.0	51.0	71.3	44.7	2.1	87.2	56.5	0.0	46.7	226.7	51.4	225.9	70.2	37.5	64.3	58.8	93.7	59.5	30.8	4.1	30.0	74.6	102.9	46.9	56.5	11.1	57.1	46.3	10.6	48.8	15.3	25.8	117.4	19.9	37.3	178.9	326.1	26.6	49.6	261.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 571.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	26.2	24.1	18.0	16.7	6.3	5.6	10.6	19.7	8.5	14.7	14.2	22.3	8.4	16.3	31.4	7.3	15.3	13.5	12.4	11.9	4.7	34.7	52.6	42.4	29.6	19.2	10.3	19.7	24.9	7.7	8.0	9.5	4.5	11.0	11.9	29.3	19.1	24.8	8.8	18.4	29.9	77.2	17.2	11.0	37.1	27.4	18.7	27.3	10.5	12.9	22.7	26.7	19.0	9.5	22.0	7.7	12.2	23.7	20.1	20.4	16.3	31.5	31.5	32.1	30.1	21.9	21.7	25.3	25.0	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0	26.8	21.5	49.1	53.7	42.8	68.5	65.3	43.3	56.2	14.8	59.3	11.8	107.3	139.3	95.7	197.0	54.9	69.5	46.7	95.4	80.4	81.4	55.2	63.4	41.4	123.0	57.2	95.8	47.3	50.0	571.0	83.4	67.4	118.1	174.1	57.9	60.8	85.6	73.7	122.0	109.4	50.6	64.7	97.1	136.8	72.0	57.6	46.0	94.4	62.6	47.8
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.4	18.1	19.0	12.9	13.0	10.9	10.1	10.6	12.2	13.0	13.4	9.1	11.5	4.6	31.0	10.9	17.6	11.0	16.8	18.6	16.1	11.7	37.8	7.9	21.6	23.9	7.2	12.5	6.7	7.3	10.3	14.2	4.9	14.7	13.2	14.2	13.3	20.6	9.7	18.7	10.9	21.1	13.5	17.6	16.4	10.9	15.1	13.7	16.5	10.8	12.2	21.7	12.4	5.8	10.9	14.6	9.0	11.5	13.2	5.9	9.1	16.2	7.7	7.1	7.6	7.7	17.0	12.6	6.4	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9	62.5	35.0	52.8	54.1	38.4	26.9	74.7	81.5	84.3	51.2	113.4	7.9	137.4	154.2	102.6	10.6	70.5	117.6	23.3	102.2	92.0	70.9	50.1	55.5	238.7	95.4	27.0	88.9	80.4	73.2	6.2	69.0	61.7	57.3	68.5	76.9	55.6	124.5	101.7	76.4	218.0	33.7	84.1	78.3	14.4	39.1	40.9	100.9	62.3	82.1	54.0
PINK1	PARK6	ENSG00000158828	"PTEN induced putative kinase 1"	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA					"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	17.9	35.9	38.9	6.7	38.0	6.0	10.1	16.8	45.0	9.8	13.0	17.8	10.0	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31.0	28.7	20.2	26.1	10.0	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31.0	12.4	7.7	10.6	23.9	15.4	142.0	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16.0	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.7	8.1	3.8	11.0	13.3	12.6	4.0	25.1	25.2	12.2	21.3	2.8	14.5	4.2	19.9	25.5	28.4	8.2	5.5	13.3	6.1	5.0	21.0	2.1	22.7	4.3	10.3	2.2	6.7	11.8	14.4	15.2	5.3	13.7	7.9	3.9	5.1	5.4	8.7	7.5	3.2	5.0	1.7	4.6	26.8	2.8	6.7	3.3	7.6	4.2	14.2	5.5	27.3	9.0	7.6	4.8	3.0	7.8	11.9	11.0	5.7	18.4	3.5	6.3	1.2	1.9	23.9	6.4	5.1	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1.0	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38.0	16.8	45.0	31.0	28.7	39.5	27.1	31.0	16.8	20.8	16.3	7.5	31.9	14.0	40.7	0.8	28.1	1.4	6.8	41.8	35.3	21.6	68.0	22.2	58.2	29.5	63.2	23.3	24.0	29.3	21.6	60.4	0.0	92.6	20.3	27.0	19.3	46.6	19.9	102.1	32.8	20.6	20.3	4.6	26.4	52.6	41.8	45.6	53.4	91.3	57.1	84.1	37.3	110.5	24.5	21.0	28.6	13.1	18.0	30.8
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.6	8.8	9.3	7.6	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.1	15.6	9.1	38.6	13.7	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.3	6.7	6.4	7.4	5.3	2.9	1.1	6.7	5.6	0.8	3.6	17.1	8.9	13.2	7.5	11.2	2.5	10.6	8.8	18.7	12.1	11.2	1.9	8.5	20.9	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5	14.9	4.5	5.1	14.7	36.5	16.4	6.3	5.1	2.7	11.4	3.5	7.9	30.0	13.3	20.5	77.4	5.1	0.7	0.0	10.2	12.8	18.9	7.8	4.6	1.7	6.7	4.8	5.2	5.5	3.8	22.6	25.0	4.1	5.0	1.8	2.8	28.6	13.9	1.4	18.4	4.4	5.9	6.5	17.0	0.9	1.0	25.7	17.4	7.9	2.3	17.6
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.3	25.6	33.1	36.3	18.1	19.6	29.6	15.5	25.5	7.6	16.2	15.3	27.2	37.6	25.0	6.9	19.4	24.1	28.5	13.0	7.3	17.7	16.9	10.3	23.5	13.2	26.3	25.0	20.2	20.7	29.9	27.9	24.7	13.8	12.1	28.9	25.0	7.2	15.8	12.2	6.6	7.3	5.5	10.3	29.3	25.5	24.1	10.7	6.4	16.4	20.2	7.4	23.6	23.3	16.7	19.6	28.4	22.1	10.8	20.3	9.1	19.5	16.6	18.2	23.4	18.4	14.5	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4	62.5	47.1	47.1	45.8	56.3	93.5	116.8	50.9	41.5	45.5	54.1	58.9	19.9	41.4	32.7	16.4	64.5	53.5	0.0	28.7	23.4	57.5	66.5	46.2	90.1	46.6	73.1	64.9	65.1	78.4	15.1	78.9	53.7	57.3	31.5	47.8	99.2	29.4	20.1	87.0	45.1	78.2	77.6	80.4	73.2	30.2	50.8	22.0	50.7	29.6	32.0
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.9	17.5	6.8	9.8	0.1	0.3	18.6	19.4	4.6	12.3	11.8	13.6	14.8	15.6	8.7	2.1	7.3	32.1	4.8	6.2	2.2	20.0	15.7	7.9	15.8	11.9	0.0	8.8	22.5	0.2	0.5	7.3	2.0	1.5	2.5	17.3	22.7	27.7	4.0	37.4	24.6	24.5	11.2	11.7	9.3	26.9	15.3	30.2	2.3	5.5	13.0	13.8	9.4	24.5	7.3	3.9	14.0	17.6	2.3	16.6	21.0	24.2	20.3	21.0	15.6	26.8	6.3	11.8	19.2	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2	0.0	1.4	0.0	0.8	2.3	0.1	0.4	2.5	0.0	2.3	1.8	5.9	3.0	0.0	1.1	11.2	0.3	0.2	0.0	0.5	39.8	0.4	0.5	0.0	0.2	10.2	0.0	1.7	0.0	1.3	7.5	0.3	1.3	0.0	1.0	1.2	0.3	0.3	0.0	0.4	0.0	6.7	0.0	0.0	108.0	40.5	0.5	6.2	0.7	3.5	0.4
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Focal adhesion sites,Cytokinetic bridge"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26.0	20.9	16.5	10.0	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24.0	22.1	30.5	11.5	17.0	24.1	30.6	13.5	20.7	15.2	37.7	22.5	8.4	17.4	13.6	16.1	13.8	13.6	16.3	14.4	13.8	8.8	21.7	36.1	35.2	23.3	18.0	8.8	13.4	6.0	5.6	29.2	17.4	43.2	14.4	18.6	45.1	17.0	27.1	11.5	4.4	8.7	13.7	16.4	33.4	19.2	19.1	25.1	10.6	15.5	25.5	15.7	15.2	13.7	25.8	34.3	11.5	25.9	7.1	6.2	30.6	43.4	8.4	10.8	22.0	4.2	9.7	29.6	49.9	28.6	12.3	34.6	20.6	33.0	30.0	19.7	18.8	34.1	22.4	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14.0	14.2	17.0	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9	3.0	2.1	24.5	5.5	3.3	36.7	3.5	25.5	1.4	1.2	33.2	15.7	1.9	1.7	23.7	4.1	29.5	2.6	0.0	25.6	12.9	16.0	10.2	2.3	9.6	49.5	46.1	38.6	51.0	56.2	6.7	18.4	27.1	16.9	29.7	12.0	47.4	49.8	9.5	21.5	12.7	25.3	25.8	16.5	6.3	26.6	2.4	3.1	48.4	6.6	3.2
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702523-128720918	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 13.4;Extravillous trophoblasts: 5.1;Ito cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.4;REH: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	11.4	1.8	1.5	6.8	3.8	3.7	10.5	10.1	3.9	4.3	5.8	3.7	4.8	7.7	9.7	2.2	7.1	5.3	10.9	7.3	2.3	1.7	5.0	6.4	8.9	9.1	3.9	1.2	4.0	4.2	3.3	1.4	5.6	4.5	4.2	1.6	4.1	12.9	3.7	7.4	6.7	5.4	4.9	4.4	7.8	7.4	4.3	1.7	9.3	8.1	6.1	5.9	4.4	5.0	0.4	1.0	2.3	0.7	1.0	1.8	0.3	1.4	6.9	5.6	8.5	0.0	0.1	13.9	4.3	1.3	6.3	6.5	0.0	5.0	0.0	4.2	2.3	1.3	9.3	6.8	1.0	1.4	4.3	12.8	8.2	33.4	9.7	1.0	1.0	1.5	0.3	0.3	3.4	0.9	1.3	12.4	2.5	18.6	0.9	1.1	12.8	1.2	4.4	5.2	6.3	2.0	20.3	10.6	1.8	2.6	0.8	0.9	4.2	3.2	1.7	3.2	3.2	6.1	6.6	10.7	0.0	5.3	9.9	3.2	3.1	1.3	2.7	0.8	1.0	3.9	0.0	0.1	1.4	0.9	0.7	1.8	0.2	0.6	0.8	1.0	0.4	0.8	0.1	2.3	1.0	0.2	0.2	1.0	0.3	1.5	3.8	10.1	3.9	2.3	1.7	3.9	1.2	4.5	1.7	0.0	1.3	0.0	1.4	0.9	0.0	1.5	0.0	0.0	2.3	0.0	0.0	1.2	0.0	1.6	0.3	13.4	1.1	0.0	2.3	5.1	0.9	0.9	0.0	0.2	1.5	0.0	0.0	6.2	0.3	0.4	1.4	0.2	0.0	1.8	1.0	0.5	2.6	0.8	0.7	0.3	0.2	0.0	0.8	1.0	3.4	0.9	1.1	1.0	1.4	1.6
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA051638, HPA053229"	Approved					NA	Yes					"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.5	45.5	37.6	20.4	1.1	2.6	21.1	24.9	16.5	39.1	29.1	39.7	28.8	21.8	13.0	16.8	20.6	25.1	51.2	20.5	47.1	31.0	28.9	27.7	35.9	54.2	0.3	31.9	30.4	1.0	1.1	27.7	28.6	4.9	28.5	28.6	43.0	30.1	30.1	39.8	30.1	31.9	42.9	17.9	23.2	46.9	25.5	34.6	11.1	9.5	21.2	14.7	28.5	20.0	12.9	22.4	25.4	19.7	14.4	18.6	23.8	18.2	42.5	21.5	33.3	37.8	15.8	27.8	30.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5	3.0	0.0	0.8	1.0	1.1	1.3	0.6	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.6	86.9	0.5	1.5	23.3	0.7	48.0	0.7	1.0	1.1	0.9	17.0	0.0	0.0	3.1	3.7	4.8	1.1	2.6	0.0	0.0	2.9	1.1	0.8	0.0	0.7	0.0	1.1	0.0	0.3	3.2	5.0	1.6	3.2	1.3	3.9	1.8
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PLK3	"CNK, FNK, PRK"	ENSG00000173846	"Polo like kinase 3"	Q9H4B4	1	44800225-44805990	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060318	Enhanced					NA	NA					"HPA060318: AB_2684252"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.78e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	14.8	7.6	4.4	16.3	18.8	8.6	10.0	2.4	6.4	8.6	5.3	13.9	3.2	4.0	9.9	5.8	23.9	8.5	21.6	6.8	10.5	6.0	6.7	9.0	14.9	10.0	9.9	2.5	7.8	10.7	15.6	9.0	29.6	14.8	6.4	4.0	7.6	8.2	6.8	7.0	16.6	7.0	6.0	15.2	9.1	6.1	4.5	5.6	4.6	8.4	25.0	18.2	9.9	9.5	1.3	4.2	2.8	5.1	0.6	11.0	3.5	4.1	2.7	4.2	1.9	3.1	10.1	7.8	9.7	13.7	3.7	3.7	1.6	5.8	5.0	4.1	7.9	12.0	3.7	2.3	13.2	2.1	8.1	0.7	5.6	1.5	3.6	15.2	1.8	7.2	7.9	8.0	11.0	10.8	12.9	11.6	1.8	2.8	2.1	8.3	2.7	3.7	1.6	2.8	2.5	3.3	4.4	2.8	7.3	13.2	1.5	3.2	2.0	2.6	4.5	10.7	6.7	0.4	1.7	14.8	2.3	5.7	4.5	5.7	5.8	2.7	1.3	4.9	2.9	4.5	0.0	2.9	0.8	1.7	5.0	2.1	1.3	9.9	4.2	4.2	1.1	11.0	4.9	2.8	0.6	5.1	1.8	10.5	3.5	4.4	18.8	2.4	6.4	10.5	6.0	9.9	2.5	14.8	5.6	11.9	41.5	19.3	51.6	39.2	5.3	2.2	12.7	9.4	12.5	5.2	2.0	13.1	0.0	17.7	0.6	29.7	73.5	0.0	11.3	19.2	25.9	18.8	78.3	5.4	35.4	6.4	50.8	24.5	18.9	0.4	9.2	52.8	11.8	10.8	21.9	5.4	18.2	66.6	4.9	2.3	9.6	25.8	26.8	1.7	4.9	29.4	49.5	24.5	28.1	55.0
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 215.9;Sertoli cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	16.9	14.5	8.0	37.4	54.7	30.6	6.4	50.4	67.0	26.6	45.3	16.5	11.1	9.8	53.4	55.7	19.8	14.3	11.6	17.6	18.3	10.2	12.4	5.3	23.3	20.9	33.9	3.3	25.8	37.1	9.3	32.1	12.9	90.3	47.1	2.2	14.8	4.8	27.7	11.0	0.8	8.9	3.5	17.3	21.6	3.9	16.3	21.3	15.3	3.8	3.0	12.7	22.0	15.1	25.4	13.1	7.6	8.5	46.5	30.4	22.8	38.0	24.7	11.3	18.3	5.8	67.4	11.6	49.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4	0.0	9.3	3.7	7.6	6.3	4.2	16.2	10.2	4.0	5.7	10.4	2.0	34.8	3.3	30.5	1.1	20.4	18.7	0.0	8.4	215.9	28.4	9.2	0.0	29.9	41.8	6.4	8.1	46.6	21.6	1.7	41.1	15.6	10.1	18.0	9.8	10.1	24.0	12.9	23.0	13.7	2.7	103.5	26.2	0.5	3.6	4.4	28.1	4.4	11.0	3.8
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	27.1	0.0	0.0	2.9	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.2	0.0	0.1	2.2	0.8	0.3	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7	0.0	0.0	0.0	0.4	0.6	16.5	2.8	0.0	0.0	0.0	0.0	21.6	8.3	0.0	0.2	0.2	0.3	2.0	0.0	0.3	44.0	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.4	2.7	4.8	0.0	0.4	0.1	19.4	0.0	0.4	0.5	0.6	0.5	41.4	0.0	0.0	0.9
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	13.0	8.8	8.9	14.0	8.5	6.6	14.5	21.1	10.8	9.8	8.6	7.0	17.2	8.5	6.7	6.4	5.7	10.7	3.2	11.9	5.8	10.9	13.5	14.4	16.6	6.1	6.4	13.6	19.3	6.2	6.3	8.9	5.8	8.7	12.8	10.7	7.0	17.1	12.7	8.3	13.7	10.8	8.3	13.5	18.0	11.7	8.2	17.1	10.0	27.9	10.6	17.1	9.2	27.8	4.7	8.1	4.8	8.4	18.1	19.1	11.7	4.6	17.4	18.9	7.6	6.9	17.3	6.1	15.2	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9	14.9	23.4	40.2	28.5	11.8	40.7	8.9	15.3	24.1	9.1	19.2	76.6	37.9	19.9	36.3	12.0	20.2	24.9	0.0	34.6	29.2	14.8	28.4	27.8	18.7	34.1	31.8	29.3	31.9	22.4	20.0	55.0	24.9	13.5	42.3	23.1	20.6	38.1	20.1	42.1	26.9	76.0	19.4	14.4	18.2	29.6	11.4	41.2	42.4	27.4	25.2
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 443.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.8	28.2	12.9	24.0	48.9	18.6	21.6	5.4	17.7	10.2	14.3	21.1	57.3	12.3	5.0	11.7	34.8	6.3	16.9	8.5	4.4	10.5	12.5	5.7	8.3	39.0	34.0	5.7	10.2	38.1	10.7	13.4	9.8	8.2	9.4	6.1	17.0	5.3	9.1	18.9	6.1	10.2	16.1	20.2	16.0	8.8	8.5	13.2	11.5	15.6	13.5	12.9	14.5	74.1	19.5	7.6	21.2	9.6	8.5	9.6	10.6	14.4	10.6	5.2	8.0	8.4	13.6	8.7	12.3	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0	35.7	31.2	12.6	24.7	15.1	30.1	9.3	56.0	78.9	37.5	69.8	11.8	88.1	1.7	55.5	13.2	25.3	144.8	0.0	25.7	71.6	24.8	20.8	24.3	443.8	58.9	14.3	19.0	27.6	38.6	6.1	70.2	40.5	11.8	16.2	29.0	33.2	24.3	119.3	105.7	27.5	21.8	64.7	30.9	14.7	32.6	12.8	161.6	20.0	36.8	40.7
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 93.5;Hepatocytes: 134.7;Rod photoreceptor cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 12.1;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;granulocytes: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	5.7	6.6	5.8	6.0	6.2	4.2	6.9	2.6	4.5	3.8	11.8	5.9	9.9	13.9	4.8	6.6	6.3	3.9	9.1	19.6	5.1	4.1	17.8	30.9	3.8	3.4	6.1	4.9	9.1	13.4	6.6	3.5	3.1	7.8	6.2	7.1	13.5	8.1	8.2	17.1	5.8	19.7	5.0	4.7	3.5	5.7	2.7	7.1	1.3	5.4	10.4	4.8	7.3	12.3	1.5	3.8	12.1	1.4	0.9	1.5	0.3	6.9	1.7	2.2	7.7	12.4	8.0	4.9	6.1	12.1	6.6	6.8	3.4	3.4	2.5	3.1	14.1	6.0	3.1	6.5	8.0	5.9	7.2	8.3	7.7	4.4	7.1	7.7	5.3	13.3	6.3	6.4	4.8	11.1	5.6	1.4	5.7	2.8	5.8	6.1	1.8	6.0	1.9	0.3	5.8	1.7	7.1	8.0	3.2	4.5	4.1	2.2	6.6	2.3	2.2	7.7	3.2	2.5	4.1	2.3	6.8	7.4	6.2	2.6	5.9	3.4	1.0	10.7	6.0	2.1	1.7	1.0	12.1	1.4	1.4	1.2	1.0	0.7	0.7	0.7	1.5	0.8	0.6	0.8	0.9	0.8	3.8	1.5	0.3	5.8	6.2	2.6	4.5	5.1	4.1	6.1	4.9	7.8	7.1	3.0	9.9	5.2	13.1	20.7	14.7	84.0	25.5	2.7	7.9	7.0	58.9	6.8	8.3	7.2	0.4	16.1	66.1	93.5	14.3	5.4	13.0	13.9	4.7	134.7	7.4	4.8	19.1	20.9	22.5	0.4	18.1	9.6	3.3	11.8	34.6	15.2	11.6	24.6	28.3	36.9	152.6	6.5	14.4	0.7	1.7	29.9	2.5	7.5	31.6	17.9
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;testis: 20.2"	"Group enriched"	"Detected in some"	11	"Early spermatids: 51.1;Late spermatids: 94.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.5	3.1	0.2	6.4	1.4	3.9	0.2	10.6	0.2	0.2	0.1	0.0	0.1	0.3	0.9	0.2	0.2	0.3	0.3	1.9	1.0	0.3	0.1	0.4	0.3	1.7	6.9	0.2	0.2	0.1	0.7	1.0	0.2	0.5	0.1	0.0	0.3	0.6	0.1	0.7	0.1	0.2	10.5	0.3	0.1	20.2	0.0	0.1	0.4	0.0	0.3	0.4	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.2	0.0	3.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.2	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	6.4	0.2	10.6	1.9	1.0	1.7	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.4	0.0	0.0	0.0	94.3	0.6	0.0	3.3	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 75.7"	"Group enriched"	"Detected in some"	22	"Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 518.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.1	0.0	0.0	0.2	0.4	0.2	0.3	3.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	75.7	0.0	0.0	0.3	0.4	0.1	0.1	0.1	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	3.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.2	518.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		420000000			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.4	114.8	145.8	105.8	122.2	185.9	48.1	125.3	196.9	240.8	236.3	127.3	131.1	193.3	64.6	159.6	265.6	116.9	187.4	240.0	222.2	110.5	136.7	78.1	132.3	121.2	99.2	158.2	81.5	136.0	164.8	170.6	187.5	123.7	244.4	134.0	160.4	156.3	247.6	121.7	173.3	280.1	166.4	289.1	158.3	124.5	88.3	245.9	326.5	120.9	109.2	90.5	105.6	303.0	82.3	181.0	162.4	216.0	108.6	124.1	119.7	83.0	164.2	114.1	225.3	326.2	108.2	180.1	187.2	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8	738.4	649.6	630.7	788.0	769.8	81.7	43.6	573.3	655.8	728.0	572.3	17.7	772.4	1198.7	1053.9	61.2	614.7	668.4	210.2	1054.9	1359.4	612.8	450.0	590.8	641.5	1374.9	104.9	508.7	685.7	1073.8	53.8	539.0	844.5	656.3	1506.8	976.8	169.9	1130.2	533.1	576.3	1183.4	66.5	388.1	545.9	364.4	288.3	865.6	509.5	657.9	1124.8	784.3
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell type enriched"	"Detected in single"	10	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.2	3.8	0.3	0.6	1.7	4.6	2.5	0.0	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.7	0.4	0.1	3.1	2.5	0.7	3.0	1.2	2.9	1.7	1.4	0.9	2.5	2.6	1.6	3.2	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 14.4;THP-1: 16.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.6	0.3	0.4	3.1	0.1	0.3	2.0	0.6	0.4	1.0	0.7	0.0	4.8	1.3	2.1	0.0	2.5	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.0	0.5	0.9	5.4	0.7	0.4	5.3	14.4	6.2	1.0	0.1	5.3	0.0	9.0	0.2	0.0	4.0	5.5	1.1	11.3	6.2	0.3	5.3	16.9	1.3	3.6	5.6	3.3	8.2	4.2	5.6	9.2	3.9	4.6	7.8	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9											0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.2;hTERT-RPE1: 1.9;NB-4: 1.4;SK-BR-3: 2.0;TIME: 1.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.3	1.0	0.0	0.0	1.9	0.1	0.5	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148479824-148483679	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;skeletal muscle: 6.8"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 6.1;Suprabasal keratinocytes: 10.9;T-cells: 6.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.2	0.1	1.3	0.7	1.8	1.3	0.3	6.9	1.2	0.1	0.2			0.5	0.4	1.0	0.3	0.1	0.3	0.2	0.9	1.1	0.1	0.2	0.2	1.1	0.5		0.4	0.0	0.1	0.3	0.1		0.2	0.3		0.4	0.0	6.8	0.8	0.7	0.0	0.4	2.7	0.5	0.5			0.4		0.3	0.0	0.0	2.2	0.6	2.4	0.8	2.4	3.2	0.2	0.8	1.1	0.5	1.7	0.2	0.3	1.3	0.3	0.3	0.1	0.1	1.3	0.9	1.2	0.8	0.3	0.2	1.0	0.1	0.2	0.2	0.5	0.7	1.2	2.4	1.0	0.1	1.5	1.2	0.2	1.8	0.1	0.3	0.3	0.2	1.0	0.7	1.8	0.0	0.9	0.8	2.5	1.1	0.1	0.3	0.6	0.3	0.8	0.3	1.3	0.7	1.0	1.0	0.7	0.4	0.9	1.2	1.4	0.8	0.9	0.9	1.4	0.7	1.4	1.2	1.0	0.7	1.0	0.9	2.2	0.4	1.0	3.2	0.4	2.4	0.9	1.5	1.7	0.3	2.2	1.6	2.8	2.4	2.4	0.8	0.6	0.5	0.2											0.0	1.1	0.0	0.4	6.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.1	0.4	0.2	1.6	0.0	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	10.9	0.1	6.7	0.0	0.1
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PPIC	CYPC	ENSG00000168938	"Peptidylprolyl isomerase C"	P45877	5	123023250-123036741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 273.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039163	Approved				"Intracellular and membrane"	NA	NA		5700000			"HPA039163: AB_2676374"	"unprognostic (7.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.43e-2)"	22.5	13.7	3.3	10.8	3.6	0.0	29.9	1.6	4.2	24.3	30.0	3.6	26.6	15.7	20.4	32.7	35.5	9.0	25.8	43.7	4.0	2.7	27.4	24.0	16.3	9.0	3.7	2.1	13.3	24.3	8.7	5.8	28.3	10.0	17.8	22.0	5.3	25.9	18.0	18.4	12.0	35.2	37.9	5.4	8.9	13.5	8.0	3.2	2.5	42.7	29.6	12.9	31.5	21.5	0.0	1.1	0.0	0.1	0.0	0.3	0.0	4.7	4.1	1.6	33.9	58.9	27.1	6.7	13.4	10.5	7.0	14.4	6.8	31.8	0.0	23.8	35.9	21.0	5.3	4.6	16.8	5.6	0.0	8.2	6.7	15.4	7.8	15.1	0.0	3.7	16.9	12.9	8.1	8.6	12.6	14.4	0.0	1.8	0.0	5.0	27.9	0.0	0.0	2.9	29.2	7.2	0.0	3.6	0.0	22.0	16.3	2.1	3.7	26.2	12.7	2.8	20.5	17.9	15.0	15.9	13.4	8.4	4.6	5.7	0.0	0.0	0.0	11.6	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	3.3	3.6	1.6	4.2	4.0	2.7	3.7	2.1	10.0	3.2	29.8	13.9	0.9	43.9	42.1	13.9	38.9	53.5	25.4	14.8	69.8	3.9	50.1	24.9	171.5	1.0	100.3	130.1	0.0	111.8	45.8	273.0	38.3	1.1	48.9	36.5	0.0	12.2	66.9	4.8	3.5	104.2	7.7	30.4	5.4	148.2	1.8	98.5	178.9	94.0	64.2	3.8	38.8	61.4	26.6	14.1	43.2	20.9	2.2	72.5	66.5
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.5	14.5	14.6	20.0	21.7	16.3	22.1	15.4	8.4	14.2	10.8	18.8	10.7	16.5	6.9	14.3	22.3	12.0	44.2	17.7	17.3	54.5	15.4	29.5	13.1	25.8	16.8	18.4	22.2	10.3	14.4	12.1	18.2	18.4	15.4	28.2	36.7	29.4	15.8	14.9	26.4	16.7	20.1	25.5	19.4	12.0	7.2	14.1	15.6	7.8	24.7	16.6	11.5	24.0	21.9	22.1	11.0	17.7	14.9	14.2	16.0	15.6	20.3	16.9	35.0	21.0	18.1	20.0	14.2	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4	6.0	12.0	18.8	25.3	9.0	24.6	50.0	28.1	76.3	33.0	26.2	21.6	33.4	31.5	34.8	23.6	25.6	19.0	0.0	20.1	39.2	21.3	25.8	31.2	16.1	36.7	71.5	18.8	18.4	11.0	15.7	19.0	21.8	13.5	63.1	22.9	21.7	26.7	21.6	21.2	24.9	25.3	6.5	30.2	78.8	76.3	10.3	39.8	27.4	24.2	17.2
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.8	17.1	15.7	12.6	17.5	15.6	8.3	17.0	17.1	26.0	24.5	21.3	29.2	28.0	24.1	19.0	16.7	15.1	21.5	25.2	24.8	18.1	23.2	30.9	19.8	6.4	24.0	27.8	16.9	14.1	23.1	24.4	9.0	18.9	23.3	25.0	31.3	19.6	18.9	17.7	12.8	22.6	18.8	23.3	19.1	19.0	11.8	15.9	19.6	18.4	22.4	17.9	17.8	14.5	12.3	19.4	18.2	73.1	15.1	16.3	18.1	20.2	26.0	26.9	26.9	19.4	11.3	35.9	25.6	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2	29.8	27.1	41.2	35.7	22.0	24.9	29.6	17.8	64.3	56.9	31.4	13.7	54.2	56.3	49.6	25.8	24.5	23.9	0.0	42.1	51.6	34.0	28.9	54.3	27.6	48.7	22.3	27.6	25.8	36.1	47.7	27.6	34.0	37.1	53.3	28.0	35.4	38.6	28.1	42.5	54.9	25.9	58.2	41.0	62.7	44.8	23.1	29.1	40.6	33.0	29.5
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		27000000	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.6	15.2	10.7	21.0	10.0	13.0	13.7	20.8	27.3	45.8	43.4	35.5	17.3	37.1	11.6	14.6	32.6	21.4	33.1	19.4	71.5	11.7	31.2	58.1	14.9	62.4	17.0	40.0	13.8	30.4	13.9	45.4	45.5	14.9	8.0	14.6	56.5	45.8	15.5	18.3	10.3	33.5	9.0	16.4	84.5	17.8	16.5	19.0	17.8	33.3	21.3	15.8	10.7	43.3	16.0	7.3	18.9	30.9	7.2	20.1	18.3	23.6	40.0	21.3	21.6	30.0	19.9	52.1	5.4	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0	6.0	5.0	34.4	26.4	37.8	4.4	106.2	15.3	12.0	9.1	12.2	5.9	70.1	77.9	37.7	11.0	13.8	22.2	46.7	24.2	113.4	24.0	17.4	13.8	70.1	83.0	7.9	20.7	8.6	32.4	11.1	5.8	60.2	33.7	33.3	62.3	9.9	40.0	17.5	5.6	31.1	4.9	19.4	24.1	7.0	22.2	33.0	119.0	17.5	63.7	28.5
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.5	9.3	26.3	14.4	14.6	17.9	24.8	22.4	16.8	16.5	17.1	25.4	22.6	33.7	20.6	16.1	20.7	18.8	20.6	18.3	24.5	23.4	16.6	50.7	13.9	30.9	14.1	47.7	22.6	15.0	20.7	22.4	25.2	15.7	18.1	20.6	48.9	28.2	18.8	15.8	35.2	29.3	37.7	15.9	9.5	32.4	26.3	32.9	20.4	29.4	23.0	15.2	24.0	17.9	24.3	21.1	16.7	27.6	20.8	21.6	16.5	14.4	18.3	16.4	23.6	47.1	15.9	25.6	19.7	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7	205.4	160.5	152.0	169.4	134.5	178.8	130.1	61.1	132.5	155.8	89.0	51.1	146.0	68.0	90.9	6.8	121.2	97.1	70.0	90.5	147.9	117.4	133.0	172.3	157.2	134.3	208.2	100.6	106.2	118.2	8.4	131.5	135.1	104.6	124.4	115.6	123.1	82.2	108.7	137.9	99.6	103.2	161.7	154.6	225.0	148.0	150.9	171.9	152.4	132.6	136.1
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658425-42676758	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059019	Approved					NA	NA					"HPA059019: AB_2683885"	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	17.5	19.7	20.4	35.7	19.6	40.7	21.4	23.9	23.3	19.5	24.0	20.9	14.7	18.0	29.8	24.2	29.6	19.2	14.4	21.2	18.0	16.1	17.5	13.6	17.8	31.0	15.8	19.9	22.0	17.7	7.0	15.2	24.6	17.2	17.1	26.5	19.2	24.4	18.8	18.4	20.9	20.7	20.8	15.0	27.2	18.0	21.1	18.6	39.7	26.9	28.1	36.8	15.3	20.3	20.0	14.9	16.8	12.3	18.5	26.3	14.0	19.3	12.5	15.8	22.1	5.2	9.9	21.3	13.2	9.3	24.7	22.6	19.7	22.1	32.0	16.6	9.7	12.0	15.7	28.7	20.2	26.0	26.9	23.2	30.4	23.0	18.2	4.5	58.2	17.8	6.4	10.7	23.0	18.0	9.6	11.5	31.0	37.6	18.2	12.1	16.2	45.1	82.0	38.8	18.6	15.0	25.3	29.4	28.4	11.8	12.6	12.4	22.5	11.6	19.3	14.5	20.5	10.6	85.3	9.5	10.9	27.9	14.9	31.5	11.8	27.5	58.2	12.2	54.5	17.8	12.6	8.8	16.8	21.0	12.3	19.8	20.0	21.7	23.9	11.7	19.2	22.3	26.3	1.8	18.5	11.2	14.9	20.2	14.0	20.4	19.6	23.9	23.3	18.0	16.1	15.8	19.9	17.2	18.6	17.9	20.2	42.4	37.9	25.6	8.9	12.2	15.3	16.0	14.8	21.0	3.9	53.8	38.1	23.6	19.6	18.3	12.3	0.0	23.0	87.1	17.1	22.2	30.1	9.6	45.9	4.8	20.6	18.4	15.3	7.6	27.0	26.9	15.1	27.9	25.8	14.3	22.0	17.5	20.1	25.0	11.8	19.4	16.9	16.3	29.6	18.7	31.7	41.5	31.9	30.1
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666009-21700015	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 71.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	15.0	21.5	19.4	20.9	24.6	16.6	13.5	24.1	30.9	17.7	17.4	25.3	19.1	18.6	21.8	17.0	22.3	15.7	16.5	20.0	17.2	17.1	21.2	20.3	14.6	23.7	15.6	20.9	16.6	31.4	23.6	30.2	31.4	19.0	19.5	17.6	23.6	22.0	16.5	25.5	17.5	19.1	15.2	15.0	21.3	19.5	18.4	17.6	32.8	27.0	13.6	33.5	17.4	16.2	8.7	11.7	4.8	17.3	12.8	13.2	9.1	6.6	6.9	8.1	8.5	8.3	7.1	7.3	8.7	6.2	10.7	9.2	7.0	4.4	11.5	5.3	9.7	5.4	9.8	10.8	7.5	6.4	7.1	11.1	10.7	6.9	8.3	6.0	16.9	10.1	7.7	6.8	7.6	5.8	6.5	9.2	7.3	71.2	8.3	7.6	10.4	7.6	4.6	7.8	12.4	4.3	9.8	12.0	2.3	5.4	6.7	12.7	6.9	7.9	12.7	2.9	5.0	9.1	5.7	11.1	6.7	11.0	7.9	5.5	9.6	7.0	8.7	7.6	6.4	8.1	1.0	8.6	4.7	9.5	13.9	11.4	7.0	11.1	12.0	11.7	8.7	9.8	8.9	4.8	12.8	17.3	11.1	13.2	9.1	19.4	24.6	24.1	30.9	17.2	17.1	15.6	20.9	19.0	17.6	8.9	25.6	20.6	7.3	2.9	22.7	4.0	30.6	6.7	17.0	14.0	31.4	13.2	11.6	10.6	57.9	5.4	16.9	0.0	14.6	12.4	5.7	12.9	16.2	16.6	13.2	17.5	10.9	11.1	24.4	67.5	11.2	14.4	1.7	10.0	20.5	12.3	15.0	17.3	12.7	7.0	29.8	0.0	4.4	18.6	16.3	5.0	18.5	15.9	18.4	10.3
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	11.1	6.0	21.0	17.3	12.5	16.4	19.6	22.0	21.0	24.1	25.7	12.6	11.4	11.8	15.2	16.9	14.4	10.1	16.0	8.4	38.3	17.1	15.1	13.0	13.2	21.6	19.7	23.6	11.1	12.8	14.4	24.6	20.6	13.5	13.1	8.6	28.3	7.1	18.7	11.9	13.4	20.3	16.6	11.2	9.5	18.2	19.4	5.9	18.3	8.5	12.4	9.5	26.2	11.5	15.0	15.2	13.5	17.2	15.3	16.0	12.5	28.3	20.9	9.4	4.8	18.5	13.5	19.0	23.0	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4	62.5	64.3	22.6	54.3	43.4	44.2	33.3	17.8	80.3	61.4	43.6	7.9	43.1	36.5	34.7	17.2	37.3	15.2	0.0	23.1	37.9	55.5	27.1	73.0	18.7	31.8	27.0	22.3	30.7	21.3	9.6	57.2	29.9	38.8	47.7	19.7	40.0	26.4	22.9	52.6	27.5	35.5	51.8	68.4	58.2	53.4	39.5	54.6	41.5	20.0	32.7
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 187.4;Early spermatids: 262.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.0	1.2	6.5	10.4	12.9	1.1	0.0	2.3	0.5	0.2	0.1	1.8	0.0	0.5	0.6	0.9	1.2	1.0	0.0	0.3	0.5	0.9	0.5	0.1	0.0	5.2	0.6	0.3	2.7	6.2	0.2	3.9	9.3	0.8	1.4	0.9	0.3	0.4	0.6	0.1	0.6	0.2	4.2	1.3	0.8	0.0	0.6	5.0	0.1	1.5	2.5	0.2	0.3	4.3	0.3	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.1	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3	6.0	5.8	0.0	3.5	1.9	2.1	3.3	5.1	187.4	22.7	3.5	2.0	0.5	21.6	1.6	262.5	1.5	0.7	0.0	1.0	0.7	1.7	2.9	0.0	0.0	0.3	1.6	2.9	0.6	0.0	40.8	4.9	0.5	3.3	1.0	1.8	4.9	0.7	0.0	4.9	8.0	11.5	0.0	1.2	52.6	22.0	2.6	0.6	0.5	1.7	1.1
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 362.9;Late spermatids: 423.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		850000	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	48.6	11.0	9.6	8.1	14.7	13.6	12.2	13.4	15.7	10.0	9.5	6.2	14.4	29.3	12.8	15.1	7.4	10.8	9.9	13.8	17.5	26.3	5.6	18.0	7.8	9.6	12.3	20.4	12.9	11.5	16.6	11.7	16.0	11.7	9.7	15.0	9.9	23.3	12.1	21.3	26.5	4.8	9.0	9.7	9.3	9.5	22.2	9.4	12.0	23.4	16.3	12.2	13.9	16.3	11.3	9.1	16.4	8.9	13.4	20.8	20.8	9.1	9.5	18.2	10.3	34.3	9.5	8.1	10.5	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7	14.9	23.5	24.8	36.4	68.7	40.5	85.1	38.2	9.4	15.9	36.6	60.9	27.7	28.2	22.7	362.9	29.7	97.1	70.0	21.2	20.1	41.4	73.1	26.5	65.2	24.8	55.6	58.3	21.5	27.7	423.8	39.1	33.5	57.3	16.2	52.8	37.7	29.2	66.2	49.1	73.2	62.7	38.8	44.2	46.9	24.8	72.0	61.4	35.5	36.5	38.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.0	15.3	20.4	14.8	25.4	11.9	23.1	13.2	15.3	13.8	12.2	20.5	11.1	18.8	20.8	15.3	11.2	9.3	22.7	8.7	20.4	18.9	8.8	19.8	9.1	14.1	20.6	17.7	16.6	11.4	15.2	10.9	18.6	10.8	11.2	8.8	14.4	20.0	12.3	14.2	17.5	28.5	25.1	15.8	5.2	18.6	22.7	12.6	32.1	17.3	16.4	20.7	11.9	17.9	15.3	31.7	9.7	12.4	10.2	12.1	17.4	10.0	12.7	17.5	11.4	17.6	6.4	29.5	8.7	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1	17.9	17.3	29.6	37.1	53.8	47.2	45.6	28.1	5.3	20.5	38.4	60.9	27.6	39.7	35.0	59.2	17.3	39.4	0.0	41.1	24.4	27.3	58.6	26.5	49.9	23.3	101.7	38.6	16.5	48.5	32.9	33.1	41.2	54.0	37.9	27.4	54.4	35.2	40.3	31.8	30.8	128.5	25.8	38.7	33.8	26.0	54.5	54.0	54.2	32.8	45.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.0	0.0	0.8	0.0	0.0	0.8	1.2	0.0	0.0	6.5	0.1	0.1	2.3	0.0	16.5	0.0	0.4	0.1	4.9	0.0	0.1	0.0	1.2	0.5	2.1	0.3	1.3	0.1	0.0	0.5	0.0	4.1	1.6	0.0	0.0	2.9	7.8	0.0	2.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	7.6	15.8	0.2	0.0	1.0	0.1	0.0	7.0	0.0	0.0	1.9	0.0	2.4	0.0	0.1	4.4	0.3	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0	0.0	0.0	0.0	0.0	0.0	16.0	1.6	0.0	0.0	3.4	0.0	29.5	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.1	73.1	2.9	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	0.0	11.7	0.0	0.0	9.3	2.5	0.0	0.0	0.0	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 61.4;Kupffer cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 36.5;K-562: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.2	9.9	6.4	6.2	3.5	6.3	8.1	10.6	6.3	9.4	6.5	4.5	3.7	5.6	13.3	7.4	4.0	11.2	2.8	6.6	3.3	8.0	9.0	21.7	4.6	4.3	5.9	8.0	5.9	5.9	2.0	9.1	4.3	6.7	36.5	5.6	55.2	2.4	12.0	8.6	4.7	6.2	2.7	2.9	10.9	7.1	16.5	1.6	3.2	3.9	2.6	10.0	10.0	3.3	8.6	2.6	4.1	5.6	30.7	11.3	11.5	10.3	10.1	4.7	3.7	6.2	11.4	15.3	21.6	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9	6.0	5.9	5.1	4.4	7.2	7.0	13.1	15.3	4.0	3.4	1.8	2.0	13.3	3.3	4.9	1.1	31.9	2.0	0.0	4.3	7.2	7.7	3.9	3.5	5.5	17.5	7.9	5.8	61.4	32.9	1.1	6.6	18.0	6.8	8.2	3.9	3.8	5.6	0.0	6.3	3.4	6.5	6.5	5.7	7.4	10.5	5.0	2.5	5.7	3.8	5.4
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381194-27409687	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.3"	"Cell type enhanced"	"Detected in all"	17	"Early spermatids: 1236.5;Late spermatids: 2467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	12.7	17.0	9.9	19.9	9.2	19.4	30.2	10.9	19.3	17.9	14.6	9.1	16.9	12.1	26.8	12.5	19.4	19.2	17.7	13.6	8.8	7.6	12.6	18.6	14.7	20.2	9.4	8.0	13.4	18.6	13.8	13.2	11.4	8.7	10.2	16.4	9.1	16.4	18.7	24.1	10.9	12.2	14.9	6.7	14.7	14.1	93.3	8.4	25.8	14.1	19.1	22.5	25.2	17.3	20.2	40.3	24.5	29.1	22.7	38.3	19.0	50.9	42.1	30.9	23.7	19.7	16.1	28.5	31.8	20.9	38.2	30.7	64.8	27.0	60.2	23.4	22.5	32.5	27.9	51.9	35.7	34.4	25.1	42.2	58.6	30.7	68.4	17.8	57.8	24.8	17.4	20.7	38.9	31.4	18.2	36.5	29.9	49.0	18.7	28.9	45.6	42.9	62.8	44.9	35.4	30.4	44.4	64.8	31.6	25.8	35.6	41.6	47.1	28.5	31.6	22.8	25.6	17.5	19.0	29.3	28.6	34.6	25.0	48.2	40.8	45.7	95.2	22.4	47.4	21.4	22.1	17.8	24.5	26.9	22.3	26.5	20.2	28.7	27.9	28.5	18.0	21.7	22.4	9.1	22.7	29.1	40.3	38.3	19.0	9.9	9.2	10.9	19.3	8.8	7.6	9.4	8.0	8.7	8.4	59.6	43.5	61.1	65.0	72.0	42.0	33.6	50.9	61.6	66.0	66.3	27.5	71.4	28.2	97.8	1236.5	66.3	54.6	23.3	120.2	139.9	42.7	66.0	58.8	37.8	76.1	46.1	77.4	35.6	49.4	2467.5	65.0	65.1	23.6	147.9	59.6	64.9	122.3	42.1	66.8	48.3	34.6	45.3	45.8	594.3	323.3	70.4	44.4	79.7	83.2	121.2
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 417.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.2	0.7	2.8	5.0	4.3	5.6	1.1	3.5	6.4	11.8	14.0	5.7	0.5	27.5	3.9	2.2	5.7	0.2	8.4	2.7	4.7	21.2	3.5	4.9	2.2	5.1	3.3	6.7	2.6	3.7	1.3	7.2	6.3	2.4	1.9	11.9	7.3	24.0	3.4	3.1	8.8	3.7	1.7	1.6	1.1	5.0	4.7	10.5	4.1	0.9	2.2	1.9	2.2	0.2	2.6	4.9	11.4	1.9	0.4	4.1	2.1	1.3	2.0	7.6	6.9	23.0	4.5	5.5	6.8	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4	44.7	11.3	104.3	16.5	8.8	97.4	417.4	7.6	24.1	17.0	47.1	17.7	9.4	132.6	5.9	6.1	17.6	2.0	46.7	5.4	2.6	28.3	31.2	18.5	22.1	23.1	81.0	9.2	20.3	11.1	6.2	22.2	13.9	20.3	111.0	15.6	19.2	6.3	4.9	29.7	39.1	14.1	25.8	38.7	35.6	21.3	4.6	2.4	54.8	2.9	5.7
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245793-52250597	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 38.2;Kupffer cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.2"									"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	14.3	7.2	13.9	22.7	14.8	16.5	26.3	3.6	9.2	16.9	12.5	4.6	7.8	4.4	13.6	12.0	10.8	11.7	19.4	14.5	8.7	8.5	8.7	4.9	30.1	38.0	5.4	12.3	14.9	5.9	6.9	7.5	8.6	4.9	15.1	6.7	11.0	10.8	12.4	3.1	7.5	8.8	18.1	6.8	22.5	8.3	6.2	5.9	20.5	11.3	9.9	20.5	11.3	13.5	5.0	9.6	19.6	18.6	7.4	15.0	10.1	0.4	2.5	1.5	3.7	22.8	22.8	2.4	5.8	12.5	8.2	6.4	1.4	2.0	4.2	1.7	15.1	4.6	0.7	5.1	1.1	3.3	5.0	1.2	9.6	6.7	1.5	16.7	1.4	9.1	18.8	2.5	9.2	5.8	13.3	10.6	19.5	1.6	7.0	9.6	1.0	6.2	0.4	2.0	1.9	7.0	1.4	0.7	9.2	3.5	1.1	1.1	4.5	4.2	1.0	5.2	3.4	3.6	3.7	7.3	3.1	5.3	1.8	0.7	26.2	4.8	4.5	6.2	2.5	3.8	1.2	15.7	8.5	15.0	12.4	11.7	5.0	11.8	13.8	9.6	3.8	11.1	13.8	19.6	7.4	18.6	5.8	13.2	10.1	13.9	14.8	3.6	9.2	8.7	8.5	5.4	12.3	4.9	5.9	0.0	4.8	11.5	3.9	4.5	1.0	2.0	5.1	1.4	3.4	1.8	0.0	3.0	3.3	1.7	9.9	6.9	0.7	0.0	1.0	5.3	8.2	2.7	5.7	2.4	38.2	1.6	1.2	10.4	40.0	14.2	11.8	24.5	5.0	10.0	0.2	5.1	1.6	1.9	9.2	2.2	0.4	19.4	6.1	0.4	3.6	3.3	1.6	22.0	0.7	1.8
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	45.3	52.4	31.1	45.8	15.5	19.0	31.7	22.5	26.4	45.4	34.5	74.9	54.8	39.1	38.4	34.1	33.8	39.8	35.9	46.8	27.9	41.1	24.4	37.5	24.7	39.2	33.9	47.6	48.5	21.4	31.0	38.6	22.8	21.6	45.5	38.3	34.8	32.4	36.7	103.5	60.3	93.6	51.6	86.5	41.5	42.9	43.0	33.8	44.6	37.6	24.3	40.4	26.1	46.9	69.4	24.3	56.1	33.0	32.4	35.1	35.9	41.3	29.1	32.5	30.1	44.4	42.0	32.7	36.9	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4	71.5	93.0	166.0	108.0	88.8	35.0	7.9	117.2	41.5	46.6	82.0	9.8	320.7	180.8	238.7	1.8	77.3	292.4	23.3	272.4	398.0	69.2	127.9	107.3	102.4	338.5	41.3	93.0	87.2	194.1	5.3	45.5	157.2	129.9	390.5	160.1	42.9	250.4	210.5	26.9	236.5	23.6	97.0	60.9	13.0	106.5	106.3	357.3	222.6	164.6	168.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7700000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	37.1	23.4	81.7	25.2	28.0	26.1	47.6	20.0	22.8	19.5	19.3	20.7	22.0	29.7	25.1	20.6	21.6	23.0	23.2	26.7	23.2	47.1	12.0	22.5	28.8	22.4	61.0	25.4	10.6	20.0	38.0	21.0	44.0	20.5	23.5	15.8	20.4	29.5	25.5	18.6	26.9	22.0	26.8	28.6	18.6	26.4	72.4	22.6	63.3	44.9	22.4	27.7	31.0	34.6	27.1	24.4	16.7	14.2	28.1	26.1	28.7	18.6	24.0	21.1	33.1	60.9	27.7	27.4	19.3	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4	86.4	80.7	105.5	134.5	437.2	53.8	298.4	104.4	129.8	72.8	294.8	25.5	104.9	207.2	242.7	375.6	106.2	128.9	163.5	183.3	167.5	182.4	291.0	146.3	81.8	104.3	154.1	271.6	108.6	144.9	304.1	182.1	233.4	318.9	92.8	133.9	100.9	238.2	181.4	283.9	113.6	53.2	620.9	265.8	57.5	61.8	400.4	328.6	110.8	99.3	394.6
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 486.0;Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		7600000			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	23.3	29.4	27.4	23.4	29.8	28.8	24.1	31.9	32.3	25.2	63.3	22.2	15.4	63.0	25.9	19.8	31.3	22.9	21.5	66.5	29.4	21.0	19.8	20.6	19.6	41.4	32.0	21.9	31.7	38.8	19.6	25.8	17.0	25.9	26.1	36.4	28.7	26.9	19.4	63.4	24.0	73.3	46.3	25.9	27.1	25.2	43.7	28.3	42.3	25.9	18.3	41.3	37.9	23.2	17.8	19.1	30.8	19.1	8.5	14.9	12.5	45.8	27.7	47.4	34.6	28.8	39.8	36.3	26.5	39.5	44.1	35.3	47.3	23.4	71.8	20.1	28.4	27.6	26.2	63.5	34.8	61.7	41.7	42.8	46.4	20.8	48.2	23.5	59.0	40.4	25.1	28.5	33.3	29.8	46.9	50.9	40.8	46.2	19.5	40.3	19.1	47.7	66.2	74.6	30.3	41.0	47.0	32.7	45.4	28.2	34.9	38.3	30.8	29.2	35.2	51.0	43.6	55.1	46.2	22.6	22.5	37.3	30.3	33.2	30.7	31.9	61.5	21.2	43.0	34.2	18.7	19.1	30.8	8.2	14.9	8.0	17.8	14.9	11.7	19.1	15.4	12.4	10.2	16.3	8.5	18.8	7.4	13.7	12.5	27.4	29.8	31.9	32.3	29.4	21.0	32.0	21.9	25.9	28.3	32.8	25.1	131.3	108.1	185.8	159.6	121.9	61.1	12.0	21.6	34.9	64.8	118.3	79.6	59.1	486.0	77.6	126.9	70.0	109.1	164.3	97.7	101.2	58.7	34.2	118.8	96.9	81.6	50.3	154.1	696.0	83.1	84.6	121.4	49.5	90.9	76.2	74.1	147.3	130.4	66.8	93.8	109.9	130.8	168.8	41.4	183.6	110.5	92.7	142.6	110.4
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.0;skeletal muscle: 227.2"	"Cell type enriched"	"Detected in many"	5	"Distal tubular cells: 1142.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Group enriched"	"Detected in some"	4	"ASC diff: 6.5;NTERA-2: 21.2;RPTEC TERT1: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007811, HPA041542"	Approved					NA	NA					"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	67.0	2.1	9.9	1.6	33.2	1.3	51.8	2.2	8.2	1.6	4.0	2.9	0.5	2.2	1.7	1.8	4.3	1.6	1.9	34.6	6.6	3.7	35.4	27.5	1.3	1.4	6.4	4.8	3.3	5.6	3.9	0.1	1.2	4.8	2.9	1.8	0.1	3.1	2.3	227.2	1.3	2.4	2.3	2.7	1.3	4.7	1.7	7.8	0.0	1.4	16.6	1.4	1.4	4.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.9	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0	0.0	0.0	0.1	23.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	33.2	2.2	8.2	6.6	3.7	6.4	4.8	4.8	7.8	0.0	0.0	1.9	0.0	0.1	0.7	215.5	2.5	0.0	0.0	17.4	0.0	0.0	1142.3	2.9	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	215.6	0.7	106.5	2.4	6.2	3.8	1.3	1.1	0.0	0.0	0.0	0.3	1.4	4.1	0.0	1.1	55.9	2.9	0.0	9.8	0.0	1.7	0.3	0.0	0.0	0.5	0.1
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 173.9;salivary gland: 105.3"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 128.2;Mucus-secreting cells: 299.8;Undifferentiated cells: 342.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 173.9"	"Cell type enriched"	"Detected in single"	37	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;OE19: 10.7;SCLC-21H: 19.3"	"Region enriched"	"Detected in many"	8	"basal ganglia: 1113.7"	"Region enriched"	"Detected in all"	20	"basal ganglia: 1698.9"	"CAB004026, HPA048630, HPA061142"	Approved	Approved				NA	NA					"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438"	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	26.2	10.0	25.6	5.8	173.9	0.6	23.3	14.6	24.1	7.4	64.1	16.2	39.4	25.7	1.8	2.2	1.9	9.4	4.6	0.7	17.3	11.2	2.0	0.5	5.1	0.5	21.9	22.2	2.6	19.1	0.6	1.7	0.5	17.9	19.9	63.3	6.9	105.3	49.6	0.5	5.7	20.9	4.1	12.4	0.5	13.6	4.6	40.0	0.0	0.5	0.3	0.8	3.6	1.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.3	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	10.7	0.6	0.0	0.0	0.4	0.0	0.0	19.3	0.4	0.0	1.0	0.0	1.8	0.4	0.7	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	173.9	14.6	24.1	17.3	11.2	21.9	22.2	17.9	40.0	0.0	26.7	0.0	99.4	1.1	0.3	1.1	0.0	0.0	0.0	1.8	0.0	0.0	102.8	13.3	0.7	0.1	36.6	0.0	3.1	0.0	1.3	59.5	4.6	0.0	0.2	0.0	92.9	3.1	0.0	2.2	31.9	1.0	128.2	0.0	299.8	28.7	1.0	94.7	5.3	0.4	0.9	0.0	0.6	0.5	3.2	0.4	0.0	0.0	342.5	101.6
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514425-195543386	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 363.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 67.5"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	16.4	12.7	19.9	17.7	26.0	45.2	18.3	16.2	22.9	16.1	21.2	11.4	17.4	19.5	18.9	20.7	25.6	15.3	15.8	23.3	18.6	21.7	16.7	13.0	21.7	30.4	16.5	15.4	17.1	12.0	9.5	17.6	16.1	21.2	17.0	16.0	13.7	15.0	19.0	57.1	14.1	22.6	17.7	15.4	24.2	13.9	21.8	7.0	38.1	19.1	25.2	23.5	26.5	15.5	26.0	26.6	63.2	16.9	22.8	50.2	30.1	11.6	2.5	4.3	4.9	7.3	7.8	7.9	7.3	10.6	7.8	6.7	39.5	5.3	4.6	29.2	8.9	8.4	5.2	4.5	7.4	9.6	9.1	8.5	5.3	4.2	13.2	11.3	5.5	5.5	9.5	5.7	5.8	11.8	6.2	6.7	4.9	4.0	9.9	6.8	8.1	9.8	6.2	4.5	14.0	11.8	4.6	7.5	13.7	9.3	8.9	10.2	5.6	8.8	9.7	13.1	8.3	15.3	5.6	7.4	5.0	5.8	8.2	9.9	67.5	29.3	22.1	7.0	10.1	9.7	26.3	16.7	63.2	19.6	16.9	26.9	26.0	41.2	27.0	17.6	23.6	50.2	34.0	39.4	22.8	16.4	26.6	41.7	30.1	19.9	26.0	16.2	22.9	18.6	21.7	16.5	15.4	21.2	7.0	20.8	39.2	125.0	121.2	83.7	47.5	46.2	25.5	66.9	38.7	21.0	55.0	57.7	106.1	61.4	363.0	65.1	53.1	46.7	57.9	34.5	51.3	104.3	109.6	24.6	55.6	49.3	55.0	39.3	59.0	190.1	47.8	82.0	92.8	141.5	44.1	50.2	58.5	55.2	59.8	82.6	79.3	25.8	64.1	239.4	84.1	67.9	86.3	140.6	44.9	143.1
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 136.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	64	"THP-1: 18.1"	"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA					"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 213.5;Hepatocytes: 61.4;Muller glia cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4;HHSteC: 20.8;hTERT-RPE1: 33.7;LHCN-M2: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA					"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	10.4	4.7	2.2	0.0	11.4	8.9	4.7	5.1	0.0	0.8	0.0	0.4	10.7	1.9	0.6	0.2	1.2	8.7	0.0	0.0	0.1	16.4	1.8	20.8	0.0	0.0	7.6	2.0	3.0	0.1	33.7	1.1	0.0	5.3	0.0	39.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.4	10.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.7	7.8	2.1	2.1	2.7	1.6	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1	0.0	0.0	0.0	10.2	4.0	8.9	213.5	0.0	0.0	0.0	3.5	0.0	0.1	6.6	1.7	0.0	3.5	0.0	0.0	10.2	0.2	6.6	3.2	0.0	61.4	1.1	17.5	9.7	1.8	2.4	0.0	2.6	0.0	11.8	0.0	0.0	120.0	6.4	0.0	7.1	1.6	12.5	0.0	21.7	0.2	1.4	3.4	0.2	0.0	0.0	0.9
PPP2CA	"PP2AC, PP2Calpha"	ENSG00000113575	"Protein phosphatase 2 catalytic subunit alpha"	P67775	5	134194334-134226142	"Enzymes, Predicted intracellular proteins"	Meiosis	"Hydrolase, Protein phosphatase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003848, HPA043236"	Approved					NA	NA					"CAB003848: AB_562203, HPA043236: AB_2678379"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	26.0	30.5	37.6	22.0	41.0	57.9	26.0	54.2	56.6	23.0	27.3	29.6	15.6	24.8	29.8	20.4	39.6	21.9	24.7	47.9	39.8	38.1	31.7	33.2	22.7	29.1	35.0	35.8	23.4	23.9	44.5	20.6	44.0	47.5	22.3	26.4	18.4	23.6	23.7	43.1	32.6	26.5	31.6	32.8	30.4	21.8	18.8	24.1	45.6	33.2	30.5	39.9	26.9	24.5	29.2	41.1	39.0	33.4	38.9	37.5	43.8	37.9	32.0	45.7	24.6	23.9	25.7	32.1	35.9	30.8	54.7	55.3	61.3	29.8	33.3	33.8	33.1	62.0	19.8	43.9	51.8	64.1	30.1	25.1	23.6	37.4	38.1	35.4	23.3	21.4	23.8	35.9	42.8	42.7	27.3	38.3	33.7	23.2	25.0	41.4	27.3	36.9	22.7	25.0	30.2	19.3	33.1	45.5	32.3	32.9	42.8	36.5	25.4	37.0	13.8	40.2	47.8	28.2	27.6	26.9	31.6	17.8	25.3	50.5	22.5	40.2	52.6	21.3	30.9	32.6	20.3	33.4	39.0	26.7	33.0	34.1	29.2	30.7	35.6	41.1	28.6	35.7	32.7	38.7	38.9	33.3	22.0	37.5	43.8	37.6	41.0	54.2	56.6	39.8	38.1	35.0	35.8	47.5	24.1	47.6	47.1	62.7	174.1	212.2	43.8	101.7	71.4	50.9	51.2	54.1	21.6	139.8	91.2	89.5	23.5	75.5	59.4	70.0	77.0	143.4	86.8	121.4	62.2	58.2	98.2	47.7	83.5	49.7	91.0	21.8	35.6	80.0	99.5	125.4	51.7	61.5	82.5	50.1	42.8	83.6	24.4	19.4	109.5	69.9	85.0	204.9	259.0	79.8	56.2	157.9
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	26.7	21.0	61.3	11.9	54.9	2.6	28.7	32.0	46.2	28.8	24.1	30.7	19.4	21.7	34.5	37.5	29.7	28.2	23.1	27.2	57.3	43.7	41.0	35.7	27.7	8.4	52.6	39.8	48.0	22.9	33.7	14.8	27.4	47.7	23.7	24.5	12.5	19.5	29.1	27.4	18.0	31.2	39.0	49.7	15.0	18.9	18.8	48.2	6.3	44.5	14.0	14.0	17.7	34.3	5.8	7.9	5.1	6.5	7.3	4.8	1.7	22.1	19.4	33.9	12.9	33.9	30.9	18.9	29.7	27.8	30.8	32.3	20.3	16.3	10.8	29.2	39.5	29.5	13.4	20.2	34.1	41.6	6.7	10.6	14.4	13.2	20.4	38.9	6.4	8.2	27.2	39.0	26.0	29.2	31.3	36.9	18.1	22.3	11.5	51.9	10.9	17.5	8.2	24.7	33.5	11.2	12.3	13.6	8.0	41.2	18.0	32.6	13.5	13.7	14.6	28.6	39.5	8.0	11.0	38.7	26.6	20.0	8.7	24.5	5.9	7.7	12.8	22.8	6.0	34.0	4.8	5.0	3.3	4.2	6.5	4.8	5.8	3.8	4.2	3.5	2.7	3.8	4.6	5.1	7.3	3.0	7.9	2.8	1.7	61.3	54.9	32.0	46.2	57.3	43.7	52.6	39.8	47.7	48.2	65.5	53.8	13.8	81.2	92.5	34.5	71.2	40.8	34.8	50.0	82.0	29.5	36.8	39.7	34.2	13.3	49.6	112.3	0.0	42.0	43.1	62.0	108.1	17.3	81.5	48.8	44.5	31.0	101.3	52.3	13.4	67.9	30.8	38.8	16.2	51.0	105.4	64.5	41.8	248.2	63.4	21.1	45.3	59.7	30.2	35.8	83.6	59.0	14.0	32.4	132.7
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190039-52229533	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		3400000	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	25.3	57.3	60.7	20.5	71.0	18.0	21.4	47.5	82.1	29.6	31.2	26.6	21.5	33.4	26.4	37.9	37.7	47.0	39.9	74.7	70.2	44.8	31.0	29.3	20.0	27.5	44.0	50.9	45.8	24.3	37.8	29.5	24.6	51.0	31.0	29.8	31.0	24.3	35.6	50.6	33.5	25.3	34.5	25.2	20.5	19.8	21.7	18.1	29.0	28.9	35.9	30.6	27.3	23.1	52.8	62.8	51.9	67.2	69.8	56.3	67.8	30.9	52.6	42.0	37.3	34.2	35.8	22.1	26.1	34.2	34.9	30.6	26.4	24.5	27.1	18.8	41.5	19.2	22.4	45.0	39.4	20.3	20.0	121.9	19.9	29.0	29.7	31.3	21.5	19.0	48.0	32.6	32.7	30.1	32.8	33.1	18.2	23.1	19.1	38.7	35.8	30.0	41.0	41.5	31.2	46.5	29.5	24.4	30.3	56.1	51.0	31.7	33.9	32.0	32.0	19.5	28.6	28.9	38.0	31.4	27.7	25.1	13.5	29.8	19.8	29.0	31.8	29.8	21.8	34.9	45.0	55.3	51.9	50.4	67.2	45.8	48.4	45.1	47.1	62.8	52.8	37.7	43.0	33.7	69.8	59.8	39.0	56.3	67.8	60.7	71.0	47.5	82.1	70.2	44.8	44.0	50.9	51.0	18.1	41.7	30.7	69.2	78.9	62.5	111.3	81.8	68.8	52.2	36.4	113.4	23.6	183.6	99.5	195.0	3.8	51.7	133.3	0.0	136.1	214.1	70.0	78.9	68.0	44.8	127.2	136.7	102.6	66.9	55.1	6.8	67.0	47.0	50.6	131.7	108.9	97.9	137.7	175.6	80.2	103.3	48.5	77.6	81.4	14.8	54.1	55.3	152.2	70.3	147.4	93.1
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	13.0	8.8	12.7	8.6	12.8	6.9	12.8	13.0	9.1	9.7	8.9	29.7	13.8	16.6	9.8	8.4	9.2	12.4	18.8	10.7	12.4	11.5	5.8	16.2	5.2	12.9	6.3	18.9	12.9	7.8	6.5	10.9	8.0	6.8	11.9	17.4	19.6	22.1	10.6	4.2	20.4	7.7	15.6	14.2	9.6	15.7	8.4	20.3	14.4	14.5	4.1	11.3	11.6	10.7	2.1	14.3	12.4	7.1	12.8	11.3	13.7	5.6	8.2	2.3	5.8	60.8	4.0	22.1	14.3	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9	17.9	8.0	12.6	9.8	12.7	4.9	3.0	10.2	16.0	6.8	12.2	7.9	11.5	11.6	16.5	249.6	12.3	16.1	23.3	20.0	14.9	9.4	9.7	8.1	68.4	8.4	1.6	15.0	8.6	7.8	93.2	6.1	5.6	8.5	11.8	11.5	9.1	21.0	7.0	7.1	15.9	10.5	12.9	9.5	71.5	18.5	12.8	14.8	7.5	11.5	13.6
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291491-26372680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	26.1	14.8	25.1	19.1	30.3	21.2	41.7	23.7	28.0	25.2	18.2	27.9	16.0	23.4	20.5	16.0	50.3	19.1	16.8	24.6	21.2	16.2	21.5	32.0	21.7	17.6	28.9	22.3	22.5	13.3	19.3	18.3	39.4	24.8	20.6	18.4	11.3	24.3	18.3	41.6	31.7	16.2	21.1	22.6	15.9	15.3	19.2	32.1	18.3	21.6	29.1	30.4	21.8	29.9	8.0	4.8	6.5	4.8	7.9	10.1	3.6	18.9	18.4	23.8	17.0	14.9	21.3	25.4	29.6	19.0	27.8	26.7	22.6	14.1	26.2	9.0	15.8	18.3	22.8	28.7	24.0	38.1	11.5	15.1	19.8	18.4	11.9	23.5	11.4	15.4	16.9	34.0	24.0	33.4	18.2	43.2	14.8	27.0	25.5	25.3	12.1	25.9	12.7	31.4	45.1	13.0	18.6	17.8	21.8	17.4	28.7	10.0	13.1	14.2	14.3	23.1	22.9	15.1	10.3	23.2	17.4	21.6	17.7	20.7	9.3	12.1	33.9	20.7	20.8	29.3	3.1	2.3	6.1	4.3	4.4	5.4	8.0	6.0	7.6	4.3	6.8	6.1	7.9	6.5	7.9	4.8	4.8	10.1	3.6	25.1	30.3	23.7	28.0	21.2	16.2	28.9	22.3	24.8	32.1	68.5	57.4	46.7	211.9	121.3	52.2	30.0	30.6	123.1	100.1	14.0	45.2	66.8	41.4	40.1	32.5	64.2	45.3	70.0	28.2	56.0	37.8	125.3	54.3	29.2	32.0	35.0	73.7	52.2	31.3	86.3	43.4	50.2	57.3	42.3	32.7	48.8	45.2	26.2	68.9	36.8	37.6	51.8	57.7	28.9	62.2	125.0	56.0	43.7	33.3	178.5
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146581146-147084784	"Disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 73.2"	"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0"	"Group enriched"	"Detected in many"	33	"NK-cells: 9.5;T-cells: 16.1"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	2.0	9.7	30.8	2.5	35.2	2.9	1.8	10.2	73.2	1.6	2.7	26.0	0.0	3.0	1.7	1.8	2.9	14.5	2.9	2.9	26.4	20.9	4.7	2.4	2.5	4.3	25.5	22.4	1.6	2.9	16.0	6.4	2.6	27.5	2.7	2.8	4.6	2.0	2.9	1.5	4.9	2.3	3.5	18.6	2.9	2.2	15.7	29.3	0.0	4.2	0.0	2.4	6.8	1.1	0.0	0.0	0.3	0.0	9.5	16.1	4.1	0.4	0.4	2.4	1.0	0.1	0.1	0.2	0.5	0.2	1.1	1.6	1.3	4.8	0.2	0.1	0.0	0.0	10.2	0.8	1.0	1.1	47.5	0.2	0.6	2.8	0.5	0.2	0.0	0.2	0.1	0.7	0.0	0.2	0.7	0.1	0.4	0.6	0.5	0.7	0.3	0.0	0.0	6.3	0.0	1.1	0.7	0.1	0.1	4.2	10.9	1.9	0.2	0.3	0.0	0.2	1.7	0.4	0.1	0.3	0.2	0.7	2.5	0.4	0.4	0.2	0.0	1.7	4.3	1.4	0.2	0.0	0.0	15.1	0.0	13.8	0.0	7.1	16.1	0.0	0.0	1.3	12.0	0.3	9.5	0.0	0.0	8.0	4.1	30.8	35.2	10.2	34.1	26.4	20.9	25.5	22.4	27.5	29.3	3.0	2.6	0.0	1.1	1.8	83.2	1.2	12.7	0.0	1.2	8.7	141.4	14.1	18.3	1.3	312.5	2.1	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.8	44.5	12.5	0.0	1.2	670.1	3.1	1.7	5.0	0.0	0.0	31.8	0.8	0.0	2.1	4.0	261.9	0.0	8.6	3.7	1.6	1.3	4.5	16.7	0.0	0.7
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.2;Late spermatids: 144.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	1.5	6.6	28.2	1.6	33.9	1.1	2.4	17.0	78.4	11.8	1.5	13.8	0.5	1.7	25.3	7.0	25.2	10.5	1.4	1.9	25.8	19.5	1.2	1.1	1.1	1.3	25.6	19.3	1.3	1.7	1.1	5.9	1.1	19.1	5.5	1.4	0.4	1.4	14.4	1.7	28.8	2.0	11.8	32.0	1.3	1.9	4.7	13.5	0.0	1.1	3.9	3.6	1.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	9.2	0.0	34.1	6.6	10.3	0.3	0.0	0.0	1.2	0.0	1.4	1.6	0.3	0.0	0.0	3.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.8	17.3	0.0	0.0	1.0	0.3	19.9	0.0	0.0	0.6	0.0	0.0	19.3	3.6	0.6	0.0	0.0	0.6	8.9	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	33.9	17.0	40.2	25.8	19.5	25.6	19.3	19.1	13.5	0.0	0.0	0.0	0.5	13.1	10.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	0.1	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.1	3.2	0.0	0.0	0.0	144.3	6.4	0.0	0.0	0.0	0.0	4.1	1.3	0.0	4.2	0.0	2.4	0.0	1.4	1.0	0.9	19.3	0.0	0.0	0.0	0.1
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965673-136147891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;BJ hTERT+: 18.8;RPTEC TERT1: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	6.3	3.3	3.4	1.9	6.4	0.7	4.3	1.5	4.9	5.5	6.7	5.2	5.8	1.7	6.8	5.1	5.0	3.0	3.3	27.4	3.9	2.8	31.7	1.2	2.6	0.9	7.0	4.4	3.7	3.8	7.5	3.7	9.0	5.3	3.8	3.5	1.6	7.7	7.8	85.6	10.4	2.5	11.4	6.1	1.2	5.2	4.2	6.5	0.0	2.3	31.6	1.2	6.5	3.9	1.5	1.8	1.7	1.4	1.8	1.5	0.6	19.2	1.1	5.5	2.6	4.5	5.7	6.4	15.1	18.8	7.1	8.9	1.2	1.2	0.0	5.8	15.4	5.1	2.5	2.3	5.3	15.5	0.0	0.7	0.8	0.6	0.0	3.2	0.0	0.8	5.1	4.6	9.1	4.3	7.2	6.8	0.5	0.5	0.0	10.2	3.2	0.1	0.1	3.8	0.2	3.7	0.0	8.1	0.0	25.0	0.7	0.4	3.1	2.4	3.0	5.8	5.2	4.8	0.2	4.4	7.5	4.1	10.1	6.6	0.2	0.5	0.0	5.5	0.4	2.6	1.1	1.2	1.5	0.9	1.4	0.5	0.7	1.0	0.8	1.1	1.5	1.5	1.2	1.7	1.8	1.2	1.8	0.7	0.6	3.4	6.4	1.5	4.9	3.9	2.8	7.0	4.4	5.3	6.5	26.8	22.2	2.7	15.3	23.5	4.1	102.3	0.0	9.4	11.4	52.4	0.0	7.6	18.3	18.1	6.1	8.7	15.8	0.0	8.5	13.2	12.8	12.5	3.5	2.4	2.2	3.2	12.5	5.5	2.1	9.5	22.7	4.6	27.0	14.4	7.9	9.5	12.6	9.9	17.3	37.2	2.2	6.5	11.9	6.6	19.6	29.1	8.7	3.8	7.3	15.3
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 15.5;U-698: 24.3"					"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.3	0.7	2.2	0.1	0.2	7.1	5.9	1.5	5.3	6.3	5.3	0.0	0.0	3.2	4.5	0.6	0.0	0.2	0.0	1.4	3.7	4.3	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.2	0.1	3.2	1.0	0.3	1.2	2.6	9.0	7.8	2.3	0.1	15.5	4.1	3.4	0.3	1.4	1.5	0.0	9.2	0.0	0.9	4.2	4.2	0.0	2.3	0.3	3.1	2.9	0.0	2.0	0.0	0.0	24.3	0.1	2.7	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0	0.0	1.7	0.9	7.8	6.1	11.5	62.0	2.5	2.7	1.2	0.0	25.5	5.6	0.0	2.8	0.5	3.5	1.4	0.0	3.5	5.6	3.0	2.2	0.0	1.0	3.2	6.4	4.6	4.3	2.1	1.5	3.7	5.3	5.0	3.6	3.8	11.2	2.6	0.0	2.8	1.3	19.8	0.0	3.8	12.9	25.5	6.6	3.3	1.9	3.1	3.9
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.8	17.0	5.7	25.4	8.2	10.3	15.3	13.5	24.4	23.8	12.5	7.2	9.6	12.7	16.3	16.0	15.1	26.8	16.3	16.3	21.9	31.9	11.9	14.9	9.0	20.0	34.8	6.0	14.3	14.8	7.7	8.4	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.8	12.9	16.5	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.5	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9	3.0	11.0	18.2	26.7	22.8	52.0	42.6	10.2	13.4	11.4	17.4	19.6	17.9	53.0	15.6	5.9	18.3	10.2	0.0	16.6	13.6	21.4	23.8	20.7	12.3	17.9	36.5	40.9	17.2	30.2	7.6	31.1	18.8	25.3	27.1	12.3	32.9	15.6	14.4	27.3	25.6	28.0	6.5	37.1	38.5	44.0	27.6	18.5	15.7	14.4	19.3
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	18.0	8.3	6.9	13.7	8.1	15.2	21.1	11.9	12.0	10.3	10.2	10.9	3.7	6.1	13.4	7.8	11.6	9.0	10.7	27.5	7.6	7.3	8.9	8.2	16.5	22.3	7.7	4.9	10.1	9.9	13.7	15.1	12.7	9.9	11.1	7.1	20.7	15.5	6.0	52.4	9.1	9.8	13.5	7.9	14.1	9.5	41.6	6.9	6.8	11.5	13.2	20.0	14.7	11.0	15.5	4.0	6.6	2.9	11.9	16.0	3.9	5.5	4.1	3.6	4.4	9.7	12.1	5.3	7.7	13.6	11.5	12.8	2.3	3.5	21.0	9.5	11.9	19.2	3.9	8.4	7.7	14.7	12.0	4.5	4.5	4.7	6.7	13.1	3.2	7.4	7.3	10.7	7.7	7.9	12.3	9.9	10.3	8.8	28.0	12.8	2.6	7.5	5.3	2.6	5.7	5.6	24.7	8.6	6.9	10.7	5.2	2.6	6.1	5.8	3.4	7.9	7.2	2.3	5.4	10.6	17.9	3.8	27.1	5.9	14.0	16.9	22.0	9.5	4.3	11.8	3.4	1.6	6.6	11.4	2.0	8.7	15.5	12.9	16.0	3.2	13.9	12.4	10.1	0.4	11.9	2.9	4.0	10.1	3.9	6.9	8.1	11.9	12.0	7.6	7.3	7.7	4.9	9.9	6.9	6.0	3.2	39.8	18.1	14.7	9.7	7.0	12.7	2.7	3.4	7.0	45.2	15.0	6.6	12.0	88.7	24.7	7.2	0.0	18.7	19.5	22.6	23.7	3.5	6.8	11.9	3.2	9.9	23.9	11.3	9.4	20.8	18.5	27.0	43.3	3.1	12.3	15.5	9.9	20.1	10.4	50.5	32.3	26.2	71.2	27.9	9.9	11.8	43.6	6.0	23.0
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.2"	"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		43000	"Plasma membrane, Cytosol"		"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	25.8	20.1	43.3	15.9	66.2	32.3	25.7	47.9	78.2	14.8	14.0	7.7	6.9	13.1	16.6	14.2	15.7	10.5	14.7	10.2	56.2	28.7	11.3	29.6	15.5	18.8	23.7	45.1	13.6	9.8	9.4	8.9	18.5	25.4	14.3	14.8	6.8	12.1	16.6	41.7	17.1	12.0	18.5	21.6	16.5	12.6	10.4	16.5	12.7	12.6	7.7	20.1	14.4	13.3	1.0	1.8	6.4	1.4	0.9	1.4	0.9	17.8	15.2	20.6	14.1	14.2	16.5	21.0	25.9	22.1	29.3	25.9	21.9	16.2	24.9	8.9	17.5	20.9	12.1	21.7	18.7	35.8	17.5	15.5	80.8	12.4	20.1	28.1	31.7	27.3	16.6	17.0	22.7	23.3	16.6	19.6	21.1	19.5	28.5	21.3	15.4	26.8	27.9	24.2	15.0	13.0	19.6	27.2	39.6	18.1	19.0	27.2	19.2	14.9	21.2	18.6	14.0	10.0	14.8	20.5	25.3	23.2	19.1	22.3	16.1	17.7	36.9	18.4	33.4	15.8	3.2	1.2	2.9	0.7	0.8	1.4	0.5	0.8	0.5	1.3	1.0	0.9	1.4	6.4	0.9	1.4	1.8	0.9	0.9	43.3	66.2	47.9	78.2	56.2	28.7	23.7	45.1	25.4	16.5	8.9	16.7	16.6	10.6	66.4	21.5	16.1	10.2	2.7	6.8	15.7	49.1	9.8	10.0	5.9	11.6	21.5	14.4	23.3	7.5	14.8	14.0	14.4	19.6	18.5	21.1	11.1	14.6	15.4	42.9	6.5	9.2	22.7	33.7	4.6	14.0	20.4	10.5	10.1	8.1	12.9	86.2	12.9	17.3	2.6	5.3	61.6	10.1	20.3	12.0	16.8
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591615-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 81.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in single"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	6.5	0.0	319.9	3.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.8	34.6	23.1	32.2	21.9	18.5	36.0	27.5	30.7	36.2	40.2	30.4	40.3	24.0	35.4	32.4	23.6	25.2	28.6	34.1	21.4	30.1	51.2	16.3	21.5	67.2	33.3	22.9	30.9	26.8	30.2	33.0	21.0	21.7	42.0	31.3	31.8	22.0	27.6	88.9	39.9	41.8	44.0	24.5	18.4	44.7	24.0	41.8	34.2	31.8	22.5	33.3	13.5	40.8	23.5	20.2	37.6	39.0	26.7	21.2	22.3	17.1	21.1	37.8	41.5	28.1	30.2	29.6	25.6	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5	47.6	33.1	81.7	96.8	130.7	20.0	9.3	89.2	54.9	23.9	73.3	27.5	268.8	134.3	208.0	127.6	84.2	174.4	0.0	169.7	278.1	71.4	111.6	69.1	85.6	210.3	33.4	120.5	58.9	91.3	98.3	58.1	124.3	75.9	252.5	114.3	41.8	254.7	168.4	49.1	156.3	25.7	71.1	65.1	231.9	141.6	150.8	352.1	111.4	129.3	192.9
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46346994-46392981	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		47000	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	18.9	24.7	23.0	18.1	28.8	13.4	15.9	25.2	50.8	20.4	21.1	19.4	15.2	18.0	23.0	15.2	20.1	27.8	20.5	48.2	20.8	23.9	22.6	22.1	17.4	19.3	21.9	29.8	16.7	21.5	26.3	23.9	17.3	34.5	19.5	17.5	19.7	21.0	21.4	40.8	16.4	15.3	23.5	16.2	21.7	20.6	19.0	15.3	15.6	18.1	20.5	16.1	17.1	18.1	10.6	11.1	1.9	14.1	14.0	19.8	8.9	19.5	36.8	22.0	16.6	16.6	17.8	10.2	24.4	19.8	29.6	26.7	26.4	15.6	30.1	13.3	17.7	16.2	16.1	28.9	28.8	8.9	20.8	39.3	25.0	27.0	18.7	18.6	33.8	17.5	16.2	13.6	20.8	15.5	11.4	25.4	25.7	24.0	15.5	16.8	21.2	18.9	63.4	16.6	35.1	20.1	28.2	19.0	24.1	17.7	26.8	31.3	23.0	20.4	26.0	8.7	10.4	16.3	21.6	21.1	13.0	21.6	9.6	25.5	12.5	28.7	36.0	13.9	28.4	21.6	0.0	6.8	1.9	19.8	12.1	12.7	10.6	9.2	15.3	11.1	8.7	8.9	12.0	0.1	14.0	14.1	7.9	9.3	8.9	23.0	28.8	25.2	50.8	20.8	23.9	21.9	29.8	34.5	15.3	6.0	12.2	13.4	14.5	8.4	19.1	4.7	50.9	9.4	10.3	15.7	15.7	20.7	28.2	26.1	1.0	13.4	17.7	0.0	16.8	30.9	14.6	11.3	4.6	22.8	19.0	15.9	14.3	30.7	10.8	1.7	16.1	7.6	15.1	14.4	15.1	19.1	22.4	11.5	17.3	17.3	16.9	38.8	20.6	14.6	39.2	11.5	21.5	17.0	21.3	8.4
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050940	Uncertain					NA	NA					"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	21.7	20.1	20.1	15.7	24.5	24.8	21.2	20.8	26.2	17.0	19.1	25.9	15.1	13.9	15.6	17.2	21.2	14.0	12.9	15.3	19.8	16.6	22.8	17.8	16.3	21.5	20.1	16.1	17.5	27.7	21.3	17.3	17.6	17.8	14.5	21.8	16.8	26.9	14.6	50.5	19.3	17.3	16.3	22.6	19.4	16.5	22.8	23.7	34.1	22.2	20.5	24.0	13.8	15.6	17.3	14.8	32.2	19.5	13.9	23.3	13.8	14.1	10.3	18.8	17.8	20.2	16.9	19.0	15.0	16.3	22.2	18.6	16.5	15.0	20.4	11.7	20.1	18.9	28.9	25.4	16.3	25.8	18.2	12.3	16.7	16.2	14.6	16.6	29.1	23.2	13.9	22.4	18.2	17.4	17.1	20.7	23.4	19.5	23.7	23.9	21.0	27.4	18.4	17.5	39.6	19.2	22.4	28.5	27.2	18.8	14.3	19.5	19.3	26.8	21.6	17.4	16.7	33.4	18.4	20.0	13.7	13.1	26.5	19.9	26.2	47.2	27.0	18.4	19.1	22.2	27.2	13.2	21.4	14.7	17.4	18.0	17.3	18.9	16.6	14.8	13.3	18.9	17.5	32.2	13.9	19.5	10.7	23.3	13.8	20.1	24.5	20.8	26.2	19.8	16.6	20.1	16.1	17.8	23.7	38.7	27.8	41.7	45.6	68.7	15.2	30.8	35.7	21.4	23.9	26.2	7.9	40.2	48.0	40.6	102.7	41.4	34.6	23.3	47.6	45.3	30.1	41.0	43.9	36.1	46.7	14.3	46.0	46.6	52.3	56.7	27.6	48.9	42.2	46.9	41.6	28.7	41.6	38.6	33.9	54.9	12.9	51.8	44.8	93.3	43.0	76.5	72.9	49.0	37.9	48.2
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163680	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	8.5	13.1	10.4	9.3	10.6	3.0	9.6	21.9	11.8	16.1	10.5	13.1	11.7	15.8	13.8	14.9	13.7	14.2	10.6	12.3	10.7	7.5	17.8	13.1	14.3	6.6	12.2	7.7	25.1	7.0	3.1	7.7	14.3	9.8	10.5	9.6	16.1	7.2	11.4	19.1	30.9	6.9	10.4	7.1	11.8	15.2	6.4	11.5	11.5	7.4	13.2	8.1	13.9	12.0	0.2	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.8	0.0	4.8	1.6	2.6	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.0	1.2	1.3	0.0	7.4	0.0	0.4	1.0	8.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	7.0	0.2	13.3	10.4	0.0	0.4	0.0	0.0	6.0	0.0	0.0	0.5	7.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.4	0.0	10.4	10.6	21.9	11.8	10.7	7.5	12.2	7.7	9.8	11.5	0.0	0.3	0.0	2.7	3.0	12.0	5.8	2.5	0.0	3.4	3.5	15.7	11.6	1.7	1.4	0.2	4.6	1.3	0.0	2.6	7.8	4.8	1.0	0.0	3.9	2.4	3.2	4.7	4.9	1.5	1.0	3.7	1.4	6.8	0.0	2.9	7.5	1.3	3.4	2.8	2.3	5.2	0.0	4.7	3.1	4.5	1.9	19.5	1.3	2.8	1.3
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	17.5	15.8	24.3	23.5	26.1	26.0	18.9	28.3	29.7	21.3	16.5	17.9	16.8	15.0	22.0	20.9	17.3	20.4	17.1	14.9	20.0	12.6	14.2	17.3	16.3	28.7	20.9	18.3	26.0	18.6	22.7	26.9	20.9	20.9	18.7	21.5	13.1	16.6	17.7	18.0	23.7	21.2	16.9	19.3	28.9	17.8	19.1	21.1	32.4	19.5	15.2	26.7	16.7	23.7	15.6	13.5	18.1	12.3	15.4	23.3	14.5	19.5	12.9	19.4	18.8	17.1	21.2	20.7	19.0	13.6	20.5	25.7	19.5	19.4	22.2	15.1	13.6	26.9	17.4	21.0	19.5	27.9	18.5	18.3	13.7	20.3	17.1	14.9	12.7	14.5	16.8	8.0	19.7	14.0	14.2	17.6	17.0	18.7	15.6	16.2	19.7	19.6	16.1	13.6	7.6	7.7	18.3	25.9	18.7	12.0	16.5	9.9	7.9	18.7	8.1	16.9	15.7	11.9	16.8	13.4	11.3	15.8	12.1	27.8	8.9	13.3	23.2	12.4	18.8	12.0	18.1	10.1	16.7	17.2	11.1	20.7	15.6	18.9	18.7	13.5	12.3	23.3	20.4	8.2	15.4	12.3	7.8	20.7	14.5	24.3	26.1	28.3	29.7	20.0	12.6	20.9	18.3	20.9	21.1	26.8	15.3	15.7	13.4	11.0	15.8	15.9	2.5	20.1	27.3	10.4	7.9	23.5	8.3	7.4	68.1	14.3	6.6	23.3	6.6	11.2	13.4	6.0	10.5	4.2	10.2	6.4	9.2	16.5	14.2	27.5	18.7	10.8	13.5	19.0	14.2	14.9	7.6	14.0	17.7	6.5	20.4	6.5	11.0	20.2	31.1	10.3	21.1	20.0	10.3	7.2
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	11.0	13.5	14.5	16.2	34.3	20.3	14.3	14.9	14.0	19.7	20.9	17.2	7.0	14.2	14.7	17.5	18.2	17.2	21.3	43.6	22.4	21.4	20.8	19.0	11.4	19.6	13.2	19.2	13.9	18.8	26.6	14.1	36.5	14.9	18.3	25.1	32.4	25.4	23.8	18.0	12.8	19.5	14.0	21.4	13.6	19.8	24.9	9.2	14.7	26.4	19.0	27.1	13.1	21.9	10.4	19.2	9.4	30.8	18.4	9.0	12.6	11.3	18.3	7.4	4.9	18.6	16.0	20.9	28.1	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8	3.0	7.0	6.1	5.7	9.6	5.3	13.2	5.1	1.4	7.9	7.0	13.7	16.0	5.0	9.1	0.9	9.0	15.7	0.0	10.2	27.4	9.0	4.3	13.8	13.9	13.4	12.7	18.6	9.2	15.8	2.4	10.0	10.0	5.0	18.0	33.1	3.3	12.9	17.3	8.5	6.7	9.5	0.0	12.3	2.1	17.9	7.4	56.8	11.3	34.9	7.6
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 230.0;Late spermatids: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	40.6	15.7	9.4	15.9	16.1	29.0	26.2	14.3	17.7	30.2	24.0	19.9	18.9	21.7	23.5	20.9	22.5	20.4	21.3	15.0	10.5	11.7	35.9	40.7	24.8	16.7	12.2	8.5	28.8	20.6	25.3	20.0	16.8	35.7	26.1	22.3	20.0	23.2	17.9	18.5	16.6	32.6	20.7	14.1	25.1	22.1	29.3	11.4	21.4	28.0	20.5	22.9	32.5	17.9	8.4	6.5	15.9	8.9	10.8	12.6	6.5	11.4	11.9	9.6	12.7	23.7	24.8	9.1	19.6	20.0	14.7	13.2	11.2	14.9	6.7	9.1	20.0	19.2	9.3	8.8	17.8	27.7	19.8	8.0	13.4	27.6	8.9	19.6	12.7	14.2	22.8	8.7	19.6	20.3	16.3	21.6	8.7	6.3	19.6	21.9	5.5	11.8	10.0	4.2	11.7	14.4	9.9	20.5	9.9	22.5	19.5	8.3	8.4	34.3	22.8	11.6	5.4	12.0	10.6	23.1	26.5	14.3	15.2	15.9	7.8	6.1	8.1	16.6	27.7	14.1	14.1	6.6	12.7	10.0	8.1	12.6	8.4	9.4	9.4	6.5	7.7	11.5	10.0	15.9	10.8	8.9	2.0	11.3	6.5	9.4	16.1	14.3	17.7	10.5	11.7	12.2	8.5	35.7	11.4	38.7	27.4	25.1	20.8	21.4	19.2	15.3	43.3	22.7	28.4	45.4	33.4	10.9	6.6	24.4	230.0	32.8	33.8	0.0	39.5	11.7	23.6	34.6	17.4	73.6	17.7	14.3	20.3	36.2	21.5	337.0	28.1	24.1	33.7	36.1	27.4	15.4	29.5	31.7	24.4	26.4	25.7	0.0	33.0	20.4	16.8	28.5	15.6	28.8	30.2	28.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.4	4.2	3.7	4.7	0.0	0.6	0.6	7.4	0.0	7.7	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.7	0.8	1.9	0.0	0.0	1.0	0.1	0.0	0.0	5.5	0.0	5.4	0.0	0.0	0.0	13.9	1.2	2.0	5.4	5.7	0.1	0.0	6.2	3.2	0.0	0.0	1.5	2.3	2.7	6.2	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8	8.9	3.7	0.0	5.9	0.8	39.3	309.5	22.9	10.7	15.9	47.1	47.1	0.8	46.4	9.1	2.3	11.7	1.0	0.0	4.1	0.3	3.5	15.6	2.3	6.4	0.1	25.4	13.8	3.7	0.0	1.9	6.4	0.9	5.0	0.0	7.7	16.8	6.7	0.0	27.6	74.2	106.6	6.5	21.2	7.2	2.8	0.4	0.3	0.0	5.2	11.2
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	7.7	7.6	5.6	4.6	7.1	4.7	7.6	13.3	10.9	9.3	24.6	8.9	8.9	19.1	13.0	8.1	10.0	7.4	6.5	15.2	5.6	5.2	6.2	32.6	6.3	3.8	5.9	9.3	8.1	21.0	18.4	6.2	7.5	7.8	10.9	6.9	6.3	5.7	12.6	52.1	9.4	19.1	20.5	8.4	5.7	11.1	6.9	5.5	2.6	5.8	19.9	4.7	19.0	10.3	1.2	1.7	2.9	1.6	5.1	2.5	0.8	3.9	2.2	5.9	4.5	14.0	12.1	21.3	7.5	4.1	5.0	5.5	8.8	7.9	7.2	3.8	5.9	2.9	10.6	6.8	8.4	4.9	2.8	4.7	3.2	7.0	14.2	9.6	3.7	1.4	9.5	16.9	5.2	24.7	7.5	4.9	5.6	4.4	2.9	4.3	4.0	2.7	2.1	12.3	6.8	9.8	4.3	7.9	3.5	3.6	3.2	3.8	7.1	5.6	6.4	26.7	22.0	6.0	4.6	5.6	5.7	12.6	5.2	12.1	4.7	5.1	3.7	5.9	3.3	7.4	2.9	1.2	1.9	1.5	1.2	2.5	1.2	1.6	0.9	1.7	1.1	1.7	1.1	0.3	5.1	1.6	0.8	0.7	0.8	5.6	7.1	13.3	10.9	5.6	5.2	5.9	9.3	7.8	5.5	3.0	1.3	5.0	9.8	14.7	13.2	57.1	25.5	4.0	2.3	17.4	13.7	15.9	1.7	5.0	0.4	6.7	25.7	0.0	6.0	30.8	10.6	4.3	1.1	35.0	5.1	11.1	10.9	6.7	7.3	1.1	8.9	4.1	15.1	9.0	10.7	6.6	7.4	10.1	15.2	4.7	18.6	19.4	21.1	12.4	9.4	12.3	17.2	7.5	8.8	3.9
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1300000	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	26.2	15.3	34.7	41.3	30.7	32.7	6.3	28.0	25.9	39.8	36.5	18.6	9.4	11.4	22.7	44.3	19.4	17.2	24.4	26.5	37.8	20.7	12.3	20.9	28.9	18.0	26.3	12.9	22.2	31.1	12.8	31.6	11.0	24.6	33.5	18.7	19.6	29.8	40.6	38.9	29.0	9.7	12.4	26.6	34.1	26.2	32.0	26.3	19.4	16.7	27.4	17.5	25.3	15.5	11.5	17.5	22.1	12.5	25.9	47.0	13.1	62.9	26.1	20.6	21.1	16.8	31.5	19.6	17.6	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1	6.0	4.3	11.5	6.1	7.8	40.4	110.4	28.1	4.0	2.3	14.0	25.5	5.8	6.6	10.7	25.7	21.6	16.0	0.0	16.2	4.8	14.3	7.3	0.0	30.1	29.0	3.2	16.8	31.9	44.8	12.8	45.5	32.4	13.5	7.2	14.3	24.1	13.5	7.0	48.8	9.6	23.0	19.4	17.3	25.7	6.4	9.8	6.8	7.2	11.4	6.4
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1500000	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.3	10.1	12.1	11.7	10.3	4.7	15.6	11.9	8.0	7.5	0.1	2.8	16.6	10.8	12.2	14.6	2.2	4.7	5.1	8.5	16.1	2.6	36.5	8.6	1.2	11.5	14.4	0.8	6.1	2.3	7.7	4.3	11.6	36.6	6.2	1.1	9.6	12.9	0.6	18.7	7.6	9.9	0.0	4.4	14.5	15.7	10.0	19.4	11.2	3.3	12.9	8.6	3.3	9.5	7.9	3.0	3.0	32.4	11.1	8.6	11.2	11.8	7.1	8.5	16.7	5.3	15.4	13.8	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9	0.0	1.0	20.3	6.7	4.5	44.0	38.9	15.3	4.0	5.7	14.0	33.4	1.4	28.2	6.9	2.4	8.4	61.7	0.0	10.3	1.0	11.0	15.2	57.7	14.8	23.2	44.5	20.8	26.4	52.7	2.6	13.8	32.7	15.1	1.0	61.1	36.9	13.3	28.8	20.5	15.6	30.0	12.9	13.7	5.9	6.9	2.5	0.6	69.2	52.4	6.5
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556111-151877125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	12.8	5.5	15.3	8.7	28.8	6.3	9.7	31.1	19.2	8.8	11.5	7.5	9.4	16.7	10.4	10.9	10.8	8.6	12.0	77.2	15.1	13.5	15.4	18.5	8.6	7.7	12.3	14.3	6.8	6.2	6.7	5.1	20.0	18.3	17.5	13.5	7.8	11.9	14.8	21.5	6.9	17.8	32.8	8.5	12.8	13.8	9.7	9.5	2.3	12.6	5.2	7.1	22.4	12.4	7.9	7.8	18.4	6.0	3.1	6.1	3.5	15.5	4.5	3.0	3.6	13.9	11.8	5.4	7.1	6.4	7.7	7.6	2.9	19.9	0.0	11.8	9.5	58.6	5.0	1.9	8.3	12.5	3.7	2.1	4.1	0.5	0.3	20.7	3.1	4.0	5.7	17.8	7.7	8.2	12.8	13.2	4.7	1.4	1.9	23.3	5.8	1.6	2.2	3.1	6.8	13.2	1.5	2.2	3.2	14.7	3.7	13.7	2.1	4.2	7.8	3.1	8.3	2.5	4.1	17.6	1.8	1.5	0.9	4.5	1.4	1.6	0.0	21.9	9.6	17.3	18.4	6.0	10.5	5.1	5.4	3.7	7.9	4.5	4.5	4.3	3.8	4.2	6.1	13.6	3.1	5.4	7.8	2.4	3.5	15.3	28.8	31.1	19.2	15.1	13.5	12.3	14.3	18.3	9.5	6.0	17.5	17.5	32.5	9.4	15.4	84.3	7.6	14.7	13.6	43.6	7.9	2.9	54.7	13.4	39.3	19.4	29.8	0.0	19.9	19.0	16.6	41.6	21.9	55.7	17.5	3.2	12.6	19.6	50.9	26.6	6.9	39.9	15.1	42.3	27.6	18.6	19.6	17.5	7.4	14.7	4.4	12.9	29.1	3.5	19.8	9.5	42.3	26.1	25.4	38.3
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol		NA	NA		11000000	Cytosol		"CAB019378: , HPA049979: AB_2680980"	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	47.1	48.0	41.7	34.5	54.8	14.6	38.7	40.4	57.4	48.2	23.8	44.9	31.4	15.1	43.6	37.7	29.6	43.2	37.4	122.7	42.5	52.3	49.2	43.4	47.3	29.5	50.1	43.6	62.5	19.1	107.8	41.9	47.3	57.7	35.6	24.2	32.2	47.5	43.6	99.8	22.8	19.3	39.4	52.8	35.3	25.1	36.9	40.1	28.2	51.8	23.6	29.2	33.8	33.4	11.3	26.9	52.6	28.7	18.5	13.0	22.9	16.6	32.1	41.2	24.6	55.0	62.5	6.2	22.5	46.5	35.2	31.2	12.5	22.5	16.9	15.5	49.1	36.1	13.8	30.4	36.5	50.6	11.4	10.9	26.2	27.9	40.8	39.9	20.0	29.4	44.6	38.0	40.6	34.3	39.6	58.4	14.5	11.8	26.7	42.6	31.6	22.0	10.7	15.2	17.2	21.9	15.4	68.2	18.7	53.4	36.3	15.0	20.3	20.6	37.7	86.7	40.0	29.5	28.3	41.4	49.7	23.7	22.4	20.9	22.3	15.8	25.2	30.1	19.1	30.9	31.1	26.1	46.3	13.0	25.5	13.0	11.3	9.8	11.6	26.9	8.5	8.9	9.8	52.6	18.5	28.7	8.8	12.3	22.9	41.7	54.8	40.4	57.4	42.5	52.3	50.1	43.6	57.7	40.1	137.0	210.8	75.1	77.8	126.8	93.4	608.0	89.2	258.3	168.4	239.0	62.8	66.4	150.9	74.2	287.1	138.4	34.9	23.3	45.5	74.3	135.4	82.7	180.2	101.7	123.8	131.9	131.3	160.2	157.1	53.4	123.7	102.2	182.2	93.8	51.5	115.8	62.1	52.9	179.3	150.9	56.6	84.1	208.1	100.7	40.5	115.2	69.0	106.6	36.6	95.0
PRKAR1B		ENSG00000188191	"Protein kinase cAMP-dependent type I regulatory subunit beta"	P31321	7	549197-727650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 83.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 48.9;Horizontal cells: 50.9;Late spermatids: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026719	Approved					NA	NA					"HPA026719: AB_1855419"	"unprognostic (4.90e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.00e-1)"	5.0	6.8	33.6	4.3	30.4	4.5	4.0	24.0	83.6	4.8	5.7	3.4	1.6	7.2	7.2	2.7	4.2	6.2	4.6	7.7	35.5	42.8	5.4	3.8	5.5	5.2	22.5	29.2	12.9	4.1	5.6	7.0	3.5	29.7	6.0	4.2	2.5	3.9	5.5	3.8	3.0	7.6	5.3	9.1	8.2	3.8	4.8	3.7	2.5	2.9	1.4	3.3	3.5	2.6	7.0	5.5	1.5	2.6	3.5	12.8	10.3	25.3	17.5	2.6	6.4	1.7	1.5	7.4	5.1	2.4	3.3	1.9	31.3	5.6	19.2	3.5	2.3	10.9	18.7	8.7	9.7	1.4	4.0	6.3	1.3	11.3	20.6	3.2	12.1	3.1	4.3	3.0	2.1	6.2	3.6	3.5	5.1	18.4	3.9	2.9	24.3	14.7	8.0	41.0	7.0	6.9	9.5	0.5	8.5	8.2	6.7	34.4	25.9	13.0	12.8	10.0	1.1	6.6	4.6	4.2	1.5	3.2	1.9	10.3	2.4	6.9	12.5	2.7	9.4	19.1	1.5	2.0	0.0	4.6	2.6	6.9	6.2	7.9	7.1	2.4	7.0	12.8	11.7	0.8	3.5	0.9	5.5	5.2	10.3	33.6	30.4	24.0	68.6	35.5	42.8	22.5	29.2	29.7	3.7	3.0	4.1	8.2	6.8	3.4	9.4	11.5	0.0	0.0	5.7	5.2	3.9	3.1	21.6	4.0	48.9	11.3	13.8	0.0	3.0	5.1	4.7	4.5	6.9	7.4	9.0	50.9	4.1	16.0	3.3	101.7	10.9	2.3	6.8	1.0	10.6	5.1	6.7	12.9	14.5	15.3	4.4	0.0	5.0	9.5	8.5	4.1	2.9	8.7	13.8	4.1
PRKAR2A	PRKAR2	ENSG00000114302	"Protein kinase cAMP-dependent type II regulatory subunit alpha"	P13861	3	48744597-48847846	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 709.6;Late spermatids: 1080.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005023, HPA038268"	Uncertain					NA	NA		350000			"CAB005023: AB_562330, HPA038268: AB_2675921"	"unprognostic (2.81e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.17e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (4.77e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-2)"	14.4	14.0	7.7	8.2	7.9	10.0	8.7	8.3	9.1	11.0	13.9	9.7	12.7	7.9	10.5	9.6	13.7	11.2	10.6	16.8	6.5	8.4	13.2	20.1	8.1	7.2	7.7	7.9	13.2	9.2	11.6	6.9	7.0	7.9	10.6	12.4	11.3	14.3	13.5	47.7	9.5	12.6	10.6	6.9	8.3	9.7	58.4	6.1	3.2	11.0	14.2	10.6	13.3	13.9	8.1	8.7	13.3	14.6	9.7	10.1	6.7	17.2	11.6	9.7	7.5	14.7	14.9	11.0	19.8	9.9	17.4	11.1	15.3	7.8	15.2	13.9	20.5	11.3	7.9	27.7	17.4	23.6	12.4	10.3	20.2	21.2	11.3	10.8	21.1	13.1	12.4	13.7	22.4	16.5	6.5	18.3	5.2	22.7	9.8	16.4	6.7	0.1	6.9	6.9	12.7	13.0	6.4	12.4	19.2	11.2	19.0	9.7	10.0	19.5	23.4	13.1	11.0	15.7	16.5	23.1	15.4	12.3	24.9	27.2	16.7	32.0	14.7	20.7	23.5	11.6	10.9	9.1	10.5	10.1	8.1	9.7	8.1	8.5	8.6	8.7	7.6	6.1	6.0	13.3	9.7	14.6	5.4	7.4	6.7	7.7	7.9	8.3	9.1	6.5	8.4	7.7	7.9	7.9	6.1	17.9	57.6	32.6	21.1	37.3	43.0	58.5	48.4	37.5	29.6	43.6	64.8	20.5	18.3	35.9	709.6	35.8	55.1	0.0	52.6	28.9	32.5	32.7	12.7	106.1	42.1	58.8	40.4	56.4	50.0	1080.4	50.9	37.1	28.7	25.2	39.0	26.1	51.6	31.6	52.3	35.6	43.2	51.8	53.8	64.4	59.7	54.8	19.7	27.4	66.4	22.6
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 49.8;Smooth muscle cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		1600000	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.6	20.1	10.8	0.0	0.0	1.0	3.2	0.8	0.8	0.0	0.0	27.6	0.2	0.6	2.5	0.0	2.0	0.0	1.6	0.7	2.2	9.2	0.0	0.0	3.0	0.1	1.3	0.1	0.0	0.0	0.0	0.9	12.1	1.5	16.6	0.8	0.0	2.0	3.7	0.1	4.9	0.0	0.8	1.1	0.0	0.0	0.0	0.0	3.3	4.8	1.5	0.3	1.0	6.9	0.6	1.9	6.8	1.0	2.6	0.0	1.9	0.6	0.0	71.0	0.7	4.8	9.6	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6	3.0	1.0	0.8	1.4	2.2	29.0	26.0	10.2	6.7	1.2	7.0	9.8	0.0	0.0	1.7	6.2	15.5	0.0	0.0	0.0	0.4	5.1	5.9	4.6	0.0	1.5	4.8	0.0	14.1	14.0	4.7	27.6	10.4	16.9	13.6	0.5	5.5	0.2	2.6	49.8	0.6	9.1	19.4	35.8	1.6	4.5	2.0	0.0	2.9	1.9	3.9
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.5	2.6	2.6	6.3	16.1	0.3	13.4	8.8	9.7	8.3	1.4	1.5	3.1	3.6	21.7	16.3	0.3	1.3	1.6	21.2	5.2	3.0	0.0	7.4	6.5	8.6	3.9	21.1	7.0	0.6	12.1	10.4	14.2	8.3	15.1	8.1	0.0	15.0	0.7	7.8	2.4	1.0	6.1	6.7	1.4	19.1	0.0	3.4	2.1	1.5	8.6	4.4	2.6	0.1	2.8	0.3	5.5	24.8	16.9	9.8	10.5	8.4	0.0	0.0	0.3	53.7	0.0	8.3	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4	0.0	9.6	3.9	15.4	9.4	33.9	7.9	40.8	5.3	4.5	38.4	2.0	3.3	6.6	11.3	2.5	3.0	24.2	0.0	5.9	2.8	11.0	12.4	20.7	11.9	19.7	9.5	8.1	36.8	8.2	1.3	49.5	7.7	10.1	1.8	32.8	43.1	7.2	20.1	45.6	16.8	77.1	25.8	17.0	1.1	1.7	9.2	12.7	24.1	21.3	12.3
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	41.7	2.0	0.0	0.0	6.0	41.8	0.0	0.2	0.0	0.0	0.0	0.0	7.2	59.4	0.1	0.0	0.0	13.1	13.2	0.4	0.0	0.0	12.5	0.1	2.4	0.1	3.6	7.3	0.0	0.0	0.0	0.6	0.2	0.0	18.8	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	16.8	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4	3.0	8.2	149.8	3.5	5.4	172.0	1.7	5.1	2.7	1.2	1.8	2.0	0.1	0.0	0.0	16.3	1.4	1.7	0.0	0.2	0.2	1.3	0.7	69.4	1.6	41.0	74.7	0.0	16.5	192.8	10.0	0.0	22.7	3.3	6.4	0.7	9.9	0.0	9.5	0.4	0.1	7.3	0.0	2.2	3.6	3.7	12.5	0.7	57.5	1.2	4.3
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 64.7;THP-1: 46.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.9	3.0	1.2	2.1	9.2	5.3	11.4	4.8	6.1	5.9	5.8	7.4	7.8	20.4	2.1	10.4	10.3	3.6	8.1	11.8	4.9	17.8	6.1	11.3	4.2	7.9	5.9	14.9	25.7	4.1	8.6	6.1	5.6	5.3	5.1	2.2	2.2	2.9	8.5	19.5	1.6	25.5	3.2	11.9	5.6	1.7	3.1	4.9	6.4	17.0	2.0	1.4	3.6	64.7	9.9	6.3	5.4	46.1	7.4	2.9	3.6	3.8	4.5	4.5	6.9	10.5	6.8	25.8	5.5	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0	3.0	19.7	17.6	21.2	26.0	0.0	4.5	12.7	16.0	17.0	14.0	0.0	2.5	3.3	7.6	26.7	1.8	56.8	0.0	9.6	13.5	8.7	14.8	5.7	1.7	38.4	1.6	25.5	3.7	43.0	59.4	8.3	35.2	10.1	21.6	29.0	1.8	10.3	49.1	6.3	10.9	0.0	6.5	9.4	5.2	1.9	24.3	7.3	7.5	20.6	28.8
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 209.3;Late spermatids: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 19.4;TIME: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10.0	12.8	15.5	17.5	6.9	6.0	15.0	4.1	4.2	16.3	6.0	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3.0	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5.0	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.4	2.0	2.9	2.9	4.4	5.2	2.3	3.8	7.0	3.2	3.5	0.5	5.4	8.2	3.6	4.0	4.6	1.3	1.8	2.0	4.6	4.9	3.5	0.0	1.4	1.1	5.0	0.6	2.9	4.6	2.3	4.8	3.5	2.7	11.8	1.8	1.1	2.0	3.7	2.8	2.6	0.3	1.0	3.0	1.0	19.4	13.8	8.8	2.9	3.7	2.0	4.4	1.7	5.8	12.5	1.1	4.7	1.9	19.5	6.3	6.6	4.6	3.8	0.0	0.0	6.9	5.2	4.6	6.3	0.0	1.2	1.7	1.0	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0.0	0.6	15.3	14.2	28.8	33.2	22.5	10.0	6.0	15.0	9.1	3.7	6.0	8.6	20.1	6.3	4.4	47.5	9.3	12.7	22.7	27.3	10.4	13.7	0.3	3.3	3.0	209.3	9.9	4.5	0.0	3.3	6.9	8.0	5.7	6.9	7.3	2.6	11.1	7.5	12.3	17.0	297.3	4.9	11.1	13.5	7.2	5.3	7.0	3.0	3.5	5.6	21.3	6.7	12.9	6.6	2.7	2.2	4.3	2.4	4.3	6.2	7.1
PRKCG	"MGC57564, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 49.9"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.7;Horizontal cells: 4.8;Spermatocytes: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.8;OE19: 8.5;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054560	Enhanced					NA	NA					"HPA054560: AB_2682523"	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	1.0	0.9	28.0	1.1	49.9	2.2	0.9	12.1	39.2	0.9	1.3	1.6	0.0	1.5	1.0	0.9	1.0	1.4	1.0	0.9	49.7	4.4	0.9	0.9	1.0	0.9	2.9	20.8	0.9	3.5	2.1	0.2	0.9	0.7	0.9	1.2	0.0	0.9	1.0	1.0	0.9	1.3	1.1	1.4	0.9	1.8	4.4	2.1	1.3	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	4.8	1.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	1.2	1.3	0.2	1.4	0.0	0.5	0.4	2.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.5	0.0	0.9	0.0	1.2	0.0	0.1	0.0	0.5	0.4	0.1	0.8	8.5	0.4	0.8	0.5	0.0	0.9	0.0	0.0	3.3	1.3	0.1	0.0	1.7	1.6	0.0	0.8	0.0	1.6	0.0	0.0	1.4	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	49.9	12.1	28.5	49.7	4.4	2.9	20.8	0.7	2.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.0	0.0	0.2	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.4	2.2	0.3	1.7	1.0	0.2	30.4	0.1	0.5	0.3	0.3	0.7	3.8	0.1	4.6	0.0	0.6	4.4	0.2	4.9	0.5	0.8	2.9	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.1	0.2	3.5	0.4	39.9	12.9	0.0	0.1	2.3	11.7	26.5	0.2	0.5	4.6	3.1	2.2	1.1	0.0	0.0	16.8	1.1	1.9	0.7	5.9	3.6	5.6	5.8	0.5	26.1	0.7	5.2	0.8	0.3	0.5	0.1	0.2	1.1	0.4	1.3	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4	6.0	10.7	4.6	15.8	16.7	0.2	3.9	10.2	10.7	18.2	0.0	0.0	23.4	3.3	4.6	25.5	56.0	1.7	70.0	5.9	16.9	3.7	13.1	1.1	1.0	5.6	0.0	11.3	55.9	11.1	3.6	1.7	9.0	15.1	5.4	2.6	9.3	4.4	2.9	6.3	0.8	0.3	0.0	4.1	0.0	2.1	23.3	40.4	137.1	0.7	24.4
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	34.3	8.7	8.8	9.4	7.8	10.9	14.2	8.8	13.0	11.7	12.7	12.7	16.8	10.5	29.1	12.3	16.1	16.1	16.5	17.3	20.1	7.6	10.2	9.7	11.0	7.0	12.4	8.7	4.4	9.8	12.1	10.0	15.7	19.0	9.1	5.8	10.7	8.7	11.7	11.8	12.6	3.4	18.4	36.7	9.7	9.2	13.5	17.3	18.4	10.5	14.0	11.4	19.0	25.0	8.6	13.6	27.5	6.0	9.6	12.2	9.4	11.4	14.5	15.0	14.4	15.0	8.8	6.9	4.7	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3	68.5	56.0	2.2	46.0	50.7	15.9	14.9	25.5	22.7	46.6	47.1	13.7	23.8	21.6	13.9	5.5	18.0	21.2	0.0	19.5	22.1	25.6	78.7	8.1	17.8	8.9	14.3	28.2	16.5	20.8	3.6	21.6	10.0	16.9	6.4	28.1	8.1	36.5	17.5	26.9	15.1	9.3	19.4	11.4	12.9	15.1	55.7	17.3	5.7	27.7	69.1
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 2: 6.5;Distal tubular cells: 6.6;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Cell line enhanced"	"Detected in some"		"HEL: 29.8;JURKAT: 21.2;MOLT-4: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA		200000	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	0.0	1.8	3.1	0.0	0.0	2.0	29.8	0.0	0.2	0.3	1.4	0.3	0.1	1.9	0.1	0.1	0.0	0.2	21.2	6.5	0.0	0.0	0.0	22.3	4.2	3.1	0.2	0.0	4.3	0.7	0.0	6.3	1.5	0.2	1.1	0.0	0.0	0.0	1.9	0.0	3.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5	3.0	6.5	0.0	0.1	0.0	1.6	0.3	0.0	1.4	1.2	1.8	0.0	0.0	6.6	0.2	1.8	0.0	0.0	0.0	0.7	0.1	0.3	0.0	1.1	0.0	0.4	0.0	1.7	1.3	1.5	4.5	0.0	0.5	0.0	0.0	0.3	1.5	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.9	2.0	0.0	0.0	25.4	0.3	0.1
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.4	34.0	37.8	63.3	64.8	84.0	39.3	52.2	71.3	61.2	57.8	49.6	54.6	31.2	84.6	71.8	30.6	48.2	38.9	56.8	49.6	33.4	25.0	27.1	42.7	43.0	48.5	42.2	39.8	76.7	42.5	57.5	45.4	75.7	41.9	35.1	31.3	70.7	52.9	71.5	32.9	48.8	79.5	23.1	44.0	35.2	34.5	79.3	42.6	42.5	24.0	47.3	45.6	47.5	42.7	36.1	48.8	46.8	42.2	74.4	35.1	70.5	61.1	87.0	103.5	21.7	56.9	44.4	50.7	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8	11.9	16.3	75.4	50.7	37.2	17.1	7.8	66.2	16.0	11.4	61.1	31.4	147.4	28.2	75.5	15.3	39.1	147.7	0.0	111.1	158.0	54.4	53.8	41.5	78.4	82.6	9.5	56.6	52.2	73.7	39.6	72.8	59.1	50.6	87.4	103.8	61.8	88.9	99.5	68.2	54.0	21.2	38.8	46.2	36.5	51.7	33.1	120.0	55.4	107.3	50.1
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 539.8;Syncytiotrophoblasts: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.3	4.7	1.7	8.7	0.0	0.0	23.0	0.5	0.2	5.5	0.3	11.9	16.0	0.0	14.6	1.8	4.8	12.9	9.9	12.3	3.9	0.5	11.0	0.0	7.6	15.8	1.6	0.0	5.7	0.3	7.4	0.0	4.2	0.0	0.0	1.9	3.2	0.1	0.1	9.0	0.4	0.0	3.3	20.2	11.4	0.0	0.0	2.5	9.4	7.8	12.0	9.7	6.0	13.4	2.5	14.9	9.4	2.0	0.0	0.0	6.9	0.0	0.0	3.5	0.6	0.1	0.6	0.1	8.3	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5	113.2	71.1	0.8	10.2	11.6	22.8	1.2	2.5	21.4	26.1	7.0	3.9	84.1	6.6	10.9	181.6	6.0	56.7	0.0	9.3	48.8	3.1	16.4	8.1	12.5	12.7	58.8	9.8	6.7	1.0	539.8	8.9	3.3	6.8	5.4	22.1	15.6	12.2	31.6	8.1	19.0	21.6	0.0	2.2	15.8	26.8	11.7	926.6	7.7	25.3	11.9
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.1	18.2	17.0	0.1	12.3	9.5	12.6	6.8	0.0	0.5	0.0	1.2	19.3	4.3	0.1	6.0	1.4	6.9	0.0	4.2	0.0	0.1	0.4	9.2	0.0	0.1	18.0	0.6	0.9	1.5	6.5	2.5	0.0	1.2	0.4	11.8	1.4	0.0	0.0	2.5	0.0	6.4	0.0	7.1	3.2	13.5	5.7	3.6	7.2	2.1	0.0	4.7	4.9	0.0	0.1	6.4	12.0	4.9	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6	0.0	6.1	0.0	3.8	0.5	1.2	1.4	7.6	0.0	0.0	12.2	5.9	0.0	24.9	1.5	31.1	4.5	0.0	23.3	3.6	0.1	3.8	16.3	0.0	1.5	0.2	1.6	2.9	12.3	2.6	12.4	6.9	0.3	6.8	0.0	0.2	16.1	3.2	0.0	12.0	3.7	2.8	0.0	4.7	3.4	4.9	0.6	0.2	0.0	0.0	0.9
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	17.1	7.6	7.0	25.8	6.5	18.1	18.0	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17.0	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33.0	17.4	37.5	6.6	0.4	7.3	1.0	2.9	6.1	1.9	8.8	13.7	5.4	6.6	4.5	3.6	7.0	4.6	7.3	9.6	10.6	7.6	8.6	10.3	8.1	6.1	5.2	13.2	4.8	12.3	3.0	8.7	7.1	10.8	4.2	3.9	6.0	7.9	16.1	4.4	6.0	5.5	4.7	7.2	16.9	9.7	6.9	14.9	3.9	9.3	15.1	25.6	4.6	12.8	7.0	9.9	2.6	16.7	5.9	13.2	3.5	11.0	8.6	7.2	1.8	5.9	5.7	3.1	8.0	4.1	8.2	3.4	3.7	14.6	58.2	5.1	4.3	6.5	4.3	0.9	1.0	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0.0	4.0	1.9	7.0	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2	8.9	13.5	45.5	26.8	19.6	5.8	11.5	17.8	4.0	10.3	8.7	0.0	11.1	6.6	16.0	0.9	29.2	30.9	23.3	24.3	11.4	10.0	21.5	13.9	7.3	7.7	1.6	20.7	36.2	12.7	2.4	10.9	7.2	11.8	5.4	17.7	6.1	22.1	24.6	6.3	7.1	4.5	12.9	5.9	2.8	15.8	23.3	24.8	23.0	11.2	24.6
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18.0	7.2	7.2	6.0	19.2	16.0	9.8	11.3	10.0	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15.0	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22.0	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.8	5.4	14.5	11.9	11.1	18.6	10.6	8.3	15.5	9.4	9.6	8.7	4.5	18.8	7.0	12.4	14.1	5.1	9.8	10.2	12.7	24.3	14.4	12.4	8.4	5.8	4.5	8.8	7.6	8.8	5.2	14.9	9.8	8.7	16.7	6.3	10.4	23.2	10.9	2.1	3.8	6.9	15.3	0.1	5.3	13.0	22.9	16.1	6.2	14.4	10.9	28.3	8.0	4.6	48.8	7.8	4.9	8.1	16.1	27.0	14.0	10.7	9.3	26.5	49.1	22.0	9.4	3.7	16.2	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8	38.7	16.2	38.3	20.7	33.7	29.6	7.1	15.3	5.3	13.6	17.4	64.8	9.1	3.3	10.9	42.2	44.7	5.4	0.0	9.0	28.2	34.8	27.0	77.1	11.3	11.1	41.3	18.1	38.1	28.4	78.9	31.1	24.5	47.2	12.6	6.1	16.0	12.3	3.5	29.0	7.1	110.0	25.8	26.9	56.0	44.5	20.8	8.1	27.4	11.0	32.3
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.9	28.2	27.5	26.1	17.1	18.2	11.6	14.0	13.8	19.8	19.5	18.4	10.9	31.5	12.2	17.2	14.7	18.8	36.3	19.2	31.0	6.9	22.5	61.8	25.4	22.5	7.4	23.5	12.9	13.1	6.3	31.1	32.7	7.6	20.3	21.9	41.1	13.3	21.8	15.5	33.1	19.4	30.2	23.1	8.6	16.2	21.6	11.1	9.9	28.4	13.8	17.5	43.3	14.1	13.6	17.7	20.2	16.2	23.5	25.9	22.0	20.4	28.1	11.6	14.8	45.3	14.6	26.7	20.9	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9	35.7	26.0	39.5	30.4	34.1	100.6	65.8	25.5	52.2	39.8	40.1	117.8	48.3	14.9	34.6	26.1	40.5	10.5	0.0	30.9	53.5	37.0	37.2	43.9	39.8	32.1	98.5	24.8	33.7	41.6	10.8	52.6	32.7	18.6	29.7	26.8	69.1	30.3	14.0	65.4	18.7	102.0	51.8	28.8	106.0	117.5	35.5	27.6	38.3	45.0	27.8
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 43.8;Late spermatids: 40.9;Peritubular cells: 37.1;Sertoli cells: 38.8;Smooth muscle cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;BJ hTERT+: 15.9;fHDF/TERT166: 13.1;U-138 MG: 9.7;U-87 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.5	11.6	5.6	5.3	0.0	5.0	15.9	1.6	2.4	0.1	0.8	0.2	0.0	13.1	1.7	0.1	0.0	0.0	1.5	0.0	4.3	0.8	0.3	0.0	4.8	0.0	0.0	6.8	0.0	4.2	0.1	0.4	0.0	0.0	0.0	0.1	4.4	0.1	0.0	0.0	3.3	0.0	2.0	0.0	3.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	1.6	0.1	0.0	0.0	9.7	1.7	4.9	2.9	1.2	0.6	0.0	8.6	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1	14.9	9.6	0.0	1.4	0.8	6.8	29.7	0.0	1.4	0.0	3.5	0.0	0.8	0.0	1.8	43.8	3.7	2.6	0.0	3.3	0.9	13.0	0.4	4.6	0.0	0.3	0.0	0.0	4.3	0.0	40.9	30.2	0.3	3.3	0.0	4.3	23.0	3.5	11.4	37.1	0.0	1.3	38.8	47.0	0.7	0.6	0.5	1.8	0.0	3.2	0.7
PRKG2	"cGKII, PRKGR2"	ENSG00000138669	"Protein kinase, cGMP-dependent, type II"	Q13237	4	81087370-81215117	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.3"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 32.8;Enterocytes: 13.8;Paneth cells: 8.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.0;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.2;ASC TERT1: 4.0;HEL: 20.8;hTCEpi: 4.1;SCLC-21H: 6.4"	"Low region specificity"	"Detected in many"							"HPA007386, CAB018739"	Approved					NA	NA					"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	4.7	0.4	5.2	0.4	2.9	0.6	2.2	0.8	5.3	1.4	7.7	1.2	0.7	12.2	0.6	0.6	3.8	0.6	0.4	6.3	2.9	3.3	0.7	0.3	4.3	0.3	2.5	1.9	0.3	1.8	0.0	12.1	0.2	9.3	12.7	3.8	1.4	0.8	4.6	0.3	2.1	34.3	0.7	1.3	0.3	1.3	1.7	2.4	0.0	1.3	0.0	0.6	1.2	1.3	0.4	0.0	2.0	0.0	0.4	2.2	0.4	0.1	0.3	0.1	0.0	5.2	4.0	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.6	0.0	0.4	0.0	20.8	0.6	0.0	0.0	0.0	0.0	0.6	4.1	0.0	0.0	1.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.3	0.0	0.4	0.8	0.9	0.0	0.4	0.0	0.0	0.0	0.4	5.2	2.9	0.8	5.3	2.9	3.3	2.5	1.9	9.3	2.4	32.8	1.6	0.0	0.6	0.0	0.0	2.6	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.1	5.3	0.0	13.8	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.6	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.2
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.1	0.3	1.3	3.7	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.9	0.0	0.2	0.2	0.0	0.4	0.6	9.2	0.2	0.0	0.9	0.2	0.1	3.2	0.1	0.0	0.5	0.6	0.0	0.4	0.4	5.9	1.0	0.5	0.1	0.1	0.2	0.6	0.9	0.0	0.0	5.9	0.7	0.1	1.0	2.5	0.0	0.0	0.3	1.2	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.2	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8	8.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	1.8	0.0	0.4	16.6	0.8	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8"	"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	2.8	3.1	10.7	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.8	2.0	8.7	1.4	5.3	3.7	13.1	6.3	5.8	6.5	4.4	3.9	7.3	5.7	7.7	3.5	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	19.0	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7	3.0	13.1	6.5	16.9	19.1	0.6	1.4	25.5	17.4	9.1	5.2	0.0	17.4	11.6	10.4	7.2	17.0	7.7	0.0	2.7	3.8	9.7	9.1	85.2	1.7	15.1	1.6	4.6	11.1	19.0	34.3	18.4	20.8	5.0	6.4	11.4	2.1	4.7	10.5	20.5	5.1	0.7	32.3	22.0	1.6	21.7	23.5	6.5	25.5	22.2	16.5
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.7	12.8	20.2	13.8	11.5	10.7	9.8	14.3	15.7	15.6	15.8	12.2	7.5	24.1	18.0	16.1	12.8	13.2	25.4	12.4	22.5	11.3	18.6	27.1	14.7	10.9	8.8	29.9	14.8	9.7	8.2	11.1	6.9	7.6	15.5	11.8	37.1	8.9	15.3	8.6	21.9	10.0	12.1	12.9	11.9	24.9	19.5	23.4	10.0	16.6	15.7	10.3	16.6	10.4	12.6	16.8	16.2	15.0	16.6	15.4	8.9	10.1	13.8	10.1	15.8	28.1	8.4	13.7	18.7	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2	101.3	91.8	89.2	53.8	74.1	81.8	69.0	61.1	89.7	101.2	92.5	84.4	51.4	61.3	56.7	8.7	82.4	58.2	46.7	49.5	40.6	50.2	53.8	86.8	76.7	36.1	100.1	72.3	68.2	59.0	11.9	91.5	57.7	33.7	71.3	57.5	80.9	52.5	57.5	83.8	50.1	181.0	58.2	43.9	67.7	79.4	79.8	53.2	69.3	57.5	63.7
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.8	7.4	1.0	3.7	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.4	3.2	0.6	2.0	2.7	0.4	0.3	5.2	1.6	1.3	8.8	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	12.2	1.0	0.6	0.2	1.6	0.6	3.3	0.5	0.6	5.7	0.0	1.0	15.1	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	3.2	7.3	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2	3.0	0.0	0.0	1.3	1.0	79.8	0.8	0.0	6.7	1.2	0.0	29.5	1.5	1.7	1.1	1.7	2.0	9.6	0.0	1.4	0.6	9.3	1.4	0.0	0.0	0.3	19.1	5.8	2.5	0.0	6.3	33.4	0.0	0.0	1.0	2.0	6.5	2.3	10.5	37.8	0.2	40.1	6.5	13.2	2.4	3.2	0.4	2.2	0.0	1.7	1.0
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893272-67929678	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.3	13.6	14.0	16.6	4.8	15.1	13.3	13.3	11.0	14.7	17.7	24.0	14.0	19.2	14.6	17.7	20.2	19.3	17.8	12.2	8.4	18.8	15.1	13.1	10.4	16.2	12.7	21.2	35.3	33.2	13.0	9.8	16.1	14.3	11.4	16.2	19.0	14.8	19.9	14.0	15.2	16.3	11.3	12.8	19.1	31.7	15.0	12.5	14.9	12.9	8.6	14.8	18.7	4.0	5.2	4.5	5.8	5.2	5.6	3.5	7.4	13.3	15.2	16.7	23.6	12.0	9.8	9.0	13.7	9.6	8.5	10.0	10.8	7.0	13.7	15.1	7.6	11.3	8.7	9.2	3.2	2.7	9.8	8.0	9.9	12.7	16.2	7.6	4.8	22.0	16.1	11.3	11.9	12.9	13.9	13.3	12.2	3.0	9.9	16.6	10.3	4.9	14.5	8.1	8.3	15.9	5.8	14.5	11.2	9.3	13.2	15.7	27.9	7.6	9.1	6.3	14.0	13.9	12.2	10.8	3.8	9.0	4.5	9.2	4.9	15.2	13.0	5.1	11.8	0.0	4.3	4.5	5.6	5.8	3.8	4.0	3.9	5.3	5.2	3.5	3.4	4.3	2.7	5.2	3.6	3.8	2.3	3.5	13.6	16.6	13.3	13.3	12.2	8.4	16.2	12.7	16.1	15.0	0.0	2.2	5.1	2.5	1.0	10.7	1.7	7.6	4.0	2.3	5.2	5.9	5.2	10.0	5.5	10.8	2.9	8.1	0.0	6.5	4.0	3.9	3.5	5.8	7.7	4.1	6.4	10.4	4.3	5.6	16.9	4.4	1.2	5.0	3.6	6.3	8.2	6.9	3.5	7.4	6.3	6.7	12.9	4.7	3.5	5.7	1.4	4.9	3.1	6.3	1.4
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell type enhanced"	"Detected in single"	35	"Rod photoreceptor cells: 1.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HEL: 14.3"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
PTRH1	"C9orf115, PTH1"	ENSG00000187024	"Peptidyl-tRNA hydrolase 1 homolog"	Q86Y79	9	127690348-127724873	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021223	Uncertain					NA	NA					"HPA021223: AB_1845798"	"unprognostic (6.58e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.46e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.74e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-2)"	14.9	15.0	12.5	8.3	11.9	7.1	9.1	3.9	13.7	9.4	7.8	10.7	12.9	7.7	7.8	16.1	7.8	9.9	12.6	13.1	10.7	9.4	14.5	19.3	7.5	14.7	11.6	8.5	6.2	24.7	8.8	11.0	7.2	8.9	9.9	4.0	8.3	9.3	9.9	13.0	15.1	5.8	6.4	6.2	9.4	12.4	16.1	6.2	7.1	18.8	9.1	5.7	9.4	5.6	8.7	11.4	5.6	14.4	10.5	29.4	12.8	15.9	7.1	1.6	4.4	2.3	3.0	12.5	10.6	2.9	4.1	2.2	3.7	6.0	6.0	14.3	4.4	5.5	17.6	1.3	7.7	1.2	8.7	2.4	2.6	8.9	7.1	6.9	3.9	7.2	2.5	8.0	4.9	5.1	2.2	8.1	8.4	6.8	4.8	4.6	14.7	7.0	5.8	2.2	14.6	32.3	6.1	3.5	13.6	7.4	3.5	7.1	6.5	11.4	13.7	8.0	1.5	12.3	2.5	9.6	5.9	8.2	20.9	6.6	14.4	7.7	3.9	7.9	3.0	7.1	2.5	13.2	5.6	29.3	14.4	29.3	8.7	15.1	29.4	11.4	7.2	11.1	25.5	1.7	10.5	7.5	10.4	14.2	12.8	12.5	11.9	3.9	13.7	10.7	9.4	11.6	8.5	8.9	6.2	3.0	7.8	12.4	33.6	15.0	22.3	0.3	25.5	46.8	6.8	45.4	43.2	11.0	56.3	56.3	53.7	19.7	8.1	0.0	29.3	19.6	18.8	39.9	17.3	25.2	41.1	15.9	28.9	19.0	9.1	11.4	20.4	13.7	15.1	17.2	19.3	20.7	39.4	10.4	88.4	101.3	60.3	0.0	21.5	27.4	7.9	18.4	15.7	20.3	16.6	30.8
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	15.9	22.9	17.1	12.4	17.1	9.9	20.7	12.5	22.1	15.6	17.2	11.8	16.3	11.6	14.3	36.7	16.4	13.8	13.1	12.6	19.3	17.8	14.8	34.7	12.1	12.5	16.7	15.2	14.2	19.9	10.3	18.3	13.6	21.0	15.9	20.7	8.1	13.7	18.7	23.3	11.4	11.0	16.8	17.1	15.5	14.3	15.7	18.1	9.0	11.8	13.5	16.9	13.0	10.5	15.6	21.6	12.6	29.3	13.1	15.5	13.0	18.9	36.2	11.7	10.6	22.2	19.1	12.5	18.3	16.1	15.7	23.0	23.4	14.9	13.8	27.8	15.3	26.9	18.9	25.1	23.6	22.9	26.5	34.1	24.6	18.8	42.8	34.3	21.7	14.0	21.5	30.7	24.3	28.3	11.2	26.1	9.7	27.4	15.4	23.3	45.8	18.5	17.7	10.0	49.3	28.7	10.1	19.6	20.1	26.1	27.3	15.1	19.6	9.4	10.3	22.4	14.0	24.1	15.5	17.1	20.5	20.7	12.2	19.8	20.0	22.2	20.4	13.5	13.6	15.6	1.9	25.8	1.1	9.2	24.4	12.4	15.6	10.8	10.4	18.5	13.1	15.5	11.1	12.6	13.1	29.3	21.6	12.3	13.0	17.1	17.1	12.5	22.1	19.3	17.8	16.7	15.2	21.0	18.1	14.9	12.8	13.4	31.9	32.5	3.3	14.8	7.6	30.8	50.0	10.4	3.9	22.1	10.0	25.9	17.7	18.3	9.1	0.0	22.0	20.6	19.7	23.3	22.0	27.3	15.2	7.9	6.4	11.6	7.3	7.9	16.1	18.7	13.5	10.0	9.7	6.6	25.9	13.9	9.2	13.2	3.2	12.9	21.7	16.7	11.4	31.1	26.5	8.3	13.2	31.5
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.4	20.2	4.8	8.5	4.6	7.9	29.5	11.9	5.0	9.1	5.9	22.3	10.1	18.4	13.8	6.5	7.1	19.6	15.8	11.3	5.9	8.1	31.9	18.5	9.8	19.4	12.5	31.7	17.1	8.0	9.2	10.4	8.9	4.4	8.9	12.9	22.9	5.7	5.2	26.8	20.8	28.5	25.3	12.6	30.8	19.9	6.8	19.1	7.4	21.5	13.4	7.5	10.0	13.7	11.0	4.9	15.0	34.3	7.7	7.3	15.6	15.4	17.2	15.6	11.7	21.9	7.5	25.4	10.0	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4	0.0	6.7	10.0	16.1	26.3	5.2	4.5	12.7	4.0	3.4	5.2	21.6	12.0	5.0	9.3	0.6	9.0	4.5	0.0	8.2	14.4	9.6	13.4	16.1	11.3	13.6	0.0	13.8	8.0	7.3	2.0	7.2	8.9	6.8	8.2	17.2	4.6	12.7	7.0	8.9	10.4	9.6	6.5	11.8	16.5	22.1	19.8	7.2	7.5	15.5	13.7
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Group enriched"	"Detected in many"	6	"Intestinal endocrine cells: 208.4;Melanocytes: 501.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	8.0	0.0	0.0	1.1	2.7	0.0	1.1	17.9	1.3	2.1	0.5	1.4	0.0	0.6	6.0	15.2	0.0	0.5	0.0	2.1	0.1	15.6	3.6	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.9	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	8.8	2.2	24.3	0.0	1.3	0.0	81.6	1.6	0.1	0.6	3.8	0.0	0.0	0.0	0.1	3.1	63.8	0.0	5.5	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5	3.0	2.9	8.2	9.7	34.7	10.9	1.1	2.5	1.4	0.0	21.0	2.0	0.5	1.7	45.4	0.4	7.3	2.0	0.0	2.1	4.3	11.0	9.5	55.3	0.2	21.3	41.3	208.4	22.7	29.2	2.2	2.8	35.6	501.0	10.8	5.8	1.2	25.4	1.9	22.3	4.7	2.9	12.9	15.5	2.1	0.6	12.7	3.9	1.9	6.9	5.5
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	14.0	18.4	20.6	13.4	29.1	14.2	11.5	18.0	21.3	11.3	14.5	13.3	19.4	12.8	15.3	11.6	14.6	15.8	13.5	19.5	19.7	13.1	11.8	18.9	8.4	13.5	22.9	19.3	22.1	33.9	5.8	12.0	9.8	19.9	13.7	6.6	10.5	26.6	12.7	20.5	12.6	14.2	13.3	12.7	11.5	12.5	5.0	22.2	5.3	19.0	11.9	10.3	12.0	10.3	19.6	19.1	0.9	14.4	18.5	18.8	10.4	17.2	13.9	6.6	19.3	7.0	8.4	8.7	8.8	7.9	10.3	10.2	11.1	6.6	19.5	21.7	5.0	6.2	11.6	6.0	10.6	3.4	11.5	8.4	12.8	5.6	23.3	12.1	19.0	11.3	12.4	9.1	6.7	9.9	4.7	10.5	10.8	14.1	22.4	5.1	26.9	16.3	23.7	17.5	10.8	21.5	17.2	8.8	30.1	8.4	11.1	21.5	9.3	13.5	14.8	11.5	2.9	9.5	8.0	8.1	15.9	8.9	25.4	20.5	24.7	19.0	9.5	8.6	23.1	19.2	0.9	8.3	0.2	15.1	14.4	18.8	19.6	16.3	13.1	16.4	19.0	17.5	13.9	0.6	18.5	7.3	19.1	17.7	10.4	20.6	29.1	18.0	21.3	19.7	13.1	22.9	19.3	19.9	22.2	0.0	5.0	26.7	54.7	56.6	36.4	5.6	28.1	12.0	5.7	54.1	47.1	41.0	54.7	20.6	1.3	27.0	191.9	70.0	23.8	30.6	33.2	38.0	16.1	26.7	26.1	85.8	185.1	16.5	20.2	1.1	46.9	9.6	47.2	7.2	232.5	24.4	15.1	244.4	35.3	58.5	54.3	19.4	30.3	12.1	28.9	36.6	23.5	26.2	247.9	33.9
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	17.1	13.9	8.7	12.4	10.4	13.3	14.1	6.4	10.3	11.0	11.2	14.9	7.9	10.4	16.1	9.2	13.7	13.1	13.6	7.5	6.7	6.7	15.8	15.7	12.2	14.9	11.0	7.6	12.6	15.3	10.7	16.9	11.6	9.4	11.2	12.5	17.7	11.8	9.8	7.5	12.4	12.9	10.8	11.3	19.9	10.7	14.1	10.0	17.3	13.2	10.9	21.6	11.6	10.9	13.9	15.8	5.3	12.9	6.4	6.6	5.0	13.4	14.0	11.7	12.9	5.2	6.4	11.1	7.1	4.5	12.1	11.2	13.3	9.8	25.1	10.4	6.5	14.5	13.5	22.7	10.7	16.0	4.7	10.2	11.3	8.4	9.4	7.4	20.4	10.6	5.0	9.7	11.0	15.7	4.9	12.5	11.7	11.8	9.0	6.8	10.7	17.1	8.0	22.4	19.2	15.4	15.5	8.2	13.5	9.5	9.3	16.0	7.6	10.3	10.2	13.0	10.2	11.3	10.4	8.2	10.6	11.6	4.1	13.7	6.4	9.2	35.1	9.3	15.2	21.3	0.3	12.4	2.9	5.6	12.9	5.3	13.9	4.8	5.5	15.8	9.5	6.6	5.3	5.3	6.4	9.1	6.6	5.9	5.0	8.7	10.4	6.4	10.3	6.7	6.7	11.0	7.6	9.4	10.0	17.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	8.1	19.4	3.5	0.0	9.4	1.7	13.8	0.0	0.0	0.0	0.0	10.8	8.6	0.0	0.0	14.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	14.4	0.0	0.0	12.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.9	9.4	7.9	4.7	2.0	4.2	9.7	15.8	5.4	15.2	10.5	8.6	6.4	12.3	3.0	8.9	8.9	3.5	8.3	8.2	15.6	7.6	10.5	10.4	9.5	5.1	1.2	13.7	9.0	1.6	3.0	15.0	10.2	4.1	4.9	10.5	11.1	12.2	13.3	11.5	13.9	9.8	11.0	7.9	17.4	11.1	8.8	9.7	4.4	7.7	3.3	7.5	7.0	6.8	5.1	6.5	7.0	6.1	4.0	12.7	6.9	10.7	13.5	6.2	9.4	26.7	9.3	15.3	9.3	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8	14.9	9.8	8.2	5.8	9.8	5.1	2.0	5.1	4.0	9.1	3.5	2.0	6.6	1.7	6.5	3.3	4.2	3.8	0.0	7.1	10.7	4.3	7.0	12.8	2.9	5.9	3.2	1.7	4.9	3.7	2.1	3.7	4.6	3.3	7.2	5.0	2.8	7.9	5.8	2.5	2.4	2.2	6.5	4.7	15.5	13.6	10.3	5.6	4.6	5.2	2.7
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664226	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 53.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 53.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002640, CAB019291"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB019291: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	19.5	15.6	15.1	14.7	17.1	32.2	17.5	35.2	18.9	19.9	20.3	21.1	19.6	18.4	24.9	15.7	24.6	18.6	20.2	39.3	15.3	11.0	21.7	36.2	19.7	15.7	16.0	13.4	24.9	31.3	30.7	16.9	24.8	14.3	18.8	19.2	25.0	18.3	18.4	79.7	23.9	29.6	23.7	13.8	22.1	23.7	16.7	17.8	27.7	26.9	27.9	26.1	20.5	20.4	6.6	9.3	53.9	9.9	8.5	8.6	7.7	15.4	17.8	27.1	21.0	23.6	19.1	54.6	23.6	40.0	31.3	35.5	13.9	12.8	16.2	11.3	36.5	16.9	9.9	28.5	20.9	32.6	28.3	22.4	21.8	21.4	12.9	23.9	21.2	20.7	17.6	21.2	32.2	26.1	21.6	22.4	24.9	15.8	42.6	30.1	26.4	27.2	15.7	27.6	19.3	24.2	22.0	23.8	20.4	18.7	23.4	8.5	17.8	19.3	18.7	12.5	22.0	31.0	28.1	16.0	21.5	20.5	18.0	26.2	33.2	52.9	34.9	18.5	24.8	22.8	11.3	9.7	18.4	7.4	9.9	7.5	6.6	7.3	7.2	9.3	6.3	7.5	7.6	53.9	8.5	9.6	4.2	8.6	7.7	15.1	17.1	35.2	18.9	15.3	11.0	16.0	13.4	14.3	17.8	20.8	36.5	39.7	31.1	30.6	51.6	25.8	28.1	25.4	21.6	26.2	62.8	34.3	11.6	22.9	7.1	29.1	32.5	0.0	32.0	39.8	32.9	38.2	33.5	36.5	25.2	41.3	28.2	31.3	36.8	3.4	36.2	34.2	25.3	29.7	29.6	32.1	28.8	34.8	38.9	15.7	84.2	32.3	33.0	17.7	27.4	38.0	52.1	38.3	29.5	36.9
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 3.3;Ito cells: 9.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MOLT-4: 67.2;REH: 64.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043939			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.1	0.0	67.2	0.0	0.5	0.0	0.0	64.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.0	0.0	0.0	1.0	0.1	1.2	0.8	0.0	0.0	0.0	1.8	0.0	0.2	3.3	0.4	1.7	1.5	1.4	0.0	0.4	0.1	0.2	0.3	0.0	1.7	0.3	0.0	0.0	9.2	1.6	1.3	0.0	0.0	0.0	1.8	0.6	0.1	0.7	0.0	0.0	2.1	0.8	0.0	0.4	1.2	0.7	0.4	0.3	0.0	0.4	0.5
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.7	9.3	21.9	22.8	16.8	17.6	23.8	14.4	13.3	13.2	14.3	10.3	14.4	24.7	10.9	12.2	15.1	17.2	23.5	12.5	21.9	13.5	18.2	21.3	26.7	29.3	13.1	28.2	12.7	15.2	17.5	17.2	20.3	14.9	18.9	21.7	26.7	22.6	15.2	18.3	22.7	25.5	25.2	12.0	8.8	31.4	22.3	21.7	12.7	15.9	17.6	15.4	20.3	18.2	25.5	25.5	14.2	25.1	16.3	16.4	12.1	14.1	15.4	20.1	20.0	31.2	13.2	18.8	13.5	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7	80.4	103.7	61.9	93.7	89.4	65.1	127.0	28.1	61.6	67.1	26.2	94.2	37.6	21.6	42.4	225.8	76.4	57.3	46.7	41.4	46.4	91.5	72.4	49.7	50.4	33.6	58.8	78.7	66.3	46.7	20.2	67.0	54.3	59.1	55.1	59.4	50.8	43.9	28.1	55.2	17.7	56.2	51.8	113.1	66.6	47.7	89.0	84.9	56.5	56.8	89.7
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.1	3.2	9.5	8.9	10.0	8.8	5.4	4.1	9.7	8.6	10.2	8.7	7.6	10.2	7.9	5.9	8.5	3.7	24.1	7.3	13.1	8.3	7.9	13.2	6.0	11.1	8.6	17.8	7.3	8.1	9.2	9.9	9.3	10.4	17.3	13.3	12.2	10.4	20.0	9.9	16.3	7.2	15.8	16.8	5.6	8.8	22.4	8.7	13.4	10.5	14.7	8.1	6.8	16.0	17.7	10.9	9.0	8.1	6.8	5.7	5.6	5.0	6.9	11.1	7.9	14.5	6.9	12.7	8.9	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4	17.9	6.4	18.7	28.1	36.1	36.0	49.4	12.7	6.7	7.9	22.7	19.6	28.8	58.0	26.3	26.2	18.6	15.4	0.0	19.8	19.5	23.5	31.2	4.7	21.3	16.6	22.3	13.3	23.9	33.0	39.2	20.8	22.4	27.0	14.4	23.7	22.1	21.3	24.6	23.7	44.0	19.0	32.3	22.7	60.0	42.9	27.0	28.3	34.8	27.1	23.7
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 35.1;HEL: 90.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.6	6.7	2.6	4.1	3.9	2.6	6.8	2.6	2.9	5.0	4.2	3.4	3.3	10.9	1.9	2.4	5.6	3.6	11.9	8.0	5.8	35.1	6.1	90.1	8.1	6.7	5.6	8.1	7.3	5.8	4.6	4.8	7.4	2.7	4.9	8.0	9.2	7.1	3.0	7.3	6.6	14.0	8.9	6.8	2.7	8.2	3.4	5.7	6.1	6.4	7.4	6.1	3.4	5.0	3.9	5.3	4.7	9.6	3.4	3.0	3.3	4.1	8.2	2.9	8.2	11.7	5.4	5.0	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6	6.0	5.0	10.0	14.8	22.7	4.8	10.1	5.1	16.0	6.8	3.5	0.0	33.2	21.6	11.0	59.1	7.7	2.2	0.0	9.9	10.9	10.3	6.4	13.9	135.7	15.5	4.8	2.9	16.0	8.8	39.4	21.3	5.8	3.3	15.4	6.4	7.8	9.2	2.9	35.3	12.1	6.5	12.9	14.6	17.7	19.5	18.4	29.6	10.1	7.2	12.6
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	14.1	18.2	13.8	10.0	2.9	4.0	15.5	12.8	9.9	20.5	17.9	23.7	14.9	19.8	10.5	10.0	10.3	17.1	22.4	13.3	25.2	6.2	13.4	17.5	14.8	13.3	2.5	17.6	18.3	2.8	4.2	25.8	16.0	5.3	8.7	16.9	26.4	8.9	15.4	22.6	25.6	16.1	27.1	8.3	8.8	39.9	9.3	17.4	7.3	15.1	10.2	10.9	20.6	7.3	9.1	13.0	13.4	15.0	8.4	15.0	14.4	8.4	16.1	12.1	22.4	59.4	10.7	13.6	18.2	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2	0.0	5.1	11.2	5.0	9.6	5.8	2.4	2.5	2.7	5.7	1.8	9.8	9.1	10.0	5.6	4.2	5.2	4.2	23.3	6.6	6.6	4.8	9.2	4.6	6.4	7.6	3.2	9.1	10.4	13.7	5.4	3.4	6.1	15.1	3.6	8.3	3.5	8.2	0.0	3.9	3.4	6.8	6.5	5.6	46.5	30.6	8.2	6.3	7.5	7.3	12.0
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.6	4.2	4.1	4.3	1.4	9.8	11.2	6.8	4.6	4.7	3.8	3.2	7.0	4.7	4.5	5.8	7.7	3.6	3.4	3.2	8.6	2.9	8.4	5.9	7.2	9.7	4.8	6.9	0.0	3.4	4.1	7.6	3.6	1.7	3.8	12.1	5.4	4.8	0.0	0.3	3.7	1.9	3.1	4.6	4.5	7.0	7.7	5.0	3.7	8.4	5.2	4.0	4.3	11.6	1.1	5.0	8.4	2.3	5.1	3.8	0.0	9.2	6.1	6.2	6.7	3.8	4.4	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8	0.0	22.7	20.1	35.5	24.5	30.5	21.4	17.8	17.4	14.8	21.0	15.7	36.0	13.3	28.6	21.1	23.2	23.3	0.0	30.3	27.6	28.0	27.3	19.6	30.5	26.3	23.8	29.4	30.7	29.6	13.2	37.2	20.0	16.9	20.8	19.8	38.3	26.5	21.0	28.0	26.9	18.0	25.8	22.7	32.9	18.8	26.7	52.7	25.4	21.0	24.7
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.6	4.4	7.2	16.8	11.2	9.2	11.0	9.6	6.5	9.0	7.4	12.9	3.9	19.9	17.1	7.8	7.8	7.8	18.1	7.7	11.5	13.1	19.5	10.6	7.1	13.8	9.5	30.5	13.9	6.8	10.7	9.7	20.0	4.3	7.9	15.0	27.0	4.7	8.4	10.0	20.7	14.5	15.4	14.2	10.5	15.9	9.4	21.6	5.0	7.4	24.0	11.8	8.1	4.9	14.0	19.4	7.4	10.1	7.9	9.8	7.4	6.5	14.5	6.4	12.2	29.6	3.0	15.7	15.0	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2	6.0	26.6	22.4	26.7	46.9	9.2	20.4	2.5	25.4	45.5	7.0	9.8	29.8	3.3	13.2	34.2	23.9	5.8	0.0	10.2	28.8	22.0	11.9	32.4	8.9	20.4	4.8	6.9	17.2	6.5	6.5	18.4	16.7	16.9	11.8	10.4	5.5	10.9	5.8	18.7	9.0	10.4	19.4	26.4	55.6	78.8	56.7	23.3	22.0	15.3	20.6
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	24.9	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.1	12.8	14.6	14.8	12.7	18.1	14.8	21.8	22.3	11.5	5.3	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.1	15.4	15.1	14.7	17.8	13.7	20.3	14.1	16.1	24.3	12.5	16.2	44.0	12.1	19.1	18.5	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6	8.9	10.9	13.0	14.3	23.5	16.4	15.9	12.7	10.7	11.4	7.0	11.8	16.7	14.9	14.2	1.1	14.0	7.0	0.0	13.1	19.4	15.8	9.9	27.6	7.8	15.9	12.7	9.2	6.2	11.0	1.8	12.4	11.5	5.0	13.6	11.2	12.3	10.5	10.5	15.2	12.2	17.2	6.5	21.7	20.7	20.2	16.6	14.5	14.4	12.1	11.4
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.8	5.8	6.1	7.9	11.1	12.4	11.0	14.9	11.0	10.6	10.2	6.7	16.1	10.3	19.6	16.6	10.8	19.5	10.3	17.0	16.4	10.2	4.3	9.6	10.9	8.4	27.8	27.0	8.4	14.8	32.4	18.8	26.0	12.1	14.7	6.5	13.9	13.0	15.9	7.9	9.3	4.4	5.6	21.7	11.7	10.5	12.7	12.5	12.1	19.5	14.2	10.2	19.1	8.7	10.9	15.9	7.7	14.6	23.1	17.5	4.4	7.7	9.6	23.5	19.7	15.3	10.3	12.5	13.1	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6	74.5	51.9	21.7	78.2	107.0	43.0	61.7	43.3	56.2	67.1	24.4	53.0	38.5	21.6	40.3	191.3	39.6	193.3	116.8	45.8	56.7	46.6	92.4	61.2	72.5	37.1	27.0	60.3	33.7	55.0	227.3	20.8	49.5	40.5	47.7	85.9	17.1	98.8	75.8	28.3	40.3	43.8	6.5	38.7	23.6	9.5	125.6	73.9	34.1	42.3	194.9
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.8	10.3	10.6	22.0	14.1	5.7	15.0	20.4	15.9	18.3	9.2	6.6	8.9	14.5	21.5	16.7	11.0	12.8	12.3	17.4	18.4	6.9	11.5	4.5	6.7	12.4	9.9	14.7	19.0	11.0	14.7	10.7	13.0	13.7	5.5	12.9	5.1	15.3	12.3	6.8	10.8	6.5	11.5	8.5	8.3	7.6	10.0	14.2	19.1	8.9	8.8	9.9	6.2	16.6	21.9	11.4	7.1	16.6	17.4	9.3	6.6	11.1	7.9	10.2	9.5	7.3	5.5	19.2	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4	6.0	8.1	8.8	8.6	9.7	3.4	6.9	12.7	21.4	20.5	8.7	11.8	7.3	5.0	8.1	1.6	15.8	13.6	0.0	11.3	5.6	9.8	8.2	10.4	12.3	10.1	4.8	6.3	11.6	5.1	0.4	6.4	11.1	3.3	17.2	15.4	7.2	10.3	10.1	5.6	8.2	21.0	19.4	15.1	0.9	2.5	8.7	10.0	12.5	9.3	12.2
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.3	3.6	1.8	2.6	4.5	6.3	3.4	11.5	19.6	6.1	7.9	3.1	5.4	8.0	17.9	6.4	4.9	2.5	4.9	3.8	11.3	5.7	4.9	6.7	1.7	3.1	12.7	2.4	3.3	5.0	3.1	8.7	28.1	6.5	6.4	0.0	3.2	2.6	5.6	2.1	0.0	5.1	1.0	4.7	8.5	1.7	2.6	3.9	14.3	4.6	0.3	2.0	2.7	7.2	5.4	2.5	7.0	3.0	5.7	3.7	3.5	6.3	5.3	5.3	2.4	4.8	9.1	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5	32.8	17.8	13.4	31.1	51.2	2.4	2.8	5.1	10.7	22.7	3.5	0.0	10.6	5.0	66.4	5.0	9.5	2.3	0.0	53.1	35.2	38.5	46.3	42.7	2.6	39.0	3.2	0.0	5.5	25.3	1.6	7.2	48.6	18.6	50.5	5.2	10.0	41.2	0.0	5.6	6.7	0.1	12.9	22.7	8.1	10.9	42.2	70.0	12.7	6.6	40.4
RIPK3	RIP3	ENSG00000129465	"Receptor interacting serine/threonine kinase 3"	Q9Y572	14	24336021-24340045	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 20.6;Exocrine glandular cells: 30.8;Paneth cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HDLM-2: 4.3;OE19: 11.3;SK-BR-3: 12.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-2)"	7.6	1.3	1.8	9.7	2.4	4.3	6.0	0.9	1.6	4.5	13.6	1.8	1.4	10.6	3.7	3.8	9.2	3.2	12.7	2.6	2.7	0.6	3.8	1.3	6.4	7.2	3.9	0.8	1.7	8.4	0.5	0.9	3.7	2.3	3.7	11.8	3.6	7.5	1.7	2.1	5.9	25.8	2.1	3.8	15.1	9.2	1.6	3.6	7.2	8.7	6.1	13.3	4.6	5.6	3.5	5.2	6.3	8.8	3.9	9.1	4.3	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.7	3.9	0.0	0.0	0.1	7.6	0.1	2.0	0.3	0.0	1.9	0.0	0.1	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	1.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	11.3	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.2	3.3	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	2.6	5.1	6.3	6.3	7.7	6.4	3.5	5.4	6.2	5.2	3.5	2.9	4.0	2.6	3.9	8.8	2.6	9.1	4.3	1.8	2.4	0.9	1.6	2.7	0.6	3.9	0.8	2.3	3.6	3.0	10.8	1.9	1.6	1.3	0.0	0.4	2.5	1.4	1.2	3.5	0.0	0.3	3.3	6.3	0.1	2.9	20.6	0.0	30.8	0.2	1.8	0.6	11.6	0.0	11.0	0.0	5.8	0.0	10.0	0.0	0.0	6.3	3.3	10.8	9.2	0.0	15.3	17.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.3	0.2	8.7	6.5	2.3
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030942	Enhanced					NA	NA					"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	6.8	4.4	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.1	11.4	15.9	0.0	6.7	1.4	20.8	23.5	0.3	9.5	0.0	0.0	4.7	0.0	3.3	4.2	0.0	0.0	0.0	0.0	15.8	0.1	2.1	0.0	0.0	7.1	0.0	0.0	0.0	5.0	0.9	0.0	0.4	4.5	13.1	0.0	0.0	1.1	14.2	15.1	2.3	0.1	7.7	7.8	7.1	0.7	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0	26.8	10.8	0.0	26.1	14.1	0.0	1.0	12.7	17.4	14.8	3.5	0.0	7.0	8.3	10.8	0.4	0.0	17.3	0.0	9.0	4.7	0.7	20.1	2.3	16.1	0.9	0.0	21.8	0.0	1.6	1.1	0.0	0.6	6.8	0.0	13.4	0.0	14.2	8.7	0.0	10.0	0.9	0.0	0.3	1.1	0.6	13.2	2.1	0.0	9.8	19.5
RNF103	"hkf-1, KF1, ZFP103"	ENSG00000239305	"Ring finger protein 103"	O00237	2	86603393-86623866	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057922	Approved					NA	NA					"HPA057922: AB_2683555"	"unprognostic (4.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.77e-5)"	13.2	13.5	18.0	9.8	20.6	9.8	18.5	38.3	24.6	15.8	28.1	16.9	9.6	15.6	18.8	39.7	11.7	12.7	23.3	29.5	16.7	15.9	13.1	43.8	8.6	8.5	17.8	10.6	13.2	20.2	23.8	12.2	16.2	14.7	20.5	14.2	14.5	13.8	16.1	17.7	10.4	27.2	17.9	21.8	8.1	18.7	13.7	16.5	11.9	9.0	8.8	8.3	13.4	11.5	1.4	1.6	9.9	0.9	3.0	3.4	0.9	5.6	7.7	3.9	6.0	18.0	11.7	6.4	8.1	12.5	4.2	5.7	4.4	9.7	9.4	9.9	12.2	15.3	6.9	5.2	6.4	6.4	7.8	7.1	5.3	3.5	9.8	17.1	1.8	8.0	17.0	13.5	6.2	7.8	15.1	12.6	4.5	1.9	5.7	11.5	6.9	4.0	4.7	1.8	11.2	5.5	2.5	16.9	5.5	15.4	8.9	6.2	6.4	9.6	21.5	8.0	5.2	8.2	4.4	14.2	8.2	3.9	8.2	4.8	19.9	6.6	6.3	6.5	3.0	3.9	6.5	0.7	9.9	1.1	0.9	1.5	1.4	1.6	2.4	1.6	1.4	1.9	1.3	1.5	3.0	0.6	1.0	3.4	0.9	18.0	20.6	38.3	24.6	16.7	15.9	17.8	10.6	14.7	16.5	8.9	12.6	8.5	27.7	42.8	14.8	30.8	22.9	17.4	15.9	19.2	3.9	10.6	1.7	14.0	14.5	16.6	43.9	23.3	24.9	6.3	29.6	44.0	18.4	58.4	8.3	17.5	30.5	23.4	11.8	7.0	23.6	10.6	10.1	2.8	35.6	17.5	25.0	38.6	21.5	12.8	8.8	6.5	25.8	21.5	13.0	38.6	34.2	6.4	20.1	37.4
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.6	11.4	11.8	17.4	10.8	12.3	8.8	11.7	11.3	12.6	10.2	11.7	16.5	8.1	12.6	10.0	8.5	8.6	13.3	7.9	10.9	11.8	13.4	18.9	22.3	17.4	13.0	14.6	13.6	13.1	10.6	12.3	11.2	11.6	16.8	14.1	14.3	9.5	10.1	13.7	21.1	6.3	8.5	15.5	6.5	7.0	17.0	15.4	11.5	7.8	15.7	12.2	10.8	13.4	6.7	11.1	23.4	12.0	9.9	12.1	8.9	10.9	19.5	19.1	6.6	14.1	16.5	14.9	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8	8.9	4.0	4.4	2.4	2.1	8.6	1.0	20.4	1.4	4.5	3.5	3.9	5.6	5.0	4.9	10.6	3.6	13.1	0.0	4.8	3.6	4.9	4.4	6.9	23.8	4.8	6.4	6.4	9.8	9.9	12.6	6.9	3.2	3.3	4.6	5.9	3.5	6.0	7.0	5.3	8.5	8.2	0.0	4.9	8.7	9.1	2.6	7.1	2.9	6.3	3.7
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 67.5;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.5	0.9	0.8	0.1	4.0	1.6	0.2	0.2	0.2	0.1	5.2	32.5	1.0	1.5	0.0	1.8	0.2	0.3	1.6	0.1	1.2	0.0	1.2	1.3	4.9	2.6	5.3	0.9	5.5	0.4	0.1	0.3	0.3	0.5	0.2	0.1	0.1	8.0	1.1	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.8	0.1	0.1	0.4	7.0	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3	3.0	8.0	9.9	2.9	8.8	0.4	1.4	2.5	2.7	5.7	12.2	0.0	0.3	1.7	0.8	67.5	23.2	25.5	0.0	1.6	0.1	1.9	2.4	17.4	15.5	8.9	0.0	1.2	6.7	14.8	11.5	2.6	13.9	1.7	1.0	8.2	1.2	1.3	0.0	0.0	1.1	0.6	0.0	1.9	0.5	0.7	5.9	0.7	66.0	13.6	2.1
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.3	1.7	2.4	12.5	13.6	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	3.1	17.4	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.6	16.1	4.1	8.1	6.5	5.1	3.2	7.2	17.7	21.9	21.7	4.1	20.9	22.1	10.1	19.5	5.5	17.0	16.1	6.3	33.8	6.0	14.5	17.4	13.6	10.3	13.6	13.9	2.6	8.7	17.0	9.4	14.4	10.4	21.1	23.3	38.3	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3	11.9	6.1	54.8	41.2	122.5	31.3	24.2	15.3	12.0	10.3	8.7	15.7	58.6	46.4	55.4	113.7	26.1	51.9	0.0	66.1	118.3	35.3	49.3	14.9	20.2	38.3	30.2	20.8	20.3	27.6	18.2	19.8	38.3	40.5	56.9	34.2	27.0	95.1	54.9	18.4	25.6	22.0	58.2	45.0	118.2	66.8	126.6	73.7	55.3	49.7	76.9
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 62.5;Cholangiocytes: 61.1;Enterocytes: 52.7;Hepatocytes: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.5;CAPAN-2: 13.6;Hep G2: 11.6;OE19: 36.6;RPTEC TERT1: 12.0;RT4: 34.2;WM-115: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA					"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.1	0.0	0.0	0.0	1.4	0.7	16.5	0.0	0.1	0.0	0.0	7.2	13.6	0.0	0.0	0.2	0.1	5.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	36.6	0.1	0.0	0.0	0.0	12.0	34.2	0.0	0.0	0.0	0.9	0.8	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0	62.5	15.8	0.0	5.7	6.1	0.0	0.5	61.1	9.4	20.5	31.4	0.0	18.2	0.0	9.8	0.0	0.1	52.7	0.0	13.5	2.1	0.4	1.8	0.0	73.1	1.6	0.0	23.8	0.6	3.8	0.0	0.0	0.2	3.3	0.0	36.5	0.0	21.8	22.4	0.0	21.1	0.0	0.0	0.2	0.0	2.2	4.5	13.8	0.0	23.4	7.4
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.7	12.3	8.3	9.5	32.8	20.1	13.9	10.9	28.2	10.6	15.8	10.8	28.4	8.2	16.0	13.4	19.5	18.8	11.1	14.0	14.9	10.0	8.1	9.9	5.7	10.5	21.8	10.6	14.1	21.2	26.6	8.9	24.2	12.8	11.7	7.9	3.1	16.7	9.4	11.1	7.6	7.0	5.5	19.1	9.6	5.5	8.9	34.8	20.5	9.2	4.4	12.7	9.0	13.6	35.2	6.8	25.9	11.2	12.2	14.4	5.8	15.2	7.0	28.4	18.7	16.9	12.1	9.9	7.7	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2	101.3	59.5	39.3	61.2	65.4	43.7	25.6	38.2	34.8	61.4	45.4	27.5	86.4	36.5	54.3	2.2	62.6	27.6	0.0	62.0	65.2	68.3	63.5	58.9	46.6	172.6	20.6	19.4	77.3	168.9	4.7	70.5	155.4	97.8	42.3	26.4	85.9	48.5	29.6	82.7	59.8	32.2	90.5	50.9	19.7	29.6	63.2	43.8	51.0	24.3	45.5
RNF130	"G1RZFP, GOLIATH, GP"	ENSG00000113269	"Ring finger protein 130"	Q86XS8	5	179911651-180072118	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 270.4;Kupffer cells: 303.4;Macrophages: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9"	"Group enriched"	"Detected in all"	11	"dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 41.5"	"Low region specificity"	"Detected in all"							HPA014499	Approved					NA	NA					"HPA014499: AB_1856328"	"unprognostic (2.01e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.38e-2)"	36.3	16.3	23.5	16.3	32.5	29.5	24.0	19.0	25.3	26.0	16.7	56.0	19.0	10.6	18.5	12.0	10.6	19.5	21.9	17.0	27.8	21.1	20.7	64.4	25.5	19.1	50.2	20.3	21.7	28.6	11.0	16.7	19.8	30.3	16.3	16.1	15.8	30.6	28.3	17.3	7.9	12.1	22.2	58.2	20.4	20.5	7.3	38.8	2.5	14.3	6.3	10.3	20.7	13.3	1.2	31.1	68.1	38.1	4.0	2.0	20.3	8.0	5.9	29.0	21.2	28.3	15.4	5.5	6.3	7.9	6.9	7.5	1.9	6.9	0.0	19.5	11.0	12.3	0.8	20.1	12.8	7.6	0.1	17.9	15.9	3.2	4.1	7.2	3.8	41.5	14.5	6.8	0.5	3.9	17.4	11.2	16.4	3.2	0.1	6.9	12.2	7.2	12.3	7.9	1.5	9.0	16.2	6.7	0.0	8.7	1.4	17.6	7.9	11.7	6.4	24.3	12.3	9.2	9.1	8.7	11.7	4.7	8.2	6.7	0.0	6.2	1.6	1.5	30.5	9.1	17.0	38.1	24.6	2.0	27.5	1.9	1.2	0.9	1.0	31.1	1.2	1.0	1.2	68.1	4.0	23.8	22.9	0.1	20.3	23.5	32.5	19.0	25.3	27.8	21.1	50.2	20.3	30.3	38.8	17.9	25.0	20.3	17.8	12.6	26.9	27.4	73.9	65.6	22.7	40.1	49.1	10.0	19.9	43.4	9.6	42.9	21.0	0.0	67.5	13.5	39.8	43.3	79.8	129.2	270.4	6.4	15.6	43.0	303.4	14.4	33.9	212.8	30.4	45.1	37.0	18.1	46.5	35.1	45.3	34.2	17.7	45.3	40.1	8.6	27.9	11.3	7.3	17.3	61.0	17.1
RNF133		ENSG00000188050	"Ring finger protein 133"	Q8WVZ7	7	122697712-122699156	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 28.3"	"Group enriched"	"Detected in some"	104	"Early spermatids: 461.8;Late spermatids: 540.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.82e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.3	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	4.1	0.0	1.5	0.0	0.0	1.2	0.5	1.1	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	540.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	0.0	0.0	0.0
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Group enriched"	"Detected in many"	16	"Early spermatids: 845.1;Late spermatids: 2984.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria		NA	NA			Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	9.1	5.4	22.4	11.1	2.9	6.1	12.7	9.3	5.3	11.7	13.6	6.4	6.4	22.0	11.7	6.1	7.6	9.5	11.7	10.5	16.0	12.2	19.6	17.3	7.0	7.8	11.5	47.6	15.4	5.9	10.6	12.9	18.4	6.8	11.9	19.7	23.8	9.0	7.5	8.7	32.1	21.3	25.0	15.8	7.5	33.2	14.1	12.6	10.7	6.8	25.4	12.7	12.5	7.2	9.7	10.7	4.7	20.1	9.1	14.1	10.3	3.4	10.4	15.0	19.9	38.1	7.7	26.6	13.8	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1	14.9	22.4	13.8	29.1	61.6	6.1	6.7	25.5	16.0	18.2	15.7	0.0	25.9	14.9	15.3	845.1	21.2	16.7	0.0	16.0	16.6	21.4	26.1	22.0	14.7	21.1	7.9	28.7	20.3	27.6	2984.7	27.3	30.7	25.3	10.8	21.0	8.0	10.5	20.1	20.8	10.7	4.8	32.3	25.9	118.9	102.4	45.7	7.4	27.7	27.0	31.8
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474738-124487914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 763.4;Late spermatids: 690.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved					NA	NA					"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	15.1	17.3	10.4	9.5	12.2	54.5	13.4	12.0	17.1	14.2	10.9	14.0	9.4	6.2	15.3	10.0	12.2	14.2	11.0	11.4	10.4	10.8	11.4	17.7	11.3	14.2	12.4	11.5	17.1	10.3	7.6	10.6	18.4	9.9	12.8	10.4	10.2	10.3	10.5	15.2	12.6	11.3	14.2	12.2	11.8	11.2	60.3	13.3	16.8	11.2	9.6	10.4	14.8	10.7	9.2	9.4	11.8	11.7	8.6	13.9	8.0	13.2	8.9	10.7	10.5	23.6	18.8	8.8	11.9	22.7	10.0	13.0	5.7	11.1	13.7	14.0	15.4	7.2	9.8	9.1	14.6	15.0	19.0	11.5	20.4	5.9	11.8	18.0	9.6	11.8	16.1	21.2	10.6	28.8	13.7	13.4	12.7	14.3	21.1	11.8	35.9	16.2	6.9	7.5	26.6	12.6	6.5	7.9	13.7	18.8	17.0	4.5	11.7	15.5	39.0	16.8	8.4	18.7	10.5	10.5	6.7	15.5	11.3	13.3	17.1	18.2	12.4	10.5	16.3	6.7	3.3	7.4	11.8	11.6	4.7	13.9	9.2	10.8	13.2	9.4	8.5	10.8	11.3	10.8	8.6	11.7	5.1	13.2	8.0	10.4	12.2	12.0	17.1	10.4	10.8	12.4	11.5	9.9	13.3	3.0	6.7	27.4	55.8	58.7	13.6	14.1	33.1	5.3	5.7	21.0	5.9	34.4	10.0	17.2	763.4	21.8	13.6	0.0	15.7	43.0	28.5	26.2	20.7	28.2	22.9	15.9	20.8	16.0	27.6	690.0	27.3	26.6	33.7	19.0	17.2	19.8	18.3	7.0	25.5	12.9	22.3	19.4	53.6	37.9	24.2	61.6	63.2	26.2	16.8	48.5
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.7	21.4	15.0	29.5	27.1	28.4	10.1	26.3	14.7	18.5	20.5	17.7	14.9	22.6	30.8	26.9	27.9	7.0	19.1	25.8	16.6	17.0	16.5	14.4	11.2	8.0	29.8	15.7	12.9	21.3	22.8	24.6	30.9	16.1	22.9	15.8	17.4	31.6	37.8	15.2	15.2	5.0	6.3	15.6	24.4	10.1	16.7	24.5	25.4	22.2	16.6	13.5	23.0	42.2	44.6	17.6	29.3	12.3	23.6	24.6	7.9	11.6	24.9	19.9	23.2	20.7	21.1	19.3	30.3	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0	8.9	22.9	9.0	14.0	9.5	20.9	36.8	7.6	13.4	13.6	21.0	15.7	24.8	58.0	23.0	162.7	16.9	20.2	23.3	21.8	21.4	16.2	17.2	21.9	29.6	21.4	22.3	14.5	17.8	25.5	22.0	17.8	19.3	30.4	10.8	14.1	20.6	22.7	11.5	31.5	34.8	14.6	38.8	25.8	42.6	27.1	9.3	50.6	17.5	13.3	12.7
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917392-7068286	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	12.9	28.8	13.3	4.2	21.2	12.1	11.1	45.5	20.7	17.3	5.2	28.7	9.0	3.0	26.0	8.3	4.7	8.4	7.5	8.0	15.6	11.6	7.5	1.8	5.7	7.9	26.5	12.2	20.0	29.7	21.5	12.5	6.2	13.2	8.7	5.7	5.9	4.0	7.4	8.7	5.7	4.1	12.2	21.8	21.1	2.8	5.0	27.1	3.4	3.2	1.2	5.8	5.8	6.5	0.1	0.2	8.7	0.1	0.8	4.1	0.6	0.3	2.2	12.0	2.4	2.7	5.6	9.2	0.0	0.0	0.4	1.1	0.0	0.2	1.1	1.3	0.1	3.5	0.2	3.9	0.0	0.0	0.6	1.0	15.2	0.1	4.5	0.1	0.3	51.6	8.9	0.0	0.8	0.0	0.0	0.0	3.9	6.5	0.2	0.0	1.9	7.8	0.6	4.4	0.3	5.4	6.1	8.7	1.0	0.4	3.9	3.9	15.7	0.2	1.6	15.4	1.6	0.7	1.0	0.0	1.6	4.1	4.2	1.7	4.1	1.3	0.0	6.0	3.4	5.6	1.5	0.1	8.7	2.1	0.0	3.0	0.1	2.1	1.5	0.2	0.1	4.1	2.8	0.4	0.8	0.0	0.0	0.8	0.6	13.3	21.2	45.5	20.3	15.6	11.6	26.5	12.2	13.2	27.1	3.0	3.4	0.5	0.7	2.2	3.6	10.6	2.5	2.7	3.4	0.0	70.7	1.7	1.7	2.7	5.7	7.0	4.2	23.3	5.0	2.7	5.3	3.5	9.2	0.8	3.8	9.5	24.5	28.3	1.0	10.4	4.0	1.0	23.6	1.0	2.5	7.2	4.5	9.1	9.9	0.0	42.2	0.0	3.8	1.6	6.0	1.4	0.9	6.4	2.9	0.2
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.7	3.3	3.6	0.0	0.1	55.9	15.4	0.6	0.2	4.8	0.0	4.7	4.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.8	1.3	4.0	1.5	16.5	1.2	0.0	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.3	0.2	0.5	3.3	10.0	3.1	0.5	0.0	0.3	7.1	5.3	0.4	8.4	0.1	16.5	2.6	0.5	0.2	0.3	0.0	0.0	47.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9	41.7	12.9	4.2	36.0	563.5	0.9	10.4	10.2	21.4	36.4	36.6	2.0	9.7	16.6	8.2	1.6	32.1	1.0	0.0	7.7	2.9	12.4	85.1	3.5	17.4	13.8	0.0	1.2	28.8	98.2	1.6	1.1	68.0	57.3	44.1	1.3	16.0	6.0	2.9	2.8	16.3	1.0	0.0	10.1	1.7	2.6	1312.2	1.3	3.2	2.4	20.3
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 255.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.7	5.8	4.4	5.5	16.5	16.6	25.7	12.1	15.9	16.4	18.5	14.5	25.8	2.9	14.7	11.9	21.7	19.9	6.2	12.3	15.3	8.4	8.5	6.0	5.1	24.5	22.1	6.5	9.8	15.1	20.3	19.4	12.9	12.6	29.8	6.4	5.3	9.1	16.4	8.3	8.7	6.5	3.0	13.2	10.5	5.7	7.3	11.2	19.3	23.9	5.8	4.3	7.3	18.1	17.5	5.0	4.9	8.8	19.7	8.3	4.7	12.4	2.6	18.4	10.8	0.1	2.7	9.1	6.1	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7	44.7	56.9	34.7	63.4	68.3	20.3	10.6	48.4	24.1	23.9	52.4	53.0	48.5	1.7	48.9	61.2	33.8	33.9	0.0	36.5	60.6	44.7	62.7	37.1	38.9	76.7	7.9	8.2	28.8	255.2	27.7	28.4	171.2	38.8	16.2	35.9	11.9	49.2	36.6	18.4	25.1	19.7	58.2	44.3	31.2	36.2	80.0	107.1	69.8	31.9	137.0
RNF152	FLJ39176	ENSG00000176641	"Ring finger protein 152"	Q8N8N0	18	61808063-61894247	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"kidney: 53.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 71.0;Proximal tubular cells: 104.4;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.3;HBEC3-KT: 8.7;SH-SY5Y: 10.1;TIME: 10.1;U-138 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (1.13e-8)"	"prognostic unfavorable (2.85e-5)"	"unprognostic (3.26e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.83e-2)"	8.3	3.9	2.4	2.3	6.8	1.5	8.8	19.1	3.8	8.5	7.4	4.0	6.2	2.2	8.6	10.4	4.5	3.9	8.0	6.5	2.5	3.1	53.7	28.3	7.8	1.2	4.1	1.4	3.8	3.1	4.7	2.6	6.6	7.7	4.7	6.7	3.4	11.8	6.8	4.6	9.6	9.8	4.6	4.2	1.3	5.7	3.9	4.5	0.0	5.1	4.9	2.0	5.0	11.6	0.5	0.4	1.7	0.4	0.6	0.4	0.2	0.0	0.0	3.5	0.8	3.4	0.5	0.0	2.3	7.1	0.5	0.4	0.0	0.1	0.1	0.7	3.6	0.1	16.3	4.4	8.7	1.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	0.5	6.0	2.8	1.7	1.6	6.5	0.0	0.0	0.0	1.0	0.7	0.6	0.0	0.2	0.5	0.0	0.2	2.3	0.0	0.3	2.6	3.0	10.1	0.0	6.4	1.1	3.2	3.9	0.0	10.1	16.5	1.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.4	1.5	0.6	0.4	0.4	0.3	0.2	2.4	6.8	19.1	3.8	2.5	3.1	4.1	1.4	7.7	4.5	0.0	0.0	0.0	21.4	37.5	13.4	2.5	12.7	0.0	2.3	19.2	0.0	0.4	39.7	2.0	0.2	16.3	37.1	0.0	2.4	0.1	8.3	7.3	0.0	71.0	0.1	20.6	15.5	5.5	2.2	0.0	8.1	2.2	27.0	0.0	4.9	3.7	1.1	31.6	17.3	104.4	3.6	64.7	48.4	0.1	0.1	28.4	0.2	0.0	11.8	18.8
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	24.2	35.2	15.3	18.8	37.8	18.9	22.9	15.0	21.0	31.7	25.1	24.5	11.2	17.9	29.2	24.8	15.8	37.3	26.6	29.2	23.7	17.3	42.8	30.6	44.4	24.1	28.6	14.4	64.6	22.1	46.1	33.0	31.4	19.9	20.4	26.7	11.9	61.3	25.3	17.3	22.7	17.9	18.3	25.7	22.6	15.7	15.3	22.3	36.5	20.4	12.1	15.0	13.8	23.7	20.0	22.4	22.6	14.7	12.5	19.0	12.6	17.0	28.5	20.4	20.6	5.9	26.1	20.8	19.8	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1	0.0	3.8	37.8	33.1	60.9	40.7	13.4	66.2	2.7	2.3	47.1	19.6	101.9	48.0	68.5	41.4	35.8	73.2	46.7	58.4	102.1	39.8	31.4	13.9	83.9	52.2	17.5	30.5	38.1	36.1	68.6	45.1	42.0	37.1	57.7	40.4	45.0	52.7	40.3	50.5	53.1	25.5	38.8	27.8	111.1	83.5	72.8	104.7	90.0	54.4	39.3
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.6	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.7	0.0	0.1	5.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.5	0.0	1.3	0.1	3.3	25.4	1.9	0.3	0.3	0.1	0.0	0.3	0.0	1.7	1.3	0.1	0.1	0.0	3.2	0.1	2.9	0.0	0.0	0.0	0.5	0.0	3.6	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1	14.9	10.5	0.0	6.5	4.0	16.5	9.6	12.7	2.7	7.9	15.7	13.7	0.0	6.6	4.5	3.7	5.6	0.0	0.0	2.3	0.1	2.5	5.0	0.0	5.4	0.1	11.1	1.2	12.3	1.2	5.5	31.9	0.2	5.0	0.0	1.6	32.9	2.8	0.6	23.7	14.3	17.3	38.8	17.9	15.4	9.7	6.5	0.0	0.0	0.1	3.8
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.0;RPTEC TERT1: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	5.3	0.0	1.8	2.3	0.3	2.7	3.7	7.5	7.3	0.1	0.0	0.0	0.0	2.9	8.2	0.0	6.2	0.0	13.8	0.0	2.0	0.1	37.0	0.0	0.0	0.0	0.0	1.2	0.0	11.6	0.1	8.7	0.1	1.5	0.2	0.0	5.2	0.0	0.0	0.9	3.0	0.0	10.3	1.5	1.3	0.4	29.7	0.0	6.4	6.1	0.2	0.0	10.4	2.0	0.0	1.0	2.8	9.2	2.0	0.1	6.1	0.0	0.0	0.0	6.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9	0.0	0.0	0.0	0.0	0.2	16.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	14.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.5	1.2	6.5	0.8	3.0	1.9	0.0	0.2	0.0	0.0	0.0
RNF185	FLJ38628	ENSG00000138942	"Ring finger protein 185"	Q96GF1	22	31160183-31207019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.76e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"prognostic favorable (4.82e-5)"	"unprognostic (3.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.10e-1)"	18.3	16.1	15.2	11.6	20.3	6.8	18.4	16.7	23.4	19.4	17.0	24.3	14.4	15.6	21.8	20.2	20.5	18.3	13.6	15.6	14.7	15.6	27.6	39.7	14.4	11.1	15.9	14.6	21.2	23.5	32.5	24.3	19.8	20.9	30.5	17.3	24.1	27.0	23.5	18.0	22.9	24.4	22.8	16.4	14.4	18.0	11.8	15.1	12.6	39.9	14.4	18.0	19.4	18.5	10.3	12.6	21.5	15.1	15.4	14.0	13.0	9.6	5.7	11.1	12.5	22.5	15.1	10.6	11.5	22.3	15.8	21.5	6.3	4.6	9.2	6.5	20.3	14.0	6.1	10.5	11.9	16.4	9.1	11.4	4.0	5.5	7.7	31.6	9.6	6.2	16.1	42.9	11.1	25.8	14.5	13.2	9.8	4.6	11.0	18.9	6.8	8.3	5.5	4.9	20.0	6.3	8.6	11.0	10.7	11.4	8.4	4.9	9.9	8.4	11.2	16.8	11.9	7.7	6.4	9.2	11.3	8.1	13.0	5.6	15.4	12.5	11.7	14.8	6.2	9.0	15.0	14.6	8.0	12.4	15.1	14.0	10.3	12.7	13.8	12.6	9.0	12.9	11.8	21.5	15.4	12.2	4.7	13.6	13.0	15.2	20.3	16.7	23.4	14.7	15.6	15.9	14.6	20.9	15.1	20.8	9.3	8.3	9.7	8.0	10.1	5.1	12.7	12.0	10.3	17.4	7.9	10.4	18.3	13.4	16.1	8.7	13.4	0.0	12.9	17.5	8.9	12.2	5.7	24.3	12.1	7.9	16.1	27.0	8.1	14.3	6.9	8.8	8.5	11.8	12.0	10.9	13.9	12.7	14.9	18.7	6.7	6.5	8.2	7.0	9.1	9.4	31.1	6.9	7.7	7.4
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.3;U-266/70: 76.8"	"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.4	7.1	5.0	10.5	5.5	3.6	9.7	7.9	4.9	5.0	3.8	3.6	6.6	21.6	16.6	9.0	4.1	7.6	6.3	6.7	1.9	9.8	8.1	6.5	5.3	4.7	15.0	7.4	12.8	6.3	12.1	3.8	5.2	6.1	4.4	16.5	10.4	42.3	3.6	5.3	11.8	6.6	11.2	6.7	7.3	10.1	4.6	20.3	3.6	6.0	11.1	11.2	8.1	16.8	21.4	1.7	11.8	17.8	10.1	6.2	6.4	6.7	7.5	76.8	23.0	11.8	16.7	7.8	10.4	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4	23.8	13.3	36.1	41.5	32.2	84.0	56.1	38.2	8.1	18.2	38.4	17.7	14.3	96.2	13.8	0.5	22.6	33.3	0.0	20.8	20.1	31.6	30.3	44.9	56.2	24.8	52.4	38.4	29.4	29.7	2.5	22.7	23.8	37.1	6.4	26.7	103.2	20.8	20.4	24.4	99.3	37.8	19.4	38.1	4.4	22.0	48.3	14.8	41.5	27.6	24.7
RNF19A	"DKFZp566B1346, dorfin, RNF19"	ENSG00000034677	"Ring finger protein 19A, RBR E3 ubiquitin protein ligase"	Q9NV58	8	100257060-100336218	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011455, HPA023652"	Approved					NA	NA					"CAB011455: AB_2180446, HPA023652: AB_1847836"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (8.44e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.28e-5)"	28.2	13.8	30.2	21.8	20.8	34.9	26.7	16.3	29.5	40.6	22.8	26.4	11.4	17.0	29.4	19.0	17.6	24.7	30.8	20.1	28.7	16.1	23.0	33.9	28.4	35.2	19.7	25.2	24.8	20.3	14.5	15.7	18.6	23.6	20.7	19.2	11.5	19.8	14.2	23.0	26.6	38.5	32.7	30.1	22.7	21.5	35.4	27.7	25.1	17.0	14.7	29.5	33.9	23.7	13.5	11.4	17.6	10.5	4.8	14.4	4.5	8.6	5.6	4.9	5.6	9.3	8.1	6.4	7.8	7.4	7.4	6.8	3.0	5.8	5.1	14.3	7.9	3.4	6.1	3.8	5.7	10.1	21.5	3.1	8.6	25.8	4.3	7.8	1.7	5.5	8.0	8.8	5.9	11.2	9.0	11.3	5.7	4.7	60.1	7.2	4.3	7.8	2.8	1.7	5.8	5.2	3.2	3.4	10.0	20.2	13.6	3.9	8.4	8.1	4.9	7.5	10.7	4.3	6.7	11.2	8.6	6.8	6.3	4.7	29.2	18.7	3.5	5.6	5.7	5.1	17.6	7.5	6.5	14.4	5.6	9.0	13.5	11.8	10.8	4.6	12.7	6.1	8.8	16.6	4.8	10.5	11.4	12.0	4.5	30.2	20.8	16.3	29.5	28.7	16.1	19.7	25.2	23.6	27.7	47.6	39.3	23.5	84.9	35.6	27.9	35.0	84.1	108.4	101.2	41.8	56.9	8.1	6.6	52.3	151.8	52.5	38.7	46.7	35.2	12.6	44.8	62.3	40.6	34.1	19.7	55.6	20.0	30.7	27.9	203.2	54.1	30.2	20.3	9.0	22.2	41.1	43.0	24.6	64.7	42.5	45.0	19.4	28.3	63.0	44.7	52.8	6.9	48.4	18.2	101.9
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.3;Karpas-707: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.7	5.2	4.5	4.1	2.7	3.9	30.0	3.1	3.8	5.7	6.1	6.1	20.3	39.3	5.5	4.1	7.0	9.7	5.5	7.5	5.2	14.4	3.6	3.4	4.1	6.1	8.8	5.2	7.2	3.1	14.0	12.5	15.4	6.6	11.9	3.9	4.2	47.3	5.5	2.2	3.4	6.4	7.2	7.7	5.9	4.6	6.4	4.0	4.4	9.8	7.1	3.6	10.0	3.4	22.4	11.5	2.9	7.6	13.0	3.1	4.3	7.8	5.4	11.3	5.7	13.9	4.5	5.3	4.6	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3	11.9	4.1	1.9	20.3	41.0	4.4	12.0	15.3	6.7	2.3	7.0	2.0	11.0	1.7	9.3	30.1	8.7	34.3	0.0	9.9	5.4	7.1	22.8	4.6	3.4	12.6	3.2	10.9	3.7	20.2	18.4	2.0	28.7	5.0	43.3	16.5	2.0	19.2	17.5	3.5	7.1	7.4	0.0	5.4	29.3	12.6	28.4	6.2	3.2	10.5	35.3
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.8	7.6	28.2	11.2	8.0	13.7	26.8	9.8	12.4	15.5	12.5	12.1	23.1	4.1	12.3	12.0	10.5	4.9	19.3	14.2	18.9	12.1	10.1	22.3	4.7	10.6	11.8	22.8	12.6	12.9	8.7	12.7	16.3	12.6	15.6	14.4	17.6	9.9	11.2	8.6	19.7	6.7	37.8	11.7	4.2	22.6	17.5	3.9	11.7	9.8	8.3	14.3	6.8	4.1	19.9	32.0	8.7	12.2	11.0	11.2	14.5	10.6	12.4	16.4	10.6	15.4	7.0	10.8	12.5	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4	3.0	5.4	10.8	18.7	20.6	9.2	5.9	7.6	5.3	3.4	8.7	3.9	22.5	19.9	10.5	4.8	17.9	4.0	0.0	11.1	42.7	21.1	12.7	12.7	7.3	17.9	6.4	28.4	21.5	20.3	5.2	8.9	21.4	20.3	28.9	10.4	8.5	10.4	11.5	11.0	10.6	5.9	0.0	12.1	29.9	78.0	17.8	23.8	15.0	11.5	33.6
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.7	24.8	14.3	15.7	17.7	14.0	12.2	17.0	13.7	17.1	15.0	15.0	10.4	21.6	9.2	13.1	14.3	24.8	16.6	14.5	17.6	22.5	7.7	11.5	22.7	15.0	13.0	19.8	13.9	13.7	15.6	15.1	19.6	12.9	10.0	8.0	10.9	12.8	18.5	12.7	15.4	5.3	31.6	22.0	12.6	14.9	49.6	10.7	7.0	9.4	15.3	19.3	24.1	12.9	14.0	15.0	11.6	9.4	14.1	15.9	16.0	11.3	14.3	13.9	42.7	11.8	14.0	7.5	19.2	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8	23.8	24.5	7.5	8.1	5.7	29.1	42.4	10.2	33.5	26.1	21.0	5.9	13.6	5.0	14.3	26.2	11.3	12.2	0.0	12.1	9.6	11.5	7.2	20.9	16.8	14.4	41.3	23.6	7.4	23.8	15.2	16.7	20.0	10.1	27.9	10.7	27.6	10.2	15.3	22.3	9.1	23.0	32.3	14.4	24.7	15.8	5.1	6.4	16.0	12.0	5.4
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA					"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.3	1.5	0.5	5.4	2.1	8.6	5.7	7.7	3.9	5.1	0.0	3.9	0.0	8.0	5.4	8.9	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.4	1.3	5.2	0.0	0.2	5.9	4.8	2.9	8.6	4.6	4.4	0.0	11.6	0.0	6.8	0.0	0.0	0.0	1.3	0.0	1.1	0.1	6.0	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.2	4.4	4.2	0.7	6.9	3.2	10.4	0.0	12.2	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7	20.8	16.0	0.0	12.7	42.7	6.2	12.5	2.5	5.3	10.3	5.2	15.7	15.2	0.0	6.8	92.0	15.0	1.7	0.0	8.3	23.6	21.6	10.4	1.1	24.6	8.5	20.6	2.9	14.1	12.9	49.9	23.9	13.3	18.6	2.8	3.0	4.0	10.7	0.0	19.8	1.9	5.0	6.5	12.3	1.4	2.6	41.0	15.0	0.5	2.7	9.7
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663864-218672411	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	13.4	12.7	13.9	11.1	16.1	6.2	13.7	13.4	27.6	17.3	13.3	17.1	9.8	4.3	16.6	16.2	12.2	16.8	11.8	17.2	13.1	16.5	13.7	15.6	11.9	12.1	12.1	11.6	17.8	13.0	19.3	14.8	17.7	15.4	14.7	9.0	15.3	13.6	17.9	16.9	15.7	10.3	16.0	10.0	12.9	11.8	18.4	9.1	15.3	16.8	12.7	16.8	14.0	11.8	13.3	8.2	23.3	11.2	14.8	15.0	13.9	5.9	7.6	6.9	8.0	10.6	6.5	7.5	6.8	17.1	23.4	21.8	12.7	4.0	4.0	5.4	14.3	12.9	5.4	8.0	13.3	10.2	4.3	10.9	5.4	5.6	12.0	13.0	4.8	5.9	14.3	12.4	21.2	14.3	6.5	12.7	15.4	9.1	6.2	15.0	17.0	5.4	5.9	11.0	4.9	8.7	7.6	4.4	5.8	14.3	6.4	7.0	7.9	5.2	5.9	10.1	5.0	7.0	8.8	7.3	13.3	6.3	5.2	9.6	5.4	4.2	6.7	11.2	6.0	8.0	23.3	10.6	14.9	13.9	10.3	12.6	11.9	13.7	13.6	8.2	13.3	15.0	11.7	8.9	14.8	11.2	7.4	11.5	13.9	13.9	16.1	13.4	27.6	13.1	16.5	12.1	11.6	15.4	9.1	0.0	0.3	4.7	4.6	5.6	7.4	3.1	5.1	5.3	2.3	1.8	7.9	11.1	13.3	10.5	10.3	5.9	6.4	0.0	11.4	8.1	7.2	3.0	6.9	6.4	11.3	4.8	1.2	9.2	5.9	3.4	6.6	4.6	8.5	10.0	4.9	7.0	10.2	8.6	12.0	11.5	4.5	25.8	6.1	14.4	11.9	5.9	8.4	10.1	4.8	3.9
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160661	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.8;Club cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.4	18.5	11.7	21.5	17.4	20.0	15.1	20.0	26.4	17.7	17.3	18.4	19.9	13.4	22.4	22.3	15.4	17.4	17.2	14.5	10.7	9.8	17.2	14.8	15.3	19.3	11.0	18.0	20.6	23.6	20.0	19.2	18.7	13.4	16.4	14.1	16.9	19.6	23.1	39.5	29.1	16.1	19.7	9.1	27.3	16.5	21.8	11.0	33.6	17.4	13.1	24.9	16.3	13.5	2.4	4.6	3.8	3.7	2.5	4.8	1.3	4.5	10.6	9.9	12.2	6.7	7.0	20.1	7.9	11.7	15.6	12.5	9.6	11.5	9.0	5.0	11.3	9.2	7.8	5.6	11.3	9.3	9.4	4.2	8.4	10.8	21.0	11.1	14.1	15.0	12.8	9.7	7.1	11.1	9.7	9.9	7.5	4.9	11.9	6.9	14.1	13.3	8.3	5.3	7.9	11.6	8.9	7.3	5.7	7.9	18.8	8.8	11.0	7.3	19.3	9.6	9.0	6.8	10.4	9.7	11.0	8.4	8.0	7.4	16.0	14.1	8.8	4.1	5.6	10.2	0.0	2.1	1.5	1.9	3.7	4.8	2.4	1.9	2.1	1.8	1.1	2.3	1.3	3.8	2.5	2.1	4.6	3.0	1.3	11.7	17.4	20.0	26.4	10.7	9.8	11.0	18.0	13.4	11.0	0.0	5.8	0.5	0.2	0.6	0.7	0.2	0.0	1.4	5.7	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.3	0.0	0.0	0.6	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.4	0.6	0.5	0.8	0.0	0.3
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041330: AB_10793872, HPA054227: AB_2682422"	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	21.0	25.2	26.4	21.3	26.5	40.8	20.9	36.8	28.2	25.8	21.0	22.0	18.0	20.1	28.4	17.0	25.6	24.4	21.3	22.8	22.2	17.1	20.0	21.2	20.2	21.9	20.9	18.9	30.5	24.4	44.0	21.6	25.3	19.6	21.4	15.1	20.0	27.3	21.1	20.0	25.5	20.3	18.3	18.6	20.0	19.6	43.1	22.8	23.5	26.8	15.4	20.6	22.5	21.4	7.6	12.0	15.0	14.9	9.9	13.3	12.9	20.3	31.9	19.4	18.4	14.8	15.5	21.2	20.8	16.1	24.1	18.8	25.8	19.0	16.2	30.6	17.8	16.5	22.1	35.3	18.5	18.9	23.2	41.4	15.9	35.0	26.7	19.8	27.4	18.6	14.4	15.5	30.2	17.1	16.1	20.2	14.4	34.8	15.5	14.6	34.0	26.1	25.8	20.2	16.3	19.3	51.9	21.4	31.2	10.6	18.1	32.4	23.8	16.3	20.9	15.1	10.7	32.0	31.2	21.8	27.1	13.8	19.1	23.7	23.2	28.5	32.2	22.5	24.4	27.6	6.2	11.5	14.7	12.9	13.4	13.3	7.6	7.2	9.9	12.0	6.5	5.4	8.3	15.0	9.9	14.9	6.2	6.2	12.9	26.4	26.5	36.8	28.2	22.2	17.1	20.9	18.9	19.6	22.8	11.9	26.4	10.4	10.9	12.4	14.5	2.0	30.6	9.4	11.4	21.0	3.9	13.3	74.6	12.9	18.8	10.9	22.6	0.0	11.6	13.8	11.8	14.0	4.6	18.7	18.7	4.8	13.4	9.8	24.6	16.8	16.7	13.0	16.9	9.0	20.9	16.6	13.6	14.0	16.6	19.9	13.3	12.9	11.2	19.7	9.4	17.2	19.0	13.6	23.6	10.0
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202175-56221933	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	22.2	17.6	18.6	11.8	30.2	12.0	14.3	30.9	47.1	16.2	15.0	16.9	12.3	8.5	16.4	9.7	16.5	17.7	18.0	22.6	17.3	22.4	14.1	10.5	16.5	14.8	15.3	18.2	17.0	16.0	17.9	16.7	14.6	25.3	25.2	13.6	14.6	10.5	15.6	21.2	10.1	10.8	20.3	11.8	13.5	12.2	10.1	12.1	11.3	20.5	10.1	17.0	16.2	11.5	24.6	13.1	41.1	11.5	13.4	12.5	12.3	7.5	11.6	12.6	20.0	26.5	19.3	9.4	25.3	25.1	22.8	18.6	14.2	9.9	14.6	13.5	21.4	7.6	8.7	17.0	12.2	16.6	15.3	9.3	19.6	8.3	8.1	55.6	21.4	21.4	24.6	28.7	19.0	33.6	30.1	22.1	12.4	13.9	15.0	12.6	12.2	12.2	9.6	15.2	7.6	13.6	13.3	9.1	8.8	12.1	11.1	23.1	14.0	22.1	12.7	20.0	13.2	17.8	25.2	13.3	11.5	12.3	14.8	9.8	10.8	12.4	13.3	13.7	12.9	13.7	21.0	11.5	41.1	12.5	11.4	11.2	22.7	10.6	10.9	13.1	24.6	11.0	11.2	15.8	13.4	11.2	10.2	12.1	12.3	18.6	30.2	30.9	47.1	17.3	22.4	15.3	18.2	25.3	12.1	41.7	26.4	27.0	18.8	10.6	26.2	20.1	25.5	24.1	25.0	15.7	21.6	13.2	14.9	14.3	78.7	16.4	9.3	23.3	18.6	14.4	14.9	30.9	24.4	14.9	17.6	27.0	19.5	22.1	29.2	38.0	21.3	21.9	6.8	21.6	13.2	23.9	17.8	16.1	24.4	15.8	16.9	25.8	21.4	9.9	12.2	14.4	14.1	15.0	13.6	16.9
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.7"					"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.6	4.0	9.7	11.5	7.8	11.3	2.8	6.9	8.6	13.2	14.5	6.0	3.7	8.3	4.2	6.7	11.4	6.3	13.5	8.8	13.8	8.7	13.1	14.2	7.0	8.9	4.5	7.6	10.5	5.6	8.5	7.8	9.1	8.1	12.6	9.8	9.6	2.9	7.5	4.4	9.1	9.4	6.7	3.4	5.3	7.2	8.9	5.7	6.7	4.7	19.1	6.4	5.2	5.9	9.5	6.6	5.3	7.4	5.7	8.7	7.7	8.2	10.2	8.6	11.3	40.7	4.2	10.8	10.0	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8	17.9	23.4	13.0	21.7	16.3	26.0	28.3	10.2	28.1	15.9	24.4	37.3	20.9	13.3	20.8	35.2	15.8	8.6	0.0	16.6	21.6	23.9	20.0	27.7	14.7	15.4	47.7	21.4	22.1	14.2	20.2	24.7	13.8	10.1	20.8	16.1	21.5	23.6	15.6	29.0	16.8	29.6	12.9	16.4	43.0	33.1	19.3	4.9	15.8	16.2	17.0
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88610272-88963721	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	9.1	12.1	10.2	19.6	12.2	14.2	9.9	18.5	13.1	10.0	8.1	8.7	7.0	7.4	11.1	7.2	12.5	8.7	7.2	9.6	10.5	16.0	9.4	11.8	9.4	26.3	9.8	6.4	10.4	6.6	12.1	23.1	11.6	11.1	9.8	9.8	9.4	8.4	11.6	10.5	9.0	10.7	10.7	10.7	14.3	7.5	15.0	10.4	28.0	10.0	7.8	28.2	10.9	13.8	18.6	4.4	5.7	4.6	8.0	8.4	4.3	5.7	8.8	13.7	17.5	8.1	8.5	8.2	13.2	8.6	10.7	13.6	10.0	4.4	14.9	10.8	9.4	14.2	7.2	16.0	10.6	19.7	20.2	12.5	19.3	7.9	8.0	6.6	20.7	11.0	5.4	9.3	11.1	10.8	9.2	9.4	8.2	19.1	12.0	15.8	7.6	9.1	14.8	8.2	9.5	7.7	18.0	21.2	8.4	9.6	8.9	8.1	11.6	10.9	6.6	7.2	13.6	7.1	20.8	7.5	8.7	8.0	9.8	17.7	10.9	19.0	8.4	12.8	15.5	15.8	3.5	3.0	5.7	6.4	4.6	6.4	18.6	7.2	7.9	4.4	16.8	8.2	8.4	2.5	8.0	3.9	3.1	6.7	4.3	10.2	12.2	18.5	13.1	10.5	16.0	9.8	6.4	11.1	10.4	0.0	18.1	34.7	7.8	7.3	19.8	9.2	2.5	13.4	18.2	12.2	37.3	8.7	0.0	5.7	4.9	4.7	5.9	0.0	4.3	8.0	7.1	6.8	8.1	8.6	6.7	14.3	8.7	6.2	7.5	3.6	5.5	9.8	3.3	6.4	5.7	8.7	5.6	3.5	7.4	5.8	43.3	6.5	7.5	19.9	21.7	7.5	9.8	13.8	6.3	5.8
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764558	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	18.9	10.1	13.3	12.7	20.4	40.1	16.6	19.7	27.3	14.0	11.5	10.3	12.1	9.1	15.4	13.1	12.6	12.2	9.9	21.2	14.9	18.2	12.9	12.0	12.4	14.6	14.5	21.8	19.6	13.3	16.6	21.2	16.1	28.5	14.7	11.6	10.8	12.8	12.2	29.1	14.3	11.3	15.1	16.1	12.3	11.4	17.1	12.6	12.2	19.2	15.8	15.8	26.5	11.4	20.1	20.8	21.6	13.1	9.4	15.7	4.1	11.5	6.8	13.3	10.0	9.9	12.6	9.3	9.5	11.8	9.9	13.5	8.1	5.6	12.9	11.7	9.7	15.4	4.7	15.7	13.6	16.7	7.1	8.4	9.7	7.0	7.6	10.9	25.3	8.3	9.6	14.8	10.4	29.4	13.0	7.6	14.8	14.5	13.0	11.2	7.2	16.1	9.1	10.1	23.4	5.3	10.5	14.1	17.5	9.1	9.1	10.3	15.5	10.7	7.9	18.2	14.2	6.8	10.6	7.8	19.9	28.0	16.1	10.1	26.2	28.5	26.8	14.6	9.7	9.9	21.6	13.1	8.5	12.5	10.3	10.1	16.2	11.9	10.3	8.1	20.1	15.7	12.2	7.1	9.4	11.4	20.8	12.8	4.1	13.3	20.4	19.7	27.3	14.9	18.2	14.5	21.8	28.5	12.6	68.5	25.1	34.8	48.8	62.5	108.1	45.4	17.8	33.5	27.3	43.6	115.8	54.2	58.0	42.6	22.7	38.6	37.3	0.0	41.9	49.2	49.0	53.0	34.6	31.8	35.7	100.1	71.9	33.2	58.5	8.0	67.3	52.8	47.2	39.7	36.5	38.3	46.4	37.6	57.3	53.0	142.0	38.8	52.5	78.5	106.7	59.7	105.7	61.8	39.2	36.6
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111851	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 335.7;Late spermatids: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA		240000			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	19.3	9.7	9.7	16.3	9.7	40.0	15.1	18.3	11.0	13.9	12.6	7.1	14.4	10.1	16.0	14.9	13.3	14.4	11.7	11.9	10.3	5.6	10.5	9.2	17.0	20.5	10.1	6.0	13.7	9.5	11.2	12.2	11.5	10.3	14.2	9.4	9.5	9.4	9.8	7.9	8.5	11.6	27.7	10.7	17.3	12.0	6.6	12.4	24.8	10.9	9.6	11.2	17.9	21.0	5.4	5.3	17.9	5.0	2.6	5.1	2.0	6.4	4.0	4.0	3.9	7.6	8.2	6.6	9.0	4.4	4.0	4.4	6.7	2.8	8.0	6.5	10.6	2.2	5.3	3.6	5.2	8.2	11.3	4.2	6.4	7.4	2.9	3.9	17.6	10.0	5.9	4.8	6.0	4.9	3.3	6.1	3.2	3.6	8.3	4.7	4.1	8.3	3.8	3.4	4.3	6.8	11.8	4.7	3.1	3.9	6.0	4.7	3.7	7.2	4.9	3.6	3.8	4.8	6.7	10.1	8.2	6.8	7.3	7.3	11.4	5.1	9.2	6.1	7.6	5.0	2.8	5.0	6.3	5.1	3.1	4.1	3.7	3.8	3.9	4.0	5.4	3.7	3.6	17.9	2.6	3.6	5.3	3.2	2.0	9.7	9.7	18.3	11.0	10.3	5.6	10.1	6.0	10.3	12.4	89.3	78.4	61.5	52.6	41.1	96.1	123.9	25.5	57.6	86.4	31.4	123.7	47.6	13.3	52.8	335.7	72.9	30.7	0.0	33.3	52.8	65.1	50.5	69.5	41.2	54.5	57.2	95.0	46.1	128.2	390.9	90.3	132.9	62.4	85.6	37.7	47.5	51.9	60.4	130.4	14.9	135.4	168.1	157.5	68.9	76.9	32.0	35.9	96.4	35.1	57.6
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11.0	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28.0	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3.0	3.6	2.2	3.5	3.3	0.9	6.6	16.2	13.4	13.1	24.3	17.1	8.6	15.8	14.8	10.3	10.9	15.3	14.6	8.4	9.4	24.9	12.5	7.4	9.7	9.1	16.3	11.9	5.8	16.7	27.9	30.5	8.7	9.3	4.8	13.3	5.8	12.7	9.1	8.4	16.4	4.6	14.5	3.4	15.3	5.6	6.8	4.8	7.4	14.1	10.0	8.2	29.5	2.7	5.6	18.9	6.3	6.8	31.0	10.8	10.8	10.6	4.4	5.2	22.3	21.3	15.4	8.4	13.8	2.7	3.3	7.5	9.2	11.0	29.6	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3.0	3.5	1.7	3.0	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6	107.2	64.4	9.3	35.3	35.4	33.2	94.7	35.7	41.5	86.4	21.0	55.0	22.5	1.7	25.4	6.5	88.7	62.6	0.0	34.0	15.9	43.2	45.6	26.7	37.6	16.5	76.3	20.4	58.9	19.8	3.5	40.6	24.0	21.9	8.2	82.3	34.2	30.5	38.6	73.9	13.6	42.5	129.4	101.5	21.4	17.7	24.3	26.3	11.4	40.0	38.2
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229319	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 64.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 428.0;Suprabasal keratinocytes: 370.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 16.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.1;U-266/70: 20.1;U-266/84: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009861	Approved					NA	NA					"CAB009861: AB_2180141"	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.6	32.4	8.1	6.0	9.8	12.2	12.0	29.8	17.0	7.6	6.1	4.8	11.9	2.7	7.5	6.7	14.8	5.4	8.1	6.7	8.7	4.2	11.2	23.1	10.0	5.9	7.8	7.0	8.9	11.8	11.8	10.3	4.1	10.0	5.4	3.5	9.1	7.8	12.0	34.6	64.8	6.2	7.8	11.0	7.7	5.5	11.2	9.3	1.5	11.1	9.9	8.8	8.9	10.3	0.8	0.4	0.3	0.0	3.7	16.9	2.6	0.0	0.4	1.3	0.0	1.7	0.8	0.4	0.6	0.7	0.5	0.7	0.8	0.2	0.0	0.3	1.6	1.7	0.2	2.9	1.2	1.0	1.3	2.4	0.0	0.1	1.3	0.6	0.0	0.1	3.8	0.3	1.6	0.0	0.5	5.5	5.3	0.1	35.1	2.4	0.1	0.3	0.0	1.0	0.8	0.5	0.0	1.1	0.5	1.1	0.2	0.9	2.1	0.1	0.3	0.0	3.7	0.0	0.0	0.1	4.9	2.2	2.0	0.0	20.1	27.8	0.1	8.3	0.0	0.5	0.1	0.0	0.0	14.7	0.0	16.9	0.8	11.1	9.9	0.0	0.1	3.5	7.4	0.3	3.7	0.0	0.4	9.3	2.6	8.1	9.8	29.8	17.0	8.7	4.2	7.8	7.0	10.0	9.3	38.7	31.4	12.3	26.8	164.5	162.1	20.4	28.1	16.0	22.7	55.8	428.0	0.5	11.6	15.3	133.0	32.2	1.0	23.3	10.8	1.0	44.1	23.1	2.3	75.9	0.7	119.2	17.7	31.9	6.6	58.8	43.1	8.9	57.3	1.0	2.0	48.1	11.9	0.0	82.0	34.9	155.0	38.8	31.6	1.4	2.4	370.0	3.9	142.8	1.5	50.2
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.3	3.9	6.8	6.3	5.6	7.2	5.8	5.0	3.5	3.3	2.7	2.8	2.9	9.5	8.7	3.7	4.5	4.4	5.6	3.2	5.1	6.5	4.0	5.8	7.0	3.7	3.3	10.0	5.8	3.7	4.0	4.2	4.1	4.9	3.5	5.9	5.9	6.4	5.0	3.3	8.4	6.3	5.3	3.6	4.4	6.3	9.0	4.1	4.3	5.7	6.4	4.7	8.1	7.5	4.0	5.3	3.9	7.7	6.1	5.0	6.4	5.7	7.1	6.2	7.1	5.0	3.5	6.3	3.4	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7	59.6	66.2	8.2	15.1	8.1	55.5	21.2	5.1	75.0	68.2	7.0	104.1	17.6	10.0	16.4	39.3	17.1	7.7	23.3	11.9	12.3	13.6	12.8	59.1	7.4	8.5	33.4	12.1	8.0	10.8	4.7	17.5	8.8	1.7	15.4	11.9	39.3	12.8	10.7	20.1	13.0	87.8	25.8	12.0	18.9	18.8	8.5	19.8	24.2	11.1	9.8
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 85.8;monocytes: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.9;U-937: 32.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.9	3.5	2.8	3.7	0.1	0.0	3.8	0.8	1.6	4.2	4.1	4.0	8.2	18.5	4.6	0.5	5.1	11.7	6.4	22.9	3.0	15.3	4.1	20.3	8.6	7.1	1.3	23.9	29.9	0.7	8.4	3.9	7.0	1.9	1.8	7.4	3.4	6.7	0.2	5.5	0.8	23.6	7.3	19.3	11.1	12.8	3.6	8.1	12.1	2.7	4.1	1.6	7.0	6.6	3.2	3.1	4.2	20.6	1.2	0.2	5.4	0.7	3.3	4.2	4.9	10.1	2.5	32.2	4.1	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0	14.9	23.5	13.7	7.4	16.6	1.3	1.2	10.2	10.7	5.7	8.7	3.9	1.2	6.6	15.5	1.8	4.2	85.8	0.0	16.3	14.5	1.9	13.9	32.2	3.8	43.9	0.0	15.6	12.3	57.1	0.5	0.0	36.8	1.7	68.5	34.3	0.4	21.8	41.9	0.0	13.6	1.7	6.5	2.1	1.1	2.7	10.2	3.4	41.5	32.9	6.8
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0.0	3.9	5.7	48.4	35.5	0.0	4.1	8.1	2.3	3.2	0.0	1.2	0.2	1.3	14.6	1.8	1.7	2.0	9.0	2.1	0.8	0.5	0.0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0.0	0.0	9.5	0.4	0.1	0.4	1.0	1.9	2.3	0.6	2.0	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1.0	0.1	3.0	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0.0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10.0	12.8	12.0	47.2	0.5	0.0	20.9	0.2	8.0	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5.0	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3.0	0.2	1.3	1.2	5.8
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.9	22.7	8.6	4.4	8.4	14.8	2.6	11.2	17.1	8.4	11.6	25.7	16.7	8.5	3.9	11.8	12.3	9.2	9.8	9.5	15.7	7.1	7.8	10.0	14.3	69.0	8.6	19.5	10.4	9.4	7.6	13.2	16.7	7.4	30.4	9.0	6.6	24.4	8.8	6.1	12.6	6.0	6.2	16.9	13.7	6.7	18.2	9.8	7.3	10.9	4.0	3.9	15.1	4.6	16.4	11.2	0.0	5.8	16.9	9.2	6.4	29.1	6.3	19.5	11.9	9.5	17.4	9.7	21.7	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7	41.7	68.2	18.2	31.8	48.3	33.6	19.4	38.2	21.4	51.2	15.7	21.6	3.3	3.3	23.3	0.1	48.1	43.4	0.0	26.0	5.7	28.8	47.0	42.8	61.1	20.6	12.7	24.0	29.4	46.1	1.1	12.0	60.4	35.4	20.8	53.4	26.6	30.0	46.0	19.8	23.7	8.7	19.4	35.0	3.3	7.7	48.6	3.0	56.7	46.1	54.2
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	28.1	15.8	2.3	5.7	5.1	4.8	32.6	15.0	7.9	11.8	5.8	15.6	14.8	2.9	17.5	8.6	15.0	26.1	2.7	12.2	5.8	8.9	5.3	6.6	13.5	7.9	5.1	6.7	12.4	4.7	11.5	10.0	8.2	4.2	7.1	5.4	2.7	4.1	5.9	25.8	6.0	10.5	2.5	10.9	33.3	11.8	9.4	9.4	8.1	13.0	3.4	2.7	15.5	9.5	13.0	3.4	11.1	8.3	14.1	16.1	20.2	29.0	13.3	4.9	3.8	2.9	10.6	7.7	8.1	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5	3.0	4.0	5.7	4.6	10.8	6.3	11.8	5.1	0.0	1.2	3.5	3.9	60.8	5.0	13.7	0.2	7.4	17.0	0.0	21.8	31.5	9.1	7.1	19.5	6.4	26.9	7.9	8.1	11.6	29.2	0.7	10.3	15.3	8.5	12.6	11.6	3.1	40.7	10.7	6.3	7.3	2.0	0.0	9.2	0.7	7.2	9.4	39.0	8.7	13.9	8.5
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847862-91060636	"Enzymes, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 86.9;Syncytiotrophoblasts: 93.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.1;SK-BR-3: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	4.9	2.4	8.3	13.0	21.6	5.8	16.3	32.9	12.2	7.0	11.0	12.0	4.2	9.3	11.8	2.6	11.9	8.9	6.7	6.1	9.0	7.9	4.5	4.1	6.1	7.3	12.8	9.7	10.2	4.9	12.0	6.9	14.9	11.0	8.0	11.7	2.8	8.7	9.9	14.3	6.6	9.8	19.4	17.1	7.4	9.8	5.2	13.7	4.8	8.6	7.8	7.7	11.6	7.3	5.8	2.5	20.0	3.2	8.4	7.1	2.2	1.2	1.7	2.0	1.3	0.0	0.4	8.7	0.7	1.1	2.3	3.4	0.9	2.3	5.9	2.5	2.2	1.6	3.8	1.7	1.7	4.8	0.9	3.1	5.9	1.7	0.2	0.0	5.8	30.1	0.5	3.6	1.4	1.1	0.5	2.5	4.1	0.6	6.7	2.3	2.5	1.8	2.9	0.6	3.7	2.7	3.2	9.6	3.0	2.5	2.2	10.1	3.2	2.5	15.1	8.5	1.8	2.9	1.9	0.5	0.7	1.3	0.6	2.9	2.9	2.8	5.1	1.4	4.3	9.5	10.5	2.7	7.8	3.6	2.1	5.9	4.4	4.8	3.5	2.5	5.8	5.6	3.0	20.0	8.4	3.2	1.0	7.1	2.2	8.3	21.6	32.9	12.2	9.0	7.9	12.8	9.7	11.0	13.7	17.9	27.4	40.7	37.9	35.8	29.4	14.1	12.7	37.5	29.6	7.0	15.7	31.0	0.0	8.9	5.5	19.6	27.6	0.0	4.6	4.7	13.2	25.2	86.9	6.8	6.4	25.4	15.6	14.1	16.1	2.1	13.0	16.9	18.6	2.8	17.9	12.9	3.0	11.5	11.0	2.8	29.2	12.9	27.6	13.1	23.7	40.5	93.5	39.5	18.8	42.3
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.7	3.6	0.0	3.4	3.4	0.0	7.7	4.1	3.4	2.9	2.8	3.0	0.0	0.0	4.1	0.0	0.1	9.1	6.1	8.1	0.0	4.6	0.0	0.1	0.0	3.1	0.0	0.0	1.9	0.0	0.0	3.8	3.8	0.8	0.0	0.0	0.2	2.7	0.0	1.3	0.1	11.0	0.0	11.9	0.0	14.6	0.0	0.6	8.5	0.0	11.7	0.0	4.2	0.0	5.2	2.0	0.0	0.0	0.1	4.4	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7	8.9	2.4	2.0	4.4	0.2	19.9	2.0	12.7	6.7	3.4	17.4	23.6	2.1	1.7	0.4	0.4	0.6	3.4	0.0	1.1	0.6	0.3	7.4	0.0	1.5	0.2	1.6	24.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	5.0	2.8	1.3	2.9	5.6	3.3	18.2	0.0	0.6	3.7	6.3	0.4	1.9	0.0	5.3	4.2
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	18.4	18.3	16.6	23.2	19.5	20.5	18.4	25.7	24.2	18.1	18.2	13.1	18.4	13.1	19.6	16.5	25.4	14.5	14.9	14.2	15.7	12.6	13.5	20.0	14.8	17.3	20.3	17.5	21.6	22.3	24.5	18.9	20.3	17.6	16.7	15.0	10.1	17.3	21.5	50.3	15.8	14.1	19.3	19.8	17.6	17.5	10.7	20.0	17.8	16.8	18.4	22.0	18.5	20.8	8.9	12.8	25.9	11.1	9.4	13.5	8.3	10.9	10.6	9.1	8.6	6.3	9.2	6.9	10.1	9.4	8.9	10.0	8.7	5.5	13.2	12.6	8.4	10.7	5.7	12.0	9.1	14.4	7.3	13.4	9.0	6.9	9.9	9.3	13.9	9.1	9.4	7.0	10.3	7.6	7.4	11.6	8.5	11.9	8.5	6.6	76.1	16.5	5.9	6.1	9.6	8.2	9.8	15.4	12.3	7.4	8.1	6.6	8.0	8.5	5.0	5.4	11.0	9.8	7.7	10.0	8.7	14.5	7.0	13.4	15.4	13.0	14.9	6.6	8.6	6.9	25.9	10.1	9.0	11.4	10.2	13.5	8.9	10.5	13.0	12.8	8.6	12.3	12.9	10.0	9.4	11.1	8.0	9.5	8.3	16.6	19.5	25.7	24.2	15.7	12.6	20.3	17.5	17.6	20.0	20.8	32.2	20.1	17.7	29.3	16.3	13.7	17.8	25.4	38.7	3.5	17.7	20.8	3.3	10.9	2.6	18.8	10.1	0.0	14.1	15.1	21.8	21.4	22.0	12.4	10.6	17.5	12.7	11.1	14.8	2.1	14.7	18.0	10.1	16.2	16.1	11.9	13.7	10.5	17.0	7.2	18.5	25.8	22.8	11.1	13.1	28.0	25.5	20.3	13.4	24.3
RPS6KB2	"KLS, P70-BETA, p70S6Kb, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435408	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	8.7	14.1	8.5	12.8	9.2	18.0	11.2	12.9	11.5	13.1	13.0	12.5	12.3	19.8	10.2	10.1	36.1	11.0	10.7	10.7	8.8	4.2	11.3	27.8	10.7	12.0	11.4	8.7	9.5	18.7	9.6	11.7	13.8	8.7	17.2	9.9	11.7	18.1	15.8	25.0	41.4	17.7	8.8	7.6	18.6	17.1	7.5	8.8	21.8	11.4	28.6	21.8	10.1	15.6	15.7	27.1	16.4	28.3	17.8	20.7	20.2	21.3	16.2	8.9	15.0	4.1	8.0	11.7	10.3	13.0	19.4	13.5	25.3	14.4	7.9	18.0	10.1	12.1	16.0	10.0	15.8	7.8	13.6	26.6	12.7	20.7	20.6	14.0	16.1	15.7	10.1	16.6	10.2	10.5	4.9	14.4	21.0	20.4	21.2	9.7	32.8	24.7	25.3	9.5	31.4	20.9	18.3	12.3	37.5	9.0	12.3	13.4	14.4	10.7	29.7	22.1	5.4	34.9	13.4	6.0	10.1	10.8	24.5	11.5	19.0	15.6	12.7	16.6	10.1	12.7	9.7	22.6	16.4	15.7	25.2	15.9	15.7	14.9	15.3	27.1	14.3	10.9	11.9	15.1	17.8	28.3	18.7	20.7	20.2	8.5	9.2	12.9	11.5	8.8	4.2	11.4	8.7	8.7	8.8	8.9	18.6	37.3	23.0	44.3	24.7	1.1	40.8	4.0	9.1	7.0	9.8	63.1	36.5	40.3	10.4	15.8	75.3	23.3	56.9	74.1	22.2	38.7	27.6	48.6	53.5	31.8	44.4	16.0	37.6	22.0	18.7	27.9	18.6	55.1	53.9	19.0	40.6	63.3	16.3	27.7	26.0	19.4	22.7	13.1	13.8	55.7	86.6	44.9	49.3	30.7
RPS6KC1	humS6PKh1	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274773	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	12.0	14.1	15.6	10.0	19.4	6.4	17.1	13.5	19.4	14.1	13.1	12.6	8.8	9.2	15.9	8.4	10.3	11.8	11.6	9.4	17.3	15.6	9.8	10.8	13.6	7.5	17.8	16.8	14.4	13.5	19.9	16.7	12.3	15.3	17.6	10.1	7.3	8.9	17.7	14.1	6.7	8.7	18.5	22.3	11.0	12.5	26.5	13.2	6.8	10.4	6.1	7.8	14.6	16.0	2.5	8.7	13.7	6.8	4.0	3.3	2.2	7.3	6.4	10.5	11.3	10.5	15.6	9.2	9.7	14.3	15.1	17.4	5.2	8.2	4.7	6.6	14.6	9.9	6.1	12.7	7.9	11.5	9.8	4.7	12.6	7.5	7.1	9.7	7.9	15.0	10.2	6.9	13.2	7.2	12.7	12.5	4.6	16.2	7.3	15.4	4.0	3.3	2.6	15.2	6.6	7.2	3.9	9.9	4.5	6.9	7.4	6.1	15.9	10.5	8.3	13.9	18.7	11.9	3.3	11.6	10.3	9.5	11.8	6.3	4.3	8.2	3.6	4.4	3.1	10.5	13.7	4.6	3.3	2.8	6.8	2.3	2.5	2.3	2.4	8.7	1.9	1.5	3.3	0.5	4.0	6.3	1.0	1.6	2.2	15.6	19.4	13.5	19.0	17.3	15.6	17.8	16.8	15.3	13.2	8.9	4.3	1.4	2.2	2.6	17.1	8.9	7.6	4.0	4.5	0.0	13.7	2.6	0.0	4.4	25.9	6.5	4.0	0.0	6.8	3.3	6.9	4.5	7.0	8.1	6.1	19.1	3.5	10.4	8.6	33.0	10.3	9.8	6.8	6.4	3.2	6.6	5.4	2.8	7.1	4.6	18.9	12.9	5.1	13.4	17.2	3.9	3.2	5.1	3.7	2.6
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266207-100292769	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		8700	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	20.9	25.0	19.4	17.8	24.9	25.5	20.0	22.6	31.7	14.7	22.9	20.3	19.9	31.7	14.2	26.0	27.0	13.4	19.9	25.5	20.0	21.0	31.7	23.0	16.1	21.8	21.5	20.7	13.3	27.7	21.1	17.2	21.2	33.1	20.9	22.2	14.1	18.5	17.4	35.4	14.6	37.8	15.4	20.5	24.2	21.8	12.2	12.4	25.0	18.3	20.2	20.8	18.7	17.5	9.6	8.0	8.2	19.6	11.0	20.1	7.7	22.0	11.4	11.3	15.2	14.3	23.3	30.9	26.2	12.8	17.1	14.8	18.6	11.1	22.6	19.9	16.6	21.1	11.2	13.8	12.4	20.7	22.6	11.5	14.9	13.0	23.4	22.1	27.1	23.6	18.9	19.6	22.3	29.9	17.0	21.2	16.5	25.6	34.5	25.8	7.3	13.9	21.1	17.3	15.7	22.1	10.0	20.2	9.9	21.0	18.1	9.1	11.4	16.9	24.5	35.8	18.5	5.3	34.8	18.4	16.2	11.3	25.2	31.4	20.0	20.1	18.1	34.0	23.6	9.6	8.2	9.1	7.5	10.8	11.3	13.8	9.6	10.0	12.8	8.0	7.1	9.3	10.5	4.4	11.0	19.6	7.6	20.1	7.7	19.4	24.9	22.6	31.7	20.0	21.0	21.5	20.7	33.1	12.4	6.0	14.4	26.1	13.0	12.0	22.2	49.6	7.6	13.4	10.3	17.4	11.8	48.9	21.6	37.0	11.5	17.5	35.4	0.0	30.2	65.3	13.9	14.2	12.7	15.3	69.5	20.6	18.5	22.7	41.9	6.4	17.8	28.9	15.1	50.5	26.6	20.6	46.7	37.1	12.0	49.6	26.8	6.5	12.3	27.2	14.7	12.8	38.8	32.0	29.7	15.7
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 186.8;Kupffer cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HaCaT: 27.4;RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.6	15.8	2.0	5.0	3.6	3.3	24.3	3.0	3.5	4.4	2.5	8.8	8.8	0.0	8.3	4.4	3.8	27.4	0.7	10.7	0.2	8.0	2.0	0.0	19.3	13.3	4.6	6.6	2.4	5.4	4.6	5.5	2.6	0.6	3.7	0.9	10.9	0.5	1.0	15.1	0.5	1.4	3.8	4.1	5.5	2.9	7.5	10.9	0.2	24.4	4.5	2.0	9.6	9.2	2.4	0.1	12.8	9.0	4.8	5.4	6.5	5.7	2.7	0.7	0.0	0.1	4.1	6.7	3.5	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1	29.8	22.2	2.2	14.1	30.7	3.8	30.8	79.0	8.1	21.6	8.7	23.6	24.3	1.7	11.9	4.5	17.5	46.7	23.3	12.2	27.0	17.3	15.8	1.1	186.8	29.1	31.8	9.2	72.4	115.8	14.1	30.0	27.5	11.8	5.4	24.8	42.2	14.1	34.5	19.8	16.2	21.2	19.4	17.9	0.7	12.3	40.9	20.0	13.1	23.9	26.0
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	20.1	17.8	26.7	22.8	30.5	24.0	18.6	21.9	45.9	23.6	50.1	17.6	21.6	14.0	30.2	13.1	27.5	21.3	17.1	22.5	21.2	23.9	14.6	16.0	19.2	30.6	20.4	34.6	19.0	14.4	28.0	13.9	26.8	24.3	20.2	27.3	20.9	15.7	28.6	24.1	19.0	20.1	38.5	15.9	25.8	30.5	60.2	16.2	32.7	37.5	17.2	37.5	33.0	25.8	19.1	22.3	22.8	19.0	35.2	41.3	29.4	36.2	39.8	62.5	29.8	21.5	25.3	21.2	44.9	39.2	50.7	62.0	34.2	24.2	43.7	17.7	36.0	26.9	17.3	64.0	28.3	55.2	36.6	46.5	42.5	26.9	39.0	23.7	47.0	26.5	18.8	14.6	27.7	29.9	20.0	48.5	31.5	50.5	22.1	47.8	29.1	30.8	129.8	31.2	39.3	21.3	48.5	41.9	17.9	22.7	43.0	24.7	27.2	46.0	31.7	27.1	35.8	25.9	28.7	25.2	26.7	30.7	17.5	48.2	27.6	80.2	62.1	18.8	39.1	39.0	22.8	19.0	10.4	23.0	16.9	24.8	19.1	29.0	23.2	22.3	15.7	41.3	31.3	7.9	35.2	11.3	15.0	33.5	29.4	26.7	30.5	21.9	45.9	21.2	23.9	20.4	34.6	24.3	16.2	8.9	16.0	34.0	28.7	22.8	17.8	18.6	7.6	4.0	10.3	12.2	5.9	57.7	10.0	35.8	11.1	31.4	10.5	23.3	30.4	80.2	33.8	28.6	15.0	17.4	48.9	19.1	18.5	20.3	19.0	12.8	14.4	20.0	43.9	71.3	22.5	18.0	30.8	14.4	17.7	11.5	15.0	51.8	35.6	95.2	109.0	21.5	48.1	33.2	28.3	25.8
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 54.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.3	8.7	8.9	10.4	11.3	18.0	7.8	12.2	14.1	9.7	9.3	13.8	6.6	8.2	11.7	9.5	9.9	9.4	8.2	8.0	9.6	8.5	6.8	7.8	7.9	9.1	9.7	9.0	11.6	8.4	16.3	13.8	10.4	9.6	9.1	9.8	8.8	11.3	8.5	10.5	11.6	8.9	10.3	8.9	8.3	9.0	50.3	9.9	17.1	8.8	6.9	11.9	9.9	9.5	5.8	6.8	15.6	8.5	3.5	6.2	3.5	20.5	11.4	21.5	17.3	14.3	9.9	23.6	13.2	12.9	20.5	16.2	27.0	8.6	17.3	11.9	14.8	10.7	14.5	23.7	13.6	21.3	9.6	15.2	17.1	10.3	21.0	17.2	14.8	13.6	9.3	10.2	27.0	17.0	10.8	16.3	14.6	20.7	12.8	17.1	23.0	20.5	11.7	22.2	12.2	12.8	14.2	17.7	11.5	10.9	18.3	11.4	13.7	13.9	13.2	8.2	14.2	9.9	10.2	13.9	19.8	21.6	18.4	13.9	18.0	17.7	20.6	16.3	10.1	12.7	2.4	4.2	4.8	6.2	3.0	4.8	2.4	4.4	4.0	3.7	5.8	3.2	3.5	15.6	3.5	8.5	6.8	3.0	3.5	8.9	11.3	12.2	14.1	9.6	8.5	9.7	9.0	9.6	9.9	0.0	10.4	3.2	1.9	7.0	4.2	11.9	5.1	4.0	1.2	1.8	7.9	9.4	0.0	3.7	54.0	5.3	6.6	0.0	4.1	10.7	4.7	4.4	1.1	5.1	6.6	7.9	6.4	7.4	11.0	34.3	7.8	5.7	5.0	1.0	6.5	4.1	4.3	7.0	7.8	2.9	5.8	6.5	5.0	17.9	16.6	9.2	16.1	5.0	6.6	3.0
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6"	"Cell type enriched"	"Detected in many"	8	"Cone photoreceptor cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 1.4;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 306.7"											NA	NA						"unprognostic (5.15e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.9	2.0	8.0	1.8	7.3	2.0	1.7	31.1	17.5	1.7	1.2	1.5	0.0	1.1	1.9	1.3	1.5	1.6	1.0	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6.0	4.0	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1.0	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0.0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.3	11.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.3	0.3	4.6	0.1	0.0	1.5	0.5	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	5.8	0.0	1.0	0.0	1.8	7.0	0.1	15.8	1.0	0.1	16.7	0.8	0.1	0.1	0.9	24.3	22.9	0.4	1.4	0.2	1.9	1.7	0.0	0.4	0.0	2.4	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.9	0.2	0.1	0.1	4.3	0.0	1.4	0.0	1.2	2.4	0.0	0.2	1.4	3.0	0.1	1.4	0.1	0.2	1.4	0.4	8.0	7.3	31.1	17.5	9.9	5.6	6.0	4.0	8.3	3.1	3.0	0.3	0.0	0.8	0.6	9.4	3.1	2.5	2.7	3.4	0.0	76.6	0.0	1.7	6.1	1.0	0.0	0.0	0.0	4.8	0.0	0.4	1.5	0.0	0.2	0.1	0.0	5.8	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.3	4.2	4.7	0.0	0.0	0.5	2.7	0.0	0.3	1.4	2.3	0.1	0.1	2.5	0.8	0.3
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060889-238099413	"Enzymes, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 82.6;Late spermatids: 106.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		110000	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	4.1	3.8	6.0	6.3	7.4	5.3	3.6	10.2	7.4	4.3	6.3	11.1	5.7	9.8	8.4	8.3	4.5	4.6	5.4	6.5	7.3	6.8	9.9	24.1	4.0	6.5	9.6	4.7	6.3	22.7	5.2	5.1	2.6	6.6	5.0	4.3	6.4	4.5	5.6	5.1	2.8	9.6	5.1	9.4	5.6	3.9	15.3	6.1	8.9	8.1	6.3	5.3	4.6	4.0	5.0	5.7	6.9	5.6	4.2	8.1	4.3	5.7	9.7	6.2	16.6	5.0	3.4	12.6	5.8	2.9	6.2	7.6	6.4	4.7	9.6	1.7	3.3	19.9	8.4	24.3	12.4	5.9	10.9	21.8	11.1	13.0	22.0	9.4	9.2	9.6	3.8	6.1	11.6	13.3	2.6	11.5	13.3	19.3	2.7	6.3	8.6	9.1	16.9	20.1	8.0	8.1	10.7	12.0	9.5	5.9	2.0	7.1	15.1	6.4	10.3	10.4	4.8	3.2	13.6	4.9	9.4	6.1	12.4	12.4	6.8	6.2	4.8	5.8	18.7	7.4	2.0	5.3	6.9	4.7	4.3	3.7	5.0	5.7	8.1	5.7	3.5	4.3	4.2	0.9	4.2	5.6	1.2	5.3	4.3	6.0	7.4	10.2	7.4	7.3	6.8	9.6	4.7	6.6	6.1	0.0	0.0	3.7	1.9	1.4	5.3	2.4	0.0	1.4	0.0	0.0	7.9	1.1	3.3	4.4	82.6	2.7	2.1	0.0	3.2	1.4	1.9	1.0	0.0	2.4	3.4	6.4	2.4	1.3	0.0	106.4	2.8	2.0	1.7	2.8	2.6	2.3	2.7	5.8	0.0	1.7	6.1	0.0	1.7	6.0	4.8	1.4	0.6	2.2	2.8	1.4
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	18.9	21.9	33.1	18.2	29.1	13.2	40.9	58.0	38.9	21.7	20.7	15.4	22.1	14.0	24.0	27.0	20.7	22.0	18.4	18.3	29.6	13.8	15.4	22.1	26.5	29.8	23.0	30.1	29.7	22.7	25.6	31.4	23.0	25.1	20.6	20.4	16.7	22.3	22.7	16.6	29.0	19.8	24.1	22.8	22.5	18.7	21.3	26.6	21.0	25.9	14.8	24.2	20.4	37.5	3.7	4.0	4.7	2.0	4.3	4.1	1.0	9.9	12.0	24.7	11.2	14.6	15.2	59.0	9.8	13.3	14.3	16.5	11.9	12.4	21.7	5.9	14.3	12.6	8.3	23.0	13.0	15.8	15.3	11.4	21.2	20.2	11.0	14.9	16.2	14.1	14.7	21.2	21.6	25.7	14.8	15.1	15.4	20.8	14.3	12.2	14.6	14.3	13.5	18.7	7.6	9.7	16.6	19.5	9.6	11.2	16.1	9.9	15.4	14.3	11.8	8.9	23.0	15.8	11.9	17.9	15.1	17.3	8.1	11.7	10.4	13.0	36.2	10.8	11.7	14.1	2.3	2.0	1.7	3.8	1.2	2.5	3.4	2.5	4.1	1.3	3.7	2.4	2.2	4.7	4.3	1.4	4.0	1.0	1.0	33.1	29.1	58.0	38.9	29.6	13.8	23.0	30.1	25.1	26.6	38.7	45.3	34.4	46.5	83.5	109.6	20.7	48.4	56.2	59.1	40.1	108.0	31.2	3.3	31.7	6.2	57.1	35.1	0.0	29.5	33.8	55.5	67.5	46.2	41.4	21.1	52.4	60.0	57.1	28.8	7.5	61.9	31.1	42.2	30.7	47.0	38.4	36.6	45.6	50.5	9.8	62.8	12.9	58.0	37.5	39.3	79.9	47.9	50.7	42.2	63.9
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 455.4;Syncytiotrophoblasts: 484.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.8	2.2	1.0	12.6	26.3	16.5	13.5	1.9	1.7	2.1	1.9	13.0	8.1	0.4	1.1	2.0	12.2	0.0	0.5	0.1	31.4	1.4	51.2	0.1	1.1	13.2	12.6	16.2	21.0	6.6	27.6	0.3	4.0	32.0	5.9	0.1	0.1	0.4	0.8	3.2	1.3	0.4	1.5	0.2	78.5	0.2	0.3	3.1	39.6	0.1	50.9	7.6	0.1	0.3	61.1	4.8	2.1	29.5	2.7	6.0	56.0	6.5	4.5	1.9	6.5	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1	35.7	233.2	40.3	98.2	162.8	10.8	19.4	96.8	24.1	99.0	64.6	33.4	39.9	18.3	60.3	7.2	107.9	230.9	0.0	151.5	27.8	58.7	45.7	257.3	17.5	283.4	0.0	10.2	455.4	148.5	5.6	14.1	322.4	254.8	6.4	46.9	4.3	52.7	129.6	14.9	92.1	28.6	12.9	39.1	48.4	7.5	101.6	484.9	9.6	6.4	68.4
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.1;kidney: 39.1;liver: 32.9"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1.0	10.2	1.4	21.3	33.1	0.9	17.8	1.0	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0.0	0.9	1.8	0.4	3.2	20.7	1.0	14.2	0.7	11.9	1.0	6.0	0.0	1.0	0.2	0.2	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	8.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	10.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	34.0	0.0	0.0	0.0	0.0	14.7	1.7	0.1	0.4	0.0	0.7	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	9.9	1.0	10.2	4.3	2.5	6.9	5.1	13.7	6.0	0.0	0.0	0.0	0.1	0.1	0.8	2.2	12.7	0.0	0.0	10.4	0.0	3.4	64.6	3.9	0.1	0.1	26.9	0.0	5.4	1.0	0.2	0.1	0.0	26.9	0.6	6.4	1.7	1.3	1.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	2.6	8.4	0.4	15.7	0.8	0.0	0.0	0.0	0.2	0.1	14.3	0.0	5.9	0.1
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 9.0;Horizontal cells: 9.5;Ito cells: 9.2;Sertoli cells: 12.9;Smooth muscle cells: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.1;RPMI-8226: 13.4;TIME: 15.6;U-266/84: 18.2"	"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.5	6.4	4.9	0.0	2.8	8.3	2.2	0.8	0.7	0.0	0.0	2.2	2.0	0.5	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	14.1	0.0	0.0	8.5	2.0	9.7	4.4	1.2	7.8	1.5	0.0	8.0	4.9	0.0	0.0	4.3	0.7	0.0	8.1	1.7	0.0	13.4	0.0	0.0	0.5	1.7	0.0	0.0	0.3	0.1	0.1	0.0	15.6	2.8	8.3	7.9	3.6	2.7	18.2	0.0	0.0	4.2	3.8	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9	0.0	0.0	0.0	0.2	1.6	0.1	9.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.5	2.0	3.8	0.0	0.0	0.2	0.1	4.1	0.2	0.0	0.0	3.6	9.5	1.7	9.2	3.7	3.6	2.0	0.5	5.0	0.0	0.2	0.8	0.1	0.0	2.8	0.8	0.0	12.9	10.8	0.7	6.6	0.6	0.1	0.0	0.0	0.0
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	10.9	7.3	8.3	11.0	10.0	5.5	10.4	38.0	11.5	10.6	8.0	4.5	10.8	6.0	14.1	9.2	8.5	9.8	6.7	7.2	7.2	4.2	8.4	6.5	7.1	9.0	7.6	5.9	18.8	8.7	11.4	19.7	6.6	8.5	8.3	7.4	7.3	10.2	13.7	11.4	13.9	8.2	11.0	10.3	8.8	8.5	10.7	8.7	8.4	12.5	7.2	8.0	10.7	11.5	6.7	4.8	4.4	2.4	3.4	4.3	1.2	3.0	2.3	11.7	6.8	5.4	5.8	5.6	3.6	2.9	4.5	5.8	5.3	2.1	10.6	4.5	2.7	3.5	5.2	7.1	5.1	5.9	4.7	8.1	10.7	5.3	4.4	4.0	22.4	6.7	4.0	5.9	4.2	6.2	4.4	4.8	7.6	14.8	6.0	3.8	2.7	14.4	8.3	7.8	5.0	4.1	10.4	18.1	3.6	6.1	3.0	9.6	6.7	6.4	5.9	4.0	8.4	3.1	10.8	5.3	2.9	5.4	5.6	4.2	4.9	7.0	12.7	3.0	9.6	4.4	1.6	2.3	4.4	4.3	2.4	3.7	3.9	3.6	2.9	2.7	6.7	4.1	3.3	0.1	3.4	2.4	4.8	3.3	1.2	8.3	10.0	38.0	11.5	7.2	4.2	7.6	5.9	8.5	8.7	26.8	18.9	20.8	15.3	18.8	113.2	15.9	17.8	12.0	23.9	21.0	198.3	12.7	6.6	15.4	8.3	19.7	10.0	0.0	11.1	5.8	14.4	13.4	12.7	14.8	10.2	89.0	18.5	14.1	21.8	5.1	46.9	15.5	13.5	15.4	14.3	57.4	13.0	10.5	32.2	4.5	175.4	71.1	21.7	76.9	67.5	17.2	5.5	20.3	15.0	9.6
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	79.9	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	29.8	0.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.7;Enterocytes: 65.0;Paneth cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.6;ASC TERT1: 32.9;HSkMC: 35.2;OE19: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		1800000			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	9.0	12.3	9.0	6.7	13.4	1.9	8.2	8.2	16.8	7.0	46.7	15.7	7.3	16.8	5.9	17.8	10.2	9.9	8.4	23.0	10.3	17.6	42.5	28.3	10.7	2.8	18.2	8.1	5.1	11.2	32.4	13.1	7.8	31.4	10.7	51.7	9.9	15.9	8.3	17.3	6.7	25.5	5.4	19.9	7.9	9.3	5.6	8.1	1.9	46.1	11.1	7.0	9.8	4.7	2.7	4.1	8.6	5.8	1.2	4.3	3.2	3.0	4.7	2.8	12.1	31.6	32.9	7.4	5.8	8.2	1.5	0.9	3.6	21.0	1.9	8.5	7.2	3.3	5.9	4.4	6.4	1.5	8.7	1.3	2.9	1.5	3.8	14.9	0.5	2.7	35.2	8.7	3.9	6.0	20.6	10.5	3.8	2.4	13.1	5.0	5.5	0.2	1.3	1.8	32.8	9.8	1.1	0.1	3.2	18.0	4.3	1.0	1.8	15.8	6.5	2.7	8.8	12.7	2.8	11.6	8.4	1.6	9.3	1.4	3.5	2.6	0.4	3.0	1.6	3.4	8.6	5.6	0.3	1.9	4.2	2.2	2.4	3.1	2.0	4.1	2.7	4.3	3.4	1.2	1.2	5.8	2.5	2.2	3.2	9.0	13.4	8.2	16.8	10.3	17.6	18.2	8.1	31.4	8.1	17.9	47.6	2.2	5.0	2.9	6.2	56.7	17.8	12.0	9.1	34.9	0.0	6.7	8.3	9.3	7.8	5.8	65.0	0.0	3.4	7.5	3.3	9.8	1.1	26.0	4.0	4.8	13.9	10.4	3.2	9.8	2.8	2.8	3.3	4.6	27.5	2.3	6.8	57.5	1.1	21.4	1.6	0.0	6.6	12.8	9.1	4.5	5.6	1.0	46.6	6.5
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.6	7.8	16.9	15.1	14.6	12.8	17.3	8.1	11.0	12.1	5.9	5.9	11.3	11.2	9.0	10.2	8.4	10.1	11.6	11.8	14.9	4.5	9.4	6.0	6.1	15.4	20.4	5.9	9.3	15.3	21.3	7.0	16.4	13.5	10.1	10.5	9.7	10.7	9.8	5.9	15.9	12.1	20.6	9.6	12.1	18.6	25.4	11.8	11.2	10.9	19.3	17.1	24.0	12.0	20.7	15.2	7.6	13.7	10.7	12.9	11.7	7.0	8.6	14.0	5.8	20.6	9.6	7.4	11.6	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0	11.9	11.9	16.4	51.3	76.1	18.3	12.0	10.2	9.4	10.3	15.7	7.9	161.7	26.6	21.4	60.8	27.0	18.8	0.0	19.9	25.3	52.6	43.7	4.6	19.5	29.5	33.4	21.7	28.8	18.3	53.9	21.0	23.2	47.2	38.7	18.3	30.7	19.2	14.4	18.4	21.1	16.5	19.4	37.1	68.6	47.5	66.1	624.0	13.4	16.7	38.7
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602391-111730853	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	32.8	10.7	10.1	6.6	17.2	4.0	22.5	10.6	17.3	10.0	9.9	15.1	5.2	7.7	9.5	7.0	7.9	9.7	12.7	14.5	10.5	10.3	14.6	24.4	13.6	5.4	9.7	9.9	16.4	37.8	22.0	28.6	7.5	11.9	8.4	8.3	14.9	15.4	8.6	35.1	8.7	7.7	8.7	9.6	5.8	19.6	4.2	13.0	4.4	11.1	7.9	5.8	8.6	10.0	2.2	2.7	2.8	3.6	2.2	3.5	2.1	5.9	4.0	7.0	7.5	34.8	10.3	4.1	5.2	7.5	4.0	4.6	13.4	6.4	4.7	7.3	6.1	4.7	8.4	5.4	3.9	5.2	3.5	2.3	5.1	3.5	6.6	7.5	4.9	3.3	10.0	5.8	5.8	7.6	8.0	4.7	4.7	4.7	6.9	6.2	2.8	5.1	4.5	2.4	5.0	3.9	6.9	7.4	5.6	8.9	5.4	3.3	7.7	7.7	3.1	3.1	6.6	7.7	4.0	6.5	8.8	5.3	5.6	7.1	2.0	1.5	9.9	2.8	7.0	5.9	1.1	3.3	2.8	3.5	3.6	1.9	2.0	2.5	2.5	2.7	2.2	1.4	2.0	1.4	2.2	2.9	1.5	2.4	2.1	10.1	17.2	10.6	16.4	10.5	10.3	9.7	9.9	11.9	13.0	17.9	32.3	9.1	6.7	13.1	14.4	16.6	22.9	13.4	11.4	15.7	62.8	3.5	5.0	7.1	12.4	18.0	9.5	46.7	6.7	4.1	14.4	5.8	9.2	34.2	4.8	30.2	17.3	9.8	12.4	9.7	10.6	8.6	18.6	2.8	10.2	13.3	9.2	8.6	13.8	20.7	60.3	0.0	13.7	3.2	5.9	10.5	4.3	7.4	9.9	6.5
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"		11	116843402-117098437	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 106.0;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	13.0	12.2	24.7	13.8	36.9	14.3	13.5	24.0	34.4	13.5	16.6	40.5	10.4	10.9	18.6	9.9	13.7	16.6	12.8	16.0	23.7	16.2	13.9	17.6	13.7	11.9	25.8	24.4	22.4	19.5	29.4	18.4	16.3	23.9	11.4	11.7	10.6	11.7	15.6	16.9	11.3	14.0	18.4	17.2	14.2	14.5	26.0	38.0	10.4	22.1	6.9	12.9	14.5	12.9	2.4	1.7	3.9	3.7	1.6	1.8	0.7	7.9	6.1	9.7	10.2	8.4	9.1	15.6	6.0	10.9	4.8	5.4	14.8	9.2	9.4	9.9	11.1	10.6	12.5	8.0	8.7	6.7	25.8	5.1	21.1	6.7	9.1	7.8	7.5	8.3	10.0	5.1	10.2	16.5	6.1	6.4	6.3	10.1	7.0	6.5	2.7	6.7	8.1	5.4	5.4	4.5	8.7	5.6	7.4	6.6	1.5	9.5	7.6	16.3	7.2	3.2	7.8	4.7	8.0	7.3	5.9	7.5	9.8	6.0	5.0	3.6	12.0	5.5	12.4	7.9	3.9	1.1	0.0	1.0	1.5	1.8	0.4	0.9	0.4	1.7	2.4	0.3	0.1	2.6	1.6	3.7	0.1	0.1	0.7	24.7	36.9	24.0	32.2	23.7	16.2	25.8	24.4	23.9	38.0	8.9	26.1	22.2	23.4	23.6	42.8	19.3	12.7	18.7	15.9	5.2	106.0	7.4	5.0	6.7	76.2	16.5	9.7	0.0	6.4	2.6	20.8	17.6	17.3	18.4	6.8	44.5	16.6	14.1	21.4	130.5	9.5	18.7	15.1	4.6	12.0	47.3	7.9	8.6	13.4	5.6	64.0	0.0	20.6	20.4	11.3	21.2	24.8	25.9	10.3	24.3
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	21.0	15.4	14.0	19.4	18.5	31.6	20.4	26.3	15.5	26.3	20.2	19.9	15.3	11.8	26.6	16.8	17.7	22.1	15.9	13.4	14.2	11.8	13.6	13.9	17.4	20.7	13.0	14.2	27.6	19.8	23.4	16.8	17.2	13.0	22.9	14.3	23.0	17.6	20.5	18.2	23.5	17.9	24.5	12.8	20.3	16.8	28.5	15.1	48.7	24.0	12.8	26.9	26.0	19.0	9.8	6.5	9.3	8.3	9.7	12.7	6.3	12.9	26.9	24.1	15.8	12.0	12.7	13.9	9.7	15.2	14.4	15.5	14.8	17.7	28.3	10.2	14.4	19.7	23.3	34.9	14.7	15.8	22.8	18.1	26.7	20.5	11.6	9.1	25.3	22.9	15.4	11.4	16.7	17.5	14.9	12.9	20.3	21.0	31.6	11.6	15.1	24.8	16.3	23.4	17.3	11.3	25.1	31.9	17.4	10.3	23.9	19.1	19.0	24.1	10.8	13.5	24.2	16.4	20.1	11.2	17.9	24.2	11.8	14.4	21.8	34.0	30.1	10.6	25.9	9.9	3.3	4.8	6.9	8.5	4.8	12.7	9.3	10.8	10.7	6.5	9.8	11.1	9.5	9.3	9.7	8.3	4.4	9.5	6.3	14.0	18.5	26.3	15.5	14.2	11.8	13.0	14.2	13.0	15.1	32.8	26.7	28.9	21.6	34.9	19.3	12.6	17.8	29.4	31.8	26.2	29.5	18.2	5.0	13.3	6.8	23.9	11.8	0.0	11.0	9.1	23.6	23.5	29.9	14.3	11.4	19.1	16.6	26.4	23.0	3.1	21.3	20.0	10.1	12.6	17.1	17.2	12.3	15.0	19.1	8.4	31.7	12.9	17.6	37.7	41.7	46.4	18.3	22.3	15.9	16.6
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829400-16880353	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	19.1	17.9	22.2	17.2	28.1	9.8	21.5	25.1	38.6	24.4	16.0	20.8	50.0	12.8	37.5	21.5	14.5	23.3	17.3	15.7	24.2	20.8	15.9	9.8	21.7	20.8	16.5	30.4	32.5	16.2	60.8	17.7	53.2	24.8	22.7	11.0	15.5	20.2	54.7	17.1	22.7	17.7	26.5	14.8	25.1	13.7	30.2	13.4	9.3	22.5	9.6	15.8	17.2	22.2	4.8	2.6	6.1	6.7	1.9	2.0	2.3	14.7	7.9	13.4	17.2	11.1	10.2	42.4	12.6	10.4	17.5	15.6	19.4	13.9	13.3	14.1	14.5	14.8	12.7	11.1	11.3	16.2	13.8	20.0	14.2	17.3	8.8	14.6	8.3	11.5	16.8	14.9	11.7	10.1	13.9	15.8	10.7	11.5	8.2	12.2	17.7	11.2	13.4	16.6	7.7	25.4	14.9	12.3	8.7	9.9	12.6	9.9	12.4	15.9	12.3	9.9	18.8	8.6	7.8	20.7	17.0	10.4	24.5	14.0	11.8	8.6	13.3	11.8	10.9	12.6	0.1	6.7	6.1	1.8	6.0	1.2	4.8	1.7	2.0	2.1	3.8	2.0	1.4	3.3	1.9	5.3	2.6	0.5	2.3	22.2	28.1	25.1	38.6	24.2	20.8	16.5	30.4	24.8	13.4	20.8	14.8	10.7	8.6	7.0	18.1	6.9	2.5	5.3	7.9	3.5	13.7	17.1	3.3	9.2	7.9	11.7	4.7	0.0	7.4	24.5	8.6	10.0	4.7	5.6	15.1	9.5	4.7	8.0	13.0	18.2	46.9	6.6	5.0	10.0	7.9	8.7	12.5	3.5	62.6	4.5	15.7	6.5	6.6	9.3	10.4	7.0	104.5	6.4	5.8	11.2
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 181.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.6	12.7	15.1	10.8	16.4	22.9	6.4	13.5	18.0	10.1	9.5	8.0	23.3	11.5	8.5	13.9	8.6	23.6	8.0	17.1	14.8	9.2	11.0	11.7	10.4	6.7	12.3	13.9	10.1	11.7	22.5	13.6	39.9	14.1	18.1	7.5	14.6	8.0	13.2	7.5	9.7	7.7	3.7	14.0	8.1	9.5	18.6	6.0	13.2	25.0	3.5	6.2	11.7	11.4	11.2	8.0	5.9	10.1	27.3	7.4	7.8	13.6	15.8	9.7	11.8	7.3	11.0	18.8	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8	166.7	108.1	23.8	57.3	50.6	27.3	89.7	28.1	66.9	138.8	41.8	23.6	27.8	3.3	28.4	6.3	53.4	45.3	23.3	46.5	11.5	39.3	60.5	32.5	21.7	17.3	23.8	17.7	41.7	24.0	11.0	43.1	31.1	8.5	37.9	31.8	23.4	61.5	54.9	59.4	11.3	24.1	6.5	34.9	42.3	39.1	59.8	43.8	21.8	29.4	181.1
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	9.7	16.0	34.2	4.0	40.3	4.9	9.8	25.4	36.8	12.9	5.6	7.8	7.9	2.9	8.6	11.4	6.7	14.5	10.7	38.5	22.2	24.7	4.9	2.0	8.3	4.0	18.7	18.8	19.2	7.5	6.8	14.7	4.6	13.3	10.8	3.6	7.6	6.6	18.1	75.2	5.7	3.4	10.0	14.1	4.3	4.8	9.0	11.6	0.0	7.4	9.5	2.5	10.1	4.8	0.2	2.6	3.1	8.8	0.0	0.8	2.1	0.3	2.8	9.4	33.3	15.0	6.7	0.7	6.1	6.2	3.6	2.1	2.1	1.9	3.6	2.2	9.6	1.4	0.6	7.5	0.6	1.4	1.1	4.6	0.0	1.9	0.6	12.9	0.1	6.1	15.9	0.8	1.2	0.1	15.7	0.7	9.3	7.2	1.2	19.0	3.8	0.6	4.7	2.9	0.9	1.2	0.2	14.8	0.1	3.2	0.0	5.4	11.0	5.8	1.0	4.4	1.5	0.8	9.3	1.1	2.3	3.7	7.1	2.0	7.9	0.0	3.0	6.6	8.2	10.3	0.6	8.8	0.0	0.2	1.9	0.1	0.2	0.8	0.0	2.6	0.0	0.5	0.8	3.1	0.0	0.4	0.0	0.7	2.1	34.2	40.3	25.4	27.9	22.2	24.7	18.7	18.8	13.3	11.6	6.0	20.8	0.0	31.9	9.5	12.7	59.6	17.8	6.7	5.7	10.4	3.9	0.4	26.6	14.9	1.8	4.7	0.0	0.0	2.1	0.2	19.3	7.3	2.3	0.4	3.4	11.1	3.4	2.5	17.1	8.9	46.9	6.4	6.8	1.0	0.0	23.4	4.3	0.0	83.1	1.7	4.6	64.7	51.5	1.7	9.5	4.1	0.9	0.9	0.0	8.1
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1, nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804853-18926454	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	4.7	3.0	2.1	4.5	3.5	11.7	6.2	13.2	3.0	4.4	4.5			3.1	5.4	5.1	5.5	4.0	3.0	4.5	2.3	2.2	4.6	5.4	4.1	6.2	2.3		6.3	4.5	7.2	3.9	3.1		4.2	5.0		4.7	3.3	21.1	14.4	5.0	3.9	3.4	4.5	4.3	4.0			6.0		5.8	5.2	4.9	7.1	4.6	19.1	5.6	2.3	6.1	1.0	23.5	15.8	14.9	10.5	17.1	18.1	11.1	11.0	10.9	12.0	13.5	13.9	8.7	32.5	15.9	15.3	12.7	13.4	17.1	9.6	19.2	20.9	10.7	14.8	13.9	17.7	13.9	19.9	11.7	10.6	16.3	24.9	30.0	11.9	16.8	17.7	22.7	18.1	13.2	12.6	13.7	11.9	15.9	8.6	9.1	15.9	20.1	11.1	10.4	18.5	13.5	10.4	17.1	11.6	12.1	12.8	9.3	12.7	21.2	18.1	12.1	11.1	16.3	9.3	12.0	21.4	12.0	15.5	10.8	19.1	2.5	3.4	6.1	2.8	2.9	3.7	4.0	4.3	2.5	7.1	5.4	4.7	7.6	2.3	5.6	4.6	3.7	1.0											71.5	85.2	53.9	67.9	171.7	51.1	42.5	20.4	48.2	92.1	26.2	70.7	16.8	3.3	19.5	15.5	65.3	48.7	23.3	20.4	15.0	55.9	71.2	38.1	39.9	21.0	39.7	37.7	36.8	38.1	15.4	27.6	61.1	37.1	36.1	38.6	20.1	26.6	57.5	24.8	12.2	43.3	45.3	56.7	45.2	29.8	178.7	25.1	60.7	35.2	83.0
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.7	7.9	6.4	4.5	5.1	5.4	9.6	7.7	7.4	6.3	5.9	3.9	11.4	4.3	8.4	7.2	13.9	7.5	3.5	10.0	6.5	3.2	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.8	6.9	9.9	11.5	9.6	5.9	4.2	6.9	7.6	5.8	11.2	4.5	5.4	7.5	7.6	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	11.8	3.1	5.0	8.7	10.0	10.3	17.8	15.4	6.8	4.6	4.5	5.0	5.2	15.4	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8	17.9	28.0	5.2	20.4	23.0	25.8	3.9	20.4	20.1	20.5	12.2	7.9	6.1	1.7	13.9	3.7	10.8	7.8	0.0	13.9	8.0	10.1	31.9	2.3	6.7	5.7	25.4	10.9	7.4	3.1	5.3	5.8	8.5	8.5	4.6	8.7	3.7	25.0	10.5	13.1	4.4	6.9	6.5	15.5	41.5	1.0	19.3	17.6	2.5	7.8	65.2
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542295-64662068	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.2;HBF TERT88: 42.4;LHCN-M2: 42.4;TIME: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA071508: AB_2686406"	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	12.3	9.2	10.5	9.0	15.0	11.5	10.2	16.7	10.0	9.2	9.1	11.5	8.1	9.3	7.9	6.9	7.6	7.8	10.5	8.2	12.6	4.6	9.4	5.7	19.0	8.6	9.5	4.8	8.5	9.0	8.2	10.7	15.3	10.1	10.6	8.2	9.6	9.9	7.6	7.5	11.0	13.7	8.9	6.6	9.9	9.8	21.6	10.6	8.9	11.4	4.1	9.6	9.4	11.7	3.0	3.0	4.8	2.2	7.3	3.5	1.7	15.9	4.4	3.8	2.8	2.6	10.2	1.8	55.2	25.1	21.6	18.8	2.4	12.2	2.1	3.5	9.4	8.5	3.5	3.6	9.5	42.4	1.1	2.4	2.2	2.7	2.9	2.4	2.9	1.4	2.7	3.7	29.9	11.5	13.1	24.9	2.7	3.3	2.1	42.4	3.5	6.8	1.3	2.2	2.5	5.8	1.6	9.2	1.4	5.9	2.8	3.6	3.2	3.4	1.7	2.5	7.3	2.9	2.4	48.9	24.5	13.3	9.4	36.6	2.4	2.9	3.8	6.0	1.7	7.4	2.8	2.2	4.8	3.3	2.0	2.8	2.0	2.4	3.5	3.0	3.0	2.3	2.6	4.4	7.3	1.0	2.6	1.1	1.7	10.5	15.0	16.7	10.0	12.6	4.6	9.5	4.8	10.1	10.6	29.8	21.3	9.5	27.8	38.9	26.4	9.1	7.6	13.4	19.4	8.7	41.2	10.4	8.3	13.5	18.7	24.0	18.8	0.0	8.4	2.7	21.3	22.7	12.7	4.5	12.6	25.4	17.1	43.6	16.7	7.8	11.5	14.0	20.3	4.6	10.3	20.6	18.4	17.3	11.3	7.4	46.8	0.0	20.3	31.2	24.5	34.8	6.1	20.8	11.5	21.8
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 654.8;Proximal tubular cells: 226.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.6	13.8	3.5	11.3	3.0	5.3	3.7	4.3	3.0	9.9	8.4	11.5	8.6	2.0	9.8	5.3	10.7	23.6	18.1	16.4	7.9	34.0	11.2	15.7	18.1	25.3	2.3	27.3	26.4	6.8	12.5	5.7	9.1	4.8	9.3	24.2	17.6	5.6	9.3	6.3	16.5	14.8	13.5	26.5	14.7	0.0	22.8	7.6	7.2	15.3	24.8	13.0	8.9	14.0	6.6	3.9	20.2	11.2	8.3	7.9	7.0	17.6	10.4	1.0	6.9	2.0	12.8	24.1	20.6	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9	0.0	1.9	16.8	20.6	6.9	9.5	2.8	38.2	28.1	28.4	31.4	0.0	1.0	24.9	52.5	26.1	3.8	9.1	0.0	118.4	3.9	5.8	134.4	8.1	654.8	14.4	3.2	81.4	20.9	21.2	17.1	3.4	8.2	15.1	8.2	29.3	6.8	90.9	13.3	5.6	226.9	3.6	0.0	9.2	6.5	2.5	17.8	0.8	6.4	32.6	87.8
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.9;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	3.6	0.3	1.8	3.1	0.9	2.9	1.2	7.7	5.2	5.2	3.9	2.8	1.3	0.0	2.8	5.6	2.9	4.5	1.5	1.8	2.0	0.4	1.2	0.4	3.3	0.1	1.3	0.0	0.6	8.2	2.7	4.7	1.1	27.9	0.0	2.0	2.7	0.0	3.7	1.0	0.0	11.0	3.9	0.1	1.4	1.8	4.2	0.6	5.0	0.0	2.1	9.6	0.5	0.0	0.1	9.2	0.3	0.1	0.1	13.0	13.2	1.5	12.1	0.4	0.0	0.1	14.6	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9	0.0	2.1	0.0	5.6	2.9	1.1	55.0	5.1	0.0	0.0	1.8	2.0	0.8	0.0	1.2	17.7	1.4	5.9	0.0	1.0	0.7	8.5	2.7	0.0	2.4	1.0	4.8	6.4	3.7	6.6	30.8	9.8	1.7	3.3	1.8	3.3	6.5	0.3	2.9	17.7	2.3	0.8	45.3	36.2	1.1	2.6	1.3	1.1	0.0	2.4	3.5
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 311.7;Late spermatids: 401.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.9	11.4	16.8	25.0	9.4	12.3	21.2	18.4	17.8	17.2	18.3	32.0	10.1	40.0	15.6	11.3	20.0	15.4	32.8	21.9	31.0	27.3	23.6	21.0	13.4	27.7	8.3	31.1	10.4	7.9	12.0	19.8	26.0	13.7	21.6	22.9	44.5	17.0	14.4	10.6	32.0	24.2	13.7	18.3	12.5	22.5	20.1	24.7	17.3	50.4	35.8	13.1	18.9	18.0	12.7	17.8	10.1	20.7	15.6	16.2	12.7	11.0	23.1	10.0	22.1	37.6	6.4	36.1	14.4	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6	8.9	26.3	24.4	65.1	37.5	33.6	21.8	12.7	32.1	38.7	21.0	35.3	43.2	24.9	50.7	311.7	24.1	38.6	23.3	58.8	43.3	21.3	68.6	7.0	40.0	19.1	9.5	44.4	11.1	17.1	401.7	20.4	16.9	15.1	36.1	44.8	13.4	78.7	42.1	23.3	44.4	84.4	6.5	23.1	154.9	90.6	36.5	33.2	34.8	87.4	132.9
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1076.1;Late spermatids: 1865.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.3	8.9	14.2	28.1	15.2	17.2	7.9	13.1	15.3	13.1	15.3	6.9	11.4	8.5	16.7	16.9	14.7	8.0	14.3	13.8	16.8	14.7	12.7	12.0	8.4	6.0	17.6	11.4	18.0	11.9	25.7	11.1	20.9	12.7	22.5	20.3	11.8	34.8	14.5	25.2	42.2	8.7	11.7	7.6	9.7	13.7	15.6	18.4	18.9	20.7	20.8	14.4	14.8	22.3	13.8	19.6	8.3	8.0	14.7	24.2	17.6	23.0	12.2	38.2	37.6	20.9	9.5	11.8	18.0	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3	26.8	28.5	33.3	51.2	189.1	70.3	20.1	33.1	48.2	27.3	22.7	47.1	40.1	23.2	44.1	1076.1	52.5	12.9	0.0	40.5	30.6	44.1	65.7	40.4	25.1	41.0	117.6	27.6	43.0	45.7	1865.0	71.1	31.8	55.6	40.5	32.1	65.3	32.7	21.0	90.2	21.7	65.2	45.3	45.3	237.2	50.3	90.3	53.9	56.8	23.6	46.7
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 23.8;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4;U-266/70: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.4	0.8	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.7	0.6	3.3	0.4	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.1	1.7	2.7	0.6	0.0	0.8	5.1	2.8	0.0	0.0	0.0	0.2	0.0	4.7	2.2	3.9	0.9	7.0	0.6	4.8	0.8	0.2	1.2	1.5	31.4	0.9	0.0	1.5	5.3	2.5	0.0	2.3	1.0	0.3	2.9	3.8	0.1	1.2	2.8	2.3	0.4	13.0	2.1	2.2	0.6	6.2	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9	0.0	0.0	0.0	1.0	0.6	2.2	23.8	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.7	0.0	0.0	2.8	0.0	0.2	0.0	2.7	0.0	0.1	0.4	0.0	0.0	0.2	0.3
SSH1	KIAA1298	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778192-108857590	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	7.3	7.8	8.5	7.4	8.1	10.6	9.3	20.3	8.8	7.4	8.5	6.8	13.1	4.4	9.8	7.9	7.6	8.2	8.3	10.1	8.0	6.9	5.8	7.4	10.1	8.7	7.7	5.2	7.9	8.0	9.7	6.8	7.8	8.4	6.5	6.5	15.0	5.9	8.0	21.4	7.1	6.5	10.4	8.1	8.6	7.1	5.2	6.6	2.0	7.0	7.9	6.6	10.0	13.3	1.8	2.0	5.7	4.0	2.1	2.9	1.2	5.1	6.8	4.5	3.5	8.5	7.3	4.0	6.6	14.2	6.1	5.4	3.4	2.5	2.4	4.7	15.5	10.4	5.1	2.7	11.2	5.0	5.0	2.6	5.7	3.1	2.1	4.6	2.9	15.2	10.0	3.8	5.5	12.3	15.1	5.6	3.0	1.3	2.0	15.9	2.9	3.3	4.2	3.1	2.0	5.5	2.4	5.3	3.2	2.4	9.2	3.3	4.5	5.8	1.6	12.8	6.5	2.1	2.6	4.4	10.9	4.7	6.5	3.8	3.9	3.5	3.0	5.7	2.4	34.4	4.2	2.4	4.8	2.9	4.0	2.7	1.6	1.5	2.5	1.6	1.8	1.4	1.6	5.7	2.1	3.2	2.0	1.7	1.2	8.5	8.1	20.3	8.8	8.0	6.9	7.7	5.2	8.4	6.6	8.9	17.3	4.7	15.4	8.4	10.6	21.2	12.7	8.1	14.8	14.0	15.7	4.7	5.0	7.7	1.6	37.5	3.5	0.0	7.0	3.7	10.3	7.2	19.7	13.4	11.2	11.1	5.2	25.8	24.7	2.6	6.1	17.8	11.8	43.3	6.6	8.8	10.1	0.0	12.0	4.9	20.7	6.5	17.6	1.1	6.6	7.9	1.9	15.4	5.7	12.2
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 119.4;Late spermatids: 117.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 37.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA					"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	12.3	7.7	15.8	19.0	16.0	43.1	7.9	23.9	18.0	6.8	10.6	17.5	8.8	7.4	6.1	8.5	9.4	6.5	7.9	12.0	12.9	8.4	10.8	9.8	15.1	20.9	13.6	12.4	3.7	11.8	6.4	6.5	8.8	10.6	5.1	10.0	7.9	8.6	11.6	59.6	10.5	14.5	6.9	12.6	21.3	10.3	26.1	15.2	22.7	10.7	9.5	19.9	7.8	6.5	7.9	4.0	37.8	4.5	1.4	5.9	1.8	12.0	9.8	6.3	5.4	17.4	11.9	3.7	6.0	6.8	9.9	10.5	5.3	4.5	10.0	9.6	7.1	6.6	14.0	7.7	8.7	11.5	3.5	13.7	6.9	10.0	7.7	8.2	7.4	15.0	14.0	5.8	10.5	7.0	4.9	22.6	17.8	4.9	7.8	6.9	3.4	34.8	7.5	4.7	4.6	5.1	16.7	15.9	17.5	17.1	9.4	10.6	11.8	8.7	9.7	17.3	8.9	6.4	7.8	12.4	6.7	13.8	11.8	7.2	11.9	7.8	25.0	8.0	5.9	6.2	11.0	3.8	37.8	3.5	4.5	2.9	7.5	4.4	3.5	4.0	7.9	4.1	3.0	9.6	1.4	3.8	2.6	5.9	1.8	15.8	16.0	23.9	18.0	12.9	8.4	13.6	12.4	10.6	15.2	8.9	36.3	54.0	11.9	35.1	12.4	22.6	10.2	12.0	13.6	15.7	25.5	18.7	21.6	14.9	77.6	21.9	36.6	0.0	30.8	18.1	14.6	14.0	11.6	24.1	20.1	19.1	34.0	22.1	119.4	117.3	11.2	43.4	33.7	19.0	31.7	6.8	31.7	27.4	7.8	39.3	20.1	6.5	14.4	41.9	16.4	31.7	15.2	40.3	22.3	20.4
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.8;RT4: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.2	6.7	0.1	0.2	4.8	4.9	7.4	4.1	5.4	2.1	2.0	7.3	16.5	0.3	12.6	3.7	4.5	23.8	2.2	17.2	1.2	1.3	2.5	1.6	10.9	2.9	3.3	0.3	6.1	4.3	15.9	3.1	3.3	5.0	2.4	0.1	0.0	0.6	2.5	21.0	0.2	3.0	1.5	17.0	5.4	7.7	0.2	1.1	7.0	36.0	1.4	2.2	9.5	14.1	4.4	2.6	19.8	5.2	3.9	1.7	3.7	4.8	1.1	0.7	0.3	0.2	4.9	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7	3.0	5.4	0.0	20.7	6.3	1.1	3.4	15.3	8.1	10.3	15.7	0.0	12.6	3.3	16.4	0.0	3.9	17.2	0.0	19.0	20.2	6.2	13.1	3.5	4.3	6.8	1.6	3.5	4.3	8.6	0.0	12.0	2.9	8.5	12.6	14.7	4.6	16.4	17.5	11.3	6.3	0.4	0.0	8.3	0.3	0.0	9.2	13.2	4.3	18.5	22.9
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 520.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	41.4	26.6	19.2	29.6	33.1	32.0	19.7	36.1	28.2	31.5	32.9	24.9	48.2	42.2	19.8	28.4	30.8	32.4	31.0	29.7	30.8	35.1	36.6	26.5	23.3	39.3	37.5	33.5	23.2	28.5	25.1	33.7	32.2	26.5	29.4	25.7	45.8	32.7	24.9	36.9	38.3	53.8	33.6	40.9	40.4	30.5	31.0	59.0	34.5	12.8	35.6	24.4	24.4	62.7	106.5	34.0	32.7	29.2	22.4	30.4	19.3	34.2	30.9	39.9	47.9	52.7	31.8	53.4	14.7	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4	26.8	71.4	136.9	121.9	165.4	98.0	80.5	117.2	36.1	37.5	96.0	19.6	178.0	247.1	62.6	202.0	95.1	177.2	0.0	92.6	189.0	93.0	151.4	60.0	123.8	125.1	106.5	136.4	90.9	152.3	520.2	97.0	118.3	158.6	91.0	137.9	96.8	78.9	168.6	80.6	258.7	57.5	58.2	97.3	81.2	147.4	192.6	205.2	116.7	134.0	129.8
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 162.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.4	6.3	5.0	4.6	4.7	5.7	5.8	3.3	4.6	6.2	6.0	10.5	5.2	4.6	5.3	2.8	8.3	4.3	5.3	11.8	7.1	8.0	6.0	6.1	4.4	8.2	6.5	5.0	7.4	4.5	8.5	7.3	10.6	7.9	3.6	6.3	6.6	7.0	162.7	6.6	7.7	4.5	8.0	7.8	3.4	5.4	13.2	6.5	6.6	6.2	9.2	6.8	4.1	5.0	7.1	5.6	4.7	3.0	3.1	5.6	6.7	3.3	5.9	6.6	6.4	3.5	6.9	5.4	6.5	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3	17.9	15.3	14.1	25.1	14.4	19.9	35.5	35.7	25.4	27.3	24.4	11.8	35.2	41.4	32.4	59.2	21.7	40.9	46.7	31.9	28.3	22.6	34.8	51.9	34.7	29.0	25.4	9.9	20.3	24.7	104.7	30.2	29.2	6.8	36.9	31.9	21.5	36.9	38.6	32.5	47.1	19.2	38.8	20.6	32.3	49.5	18.9	37.2	19.5	31.2	23.0
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 18.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.8;Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	15.9	3.7	6.8	5.1	2.8	2.1	12.4	8.9	2.0	5.8	3.4	1.5	4.5	2.7	1.5	2.7	1.2	2.9	4.8	3.3	3.4	1.5	1.7	2.9	11.3	2.6	14.8	8.5	1.8	2.2	6.6	1.5	4.1	1.9	8.0	1.5	1.5	1.5	1.5	3.4	6.1	1.8	3.1	6.0	3.1	18.6	3.2	1.5	1.5	1.5	9.5	3.9	2.7	10.5	15.2	4.3	0.6	13.1	14.7	4.5	6.8	8.1	0.5	0.3	8.1	15.6	0.0	14.4	14.2	9.3	8.3	0.3	13.1	8.4	1.0	7.8	6.2	3.4	2.0	2.9	9.4	7.4	5.1	2.1	5.8	0.4	5.5	9.2	3.0	5.5	0.7	15.5	4.9	10.6	0.2	10.1	0.0	3.8	24.9	1.4	15.3	10.9	3.0	6.5	6.3	1.5	6.1	1.8	3.5	2.6	4.7	5.6	1.8	0.6	16.4	2.0	1.0	1.9	2.1	8.3	6.0	9.9	9.0	8.9	8.4	7.8	9.1	9.4	7.8	4.3	0.6	4.2	6.3	0.6	8.2	10.5	9.2	7.9	0.9	7.0	9.9	5.9	0.9	13.1	0.3	15.2	14.7	4.5	3.7	5.1	12.4	8.9	3.3	3.4	2.6	14.8	4.1	3.2	0.0	5.0	9.3	4.1	8.5	3.7	5.0	0.0	8.1	0.0	5.2	0.0	0.1	0.0	0.8	37.8	2.2	7.4	0.0	1.6	0.1	5.1	1.5	4.7	1.9	3.0	6.4	8.7	1.8	1.0	13.9	6.6	3.5	0.0	1.0	8.1	10.6	1.2	0.0	1.4	0.5	0.2	0.0	6.7	27.6	2.4	9.9	0.1	14.9	13.3	1.6
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 78.5;T-cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.8	7.3	4.5	6.8	5.3	6.6	11.6	10.2	8.5	7.4	6.9	3.8	10.4	9.5	5.4	12.6	15.7	9.2	2.0	12.5	4.8	12.3	3.4	11.4	3.0	2.1	7.6	11.5	13.5	6.5	2.7	10.1	8.4	2.7	6.4	3.7	1.0	13.3	5.2	12.6	8.2	25.8	1.8	3.9	5.8	13.6	3.6	6.2	3.0	9.9	3.1	3.8	5.9	8.3	28.0	5.9	2.9	24.4	8.9	8.3	4.2	5.8	5.5	11.2	16.5	6.0	10.9	17.7	52.3	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5	3.0	12.8	25.0	7.9	6.0	3.8	3.6	2.5	5.3	5.7	1.8	5.9	2.8	1.7	4.4	1.7	17.8	8.4	0.0	5.3	25.1	7.4	6.7	26.7	2.1	30.8	44.5	11.5	20.3	78.5	2.7	2.6	39.2	8.5	9.0	15.0	3.1	7.9	7.0	1.4	1.5	2.2	12.9	8.2	5.7	6.8	3.6	4.2	70.5	4.7	9.5
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 124.0;Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.2	10.3	7.8	14.8	7.4	6.7	16.5	10.4	10.9	9.8	10.4	8.4	14.9	13.9	11.5	10.8	4.4	13.8	7.7	16.0	3.0	26.0	18.8	14.2	0.6	10.5	16.0	14.3	23.9	12.2	11.7	7.5	11.2	8.9	9.8	11.1	26.6	19.2	5.5	15.9	13.7	14.5	15.0	7.3	12.7	21.8	8.4	15.6	8.8	15.6	18.1	13.1	0.0	7.7	11.2	4.7	12.1	23.5	13.2	10.1	11.5	19.8	16.5	37.8	15.9	10.4	10.1	19.1	10.4	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5	6.0	13.6	11.1	6.4	14.8	23.6	11.8	17.8	2.7	6.8	22.7	17.7	6.7	6.6	8.1	124.0	14.7	29.5	0.0	11.9	4.5	10.4	14.2	2.3	25.2	12.9	17.5	14.5	16.0	22.2	234.7	22.7	10.4	15.1	17.2	29.2	19.3	13.0	25.9	19.4	8.6	19.8	12.9	20.8	49.9	19.4	13.6	7.3	8.6	33.0	10.9
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	10.2	19.0	15.7	12.8	20.3	13.3	14.6	8.8	21.0	11.5	16.2	15.2	20.5	17.2	11.4	22.1	16.0	18.3	15.5	13.0	14.5	11.9	19.5	30.1	11.4	24.6	14.2	13.2	13.2	24.5	16.5	15.1	14.0	13.3	14.3	13.7	12.8	19.0	16.3	9.9	12.2	14.2	11.5	12.3	15.9	16.8	18.9	12.7	27.2	19.8	12.8	17.0	12.9	10.3	7.9	7.8	5.8	7.6	14.5	11.2	9.7	7.4	9.8	8.6	7.3	21.5	21.0	9.9	9.6	13.3	8.2	8.2	11.4	16.6	4.3	13.5	16.0	13.1	7.7	10.0	16.0	4.4	10.5	11.5	9.7	8.9	9.8	19.5	9.2	11.4	22.4	25.7	11.3	29.9	16.2	9.9	10.1	12.1	11.8	14.0	13.7	10.0	20.1	8.0	13.5	6.0	9.5	9.7	12.6	17.1	8.6	6.9	8.8	3.4	13.7	19.7	6.5	14.3	19.5	7.6	11.2	7.9	9.1	9.2	14.6	6.2	10.3	12.4	9.8	9.8	2.0	7.6	5.8	6.0	4.2	6.8	7.8	7.5	11.2	7.8	7.9	7.8	10.0	5.2	14.5	3.6	6.7	8.4	9.7	15.7	20.3	8.8	21.0	14.5	11.9	14.2	13.2	13.3	12.7	6.0	6.4	22.9	15.0	8.8	7.4	7.8	28.1	5.3	5.7	7.0	15.7	20.2	58.0	33.5	69.7	11.7	27.6	0.0	51.6	21.3	17.4	15.1	8.1	39.4	25.1	12.7	24.8	11.6	19.1	56.4	14.1	15.7	20.3	43.3	36.3	18.3	30.3	42.9	12.7	72.1	18.4	0.0	12.2	38.1	6.9	9.8	10.8	30.5	35.9	14.0
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 549.3;Urothelial cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.4	5.5	5.0	3.4	6.3	8.3	2.1	15.9	17.3	8.7	8.9	4.8	3.2	7.1	25.1	13.3	17.8	9.1	3.8	21.2	12.2	17.5	4.3	6.3	4.1	5.9	4.7	10.8	4.2	6.8	25.0	11.5	10.6	34.5	16.3	7.7	7.4	24.4	10.0	2.0	17.6	5.0	7.7	2.6	18.1	6.1	3.2	14.0	15.2	3.3	2.7	6.1	7.2	3.3	4.6	10.7	3.8	5.5	16.3	19.0	7.2	11.2	17.8	14.8	7.3	10.2	19.3	9.6	30.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8	113.2	27.8	121.1	549.3	161.6	3.0	25.4	5.1	52.2	81.9	19.2	9.8	44.4	28.2	110.3	36.3	19.4	29.1	0.0	82.8	19.7	31.9	134.1	39.1	7.7	15.8	0.0	6.9	16.5	16.2	8.8	5.5	19.9	33.7	55.1	27.8	8.1	75.9	56.1	2.5	9.7	25.2	6.5	55.6	45.1	29.6	118.9	55.8	186.8	10.0	279.4
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5"	"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.2	2.2	3.4	1.2	15.0	5.7	3.8	7.7	11.6	8.5	8.9	6.8	1.1	36.3	7.1	4.4	2.2	2.2	1.4	3.3	10.4	6.4	3.8	3.4	2.9	0.6	4.5	13.7	36.8	7.2	3.3	10.5	5.5	12.1	3.5	8.6	2.6	34.1	21.1	1.7	17.8	31.0	1.9	5.9	5.2	2.9	20.7	11.0	5.0	7.6	1.3	1.3	1.9	1.9	1.6	5.5	1.3	7.2	4.2	8.3	4.1	5.9	4.3	14.0	22.6	39.5	6.2	4.7	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4	83.4	80.3	158.6	22.9	53.1	0.3	2.2	10.2	34.8	52.4	10.4	0.0	5.9	3.3	5.2	4.6	11.6	59.1	46.7	2.5	20.9	21.2	28.7	189.5	2.4	23.5	0.0	2.9	7.4	142.8	2.0	5.2	145.8	55.6	40.5	11.0	0.9	7.9	38.6	4.2	1.4	0.2	6.5	20.5	28.6	24.9	55.5	4.2	178.5	10.5	39.9
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.9;HEL: 3.6;HL-60: 3.8;REH: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031510, HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	6.4	8.2	3.8	4.3	6.5	2.9	4.0	9.9	6.3	5.7	6.6	5.5	4.2	2.2	6.0	5.5	5.3	3.5	5.3	3.6	5.0	3.5	3.9	6.6	4.1	2.5	4.3	7.5	5.7	12.4	4.7	4.6	6.3	4.0	6.2	2.7	5.6	2.9	6.7	6.1	6.8	2.6	5.9	3.7	7.0	6.3	7.9	4.2	2.6	4.7	4.1	3.8	4.4	4.2	2.1	2.7	0.4	3.8	0.9	1.1	0.5	0.0	0.3	0.0	1.1	3.0	1.7	0.0	2.4	0.3	0.5	1.1	0.0	2.0	1.5	0.6	1.2	0.0	2.1	0.0	0.6	0.9	4.9	0.9	3.6	1.0	0.2	1.5	3.8	0.0	1.6	0.1	0.9	0.3	1.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.6	0.1	0.0	4.5	2.5	1.2	0.0	0.0	1.0	0.9	0.3	0.6	0.2	0.0	1.7	0.0	0.0	0.0	1.1	1.1	0.0	0.1	2.3	0.1	1.9	0.6	0.1	0.0	3.8	0.1	0.6	1.4	0.7	2.1	0.9	0.1	2.7	1.0	1.1	0.5	0.4	0.9	1.4	1.5	0.1	0.5	3.8	6.5	9.9	6.3	5.0	3.5	4.3	7.5	4.0	4.2	8.9	19.2	8.6	14.6	11.6	11.5	7.5	10.2	33.5	22.7	21.0	19.6	30.1	33.2	22.2	63.7	15.8	13.1	0.0	24.4	16.5	21.1	11.5	9.2	19.6	16.6	9.5	18.6	13.5	11.9	51.4	18.7	8.9	16.9	8.2	15.4	23.5	20.7	14.4	17.3	132.6	19.7	32.3	16.9	29.9	17.8	15.8	41.5	21.8	11.2	9.8
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.3	20.0	18.5	30.8	18.5	28.5	16.9	23.8	23.7	23.2	33.0	49.1	25.7	8.6	21.1	14.9	32.7	18.5	37.3	22.7	64.1	9.5	27.5	14.4	18.9	43.6	27.6	19.5	11.9	59.6	18.6	54.9	25.1	20.4	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	49.1	8.5	26.1	12.3	13.9	22.9	32.6	11.7	16.8	10.7	17.3	22.8	31.9	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6	11.9	24.3	29.0	62.3	63.0	20.3	2.8	68.8	34.8	44.3	64.6	53.0	35.6	21.6	29.9	2.5	26.3	110.9	0.0	47.8	36.3	36.7	53.4	18.4	22.9	24.7	9.5	40.9	27.0	68.7	3.4	24.7	40.1	54.0	16.2	70.9	22.1	67.8	59.4	28.7	31.9	11.4	38.8	29.0	1.8	3.6	71.8	16.7	21.8	51.8	117.9
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 164.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain					NA	NA					"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	17.8	13.6	22.3	14.2	26.0	16.3	12.9	22.3	35.3	16.4	17.1	17.0	13.0	14.6	17.7	15.9	19.3	15.4	16.7	19.0	19.4	20.0	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20.0	24.6	12.6	14.6	16.6	15.0	13.6	13.7	16.4	21.5	19.9	10.6	18.7	11.9	23.9	29.6	29.4	20.6	36.7	31.3	21.1	23.9	27.4	13.3	16.6	7.1	8.8	41.7	21.7	16.0	33.6	34.1	29.1	26.7	35.3	20.0	25.3	34.3	26.7	12.1	15.5	29.5	24.5	23.1	18.6	29.4	53.9	26.4	30.8	6.4	43.7	19.7	18.0	18.9	33.3	17.5	17.2	30.3	30.4	10.7	21.0	15.9	40.2	18.4	15.2	11.5	19.6	28.3	9.2	21.6	62.8	18.1	22.1	20.7	22.2	13.2	2.9	12.1	17.5	10.0	20.5	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15.0	12.0	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26.0	22.3	35.3	19.4	20.0	16.3	20.4	16.4	14.4	20.8	36.6	14.1	25.2	22.7	49.3	31.3	33.1	16.0	19.4	24.4	25.5	71.0	23.2	38.2	10.6	44.7	31.6	46.7	29.7	65.7	31.3	25.3	25.3	21.2	39.2	30.2	34.0	44.8	29.8	9.6	30.2	21.3	18.6	65.9	34.9	46.4	36.1	52.6	37.4	37.8	36.1	45.3	29.9	72.8	32.6	26.6	43.8	25.4	41.9	24.5
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 41.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.1	3.2	0.4	0.0	1.5	1.4	21.0	0.3	1.1	0.1	0.1	8.4	8.3	12.5	5.7	2.0	6.5	10.4	23.4	14.7	0.0	10.8	19.1	18.0	7.9	7.9	1.4	37.6	1.5	2.0	8.8	0.0	9.9	4.4	4.1	17.2	8.0	11.8	3.5	8.1	38.7	35.0	18.8	6.2	1.2	28.0	11.6	16.1	9.5	14.8	7.8	8.6	5.5	5.0	0.2	17.0	6.4	9.9	0.1	3.8	4.0	11.4	13.5	9.1	14.2	13.9	3.4	41.0	1.9	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8	20.8	14.1	8.6	27.8	0.0	0.0	1.1	5.1	12.0	14.8	10.4	0.0	44.8	3.3	4.4	0.4	0.4	0.9	0.0	6.3	28.5	4.9	17.5	10.5	3.0	10.7	0.0	1.2	0.6	10.1	0.0	3.1	7.2	0.0	9.0	6.4	0.0	8.6	3.5	2.1	1.2	0.0	6.5	2.9	1.1	2.3	0.0	49.4	17.5	6.3	15.3
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.3	7.0	7.5	9.8	24.2	12.1	7.5	13.0	11.7	12.2	10.6	5.2	15.9	0.0	11.4	12.9	6.4	15.1	5.2	11.2	19.7	9.0	6.6	10.0	3.5	3.5	8.3	3.3	8.7	8.0	19.4	6.2	17.0	8.0	5.2	5.9	4.2	5.4	8.8	4.7	8.3	4.0	2.2	25.8	2.7	7.4	6.4	3.2	13.8	4.7	1.9	4.3	8.3	9.6	8.0	10.0	7.9	5.4	3.9	8.2	5.2	12.4	7.2	4.3	6.5	2.7	7.4	4.2	13.0	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4	35.7	32.0	4.7	38.6	38.8	6.0	15.1	22.9	33.5	42.1	27.9	13.7	36.5	19.9	17.3	118.9	30.2	17.6	0.0	16.5	49.2	41.3	37.6	16.2	18.4	16.1	9.5	8.7	22.1	14.6	63.7	84.3	20.2	23.6	7.2	7.6	15.1	19.7	9.5	69.6	20.3	14.2	38.8	39.6	17.0	11.9	35.4	54.1	8.2	9.3	31.1
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710167-23832513	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 56.0"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 163.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023194	Enhanced					NA	NA					"HPA023194: AB_1857590"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.0	0.1	0.1	0.7	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	56.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	20.1	2.5	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.1	3.0	1.4	0.0	0.2	0.1	1.7	0.4	2.5	6.7	4.5	0.0	0.0	0.5	0.0	0.2	16.5	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.0	0.8	0.2	0.0	1.2	0.0	0.0	12.3	3.1	0.0	0.0	0.0	0.2	1.3	0.4	0.8	2.8	0.0	1.2	0.0	0.0	163.1	32.6	0.1	0.5	0.0	0.4	0.4
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.7;brain: 21.1;retina: 31.9"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 5.0;Melanocytes: 15.1;Muller glia cells: 4.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"RT4: 9.8;SK-MEL-30: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA			Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1.0	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0.0	15.7	0.5	0.5	4.1	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	3.8	9.8	0.9	0.4	0.0	0.1	34.7	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.4	1.1	0.2	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9	0.0	1.6	0.0	0.2	1.3	1.2	0.4	0.0	0.0	1.2	1.8	0.0	0.0	1.7	1.2	5.0	0.0	0.0	0.0	2.4	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.9	0.0	15.1	0.0	0.0	4.6	4.1	0.0	3.9	3.0	0.9	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.6
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell type enhanced"	"Detected in some"	25	"Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.9	8.2	11.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.1	11.7	0.6	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	0.0	10.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.3	0.0	0.0	3.0	0.0	1.2	18.7	0.0	0.4	0.0	0.0	0.0	0.0	47.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9	0.0	0.6	0.0	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.8	83.1	1.6	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.4	1.4	0.9	5.0	0.0	0.0	0.0	0.3	0.0	1.1	13.3	0.0	0.0	0.3	0.9	3.0	0.9	0.0	0.0	0.0	0.0
STK32C	"MGC23665, PKE, YANK3"	ENSG00000165752	"Serine/threonine kinase 32C"	Q86UX6	10	132207492-132331847	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017894	Uncertain					NA	NA					"HPA017894: AB_1857591"	"unprognostic (2.11e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.68e-6)"	"unprognostic (2.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.31e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-1)"	6.8	8.2	23.5	6.4	23.5	6.1	7.1	8.3	31.6	4.1	4.9	6.3	6.0	5.0	4.6	15.5	3.4	9.4	7.8	7.0	17.9	12.8	6.3	4.2	7.3	8.5	9.2	16.1	5.8	7.0	6.2	6.7	4.8	7.7	4.6	4.7	3.2	5.6	5.5	11.3	7.1	4.7	4.9	7.7	10.7	4.8	26.1	8.1	8.7	4.9	3.0	6.1	4.6	3.6	5.5	14.5	25.0	11.2	3.2	4.9	3.6	32.1	21.1	6.5	16.3	9.1	11.6	1.3	6.8	5.3	8.6	11.1	4.7	22.5	7.1	5.1	7.8	10.9	7.4	9.4	2.7	8.4	4.2	15.1	4.1	21.6	22.3	11.5	3.7	15.5	8.7	10.3	7.8	8.9	11.0	7.5	12.1	7.2	5.0	9.2	9.7	4.7	14.2	4.2	5.9	15.4	5.7	4.1	2.2	11.2	5.6	17.0	13.3	4.8	4.5	9.5	4.0	5.2	9.0	5.0	7.1	7.1	8.9	5.3	9.3	1.7	17.7	15.5	3.6	3.4	25.0	10.7	9.2	3.5	11.2	4.5	3.6	2.9	4.0	14.5	5.5	3.6	2.9	1.4	3.2	9.5	8.3	4.9	3.6	23.5	23.5	8.3	31.6	17.9	12.8	9.2	16.1	7.7	8.1	0.0	11.1	5.2	5.5	4.6	8.8	2.9	2.5	14.7	5.7	12.2	11.8	2.8	16.6	5.0	222.3	8.3	2.6	0.0	7.5	2.0	7.3	7.5	15.1	4.9	13.1	35.0	18.4	11.1	20.5	53.0	8.3	18.4	11.8	6.4	5.5	7.3	6.0	4.0	6.3	9.7	14.6	6.5	5.3	31.4	17.2	4.4	1.3	9.2	7.9	6.2
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.7	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.1	0.0	14.0	7.3	0.3	5.5	0.0	4.3	1.3	3.7	0.0	11.9	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	14.2	0.3	6.9	0.0	13.1	0.1	0.0	0.2	0.0	6.9	0.0	0.0	5.2	1.3	8.8	3.8	0.0	14.7	3.9	0.0	0.0	0.1	2.7	0.0	0.8	0.0	0.0	6.6	0.1	14.8	3.1	12.4	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6	17.9	12.6	5.4	1.1	0.0	19.2	34.4	10.2	245.0	47.8	19.2	66.8	0.1	3.3	7.5	72.9	1.3	0.0	0.0	4.4	2.7	0.3	0.2	1.1	0.0	0.2	1.6	8.7	0.0	0.0	113.1	4.0	0.4	0.0	0.0	1.3	30.6	4.5	0.0	15.9	11.9	83.4	0.0	0.2	126.9	25.1	0.0	0.0	0.0	2.9	0.0
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	15.1	12.9	10.0	17.2	4.6	6.4	12.2	6.2	7.7	8.3	8.6	16.9	11.8	10.4	5.1	7.7	13.0	22.9	11.8	14.3	9.5	4.1	5.6	9.9	4.5	18.3	5.9	8.9	4.6	5.5	12.6	13.3	11.5	7.7	7.9	10.1	9.5	8.6	5.4	6.7	11.1	12.6	18.6	12.1	8.7	9.7	9.0	6.6	7.5	15.2	16.7	8.1	11.1	19.9	9.9	12.2	9.8	8.9	6.6	14.3	9.8	7.1	9.8	7.6	9.8	7.3	7.6	9.7	6.2	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4	11.9	9.8	1.9	4.0	10.3	110.1	11.0	0.0	0.0	6.8	3.5	141.4	6.0	1.7	5.5	169.1	7.7	8.1	0.0	5.9	9.9	6.4	5.1	9.2	7.8	5.0	278.1	5.8	4.3	6.0	665.5	6.4	3.9	6.8	1.8	7.6	155.8	8.1	11.5	5.6	3.1	88.5	0.0	4.6	14.9	11.5	10.3	4.8	6.4	9.9	5.1
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672026-218702716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 20.1;Cone photoreceptor cells: 35.3;Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	4.8	10.0	7.5	4.7	11.4	2.0	6.4	7.9	11.1	9.1	7.4	7.0	11.9	4.1	14.4	13.3	5.0	13.9	9.8	3.3	6.3	3.5	10.1	4.4	6.9	3.9	2.3	6.6	13.6	9.7	12.3	23.2	3.9	7.6	9.5	6.3	9.3	7.3	8.3	3.3	4.6	5.8	7.8	5.5	4.9	7.9	63.2	4.2	3.5	11.4	3.7	5.0	9.3	7.1	1.8	1.6	3.2	1.9	2.2	1.6	1.7	2.5	5.8	12.8	10.9	14.0	10.9	7.9	7.0	5.6	8.9	8.4	7.6	4.2	3.4	9.8	7.3	6.0	5.2	8.8	7.3	7.9	1.4	7.3	3.3	17.6	10.5	6.8	4.6	5.6	11.7	5.5	8.7	6.2	23.8	6.7	4.5	7.6	4.3	7.4	5.9	2.7	5.8	7.7	3.2	3.7	5.1	5.5	3.4	10.9	12.9	10.4	8.9	5.4	8.9	3.6	13.9	9.0	3.8	6.3	12.4	4.6	4.7	4.7	5.5	4.2	1.8	7.7	2.2	5.1	0.0	1.9	3.2	1.5	1.2	0.9	1.8	1.1	1.3	1.6	0.6	1.1	1.6	0.2	2.2	1.4	1.3	1.0	1.7	7.5	11.4	7.9	11.1	6.3	3.5	2.3	6.6	7.6	4.2	8.9	4.6	1.7	1.0	1.0	7.7	2.8	5.1	20.1	1.2	3.5	35.3	1.4	0.0	2.9	11.3	2.1	2.0	0.0	2.2	1.3	1.8	1.3	1.1	4.9	2.3	1.6	2.4	4.3	2.8	4.1	5.5	1.2	0.0	1.0	4.4	5.6	1.9	3.7	4.6	3.3	9.8	6.5	2.1	26.8	8.2	0.9	0.7	1.5	3.8	0.4
STK38	NDR	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	19.1	8.4	12.4	39.8	10.0	19.4	32.8	18.8	12.7	16.0	26.3	7.8	14.9	17.0	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7.0	15.0	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11.0	15.4	9.0	17.0	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11.0	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.8	13.2	14.0	15.1	28.3	21.6	12.2	20.0	16.2	20.8	21.0	10.1	12.3	24.1	15.5	29.7	17.3	19.2	11.6	8.3	24.6	9.8	9.9	17.2	17.2	9.1	14.0	6.5	9.5	14.2	21.9	16.1	10.4	24.0	13.0	12.3	14.0	14.1	29.6	10.7	10.5	17.0	5.8	21.3	11.8	40.8	17.0	6.4	19.7	22.5	16.4	7.8	24.3	11.2	14.0	16.4	12.0	17.2	12.5	16.9	15.0	13.5	12.9	11.8	21.0	17.0	3.8	25.4	16.3	33.2	19.8	15.0	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10.0	18.8	12.7	12.1	7.0	11.9	6.4	9.0	11.0	17.9	16.5	10.8	8.5	11.9	2.5	15.1	22.9	37.5	50.0	7.0	0.0	11.8	1.7	16.1	5.8	12.4	32.4	0.0	11.2	15.4	19.9	11.5	12.7	13.6	11.7	4.8	13.8	11.1	28.5	4.1	25.0	31.7	16.9	9.0	22.9	6.1	19.6	25.9	28.3	13.6	8.5	12.9	13.7	23.6	9.6	18.4	12.8	23.6	22.1	22.5
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	21.2	8.4	11.0	14.6	10.9	10.9	27.2	9.6	14.6	13.0	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15.0	6.8	14.0	10.9	9.1	10.8	14.6	52.3	17.0	7.6	15.6	7.5	10.1	10.0	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13.0	4.0	4.0	5.3	4.2	5.8	15.1	6.7	6.9	4.7	11.2	2.7	4.0	1.7	2.5	7.3	3.2	9.9	6.5	2.4	5.2	7.9	6.8	4.7	2.7	57.8	5.6	6.1	7.0	3.6	5.8	15.0	7.1	5.7	4.9	6.4	8.2	11.2	13.9	12.8	7.4	7.8	3.5	3.0	9.8	16.3	17.9	11.2	8.8	3.7	17.6	7.6	2.5	8.1	2.4	8.1	12.2	7.5	4.7	15.4	3.7	5.1	5.4	6.0	5.3	8.6	7.4	2.8	2.8	10.4	3.0	7.0	2.4	6.0	13.0	22.9	4.0	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4.0	8.1	8.2	4.0	5.3	11.0	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1	17.9	14.4	9.8	27.4	31.5	11.3	44.5	10.2	9.4	20.5	8.7	2.0	10.0	8.3	41.2	13.6	21.5	19.7	0.0	35.8	7.9	16.0	21.3	16.3	13.0	27.6	9.5	18.5	18.4	33.1	2.3	6.1	48.1	20.3	45.1	27.7	7.5	51.1	31.7	11.3	10.5	6.4	19.4	50.7	6.5	12.1	28.0	23.2	12.5	20.5	39.1
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 65.7;Urothelial cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	6.2	2.1	8.4	4.6	11.0	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5.0	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19.0	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8.0	5.6	5.3	0.7	1.0	0.0	0.7	1.9	3.4	0.5	6.7	4.1	15.5	4.9	9.5	14.1	1.5	17.0	12.5	11.4	10.6	0.0	22.0	18.7	4.7	11.0	9.9	17.7	9.9	12.4	14.3	5.9	6.1	7.7	4.5	13.8	17.8	10.4	0.8	9.7	17.7	13.5	14.1	13.8	7.7	14.7	0.1	0.0	23.9	3.9	18.1	3.7	10.7	14.0	8.6	25.8	6.1	1.5	8.6	16.8	22.9	9.7	5.9	0.9	6.9	7.7	3.1	7.6	7.3	13.8	4.3	9.7	11.1	0.0	0.0	15.0	10.5	9.3	9.3	0.0	0.7	0.0	2.5	0.4	1.3	0.7	1.9	3.4	1.0	0.7	0.4	2.0	0.0	1.9	0.3	0.3	3.3	0.5	8.4	11.0	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5	3.0	12.3	0.8	21.2	3.4	13.8	25.8	22.9	6.7	7.9	5.2	15.7	0.1	18.3	9.7	21.3	3.5	23.2	0.0	19.9	0.0	7.3	65.7	0.0	0.0	3.5	19.1	21.9	3.1	5.1	13.5	9.5	5.2	16.9	1.0	13.9	26.9	26.4	17.3	10.6	3.8	25.3	6.5	7.2	19.9	7.7	3.9	0.2	15.2	20.4	55.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"monocytes: 469.7;T-cells: 231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12.0	29.1	9.6	7.4	9.6	32.3	8.0	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.8	8.0	10.3	7.3	6.3	7.9	7.1	10.5	16.0	17.7	16.1	22.7	6.5	28.9	9.1	7.4	14.9	12.6	10.8	14.0	22.8	12.9	5.7	21.1	11.7	16.0	11.1	27.1	30.0	6.4	11.6	16.6	18.2	8.9	6.5	19.6	9.7	16.7	8.9	9.3	20.2	18.3	6.2	7.7	5.5	13.1	11.3	13.4	6.5	8.1	4.9	6.0	15.5	9.0	11.8	8.2	8.2	17.1	8.3	13.4	13.0	15.4	12.0	21.8	17.1	32.3	13.1	13.0	9.8	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6	14.9	24.0	181.6	40.4	49.5	24.2	7.0	15.3	16.0	18.2	40.1	49.1	20.3	8.3	14.1	4.8	32.3	20.5	0.0	15.3	21.4	24.3	25.1	129.5	19.1	53.0	41.3	24.6	22.7	103.3	3.6	21.0	108.8	126.5	469.7	17.4	20.3	16.0	25.9	15.9	10.9	64.0	12.9	30.2	36.4	43.8	46.3	16.2	231.2	17.4	36.3
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	18.0	24.5	16.6	28.0	37.9	34.7	9.5	24.6	29.0	29.3	26.1	30.4	23.1	18.3	17.5	41.3	18.9	15.4	20.4	37.1	12.2	20.1	67.6	11.4	35.3	25.4	54.6	19.1	22.7	41.3	39.8	34.3	21.7	23.1	29.6	17.9	18.3	30.6	45.3	71.5	20.7	18.8	18.5	29.0	26.8	32.1	10.9	45.0	39.1	18.0	28.9	23.5	19.8	43.5	30.9	11.0	27.7	36.7	23.4	26.9	23.6	22.2	29.6	30.3	31.3	29.5	21.2	17.3	30.3	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4	35.7	24.7	77.5	88.5	102.0	92.7	1.1	101.9	28.1	22.7	123.9	49.1	67.7	242.1	127.5	6.6	66.9	130.5	23.3	147.7	75.3	72.2	130.8	20.7	112.4	99.1	79.4	72.9	61.4	56.4	11.8	100.9	74.8	111.3	200.2	92.2	123.1	150.1	93.1	105.4	269.6	58.7	71.1	101.9	23.5	69.3	105.3	84.2	61.0	87.3	99.9
STYXL1	"DUSP24, MK-STYX"	ENSG00000127952	"Serine/threonine/tyrosine interacting like 1"	Q9Y6J8	7	75996338-76048004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050261	Uncertain					NA	No					"HPA050261: AB_2681066"	"unprognostic (6.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.88e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.77e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.22e-4)"	9.4	19.2	16.0	10.2	23.1	12.7	17.5	12.8	19.8	15.7	15.1	19.6	13.9	10.5	10.3	21.0	21.1	28.2	9.4	13.2	16.6	12.1	14.8	20.1	11.3	13.7	20.9	13.5	15.4	30.0	15.9	19.9	24.6	16.8	16.6	20.1	12.2	16.0	13.9	12.4	19.3	10.3	14.0	17.0	17.4	14.0	25.0	19.7	20.8	19.9	12.1	19.5	14.8	14.6	19.7	23.0	30.8	29.3	24.7	22.1	17.4	19.8	10.6	8.4	11.2	13.3	14.5	8.7	9.0	12.8	14.6	14.5	12.3	18.1	4.6	4.5	11.8	23.1	8.8	13.5	17.9	21.2	14.8	6.0	5.6	5.0	11.0	18.9	7.8	10.3	14.0	21.1	17.4	43.9	18.8	14.1	7.0	18.1	14.0	13.0	16.0	3.1	33.5	7.1	19.2	25.7	11.9	7.0	12.2	18.5	13.0	11.0	11.4	8.4	19.2	22.4	21.9	21.1	15.1	7.0	12.6	5.3	13.8	12.7	15.2	9.6	15.7	11.1	15.0	19.5	30.8	29.3	25.8	13.7	25.3	15.2	19.7	13.2	15.2	23.0	15.6	11.7	13.2	24.6	24.7	23.7	15.1	22.1	17.4	16.0	23.1	12.8	19.8	16.6	12.1	20.9	13.5	16.8	19.7	20.8	10.4	12.3	13.2	6.5	5.6	15.4	10.2	54.9	30.7	10.4	0.0	25.9	33.2	13.9	68.8	7.8	14.4	0.0	22.7	20.3	7.6	16.5	10.4	15.5	26.7	3.2	19.4	12.9	23.8	50.5	10.6	18.9	3.3	32.5	24.6	18.8	19.6	40.3	9.6	16.3	8.9	6.5	6.1	22.2	12.6	8.7	37.6	9.6	17.7	15.9
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.6	11.1	6.7	9.0	17.1	9.8	6.7	9.0	9.3	11.5	8.2	6.0	15.2	49.0	12.3	11.5	15.2	13.5	7.3	9.1	9.5	7.6	5.5	7.7	12.9	13.4	20.8	11.5	14.0	12.4	16.5	10.1	23.0	10.3	7.4	5.2	9.6	25.1	6.7	12.9	5.0	8.3	7.2	9.1	7.7	8.5	5.7	19.7	7.2	8.6	4.4	9.0	8.3	20.7	14.5	6.2	15.4	7.6	7.1	8.0	5.3	14.3	6.0	50.2	34.7	56.6	10.8	5.9	8.9	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9	14.9	21.3	22.2	6.0	15.7	10.2	3.4	33.1	9.4	20.5	10.4	31.4	11.5	1.7	10.5	4.3	8.3	15.8	23.3	16.3	12.6	12.1	13.4	1.1	60.4	13.6	12.7	8.1	14.1	14.8	3.5	19.0	11.6	11.8	6.4	25.0	10.8	17.1	12.4	12.4	7.2	17.1	12.9	7.5	21.0	10.9	14.1	35.8	10.2	14.5	11.6
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366239-71532374	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 76.6;Erythroid cells: 70.0;Rod photoreceptor cells: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	20.1	16.2	15.0	17.1	19.8	16.3	17.7	20.7	18.0	20.7	15.5	23.8	17.1	10.0	25.4	17.1	14.4	19.1	16.1	12.9	15.4	12.0	11.9	12.9	13.8	17.8	18.5	16.5	23.9	17.5	25.5	19.3	15.4	17.3	16.9	15.4	20.8	14.5	16.1	19.6	16.8	17.1	18.3	17.2	21.3	15.8	12.2	21.3	19.4	20.1	12.0	18.7	18.4	15.8	5.0	4.7	5.2	4.8	4.2	4.9	1.8	11.4	10.0	11.4	7.7	9.1	15.9	7.1	8.6	8.0	9.0	7.5	7.5	6.9	10.7	7.3	9.5	8.0	10.9	15.9	6.8	11.6	7.1	13.9	12.8	13.1	7.3	6.6	24.2	12.3	9.2	6.9	9.7	18.4	8.1	9.4	8.3	17.3	26.0	9.1	8.1	13.4	10.7	13.1	12.8	13.1	12.3	23.2	13.1	6.1	14.9	6.1	9.4	23.9	8.4	10.5	9.4	6.1	12.9	11.8	10.7	9.0	8.6	5.9	11.2	10.3	13.8	5.9	19.5	7.9	4.4	4.1	1.1	4.4	2.8	3.8	3.0	4.6	4.5	4.7	5.0	4.4	4.9	5.2	4.2	4.8	3.5	3.1	1.8	15.0	19.8	20.7	18.0	15.4	12.0	18.5	16.5	17.3	21.3	29.8	25.3	10.9	8.1	10.5	33.8	14.8	5.1	13.4	34.2	3.5	76.6	6.7	1.7	5.1	2.0	23.9	8.4	70.0	6.0	4.9	10.4	8.4	22.0	12.1	7.7	15.9	10.9	19.0	15.4	1.8	20.4	17.0	5.0	6.4	15.4	18.7	6.4	14.0	20.8	3.6	71.6	0.0	14.2	6.0	8.9	15.2	4.8	13.8	14.6	7.6
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390464-29551904	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		13000	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	17.2	11.5	19.1	11.9	25.0	12.7	13.3	20.1	24.4	15.8	11.9	22.2	7.9	7.1	14.9	10.8	12.7	11.0	11.6	15.3	18.7	15.5	13.6	10.6	13.2	11.1	30.0	17.6	13.5	9.3	31.7	13.7	14.3	21.8	12.0	10.7	10.9	11.1	13.3	15.0	13.8	9.8	17.7	21.0	13.0	10.8	14.3	23.5	11.7	17.7	6.0	11.2	14.5	17.1	2.4	4.8	5.5	2.1	1.4	3.0	0.9	13.7	24.5	19.3	8.2	14.4	18.3	8.1	13.0	13.9	11.9	12.6	13.2	4.8	8.5	12.7	21.1	12.8	10.8	17.6	9.0	21.6	17.8	13.0	13.6	14.1	7.0	10.5	15.0	12.6	12.0	11.6	17.6	18.1	12.6	16.3	8.7	13.9	7.8	15.6	9.2	11.8	5.6	8.2	7.6	6.3	10.9	27.2	5.9	11.3	19.9	10.7	13.1	22.3	20.9	13.4	20.4	15.1	13.9	23.6	18.3	14.9	16.0	18.2	7.2	15.4	9.9	13.4	9.4	16.5	1.7	1.9	1.5	2.0	2.1	1.6	1.6	2.0	2.4	1.7	2.4	3.0	2.2	5.5	1.4	1.9	4.8	1.2	0.9	19.1	25.0	20.1	22.7	18.7	15.5	30.0	17.6	21.8	23.5	44.7	47.4	18.4	23.0	39.5	53.4	78.7	30.6	24.1	38.7	43.6	92.3	15.2	13.3	23.9	10.7	41.3	21.4	0.0	20.9	13.5	47.9	34.5	27.7	23.6	25.9	49.3	36.1	51.5	65.2	12.5	36.8	44.8	38.8	23.4	20.1	35.6	30.2	21.2	50.9	15.9	48.3	25.8	36.8	55.4	33.6	40.1	31.5	19.8	18.0	38.2
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.6	13.9	9.3	18.1	20.7	11.1	14.0	13.1	17.2	15.1	12.2	17.6	14.9	9.4	17.6	10.7	10.4	7.6	18.9	22.7	13.1	21.7	17.2	10.1	12.9	25.3	10.9	9.1	14.9	6.0	9.8	23.4	11.7	11.8	12.4	13.3	20.8	15.0	18.3	11.4	8.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.2	11.8	15.8	6.2	7.9	19.8	14.6	32.6	24.2	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.6	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2	8.9	11.5	2.2	4.2	9.5	13.3	8.1	5.1	4.0	7.9	8.7	37.3	6.7	1.7	7.6	3.1	27.6	23.3	0.0	10.2	4.8	9.3	5.8	3.5	9.7	8.4	9.5	12.6	44.2	12.4	2.1	11.5	5.5	6.8	4.6	14.9	8.7	12.7	14.2	12.0	6.4	19.2	6.5	7.6	21.1	17.2	8.4	10.1	9.2	13.3	5.7
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372945	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 324.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	14.6	16.2	31.9	24.1	31.0	30.8	14.6	44.3	33.5	11.6	21.2	17.2	10.3	23.1	15.2	11.4	16.0	9.8	16.9	15.1	27.8	31.7	14.0	15.3	19.4	26.3	25.7	20.8	17.5	10.9	20.2	23.6	11.9	20.7	25.6	21.3	12.0	13.6	14.6	18.5	17.0	31.6	15.3	23.7	24.2	20.9	8.9	28.6	28.3	18.1	9.9	26.9	18.5	18.3	20.9	22.4	38.2	37.8	36.4	27.8	17.1	8.3	5.8	4.3	3.8	10.7	13.1	4.9	8.8	10.0	5.1	6.7	2.9	13.0	25.6	2.9	11.7	7.4	7.6	3.7	7.8	8.0	9.2	3.2	30.2	2.9	3.8	12.5	30.9	42.6	8.8	9.4	16.1	23.7	10.8	16.3	15.3	17.5	3.0	9.3	5.9	16.3	20.3	1.7	3.9	3.1	9.5	5.9	2.7	4.8	14.5	0.8	4.3	8.1	3.7	11.2	2.0	7.6	23.2	25.3	8.8	1.5	8.2	7.5	2.9	2.8	20.3	12.5	21.4	11.8	38.2	17.0	37.6	27.8	23.3	26.2	20.9	21.2	24.1	22.4	19.3	18.8	24.5	37.7	36.4	37.8	20.9	19.3	17.1	31.9	31.0	44.3	33.5	27.8	31.7	25.7	20.8	20.7	28.6	32.8	78.2	81.8	42.2	31.3	72.1	47.4	63.7	6.7	30.7	43.6	200.3	29.7	59.7	35.4	11.4	29.2	94.6	23.3	52.0	83.1	34.9	47.7	159.8	52.0	71.7	38.1	24.1	26.4	84.7	8.2	35.9	117.0	33.7	141.5	60.6	40.4	64.9	98.2	44.9	27.2	324.3	45.3	40.5	20.5	22.8	27.5	36.6	86.3	58.2	47.4
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.4	8.8	12.8	15.8	16.0	19.4	14.7	21.5	13.9	13.2	8.7	8.2	18.8	12.8	15.9	20.1	12.7	11.3	12.4	16.4	17.3	10.8	20.2	11.2	12.0	17.3	20.6	25.2	12.0	11.3	13.9	13.4	24.1	18.5	7.2	15.4	27.4	17.9	16.4	0.6	16.1	17.6	12.3	9.0	9.6	9.8	18.1	15.1	24.4	7.4	10.7	19.4	20.0	14.3	15.3	20.4	15.0	17.1	12.5	12.1	10.0	14.4	17.4	30.2	18.3	15.8	11.4	16.1	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9	17.9	15.6	14.7	23.9	9.7	18.4	10.0	7.6	18.7	19.4	21.0	9.8	24.9	10.0	17.0	24.8	24.1	10.7	0.0	20.6	24.3	13.6	35.1	41.6	14.3	18.1	17.5	16.6	16.5	19.0	20.1	17.8	26.2	13.5	27.9	8.0	13.0	14.3	10.2	19.4	11.6	15.8	25.8	17.8	49.9	12.9	13.0	77.5	25.8	9.3	32.4
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 65.3;Hepatocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"	"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	22.9	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.3	0.3	10.3	4.3	3.1	18.8	4.0	14.6	5.9	9.2	9.0	16.5	11.8	11.3	3.2	32.3	7.4	4.7	10.4	5.5	5.4	9.2	7.9	15.7	25.0	5.7	11.4	7.8	12.1	17.1	6.4	14.5	17.6	6.8	17.6	13.5	7.6	11.0	5.0	12.5	3.1	7.4	23.6	6.1	7.0	13.3	3.5	8.7	0.3	2.0	15.3	11.8	11.4	12.9	7.8	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5	0.0	5.0	15.2	9.4	5.8	11.5	9.5	22.9	12.0	6.8	29.6	21.6	65.3	11.6	9.9	0.8	9.4	2.6	0.0	6.7	2.4	10.0	18.9	10.5	59.7	10.0	6.4	21.9	11.6	32.3	1.7	13.3	19.9	5.0	10.8	4.8	38.8	8.5	3.5	26.9	17.0	22.7	0.0	25.9	1.4	17.9	10.8	37.6	10.7	4.7	22.3
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"Transducin beta like 1 X-linked receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	20.7	26.0	27.4	24.3	26.8	27.3	20.3	27.5	28.1	28.9	29.9	22.6	15.4	24.0	23.9	20.5	23.8	21.9	22.7	30.3	26.2	20.7	19.9	21.8	30.8	27.8	21.4	25.9	26.5	19.9	30.6	11.3	24.0	19.7	24.4	23.2	24.7	21.3	17.7	21.1	17.8	24.3	21.9	19.6	24.7	21.3	17.4	22.3	28.4	45.6	14.9	32.1	29.1	25.5	7.4	13.3	12.9	4.6	6.8	8.3	4.1	23.9	12.3	16.0	9.0	13.6	14.8	9.6	7.6	11.8	6.6	9.1	14.1	19.9	24.6	35.9	10.9	17.5	14.8	11.9	15.8	13.3	25.8	3.7	13.8	21.0	8.4	11.7	21.9	8.2	21.8	8.2	9.7	24.1	13.0	10.3	17.3	10.3	43.6	8.5	8.6	20.4	3.0	10.1	15.4	8.3	11.7	20.4	26.2	5.9	34.0	5.8	9.2	10.2	8.0	9.5	10.5	29.3	16.8	15.7	10.8	9.1	6.0	16.4	23.8	30.5	71.1	7.3	16.4	12.3	11.4	3.0	3.8	5.8	4.6	5.1	7.3	5.7	6.6	4.0	7.4	5.0	6.4	12.9	6.8	3.9	13.3	8.3	4.1	27.4	26.8	27.5	28.1	26.2	20.7	21.4	25.9	19.7	22.3	68.5	47.1	43.4	46.9	81.4	116.0	84.2	48.4	61.6	62.6	99.5	117.8	22.3	24.9	43.8	5.7	62.9	42.8	23.3	37.3	28.5	65.8	123.0	24.3	58.7	32.8	109.7	81.9	55.9	85.4	5.2	59.2	54.6	62.4	31.5	74.5	41.8	53.4	23.0	68.6	46.2	81.2	45.3	41.5	8.4	53.9	97.7	23.0	49.8	75.7	61.8
TESK1		ENSG00000107140	"Testis-specific kinase 1"	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15.0	9.7	13.7	15.3	13.4	11.0	12.0	13.0	12.8	13.7	13.1	10.5	10.0	11.5	10.7	14.1	10.3	17.0	16.0	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21.0	47.2	13.7	12.7	16.9	7.3	11.0	12.9	28.4	12.9	9.2	13.0	12.3	9.0	16.6	20.9	1.0	2.3	0.3	1.8	2.1	4.9	1.5	9.5	8.9	6.1	10.2	24.6	10.3	7.0	10.9	9.8	10.2	6.5	5.2	2.7	17.4	6.2	10.9	27.1	3.3	3.9	7.9	1.9	11.2	5.2	2.5	8.5	4.5	14.4	2.1	8.4	10.0	12.5	7.9	10.9	10.9	7.1	8.6	2.9	6.3	10.1	10.5	4.8	10.6	3.8	8.8	10.5	7.5	3.7	4.1	7.5	4.4	5.0	6.1	6.2	7.6	4.6	4.4	9.0	3.2	6.2	22.6	9.7	16.2	6.5	3.8	5.4	6.5	16.4	2.5	5.1	0.0	1.8	0.3	3.4	0.4	3.0	0.8	1.4	4.9	2.1	1.0	1.5	1.6	0.0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9	6.0	7.7	5.9	5.6	12.8	10.4	1.9	5.1	4.0	3.4	7.0	7.9	3.2	1.7	5.6	33.3	8.7	14.2	0.0	9.0	7.2	8.9	13.5	1.1	9.3	13.1	12.7	9.1	4.9	4.1	27.1	11.2	8.4	13.5	2.8	12.4	11.3	8.3	8.2	13.4	6.1	12.2	6.5	7.8	13.0	5.9	12.2	2.7	6.9	6.1	6.8
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;RT4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.1	0.6	4.3	1.9	3.2	3.6	1.5	5.3	0.6	1.6	4.9	2.0	3.4	2.7	1.5	3.7	4.3	3.6	1.8	2.7	1.7	1.2	9.9	1.8	2.9	2.1	3.0	2.9	1.5	7.1	0.6	10.9	1.3	0.6	3.0	2.4	3.4	1.5	1.5	4.4	0.1	1.4	1.7	12.8	0.3	1.4	3.4	6.4	12.2	8.1	10.0	1.5	0.0	0.2	2.0	1.6	1.1	7.2	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8	0.0	3.2	2.4	6.5	6.9	2.3	1.1	5.1	1.4	3.4	0.0	13.7	6.5	0.0	1.0	18.1	2.9	12.4	0.0	2.3	2.5	2.2	12.9	6.9	5.5	5.9	0.0	4.1	1.3	4.6	5.2	2.6	4.5	3.3	2.8	5.3	1.1	1.0	7.4	1.8	0.6	2.8	6.5	4.7	26.8	5.7	7.4	12.4	4.4	4.9	7.3
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 114.1;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.4	5.2	31.4	9.7	7.3	5.4	4.7	11.7	12.9	11.0	12.3	5.2	2.5	7.6	3.6	9.1	8.7	8.1	10.6	9.1	14.8	19.9	3.3	11.4	5.7	4.6	12.1	7.0	27.9	11.2	9.8	17.1	8.1	6.9	1.9	2.9	15.8	3.2	15.0	5.3	1.0	8.0	6.7	3.2	3.1	2.8	68.5	3.2	2.7	0.8	8.5	9.9	9.1	40.7	12.2	13.5	7.5	9.6	3.6	8.2	7.1	35.0	7.1	3.3	3.3	5.2	17.2	12.1	7.0	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4	6.0	9.1	9.3	6.5	20.9	7.2	6.3	5.1	1.4	10.3	57.6	0.0	17.0	0.0	14.1	114.1	14.5	3.3	23.3	27.1	5.9	46.2	13.4	29.9	11.5	43.1	0.0	9.2	8.0	20.9	74.1	8.9	36.3	33.7	19.0	6.6	2.9	25.9	3.5	12.7	12.2	1.6	32.3	22.2	8.0	10.5	14.2	16.2	11.5	7.2	8.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 188.8;Ito cells: 564.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.5	14.7	0.9	0.0	54.5	82.2	2.5	12.8	18.0	4.4	4.4	3.3	13.6	0.3	46.2	17.1	5.2	5.1	0.6	18.7	7.3	1.0	1.3	1.4	1.7	16.5	23.3	2.3	12.1	70.9	16.6	19.0	18.4	20.2	47.6	1.7	0.3	0.0	67.2	0.2	2.3	1.7	0.4	12.8	5.9	2.1	5.9	0.3	23.6	6.0	0.0	0.9	3.8	1.0	3.6	1.2	0.0	2.5	61.6	21.7	5.4	9.8	4.8	0.5	0.0	2.0	13.0	2.5	8.7	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2	134.0	83.8	41.5	14.2	33.2	1.9	64.1	48.4	12.0	53.4	26.2	0.0	5.3	3.3	11.4	2.0	188.8	9.7	0.0	13.8	4.3	48.1	7.3	28.9	45.3	27.1	0.0	8.1	564.1	139.2	2.0	30.5	46.1	28.7	1.8	11.9	0.2	25.3	10.8	44.6	5.6	0.9	32.3	36.0	0.3	1.1	26.7	3.1	39.4	13.0	9.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015159, HPA040171"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		430000	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	13.1	0.3	0.2	0.7	1.3	0.9	1.3	0.8	1.7	1.0	0.2	18.0	2.1	1.5	0.5	1.4	2.5	1.0	11.8	4.1	0.6	0.6	1.1	1.1	7.1	0.4	1.5	0.4	0.5	2.5	0.7	0.8	0.5	12.9	0.5	1.4	0.2	0.8	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.2	0.2	16.0	0.0	1.1	1.1	0.8	0.6	0.8	3.8	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	11.9	1.4	0.0	4.2	0.2	0.8	0.8	0.0	0.0	6.8	0.0	0.0	1.1	24.9	1.9	0.1	0.0	0.0	0.0	0.8	0.6	0.6	3.1	4.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.4	0.1	0.6	0.0	0.3	0.0	0.8	1.6	1.0	0.0	0.0	4.6
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"		Yes	No		1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.3	4.7	0.0	0.1	4.9	0.5	2.4	9.6	4.6	0.0	0.1	7.8	155.5	0.0	52.3	0.1	11.1	0.1	0.0	22.5	0.3	0.0	0.0	1.0	0.2	3.4	20.3	0.0	0.0	0.5	0.0	4.1	0.0	102.6	70.7	0.0	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.9	0.0	0.0	0.1	22.6	0.0	0.8	3.3	0.2	0.0	92.1	0.1	5.9	0.7	4.5	0.0	0.0	0.0	6.3	0.0	1.8	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4	8.9	28.9	15.2	9.8	0.5	0.0	156.9	48.4	16.0	27.3	14.0	2.0	276.1	3.3	184.1	2.3	166.8	4.2	93.5	124.7	21.8	45.8	45.4	2.3	137.1	49.2	0.0	0.0	326.6	22.9	3.5	1.1	11.4	0.0	10.8	0.0	0.4	240.4	0.0	5.6	19.0	0.5	0.0	65.7	0.5	4.9	0.0	312.9	1.3	0.4	12.3
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 44.4"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					NA	NA		14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	44.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	7.2	0.0	0.0	0.0	0.0
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell type enriched"	"Detected in some"	37	"Glandular cells: 201.3"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA					"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.7	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	201.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.0	2.6
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 3.1;Late spermatids: 2.6;Suprabasal keratinocytes: 5.8;Urothelial cells: 12.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 20.2"	"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	1.6	0.0	0.0	12.6
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 1.8"	HPA059196	Uncertain					NA	NA					"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276280-43302255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 60.4"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	78	"EFO-21: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0			0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9			0.0		5.9	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	2.8
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773142-55825448	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA025024: AB_1854330, HPA029824: AB_2673212"	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	12.1	10.0	7.2	18.2	9.1	13.3	12.6	18.1	10.2	11.6	14.1	7.2	18.2	7.6	14.3	16.0	13.5	14.1	9.4	8.5	8.8	6.7	12.6	8.8	10.7	18.8	5.3	6.9	14.8	9.6	12.3	13.8	10.2	7.4	11.9	10.1	7.1	11.6	20.0	19.6	14.1	16.8	11.5	6.3	17.7	10.5	10.8	8.0	29.7	11.6	13.2	18.3	14.5	14.5	10.4	10.1	10.0	7.6	6.3	13.1	4.8	9.3	7.0	8.4	9.3	7.3	7.3	8.7	8.8	9.0	9.4	9.6	6.5	9.1	21.1	6.1	5.8	7.1	9.0	17.6	11.2	11.9	11.7	6.7	22.6	7.8	3.6	10.4	12.6	7.8	7.2	7.6	9.0	18.4	4.3	7.2	12.4	18.4	8.3	7.6	7.1	28.3	8.2	30.5	13.9	2.8	20.2	6.0	6.7	8.6	9.4	8.5	11.7	11.2	6.8	10.0	9.4	9.3	7.7	7.0	6.9	8.8	8.2	7.9	7.3	4.8	26.7	6.8	9.9	8.8	10.0	5.5	8.8	11.6	6.3	13.1	9.8	11.6	11.2	5.5	10.4	11.9	12.4	6.3	6.3	7.6	10.1	9.2	4.8	7.2	9.1	18.1	10.2	8.8	6.7	5.3	6.9	7.4	8.0	44.7	29.1	31.2	30.3	32.7	29.5	10.9	17.8	33.5	53.4	48.8	21.6	24.4	3.3	15.9	2.8	25.1	8.9	23.3	21.8	24.3	18.5	18.5	48.5	13.4	17.7	20.6	10.3	20.9	16.7	3.1	27.3	18.6	6.8	17.2	20.3	28.3	19.2	10.5	21.5	14.2	27.6	25.8	18.1	52.9	61.5	22.8	18.8	30.5	18.9	23.8
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 167.6;Paneth cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.4	21.9	8.6	18.3	4.4	4.3	30.5	18.4	6.8	18.3	14.8	25.7	9.4	26.6	9.0	7.1	12.8	24.0	12.7	15.1	7.7	0.1	26.6	9.4	24.1	30.4	4.7	18.1	14.7	4.8	5.4	15.2	6.8	5.2	10.4	18.0	21.8	13.0	7.7	22.8	20.1	34.0	25.2	8.8	30.2	16.7	11.4	25.1	7.6	17.1	23.3	18.5	16.1	14.5	8.9	4.6	14.0	17.6	11.7	14.1	12.1	30.0	31.1	22.8	19.1	17.9	15.7	30.4	16.7	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9	3.0	11.7	12.3	8.7	6.1	20.3	7.3	10.2	5.3	7.9	10.4	33.4	20.9	8.3	17.0	11.4	5.7	167.6	0.0	12.9	46.8	8.4	12.6	5.7	79.1	19.9	6.4	39.2	6.2	9.5	18.4	10.6	7.0	3.3	11.8	46.9	12.9	15.9	149.7	5.6	9.1	29.7	12.9	9.2	47.9	19.4	5.1	28.3	6.5	38.5	6.4
TIPARP	"DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1"	ENSG00000163659	"TCDD inducible poly(ADP-ribose) polymerase"	Q7Z3E1	3	156673235-156706770	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 174.1;Early spermatids: 204.3;Urothelial cells: 186.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 24.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036796			Approved	Microtubules		NA	NA			Microtubules		"HPA036796: AB_10672268"	"prognostic favorable (2.00e-5)"	"unprognostic (3.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (4.90e-3)"	31.6	29.8	10.9	11.1	24.7	31.8	19.9	7.1	16.3	16.2	12.7	14.2	18.8	6.8	18.3	20.7	27.2	27.8	18.8	26.5	16.0	9.4	14.2	21.3	20.2	15.2	16.2	6.2	37.0	14.5	73.8	11.4	6.1	30.9	13.6	7.5	10.0	8.2	36.0	17.4	26.2	22.1	21.6	37.4	8.4	11.3	23.1	12.5	8.4	10.8	19.1	13.8	18.7	16.7	3.7	3.3	24.1	5.4	7.0	6.0	2.2	12.5	8.8	3.0	2.5	11.1	8.2	2.4	21.0	17.0	10.7	14.9	5.0	26.2	3.7	6.8	23.8	14.3	13.1	7.6	50.4	15.9	7.9	5.6	6.3	9.2	3.4	4.7	2.1	11.7	6.6	31.6	10.9	26.3	29.0	9.7	2.8	4.9	15.1	37.1	2.4	1.8	2.8	3.4	15.8	7.4	3.1	6.8	12.9	11.3	6.0	9.2	2.3	16.5	5.1	3.5	7.2	7.9	3.7	21.0	4.6	1.5	8.7	7.5	16.9	3.0	3.3	7.9	3.3	15.5	24.1	3.5	4.7	4.2	2.2	6.0	1.9	4.2	5.6	2.3	3.7	2.6	3.5	10.7	7.0	5.4	3.3	4.7	2.2	10.9	24.7	7.1	16.3	16.0	9.4	16.2	6.2	30.9	12.5	80.4	77.0	6.1	84.9	174.1	4.4	21.3	30.6	46.8	81.9	7.0	37.3	3.3	18.3	29.3	204.3	26.0	33.2	0.0	20.7	6.8	35.1	72.6	116.2	17.0	17.1	20.6	52.3	13.5	16.1	11.0	18.1	36.2	35.4	20.8	21.8	7.8	28.1	28.1	18.0	8.2	9.4	12.9	57.7	61.8	20.2	106.1	6.3	34.5	12.3	186.7
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	13.8	20.1	22.0	32.9	21.0	14.4	26.2	18.3	23.2	19.6	20.2	8.4	22.3	13.7	16.1	16.1	14.1	14.4	16.2	12.7	20.6	19.3	19.5	21.4	22.1	33.7	21.7	20.8	21.5	19.8	37.8	21.0	36.0	18.3	18.0	18.2	10.8	16.4	30.3	18.6	15.4	18.9	20.5	18.7	26.0	19.9	24.2	12.2	28.0	25.7	11.1	21.7	21.9	19.1	10.5	5.3	11.3	5.5	9.5	12.3	6.6	8.6	8.5	12.3	9.6	8.8	8.8	13.6	12.1	17.6	12.2	10.2	11.7	14.2	18.0	9.9	18.1	13.2	7.4	15.6	13.5	13.4	21.4	7.8	20.8	10.6	15.1	9.5	26.3	10.5	9.6	13.8	24.2	16.0	13.0	13.3	11.6	21.3	15.4	7.3	10.8	22.1	8.4	11.3	8.4	4.8	16.7	14.9	18.6	10.0	16.7	14.0	10.9	13.1	9.3	8.9	8.7	7.6	9.2	18.1	10.9	13.4	7.1	9.4	12.9	21.7	32.7	13.5	10.9	10.9	11.3	3.9	6.5	6.6	3.0	9.1	10.5	10.7	7.2	3.5	10.5	12.3	8.1	5.0	9.5	5.5	5.3	10.0	6.6	22.0	21.0	18.3	23.2	20.6	19.3	21.7	20.8	18.3	12.2	47.6	23.8	55.6	30.2	36.7	31.7	26.5	28.1	33.5	29.6	48.8	56.9	70.8	74.6	24.8	57.8	27.4	38.0	23.3	28.2	44.9	25.5	42.8	26.5	30.0	23.9	42.9	23.0	12.3	25.7	21.5	40.0	26.9	35.4	15.4	31.6	25.5	28.4	34.8	42.1	38.3	72.6	0.0	28.8	29.9	22.6	34.3	146.2	48.0	28.0	31.4
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	"Tousled like kinase 2"	Q86UE8	17	62458658-62615481	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.9"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.53e-3)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.32e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.88e-1)"	"unprognostic (7.30e-2)"	7.4	6.4	8.3	7.3	7.2	12.0	12.5	7.8	14.0	5.8	7.8	4.0	3.1	7.4	9.0	3.1	9.0	6.2	9.9	17.8	7.7	7.4	5.7	5.0	6.9	8.7	7.7	7.3	8.5	8.9	5.6	6.9	9.0	10.4	6.6	5.3	7.5	8.6	8.7	11.7	8.7	10.1	6.5	8.6	8.9	6.7	47.9	5.7	4.1	11.7	3.1	10.0	8.5	7.2	4.6	3.6	8.6	2.8	6.6	4.9	1.5	15.8	14.6	25.2	26.6	8.2	10.7	14.7	17.5	13.6	20.7	19.0	15.1	14.2	31.0	9.0	11.4	18.3	10.8	17.7	7.5	19.8	16.4	14.1	21.1	13.7	15.2	14.7	22.2	13.4	9.2	10.2	13.9	16.9	12.7	10.2	17.7	20.8	14.1	11.1	34.5	31.6	7.9	16.0	9.3	12.2	21.7	33.2	9.8	9.8	15.9	27.2	36.7	14.9	10.2	22.4	22.1	17.3	20.0	13.8	29.1	27.7	13.1	19.7	16.4	20.4	28.4	12.0	11.4	15.2	3.7	2.8	8.6	2.5	2.2	2.6	4.5	4.4	3.1	2.5	4.6	3.5	4.6	5.5	6.6	2.4	3.6	4.9	1.5	8.3	7.2	7.8	14.0	7.7	7.4	7.7	7.3	10.4	5.7	29.8	22.4	16.6	13.3	20.1	58.1	26.4	12.7	38.8	12.5	14.0	78.5	9.5	10.0	8.7	90.3	13.1	14.6	23.3	8.6	9.8	15.0	18.6	19.7	8.3	10.8	27.0	17.2	11.1	14.2	128.6	19.5	18.0	16.9	10.0	14.2	23.8	12.6	23.0	16.6	6.3	82.2	6.5	16.0	73.9	28.9	19.2	12.7	14.1	15.1	20.0
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715298	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"	NA	NA					"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.8	16.8	14.7	22.8	31.3	12.2	20.5	28.0	34.2	16.4	15.4	14.0	16.0	17.8	22.1	21.7	16.9	18.3	16.8	20.2	17.1	18.2	19.2	19.9	23.3	25.6	14.2	18.7	16.0	16.3	20.4	19.3	19.6	26.8	18.7	16.9	18.2	14.6	16.3	14.1	16.5	21.1	21.1	16.7	26.3	15.2	11.1	11.1	29.6	19.2	13.4	22.1	19.9	14.8	4.9	9.6	3.4	6.9	7.6	8.7	4.1	3.4	5.5	10.7	8.3	22.1	23.7	7.9	27.2	29.1	19.8	22.2	2.6	10.2	9.8	5.4	39.5	8.4	13.0	7.0	13.6	30.5	9.3	6.3	9.0	8.7	4.5	23.5	19.0	14.9	18.8	8.8	21.4	19.4	20.3	25.1	8.6	5.7	13.7	23.5	2.1	10.2	6.0	4.5	2.8	9.0	9.5	21.2	11.9	16.8	7.5	10.3	8.0	13.2	8.6	10.0	11.1	5.6	16.3	24.0	35.5	9.7	7.9	19.8	9.2	9.2	9.2	21.5	15.8	25.9	2.6	4.3	3.4	6.1	6.9	8.7	4.9	6.3	5.6	6.9	3.6	7.1	6.9	1.1	7.6	4.7	9.6	6.4	4.1	14.7	31.3	28.0	34.2	17.1	18.2	14.2	18.7	26.8	11.1	26.8	23.8	18.0	14.7	18.0	26.7	19.3	15.3	33.5	17.0	15.7	17.7	12.5	1.7	13.7	2.1	24.0	10.8	0.0	8.8	17.9	26.7	15.3	19.7	22.1	16.4	25.4	17.2	30.1	22.9	2.3	22.5	24.0	23.6	7.2	13.0	24.1	13.2	11.9	15.6	5.7	31.8	38.8	20.6	18.2	26.0	21.2	10.4	19.3	7.6	14.0
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 79.9;Muller glia cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.9	2.1	0.3	0.0	4.7	4.1	1.2	3.3	2.2	17.8	7.4	0.0	1.5	3.8	3.0	6.1	2.8	1.1	3.6	0.1	4.4	27.0	1.5	0.0	9.5	5.3	30.8	2.9	3.0	1.9	0.4	7.7	19.8	4.5	9.7	0.0	0.5	0.4	1.7	6.8	8.2	14.2	7.7	0.0	5.1	7.1	6.4	0.0	0.9	1.0	2.5	0.2	4.4	2.2	9.0	1.3	0.2	0.0	3.5	9.0	3.0	0.0	0.0	0.0	0.9	6.0	23.0	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1	6.0	37.9	0.5	1.4	2.3	9.3	25.7	25.5	2.7	12.5	8.7	13.7	4.7	5.0	9.2	29.5	1.6	26.2	0.0	6.8	1.8	4.4	0.6	79.9	6.8	2.5	0.0	12.7	1.3	5.6	33.0	2.3	3.3	1.7	0.0	9.4	79.4	4.8	16.5	6.0	14.9	27.7	0.0	7.6	2.8	1.0	1.4	2.1	31.2	15.3	2.4
TNKS	"PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555914-9782346	"Enzymes, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	9.1	13.4	17.8	8.7	19.6	14.6	14.0	26.5	22.3	18.1	8.9	17.0	12.5	8.5	14.9	25.3	7.7	11.9	8.9	9.5	18.6	17.9	9.0	9.1	10.3	12.9	28.7	17.2	19.2	10.2	23.9	20.0	11.0	20.1	11.5	10.0	10.9	9.4	11.7	22.1	15.6	9.8	11.0	21.0	8.7	10.1	26.3	21.8	15.6	13.7	4.4	11.7	10.8	13.6	6.8	3.6	7.4	2.8	2.9	4.8	1.2	6.1	8.1	20.8	12.5	13.2	17.7	7.7	9.5	10.8	7.7	8.8	4.8	4.9	13.2	3.9	9.3	10.4	6.5	11.8	8.9	11.2	3.4	6.1	9.2	7.4	10.8	11.9	4.7	5.7	12.5	10.8	8.0	15.8	12.6	10.4	10.3	8.6	14.1	14.2	4.0	11.9	7.2	13.6	6.7	4.7	9.6	12.9	3.8	9.3	12.5	21.2	15.6	7.4	7.1	13.4	13.2	4.7	7.1	13.9	12.7	7.8	8.6	7.0	4.9	7.9	9.4	13.7	6.7	12.2	4.8	2.3	1.8	4.4	2.2	2.4	4.2	3.5	4.2	2.8	6.8	4.2	4.8	7.4	2.9	2.8	3.6	1.7	1.2	17.8	19.6	26.5	22.3	18.6	17.9	28.7	17.2	20.1	21.8	14.9	9.4	11.0	11.2	10.2	32.0	14.3	17.8	26.8	9.1	8.7	13.7	9.0	1.7	9.8	118.1	10.9	9.0	0.0	7.4	7.7	14.9	11.9	9.3	15.8	6.2	39.7	13.3	20.9	9.4	58.4	15.5	7.3	11.8	1.8	13.5	18.4	11.2	13.1	17.0	6.0	36.2	0.0	9.9	30.7	13.5	13.6	10.3	11.5	11.7	10.2
TNKS2	"PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798312-91865276	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	17.6	16.3	16.7	23.0	18.6	26.9	18.4	27.9	20.0	18.8	13.9	18.3	18.3	11.9	18.9	18.8	24.7	16.7	17.2	12.2	16.6	14.9	14.6	16.8	17.0	22.9	20.3	14.9	26.0	19.3	20.8	26.7	47.5	16.1	16.7	14.3	16.1	21.4	16.0	39.7	23.9	16.5	18.9	18.0	22.8	15.8	9.5	17.9	42.9	24.5	21.0	23.8	18.6	18.9	3.6	5.2	3.8	2.5	3.3	3.5	1.4	14.2	12.1	25.0	21.2	17.7	16.2	27.9	15.3	28.0	18.7	23.0	10.7	11.6	13.4	7.4	19.9	12.6	15.4	15.6	11.8	26.6	13.5	15.1	11.1	11.6	11.9	17.2	21.3	16.6	16.4	15.7	18.9	33.8	28.3	17.5	12.1	8.1	14.9	19.4	7.6	18.3	14.6	12.5	6.5	8.1	17.2	15.6	10.1	12.8	15.4	6.5	11.8	15.4	6.8	19.0	21.0	16.5	14.9	18.9	10.1	8.6	13.3	14.5	18.8	15.4	17.5	13.4	16.1	9.0	1.0	2.5	3.8	3.5	2.3	3.0	3.5	3.3	3.2	3.4	3.6	2.8	2.4	2.5	3.3	2.2	5.2	1.7	1.4	16.7	18.6	27.9	20.0	16.6	14.9	20.3	14.9	16.1	17.9	38.7	18.2	20.6	28.6	66.2	37.6	18.2	10.2	37.5	27.3	41.8	45.2	36.2	6.6	14.8	4.0	33.7	12.9	0.0	21.2	46.2	23.5	36.2	2.3	30.5	23.0	39.7	31.8	35.6	54.0	5.9	28.7	29.3	32.1	17.2	20.1	33.3	24.0	11.5	33.2	14.5	30.9	45.3	29.7	16.3	19.4	95.4	84.4	29.7	13.4	52.2
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Cell line enhanced"	"Detected in all"		"HEL: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.2	7.6	10.5	9.2	12.9	11.7	6.7	10.5	9.9	8.7	10.2	4.7	4.2	13.4	6.1	10.5	7.7	5.5	12.4	11.9	12.3	11.1	6.8	45.2	13.3	5.9	8.0	12.8	12.5	9.4	13.4	12.6	8.9	10.9	10.6	10.2	7.8	7.0	14.2	4.4	11.4	23.6	14.0	6.1	7.8	11.8	9.4	6.0	11.7	8.7	5.2	8.4	10.5	5.7	6.8	12.4	5.8	7.3	11.1	9.6	9.8	5.0	7.7	4.9	7.8	14.5	8.9	7.4	4.3	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0	50.6	20.6	26.5	37.9	41.9	48.4	16.8	28.1	18.7	38.7	24.4	35.3	25.9	16.6	21.0	148.7	37.9	22.0	0.0	16.2	14.5	27.8	32.6	40.5	20.2	15.7	52.4	44.0	22.1	16.6	13.0	30.8	27.2	18.6	27.9	18.4	48.5	18.7	22.9	30.8	19.1	38.4	19.4	37.1	51.9	49.7	41.7	42.4	34.1	19.0	41.6
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689779	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 70.6"					"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA					"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	11.2	14.5	12.7	12.6	15.3	9.6	16.8	8.1	20.3	14.1	11.7	13.7	5.3	8.8	14.8	8.9	16.9	12.2	12.6	9.9	12.1	11.3	12.7	13.6	10.6	18.2	13.1	12.8	15.3	10.1	11.8	15.7	14.9	12.1	15.5	11.4	12.6	13.8	12.2	12.4	16.8	11.2	12.7	10.6	13.2	13.3	26.4	11.8	21.9	16.6	13.1	21.1	14.3	12.7	14.7	19.1	21.7	12.4	16.2	18.5	12.2	4.0	2.8	5.9	5.2	6.3	5.2	5.4	5.7	5.3	7.5	5.5	7.9	2.6	9.7	8.6	4.7	6.8	6.3	7.5	6.5	6.6	2.4	3.8	9.8	2.8	7.0	8.3	6.3	70.6	6.9	8.0	5.2	5.2	3.5	4.9	4.1	6.6	4.3	6.4	6.0	9.5	10.5	4.8	5.8	9.4	5.6	5.3	5.7	5.0	4.4	7.1	3.7	6.9	13.9	27.6	3.2	5.0	7.0	5.0	8.8	5.1	5.7	6.3	4.7	5.8	7.7	5.1	4.8	4.1	21.7	12.4	20.6	13.7	11.5	15.8	14.7	14.8	15.6	12.6	14.2	16.4	14.0	2.0	16.2	10.2	19.1	18.5	12.2	12.7	15.3	8.1	20.3	12.1	11.3	13.1	12.8	12.1	11.8	8.9	12.5	16.4	45.5	45.1	8.7	5.7	12.7	5.3	10.3	8.7	11.8	36.5	23.2	24.6	176.8	13.1	10.9	0.0	20.7	62.1	26.2	45.0	23.0	12.1	23.0	14.3	12.6	12.3	13.1	26.3	20.4	12.4	35.4	20.8	14.8	8.0	29.4	3.5	15.2	25.4	9.8	6.5	23.7	35.2	15.3	54.1	74.1	17.5	12.3	49.2
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155074	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 48.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA					"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.3	13.2	11.5	6.6	10.2	4.9	5.6	13.1	14.3	4.6	18.2	4.1	6.2	18.4	6.5	10.1	8.9	4.1	7.6	6.5	9.0	8.0	40.2	36.2	6.5	6.2	9.3	7.5	3.8	9.4	12.9	11.6	3.3	8.5	6.2	19.4	6.9	12.9	7.2	7.0	5.7	29.4	6.2	7.2	9.4	6.6	4.1	7.5	5.4	48.2	6.3	5.3	6.4	5.6	1.6	16.9	3.7	23.8	5.4	8.3	8.3	11.9	3.6	4.1	10.0	6.7	13.1	10.0	13.9	15.5	11.9	18.6	8.4	3.0	1.5	10.4	18.3	9.2	6.0	5.7	10.0	19.9	7.9	8.2	9.9	6.2	12.3	7.4	4.5	8.9	7.5	10.8	13.3	8.5	7.8	16.5	6.8	19.5	2.9	8.6	5.5	4.6	6.2	6.7	16.6	10.5	5.8	10.0	6.7	13.8	12.3	6.6	5.1	9.1	16.2	17.8	10.6	11.7	4.5	7.0	27.4	5.3	14.3	19.7	4.1	18.5	3.9	9.8	6.2	27.4	3.4	12.0	3.7	6.5	23.8	8.3	1.5	5.3	6.2	16.9	1.6	4.8	6.5	1.2	5.4	19.6	3.7	8.2	8.3	11.5	10.2	13.1	14.3	9.0	8.0	9.3	7.5	8.5	7.5	14.9	13.3	18.0	32.1	37.9	15.1	15.4	22.9	4.0	6.8	33.2	21.6	17.3	97.8	34.1	1.2	11.7	80.0	0.0	32.7	21.7	11.7	34.2	23.0	79.7	40.7	6.4	23.1	12.3	34.5	1.5	3.7	56.7	23.6	19.8	31.8	22.9	51.4	78.6	9.6	230.3	16.8	0.0	14.7	0.4	8.1	30.2	14.6	23.5	36.6	71.2
TPP1	"CLN2, SCAR7"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612763-6619485	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 223.6;Kupffer cells: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		13000000			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	37.4	64.6	32.2	28.8	36.2	43.0	23.1	15.1	33.3	24.0	26.8	41.7	13.2	28.0	32.0	22.3	20.3	18.0	26.9	25.6	24.5	25.1	36.0	45.1	35.9	42.3	31.0	29.3	22.0	14.8	35.1	30.0	56.4	25.4	19.4	28.2	43.4	18.4	29.1	15.4	15.5	31.4	42.4	32.8	69.0	19.8	17.9	24.7	21.7	24.0	9.1	26.9	25.6	29.4	9.4	43.5	12.8	38.9	7.0	15.3	26.2	4.8	9.8	4.9	9.3	57.7	31.9	3.8	9.5	45.1	7.4	12.9	4.0	20.7	6.9	6.3	24.0	45.7	14.5	9.7	13.3	11.2	6.9	5.6	5.6	5.1	10.9	43.6	8.1	34.2	47.8	21.7	8.6	19.2	49.8	31.5	6.5	10.7	21.0	21.6	6.0	2.5	10.0	3.5	11.4	11.8	6.3	4.1	13.6	13.1	7.6	0.6	3.8	10.2	7.6	17.8	16.9	5.0	15.5	36.0	21.4	6.1	19.2	3.4	17.8	17.4	2.4	27.1	19.0	11.2	12.8	37.7	8.9	10.7	38.9	8.7	9.4	8.5	11.0	43.5	8.5	5.8	7.6	6.9	7.0	26.4	24.2	15.3	26.2	32.2	36.2	15.1	33.3	24.5	25.1	31.0	29.3	25.4	24.7	23.8	31.2	61.7	25.6	21.1	22.8	35.0	58.6	10.7	23.9	15.7	11.8	31.4	5.0	32.3	10.2	39.0	51.3	23.3	11.7	36.7	29.8	25.6	62.2	63.8	223.6	14.3	16.0	90.9	312.0	7.8	25.0	115.7	86.0	64.1	29.1	42.4	18.5	39.0	24.8	46.1	22.8	6.5	22.7	0.5	1.1	17.6	73.6	44.8	28.0	23.0
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240696-1242554	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	24	"granulocytes: 5492.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	308	"basophil: 30.8"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 30.8"	"Cell line enriched"	"Detected in some"	173	"HMC-1: 301.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA					"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	22.4	0.2	1.6	5.8	1.6	0.0	10.6	1.6	1.6	13.9	17.1	1.6	1.6	17.7	18.7	10.4	15.2	6.1	33.1	4.7	1.6	0.0	4.4	2.8	29.2	16.8	1.6	1.6	2.9	4.5	0.0	1.6	1.9	1.6	24.1	10.0	5.1	14.6	6.3	3.6	29.9	31.0	15.0	1.6	1.6	24.5	5.1	1.6	3.1	3.7	3.8	6.9	21.6	16.0	0.0	0.0	30.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	301.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.6	1.6	1.6	1.6	0.0	1.6	1.6	1.6	1.6	23.8	231.9	0.0	1.4	16.6	0.0	0.2	0.0	9.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	17.1	2.5	5492.7	0.0	5.5	0.0	0.0	0.0	0.3	0.0	0.0	9.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.1	8.7	0.2	1.0	0.0	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2 (gene/pseudogene)"	P20231	16	1227272-1230184	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.2"	"Cell type enriched"	"Detected in some"	18	"granulocytes: 8345.3"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	84	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.4"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 83.3"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		7500000			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	1.8	0.0	0.9	1.9	0.9	0.0	4.1	0.9	0.9	8.8	5.3	0.9	0.9	4.9	2.9	0.9	7.7	0.1	16.2	0.9	0.9		0.9	0.9	12.3	2.4	0.9	0.9	0.9	1.3	0.0	0.9	0.9	0.9	2.7	2.3	0.9	6.2	1.2	0.9	3.4	9.7	4.4	0.9	0.9	13.6	0.9	0.9	0.9	0.9	0.9	0.9	4.2	0.9	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	83.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											35.7	468.0	0.0	1.9	0.0	0.0	1.3	0.0	6.7	30.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.9	8345.3	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	4.6
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1258998	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"granulocytes: 189.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	65	"basophil: 6.4"	"Lineage enriched"	"Detected in single"	65	"granulocytes: 6.4"	"Group enriched"	"Detected in some"	48	"HEL: 18.7;HMC-1: 28.6"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA					"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	6.6	0.1	0.6	3.8	0.6	0.8	3.7	0.6	0.8	3.2	5.6	0.6	0.6	2.7	7.5	3.3	7.6	2.3	13.0	2.0	0.6	0.0	1.3	2.3	17.0	13.7	0.6	0.6	0.6	0.9	0.1	0.6	0.9	0.6	4.3	0.4	3.1	3.6	0.7	1.6	7.8	9.3	4.7	0.6	0.6	15.7	3.5	0.6	1.6	1.1	2.8	2.6	8.9	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.8	0.6	0.0	0.6	0.6	0.6	0.6	3.0	11.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	189.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.7	26.6	15.2	27.2	15.8	29.8	17.9	16.0	20.2	18.9	17.1	32.3	26.8	13.3	19.0	20.4	12.1	24.4	14.2	28.4	7.2	21.0	18.2	19.0	35.4	24.7	20.9	20.2	27.6	29.5	23.8	18.2	23.9	15.6	36.5	26.4	20.3	18.0	18.0	47.5	20.7	23.5	29.9	28.7	13.0	38.7	25.3	26.7	15.2	11.2	30.7	25.5	13.4	25.8	17.5	8.3	29.3	24.9	27.5	23.0	32.4	21.4	17.4	26.1	19.3	17.6	13.1	13.1	17.8	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6	0.0	8.6	11.9	15.5	25.5	14.6	3.4	17.8	4.0	4.5	14.0	5.9	20.5	14.9	35.4	3.8	23.9	60.0	0.0	51.6	30.1	20.0	27.8	9.2	26.1	37.6	35.0	32.6	23.4	38.3	9.1	23.0	18.8	10.1	35.1	35.9	10.5	45.1	40.3	20.8	18.9	8.9	6.5	16.0	4.8	21.5	28.4	22.3	12.9	33.8	29.6
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.7	20.8	20.2	2.0	1.4	0.0	0.0	0.0	10.9	3.0	2.1	0.2	3.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	6.9	4.6	2.0	0.0	0.0	0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	1.4	0.0	1.8	0.0	0.0	3.3	0.0	30.7	0.0	6.9	0.0	2.2	0.3	0.5	0.2	0.0	1.3	0.2	0.0	0.0	0.0	0.0	47.8	27.3	0.3	0.0	0.0	1.5	0.3	2.1	2.9	12.7	7.4	0.6	0.0	0.4	0.1	0.7	0.0	0.1	0.0	0.7	0.1
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.9	13.2	7.1	9.7	5.4	4.4	33.6	9.1	6.1	10.6	8.5	16.1	12.2	10.5	10.2	6.1	7.0	22.7	8.6	8.8	4.5	11.6	20.6	8.7	12.2	8.6	14.6	10.9	13.2	6.0	14.0	11.0	5.5	5.4	5.2	17.2	19.7	13.5	5.4	9.0	13.2	17.2	18.1	11.8	11.7	13.0	6.4	12.6	6.9	17.1	11.9	21.8	7.6	21.6	12.0	3.0	15.3	18.3	5.8	6.8	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.8	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8	3.0	7.2	3.9	12.3	14.1	12.6	2.8	7.6	4.0	7.9	1.8	2.0	13.8	14.9	13.0	105.9	8.3	22.7	0.0	9.7	12.0	7.0	15.1	5.7	4.9	10.0	4.8	13.8	6.7	10.0	12.4	8.9	9.7	5.0	25.2	16.1	8.1	14.3	17.3	7.1	6.3	1.7	6.5	9.7	5.5	11.8	16.9	47.9	24.9	13.4	22.9
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.5	15.0	8.9	9.8	18.1	13.0	6.7	12.2	13.4	13.9	11.7	10.0	7.2	6.8	5.4	18.7	10.4	14.0	10.8	13.7	12.7	5.9	5.2	3.6	9.7	6.1	9.4	2.4	12.0	11.2	12.4	13.1	7.8	15.4	9.0	7.6	5.0	5.8	16.3	8.4	6.4	0.0	8.1	15.8	9.1	7.6	24.0	4.4	5.7	15.3	8.9	4.5	9.6	6.7	6.9	9.4	18.5	2.4	11.1	13.0	10.4	9.5	9.1	9.5	2.5	10.6	10.8	1.6	12.7	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2	6.0	1.1	3.0	5.1	3.8	11.5	6.1	7.6	6.7	5.7	8.7	0.0	6.0	1.7	7.8	2.8	2.4	2.4	0.0	7.0	3.6	6.5	2.8	2.3	3.9	5.8	1.6	4.1	2.5	2.7	1.3	4.9	1.4	1.7	1.0	5.2	4.1	4.9	3.5	11.3	2.2	4.5	0.0	3.6	9.8	11.1	3.1	6.2	4.6	4.9	3.4
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	13.1	7.1	13.4	10.0	5.7	6.0	22.9	6.7	7.2	9.4	10.0	8.0	5.6	14.1	7.0	7.8	6.1	7.6	12.2	7.8	13.0	10.6	7.2	13.6	9.4	9.3	6.3	17.1	11.3	5.7	5.8	11.1	11.4	7.2	7.8	12.0	16.9	10.0	8.9	49.4	17.2	7.3	18.1	5.0	7.2	14.9	20.5	4.6	6.7	20.7	9.3	9.8	12.7	15.4	12.1	9.0	7.0	9.4	8.8	6.5	10.6	15.1	9.4	7.0	6.5	14.7	9.2	10.0	18.5	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3	17.9	29.5	19.1	25.9	46.9	71.6	22.0	25.5	10.7	25.0	52.4	92.3	49.7	1.7	18.3	155.1	31.1	23.6	23.3	20.5	27.8	32.1	38.2	36.9	40.5	26.3	25.4	50.1	37.4	44.7	78.9	45.5	39.2	18.6	17.2	31.4	33.5	25.3	32.6	34.6	12.6	58.2	32.3	23.7	54.0	29.6	48.4	73.3	35.5	28.9	48.8
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663557-5938619	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	12.5	15.0	3.7	11.6	6.7	3.0	10.7	2.4	5.1	14.2	8.5	4.8	20.1	8.4	16.1	19.9	12.0	11.9	9.9	7.8	5.6	2.9	15.1	16.2	15.2	9.2	6.5	2.9	15.3	24.8	6.1	9.2	12.2	8.8	11.8	8.3	11.8	22.0	12.4	3.0	6.5	13.2	12.0	9.0	19.8	9.5	7.7	6.5	24.9	20.5	7.9	13.3	14.8	12.3	3.9	11.7	13.8	9.8	5.9	5.4	4.6	4.7	7.3	12.5	8.7	13.9	12.8	3.7	10.1	18.8	20.6	27.9	7.4	9.4	3.0	7.9	9.9	16.6	7.8	10.1	14.7	9.3	6.5	2.8	9.1	5.0	5.9	12.3	6.7	9.8	9.7	13.2	6.8	18.1	12.8	31.7	6.6	9.5	6.2	17.3	2.2	5.5	3.1	5.7	7.0	5.1	8.6	2.7	0.8	14.3	9.0	0.3	0.7	7.1	10.3	4.4	12.7	5.3	3.9	23.9	9.7	12.9	1.8	2.4	5.5	3.9	1.2	9.0	4.5	10.0	10.2	9.8	12.9	5.4	9.8	5.3	3.9	4.1	4.3	11.7	3.9	3.4	4.9	13.8	5.9	9.2	9.7	3.3	4.6	3.7	6.7	2.4	5.1	5.6	2.9	6.5	2.9	8.8	6.5	6.0	9.4	12.9	8.1	4.6	0.1	4.8	2.5	2.7	13.6	10.4	0.0	6.5	5.0	10.5	3.2	11.6	5.9	0.0	7.7	8.4	8.9	11.0	0.0	11.1	5.7	0.0	1.2	13.5	11.5	2.3	7.2	7.7	3.3	1.8	8.6	5.7	9.0	3.5	7.1	5.7	0.0	19.4	6.8	5.8	3.6	4.6	6.5	5.7	5.6	8.2
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 236.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"ASC diff: 10.7;SK-MEL-30: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.8	0.0	236.2	10.2	0.0	0.0	1.8	0.0	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15.0	11.7	12.6	15.8	10.9	11.0	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14.0	19.8	16.0	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10.0	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.3	4.4	10.7	5.1	23.0	30.2	12.3	11.5	13.7	9.2	10.6	2.8	4.9	2.8	8.6	15.5	22.5	3.8	1.8	5.4	19.1	7.9	2.5	1.5	12.0	3.5	11.9	3.8	4.3	14.1	5.7	32.5	10.4	8.7	8.1	1.9	0.3	1.9	22.3	2.3	0.0	2.6	2.7	1.3	4.0	2.8	6.5	9.5	9.0	5.6	4.9	19.7	9.7	2.5	5.1	14.1	1.5	0.6	18.8	17.8	11.3	12.9	13.5	0.0	0.6	3.6	63.2	2.5	4.2	0.3	1.5	0.0	0.1	1.9	0.3	2.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15.0	11.0	17.7	12.3	11.5	17.9	23.4	9.0	13.2	14.5	29.9	15.7	10.2	16.0	22.7	10.4	13.7	7.6	0.0	18.3	1.9	24.8	13.6	0.0	12.1	17.8	12.4	32.5	17.3	15.3	13.2	27.0	17.3	11.1	12.3	2.4	72.8	16.8	5.0	6.4	21.7	7.1	29.1	16.1	40.3	2.9	3.0	6.5	11.5	2.8	6.4	12.0	6.9	4.6	17.1	20.1
TRIP12	KIAA0045	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763838-229923239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	29.6	28.1	23.6	25.4	26.9	26.9	23.1	20.5	26.2	24.0	23.1	26.2	24.3	14.3	25.3	26.3	30.6	19.9	20.7	35.9	19.0	19.3	26.2	24.9	26.2	26.5	23.1	20.5	24.3	18.8	32.4	33.1	27.2	24.8	25.8	21.3	22.3	25.5	22.0	62.7	23.6	22.0	26.2	23.3	32.5	23.4	77.1	24.0	42.2	28.0	21.5	31.5	26.5	27.4	7.0	9.1	25.8	12.0	9.1	12.7	6.1	24.1	27.3	25.1	21.0	23.9	29.1	23.3	37.4	25.3	27.1	30.2	21.9	19.4	9.4	27.4	33.3	34.8	18.9	36.5	26.6	39.7	38.7	13.3	65.8	22.9	19.3	20.7	49.4	43.0	25.2	20.5	45.0	28.9	21.1	35.3	23.8	48.6	10.2	30.9	18.4	27.6	17.1	19.6	12.3	12.5	25.1	49.5	8.3	20.1	41.6	25.5	18.2	0.5	12.5	25.7	22.8	12.7	30.3	49.0	35.2	25.0	22.8	28.8	17.7	20.2	30.9	26.8	19.5	29.4	18.8	9.9	15.7	9.5	11.3	9.7	7.0	8.8	9.2	9.1	6.8	7.3	7.0	25.8	9.1	12.0	9.0	12.7	6.1	23.6	26.9	20.5	26.2	19.0	19.3	23.1	20.5	24.8	24.0	83.4	49.3	17.2	24.2	27.5	29.6	80.3	38.2	65.6	51.2	29.6	49.1	23.6	13.3	31.9	89.6	47.2	37.6	0.0	38.7	20.9	28.2	43.4	37.1	48.3	30.9	39.7	17.9	58.3	81.5	79.5	32.2	36.5	25.3	26.2	30.2	28.2	45.3	32.3	42.8	26.2	32.5	19.4	30.1	113.9	53.0	31.7	35.5	27.7	25.5	54.5
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39841022-39883511	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.5	10.3	12.9	10.4	19.1	8.0	19.8	25.8	18.4	15.1	13.4	15.9	22.7	11.4	19.3	21.3	19.8	18.4	9.1	15.9	12.5	12.0	14.6	13.2	11.9	14.8	13.9	10.4	16.7	27.7	14.1	26.7	17.6	14.4	21.4	15.8	13.5	15.1	23.9	10.1	22.9	11.7	18.0	9.8	14.0	12.9	17.3	17.9	15.4	19.2	9.4	14.7	17.2	17.5	3.9	13.4	0.9	6.6	2.4	5.2	2.8	14.7	6.8	14.8	15.1	7.4	11.2	22.4	9.8	13.2	15.8	17.8	13.1	19.5	8.6	13.0	8.4	9.5	15.1	21.3	16.9	22.2	10.4	10.8	18.3	15.8	8.1	17.1	17.7	10.0	9.4	15.3	19.8	19.6	16.2	12.7	18.9	24.7	10.3	9.9	7.2	13.5	19.1	19.9	11.2	6.2	14.4	18.6	19.6	15.0	19.0	16.8	11.2	14.1	9.6	10.8	16.4	10.7	30.4	9.1	10.6	13.0	18.2	16.2	14.0	11.0	17.3	13.4	18.1	9.1	0.0	6.6	0.9	2.7	4.9	5.2	3.9	2.6	2.9	13.4	3.2	3.4	3.5	0.1	2.4	5.8	11.6	2.7	2.8	12.9	19.1	25.8	18.4	12.5	12.0	13.9	10.4	14.4	17.9	20.8	5.6	4.4	14.1	13.2	3.1	8.9	7.6	20.1	10.3	7.0	2.0	27.7	6.6	9.5	3.6	5.1	3.2	0.0	8.1	30.0	8.3	6.6	2.3	5.8	7.2	14.3	9.8	8.6	6.2	2.0	8.9	6.8	5.0	7.2	8.2	5.2	9.2	7.0	10.6	7.0	7.3	0.0	5.2	18.6	16.7	14.9	13.8	3.5	8.9	9.0
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.4	10.4	11.3	19.2	11.5	14.8	16.2	17.4	8.7	19.2	16.7	11.1	12.7	19.4	22.8	9.3	10.0	14.3	18.9	15.3	8.9	12.6	26.4	15.4	26.8	18.7	20.9	30.8	18.2	20.9	20.6	19.9	18.8	12.3	14.1	14.5	33.3	6.2	11.9	17.1	12.5	33.3	26.8	9.8	24.5	21.1	14.6	26.7	11.9	15.7	26.9	12.2	10.8	22.6	18.1	8.6	8.8	17.3	15.6	27.7	10.8	16.7	30.4	10.8	20.8	17.9	12.9	32.7	14.4	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1	11.9	16.2	35.0	22.3	21.3	8.0	6.4	12.7	10.7	4.5	12.2	2.0	19.4	5.0	14.1	16.4	17.5	6.3	0.0	12.8	18.8	13.9	10.4	28.9	8.6	41.5	7.9	6.9	7.4	88.1	36.5	13.0	39.6	16.9	23.4	9.6	5.8	12.2	5.8	12.0	11.2	11.1	12.9	16.5	21.7	18.3	18.1	12.9	18.7	17.4	18.4
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986430-126039276	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	10.0	12.6	14.3	12.5	17.7	3.6	15.5	33.9	19.4	17.9	12.6	9.4	11.2	16.1	25.9	15.1	13.2	12.8	12.9	16.1	15.0	12.6	18.8	28.0	10.1	12.4	12.7	16.4	19.2	10.4	15.9	38.1	13.3	15.4	12.8	15.0	14.8	11.7	13.8	10.6	7.4	20.6	15.7	15.2	9.6	12.9	9.8	11.1	8.0	18.0	9.8	13.7	11.5	12.5	8.0	4.7	1.3	2.0	7.5	11.7	4.0	8.6	6.5	13.2	2.8	6.9	7.5	7.8	7.4	11.3	8.1	12.0	19.9	9.1	12.2	13.6	4.8	17.0	12.0	14.3	7.5	12.4	9.8	20.5	9.5	12.9	24.8	11.9	15.6	2.6	7.5	7.2	9.5	15.6	12.8	3.6	5.2	21.6	2.4	8.4	13.2	7.2	8.2	9.3	8.6	8.3	4.9	10.0	7.3	9.5	5.4	16.6	7.8	9.1	8.3	16.1	9.8	6.5	12.6	3.6	5.4	4.1	12.4	12.9	6.7	0.7	3.3	11.0	12.1	9.4	1.3	2.0	0.0	6.8	1.5	11.7	8.0	9.1	7.5	4.1	6.7	11.4	10.4	0.3	7.5	0.7	4.7	6.8	4.0	14.3	17.7	33.9	19.4	15.0	12.6	12.7	16.4	15.4	11.1	6.0	22.4	12.3	23.6	11.8	57.1	11.4	20.4	25.4	25.0	7.0	68.7	16.7	16.6	15.9	7.7	10.5	8.0	0.0	14.1	12.2	17.6	11.7	18.4	21.5	6.4	19.1	8.7	4.9	6.5	3.0	23.9	6.9	3.3	14.4	9.6	20.7	12.4	14.0	23.0	23.3	75.1	6.5	12.1	9.5	7.0	8.8	12.5	5.7	12.8	16.0
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	7.8	14.5	10.0	7.5	14.8	13.6	14.2	7.6	6.9	10.4	11.0	13.1	15.2	8.6	19.1	5.2	16.0	10.2	16.8	10.0	10.3	10.2	7.3	8.2	11.0	13.3	10.3	12.1	13.7	6.5	13.6	10.6	10.8	11.1	11.4	11.7	21.6	11.9	12.4	6.6	9.2	7.1	16.5	16.2	3.0	10.9	14.4	13.7	10.0	8.8	8.9	7.9	14.8	14.5	10.3	23.9	14.8	6.8	11.0	9.6	7.7	6.6	10.2	19.1	25.6	13.7	6.3	10.8	9.2	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8	11.9	10.4	9.8	7.8	2.4	8.7	25.8	10.2	45.5	15.9	15.7	7.9	13.5	23.2	9.3	32.0	7.0	7.9	0.0	5.3	9.1	7.4	5.4	8.1	20.2	11.2	3.2	5.8	8.6	13.7	15.5	11.5	12.8	1.7	18.0	7.9	9.5	6.6	10.5	11.3	18.8	8.2	0.0	5.2	83.9	26.0	2.0	9.5	7.5	7.1	4.7
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	10.0	4.3	9.7	8.1	5.7	10.8	11.3	8.0	16.1	12.6	14.1	2.8	7.1	8.1	10.1	7.0	9.7	18.2	10.1	13.8	4.6	24.5	8.5	15.3	16.6	6.9	16.2	5.8	5.4	11.4	16.7	5.3	6.7	10.3	3.7	11.7	1.7	9.8	11.4	6.3	13.2	16.1	6.6	17.6	7.4	9.2	13.2	8.0	7.6	10.2	12.3	10.0	11.8	19.0	5.6	6.7	6.7	7.5	7.2	12.9	10.2	12.6	4.2	4.5	7.6	10.2	11.8	14.5	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9	8.9	6.7	12.6	9.5	5.6	25.1	12.4	5.1	9.4	5.7	10.4	15.7	20.8	23.2	18.2	0.8	11.9	11.4	23.3	16.7	17.5	10.3	9.9	9.2	16.6	13.8	12.7	12.0	15.4	11.8	1.7	14.1	8.3	8.5	17.2	9.8	11.0	16.7	10.5	15.9	22.8	26.2	6.5	11.7	18.2	13.2	8.4	12.8	10.1	15.3	8.2
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TSSK1B	"FKSG81, SPOGA4, STK22D, TSSK1"	ENSG00000212122	"Testis specific serine kinase 1B"	Q9BXA7	5	113432554-113435031	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"testis: 59.9"	"Group enriched"	"Detected in some"	101	"Early spermatids: 408.3;Late spermatids: 766.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027827	Enhanced					NA	NA					"HPA027827: AB_10603138"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.6	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.0	1.3	0.2	2.1	0.0	0.4	0.4	0.2	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.7	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.6	0.1	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.5	0.2	0.2	0.3	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	408.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	766.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	5.8	3.2	0.0	0.0	0.0	0.0	0.0
TSSK2	"FLJ38613, SPOGA2, STK22B"	ENSG00000206203	"Testis specific serine kinase 2"	Q96PF2	22	19130808-19132623	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"testis: 95.7"	"Group enriched"	"Detected in some"	70	"Early spermatids: 1437.9;Late spermatids: 2322.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.8;SCLC-21H: 3.5;THP-1: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.0	1.6	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.8	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.8	1.4	0.5	0.0	0.2	0.1	0.9	0.3	0.0	0.3	1.2	0.0	0.0	1.0	0.4	0.0	0.0	0.5	0.1	0.8	0.3	0.7	0.2	0.5	0.2	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1437.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2322.2	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	6.5	0.0	26.9	11.5	0.0	0.0	0.0	0.0	0.0
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 68.1"	"Group enriched"	"Detected in some"	52	"Early spermatids: 242.3;Late spermatids: 839.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	1.1	2.0	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1.0	0.9	0.8	0.0	0.9	1.3	1.4	2.4	0.8	0.8	2.0	1.2	0.0	0.8	0.8	1.0	1.0	0.0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6.0	3.5	0.0	1.2	5.4	0.7	1.1	0.0	0.0	0.5	1.2	1.2	0.9	0.0	1.0	3.7	0.0	0.0	0.0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0.0	1.3	6.3	0.0	4.6	3.1	5.8	0.0	0.6	1.4	1.5	1.5	0.4	1.2	1.9	1.7	4.4	0.0	1.9	1.8	3.8	0.8	2.8	4.1	4.4	1.9	2.7	2.9	2.1	3.4	3.0	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.2	0.0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0.0	0.0	0.1	0.8	0.8	3.9	0.8	0.8	0.0	0.8	0.8	1.0	0.8	0.0	0.3	0.0	0.4	0.1	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	242.3	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	839.4	8.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	8.9	0.6	1.4	6.5	0.0	10.3	3.8	0.0	0.2	0.0	0.2	0.2
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205697-24208362	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 46.1"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0.0	0.6	0.6	0.6	0.6	0.0	0.6	1.4	0.6	1.0	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1.0	0.6	2.1	1.7	2.0	1.0	1.8	2.0	0.7	1.0	4.1	4.0	1.5	0.1	0.0	4.3	1.6	0.1	0.0	0.0	2.1	3.7	3.1	0.9	0.1	0.8	3.8	0.0	0.1	0.0	1.6	3.1	3.5	4.8	3.0	0.0	1.5	3.8	0.0	0.0	0.0	0.6	3.6	0.1	3.7	1.3	2.0	0.0	3.8	3.6	1.7	0.7	0.9	3.2	3.0	1.6	2.7	0.0	5.3	2.2	2.1	2.7	2.5	0.8	1.8	1.6	1.8	1.4	2.9	1.8	3.8	1.3	4.3	4.8	4.8	1.0	2.8	0.9	0.0	1.0	2.0	2.0	1.0	0.7	2.0	1.6	1.6	0.6	2.1	1.6	1.7	2.0	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	178.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0
TSSK6	"CT72, FLJ24002, SSTK"	ENSG00000178093	"Testis specific serine kinase 6"	Q9BXA6	19	19512418-19515685	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"testis: 50.8"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5597.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.39e-1)"	"unprognostic (7.20e-5)"	"unprognostic (3.38e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-4)"	"unprognostic (2.28e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.89e-2)"	0.9	1.2	1.0	1.2	1.5	1.3	1.0	0.9	1.9	0.9	1.1	2.2	1.6	2.1	0.9	3.7	1.1	1.1	1.0	0.7	1.2	0.8	1.8	2.2	0.7	1.2	2.5	1.0	0.9	3.3	1.1	1.0	0.6	1.3	1.4	0.6	0.9	1.3	1.0	1.0	2.7	1.9	1.2	1.9	2.1	1.7	50.8	1.7	3.1	2.0	0.1	1.7	1.1	1.0	3.1	1.0	2.2	0.7	0.4	3.8	0.8	1.6	2.7	0.1	1.1	0.4	1.0	8.0	1.1	0.5	0.6	0.3	4.2	1.3	1.4	2.0	0.0	0.5	1.4	0.5	1.1	0.2	1.0	1.9	0.7	1.7	0.9	1.2	0.9	3.2	0.6	1.0	0.6	1.9	0.6	0.3	5.4	1.9	0.8	0.0	0.5	3.4	2.0	3.7	0.8	4.4	2.7	0.7	1.2	0.1	0.5	0.6	2.9	1.6	0.4	1.4	0.4	2.6	0.7	0.3	2.0	0.6	3.9	1.7	3.5	1.4	0.8	2.2	1.2	1.9	0.0	0.6	2.2	0.8	0.2	1.1	3.1	1.7	2.0	0.3	1.9	3.8	2.1	1.1	0.4	0.7	1.0	1.0	0.8	1.0	1.5	0.9	1.9	1.2	0.8	2.5	1.0	1.3	1.7	0.0	0.0	0.0	0.2	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.6	5597.9	44.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	53.7	0.1	0.0	19.4	0.6	51.3	21.7	0.1	0.1	0.0	0.0	0.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.7	7.8	36.3	6.8	35.0	51.1	12.6	24.0	29.9	10.8	14.7	10.2	11.0	18.8	8.4	40.2	10.1	7.2	10.9	14.8	15.3	19.9	7.8	38.0	11.6	13.4	12.8	21.2	12.3	26.4	9.1	11.0	9.8	21.8	16.0	16.7	22.8	22.1	20.3	16.8	20.6	5.5	10.3	14.5	13.2	27.6	17.4	9.9	12.6	16.9	27.7	21.1	29.8	17.1	15.4	8.7	19.4	8.3	20.9	15.5	6.2	19.0	9.0	22.2	15.9	18.8	25.6	21.2	11.7	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9	116.1	118.5	109.7	81.2	58.5	344.6	127.3	56.0	75.0	101.2	71.5	214.0	39.6	140.9	74.9	160.4	67.6	60.1	0.0	65.5	79.7	132.8	164.9	62.4	80.5	56.3	311.4	182.6	102.5	80.0	149.3	194.5	74.4	200.8	61.3	133.8	187.6	72.0	84.2	245.4	81.7	228.9	51.8	103.8	264.1	280.4	54.8	44.1	76.7	118.3	90.4
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482154-112541739	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	4.4	4.0	9.9	4.2	11.9	7.1	11.3	5.0	12.5	3.3	4.1	9.2	2.5	3.1	4.6	4.2	5.2	3.2	4.9	10.3	9.4	6.5	3.9	3.3	5.9	4.4	8.1	5.3	3.2	3.8	4.1	2.4	5.3	5.9	3.2	3.9	2.6	3.0	3.7	13.1	6.0	3.2	5.8	5.4	4.0	3.2	3.0	6.5	5.1	4.2	5.2	3.8	4.8	2.9	1.8	1.2	2.7	1.3	1.0	1.3	0.5	3.7	2.9	3.7	8.2	4.4	6.3	1.4	6.4	5.3	6.9	5.9	3.5	1.4	3.5	3.6	5.5	4.5	2.6	6.4	3.3	8.3	2.4	3.6	2.9	4.1	4.4	2.0	4.1	1.5	2.8	2.3	10.0	5.3	3.1	5.8	2.4	4.8	2.8	5.4	1.9	3.6	2.3	3.2	1.1	5.8	3.9	4.1	1.9	2.1	2.9	7.8	5.4	5.0	1.7	8.9	2.5	1.7	2.4	5.8	8.2	6.0	6.4	4.8	1.6	3.1	2.9	9.0	3.1	3.5	2.7	1.3	1.0	1.3	0.8	1.1	0.8	1.0	1.0	0.4	1.8	0.9	1.1	2.4	1.0	1.1	1.2	0.8	0.5	9.9	11.9	5.0	12.5	9.4	6.5	8.1	5.3	5.9	6.5	11.9	8.3	3.7	4.2	18.0	16.4	32.0	5.1	2.7	7.9	12.2	11.8	2.6	0.0	6.0	6.1	13.0	5.0	46.7	8.3	2.1	9.4	5.0	0.0	9.4	10.2	7.9	10.9	20.9	24.8	3.6	2.8	15.5	6.8	10.8	5.5	9.1	8.6	5.8	5.3	4.9	21.2	6.5	9.0	1.9	4.3	15.7	1.0	6.1	5.2	3.7
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173884-1197935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"testis: 48.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 234.3;Late spermatids: 619.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Cell type enriched"	"Detected in single"	29	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"NK-cells: 2.9"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA					"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.2	0.0	0.1	0.1	0.5	0.0	0.6	0.1	0.2	1.7	0.1	1.0	0.1	0.0	0.2	1.1	0.1	10.9	0.1	0.1	0.3	0.3	0.1	0.1	3.1	0.1	0.1	0.3	0.7	0.1	0.0	1.3	1.5	2.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.5	48.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.2	0.3	0.3	0.1	0.3	2.2	0.3	0.0	0.3	0.0	0.5	1.5	0.0	0.6	2.5	54.9	2.3	0.0	2.0	0.0	0.0	0.2	234.3	0.5	0.0	0.0	1.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	619.5	4.9	0.0	0.0	0.0	3.1	0.2	0.9	0.0	4.2	0.0	0.0	6.5	0.0	2.8	2.1	1.8	0.1	0.0	4.1	1.0
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell type enriched"	"Detected in many"	134	"Cardiomyocytes: 19161.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 4.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.8	1.8	0.0	0.0	0.0	2.4	2.0	3.7	2.7	1.1	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.7	1.4	1.8	2.2	1.2	0.4	0.4	1.6	2.5	0.4	0.2	1.8	1.3	4.9	1.3	0.0	0.6	1.1	1.7	0.4	1.3	0.0	1.7	0.8	2.4	1.6	0.0	0.0	0.9	0.4	3.6	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	14.9	142.6	2.2	0.2	0.8	28.9	19161.7	17.8	5.3	11.4	0.0	19.6	0.4	1.7	7.7	35.3	0.7	0.0	0.0	23.6	0.2	0.5	0.1	9.3	0.5	0.2	15.9	4.1	2.5	0.0	4.3	1.1	0.4	0.0	0.0	0.0	10.3	0.9	0.0	4.2	0.0	26.3	0.0	1.4	5.7	0.2	0.1	0.3	4.9	0.0	0.0
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	46.0	47.9	54.8	83.2	37.5	34.2	24.2	30.7	32.7	44.2	36.0	38.0	35.2	34.4	20.4	61.4	65.4	44.6	68.7	65.3	32.4	28.5	69.8	21.5	53.1	30.5	26.4	36.2	46.5	32.1	34.2	64.2	50.1	31.6	57.8	41.4	23.3	30.9	43.8	58.4	34.1	32.0	58.4	27.9	74.9	39.8	38.3	58.5	35.3	49.7	35.5	26.7	91.4	44.5	20.4	61.4	61.8	22.6	42.2	33.2	38.5	47.7	28.6	21.2	22.0	49.1	34.1	25.9	39.6	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6	47.6	32.5	35.6	30.6	29.9	25.4	44.0	71.4	29.4	29.6	78.5	15.7	42.1	29.9	67.7	29.3	28.1	83.5	23.3	78.8	52.0	36.1	52.8	17.4	40.8	53.6	11.1	55.2	46.1	45.1	41.8	39.1	34.8	18.6	66.7	64.2	20.0	108.7	57.9	61.9	49.5	24.4	38.8	40.3	8.8	19.6	36.8	59.5	26.6	52.5	48.1
UBA2	"ARX, FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Sertoli cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		9400000	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	49.2	23.5	25.1	29.5	28.4	30.6	70.9	44.3	30.4	26.5	25.4	20.7	24.0	17.8	32.3	24.2	27.4	25.1	23.7	31.0	25.6	27.7	22.8	25.5	24.5	37.8	26.9	23.2	30.3	29.4	28.8	26.8	39.1	25.1	25.1	23.9	20.7	20.9	31.5	56.3	29.2	20.4	28.8	27.4	28.6	20.9	56.7	19.9	55.9	25.9	27.1	34.4	29.2	38.9	8.6	10.8	7.7	6.2	8.5	13.0	3.6	28.9	42.4	43.5	18.0	23.6	19.3	17.8	22.6	19.5	29.3	32.8	36.3	17.7	54.2	35.0	18.4	18.2	11.8	46.0	17.6	41.4	38.8	31.1	57.5	21.7	36.2	30.5	45.6	25.0	13.9	22.5	20.7	36.5	19.7	22.9	23.4	56.9	30.8	25.7	28.9	35.1	25.3	32.6	45.3	14.7	28.0	30.0	24.1	20.6	30.3	37.0	36.3	20.6	19.0	30.4	29.6	13.6	56.0	14.8	33.0	23.0	21.0	40.5	32.5	46.1	52.5	20.9	34.9	29.0	5.9	4.8	7.7	8.4	5.0	11.2	8.5	10.5	12.1	6.0	8.6	13.0	10.4	0.6	8.5	6.2	10.8	8.0	3.6	25.1	28.4	44.3	30.4	25.6	27.7	26.9	23.2	25.1	19.9	23.8	33.6	45.4	55.0	77.3	59.3	31.9	22.9	29.4	30.7	17.4	39.3	60.6	28.2	38.5	10.7	46.7	15.5	23.3	36.4	83.5	49.3	42.2	38.1	23.6	41.7	44.5	44.2	20.3	31.3	18.0	40.3	35.2	72.6	45.1	28.5	45.3	35.2	21.0	49.8	28.3	35.0	265.1	176.3	193.3	196.1	81.2	77.6	35.2	44.9	68.2
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	26.5	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	32.4	33.8	16.9	11.4	17.6	34.6	9.6	17.8	18.3	24.9	34.1	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	31.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9	32.8	28.9	17.1	23.8	30.0	21.0	57.2	20.4	37.5	23.9	33.2	37.3	64.4	16.6	30.4	10.9	27.1	14.3	0.0	20.5	47.2	31.1	21.5	40.5	16.2	30.1	31.8	17.9	20.3	43.2	7.9	37.4	39.1	28.7	53.3	15.3	27.7	25.3	8.6	35.7	26.4	44.9	25.8	29.3	32.3	33.0	37.4	47.5	33.8	16.6	28.2
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	15.1	8.5	14.1	11.0	7.0	8.2	9.5	31.4	12.3	14.4	16.9	8.9	20.5	19.2	11.2	12.9	14.7	9.0	14.5	15.6	21.8	22.1	4.0	12.3	15.0	8.3	6.0	21.6	9.5	5.9	5.0	18.6	11.3	9.9	12.7	9.9	29.2	11.4	17.0	5.7	22.4	4.9	8.3	10.8	10.3	13.3	28.9	7.1	11.8	17.2	6.9	8.7	17.7	12.6	5.9	12.3	8.4	5.8	18.3	13.4	15.1	10.8	13.7	8.2	6.4	19.4	23.8	6.0	12.8	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6	23.8	20.8	33.8	52.9	62.3	46.2	14.4	12.7	25.4	20.5	15.7	51.1	22.4	3.3	21.4	1.4	34.4	21.2	0.0	14.8	12.9	28.2	64.5	30.1	17.3	20.5	31.8	31.0	17.8	27.9	4.0	19.8	35.3	23.6	33.3	24.7	19.8	36.7	21.0	18.7	10.2	42.3	19.4	23.0	37.9	35.1	40.4	49.2	29.9	19.6	126.8
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805207-49813946	"Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1400000	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	11.3	12.1	6.8	22.0	7.5	16.0	11.5	2.0	6.7	10.8	12.7	14.4	25.4	19.6	17.2	31.6	17.7	12.9	33.1	9.1	6.7	3.9	15.9	11.9	18.8	28.2	6.0	6.2	19.1	9.5	1.4	8.4	8.9	9.4	18.5	12.1	14.2	24.5	34.2	3.3	9.0	25.5	11.3	7.7	35.9	13.2	3.4	5.9	20.4	17.8	18.4	23.5	12.6	13.1	12.4	14.3	24.8	21.7	11.1	11.8	13.0	4.3	0.0	0.3	0.1	12.2	12.9	1.4	2.3	10.6	16.9	22.7	0.0	9.3	0.1	1.9	8.6	7.3	2.4	0.0	4.2	1.5	11.3	0.0	21.2	0.2	1.3	9.0	2.0	41.2	19.8	0.2	6.6	0.4	11.8	8.5	0.7	0.0	1.3	3.9	0.1	4.3	5.1	0.0	0.0	0.4	5.5	0.4	0.7	3.5	8.6	0.0	0.3	2.8	4.2	1.4	0.2	0.4	14.1	3.7	3.3	0.4	1.4	0.9	0.0	0.0	0.1	9.2	7.5	0.7	13.9	14.7	24.8	11.8	21.7	10.3	12.3	10.8	10.5	14.3	12.4	9.9	8.9	4.6	11.1	17.2	5.2	10.6	13.0	6.8	7.5	2.0	6.7	6.7	3.9	6.0	6.2	9.4	5.9	29.8	23.6	22.9	5.9	3.4	0.1	6.9	15.3	2.7	13.6	12.2	0.0	4.5	0.0	7.6	4.5	14.3	35.5	0.0	6.9	2.2	8.9	5.1	80.8	6.7	18.2	0.0	9.1	17.8	21.9	24.1	10.3	10.6	0.0	10.8	19.5	2.9	5.1	12.9	10.6	4.1	1.1	6.5	7.1	0.9	0.4	4.1	2.4	27.4	15.3	5.0
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	31.1	26.3	16.6	14.0	29.0	35.8	15.5	32.4	28.9	38.5	36.6	13.6	21.5	24.7	32.9	35.6	64.7	22.5	23.6	17.1	37.2	34.2	14.0	10.9	21.0	12.1	26.6	27.2	18.8	24.4	24.5	37.0	16.1	27.2	26.7	22.1	13.4	22.1	43.6	33.0	42.0	25.8	27.6	32.9	29.8	21.5	17.6	23.0	31.1	20.5	12.7	13.1	43.0	19.8	23.5	21.6	17.3	23.9	26.0	24.8	11.1	48.9	36.5	21.4	34.8	24.3	26.4	34.6	19.3	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5	95.3	39.2	51.3	71.2	110.8	14.0	62.9	48.4	83.0	53.4	38.4	29.5	150.4	86.2	88.0	32.0	62.8	76.2	46.7	89.2	129.6	86.9	77.3	55.4	31.6	116.0	7.9	43.7	44.2	59.6	10.6	34.2	89.3	79.2	168.7	43.9	37.6	102.2	80.7	38.2	92.2	34.3	45.3	103.2	39.1	30.0	111.8	425.3	58.0	43.9	88.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	35.5	9.3	19.6	18.6	17.1	18.5	31.6	26.7	14.1	17.2	20.5	28.3	23.9	19.4	32.3	17.0	47.0	14.2	14.8	19.7	18.8	30.7	16.0	10.6	25.9	30.3	20.0	12.6	21.9	15.9	27.0	15.6	13.2	23.2	14.7	16.2	19.5	35.3	15.5	20.7	20.0	33.4	8.4	10.6	8.9	20.2	21.6	27.0	15.4	27.5	26.5	20.6	21.0	9.9	46.4	22.2	21.3	34.8	29.1	20.0	14.0	26.9	29.2	29.5	40.3	27.4	22.6	23.9	19.9	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7	68.5	53.6	80.6	311.1	324.0	73.3	287.9	109.5	50.9	37.5	71.5	76.6	127.7	145.9	138.0	194.0	119.9	104.0	210.2	148.2	103.0	162.4	304.2	116.3	90.1	106.8	82.6	126.4	82.3	121.3	244.2	143.5	139.6	215.9	189.4	109.5	124.2	180.7	129.8	106.4	130.7	89.5	148.8	178.2	201.6	171.6	323.2	605.1	89.5	82.7	405.3
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 397.1;Extravillous trophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"		Yes	Yes			"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.3	28.9	52.2	25.0	1.4	3.2	30.0	31.3	15.9	51.6	37.1	94.9	45.6	41.8	30.7	14.9	64.3	38.9	0.2	33.5	52.7	17.8	27.5	12.9	22.2	24.9	0.4	18.4	32.3	1.0	3.6	34.9	34.2	7.8	25.1	26.7	0.2	35.6	42.4	64.9	30.3	5.2	31.3	44.8	69.3	32.2	47.3	0.2	17.4	13.7	30.1	25.1	49.3	36.1	19.8	27.4	36.5	27.1	9.1	46.3	40.5	31.4	60.5	11.3	0.3	46.5	28.1	13.1	43.8	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5	0.0	5.9	29.5	3.6	15.3	0.0	0.0	2.5	0.0	7.9	0.0	0.0	15.5	0.0	0.8	5.8	0.2	5.5	397.1	0.4	368.9	5.1	2.7	5.7	3.9	75.1	0.0	1.2	22.7	19.9	5.4	0.9	9.3	0.0	1.8	12.8	0.0	1.0	6.2	0.0	0.0	0.0	0.0	1.9	6.1	18.0	10.2	26.1	10.1	15.1	8.2
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.7	5.8	10.9	14.0	22.4	18.1	7.1	7.1	12.1	8.1	12.0	11.8	9.3	0.0	11.2	10.6	6.0	9.8	21.1	10.3	11.5	11.1	12.4	2.8	2.1	6.7	14.7	8.5	6.9	20.9	11.6	8.5	15.8	11.0	16.2	7.5	5.5	4.5	11.0	3.4	9.1	9.5	13.4	6.5	9.2	7.7	9.9	5.9	12.2	6.3	8.3	11.1	13.9	23.5	11.3	17.5	8.6	5.7	13.1	3.1	10.9	10.6	7.8	11.6	9.0	9.5	9.9	17.7	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4	11.9	9.1	36.6	70.2	172.6	16.8	82.7	20.4	12.0	15.9	26.2	17.7	26.7	64.6	55.7	3.4	26.3	20.4	0.0	37.1	42.2	48.3	73.3	23.0	12.3	68.9	15.9	39.9	20.3	88.9	2.2	30.8	81.6	50.6	49.5	35.6	15.8	57.2	16.4	30.4	41.3	13.7	6.5	58.7	28.6	16.0	166.2	124.6	28.7	24.7	105.6
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	34.1	22.8	40.0	27.9	27.0	34.7	25.6	36.1	33.8	42.6	49.9	58.6	32.5	48.8	47.6	37.2	52.7	21.7	39.2	60.9	57.1	31.5	22.9	27.7	25.2	33.7	52.9	27.0	24.7	27.2	31.5	42.3	63.3	36.9	45.4	32.3	24.0	41.8	39.5	34.3	41.6	38.5	22.0	12.0	24.8	31.8	41.6	35.3	44.8	40.4	36.5	24.1	31.5	40.6	57.4	89.9	25.4	24.0	29.7	32.6	18.1	27.0	44.1	30.1	48.9	68.5	23.3	44.6	25.9	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3	29.8	71.1	173.0	150.9	152.6	68.0	80.9	79.0	36.1	43.3	64.6	76.6	160.4	182.4	173.6	500.3	117.4	113.7	70.0	156.3	191.8	125.8	164.5	136.2	71.0	157.1	89.0	118.5	93.9	121.3	409.1	96.7	157.7	145.1	191.2	112.3	128.4	182.8	103.7	88.1	147.6	99.0	116.4	156.8	337.7	125.2	178.2	208.7	191.8	148.1	221.1
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	53.5	30.7	51.2	41.3	54.7	79.0	44.0	54.5	72.7	48.7	46.0	46.0	76.5	57.4	35.7	55.3	63.2	30.7	54.6	73.2	67.1	53.2	27.5	52.2	31.6	37.5	57.4	73.4	45.0	59.9	46.4	53.7	75.3	63.0	63.1	47.3	65.6	58.7	64.8	43.2	107.7	41.8	37.1	61.3	30.7	56.8	50.3	41.4	49.1	51.2	51.8	43.6	33.5	86.1	61.5	63.1	35.7	43.4	57.9	51.0	43.6	33.3	49.5	52.0	67.0	87.8	54.3	40.9	54.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2	154.9	181.2	227.9	605.7	749.7	127.0	210.7	150.3	190.1	129.7	132.6	117.8	279.1	464.2	286.3	668.3	228.0	265.9	93.5	333.2	474.9	260.0	477.5	219.4	203.4	354.6	116.0	231.0	159.0	357.1	423.2	152.5	359.3	339.1	356.1	198.5	111.8	351.4	245.4	140.0	328.0	157.1	103.5	376.3	128.5	151.0	711.0	533.9	297.5	192.3	680.6
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 25.3"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.8	3.2	2.0	9.1	9.4	3.8	1.5	1.9	4.7	2.4	3.2	1.7	4.6	3.7	5.3	5.0	6.8	4.4	2.5	2.1	3.7	8.3	4.2	4.0	5.0	4.4	3.5	8.7	8.2	2.9	4.4	2.7	4.2	3.5	3.0	4.6	4.4	7.8	3.3	2.5	5.1	5.0	4.4	4.7	4.2	3.2	2.8	5.8	5.1	4.7	7.4	25.3	4.0	8.1	3.0	3.8	4.0	2.6	2.6	1.6	5.1	3.4	5.5	11.2	8.4	1.8	4.8	11.4	8.9	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1	0.0	6.2	8.8	8.1	5.6	8.3	21.8	5.1	2.7	6.8	15.7	2.0	9.7	46.4	15.9	5.0	11.9	8.4	0.0	24.7	17.3	10.8	9.8	4.6	22.2	24.7	11.1	18.0	9.2	7.3	8.0	11.2	12.9	15.1	24.4	7.1	9.1	14.6	5.8	20.5	38.0	10.4	6.5	12.0	15.1	8.3	9.8	6.4	6.9	7.9	9.3
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805903-23891316	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	32.0	28.1	50.8	34.7	44.4	56.1	52.6	38.7	43.4	41.9	40.6	32.4	27.5	23.9	35.3	35.6	57.9	29.5	29.9	58.5	47.3	43.2	33.6	34.0	34.9	44.9	52.0	36.9	36.5	32.0	41.6	22.5	44.5	38.1	38.5	37.8	23.2	30.3	36.4	52.2	33.3	25.8	44.1	55.6	36.3	29.9	24.3	43.3	33.8	41.4	38.0	47.3	52.2	46.3	6.7	7.6	6.8	9.1	7.0	7.2	4.1	33.9	21.4	33.7	16.8	20.6	30.1	29.5	25.7	40.0	28.9	38.8	16.1	37.6	30.1	21.8	24.8	24.6	11.0	39.8	31.8	37.9	36.3	44.5	41.5	16.1	19.6	29.7	40.9	22.1	28.4	30.0	36.8	49.5	34.0	45.9	21.1	29.0	33.5	23.1	17.5	28.7	44.5	49.5	18.7	54.9	32.0	14.8	86.5	45.0	24.3	9.8	35.1	23.0	21.4	37.0	35.2	24.0	54.1	29.8	21.2	26.3	15.7	19.1	28.0	16.5	59.5	22.9	39.3	16.4	2.4	8.4	6.8	4.5	9.1	6.5	6.5	5.4	3.8	7.3	6.7	7.2	4.3	3.3	7.0	5.8	7.6	3.9	4.1	50.8	44.4	38.7	43.4	47.3	43.2	52.0	36.9	38.1	43.3	41.7	28.2	30.6	52.3	64.2	26.4	54.9	28.1	46.8	28.4	17.4	3.9	83.0	48.0	80.0	20.6	53.7	35.4	0.0	68.5	82.1	57.3	58.6	40.3	19.1	88.2	19.1	44.5	42.4	63.6	39.3	37.7	75.5	92.8	111.0	36.1	49.9	62.2	59.6	45.6	32.6	20.9	51.8	80.2	36.3	62.2	78.9	60.3	35.4	44.6	59.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	6	"B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	22.7	11.4	19.2	12.0	23.3	7.6	15.9	18.8	32.7	22.4	14.5	20.8	7.5	5.9	17.7	31.9	19.7	12.0	18.5	23.4	21.3	21.8	19.1	15.8	16.7	17.7	14.1	19.7	19.0	9.8	15.5	14.4	9.0	20.9	18.2	6.4	8.4	11.2	17.0	32.0	14.8	7.2	22.4	17.6	15.9	11.1	17.8	13.3	14.8	16.8	11.1	14.5	17.0	16.2	14.8	27.1	0.4	18.3	0.8	3.6	5.2	17.1	6.2	16.3	0.3	14.5	16.2	14.8	10.8	18.5	10.2	14.4	1.7	14.1	14.9	7.5	9.5	14.1	1.7	11.8	16.9	13.2	0.1	11.9	0.0	7.3	2.0	10.4	0.0	12.0	12.8	17.8	14.7	24.8	10.5	9.8	11.8	0.8	15.9	9.2	2.7	7.8	3.3	11.6	9.8	9.0	16.4	6.3	17.1	10.0	0.4	4.2	8.7	11.9	7.0	0.2	12.3	15.0	9.9	8.5	10.1	14.3	6.7	12.2	15.3	5.0	22.0	9.5	6.7	2.8	0.0	15.2	0.0	0.2	17.8	0.3	12.3	0.5	0.2	20.9	14.8	3.6	1.3	0.4	0.8	18.3	27.1	0.2	5.2	19.2	23.3	18.8	32.7	21.3	21.8	14.1	19.7	20.9	13.3	20.8	9.8	36.3	10.5	22.8	22.7	32.7	20.4	5.3	4.5	29.6	15.7	28.0	58.0	12.3	17.6	20.4	0.0	0.0	25.6	33.5	29.3	47.2	0.0	38.4	44.7	30.2	1.7	14.7	43.5	12.0	36.5	55.4	74.2	35.1	0.7	10.9	13.5	0.3	49.8	98.2	2.9	32.3	50.9	33.5	99.2	36.9	32.3	2.5	0.5	5.1
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 115.4"	"Low region specificity"	"Detected in all"							"HPA003303, HPA030445"	Approved					NA	NA					"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.08e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	29.1	23.9	35.6	21.1	33.0	20.1	49.7	37.4	62.9	30.4	25.2	18.6	19.8	23.0	26.6	29.2	23.1	29.7	35.9	37.8	43.9	32.5	36.0	29.6	28.5	37.6	31.5	31.9	27.7	29.9	42.9	21.6	23.9	30.5	20.9	27.8	24.6	26.3	22.7	76.8	28.1	26.2	24.1	41.3	20.4	28.3	28.1	21.5	30.9	37.4	27.8	23.0	31.8	23.0	7.7	29.7	25.6	16.9	8.5	12.0	9.6	17.6	8.1	115.4	4.0	34.3	44.3	18.4	23.7	30.0	20.0	25.0	8.7	21.5	8.7	20.8	32.3	16.8	7.6	69.6	24.3	36.0	21.2	21.0	30.1	10.9	24.1	16.5	13.9	14.4	17.4	22.7	17.5	16.9	20.4	26.3	18.3	15.3	16.3	49.0	9.7	25.3	13.1	22.0	12.1	38.2	24.8	11.8	20.7	34.0	15.6	20.1	22.5	10.3	11.0	9.7	33.0	5.9	20.7	24.2	39.0	25.7	22.8	27.5	14.3	9.1	24.5	38.4	5.5	21.6	13.0	14.0	25.6	9.3	12.3	11.1	7.7	7.3	12.0	9.2	4.9	7.8	8.5	13.2	8.5	16.9	29.7	2.8	9.6	35.6	33.0	37.4	62.9	43.9	32.5	31.5	31.9	30.5	21.5	8.9	21.6	43.9	66.6	91.4	128.2	30.3	89.2	34.8	33.0	52.4	27.5	34.3	193.9	78.5	28.7	62.5	41.0	70.0	89.6	68.0	102.0	68.5	23.1	44.5	72.1	71.5	57.4	65.7	57.3	50.1	58.1	56.9	123.2	35.1	42.3	53.3	82.5	28.1	33.9	136.3	56.9	25.8	51.2	91.9	204.0	107.0	30.1	59.0	46.5	88.8
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 231.1;monocytes: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037444	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	14.5	18.4	21.3	13.6	17.6	19.9	17.2	12.2	19.8	16.7	15.8	17.7	12.3	13.6	14.7	32.2	25.0	11.0	16.3	34.6	20.2	21.6	14.6	24.1	12.9	26.4	23.4	10.1	10.4	62.8	16.3	13.2	22.2	24.2	14.9	19.6	11.4	15.3	18.2	32.1	10.3	17.9	20.2	20.2	14.6	15.1	13.9	16.8	15.8	32.9	17.4	17.7	18.7	16.4	10.9	23.1	35.6	30.0	39.9	29.1	24.6	13.5	7.7	17.8	18.2	23.2	28.3	25.2	12.7	18.3	14.4	14.8	8.4	8.7	7.0	4.6	28.5	31.4	11.5	20.1	27.7	22.6	10.6	7.8	9.6	9.8	27.4	29.2	4.0	22.7	16.2	45.8	19.0	29.0	13.4	25.5	33.0	29.3	4.5	26.0	20.3	10.9	17.7	19.6	19.5	11.8	13.3	11.8	12.4	21.7	5.7	11.9	17.8	14.9	11.3	23.6	31.2	10.2	16.8	15.8	15.9	14.0	18.0	13.6	5.6	4.3	13.7	18.8	12.2	11.7	35.6	21.0	25.2	29.1	27.6	11.5	10.9	19.9	17.6	18.6	10.1	18.6	18.8	15.6	39.9	30.0	23.1	20.5	24.6	21.3	17.6	12.2	19.8	20.2	21.6	23.4	10.1	24.2	16.8	6.0	20.2	41.4	18.8	28.8	21.7	44.5	28.1	24.1	5.7	26.2	7.9	72.4	48.0	42.5	17.3	25.5	37.0	70.0	68.9	231.1	37.6	41.8	20.8	40.0	129.2	25.4	40.1	23.9	54.8	47.2	23.9	61.5	33.7	312.0	46.7	15.8	69.1	29.2	29.0	52.2	19.3	38.8	35.6	90.0	52.7	35.3	54.9	47.3	30.7	31.1
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.1	21.6	15.8	17.7	18.7	30.8	20.8	16.7	19.8	17.5	15.9	10.9	33.4	21.8	20.4	16.2	23.1	26.8	19.3	32.0	17.5	21.8	12.5	12.3	18.1	17.4	18.1	23.7	15.9	28.9	18.8	27.4	14.0	26.5	22.5	21.8	36.2	16.3	9.5	23.0	16.6	23.8	15.8	12.0	29.9	11.4	30.5	23.1	14.0	9.3	17.4	19.6	17.1	16.1	33.3	16.7	11.9	19.8	19.9	15.2	23.3	23.2	14.1	16.5	47.2	15.3	17.0	15.3	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6	20.8	11.8	63.6	34.1	254.1	16.5	62.6	30.6	13.4	13.6	24.4	5.9	36.7	69.6	27.6	105.5	28.7	35.4	0.0	23.2	45.9	34.4	47.3	20.7	52.9	41.3	14.3	36.9	32.5	36.1	173.0	18.1	34.1	64.1	33.3	32.7	23.0	32.9	27.5	19.8	61.3	13.9	6.5	47.9	63.9	47.7	209.5	55.8	43.3	26.8	53.3
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44802019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved					NA	NA					"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	30.9	20.7	18.9	22.8	20.9	25.8	21.1	21.0	21.6	18.9	22.7	20.5	19.8	14.9	22.2	18.4	19.3	20.5	18.0	37.1	18.3	17.1	26.2	27.3	19.7	19.7	19.0	17.0	18.1	30.2	22.1	26.0	17.0	18.9	18.3	16.5	18.6	15.4	28.3	50.8	15.6	16.9	28.5	17.8	23.8	20.2	14.0	18.8	18.4	20.6	18.7	21.6	20.9	18.9	11.9	17.5	5.9	13.0	14.0	17.3	12.1	15.8	3.3	10.9	14.1	15.0	6.5	10.0	11.2	8.7	9.8	10.7	12.6	2.1	20.5	10.8	11.1	12.8	6.4	16.0	13.5	8.9	19.2	16.5	33.4	2.3	10.1	11.9	24.6	5.7	10.6	16.0	13.1	12.8	4.3	15.4	23.2	31.0	14.3	13.5	7.1	27.2	2.9	28.4	11.0	14.2	22.3	10.1	18.4	12.8	8.5	12.7	22.7	15.8	5.1	16.1	10.5	5.0	21.4	10.9	9.5	6.8	8.8	18.1	22.5	44.3	20.3	9.5	29.1	11.2	2.3	11.6	5.9	16.0	11.8	17.3	11.8	14.7	16.2	12.5	11.9	15.7	16.6	3.6	14.0	13.0	17.5	14.6	12.1	18.9	20.9	21.0	19.3	18.3	17.1	19.0	17.0	18.9	18.8	53.6	111.1	38.9	31.3	42.4	53.2	62.9	33.1	54.9	61.4	50.6	62.8	35.1	21.6	28.3	52.3	44.9	23.7	0.0	34.6	19.9	31.7	31.1	41.7	58.7	31.0	30.2	28.8	38.1	32.5	135.1	38.3	37.1	27.0	32.5	25.2	36.8	34.2	17.3	47.4	29.6	96.5	25.8	32.3	26.1	49.0	48.9	30.0	30.5	38.7	35.8
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021"	Approved					NA	NA		120000			"CAB009021: AB_2210610, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	34.3	43.1	28.8	36.3	36.9	48.4	45.2	45.6	48.5	38.1	32.0	28.6	28.1	28.9	55.4	32.9	43.4	35.6	30.3	41.8	27.4	28.4	29.4	26.6	29.1	44.2	22.7	32.9	62.5	35.5	33.4	36.2	47.2	21.4	40.7	31.0	34.1	37.8	32.2	31.6	35.8	32.2	40.0	23.2	43.7	29.4	43.6	21.6	78.0	42.5	31.8	53.9	38.7	38.8	82.2	58.0	85.4	67.4	50.9	57.8	60.0	25.5	35.2	59.5	35.0	25.5	30.9	25.7	36.8	26.6	34.3	34.2	41.7	42.0	44.5	30.6	31.7	31.2	31.1	42.5	34.6	44.2	31.9	30.0	27.8	32.6	40.2	40.4	41.2	33.2	28.6	22.4	33.6	40.1	33.3	37.0	37.0	39.8	28.0	32.3	54.4	72.7	41.5	48.4	28.9	26.1	92.4	37.7	50.5	31.9	23.5	33.7	35.6	32.3	36.7	36.6	35.5	37.3	50.0	30.5	34.0	39.0	29.8	33.2	29.6	35.0	90.7	19.1	30.6	36.0	63.9	59.3	85.4	48.0	67.4	57.8	82.2	49.0	48.7	58.0	61.8	44.1	44.2	41.3	50.9	62.3	50.1	50.9	60.0	28.8	36.9	45.6	48.5	27.4	28.4	22.7	32.9	21.4	21.6	47.6	65.0	161.9	150.2	158.7	57.7	79.1	79.0	46.8	86.4	59.3	47.1	272.2	89.5	194.9	43.7	106.6	69.9	46.7	129.2	244.2	135.3	169.8	105.3	33.7	188.2	44.5	98.2	78.5	89.4	24.8	120.3	128.8	121.4	250.7	90.2	79.4	176.3	97.7	101.1	89.7	59.4	77.6	104.9	123.1	163.1	180.8	349.7	134.6	123.3	223.4
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352848	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 501.0;Late spermatids: 1092.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 63.8;Karpas-707: 55.2;U-266/70: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA					"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	18.7	17.3	14.6	47.1	15.4	52.7	28.2	19.1	13.6	18.8	25.9	11.3	24.4	28.0	19.5	18.4	19.2	18.0	19.9	17.1	14.4	14.7	18.7	33.5	20.4	52.0	17.0	9.5	17.2	46.1	11.5	13.6	27.5	13.0	22.9	26.3	10.7	42.1	33.2	12.5	11.3	36.3	17.9	18.9	45.8	24.4	17.7	14.4	42.5	17.6	16.4	47.7	21.7	21.4	20.7	23.7	15.9	17.8	6.4	6.4	6.1	8.3	2.9	8.1	10.3	8.5	11.1	0.0	13.3	11.8	8.2	9.1	4.7	5.2	63.8	7.4	13.7	6.9	3.4	5.3	7.7	13.5	8.9	8.2	11.6	3.8	7.7	22.6	14.5	7.6	8.4	7.7	6.9	11.8	11.1	18.4	7.6	9.3	55.2	9.6	5.1	6.0	11.2	2.8	5.9	4.2	23.9	10.5	30.5	10.3	5.9	4.1	8.3	5.6	12.4	12.3	12.3	4.9	32.3	12.3	4.6	4.4	8.1	10.2	62.1	30.8	17.5	9.1	10.5	7.6	10.3	6.6	12.3	3.4	11.1	4.0	20.7	4.6	4.2	6.5	13.4	4.3	3.9	15.9	6.4	17.8	23.7	6.4	6.1	14.6	15.4	19.1	13.6	14.4	14.7	17.0	9.5	13.0	14.4	14.9	33.4	95.3	52.5	22.0	31.9	8.1	30.6	22.7	18.2	19.2	27.5	69.3	43.1	55.4	501.0	59.9	55.1	0.0	88.1	72.0	50.7	96.3	24.3	37.6	70.2	22.3	74.2	98.8	102.2	1092.2	50.6	55.8	69.2	46.9	54.1	14.7	86.7	70.2	44.9	36.1	13.7	32.3	55.6	20.7	19.6	30.4	108.2	36.2	57.4	100.2
UBE2J2	"NCUBE2, Ubc6p"	ENSG00000160087	"Ubiquitin conjugating enzyme E2 J2"	Q8N2K1	1	1253909-1273885	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 350.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.46e-2)"	24.4	22.2	17.5	21.6	17.1	19.4	33.0	23.8	24.9	17.8	22.0	17.9	19.9	22.0	22.9	21.4	25.2	21.8	20.7	21.2	17.5	17.1	21.6	27.3	17.4	27.4	15.9	15.4	19.4	36.3	14.4	22.8	22.6	15.9	16.9	16.2	18.7	24.2	20.2	29.8	23.2	23.6	19.3	13.1	25.2	22.2	68.3	12.8	26.1	22.8	21.7	23.8	18.3	19.3	24.5	22.3	39.6	23.0	22.0	25.3	17.7	25.7	10.7	15.3	14.6	12.4	12.8	11.9	19.9	15.8	27.2	19.9	19.0	18.8	13.9	21.3	18.4	15.0	18.8	15.5	19.8	21.7	23.5	27.8	20.9	21.0	17.1	24.1	19.1	20.1	12.0	11.1	21.3	15.9	14.9	19.1	19.0	28.8	13.8	15.7	12.8	27.7	21.5	16.5	17.0	26.9	25.8	14.2	22.9	14.1	8.7	56.4	27.9	13.7	29.6	31.4	14.5	15.2	21.8	15.6	16.5	15.8	19.1	20.3	30.4	29.5	38.8	21.2	30.4	13.0	38.2	23.0	39.6	22.0	22.2	20.1	24.5	23.4	22.8	22.3	21.7	21.2	20.9	32.6	22.0	21.3	20.8	25.3	17.7	17.5	17.1	23.8	24.9	17.5	17.1	15.9	15.4	15.9	12.8	8.9	15.9	25.3	40.7	37.9	27.4	16.7	33.1	6.7	21.6	27.9	7.9	59.9	48.0	58.6	187.2	33.6	39.3	0.0	81.4	63.5	40.5	45.1	16.1	24.1	46.5	22.3	16.8	23.9	23.0	350.9	34.8	33.1	38.8	45.1	36.5	29.9	79.3	31.6	35.3	57.4	25.4	32.3	40.3	121.4	83.7	38.1	73.0	44.7	38.2	51.2
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		150000	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	24.2	24.9	13.4	12.7	8.4	7.9	22.8	33.4	7.1	9.0	9.4	37.6	25.0	30.3	29.4	9.4	22.1	10.2	25.8	14.6	14.4	20.3	18.5	39.2	25.2	32.5	10.6	42.1	22.2	7.4	16.5	12.6	13.6	9.4	11.7	13.3	39.8	10.9	9.2	23.5	29.3	23.4	17.8	14.0	19.0	17.3	40.3	11.3	12.5	33.8	27.9	12.3	25.0	9.5	14.9	15.5	12.2	14.1	32.0	14.0	29.7	16.6	30.7	15.4	45.0	33.3	7.3	27.0	16.4	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9	53.6	50.8	35.6	49.5	109.2	60.1	57.3	45.9	71.0	67.1	47.1	27.5	74.8	56.3	76.3	97.5	58.3	92.6	70.0	77.7	144.5	61.6	76.6	33.5	101.0	71.4	98.5	57.3	61.4	71.5	150.7	60.4	73.4	54.0	103.6	63.5	70.2	109.4	73.0	53.0	81.7	38.2	38.8	67.9	71.4	46.9	120.6	123.3	48.4	65.5	98.3
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 110.3"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.9	14.4	21.1	16.5	23.1	20.7	12.2	21.1	24.1	27.1	25.8	16.4	12.1	23.6	10.6	27.9	20.5	21.4	28.1	22.9	27.1	23.5	30.4	27.3	14.1	19.5	15.4	39.0	19.7	18.2	20.0	19.7	14.3	19.6	30.4	14.7	110.3	12.7	29.3	18.4	20.2	28.2	15.5	28.0	15.2	16.6	31.8	6.4	25.4	20.1	19.0	14.1	16.8	21.2	19.4	20.3	13.2	21.6	21.8	19.3	24.8	16.2	21.4	12.4	20.0	21.6	26.1	18.1	18.2	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6	101.3	71.0	116.9	138.6	111.5	51.2	50.6	107.0	125.8	95.5	68.0	15.7	283.0	167.5	270.4	53.8	105.0	174.1	140.2	335.7	335.1	102.8	131.4	126.9	137.0	262.0	65.2	120.8	104.3	125.9	41.0	80.8	163.0	119.8	326.4	95.3	76.6	339.4	136.8	97.6	204.5	41.2	103.5	83.5	134.5	117.6	113.3	311.1	142.4	115.8	190.0
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	15.0	4.7	31.7	39.5	1.6	5.1	30.5	45.2	58.9	1.6	22.8	28.1	18.1	15.5	39.1	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.3	58.7	6.3	9.2	42.2	3.9	21.2	5.8	16.8	14.2	29.7	1.2	19.5	8.1	11.1	42.6	15.3	3.9	0.0	5.6	37.7	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.4	2.7	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.6	26.8	0.5	26.4	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6	26.8	17.4	54.4	23.2	20.7	10.2	5.2	28.1	24.1	27.3	12.2	3.9	3.0	54.7	68.9	3.6	46.7	22.7	23.3	57.3	31.0	37.7	34.1	53.1	27.3	148.0	12.7	23.0	41.1	54.9	9.6	44.5	69.1	8.5	44.1	29.8	31.5	45.0	31.7	31.5	19.8	3.9	25.8	41.2	1.9	6.0	24.2	2.9	74.7	21.7	24.6
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.5	39.3	19.9	18.9	10.6	12.7	14.5	22.5	19.8	16.3	14.1	23.7	16.8	22.7	17.0	15.9	32.7	14.1	22.1	22.2	12.3	25.8	134.3	33.0	25.3	15.4	26.0	29.8	26.2	13.6	17.4	24.8	29.5	17.9	19.6	21.5	16.0	28.7	21.6	22.1	23.8	27.1	12.6	25.2	34.4	22.2	16.6	29.2	18.8	27.2	35.1	28.7	19.5	23.9	21.0	7.6	14.3	27.4	14.6	51.1	10.4	16.0	39.8	34.8	52.5	24.3	32.5	26.5	33.3	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1	6.0	15.4	10.4	28.7	35.8	101.5	34.7	17.8	12.0	6.8	17.4	19.6	18.8	6.6	15.3	18.8	19.0	45.1	23.3	26.0	17.2	20.9	42.6	19.6	28.7	30.5	103.3	39.5	20.3	27.6	27.8	16.1	18.1	33.7	11.8	28.6	85.9	31.9	25.4	13.1	25.9	58.3	25.8	25.5	26.4	7.9	49.7	43.8	15.2	31.9	47.5
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2177.0;Late spermatids: 6552.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	36.5	26.5	44.7	28.6	17.3	17.2	31.2	51.1	27.3	41.1	34.5	47.1	15.9	74.4	11.6	29.9	27.2	29.1	49.3	37.5	39.2	61.9	25.6	50.0	14.6	41.5	22.2	59.7	33.4	18.0	15.5	24.5	30.6	29.2	31.6	29.2	55.6	11.6	42.6	30.0	59.0	55.6	58.2	32.3	37.1	45.9	36.3	36.4	34.2	55.3	43.8	39.9	27.0	31.8	25.0	25.2	41.6	36.8	32.6	27.9	23.3	25.0	36.8	20.0	54.3	63.2	10.9	31.9	33.9	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4	35.7	44.5	137.9	175.3	286.2	65.4	70.5	33.1	62.9	66.0	85.5	25.5	212.3	162.5	138.2	2177.0	83.9	61.7	70.0	87.1	187.9	124.3	118.3	92.3	44.8	144.3	82.6	71.7	46.1	58.9	6552.8	86.9	108.4	140.0	201.0	50.2	87.6	106.5	77.7	80.9	127.4	40.9	45.3	165.8	246.5	216.4	281.9	238.1	122.0	65.5	190.8
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389451-76453206	"Enzymes, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 42.3;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		1600000	Nucleoplasm	"Nuclear bodies"	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	8.5	8.5	13.8	10.2	22.6	19.2	7.3	25.2	38.1	9.4	7.2	12.2	7.4	9.9	9.9	8.2	11.7	10.8	7.1	15.4	12.7	15.2	6.5	7.6	6.6	12.8	11.7	14.6	13.9	14.4	16.4	14.3	9.8	30.6	9.4	6.0	10.5	13.4	10.4	23.0	15.2	8.2	8.0	8.0	10.8	10.8	18.1	12.2	10.9	15.8	6.9	9.2	8.6	9.1	4.9	4.1	2.7	1.7	1.5	4.0	1.9	13.1	15.1	15.5	19.0	9.7	6.2	13.4	6.2	6.7	10.1	9.9	13.1	6.7	18.7	4.4	7.7	15.9	13.4	18.0	10.7	7.2	5.3	22.2	18.9	9.9	21.9	8.0	11.4	11.5	6.3	8.7	9.6	8.3	8.8	13.6	10.4	15.7	16.7	5.1	10.8	22.5	13.2	14.3	7.9	20.3	22.3	20.0	20.6	4.5	11.3	23.0	20.7	9.0	23.6	12.4	14.8	13.5	8.2	8.0	11.9	11.2	10.0	10.2	13.8	4.5	15.8	13.0	9.6	7.7	0.0	1.7	2.7	4.0	0.8	2.2	2.6	2.6	2.0	1.0	4.9	2.1	3.0	0.4	1.5	1.0	4.1	2.3	1.9	13.8	22.6	25.2	38.1	12.7	15.2	11.7	14.6	30.6	12.2	3.0	7.7	17.1	5.1	7.7	42.3	23.4	7.6	4.0	6.8	7.0	39.3	5.0	0.0	5.2	1.1	7.5	4.7	0.0	8.0	6.4	7.7	7.2	6.9	5.0	7.0	42.9	22.4	8.6	7.9	1.1	8.9	3.9	5.0	9.0	8.7	8.2	6.5	7.0	7.4	3.1	23.7	6.5	10.0	16.6	18.4	10.8	4.3	6.4	7.9	4.8
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
UBE2Q2	DKFZp762C143	ENSG00000140367	"Ubiquitin conjugating enzyme E2 Q2"	Q8WVN8	15	75843285-75901078	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.28e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.92e-2)"	17.8	19.8	15.6	18.8	10.9	22.2	41.1	11.6	14.4	20.0	25.2	12.4	12.9	6.0	17.6	15.5	24.7	11.8	22.7	25.1	15.0	16.0	16.5	6.3	21.0	25.9	19.8	10.3	17.2	13.8	7.7	12.6	34.8	12.0	22.3	13.5	13.0	20.1	15.0	26.4	11.0	11.1	42.9	23.1	15.1	14.7	13.5	11.6	27.6	21.4	22.3	11.2	40.2	35.7	6.1	4.2	18.0	6.9	10.6	9.6	4.8	9.6	14.8	13.8	9.8	19.3	25.5	20.7	21.4	24.2	14.2	16.2	7.7	13.3	9.6	15.9	30.7	12.7	7.9	24.7	14.1	17.5	9.8	10.0	12.0	9.0	10.4	21.3	12.5	7.0	17.7	16.4	10.0	14.8	21.2	19.6	17.4	4.5	14.5	30.1	7.4	10.2	11.6	9.7	1.5	10.7	12.2	21.6	3.8	22.6	15.4	12.0	9.4	18.4	17.3	23.3	20.6	11.1	17.2	25.9	17.7	16.2	11.8	7.5	15.8	27.7	7.6	7.1	19.3	10.7	18.0	4.7	15.5	7.2	5.3	9.0	6.1	9.6	7.6	4.2	4.8	7.7	6.4	0.7	10.6	6.9	1.5	6.1	4.8	15.6	10.9	11.6	14.4	15.0	16.0	19.8	10.3	12.0	11.6	3.0	9.2	13.9	24.8	44.8	18.2	27.1	17.8	2.7	17.0	22.7	127.6	47.1	19.9	22.6	48.2	37.3	1.6	23.3	14.7	102.2	32.0	46.6	19.7	3.8	22.3	6.4	17.9	28.3	25.4	26.7	22.5	34.8	35.4	26.2	21.3	14.6	20.4	10.5	27.3	24.5	151.5	25.8	46.7	48.6	74.1	40.7	92.0	27.7	17.9	30.6
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.0	3.1	0.0	0.0	0.2	0.0	15.2	0.1	0.0	6.7	0.0	0.0	14.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	34.1	30.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0	0.0	0.0	0.0	0.6	1.1	23.6	25.0	0.0	0.0	0.0	0.0	5.9	0.0	5.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.8	0.1	42.9	5.2	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	8.4	0.2	0.0	6.3	0.0	49.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 295.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.5	18.1	35.0	15.2	19.3	31.5	10.8	14.7	20.5	17.3	17.3	14.5	12.4	14.1	6.0	20.5	12.6	7.4	18.3	16.8	19.0	23.2	9.7	12.2	20.0	18.4	27.5	14.4	13.3	26.7	25.0	14.1	26.8	27.7	29.0	17.0	11.4	15.2	17.1	9.6	27.1	38.0	19.9	14.2	15.1	25.3	10.6	7.3	18.3	12.5	16.4	19.7	17.2	15.4	11.0	23.2	13.5	17.6	21.7	16.7	15.2	11.5	13.6	9.7	9.1	19.8	15.9	8.4	35.9	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6	20.8	30.7	29.5	39.6	93.8	61.0	106.8	56.0	22.7	25.0	21.0	13.7	52.6	13.3	43.8	295.7	77.1	60.6	23.3	59.7	65.2	54.0	68.4	12.7	72.1	68.5	57.2	69.2	77.3	105.2	195.4	62.2	81.9	33.7	49.5	57.3	87.1	69.4	38.6	71.5	49.6	30.1	58.2	41.9	90.2	66.2	105.3	69.2	30.5	49.0	79.7
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 226.9;Spermatocytes: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	60.3	32.7	28.8	22.9	1.8	2.6	5.1	49.2	14.9	30.4	27.7	22.1	21.6	58.8	20.4	12.3	36.6	17.8	28.8	12.8	13.5	46.0	95.7	35.1	18.8	7.1	5.5	42.0	34.2	2.9	3.6	22.3	21.6	6.6	11.9	32.1	34.9	41.2	19.0	16.0	56.8	21.8	72.2	16.9	55.5	50.1	22.2	21.1	8.1	12.9	73.1	39.6	62.7	15.6	27.9	9.1	11.1	22.8	18.2	18.3	52.1	15.6	116.9	33.2	79.7	69.0	19.2	29.7	66.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2	0.0	4.3	37.3	136.4	144.5	56.5	2.4	7.6	0.0	0.0	19.2	51.1	34.3	13.3	44.4	86.7	31.2	25.8	70.0	26.4	226.9	94.9	63.2	18.4	9.6	55.5	30.2	88.9	22.7	24.7	27.7	16.1	39.9	70.9	55.1	28.4	76.7	57.6	28.1	11.7	14.8	59.0	12.9	96.6	216.2	140.8	101.4	50.0	44.7	30.4	121.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBE2U	MGC35130	ENSG00000177414	"Ubiquitin conjugating enzyme E2 U (putative)"	Q5VVX9	1	64203627-64267368	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"testis: 31.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 118.4;Late spermatids: 169.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;U-266/84: 1.3"					"Region enhanced"	"Detected in many"		"midbrain: 19.5"							NA	NA									"unprognostic (9.44e-4)"				"unprognostic (5.52e-2)"		"unprognostic (1.81e-1)"	"unprognostic (2.37e-1)"		"unprognostic (4.01e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.69e-2)"			0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	118.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	169.4	1.7	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	11.9	1.8	0.0	0.2	0.0	0.0	0.0
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.6	5.7	7.0	7.5	12.2	12.5	6.1	9.5	10.5	9.2	9.6	4.7	9.7	4.0	7.9	9.9	14.0	8.8	10.2	9.7	15.3	6.5	6.2	8.1	5.9	7.2	8.2	4.5	11.6	9.8	10.9	10.7	19.2	8.3	11.1	4.5	4.0	8.6	13.9	6.9	9.7	4.8	5.3	12.3	11.2	2.9	7.1	3.4	17.0	9.5	5.2	5.7	7.6	24.7	11.4	7.9	11.5	8.0	9.9	11.1	8.4	8.4	6.9	7.3	7.5	3.0	9.7	7.1	9.5	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3	14.9	12.3	22.7	24.3	49.1	33.4	20.4	20.4	9.4	11.4	50.6	15.7	15.8	43.1	21.3	107.9	29.2	13.4	116.8	15.1	16.5	23.4	29.3	20.7	25.1	35.4	39.7	22.3	20.3	43.6	45.7	19.0	46.1	40.5	76.7	12.2	23.6	17.3	14.0	17.7	41.3	27.1	19.4	60.9	31.4	29.8	56.3	46.1	34.9	12.5	36.9
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.9	30.9	11.6	11.0	29.6	28.8	15.9	27.3	33.5	32.8	31.6	38.5	21.6	20.3	39.2	33.5	41.2	16.2	14.6	25.5	41.9	67.1	15.8	18.4	20.5	23.9	34.2	13.0	19.8	24.5	28.3	26.7	34.6	35.1	24.0	9.7	13.4	26.5	35.1	39.8	14.0	12.9	10.8	30.5	27.1	11.3	29.6	11.5	25.6	24.6	12.0	18.2	18.5	10.0	18.6	27.4	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.6	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4	23.8	16.3	32.1	40.1	46.9	52.1	29.9	30.6	18.7	10.3	34.9	39.3	29.1	18.3	38.9	1.4	40.2	31.5	0.0	46.7	25.9	26.8	61.1	5.8	22.9	22.6	41.3	46.7	39.9	23.9	2.9	25.9	27.7	28.7	52.3	35.4	30.6	59.6	28.1	27.3	20.7	33.6	32.3	35.3	21.4	22.7	49.8	35.8	22.3	24.7	60.4
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.6	11.1	28.1	16.7	16.4	19.5	13.8	30.3	19.0	21.5	19.6	25.7	9.8	35.4	23.0	22.6	21.2	18.2	35.5	21.4	26.3	18.2	11.9	29.3	18.8	15.2	24.7	35.3	21.7	23.1	20.1	20.3	26.0	22.4	16.9	31.1	29.5	25.3	33.7	10.7	29.3	10.3	18.2	21.5	16.2	30.0	42.0	15.6	19.5	31.0	28.9	21.8	24.6	26.7	34.9	19.0	21.8	20.0	21.6	37.7	31.2	18.1	22.1	28.9	34.1	47.7	21.6	19.3	19.6	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4	89.3	73.3	52.7	60.3	63.2	78.1	154.5	43.3	71.0	67.1	36.6	53.0	43.4	16.6	42.2	101.1	45.8	39.4	0.0	43.1	41.8	44.5	85.9	62.2	52.0	41.5	76.3	65.9	47.3	56.6	43.8	52.6	44.6	50.6	37.9	48.7	54.8	47.5	42.1	60.8	44.0	56.4	77.6	54.5	143.0	88.7	79.3	61.9	44.9	47.9	87.8
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.5	13.0	9.4	22.2	17.9	11.4	13.8	15.8	16.8	11.3	17.3	10.7	6.5	10.3	22.6	14.3	13.5	13.1	17.7	16.2	14.3	9.3	12.4	10.8	15.6	14.2	10.1	10.4	20.3	16.5	16.2	19.5	25.4	18.1	15.5	13.6	6.2	19.1	16.3	6.9	14.8	13.3	11.7	19.9	11.5	12.2	12.7	14.4	18.8	12.1	22.4	16.1	21.9	10.7	15.9	22.4	10.8	16.5	20.8	6.0	10.6	9.8	13.9	11.5	11.5	20.7	8.5	17.2	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3	11.9	10.8	6.7	10.0	4.5	20.4	32.1	10.2	14.7	14.8	15.7	31.4	15.7	10.0	16.0	11.8	13.5	15.1	23.3	13.2	9.3	8.4	15.1	9.2	16.0	11.1	20.6	8.6	12.9	17.1	24.6	11.5	11.0	10.1	14.4	15.8	16.7	18.8	10.5	9.2	17.7	25.0	6.5	8.5	9.6	12.7	6.4	19.8	10.9	13.8	12.2
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.8	18.2	11.7	23.3	21.0	22.1	12.9	25.3	21.9	21.4	21.7	16.3	19.1	12.4	22.5	27.9	27.9	14.5	18.1	23.3	25.4	22.5	16.6	12.6	12.7	11.7	20.9	18.8	18.5	19.5	21.6	23.7	19.7	16.3	24.9	10.4	18.3	13.8	30.2	20.0	18.4	11.9	18.5	20.5	21.9	10.6	13.1	25.4	22.1	25.2	18.7	19.3	24.9	21.5	18.5	13.6	11.1	13.2	22.3	27.0	5.8	66.1	31.3	13.9	13.9	12.5	31.0	28.1	30.8	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1	20.8	19.5	9.7	13.9	24.5	31.4	31.5	28.1	16.0	9.1	24.4	62.8	12.2	8.3	17.0	8.4	19.9	22.1	0.0	15.2	14.4	14.7	19.9	9.2	39.2	13.9	30.2	23.5	24.5	21.2	8.5	14.4	15.0	5.0	12.6	20.6	10.9	22.5	10.5	24.1	16.5	42.8	0.0	17.6	20.4	27.4	29.1	12.6	13.8	22.4	27.3
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359585-118399211	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	19.3	18.5	17.7	20.5	30.1	16.6	19.7	49.4	36.6	19.0	18.5	33.0	16.1	20.3	23.2	21.2	21.2	19.8	17.0	20.3	17.7	18.8	20.3	29.5	18.4	22.2	25.7	25.7	24.2	26.7	31.1	24.2	18.6	35.5	21.5	23.1	21.2	20.3	17.2	32.5	25.6	23.7	19.9	25.5	24.0	25.5	21.8	27.5	22.1	22.1	15.1	22.6	21.6	20.4	5.7	11.0	14.6	13.2	7.1	9.0	5.2	9.3	9.1	11.7	11.6	20.3	18.8	11.6	13.9	14.5	10.3	12.6	25.1	23.0	19.7	26.8	17.4	13.9	20.7	16.4	13.1	17.2	11.1	7.6	32.3	8.1	12.8	17.5	18.2	24.8	18.9	9.5	21.1	20.7	13.8	17.1	17.4	18.3	18.6	14.8	17.6	15.5	18.2	10.8	18.9	11.7	9.9	16.9	20.1	11.3	21.9	10.6	11.1	20.0	17.4	6.1	13.3	23.2	8.3	17.6	15.3	10.1	13.0	11.5	5.5	6.7	18.8	8.5	21.1	15.7	14.6	10.9	10.5	9.0	12.0	6.9	5.7	6.9	6.4	11.0	4.3	7.4	6.6	11.0	7.1	13.2	6.5	7.7	5.2	17.7	30.1	49.4	36.6	17.7	18.8	25.7	25.7	35.5	27.5	11.9	26.4	13.7	19.3	23.8	18.0	14.9	15.3	37.5	22.7	14.0	17.7	16.7	5.0	16.7	12.4	18.0	17.7	23.3	24.6	14.8	17.7	22.8	10.4	40.3	19.1	15.9	17.9	20.3	28.8	11.0	15.8	24.1	23.6	16.2	19.6	21.4	21.8	17.5	20.1	10.2	16.0	19.4	18.4	31.7	19.8	34.4	20.7	21.8	19.8	23.0
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA					"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	11.8	18.6	16.4	11.5	20.2	16.5	12.7	27.1	24.2	17.5	19.3	26.5	12.6	15.1	16.7	12.8	20.4	14.1	11.3	22.5	18.9	17.3	13.0	13.9	10.5	11.3	18.5	15.0	22.8	20.4	24.3	15.3	18.3	23.6	14.5	12.8	18.2	12.0	12.7	43.5	24.3	14.5	16.6	16.3	13.0	15.1	8.6	21.4	15.7	19.7	11.2	13.6	16.8	12.0	6.0	6.7	9.4	7.9	2.9	9.8	5.3	21.7	13.9	17.1	18.9	22.8	30.1	13.5	14.3	18.1	14.0	14.5	15.0	25.4	18.7	17.4	25.4	11.1	16.1	21.5	16.5	16.7	19.1	12.0	20.2	24.3	17.6	17.3	21.0	14.4	24.7	15.0	18.9	16.1	26.6	20.7	13.7	34.5	24.9	13.0	11.3	13.5	10.3	22.9	14.1	11.6	13.3	17.0	20.1	14.2	9.9	21.0	16.1	22.5	16.1	29.7	19.1	12.3	15.5	17.8	12.6	19.5	15.5	11.7	11.4	15.4	21.7	18.5	24.4	15.9	4.2	7.9	3.6	5.3	6.0	8.8	6.0	8.8	8.5	6.7	5.6	8.0	6.5	9.4	2.9	4.4	3.2	9.8	5.3	16.4	20.2	27.1	24.2	18.9	17.3	18.5	15.0	23.6	21.4	20.8	20.0	17.1	11.5	15.7	13.3	33.5	15.3	13.4	11.4	8.7	23.6	28.0	8.3	10.9	2.4	13.5	13.1	23.3	12.7	11.4	17.5	19.5	5.8	15.3	14.9	15.9	15.6	16.5	22.1	3.1	10.3	14.2	5.0	9.0	16.9	11.3	18.3	13.9	8.1	8.6	34.6	19.4	11.2	6.6	12.4	19.6	17.2	13.1	17.9	12.2
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263081-159286040	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	17.1	16.0	16.7	18.4	19.7	16.7	16.3	20.2	33.0	18.5	12.5	12.2	11.4	9.8	22.5	13.1	22.2	14.7	14.5	13.1	20.9	19.1	17.5	14.4	17.8	24.1	19.7	22.7	16.8	12.6	18.0	23.9	19.6	36.7	14.7	14.7	10.9	15.4	17.6	15.3	14.2	13.8	19.5	20.4	22.2	13.3	24.2	15.4	26.8	14.4	16.1	30.1	18.8	16.8	11.9	10.8	21.9	13.9	25.5	19.2	8.2	14.6	10.7	22.2	24.1	23.1	21.4	13.1	16.0	24.5	16.5	22.0	8.7	10.2	13.1	17.7	20.0	23.7	11.2	13.7	30.8	28.8	26.2	13.5	10.1	9.4	7.9	29.2	22.8	15.9	18.9	28.9	14.9	29.9	13.2	15.6	13.9	13.8	17.8	22.9	4.7	12.3	6.9	15.4	7.3	6.5	15.7	21.8	15.3	16.3	11.3	11.8	15.7	16.2	10.8	37.7	14.0	11.4	15.2	16.7	17.0	14.2	8.8	20.2	14.3	14.3	20.0	18.0	15.8	25.1	21.9	6.5	16.1	16.6	13.5	18.6	11.9	15.8	17.3	8.5	10.9	18.5	19.2	19.4	25.5	13.9	10.8	16.9	8.2	16.7	19.7	20.2	33.0	20.9	19.1	19.7	22.7	36.7	15.4	11.9	38.2	22.7	8.2	14.2	9.9	12.2	10.2	34.8	30.7	14.0	3.9	27.7	29.9	18.9	3.4	20.0	9.5	46.7	21.7	14.9	21.7	11.4	43.9	14.0	33.1	19.1	10.3	30.7	42.1	2.2	19.0	27.8	16.9	25.2	14.0	17.9	18.8	8.6	23.3	23.8	13.4	19.4	14.4	70.2	48.5	18.1	14.9	21.7	13.9	7.9
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	5.0	7.3	8.4	6.9	13.4	10.4	8.0	12.4	13.6	10.9	14.1	9.3	3.9	5.9	7.3	12.6	13.7	8.8	12.2	10.8	13.0	12.1	5.9	23.3	14.7	4.5	9.3	16.4	11.2	11.2	6.1	13.4	10.9	10.7	12.3	12.0	13.3	9.0	13.5	2.8	8.8	4.9	4.8	13.4	7.6	11.7	11.6	5.1	11.0	11.9	8.6	7.6	16.2	8.6	5.7	10.2	8.3	8.6	16.8	13.5	8.3	12.0	12.5	10.6	18.0	17.1	9.2	10.4	12.1	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7	44.7	27.8	14.6	10.3	9.4	26.8	24.5	17.8	17.4	25.0	8.7	25.5	10.4	0.0	8.8	11.6	17.9	10.8	0.0	12.5	6.2	15.0	9.4	27.7	8.5	7.3	30.2	13.8	14.7	16.2	13.2	15.0	10.5	8.5	10.0	10.0	15.6	8.9	9.1	19.4	6.7	39.2	12.9	19.1	25.3	14.9	6.4	30.9	20.8	10.0	7.4
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.9	7.6	8.1	10.7	16.2	12.9	6.8	16.2	9.4	9.4	7.6	11.7	5.7	10.2	14.1	12.6	7.6	11.9	9.7	8.2	11.7	10.5	8.3	37.1	8.1	12.3	8.1	12.2	12.0	7.7	7.7	12.3	8.2	7.5	9.2	5.1	19.3	11.1	16.0	8.4	7.9	6.0	6.3	9.1	6.4	7.6	13.3	10.8	6.8	12.7	16.0	8.7	11.4	10.5	6.5	6.8	6.9	6.9	11.7	14.2	5.7	11.1	10.2	9.0	7.0	9.4	11.7	7.2	7.8	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4	41.7	21.1	7.5	11.4	23.0	40.4	97.6	15.3	9.4	19.4	12.2	76.6	14.8	3.3	8.0	6.6	23.7	13.4	23.3	9.5	6.8	18.3	22.3	16.1	32.7	8.9	60.4	16.0	31.9	21.5	7.4	23.9	16.8	15.1	4.6	12.5	63.3	9.4	14.0	18.0	10.2	53.7	25.8	26.4	13.0	7.6	25.3	19.2	13.1	9.9	12.3
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.2	22.5	20.4	15.0	38.1	19.7	17.6	17.3	18.4	18.9	17.3	35.9	19.2	13.4	16.3	22.9	16.6	15.3	15.9	17.3	17.7	11.1	14.1	30.7	21.7	23.3	26.9	18.8	20.4	17.6	22.2	38.5	37.2	18.5	20.7	23.9	21.0	12.5	17.9	15.9	8.9	22.9	16.5	45.7	12.7	12.4	15.9	11.2	17.1	13.1	14.4	14.3	20.5	11.8	14.8	19.5	8.2	14.8	32.0	22.2	13.9	26.2	19.4	14.9	9.0	15.6	15.2	29.1	18.8	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6	32.8	42.3	16.3	79.1	240.8	54.0	15.6	40.8	30.8	26.1	29.6	143.3	19.2	11.6	31.4	14.7	21.1	36.4	23.3	35.5	14.1	29.1	39.1	18.5	77.9	54.8	74.7	16.8	28.8	47.4	19.9	28.4	42.8	47.2	36.1	30.4	30.7	51.2	14.0	33.6	88.2	48.0	19.4	26.8	37.4	17.9	220.9	28.4	21.0	19.5	215.5
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053688: AB_2682230"	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.6	10.6	20.5	10.4	20.2	20.6	18.9	17.9	15.8	14.0	12.3	10.6	15.9	47.1	15.5	16.7	9.2	14.4	17.5	15.5	19.7	20.4	8.6	39.3	14.5	19.0	18.0	12.2	21.7	23.6	15.5	14.4	25.2	16.0	16.8	13.5	18.9	26.8	13.7	21.4	31.0	14.6	15.4	22.9	12.0	18.1	12.1	22.3	12.8	23.2	15.1	12.6	12.5	12.1	12.4	18.6	19.6	13.0	16.8	15.0	17.5	13.4	12.4	14.4	13.8	48.5	14.8	19.1	12.1	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3	23.8	27.7	29.8	38.5	46.4	48.4	35.8	5.1	40.2	63.7	29.6	64.8	19.1	8.3	15.1	25.0	38.3	17.3	0.0	13.1	14.9	48.2	37.7	28.9	15.8	15.4	54.0	32.0	23.4	29.4	20.2	36.8	28.9	42.2	27.1	17.9	31.5	16.2	17.3	34.3	6.7	44.0	12.9	38.7	64.7	30.4	53.3	58.2	30.5	17.7	46.9
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7 (putative)"	Q8N806	14	93207056-93229215	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 246.4;Late spermatids: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	14.1	12.3	16.4	12.5	22.9	17.0	17.5	20.0	25.8	17.1	15.7	17.7	11.3	11.1	14.9	13.4	14.8	13.7	11.9	19.0	14.2	12.8	15.3	13.2	11.9	18.0	14.0	17.1	17.0	20.4	28.2	11.5	11.4	13.3	13.9	17.1	13.6	13.7	14.9	19.9	15.2	12.7	14.1	16.9	13.8	14.1	21.1	14.3	31.9	15.4	12.9	23.3	13.4	13.3	18.1	10.7	15.8	9.5	11.5	16.5	8.2	6.5	8.7	13.5	11.2	6.3	6.8	4.8	13.8	9.8	15.4	11.7	6.3	7.4	15.5	11.6	7.0	6.7	7.9	14.4	7.7	15.8	12.0	7.8	11.2	9.4	6.0	2.9	16.4	12.6	4.1	5.4	8.5	5.4	5.7	8.6	14.9	10.4	15.6	14.7	19.1	26.6	9.0	6.2	17.2	15.9	20.5	24.1	8.5	5.2	10.7	16.9	12.1	9.9	8.3	4.1	8.3	15.0	11.3	6.5	11.3	6.1	9.7	14.2	18.1	27.7	16.0	9.9	12.7	9.6	15.8	7.3	11.8	12.7	9.1	13.3	18.1	11.4	11.7	7.8	14.8	10.0	10.6	11.5	11.5	9.5	10.7	16.5	8.2	16.4	22.9	20.0	25.8	14.2	12.8	14.0	17.1	13.3	14.3	14.9	5.4	14.3	6.6	17.6	5.8	15.3	10.2	2.7	10.3	10.4	9.8	7.8	10.0	8.8	246.4	8.2	9.2	23.3	11.2	13.2	10.2	4.3	4.7	10.4	11.8	3.2	5.2	14.1	10.1	271.2	8.6	8.5	13.5	7.2	7.6	12.6	8.2	5.8	11.7	7.0	13.4	6.5	10.7	34.9	27.7	11.8	5.5	10.7	10.7	3.3
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 83.9"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;OE19: 35.4;RT4: 19.3"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.1	0.2	0.1	1.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.3	35.4	3.6	0.0	0.1	0.3	0.0	19.3	0.1	0.2	1.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.7	6.8	1.8	0.0	0.0	0.0	0.2	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.9	0.0	83.9	0.0	0.0	0.0	1.3	3.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 16.7"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Group enriched"	"Detected in some"	8	"Club cells: 4.5;Hepatocytes: 10.5"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2"															NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A5	UGT1E	ENSG00000240224	"UDP glucuronosyltransferase family 1 member A5"	P35504	2	233712992-233773299	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.7;intestine: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;RT4: 1.6"															NA	NA												"unprognostic (2.18e-3)"							"unprognostic (1.36e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	11.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 40.4;OE19: 160.5"									"CAB009819, HPA054065"	Enhanced					NA	NA					"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	11.3	0.0	0.1	40.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	160.5	0.0	0.0	0.0	0.0	0.4	20.4	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.3	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	37.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.6	0.0	19.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	2.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 8.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	14	"SiHa: 50.6"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	50.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	8.4
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	58	"RT4: 52.5"															NA	NA								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 32.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6"									"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 21.0"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	94.3	0.0	0.0	3.5	0.0	0.0	10.0	21.3	0.0	0.0	115.5	0.0	2.3	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	28.2	0.0	6.0	52.6	0.0	125.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 221.7"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"Hep G2: 16.1"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.7	0.0	0.0	0.0	1.3	4.7	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 12.7"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.2;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1"									HPA045108	Approved					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	168.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	1.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	134.4	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.5
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Cell type enriched"	"Detected in single"	178	"Cholangiocytes: 17.8"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	10	"Daudi: 7.1;NB-4: 6.5"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 25.3"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	47.1	0.0	0.0	3.3	0.0	91.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.1	0.0	0.0	2.5	2.2	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	58.6	0.3	6.5	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8"									HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.4	5.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.3	0.0	3.9	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	5.7	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	No			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: AB_2686358"	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	21.1	9.9	5.2	12.7	14.9	11.8	11.7	28.0	15.3	23.0	16.6	6.4	13.3	17.3	24.5	20.9	11.2	12.3	9.9	15.5	37.1	23.7	7.2	17.1	12.3	5.8	11.5	24.9	20.0	12.1	16.4	22.6	21.7	16.1	13.2	12.0	14.9	24.1	39.4	8.9	13.2	6.6	6.9	15.9	13.4	8.5	23.3	14.4	15.3	21.9	9.5	8.8	24.7	23.0	18.0	7.5	19.9	28.0	20.5	26.3	14.9	18.1	39.0	25.0	34.7	20.5	21.9	12.2	23.8	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1	17.9	32.1	50.1	25.7	26.2	21.7	29.4	56.0	41.5	50.0	50.6	11.8	22.6	48.0	23.2	35.7	30.8	40.7	0.0	20.2	32.6	19.3	44.8	45.0	71.0	27.6	22.3	32.1	35.0	64.6	34.6	19.8	51.7	27.0	44.1	35.0	13.6	28.8	34.8	18.4	49.4	21.6	0.0	27.3	23.4	22.0	21.5	18.8	52.2	31.1	52.1
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.7	7.7	11.1	4.7	9.1	13.2	8.1	15.6	9.6	9.8	17.2	4.9	4.9	10.3	3.4	7.7	9.1	4.4	10.2	9.1	15.0	18.7	4.7	18.0	15.0	7.8	7.5	8.4	6.1	5.9	5.9	7.6	18.8	18.8	38.2	10.6	1.7	10.1	23.1	2.3	14.1	32.7	4.3	9.9	5.7	16.0	5.1	3.6	7.3	4.6	10.0	3.9	6.7	4.5	9.7	14.1	5.6	16.9	32.2	10.5	3.8	4.3	13.0	2.7	8.0	12.1	5.1	7.4	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8	6.0	11.8	25.0	9.7	19.2	22.6	42.0	5.1	5.3	9.1	12.2	29.5	10.8	1.7	5.1	16.0	20.4	8.1	23.3	3.4	8.5	12.4	13.9	17.3	11.3	9.2	27.0	6.8	15.4	11.7	5.9	17.8	11.0	20.3	6.4	12.4	6.7	6.0	12.9	13.8	5.1	34.9	12.9	13.7	37.2	17.2	16.7	4.9	13.8	11.3	7.1
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 50.9;Rod photoreceptor cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9;plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol		NA	NA			Cytosol		"HPA063990: AB_2685167"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24.0	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9.0	15.8	9.0	8.3	7.9	12.0	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4.0	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.2	16.9	7.8	9.7	3.5	2.9	10.7	8.3	6.0	3.6	2.9	3.6	5.4	1.4	8.8	5.8	7.2	5.2	1.7	3.3	1.0	5.6	10.2	3.5	13.8	4.9	6.6	2.5	7.8	5.3	9.1	3.9	1.6	9.9	4.4	10.8	4.6	4.2	2.3	11.9	15.6	14.7	8.6	2.4	16.2	11.8	2.8	6.9	2.1	6.5	19.9	11.0	8.9	9.2	4.6	8.3	13.9	17.1	8.3	8.5	5.1	14.8	3.8	18.6	6.7	1.9	14.4	4.4	9.8	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24.0	24.4	11.5	8.3	7.9	12.0	11.6	11.4	14.9	16.7	11.8	5.7	12.8	23.0	18.0	17.8	4.0	11.4	7.0	37.3	4.0	1.7	8.0	0.7	12.0	5.2	0.0	10.9	2.6	9.3	12.0	3.5	23.1	4.8	50.9	18.4	6.2	11.9	1.9	11.5	5.4	5.0	3.6	15.4	12.6	18.3	7.0	14.9	2.4	87.3	12.9	10.3	3.9	5.9	16.9	14.4	8.3	8.3	6.9
ULK2	"ATG1B, KIAA0623, Unc51.2"	ENSG00000083290	"Unc-51 like autophagy activating kinase 2"	Q8IYT8	17	19770829-19867936	"Enzymes, Predicted intracellular proteins"	"Autophagy, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 51.2;Spermatocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.9;non-classical monocyte: 5.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"SuSa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037021	Approved					NA	NA					"CAB037021: AB_1841237"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.38e-2)"	10.3	7.1	15.5	4.4	19.1	2.8	7.6	15.5	21.8	9.3	7.2	28.3	6.7	3.1	9.5	8.4	6.8	11.5	7.7	8.3	15.0	10.9	7.0	3.7	8.8	4.6	15.8	12.0	12.4	7.5	14.2	4.2	8.5	15.9	9.0	4.8	8.5	5.3	11.0	13.5	7.8	3.6	9.9	28.3	7.1	5.5	33.0	14.6	2.0	7.0	1.4	3.8	7.7	6.3	0.1	1.4	0.5	6.9	0.4	1.6	0.6	7.5	7.8	11.2	1.5	6.6	12.4	0.0	6.3	7.8	6.6	6.2	0.1	1.6	0.0	3.3	8.1	7.5	3.6	0.0	1.3	6.3	6.2	8.1	0.2	3.3	0.0	8.6	0.0	3.8	8.0	9.8	3.3	2.8	5.8	4.6	0.0	0.0	0.0	5.5	2.1	0.0	0.3	1.6	0.1	2.0	0.4	0.0	0.0	4.8	3.3	2.8	11.7	9.9	1.3	3.5	29.0	7.7	2.9	7.3	0.0	1.0	2.4	3.8	0.0	0.0	0.0	1.0	0.0	2.3	0.0	1.5	0.3	0.6	6.9	0.2	0.1	1.0	1.0	1.4	0.1	1.6	1.0	0.5	0.4	5.8	0.1	0.2	0.6	15.5	19.1	15.5	21.8	15.0	10.9	15.8	12.0	15.9	14.6	17.9	10.2	0.0	4.2	6.5	15.9	9.5	7.6	8.1	7.9	7.0	7.9	6.4	3.3	3.0	27.9	2.9	0.7	0.0	2.9	2.6	9.0	6.0	0.0	1.7	7.1	14.3	2.4	3.7	16.1	51.2	13.0	5.1	8.5	4.6	3.2	5.6	2.3	3.2	11.7	4.5	10.6	12.9	11.3	38.8	20.5	8.4	2.4	3.8	2.1	3.4
ULK3	"DKFZP434C131, FLJ90566"	ENSG00000140474	"Unc-51 like kinase 3"	Q6PHR2	15	74836116-74843346	"Enzymes, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 75.1;Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040474	Approved					NA	NA					"HPA040474: AB_2677003"	"unprognostic (3.67e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	7.0	11.7	11.8	8.4	15.4	2.9	7.4	21.3	20.4	7.9	13.8	9.0	9.0	7.9	5.3	9.5	33.9	6.7	9.6	14.1	11.8	8.9	13.4	9.3	6.4	7.9	11.2	15.3	4.9	14.7	12.1	12.3	5.7	21.1	8.2	14.4	10.4	10.4	7.4	19.1	24.6	20.3	7.2	5.8	9.9	11.1	6.0	7.6	4.2	6.1	10.9	13.7	8.6	10.6	3.8	4.2	3.8	7.8	5.8	12.6	4.9	3.9	10.7	5.6	9.7	6.4	4.2	3.7	3.1	4.5	6.5	7.1	4.2	8.9	8.5	6.0	3.5	7.5	4.0	15.6	4.3	2.7	16.2	15.4	25.2	13.6	5.1	9.3	6.0	16.2	5.5	8.6	5.7	5.4	2.4	9.8	11.8	6.9	9.2	5.3	5.8	4.4	6.2	6.2	9.3	5.5	13.0	6.8	16.1	4.2	5.0	10.4	13.2	6.1	5.8	19.3	5.9	8.4	15.1	5.5	8.7	5.6	8.6	6.7	12.8	11.6	6.2	4.9	17.7	7.5	3.8	3.6	1.4	12.6	7.8	10.1	3.8	7.4	10.3	4.0	3.5	8.1	5.5	0.9	5.8	6.2	4.2	9.7	4.9	11.8	15.4	21.3	20.4	11.8	8.9	11.2	15.3	21.1	7.6	8.9	11.7	3.7	6.8	9.0	75.1	15.1	7.6	2.7	2.3	12.2	15.7	7.1	16.6	9.2	0.8	8.4	42.8	0.0	10.2	2.5	7.3	8.4	20.7	11.0	13.7	84.2	10.9	13.5	6.3	1.5	12.0	6.5	5.0	19.0	17.8	18.4	10.1	16.4	11.0	13.3	54.3	0.0	7.6	9.4	19.8	19.1	4.8	17.0	20.4	7.2
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 279.5;Late spermatids: 329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.3	1.7	2.7	3.0	1.1	1.7	4.6	2.5	2.6	3.1	2.6	0.9	2.2	8.6	1.4	5.8	3.0	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.4	2.9	3.9	5.6	1.7	1.6	2.2	15.0	3.1	3.9	2.1	5.9	1.9	7.2	2.2	5.9	7.0	4.5	3.3	1.8	3.1	1.6	8.5	3.7	6.5	7.1	1.4	9.9	2.6	1.2	2.1	1.8	3.0	1.8	6.2	2.0	2.2	13.2	2.1	4.3	8.0	3.6	11.0	5.9	2.4	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4	8.9	5.8	1.9	2.8	1.8	5.4	12.8	5.1	53.5	4.5	3.5	51.1	2.8	0.0	2.3	279.5	4.4	1.1	0.0	2.1	3.9	3.3	1.2	1.1	5.9	6.5	11.1	1.7	1.8	4.1	329.6	6.1	5.6	0.0	6.4	1.1	11.2	2.8	0.0	3.9	5.0	25.1	6.5	3.3	29.9	8.7	3.1	3.5	4.4	1.7	0.8
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 281.4;Spermatogonia: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.3	6.6	27.8	15.0	6.2	7.5	15.4	21.5	14.7	26.8	29.3	11.1	10.9	40.4	15.6	12.0	24.0	13.0	22.7	14.8	37.5	20.2	16.4	33.2	22.9	11.6	6.8	35.5	16.8	4.0	9.7	24.2	18.3	7.3	12.6	27.5	24.0	35.3	18.8	10.0	36.3	13.7	24.4	13.4	13.7	34.5	47.1	25.0	10.0	16.7	28.7	16.1	24.3	19.9	23.5	19.4	11.4	21.7	8.7	20.7	22.5	30.2	30.1	14.0	19.5	46.4	14.0	28.4	18.5	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8	44.7	25.6	45.4	30.6	55.3	44.0	29.7	20.4	56.2	43.3	15.7	21.6	30.6	16.6	26.4	117.0	37.9	12.9	0.0	29.7	56.2	38.1	45.1	26.6	15.8	26.9	33.4	8.1	23.4	28.2	52.6	46.3	31.1	25.3	53.3	29.2	47.5	22.4	7.0	38.5	13.5	78.0	51.8	47.7	281.4	214.8	56.2	27.6	46.5	30.4	28.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.9	19.3	18.8	23.3	6.9	11.8	25.4	13.8	14.6	23.4	12.9	27.2	12.2	24.2	16.0	14.4	11.7	16.0	26.1	21.9	31.2	9.8	13.7	13.9	9.1	18.0	9.2	20.6	8.4	7.4	17.0	24.4	28.3	13.9	17.9	16.2	37.9	5.3	16.2	29.2	21.3	10.0	22.6	15.6	13.1	27.8	10.3	11.5	14.7	11.4	17.6	10.4	33.0	10.7	9.3	17.2	24.7	13.2	13.1	16.3	13.0	8.2	13.1	8.9	12.3	61.4	10.5	13.3	16.6	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2	50.6	41.3	27.5	36.9	45.7	24.1	56.0	25.5	124.5	62.6	26.2	27.5	85.2	26.6	26.4	61.2	28.2	27.5	23.3	21.5	65.0	33.0	35.8	53.5	33.4	27.3	19.1	27.7	27.0	34.9	79.4	21.9	31.0	23.6	27.9	26.5	20.1	22.1	17.5	21.2	35.6	48.5	25.8	38.2	32.5	29.0	43.3	50.9	25.4	33.2	36.5
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Cell type enhanced"	"Detected in all"	6	"Bipolar cells: 178.6;Horizontal cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.4	22.8	39.3	26.7	14.9	10.0	10.9	11.1	17.5	22.1	24.7	21.7	11.9	9.6	8.8	20.0	23.6	17.3	31.8	7.8	19.7	14.8	24.1	11.2	18.1	19.2	17.3	12.6	23.4	14.3	3.3	23.3	10.0	12.4	8.8	22.5	8.3	1.3	17.2	22.0	24.3	13.4	29.2	7.9	20.3	27.4	38.5	8.0	10.8	20.0	22.3	38.1	20.3	4.1	12.0	26.2	8.6	7.2	9.2	18.6	19.7	26.2	12.6	17.8	11.2	16.7	11.6	15.7	16.6	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6	20.8	15.3	34.1	35.1	12.0	178.6	20.7	12.7	41.5	29.6	31.4	53.0	16.9	43.1	13.8	20.4	19.6	7.8	23.3	9.0	11.2	33.9	14.4	45.0	6.6	12.0	131.9	34.0	23.4	8.8	28.3	27.3	12.9	27.0	26.2	7.9	89.6	11.0	7.0	39.6	12.5	53.1	25.8	33.0	11.7	38.3	5.6	13.6	30.6	8.0	25.7
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066142-27171896	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	15.7	10.4	18.3	23.3	17.8	46.0	15.6	16.6	18.3	12.1	30.6	16.1	8.8	13.0	15.3	11.6	23.5	9.5	14.5	11.3	19.3	15.9	18.3	27.9	19.9	19.6	20.5	7.5	12.0	13.4	10.7	16.2	14.8	12.4	17.5	19.1	10.1	8.9	9.5	9.8	17.3	33.0	43.8	18.5	16.5	14.7	11.0	13.1	8.4	12.0	6.6	18.5	42.8	24.2	4.6	3.0	5.3	2.1	2.3	3.6	1.2	12.1	7.6	14.6	7.6	9.8	12.6	5.2	17.1	12.1	9.5	7.1	13.8	19.1	17.3	8.6	13.5	23.1	7.5	9.5	9.9	20.4	27.9	8.2	26.7	9.9	9.7	12.4	15.4	18.8	7.8	14.6	10.7	12.4	12.1	21.9	12.0	8.9	8.4	19.7	7.1	9.4	20.6	10.5	15.6	13.5	10.8	18.7	4.1	18.8	8.6	16.2	9.8	14.7	12.4	13.8	19.1	5.8	15.0	25.8	10.0	9.6	21.3	15.5	6.5	7.2	12.3	16.8	9.2	11.1	0.0	1.2	5.3	1.5	1.3	2.5	3.2	2.4	2.0	1.6	4.6	1.6	1.7	1.2	2.3	2.1	3.0	3.6	1.2	18.3	17.8	16.6	15.5	19.3	15.9	20.5	7.5	12.4	13.1	26.8	25.1	15.1	22.9	81.5	21.6	22.6	10.2	16.0	10.3	22.7	37.3	12.2	24.9	11.8	16.7	31.9	32.8	46.7	14.0	5.6	31.0	29.2	12.7	22.2	12.6	27.0	20.1	17.2	15.8	8.2	7.2	23.3	37.1	44.1	23.6	10.9	19.7	25.8	6.0	15.7	29.9	32.3	45.3	2.5	8.9	69.1	9.2	13.8	20.4	30.3
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13.0	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0.0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2.0	20.0	9.0	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3.0	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3	8.9	31.0	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1.0	2.1	9.7	0.3	0.0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2.0	8.6	4.7	13.5	0.0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1400000	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	27.1	22.3	19.0	19.3	18.8	18.8	34.0	35.7	19.5	36.3	34.0	29.0	14.5	40.3	27.3	29.2	34.9	15.3	37.4	27.2	41.4	11.4	18.5	22.7	15.0	22.7	18.9	55.7	21.8	15.0	21.1	37.1	21.3	16.8	27.9	19.9	31.2	29.9	35.8	22.0	31.1	15.2	18.5	16.3	26.2	25.9	24.9	29.3	26.8	23.6	22.2	18.6	37.0	17.9	15.2	21.6	17.5	15.1	31.5	42.7	32.3	39.2	50.5	19.8	35.9	40.0	24.6	23.3	26.5	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5	20.8	33.1	28.2	36.7	52.1	52.7	40.0	22.9	42.8	51.2	41.8	29.5	80.1	38.1	58.5	41.3	39.3	15.4	23.3	46.8	58.4	42.1	56.1	33.5	39.4	45.0	109.7	21.2	28.3	30.4	14.7	29.4	39.1	33.7	54.1	19.4	35.6	58.1	19.5	43.2	43.1	50.1	0.0	45.7	26.2	61.2	45.8	113.4	38.8	27.3	39.1
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		280000	Cytosol	"Plasma membrane"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.4	8.9	8.9	7.8	14.1	16.5	16.0	15.4	13.7	13.6	12.2	8.9	9.5	10.1	8.8	13.2	5.8	10.4	11.9	13.4	16.0	11.2	7.3	13.9	7.6	6.8	13.6	22.0	33.8	12.0	14.0	16.1	14.3	12.8	16.2	10.3	45.0	19.6	12.6	10.5	13.1	11.1	13.0	8.6	13.2	8.4	9.4	16.3	12.7	10.9	11.3	5.4	17.8	11.3	8.7	9.7	15.0	13.2	19.3	10.6	10.6	16.5	9.5	9.3	10.4	11.6	12.2	17.9	12.0	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0	35.7	31.3	91.0	32.3	52.2	54.5	62.7	17.8	42.8	59.1	22.7	104.1	25.1	10.0	31.3	139.8	44.6	32.3	93.5	36.2	36.1	49.5	31.6	85.6	42.0	41.1	39.7	40.4	22.1	108.1	130.5	57.2	94.6	50.6	36.1	22.9	24.4	41.2	45.6	27.6	19.4	146.4	38.8	56.5	62.9	41.8	67.2	55.0	65.0	23.3	54.9
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 399.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	22.0	8.8	14.1	12.6	10.0	16.5	13.3	21.6	14.4	15.0	14.3	11.0	14.4	22.5	6.5	20.7	22.9	10.1	17.4	15.7	19.6	21.6	18.5	30.1	10.7	12.2	14.9	29.5	16.7	14.1	16.6	19.5	18.1	11.1	14.3	12.9	24.7	39.9	17.3	10.1	18.1	10.8	15.0	18.0	11.5	12.2	34.8	25.8	12.3	16.0	15.3	16.3	14.0	22.4	18.9	10.0	15.4	20.2	14.4	17.6	21.8	16.1	22.1	34.1	46.8	23.7	18.3	21.4	17.4	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3	80.4	84.0	98.9	106.9	50.8	161.8	74.6	53.5	112.4	87.6	50.6	84.4	70.3	112.7	61.8	399.0	40.7	72.4	23.3	103.3	66.4	62.2	82.7	136.5	77.6	53.4	68.3	79.3	46.1	54.6	89.6	81.1	59.7	59.1	95.6	64.7	103.3	77.6	75.8	81.7	60.8	186.0	58.2	71.0	80.0	64.3	56.2	135.5	69.2	70.2	111.6
USP17L2	DUB3	ENSG00000223443	"Ubiquitin specific peptidase 17-like family member 2"	Q6R6M4	8	12137168-12139077	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.3"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"															"unprognostic (2.01e-1)"			0.1	0.4	0.1	0.1	0.5	0.0	0.2	0.8	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	1.0	1.1	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17-like family member 22"	D6RA61	4	9267619-9269570	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4			0.5		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17-like family member 24"	Q0WX57	4	9325165-9327116	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17-like family member 25"	Q0WX57	4	9329911-9331862	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17-like family member 26"	Q0WX57	4	9334658-9336609	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17-like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17-like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17-like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17-like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17-like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18149899-18177397	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 39.7;Extravillous trophoblasts: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 48.9;BJ hTERT+ SV40 Large T+ RasG12V: 53.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	20.4	6.4	4.8	13.0	4.8	6.3	15.4	1.9	5.5	5.3	6.3	5.6	3.2	5.2	6.1	9.5	6.0	6.5	7.1	5.4	4.4	4.6	8.8	20.9	14.0	15.9	4.3	4.8	4.9	4.2	3.8	7.8	7.6	4.7	4.8	3.9	5.7	11.7	2.3	9.7	4.2	15.5	4.5	4.1	10.6	6.4	10.6	4.0	22.4	10.6	2.9	7.7	4.3	6.9	4.1	2.9	6.6	8.8	11.0	11.0	4.8	3.7	3.8	1.1	4.9	5.0	3.7	5.0	1.9	4.6	48.9	53.2	0.6	5.3	0.0	3.0	1.0	15.6	1.3	5.7	1.7	1.6	16.7	7.9	7.3	0.5	6.9	0.6	1.7	7.0	1.6	0.6	3.4	0.0	0.2	10.8	5.5	0.3	0.4	0.4	6.4	8.5	4.3	3.4	4.0	2.9	3.4	7.6	0.0	0.9	3.2	4.1	3.2	2.3	4.0	18.2	4.6	2.7	1.7	17.7	0.3	1.0	1.1	1.9	0.9	11.4	0.0	4.4	4.4	2.8	2.7	3.2	6.6	7.8	8.8	10.0	4.1	6.7	10.1	1.6	2.7	7.9	8.8	0.5	11.0	6.6	2.9	11.0	4.8	4.8	4.8	1.9	4.0	4.4	4.6	4.3	4.8	4.7	4.0	8.9	3.7	0.5	3.7	1.4	0.2	0.4	5.1	8.1	6.8	0.0	0.0	4.5	39.7	5.1	1.2	6.0	4.3	0.0	9.9	27.4	3.1	3.8	0.0	4.3	7.7	0.0	2.9	9.2	4.5	1.4	3.4	1.8	3.3	0.0	2.2	3.9	9.2	2.9	6.7	5.7	0.2	6.5	1.2	6.2	0.4	0.9	1.3	1.5	2.8	2.5
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	13.9	19.5	10.3	14.6	12.2	16.2	14.9	19.4	37.1	17.0	16.3	12.5	19.6	14.6	18.7	17.9	14.3	17.2	19.9	17.9	10.3	9.4	14.8	16.5	14.7	13.8	11.9	9.5	17.2	15.2	22.4	13.2	17.6	11.4	14.2	10.9	14.9	24.7	26.0	57.3	18.4	16.1	13.9	8.5	17.5	15.1	14.9	11.7	23.0	17.7	15.2	12.6	17.4	14.1	5.1	6.7	12.3	5.7	4.3	8.4	5.3	8.3	12.0	14.4	20.3	17.7	12.2	18.4	9.4	12.6	17.6	13.3	12.0	12.8	18.0	9.6	11.8	17.5	11.1	18.2	13.6	7.3	14.1	14.0	17.5	24.1	11.0	18.4	19.8	18.5	17.3	10.6	16.6	12.1	12.3	11.5	16.1	13.7	13.6	8.8	10.8	18.7	20.5	27.3	12.5	17.6	9.1	10.7	20.8	10.9	15.9	7.9	22.7	13.9	18.2	16.3	12.5	12.3	26.4	9.1	11.7	14.3	17.3	14.2	34.4	33.3	15.9	15.1	15.7	14.5	12.3	4.9	7.5	7.2	5.3	6.8	4.6	5.8	8.4	6.7	5.1	5.7	6.2	8.8	4.3	5.7	3.0	4.1	5.3	10.3	12.2	19.4	37.1	10.3	9.4	11.9	9.5	11.4	11.7	11.9	9.7	2.9	4.0	5.6	11.4	9.6	2.5	10.7	10.3	7.0	17.7	8.5	5.0	6.6	2.7	7.1	13.1	0.0	6.7	4.4	5.8	4.6	2.3	12.1	7.8	12.7	8.7	7.4	6.1	4.1	12.0	8.4	3.3	1.8	11.3	7.7	9.8	11.8	11.7	6.3	11.2	12.9	5.2	10.5	10.0	4.6	11.3	6.4	10.9	2.6
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 399.1;Late spermatids: 802.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.5	0.3	0.5	2.0	0.1	0.1	0.8	0.4	0.2	0.0	0.4	3.6	0.5	6.1	1.1	0.6	0.9	0.6	4.8	1.8	0.1	4.2	0.6	1.7	2.6	7.5	1.7	0.0	1.7	0.6	0.3	0.4	1.2	0.8	0.3	4.6	8.4	0.5	1.0	2.4	0.0	0.4	0.9	1.2	0.8	0.0	1.3	0.9	2.8	0.2	7.4	2.2	2.1	1.6	0.4	1.1	5.4	3.7	0.0	0.0	0.9	0.5	0.6	35.2	7.7	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8	3.0	2.4	0.0	4.5	2.2	73.3	74.6	5.1	42.8	9.1	5.2	90.3	0.3	96.2	2.6	399.1	2.2	31.5	0.0	1.4	0.5	4.6	1.0	0.0	19.8	13.2	9.5	0.0	1.3	1.5	802.9	6.1	1.3	0.0	0.0	1.6	37.9	1.5	10.5	6.7	24.9	128.7	19.4	18.6	19.9	14.9	3.4	1.1	1.5	2.2	2.0
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	2.5	2.5	4.4	6.0	5.8	5.0	6.3	4.1	3.5	3.2	2.2	2.1	2.8	3.5	3.6	4.0	3.6	6.5	2.6	3.0	1.3	19.0	3.5	6.5	6.8	1.4	4.1	6.1	4.8	4.4	4.4	4.2	3.1	5.6	3.4	42.3	25.9	4.4	1.9	6.8	23.8	14.5	3.5	5.4	6.0	4.0	5.0	5.9	2.5	2.8	1.0	4.9	4.8	6.2	3.9	2.7	6.4	8.5	5.0	3.5	1.6	4.7	2.7	4.3	6.3	2.4	7.0	8.0	3.3	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8	8.9	8.6	3.2	2.3	2.5	7.9	5.9	2.5	4.0	2.3	1.8	3.9	5.1	3.3	2.2	1.1	2.4	4.0	0.0	3.4	2.1	3.8	3.0	1.1	5.6	3.0	9.5	8.1	7.4	2.1	2.8	5.8	3.1	3.3	3.6	4.6	5.8	2.3	3.7	4.6	2.2	5.9	0.0	6.2	12.2	4.4	1.8	5.1	11.3	5.1	1.4
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	11.8	16.4	22.1	12.8	21.2	15.3	19.1	23.6	24.8	18.1	16.1	25.5	14.0	15.5	19.7	14.6	18.3	33.3	14.1	13.7	20.9	12.1	15.4	10.6	14.0	16.7	26.4	14.1	28.3	19.0	24.4	17.2	15.2	20.5	18.1	13.1	17.1	19.0	25.3	19.4	23.5	15.4	15.1	17.0	18.7	16.0	17.0	22.9	16.0	24.5	9.6	15.6	17.9	19.2	14.1	12.0	18.3	11.1	13.4	17.2	10.7	7.4	12.9	16.9	16.3	13.5	11.3	10.4	5.5	9.0	15.2	11.9	11.8	14.7	9.8	9.5	6.8	9.5	12.9	10.9	10.7	8.4	18.6	18.4	11.6	18.6	9.2	9.8	10.3	8.7	9.5	14.4	10.4	15.1	17.2	10.7	21.7	17.2	13.6	9.7	13.7	18.2	16.2	15.8	14.6	16.4	17.3	5.6	16.4	8.9	8.9	15.4	19.9	10.3	10.9	8.3	13.2	23.9	16.7	6.3	10.9	9.8	7.6	9.4	27.6	21.3	14.5	10.0	8.9	9.8	13.0	11.1	18.3	14.9	7.1	17.2	12.8	13.8	15.4	12.0	14.1	16.0	14.6	9.6	13.4	7.7	12.0	13.3	10.7	22.1	21.2	23.6	24.8	20.9	12.1	26.4	14.1	20.5	22.9	0.0	3.0	1.7	1.5	1.3	3.9	2.2	10.2	10.7	3.4	1.8	5.9	3.6	1.7	1.4	0.6	2.8	2.0	0.0	2.0	2.1	2.4	2.0	2.3	1.7	1.9	0.0	5.2	6.2	7.6	0.4	4.6	1.7	1.7	0.0	4.1	3.0	1.7	2.9	3.9	1.8	4.4	6.5	1.9	3.6	2.7	1.3	2.6	2.5	3.7	1.4
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999593-21043760	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	22.5	33.0	40.7	21.5	49.5	25.9	24.6	66.1	66.4	26.8	23.6	31.9	25.1	18.9	36.7	29.3	21.9	33.9	23.0	44.1	38.7	47.6	27.7	22.9	26.1	25.1	31.0	40.7	45.6	24.5	47.4	32.2	22.4	35.1	27.5	20.5	28.7	20.0	29.5	47.6	22.1	21.1	31.2	24.8	23.7	22.7	20.2	23.7	41.2	32.8	24.8	27.3	25.1	23.2	13.7	12.1	13.4	13.3	8.9	15.5	6.9	19.6	35.6	34.6	29.7	20.2	21.0	16.5	22.6	17.4	20.4	17.4	41.0	8.9	26.9	21.8	34.7	13.8	21.1	33.5	27.0	30.6	12.8	23.2	22.3	23.7	19.9	24.0	24.5	19.5	23.1	16.2	23.1	24.3	23.3	25.4	17.7	25.3	9.8	28.8	20.2	34.3	11.7	17.8	23.3	11.7	38.0	54.8	18.3	18.8	28.9	16.7	34.4	29.2	12.1	23.7	99.0	20.3	14.5	32.2	20.9	27.8	21.4	30.5	10.5	14.1	89.5	21.2	13.1	32.2	6.8	13.3	12.6	11.0	9.8	11.1	10.9	11.7	10.9	12.1	13.7	15.5	14.6	13.4	8.9	12.2	10.2	7.8	6.9	40.7	49.5	66.1	66.4	38.7	47.6	31.0	40.7	35.1	23.7	38.7	45.6	40.4	39.5	29.3	90.6	20.9	58.6	29.4	35.2	57.6	88.4	42.1	19.9	47.1	31.0	40.9	35.1	0.0	50.6	33.9	44.7	49.2	29.0	55.2	34.1	111.2	84.7	78.0	53.0	39.2	47.2	23.7	33.7	24.4	42.7	58.7	59.0	38.6	67.5	45.1	54.5	12.9	38.8	14.2	16.6	25.5	55.0	23.0	46.6	38.9
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.7	9.8	12.3	6.6	16.0	14.1	14.2	7.9	9.9	11.4	11.9	13.9	6.3	14.3	8.7	14.6	23.4	14.4	16.3	13.3	17.9	14.9	9.8	28.6	21.4	16.3	9.5	19.7	22.2	12.3	11.8	17.2	19.6	11.0	10.3	14.6	26.3	6.0	15.1	4.2	11.8	10.5	18.0	8.6	11.9	12.3	15.7	6.2	19.8	12.0	10.8	7.6	13.4	9.6	11.7	19.5	6.7	9.8	13.9	10.4	10.1	12.5	12.5	7.6	5.6	18.8	9.9	16.4	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7	14.9	18.3	14.2	7.0	13.3	12.9	28.1	10.2	8.1	15.9	12.2	68.7	3.6	0.0	8.8	0.4	13.1	6.8	0.0	8.7	6.5	9.6	9.6	12.7	10.9	8.4	36.5	16.6	10.4	17.5	1.3	10.9	12.2	10.1	12.6	16.4	7.1	9.9	11.5	7.4	4.5	16.7	6.5	10.5	8.6	5.8	15.1	1.3	17.1	14.9	8.6
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 124.6;Late spermatids: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	14.9	8.5	11.0	14.2	15.5	12.4	28.7	11.3	11.1	17.5	11.8	6.6	17.8	6.5	20.7	14.5	12.6	10.6	10.1	17.8	9.9	5.8	12.9	10.4	22.1	14.8	7.6	7.1	14.5	8.2	8.1	8.4	17.7	7.7	12.9	8.6	7.8	11.4	13.6	56.3	8.3	12.3	19.2	7.3	11.6	9.0	26.1	7.5	16.5	10.5	14.6	9.6	13.8	18.1	3.1	2.8	5.8	2.9	2.3	7.2	1.6	13.2	10.0	9.5	1.4	17.6	26.3	11.2	9.5	9.5	7.1	9.0	8.8	7.6	14.3	14.1	15.0	10.8	7.1	7.3	12.6	9.9	14.2	8.4	11.7	10.6	6.7	29.2	15.4	5.4	17.0	15.4	11.4	33.2	18.7	24.9	13.1	15.0	27.1	12.8	5.5	17.6	2.9	11.7	5.3	8.9	13.5	8.8	10.8	19.3	3.6	2.1	5.7	13.6	11.5	8.8	12.1	6.1	9.1	23.6	11.1	7.2	11.6	5.3	7.9	4.8	11.4	7.2	6.9	8.1	0.0	2.9	3.6	4.0	2.8	4.4	3.1	3.4	7.2	2.5	2.2	3.2	4.8	5.8	2.3	2.5	2.8	4.4	1.6	11.0	15.5	11.3	11.1	9.9	5.8	7.6	7.1	7.7	7.5	53.6	22.7	11.5	16.1	15.1	5.7	52.1	10.2	25.4	31.8	21.0	3.9	27.3	5.0	7.8	124.6	19.1	12.8	0.0	11.4	6.8	16.0	19.0	5.8	17.3	11.9	4.8	9.2	17.2	23.7	145.9	17.5	18.8	15.1	6.4	11.9	4.2	10.4	7.0	12.0	12.2	6.0	19.4	15.5	9.8	5.3	16.8	27.7	17.5	10.2	20.5
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	7	"testis: 3.8"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA000424, HPA027310"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000424: , HPA027310: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.1	3.8	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.0	0.0	0.5	0.4	0.5	0.4	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.7	0.1	0.1	0.0	0.1	0.7	0.1	0.2	0.3	1.0	0.3	1.0	0.3	0.1	0.1	0.0	1.5	0.6	0.4	0.1	0.3	0.1	0.4	0.4	0.4	0.2	0.2	0.1	0.8	0.4	0.2	0.3	0.4	0.1	0.0	0.9	0.5	0.5	0.2	0.1	0.1	0.2	1.0	0.1	0.7	0.3	0.9	0.1	0.3	0.4	0.9	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	1.8	4.7	5.5	6.3	5.2	4.3	4.6	2.1	3.4	2.4	2.0	8.5	2.1	1.2	2.0	5.4	7.9	3.0	7.8	5.2	3.5	2.4	3.7	2.0	1.4	7.7	3.5	0.6	4.3	6.0	3.6	3.4	3.4	5.9	3.3	5.5	3.9	2.0	3.8	4.5	2.9	1.7	6.0	3.5	3.3	3.1	4.8	0.4	3.9	1.8	1.4	4.1	4.0	3.8	4.9	17.9	4.4	1.4	2.5	2.8	5.4	4.8	0.8	1.9	0.5	0.8	3.2	1.7	3.0	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4											17.9	13.3	0.0	4.1	2.6	9.7	2.3	0.0	24.1	13.6	0.0	0.0	34.3	5.0	1.1	0.0	3.1	0.7	0.0	0.6	2.0	1.8	2.5	2.3	1.7	3.4	4.8	4.1	3.1	0.3	0.0	2.0	1.1	0.0	1.0	1.2	10.2	1.2	0.0	3.2	2.6	2.0	6.5	1.7	0.0	1.4	1.9	21.9	1.3	1.7	1.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	8.6	9.7	13.1	17.3	10.8	10.7	9.3	6.4	8.8	8.6	14.8	14.4	12.5	11.5	14.6	8.6	19.9	17.0	18.5	12.0	12.0	12.8	8.4	6.1	6.8	7.7	6.6	7.8	6.1	6.4	9.1	10.0	11.9	12.6	15.5	5.7	10.5	7.5	9.0	4.4	5.9	12.8	15.7	16.0	7.0	14.7	18.3	13.9	9.5	8.5	5.7	6.2	15.2	5.2	4.9	42.9	12.6	2.7	8.2	9.6	14.4	8.7	6.5	5.1	7.3	9.7	0.9	15.3	6.2	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8	8.9	9.1	10.0	6.9	1.4	16.1	130.6	5.1	14.7	10.3	5.2	17.7	3.5	5.0	5.7	1.4	4.3	5.1	0.0	3.4	3.7	4.7	6.2	1.1	6.7	3.9	4.8	4.7	6.2	4.1	1.4	6.4	6.5	1.7	5.4	10.3	10.1	4.4	3.5	13.1	6.3	20.2	6.5	5.2	10.8	10.0	1.8	0.9	24.5	9.2	4.9
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Group enriched"	"Detected in some"	9	"Collecting duct cells: 1.8;Early spermatids: 1.7;Spermatocytes: 4.8;Spermatogonia: 1.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"					"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA					"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	2.0	0.9	1.0	1.4	0.0	0.0	0.0	1.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	0.5	1.0	0.9	0.0	1.0	0.0	2.1	2.1	0.7	0.6	0.4	0.3	1.2	0.8	1.3	1.5	1.3	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	0.0	0.0	0.1
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	No	No			Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.2	15.6	9.8	7.7	12.6	13.8	7.9	9.9	7.7	9.5	11.8	17.3	9.4	12.6	7.9	5.1	11.7	14.6	12.3	7.5	15.3	7.9	10.6	10.8	12.7	6.6	6.3	12.8	9.0	16.3	9.3	16.2	7.8	16.7	16.9	14.1	12.0	4.9	14.3	13.1	10.2	19.7	18.9	13.1	19.2	9.4	16.6	9.2	31.7	13.7	10.6	4.9	16.2	9.7	8.9	9.7	12.3	15.8	8.9	18.6	5.2	10.5	10.8	19.9	20.8	8.6	17.5	7.4	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8	35.7	60.4	35.8	31.2	46.8	31.1	9.1	20.4	36.1	43.3	15.7	11.8	17.3	34.9	36.4	19.7	20.3	33.9	0.0	32.3	46.8	16.4	35.8	25.5	20.8	22.8	12.7	42.1	11.1	75.5	53.6	14.7	64.4	40.5	27.1	32.5	24.6	35.0	31.7	17.3	19.9	17.8	12.9	25.2	10.2	41.8	51.6	28.5	37.4	34.7	33.1
USP30	"FLJ40511, MGC10702"	ENSG00000135093	"Ubiquitin specific peptidase 30"	Q70CQ3	12	109023089-109088026	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016952	Approved					NA	NA					"HPA016952: AB_1858680"	"unprognostic (2.34e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-3)"	11.7	18.9	12.7	9.0	17.6	12.2	10.4	11.9	21.0	10.3	13.2	29.2	13.6	14.9	12.4	8.5	9.2	11.1	8.4	9.0	10.3	10.6	12.4	21.7	8.9	10.4	16.6	7.8	17.5	12.4	14.7	13.0	6.7	16.0	9.4	11.3	16.4	10.1	12.4	16.4	13.6	14.1	8.6	14.3	9.8	8.5	21.3	16.3	8.7	11.1	5.3	7.1	10.8	8.1	14.2	12.2	12.7	11.0	18.3	17.4	6.0	4.6	3.6	9.5	8.2	6.7	7.7	5.3	5.2	6.8	6.1	5.4	4.2	3.6	11.7	4.4	5.1	5.6	5.2	8.3	5.4	7.0	13.5	10.4	3.8	3.2	6.0	7.2	7.4	4.2	9.2	6.6	5.4	5.3	15.8	7.0	12.1	5.6	5.7	5.1	5.4	11.7	4.2	3.0	5.6	10.1	12.7	6.8	7.0	4.9	5.6	8.7	7.7	7.0	5.3	5.5	7.3	13.1	5.8	5.0	5.6	3.1	5.4	3.4	14.3	11.9	17.5	6.0	4.5	6.2	9.5	7.1	12.7	15.4	11.0	17.4	14.2	12.9	14.3	4.6	14.2	13.7	12.6	4.2	18.3	8.8	12.2	11.2	6.0	12.7	17.6	11.9	21.0	10.3	10.6	16.6	7.8	16.0	16.3	0.0	2.9	0.8	2.3	1.8	7.7	6.4	10.2	4.0	5.7	5.2	7.9	4.9	0.0	3.9	22.7	2.9	9.7	0.0	4.9	3.5	3.3	2.0	0.0	13.9	4.9	6.4	6.4	1.8	4.6	37.3	3.4	1.4	1.7	1.0	10.2	6.5	4.6	3.5	3.5	5.1	14.1	12.9	2.1	16.9	5.3	2.9	6.1	1.9	10.4	2.6
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	6.3	5.3	11.2	4.0	16.6	7.1	8.7	12.7	16.5	10.9	4.9	19.7	2.6	3.7	15.3	7.7	9.3	6.5	4.1	11.0	9.0	6.3	6.2	7.7	7.3	3.6	24.6	8.1	3.7	6.3	20.6	10.4	7.4	17.4	9.6	4.9	2.8	6.0	8.5	10.9	15.9	3.4	14.2	14.8	2.8	3.5	20.7	19.3	1.7	4.2	2.4	4.9	13.4	9.5	0.5	0.8	0.6	1.3	0.1	2.1	0.2	9.5	10.1	2.9	4.0	5.3	4.2	2.7	3.3	3.0	4.3	5.2	6.4	5.8	3.2	3.6	4.2	7.0	12.6	7.2	13.1	7.1	2.3	2.9	1.3	5.8	13.4	6.7	3.3	3.6	3.5	11.3	8.0	18.5	1.6	7.6	3.2	3.9	10.0	5.8	6.5	1.6	2.8	5.8	3.2	3.1	7.9	8.2	6.4	6.4	14.3	7.8	5.1	5.2	10.3	2.9	3.4	4.1	7.4	4.5	8.8	6.5	4.4	9.0	3.3	5.4	3.4	6.3	4.5	3.5	0.1	0.7	0.6	0.8	0.3	2.1	0.1	0.7	1.5	0.8	0.5	0.8	0.8	0.1	0.1	1.3	0.2	1.3	0.2	11.2	16.6	12.7	16.5	9.0	6.3	24.6	8.1	17.4	19.3	6.0	3.0	6.1	55.8	59.3	12.6	9.2	10.2	8.1	7.9	5.2	2.0	11.1	0.0	6.1	3.6	14.6	1.4	0.0	7.2	6.2	5.4	14.2	1.1	25.0	4.2	0.0	4.6	7.4	3.1	8.9	7.2	2.9	6.8	1.0	3.5	4.8	7.6	0.0	4.2	9.1	7.4	19.4	7.1	23.8	60.3	23.2	6.3	1.3	5.2	19.5
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60179094-60422470	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell type enhanced"	"Detected in all"	11	"Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 128.6;Spermatocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 28.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 28.4;granulocytes: 13.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.6"									HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	9.5	13.9	17.3	10.8	19.5	20.6	10.9	14.6	20.3	8.0	8.5	18.9	7.9	7.2	8.2	5.4	13.1	7.4	9.1	11.1	14.7	12.2	15.5	19.7	12.5	8.6	18.8	14.3	7.4	8.5	17.3	11.4	9.8	19.2	8.7	8.9	11.6	8.2	9.0	23.0	12.2	7.2	9.8	16.5	12.1	8.1	58.4	18.1	7.3	15.6	7.9	8.5	8.8	8.5	1.4	28.4	13.5	2.1	0.6	1.1	0.9	11.1	12.7	6.8	10.8	17.2	16.2	6.4	9.1	13.8	12.0	15.4	6.6	7.3	6.9	7.7	16.8	19.3	5.9	11.5	12.6	21.2	5.2	5.1	13.8	10.1	7.2	17.1	10.9	12.6	15.1	9.3	16.1	14.9	12.4	13.1	8.3	13.9	5.7	14.8	61.6	11.0	7.7	7.9	10.7	6.1	5.3	17.9	4.1	12.6	8.1	4.8	7.2	7.6	2.2	11.7	12.3	9.4	15.2	11.0	18.2	19.0	11.4	8.5	5.9	11.2	6.5	9.1	8.6	11.8	4.3	2.1	7.2	1.0	1.8	0.7	1.4	0.7	0.8	4.1	1.1	0.5	1.0	13.5	0.6	2.0	28.4	1.1	0.9	17.3	19.5	14.6	20.3	14.7	12.2	18.8	14.3	19.2	18.1	6.0	13.1	7.7	11.6	23.9	16.9	7.6	5.1	6.7	13.6	5.2	227.8	4.3	3.3	9.0	69.1	8.4	6.8	23.3	6.3	5.3	10.4	9.3	11.5	10.6	16.5	12.7	7.9	9.2	33.2	25.6	12.0	27.7	5.0	14.4	4.2	10.3	8.4	9.1	5.3	3.7	128.6	25.8	9.5	100.3	9.1	19.2	4.1	12.9	4.4	7.1
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.1	7.4	25.6	17.7	36.9	32.3	22.0	17.7	16.9	21.6	24.3	9.8	14.0	12.1	16.8	17.2	35.5	12.8	18.6	12.1	26.6	11.1	14.5	42.7	18.1	8.5	23.0	14.5	10.8	23.7	9.5	20.9	15.4	20.9	19.2	11.1	16.6	10.6	16.2	6.2	13.1	14.5	24.7	12.6	14.7	12.6	27.0	8.5	20.4	16.6	21.5	16.6	12.4	16.5	24.7	22.8	9.2	15.8	16.1	20.0	14.2	20.1	16.7	8.7	11.0	11.8	15.1	17.2	10.1	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6	41.7	36.3	21.6	16.5	15.2	50.9	31.5	20.4	36.1	25.0	33.2	55.0	21.0	8.3	16.9	2.8	26.4	26.8	0.0	13.4	15.9	21.2	23.9	22.0	18.1	16.5	58.8	34.1	28.8	33.6	3.6	33.1	22.3	21.9	19.8	26.0	34.5	15.7	28.6	30.1	19.2	40.3	19.4	17.5	36.1	26.3	14.3	10.0	27.5	22.9	20.0
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61470769	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	17.2	19.6	31.8	37.2	25.6	24.8	28.3	77.1	35.5	22.5	22.7	14.4	31.1	11.4	22.2	44.5	18.6	17.5	20.0	16.9	30.5	24.0	20.5	21.5	29.7	34.2	22.0	21.2	24.7	17.2	33.5	40.3	13.4	22.0	22.7	21.5	21.2	16.9	45.2	27.0	31.6	21.0	22.7	20.8	24.8	19.3	26.4	25.3	21.7	23.2	13.9	33.5	19.1	16.7	6.0	5.8	3.4	4.6	5.2	7.5	2.3	16.8	12.1	15.7	16.3	29.9	20.1	13.2	10.4	14.7	9.3	8.9	16.9	6.5	40.0	11.1	22.4	9.9	9.3	12.4	13.7	17.4	14.3	9.8	24.2	11.7	27.2	25.2	17.9	15.4	21.9	17.8	17.0	25.4	22.8	19.6	11.4	16.5	13.0	20.7	15.8	11.8	26.1	10.6	17.2	9.6	12.7	19.2	10.7	27.5	20.7	13.0	13.9	16.4	12.2	17.9	21.0	6.4	13.0	17.5	14.8	19.7	8.7	13.6	15.1	7.4	42.0	13.9	16.7	12.6	3.4	2.0	2.8	7.5	2.2	6.7	5.1	5.1	5.5	1.8	6.0	5.8	7.5	3.4	5.2	4.6	5.8	4.5	2.3	31.8	25.6	77.1	35.5	30.5	24.0	22.0	21.2	22.0	25.3	59.6	60.6	35.3	50.1	54.3	132.9	41.8	56.0	33.5	59.1	31.4	235.6	26.6	8.3	35.4	108.3	51.2	38.6	0.0	29.1	19.8	45.2	63.1	31.2	36.3	19.7	101.7	46.7	23.4	40.3	105.2	52.6	41.4	38.8	30.7	32.2	62.5	38.7	38.4	62.9	18.3	185.3	25.8	46.7	97.9	106.7	53.6	44.6	40.8	31.2	57.6
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78214711	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 32.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 20.7;Late spermatids: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	4.9	17.1	5.1	5.4	9.3	3.8	5.2	10.4	15.0	6.4	5.8	8.0	6.3	5.5	6.8	5.4	5.6	5.4	5.6	8.7	6.1	6.7	5.0	13.8	5.6	4.8	6.7	8.8	6.6	6.4	32.4	12.0	7.1	15.0	5.0	3.4	7.7	4.0	5.6	5.6	3.2	5.3	7.8	4.5	4.6	3.9	5.3	4.0	1.9	7.7	2.9	4.1	5.2	6.6	0.0	0.1	3.4	0.6	0.1	0.3	0.2	2.1	3.3	5.7	6.0	9.7	9.0	3.9	4.9	5.8	5.8	4.1	8.3	4.6	1.7	5.1	9.2	6.2	5.7	3.8	7.6	3.4	12.2	2.0	2.8	8.6	4.8	7.6	1.8	8.3	7.6	5.1	12.1	3.5	11.5	7.1	6.2	3.9	4.2	4.5	1.9	4.6	7.2	1.7	6.0	5.3	2.8	5.3	2.0	4.6	3.9	2.8	5.4	3.8	5.0	1.8	8.5	4.2	1.5	8.6	10.7	6.1	12.6	2.6	5.7	1.8	2.6	3.2	1.9	6.2	0.0	0.2	3.4	0.1	0.6	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.2	5.1	9.3	10.4	15.0	6.1	6.7	6.7	8.8	15.0	4.0	0.0	2.6	0.0	0.1	0.7	0.7	1.8	0.0	0.0	0.0	0.0	5.9	0.6	0.0	0.8	20.7	1.5	0.8	0.0	1.7	1.3	2.0	0.2	0.0	3.0	1.3	0.0	0.0	2.5	0.8	31.6	1.4	0.9	1.7	3.6	0.6	0.5	1.8	0.0	2.8	0.8	0.5	6.5	0.9	0.9	1.6	0.9	0.2	3.9	0.7	0.1
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	16.0	19.4	5.7	10.6	12.3	13.7	11.0	13.2	13.4	12.7	8.6	18.8	8.1	20.5	6.7	11.7	13.8	11.8	13.4	9.8	22.8	4.9	20.3	18.7	28.3	19.6	12.7	20.5	10.3	11.9	16.3	18.1	40.6	9.8	11.0	9.3	14.9	21.7	10.4	12.3	18.6	20.8	8.8	12.0	15.6	14.4	12.6	13.8	8.0	17.0	16.9	10.3	9.5	44.3	24.0	13.0	11.4	13.1	9.3	30.1	14.0	17.5	23.3	16.1	6.3	25.3	11.8	16.0	9.4	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7	11.9	41.5	16.3	21.0	45.9	31.4	13.5	15.3	12.0	26.1	14.0	31.4	6.9	5.0	8.7	12.1	20.4	6.8	0.0	8.3	8.9	25.9	22.8	19.7	12.4	34.2	25.4	17.7	12.3	20.6	6.1	10.9	34.8	28.7	10.8	13.6	17.3	10.7	8.6	11.7	4.1	32.5	6.5	22.7	14.2	10.6	37.9	10.8	30.5	14.0	20.4
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 117.3;Late spermatids: 116.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.4	5.4	11.5	8.8	3.0	3.7	9.8	5.7	4.1	9.9	11.2	10.2	5.9	6.8	6.2	4.4	7.6	7.1	12.5	6.3	10.9	9.2	6.6	18.3	11.0	6.7	3.4	11.9	9.2	2.0	3.8	10.4	7.5	3.6	4.2	11.9	13.2	13.1	6.2	5.5	15.3	8.2	9.8	4.8	4.7	12.4	17.2	6.2	3.4	8.8	12.6	6.8	9.1	4.5	5.7	11.5	5.2	8.4	5.4	11.2	9.8	6.2	7.4	8.9	7.9	13.9	6.0	8.8	7.6	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5	0.0	8.3	11.5	5.5	17.3	16.4	3.3	2.5	10.7	10.3	7.0	25.5	6.1	0.0	4.6	117.3	9.0	5.1	0.0	2.0	5.4	9.3	10.2	4.7	10.2	6.5	14.3	9.9	11.6	8.1	116.2	9.2	13.7	20.3	5.4	8.1	9.9	4.6	6.8	9.2	3.6	21.1	6.5	10.3	40.0	12.8	18.1	6.1	17.9	7.0	5.8
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.8	4.5	4.0	6.9	5.3	5.3	3.0	7.7	7.5	7.2	6.1	13.1	7.2	6.0	5.5	6.5	4.6	3.8	9.5	7.7	5.9	14.6	6.1	5.5	5.4	2.8	7.3	11.1	5.5	6.4	7.1	7.3	5.9	5.1	7.1	6.9	11.9	18.9	4.7	7.7	14.5	2.1	3.6	9.8	8.9	9.5	6.0	5.7	4.6	5.6	8.2	7.4	6.0	10.5	6.7	3.1	6.4	4.2	8.4	6.6	5.4	5.7	8.0	21.1	35.7	10.9	6.7	8.5	5.5	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2	20.8	13.7	10.5	16.5	47.6	7.5	15.1	7.6	13.4	14.8	0.0	11.8	10.9	1.7	7.5	27.8	12.0	18.4	0.0	6.6	5.8	9.7	16.1	3.5	32.7	9.2	7.9	29.4	17.8	14.5	15.4	6.4	12.2	11.8	1.8	19.9	13.6	8.5	11.5	8.9	14.2	8.2	12.9	15.1	9.5	5.1	51.7	22.3	13.4	14.5	38.1
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 100.2;Late spermatids: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.4	7.4	10.2	13.6	19.0	20.4	6.9	17.5	15.6	22.7	20.5	7.8	16.2	12.4	7.0	25.5	13.1	8.7	13.6	24.8	21.2	19.1	4.0	27.5	14.7	8.7	27.9	14.5	15.9	20.9	10.9	24.9	20.5	16.5	26.2	14.1	9.6	19.7	21.0	10.9	17.1	24.6	8.7	8.0	12.9	7.1	6.4	10.8	17.8	13.3	8.5	11.4	12.7	9.0	6.5	10.7	6.2	23.3	23.2	15.3	8.3	19.1	10.2	15.8	7.6	18.1	13.7	23.0	17.5	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7	38.7	21.4	18.1	15.0	16.7	16.6	15.3	15.3	33.5	25.0	19.2	19.6	18.9	18.3	14.2	100.2	17.9	11.6	0.0	11.9	12.1	12.3	13.1	32.4	12.1	21.7	11.1	10.3	16.0	38.8	90.2	14.4	25.3	15.1	30.7	11.4	12.0	14.6	5.8	18.0	10.5	21.5	12.9	14.7	18.5	13.6	16.2	20.3	24.9	11.9	11.8
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	12.5	20.5	11.0	8.2	17.7	3.5	16.1	8.2	13.5	12.4	12.1	26.1	22.5	11.6	16.2	28.1	13.9	13.4	13.2	10.8	11.3	8.5	16.9	15.7	13.9	7.6	22.1	10.1	19.6	17.2	22.8	24.3	16.3	16.5	16.1	11.2	16.4	13.9	19.7	13.6	21.7	15.2	17.1	20.1	11.4	16.3	23.3	18.9	9.8	21.2	9.4	12.0	18.0	11.8	1.9	5.0	0.4	2.8	1.4	2.2	1.4	9.5	11.1	10.2	6.9	15.0	14.1	9.0	9.4	7.3	8.8	9.6	7.9	11.4	0.2	2.8	15.1	22.6	17.0	7.8	16.7	12.6	0.0	5.1	7.5	9.2	13.3	13.1	3.1	5.1	13.4	12.1	12.9	18.2	15.4	10.1	4.6	12.1	1.8	12.3	7.7	3.4	4.7	4.5	9.9	9.0	0.0	21.2	4.4	10.4	15.4	5.6	6.1	7.5	7.8	9.7	8.0	8.8	7.1	9.9	12.2	7.6	5.1	11.4	3.4	2.6	0.4	15.9	5.7	10.6	0.0	2.7	0.0	1.3	2.8	0.6	1.3	1.5	1.3	4.0	1.9	1.9	2.2	0.4	1.4	2.3	5.0	2.0	1.4	11.0	17.7	8.2	13.5	11.3	8.5	22.1	10.1	16.5	18.9	29.8	31.5	3.7	9.6	6.5	18.6	8.9	10.2	24.1	23.9	15.7	23.6	17.1	6.6	7.9	6.7	7.1	10.9	0.0	10.6	8.8	7.4	11.3	9.2	20.9	7.0	22.3	14.5	12.3	10.4	7.8	6.4	6.7	3.3	5.4	9.1	13.0	9.7	8.6	7.8	11.6	20.8	12.9	8.2	31.2	14.9	9.3	13.2	4.4	11.2	7.1
USP41		ENSG00000161133	"Ubiquitin specific peptidase 41"	Q3LFD5	22	20350578-20390758	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;RH-30: 4.2;RT4: 1.7;SCLC-21H: 4.9;SK-BR-3: 1.8;U-937: 1.5"															NA	NA						"unprognostic (4.01e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.63e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (5.28e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (9.91e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.63e-1)"	0.7	0.3	0.4	0.0	0.6	1.0	0.6	0.0	1.8	0.3	0.3			1.6	0.2	0.0	0.2	0.2	0.0	0.1	0.4	0.4	0.1	0.9	1.3	0.1	0.2		0.1	0.2	0.0	0.4	0.1		0.4	0.2		0.5	0.0	0.7	0.1	0.3	0.0	0.3	0.3	2.0	0.3			0.4		0.3	0.3	0.1	0.4	1.2	0.3	0.4	0.4	0.5	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.9	0.0	1.6	0.0	0.4	0.0	4.2	0.0	0.0	1.7	4.9	0.2	0.0	1.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.8	1.2	1.5	0.3	0.0	0.0	0.3	0.2	0.2	0.4	0.4	0.1	0.5	0.1	0.2	0.0	0.2	0.0	0.4	0.4	1.2	0.4	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 70.7;Spermatocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064800			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	6.7	5.6	5.7	5.7	9.5	19.8	7.2	14.1	10.6	8.5	7.4	10.4	5.5	8.1	14.1	7.0	6.9	8.1	6.5	5.4	5.8	6.0	7.4	7.1	7.3	6.5	6.7	4.9	10.6	11.7	10.5	10.9	8.2	6.2	7.4	6.5	8.9	6.6	6.3	7.4	9.2	9.2	8.7	9.9	7.8	6.7	25.2	8.1	14.3	7.7	6.2	8.3	7.6	6.9	1.9	2.2	3.3	2.4	1.9	4.3	0.8	8.4	6.3	11.4	11.1	6.6	5.0	7.8	4.6	5.9	5.4	5.4	4.4	4.5	10.1	3.0	5.7	8.0	7.9	9.5	5.0	5.9	2.4	7.4	4.6	5.4	4.5	5.6	10.8	5.3	5.9	6.0	5.8	7.5	5.0	6.6	8.5	17.8	6.8	3.6	7.5	6.5	12.1	12.9	4.4	4.8	12.4	8.9	6.9	5.1	4.5	8.8	15.5	5.8	12.2	3.6	10.9	5.6	5.6	5.5	4.9	18.1	6.1	5.4	6.1	5.1	8.8	4.1	6.6	9.5	2.3	1.1	3.3	2.1	2.4	3.0	1.9	2.6	1.3	1.1	1.1	1.7	4.3	1.4	1.9	1.2	2.2	1.8	0.8	5.7	9.5	14.1	10.6	5.8	6.0	6.7	4.9	6.2	8.1	11.9	6.5	11.5	16.3	35.9	18.1	6.9	0.0	10.7	6.8	1.8	21.6	7.3	0.0	9.4	70.7	12.2	12.5	0.0	8.9	6.5	8.5	16.7	9.2	7.8	7.2	20.6	10.3	14.7	7.0	32.5	13.3	11.5	10.1	6.4	14.6	11.3	10.2	7.0	12.0	4.2	17.9	12.9	11.3	67.4	32.6	36.3	22.4	12.1	11.3	13.5
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729691	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell type enhanced"	"Detected in many"	11	"Syncytiotrophoblasts: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 12.4;SK-BR-3: 8.6;T-47d: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762"	Uncertain					NA	NA					"HPA023389: AB_1858691, HPA027762: AB_10603001"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.2	0.2	4.2	1.2	3.4	0.9	3.0	0.7	6.0	4.9	10.0	0.6	15.7	6.2	2.9	1.7	6.7	6.3	5.1	0.2	4.1	3.8	3.7	8.7	3.4	0.2	1.7	3.1	1.0	7.7	1.7	3.7	61.6	0.7	10.8	5.0	0.3	11.3	12.4	0.2	2.4	12.5	0.3	1.0	0.2	2.6	2.9	0.2	0.4	1.7	4.2	2.7	1.3	2.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	5.7	1.5	0.0	0.6	0.0	0.0	12.4	0.1	0.2	0.7	1.7	2.8	4.7	0.0	1.9	0.2	2.7	7.0	0.6	5.5	0.7	3.6	1.9	0.3	3.0	1.0	0.1	0.5	0.0	0.0	7.2	0.3	3.0	0.3	0.0	0.8	0.0	0.0	0.0	2.7	0.9	4.7	0.7	4.9	0.3	3.7	0.0	0.8	4.4	3.1	0.8	0.0	2.5	8.6	1.0	4.1	10.4	1.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	4.2	3.4	0.7	6.0	4.1	3.8	1.7	3.1	0.7	0.2	3.0	1.9	0.0	7.2	4.1	0.0	0.5	7.6	21.4	7.9	10.4	5.9	16.6	1.7	3.9	1.1	0.0	9.0	0.0	4.0	19.6	0.6	9.5	0.0	12.4	2.4	0.0	2.4	0.0	1.6	0.8	0.0	0.0	5.0	0.0	7.8	8.1	8.5	2.9	0.0	1.3	1.3	0.0	0.3	1.1	0.2	2.9	61.2	0.0	9.0	10.0
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551490	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.8"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 343.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 10.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	39	"B-cells: 5.6;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2"					"Low region specificity"	"Detected in some"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	1.3	1.0	0.7	1.2	1.3	0.5	1.4	10.9	2.1	1.7	1.7	1.7	1.4	0.5	3.0	1.0	0.9	1.6	1.1	1.0	0.7	0.6	1.9	0.2	4.7	1.9	1.3	1.2	1.6	3.6	4.8	4.0	0.3	1.8	1.7	0.6	2.3	1.8	2.6	0.4	0.6	1.3	1.2	0.6	1.9	1.0	26.8	1.2	0.8	1.7	0.0	1.6	1.1	2.3	5.6	0.1	0.1	0.0	0.1	8.6	1.3	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.4	1.3	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	10.0	0.0	0.0	2.3	4.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	22.6	1.5	0.0	0.0	0.0	5.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	2.3	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	3.4	5.6	2.3	2.0	0.0	4.4	8.6	5.5	0.1	0.1	0.0	0.1	0.3	1.3	0.7	1.3	10.9	2.1	0.7	0.6	1.3	1.2	1.8	1.2	11.9	19.9	0.0	2.9	0.9	6.2	1.2	0.0	0.0	6.8	7.0	5.9	2.1	0.0	3.9	343.6	2.3	0.0	0.0	2.7	0.3	1.0	2.7	0.0	0.0	0.1	0.0	0.0	1.3	0.3	78.5	5.2	0.4	3.3	1.0	0.0	3.4	1.3	0.0	3.2	1.1	8.6	6.5	3.1	10.0	5.2	0.6	0.9	1.7	0.0	1.6
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.2	3.0	6.0	8.5	11.2	10.6	6.4	7.4	8.3	7.7	11.1	6.3	4.8	11.3	5.5	7.4	9.1	5.8	9.2	7.3	10.7	8.9	8.8	11.0	6.0	4.9	8.6	10.2	6.3	11.3	5.9	6.9	11.9	8.2	11.4	10.3	26.5	11.3	7.3	3.9	3.2	9.8	9.7	6.6	6.5	4.8	4.5	6.3	10.8	5.0	8.5	7.0	5.3	6.9	5.4	7.9	3.7	5.0	11.5	4.2	5.4	6.2	11.2	4.8	4.4	20.7	7.3	9.7	7.5	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4	3.0	4.3	4.4	6.8	2.1	7.9	7.1	7.6	12.0	3.4	3.5	17.7	5.3	5.0	3.9	10.8	5.3	5.8	0.0	2.3	5.9	3.8	5.6	2.3	3.8	3.5	9.5	2.4	8.0	4.1	5.9	12.0	3.9	3.3	13.6	2.3	5.6	4.3	2.9	8.1	13.4	7.6	0.0	6.2	1.8	5.5	2.5	6.2	5.1	6.0	6.5
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 123.5;Early spermatids: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.4	3.8	12.5	9.2	13.6	17.1	13.8	8.9	7.2	6.6	5.6	7.7	4.2	3.6	10.5	8.8	9.3	3.2	21.7	10.3	12.1	3.1	7.6	5.6	3.7	8.6	13.6	7.3	6.5	14.5	9.7	6.8	6.4	12.9	9.8	5.1	5.5	5.1	13.9	4.9	3.1	3.9	9.2	6.0	4.7	8.0	9.1	0.7	14.2	10.0	7.5	9.0	4.3	14.9	8.5	12.5	5.4	5.5	9.0	6.5	14.2	7.6	13.3	5.2	2.4	2.9	10.0	4.5	8.0	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0	6.0	4.5	1.9	9.8	4.7	123.5	42.3	12.7	24.1	11.4	14.0	3.9	10.5	18.3	10.3	151.7	8.4	3.8	0.0	10.5	10.9	10.3	17.3	0.0	5.7	5.0	33.4	4.1	7.4	7.6	24.3	26.7	4.4	8.5	14.4	5.6	21.3	9.7	7.6	33.9	12.6	7.9	6.5	8.3	3.0	11.5	7.2	6.4	4.4	6.0	15.9
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11959323	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	16.6	17.0	17.9	18.5	20.9	20.3	16.9	25.7	19.0	16.4	18.1	16.2	21.3	11.6	18.0	15.0	18.7	13.7	13.5	25.5	18.1	13.4	14.6	25.1	16.6	13.4	21.9	12.9	16.9	19.6	38.8	31.8	23.7	19.3	18.0	14.2	10.2	15.1	19.2	58.1	18.4	15.1	21.3	19.5	13.3	18.1	16.8	23.9	27.9	16.8	12.4	15.2	21.3	19.4	9.7	10.1	14.0	13.2	22.8	19.3	9.7	21.4	13.1	23.5	11.1	17.0	18.8	10.8	24.7	18.7	16.3	18.5	12.9	19.1	24.3	11.8	22.9	19.4	14.7	18.1	12.4	25.2	23.6	15.3	14.6	24.2	9.0	15.1	18.9	20.5	17.4	17.1	10.7	23.8	18.6	18.1	17.2	29.1	21.0	19.9	8.5	17.0	8.4	6.3	21.3	10.6	17.6	24.8	7.5	17.6	24.9	8.2	16.7	22.1	15.4	13.7	15.1	12.3	13.9	20.0	23.1	14.1	19.6	15.0	6.6	15.2	23.0	15.9	11.7	16.6	13.3	7.7	14.0	15.2	9.5	19.3	9.7	13.8	14.7	10.1	8.6	17.9	15.3	3.6	22.8	13.2	6.1	9.9	9.7	17.9	20.9	25.7	19.0	18.1	13.4	21.9	12.9	19.3	23.9	65.5	50.8	26.5	58.2	63.1	66.5	188.1	30.6	62.9	67.1	22.7	45.2	55.8	21.6	33.6	26.3	35.8	25.1	23.3	33.7	29.2	48.3	58.2	51.0	50.0	24.2	60.4	56.9	30.1	18.5	22.9	40.9	32.0	23.6	27.9	30.5	80.7	36.7	31.6	47.0	17.9	50.6	51.8	47.2	72.0	59.0	76.9	105.2	47.3	32.2	47.7
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.9	7.1	16.8	12.1	14.6	18.0	16.6	18.8	12.8	12.7	16.8	6.5	15.3	16.8	12.7	17.0	9.9	13.8	20.6	15.2	19.3	16.3	14.1	35.9	26.5	11.8	13.0	18.0	19.2	14.6	13.1	12.8	14.3	17.4	37.2	12.8	28.2	47.5	15.5	7.4	14.9	23.4	10.5	15.3	12.8	21.0	16.9	19.6	14.5	12.6	20.5	12.8	17.7	16.3	42.5	23.5	8.3	21.8	26.4	13.7	11.2	16.7	10.9	38.2	27.1	16.7	13.2	22.3	20.0	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6	50.6	38.5	34.3	22.6	19.7	74.8	58.2	22.9	32.1	20.5	19.2	58.9	51.8	21.6	25.0	51.8	24.5	18.7	70.0	17.5	50.1	30.9	20.6	47.5	21.2	26.0	47.7	20.8	28.3	22.2	33.0	32.2	24.7	55.6	47.7	26.9	29.1	20.0	17.5	48.4	16.5	69.2	32.3	25.0	42.9	48.2	22.5	27.2	35.5	30.2	17.1
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 21.6;Cone photoreceptor cells: 41.2;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"REH: 23.7;U-698: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA					"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.4	2.4	7.6	3.5	6.0	7.3	2.7	12.7	9.3	2.3	1.9	2.0	4.3	2.2	4.0	2.3	1.8	2.2	2.1	3.5	7.6	4.2	1.6	1.7	2.4	3.7	3.0	5.8	4.0	3.2	2.6	4.8	1.8	4.2	2.4	2.1	3.7	2.7	2.4	3.8	4.1	2.2	3.2	3.2	3.5	2.2	7.4	3.2	7.3	7.7	0.6	3.4	2.8	2.0	1.2	0.7	8.5	1.8	0.8	0.9	0.4	3.0	0.9	12.5	6.1	1.5	1.7	5.1	1.2	1.1	1.8	2.3	3.9	0.7	12.5	1.3	1.5	2.6	1.3	7.7	1.2	2.8	3.1	5.7	4.5	4.7	1.3	1.1	3.5	2.7	1.7	0.9	2.6	1.7	1.7	1.1	13.0	9.3	3.5	1.4	1.8	13.3	5.3	3.4	3.2	1.2	23.7	6.0	2.7	0.7	2.1	8.4	3.4	1.6	0.6	0.7	3.1	1.9	3.2	3.2	4.3	4.3	1.4	1.6	6.5	5.6	33.7	0.5	3.6	0.8	8.5	1.3	1.4	0.8	1.5	0.4	1.2	0.4	0.8	0.5	0.9	0.9	0.7	2.4	0.8	1.8	0.7	0.4	0.4	7.6	6.0	12.7	9.3	7.6	4.2	3.0	5.8	4.2	3.2	0.0	11.9	1.5	2.8	4.4	21.6	3.4	5.1	1.4	6.8	5.2	41.2	2.3	1.7	1.5	6.4	2.4	1.6	23.3	1.7	1.3	3.6	3.3	1.1	1.5	1.8	14.3	0.0	1.3	4.1	6.3	3.4	3.6	3.3	1.0	1.4	3.1	1.8	1.7	5.6	1.0	11.9	6.5	2.5	8.9	15.8	5.5	4.8	2.2	1.7	3.9
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.6	40.1	27.0	30.5	18.4	17.0	34.5	27.9	21.4	33.4	24.4	37.9	25.5	31.0	14.7	29.0	26.5	22.7	29.6	27.7	21.4	58.2	25.1	28.4	32.3	20.6	14.3	25.6	30.0	17.1	16.1	28.9	20.0	22.4	28.5	12.5	24.4	12.5	27.5	28.1	38.5	12.8	52.6	26.2	17.0	30.3	35.2	21.5	19.1	25.0	14.9	30.1	19.0	29.0	12.1	35.1	11.6	21.1	27.6	28.3	34.3	21.5	34.7	15.0	34.6	47.3	31.5	16.4	27.5	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7	8.9	12.5	13.0	9.5	10.3	18.1	8.1	17.8	4.0	5.7	21.0	56.9	38.0	10.0	25.9	8.7	7.9	17.7	0.0	17.8	24.3	16.4	7.4	14.9	19.7	24.7	38.1	16.0	9.2	12.1	15.5	21.3	9.6	15.1	47.7	14.7	13.8	16.9	17.8	31.8	14.7	14.5	32.3	9.7	24.5	23.8	13.6	44.2	14.1	22.7	5.6
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.8	5.4	1.6	2.7	1.4	0.0	0.9	0.4	1.0	1.3	1.7	0.7	0.0	6.4	1.2	1.1	0.3	1.4	0.6	1.6	1.7	0.1	1.4	0.3	0.0	1.1	3.3	0.3	5.5	0.1	0.6	0.0	0.4	0.3	4.1	4.1	4.1	0.9	3.5	3.2	1.7	6.7	0.0	0.3	4.6	1.0	2.1	1.3	0.2	0.0	1.1	1.5	0.2	5.0	10.2	1.3	1.7	0.2	2.1	2.9	0.5	0.1	6.5	2.6	1.3	1.4	1.8	1.4	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1											3.0	5.6	0.0	1.7	0.8	24.4	5.0	0.0	17.4	3.4	3.5	5.9	3.4	8.3	1.0	0.3	5.8	0.0	0.0	0.0	2.1	4.3	1.1	1.1	0.8	6.1	6.4	3.5	4.9	3.9	0.8	3.7	2.5	5.0	0.0	0.3	29.9	0.3	0.0	7.8	12.2	15.2	0.0	3.9	3.6	6.7	0.4	2.3	1.7	0.2	0.4
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116438-5175034	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 18.2;testis: 29.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 19.3;Erythroid cells: 23.3;Spermatocytes: 19.2"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046969			Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.3	0.3	0.3	0.3	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.3	1.2	0.0	0.6	0.6	0.3	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	2.6	0.3	0.0	0.4	0.4	0.3	0.4	0.1	0.3	0.3	0.3	18.2	0.6	0.7	0.9	0.3	0.3	0.0	29.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.9	1.2	1.9	1.0	0.2	0.4	0.1	2.2	0.9	2.2	1.6	0.4	0.2	2.3	1.9	0.1	0.6	0.4	0.8	1.0	2.2	1.6	1.2	1.9	1.0	0.7	0.8	0.5	1.5	1.3	1.7	1.3	0.9	1.2	0.5	2.8	1.1	0.5	0.1	0.2	2.5	0.3	1.8	0.5	0.3	0.5	2.5	1.8	0.7	1.5	0.7	0.1	1.4	1.9	0.2	0.5	0.7	0.9	2.1	1.0	0.1	3.3	3.7	2.1	2.2	1.2	0.9	3.2	2.0	1.4	2.0	1.6	1.5	0.0	0.1	2.6	0.1	0.4	0.9	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.9	0.3	0.4	1.9	0.2	1.0	1.2	0.1	0.1	0.3	0.6	0.5	0.3	0.3	0.1	0.3	0.3	0.3	0.3	6.0	9.6	0.5	0.9	9.6	7.9	1.6	7.6	5.3	5.7	3.5	11.8	0.5	3.3	0.0	19.3	2.9	0.0	23.3	0.0	0.8	1.5	2.4	0.0	2.6	2.3	1.6	0.0	4.9	4.9	9.4	1.7	5.7	3.3	0.0	0.0	4.7	0.1	0.0	2.5	2.8	9.8	6.5	0.6	19.2	5.5	9.2	0.6	0.7	0.0	0.9
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892094-8964514	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	17.8	16.8	23.9	25.8	22.9	37.6	21.3	28.7	24.5	21.2	26.3	16.2	18.4	17.7	23.5	16.4	24.4	20.3	18.7	23.7	22.8	20.8	16.5	21.3	21.0	30.5	19.6	22.6	22.5	24.0	44.4	19.7	19.3	16.2	18.5	27.4	16.0	18.4	20.3	42.2	25.2	21.5	22.7	15.3	22.9	22.6	43.3	16.5	68.8	19.5	22.3	35.1	23.9	31.7	7.5	9.8	5.5	7.8	3.9	8.7	1.8	12.4	23.3	20.6	15.4	11.7	15.0	14.2	17.2	14.8	16.1	13.7	20.8	15.3	30.1	11.0	19.9	9.2	15.6	31.5	20.6	27.0	19.7	12.5	25.0	15.7	42.9	16.9	27.5	16.2	12.9	13.1	17.5	20.7	12.4	22.8	45.5	24.1	33.4	16.4	23.8	40.3	5.3	14.4	15.8	13.5	35.9	23.1	27.5	11.3	24.5	19.5	12.0	19.3	18.2	9.5	22.0	18.1	12.3	19.5	17.5	17.9	26.8	12.9	16.2	39.6	46.0	16.3	16.0	14.0	5.5	3.3	3.8	7.1	3.2	8.7	5.9	6.6	8.2	3.3	7.5	8.0	6.8	5.2	3.9	7.8	9.8	7.0	1.8	23.9	22.9	28.7	24.5	22.8	20.8	19.6	22.6	16.2	16.5	32.8	46.2	23.4	19.2	41.3	47.4	61.8	20.4	46.8	46.6	27.9	23.6	18.4	5.0	21.1	217.0	25.9	29.6	46.7	28.3	12.6	24.0	27.0	25.5	34.2	17.5	41.3	40.6	25.2	28.0	84.4	23.6	28.5	18.6	16.2	46.7	25.0	27.8	28.8	32.5	11.8	41.6	6.5	29.2	29.9	31.9	43.7	17.6	26.6	47.0	32.7
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514419	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	19.4	21.9	21.0	20.6	20.6	21.6	18.1	27.3	21.6	21.4	23.9	13.8	19.5	20.2	22.1	17.4	22.3	17.4	15.5	17.4	19.7	18.2	28.2	26.4	17.0	25.4	21.8	15.2	21.9	16.7	42.6	43.2	29.1	29.7	16.7	18.9	10.7	19.9	17.9	24.3	17.8	32.1	19.2	29.3	30.3	17.7	27.5	26.1	28.9	24.1	12.7	20.9	22.3	18.4	16.7	10.6	38.1	15.1	9.5	11.9	6.9	11.2	16.2	9.1	16.0	16.6	18.7	12.6	16.2	19.2	15.8	18.7	10.8	7.5	11.9	12.5	18.5	17.8	21.8	12.4	12.1	18.7	10.4	8.2	21.9	15.1	11.0	17.1	14.7	14.9	14.4	14.6	13.9	23.6	14.7	15.3	8.5	12.5	14.5	14.8	23.1	9.4	5.8	10.4	12.9	7.5	8.5	16.9	17.8	15.0	26.5	11.6	10.6	17.0	25.5	21.2	20.1	14.0	18.0	17.3	16.4	9.2	50.5	21.3	11.3	23.4	13.1	13.1	29.7	15.8	38.1	13.3	22.4	11.1	12.4	10.7	16.5	11.4	11.1	10.6	16.7	11.9	10.7	22.7	9.5	15.1	9.9	8.5	6.9	21.0	20.6	27.3	21.6	19.7	18.2	21.8	15.2	29.7	26.1	89.3	104.5	61.4	35.4	25.6	51.6	61.8	48.4	147.2	88.7	45.4	64.8	49.9	21.6	44.4	53.0	44.9	70.6	23.3	44.6	38.3	35.3	38.8	83.3	45.5	40.2	31.8	51.2	53.4	59.1	12.4	49.8	49.2	38.8	52.3	54.2	53.3	45.7	54.3	58.0	40.7	75.6	45.3	42.6	86.1	47.1	36.3	88.0	47.9	55.0	52.6
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	18.2	21.6	19.2	19.6	16.1	16.9	4.4	10.5	14.1	12.0	13.9	9.9	8.5	12.3	5.9	23.9	35.9	12.4	32.9	19.1	20.1	15.4	23.6	14.2	20.9	8.9	13.6	12.3	10.4	14.6	8.6	28.7	27.2	17.2	18.5	8.3	17.2	10.0	18.5	13.3	8.8	4.9	20.3	6.5	11.9	9.7	26.2	7.9	11.4	15.1	10.9	10.2	44.2	12.2	12.0	36.0	11.8	6.9	19.7	18.3	14.2	17.3	11.3	9.2	10.7	15.7	13.1	5.5	9.1	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0	38.7	32.0	23.8	26.8	42.8	35.0	73.6	43.3	30.8	36.4	26.2	35.3	31.0	6.6	26.8	13.0	39.8	39.2	70.0	22.8	21.8	35.1	30.2	24.4	55.5	29.3	35.0	25.8	52.8	43.4	13.1	30.8	38.0	32.1	33.3	42.5	32.0	27.0	35.7	46.3	20.3	29.3	32.3	39.6	31.4	69.2	48.3	39.0	26.1	36.7	34.3
USP9Y	DFFRY	ENSG00000114374	"Ubiquitin specific peptidase 9, Y-linked"	O00507	Y	12701231-12860839	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 16.2;RT4: 8.7"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	1.2	2.2	1.4	0.9	3.1	1.7	1.1	9.6	4.0	0.0	1.6			1.4	0.0	8.6	4.4	0.0	3.8	2.4	1.8	3.4	2.9	2.2	2.2	1.4	2.1		0.0	2.7	0.0	4.8	1.7		9.3	4.8		2.3	7.6	2.8	2.0	1.8	0.0	1.5	2.2	1.5	2.9			2.8		4.5	3.2	0.0	2.4	2.0	0.1	0.2	0.5	2.7	0.2	0.0	2.3	0.0	0.0	0.0	0.0	2.5	7.2	7.2	3.6	3.9	0.0	0.0	4.1	0.0	6.0	0.0	0.0	0.0	0.0	3.3	2.3	0.0	2.6	0.0	7.1	4.0	0.0	0.0	6.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.5	0.0	4.0	0.0	1.5	0.0	0.0	0.0	2.0	0.9	16.2	8.7	2.8	0.0	0.0	0.0	2.1	5.4	0.0	0.0	5.5	4.4	0.0	0.0	3.2	0.0	3.8	7.1	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.2	2.7	1.2	2.2	1.5	0.3	2.4	2.2	1.3	0.1	0.5	0.0	2.0	1.6	0.2											23.8	19.7	0.8	7.4	10.4	22.1	24.6	2.5	21.4	15.9	19.2	60.9	4.3	1.7	4.1	0.4	5.8	0.0	0.0	0.0	1.1	9.3	11.2	2.3	0.2	2.5	25.4	0.0	5.5	6.9	0.0	11.5	7.3	3.3	2.8	0.3	8.1	3.7	0.0	14.5	5.4	24.9	0.0	7.6	3.2	1.7	10.2	2.9	10.0	0.0	9.9
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 682.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 98.9"					"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.5	27.1	8.9	25.5	98.9	58.9	9.9	39.1	34.0	19.3	32.8	11.2	12.1	8.3	21.2	48.9	13.6	9.8	12.3	15.3	22.0	11.7	29.9	7.5	37.5	53.9	15.6	14.6	11.3	34.0	8.2	26.6	22.9	52.3	20.8	11.8	9.8	19.8	37.6	38.2	10.7	30.0	16.1	14.6	26.1	19.4	23.7	41.2	19.0	9.2	18.2	22.1	17.1	12.5	19.0	15.0	20.6	17.8	18.1	25.9	9.3	23.7	14.7	12.0	11.1	7.3	67.4	25.3	13.3	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6	53.6	38.2	37.9	58.4	75.2	11.2	20.0	119.8	32.1	40.9	102.9	7.9	64.0	53.0	183.3	4.8	87.9	36.0	46.7	112.2	211.1	138.5	58.9	55.3	682.4	166.1	9.5	64.4	119.7	79.0	8.3	146.4	85.1	109.6	129.8	41.2	64.7	107.2	24.6	161.9	160.1	16.9	58.2	95.7	23.7	24.7	97.9	33.1	47.3	51.3	46.5
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 69.6;Club cells: 19.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3"														"Secreted to blood"	NA	NA	150000000					"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	69.6	19.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	9.7	0.1	0.0	0.0	0.6	9.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.8	9.1	22.7	10.1	2.7	5.0	14.1	12.0	9.3	19.2	19.2	10.9	15.8	40.4	8.1	7.1	11.8	17.6	21.2	15.7	26.5	23.0	11.3	25.1	6.0	11.1	3.0	48.4	15.8	2.7	2.8	14.5	10.6	3.9	13.3	31.0	21.4	25.6	16.5	18.1	38.4	20.8	14.5	12.1	17.5	36.0	39.7	13.7	8.8	16.4	16.0	9.1	10.6	10.8	8.1	11.9	12.4	19.2	7.1	8.8	7.8	15.1	12.0	13.4	15.8	39.1	13.7	21.2	10.4	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9	3.0	2.9	30.5	11.8	14.9	12.3	10.6	15.3	42.8	13.6	14.0	7.9	19.7	10.0	9.8	13.3	11.3	2.4	93.5	16.8	39.6	10.4	5.3	27.7	2.4	16.3	9.5	2.9	6.2	9.7	10.8	5.2	11.5	11.8	12.6	8.0	5.2	7.6	0.0	9.2	8.4	6.6	19.4	11.3	141.1	122.1	12.2	12.6	26.7	11.2	8.4
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.2	9.5	1.1	6.3	7.1	13.1	19.7	13.2	13.2	9.1	9.3	19.4	15.1	17.4	17.4	11.6	15.0	10.9	13.8	14.4	13.7	31.2	9.3	19.6	7.7	13.8	11.3	16.6	11.7	7.2	17.2	14.6	21.1	10.9	26.2	2.4	19.2	11.2	15.2	8.2	0.1	12.7	12.0	22.6	4.8	19.0	4.8	11.8	15.1	11.7	3.8	0.1	20.9	12.5	10.5	10.9	8.8	10.2	14.6	0.2	30.3	8.2	0.2	16.5	13.0	9.3	7.4	20.6	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2	20.8	9.1	14.1	11.3	8.8	1.0	17.1	10.2	30.8	15.9	17.4	0.0	19.7	13.3	22.0	16.8	15.0	2.9	46.7	22.8	18.5	8.5	8.1	16.3	6.8	17.1	0.0	6.3	4.9	17.7	6.5	5.5	21.4	10.1	49.5	4.3	4.6	21.8	7.8	5.6	7.1	3.6	6.5	13.7	8.3	12.6	7.3	16.2	12.7	7.1	12.2
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 469.4;Late spermatids: 1260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.0	16.7	12.3	13.2	16.3	15.1	12.8	11.6	13.9	17.3	19.1	8.9	18.0	19.4	8.3	11.2	12.1	12.0	11.4	9.9	14.0	16.9	23.4	15.1	10.1	15.4	12.3	18.8	26.6	13.5	14.9	10.0	10.6	15.5	14.2	21.3	18.3	29.0	12.4	6.8	25.4	12.7	6.6	28.6	14.4	20.5	12.9	24.8	14.7	17.0	13.8	6.7	11.4	14.0	12.6	11.4	12.9	20.1	10.7	17.7	10.3	7.1	9.0	18.8	23.9	10.2	14.2	11.7	12.1	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1	6.0	29.4	27.3	13.1	6.0	34.9	7.1	20.4	56.2	26.1	14.0	135.5	38.6	26.6	25.3	469.4	15.8	62.6	23.3	28.7	31.8	13.8	24.2	17.4	37.6	29.7	30.2	21.4	25.2	25.0	1260.7	20.4	23.9	13.5	47.7	27.2	28.4	29.0	71.9	24.4	60.6	112.4	12.9	10.5	91.2	49.8	9.5	47.9	33.7	27.6	26.7
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 165.0;Suprabasal keratinocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.4	5.6	21.5	11.9	18.9	9.5	42.6	17.9	13.8	10.0	10.0	10.2	17.8	33.9	6.7	7.8	9.4	17.5	14.7	6.9	12.8	12.1	12.0	13.3	9.0	6.8	2.0	20.1	13.3	3.1	7.5	4.7	16.6	10.4	6.2	13.2	21.6	23.6	17.4	3.4	20.5	10.9	32.4	10.0	6.4	19.8	16.9	7.3	7.9	30.5	8.1	10.6	12.1	14.3	8.7	26.8	9.0	9.6	7.1	18.1	12.6	7.3	14.2	5.5	16.5	44.8	7.7	11.1	12.6	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0	47.6	26.9	13.5	165.0	156.6	1.8	53.3	66.2	49.5	56.9	40.1	0.0	78.4	11.6	22.0	18.2	13.0	34.2	23.3	11.8	154.6	38.6	75.9	6.9	86.3	14.7	1.6	58.5	9.2	1.6	29.5	10.9	8.4	16.9	2.8	32.0	9.3	20.6	25.7	10.3	6.7	4.4	6.5	22.1	42.6	52.9	167.1	114.8	13.1	37.4	55.3
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.1	26.8	35.4	3.3	25.6	24.6	13.5	14.1	17.0	15.3	14.3	15.0	16.1	20.0	5.0	30.2	18.6	10.7	23.9	16.3	21.6	34.5	14.3	44.5	35.6	13.0	18.8	24.0	19.4	19.0	24.8	25.3	45.4	17.0	20.7	18.8	20.3	48.2	23.1	13.0	43.2	4.0	28.9	12.0	6.4	20.6	39.3	5.3	22.0	30.6	10.3	12.1	32.9	21.4	9.5	49.5	23.5	24.7	22.8	19.0	22.0	26.6	20.7	7.4	12.2	30.2	18.1	12.7	15.4	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8	95.3	107.5	34.5	38.1	100.2	81.8	197.8	58.6	61.6	53.4	85.5	141.4	27.8	72.9	26.9	18.6	99.1	21.1	210.2	21.1	25.9	54.1	46.4	50.8	62.5	49.6	79.4	56.4	45.4	101.9	17.5	57.2	66.8	35.4	48.7	24.6	57.2	32.3	29.8	52.3	16.5	92.4	12.9	41.9	139.7	38.1	118.8	23.8	69.2	21.9	46.1
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.9	8.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.6	0.1	11.5	1.5	0.0	0.8	0.2	6.5	0.0	0.0	0.0	7.5	0.0	3.5	18.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.0	0.0	6.0	0.1	0.1	7.3	4.4	0.2	0.0	0.0	9.3	0.0	0.7	23.9	9.4	1.5	6.5	0.6	0.8	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.8	8.1	1.1	57.3	56.7	30.6	5.3	9.1	0.0	151.2	11.9	0.0	11.7	0.9	0.5	34.4	0.0	8.0	5.6	1.1	12.9	0.0	0.0	2.9	1.6	31.2	0.6	1.0	1.9	0.9	0.0	1.7	1.0	57.9	60.6	3.3	42.1	5.6	0.7	101.2	12.9	4.4	0.4	6.6	4.8	13.0	0.0	51.8	6.4
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 31.6;testis: 26.7"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 178.0;Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.9;AN3-CA: 4.5;HAP1: 6.8;NTERA-2: 11.9;SiHa: 5.8;SuSa: 5.3;U-2 OS: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA077678: AB_2686850"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.9	5.0	3.9	0.9	4.3	0.8	1.7	3.0	3.6	1.5	0.7	1.7	13.9	1.0	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1.0	2.3	3.0	5.7	0.9	2.2	14.0	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1.0	1.2	26.7	3.5	0.0	1.7	0.0	0.8	1.3	1.9	1.1	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.0	5.9	4.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	6.8	0.1	0.2	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	2.8	0.8	0.0	1.2	0.2	1.9	1.8	5.8	0.0	0.7	5.3	0.5	0.0	0.3	0.0	5.2	0.0	1.2	0.0	4.0	0.0	1.6	0.0	2.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.1	1.9	0.4	0.1	0.1	0.0	0.0	0.0	0.1	3.9	4.3	3.0	3.6	3.9	3.4	2.3	3.0	3.9	3.5	0.0	2.9	0.8	4.6	3.3	24.5	178.0	2.5	0.0	5.7	7.0	13.7	0.2	5.0	1.4	4.2	3.1	0.0	0.0	0.0	0.3	3.1	4.8	5.8	41.5	0.1	33.4	0.0	17.8	0.6	14.6	14.7	0.5	0.0	0.0	0.0	20.7	0.3	0.0	41.1	3.1	40.9	6.5	3.3	30.2	48.2	1.0	0.1	0.0	0.0	1.1
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 135.9;Mucus-secreting cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;K-562: 22.2;TIME: 21.4;WM-115: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA					"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.4	2.9	2.8	0.9	0.4	0.5	0.2	4.4	19.9	0.7	0.0	0.1	0.2	4.8	0.4	1.0	0.0	0.0	2.9	4.7	0.0	0.4	2.5	0.4	4.0	1.2	1.4	0.2	0.2	22.2	0.7	0.0	0.6	0.0	0.5	0.2	1.2	5.1	0.3	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.1	1.0	2.7	1.4	1.6	21.4	0.2	1.9	0.2	0.1	3.6	3.1	0.7	0.0	1.2	14.5	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2	0.0	1.1	0.0	0.1	0.0	0.2	0.7	2.5	5.3	1.2	7.0	0.0	0.0	135.9	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	6.5	4.6	0.0	0.0	0.0	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.1	2.9	0.4	0.5	0.3	0.0	0.3	0.7	0.8	0.4	0.0	0.0	13.3	0.1
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.6	10.6	7.4	5.2	9.3	9.2	6.8	8.3	8.8	6.6	7.9	7.5	14.0	9.7	5.6	14.1	9.2	19.5	10.3	13.3	11.4	12.1	8.3	11.2	9.4	17.5	6.8	4.4	5.8	8.3	16.9	7.2	13.4	10.2	29.1	11.5	5.9	11.5	11.1	11.3	10.6	3.4	4.5	31.7	12.0	7.0	8.9	8.6	14.8	17.3	2.2	5.2	8.2	41.6	8.8	16.8	12.4	4.2	33.4	9.9	11.7	10.4	4.2	13.6	8.3	10.0	12.2	0.8	7.5	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5	23.8	19.9	7.5	24.5	31.8	24.5	71.8	45.9	10.7	17.0	27.9	55.0	21.8	36.5	16.7	18.9	25.5	14.8	0.0	32.4	2.7	17.3	35.8	3.5	77.6	43.8	38.1	22.8	64.4	64.9	9.4	30.0	17.5	28.7	10.8	25.5	21.3	37.0	14.0	34.3	38.8	48.9	6.5	13.0	10.9	14.7	34.5	19.2	20.3	18.3	32.8
WWP2	AIP2	ENSG00000198373	"WW domain containing E3 ubiquitin protein ligase 2"	O00308	16	69762306-69941741	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.81e-2)"	"prognostic favorable (5.87e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.62e-1)"	21.8	27.0	18.0	21.5	24.4	31.0	19.1	19.1	29.0	18.9	22.8	29.7	19.6	23.9	31.9	17.2	21.3	23.9	19.3	12.2	18.0	17.4	26.9	14.9	22.7	20.6	20.0	15.9	22.5	27.3	34.1	15.9	24.1	21.7	17.7	20.7	28.1	29.0	19.4	17.6	24.4	25.3	15.3	19.7	26.2	24.1	17.0	18.4	25.2	19.7	14.6	37.7	16.5	17.3	7.1	8.2	28.0	15.5	4.6	9.5	8.1	12.6	12.8	8.4	8.7	7.1	5.9	12.8	8.5	9.9	14.7	15.5	11.9	9.8	14.8	9.3	14.9	8.1	15.2	11.0	12.9	11.2	6.9	9.5	8.2	7.8	20.4	13.3	14.4	12.2	8.7	9.6	20.1	14.1	8.3	13.5	12.8	12.4	8.4	9.4	22.4	7.9	16.2	11.7	10.6	5.7	17.8	7.0	25.1	14.3	12.4	10.4	11.4	36.4	10.5	7.8	5.7	16.4	17.9	13.4	11.5	16.9	16.1	10.2	19.4	12.9	22.3	12.4	12.3	20.3	18.2	10.0	15.6	9.5	12.9	7.3	6.4	7.1	7.6	8.2	7.1	7.5	5.1	28.0	4.6	15.5	4.0	6.3	8.1	18.0	24.4	19.1	29.0	18.0	17.4	20.0	15.9	21.7	18.4	8.9	32.3	13.8	7.1	6.5	8.7	8.0	20.4	26.8	14.8	14.0	9.8	8.0	1.7	10.3	20.1	10.8	24.8	23.3	17.3	7.2	6.1	7.5	20.8	12.1	11.3	9.5	16.1	14.7	24.8	21.3	9.5	15.1	10.1	13.6	14.2	11.0	14.2	19.0	8.1	8.4	6.0	12.9	22.8	5.6	6.1	5.3	16.7	12.5	14.3	8.6
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.8	18.1	8.6	13.0	10.0	22.8	23.5	10.2	15.0	10.1	12.3	20.8	19.7	13.1	15.9	15.5	13.0	17.9	5.9	20.1	14.4	12.6	10.8	23.3	18.7	18.4	9.9	25.9	5.8	8.5	16.9	15.3	17.0	11.4	9.7	10.9	19.2	27.2	8.0	8.8	8.7	22.8	7.1	9.8	15.6	14.5	3.7	7.5	20.1	14.2	17.3	4.8	8.3	14.6	21.3	4.9	7.1	13.3	10.7	8.7	9.1	23.8	10.9	21.8	11.5	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9	23.8	44.5	82.7	23.7	25.4	2.1	4.4	30.6	28.1	20.5	50.6	3.9	10.5	8.3	17.4	2.2	46.7	36.0	23.3	18.3	17.5	51.6	34.7	31.2	29.9	30.5	0.0	51.0	46.1	44.1	1.2	17.3	62.3	37.1	37.9	31.3	15.0	19.2	26.4	25.1	31.0	0.7	12.9	57.9	0.7	0.7	19.4	1.9	124.6	27.3	23.0
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999030-75110994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.5;T-reg: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;monocytes: 1.4;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 54.8;MOLT-4: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved					NA	NA					"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	10.0	9.5	13.4	8.1	13.7	5.2	16.6	6.3	16.5	13.2	12.5	8.1	6.7	8.3	10.7	9.1	28.2	10.0	11.3	9.1	11.6	14.6	5.6	12.8	12.8	8.7	9.1	9.4	10.1	6.1	12.2	6.2	9.7	7.8	9.1	10.8	7.2	7.5	7.5	58.6	14.5	11.2	10.1	8.8	2.8	11.8	21.6	4.9	80.1	21.4	16.9	13.3	14.0	15.5	0.2	0.8	4.5	1.4	0.0	5.2	0.3	3.2	4.7	8.1	8.4	8.7	6.8	28.1	3.9	5.5	5.4	5.3	7.6	10.0	0.8	3.0	8.5	5.2	7.7	3.9	5.4	4.3	7.8	2.2	16.8	1.5	13.8	6.9	8.0	54.8	6.1	4.5	5.6	4.6	9.6	8.8	20.7	8.0	2.6	4.1	30.8	39.2	29.6	11.3	9.3	5.1	17.4	3.0	5.1	7.6	9.1	10.9	11.7	6.2	8.3	2.2	7.0	21.9	7.7	6.0	3.7	6.5	6.6	2.3	15.6	15.8	9.3	4.9	9.0	3.8	4.5	1.4	0.9	0.2	1.1	1.3	0.2	1.5	0.2	0.8	0.0	0.0	0.2	1.2	0.0	1.1	0.0	5.2	0.3	13.4	13.7	6.3	16.5	11.6	14.6	9.1	9.4	7.8	4.9	8.9	11.8	0.8	13.7	14.2	10.6	15.7	15.3	14.7	12.5	3.5	49.1	5.5	0.0	6.8	17.8	23.3	12.9	0.0	10.9	9.4	10.4	10.2	35.8	11.6	8.3	3.2	19.0	9.2	5.9	10.1	6.4	4.0	13.5	7.2	14.4	11.9	14.8	11.5	3.9	5.1	5.5	0.0	7.6	11.3	16.1	17.1	3.8	6.4	9.8	25.7
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284307-30367692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.8	8.0	10.0	9.3	10.6	9.7	16.2	12.8	10.0	5.8	16.1	10.5	7.6	11.3	7.7	9.7	14.2	5.2	8.7	8.4	9.6	6.1	19.3	24.0	7.9	12.0	10.0	7.4	5.8	14.0	8.0	9.9	9.6	11.0	7.0	14.3	5.8	10.5	13.7	17.5	11.5	12.7	8.3	10.5	9.2	12.4	20.6	9.1	7.9	13.3	9.8	10.9	9.4	11.8	1.3	5.8	1.4	1.1	0.7	2.4	0.5	6.7	2.5	2.0	1.8	2.3	1.6	10.7	2.6	2.7	2.9	3.9	1.2	11.3	7.1	6.8	2.1	7.5	6.6	6.7	4.4	3.1	6.9	6.1	4.4	5.2	3.3	1.2	3.4	8.4	2.5	7.5	2.0	4.9	3.0	2.4	5.5	5.4	14.2	3.1	2.6	6.9	9.0	4.7	6.7	3.1	6.0	4.4	12.1	8.7	14.6	7.0	6.6	5.2	22.0	4.3	12.4	5.9	13.8	2.7	2.8	4.8	2.7	5.4	24.3	20.8	9.3	3.1	7.4	4.1	0.5	0.9	1.1	1.0	0.9	1.5	1.3	1.2	1.4	0.8	0.8	0.7	1.1	1.4	0.7	1.1	5.8	2.4	0.5	10.0	10.6	12.8	10.0	9.6	6.1	10.0	7.4	11.0	9.1	8.9	6.7	5.2	5.8	14.2	11.0	3.2	17.8	2.7	4.5	15.7	39.3	7.5	6.6	4.9	4.3	4.5	42.5	0.0	8.9	8.0	4.4	5.5	3.5	33.4	9.4	1.6	30.1	9.2	18.9	7.6	2.6	11.2	11.8	9.0	14.5	4.3	6.7	14.4	2.1	26.0	5.7	6.5	7.2	20.9	7.9	16.6	9.6	8.7	19.6	10.8
ZSWIM2	"MEX, MGC33890, ZZZ2"	ENSG00000163012	"Zinc finger SWIM-type containing 2"	Q8NEG5	2	186827835-186849208	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 17.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 41.7;Late spermatids: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.1;U-138 MG: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.00e-1)"													0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.6	0.0	0.2	0.0	0.0	0.0
